Citrus Sinensis ID: 027476
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 223 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.713 | 0.407 | 0.371 | 7e-28 | |
| Q66HA1 | 850 | Mitogen-activated protein | yes | no | 0.686 | 0.18 | 0.303 | 9e-20 | |
| Q16584 | 847 | Mitogen-activated protein | yes | no | 0.686 | 0.180 | 0.303 | 9e-20 | |
| Q80XI6 | 850 | Mitogen-activated protein | yes | no | 0.659 | 0.172 | 0.312 | 9e-20 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.695 | 0.169 | 0.294 | 2e-19 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.686 | 0.114 | 0.325 | 3e-19 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.690 | 0.165 | 0.346 | 1e-18 | |
| Q62073 | 579 | Mitogen-activated protein | no | no | 0.932 | 0.359 | 0.280 | 1e-18 | |
| Q5RFL3 | 606 | Mitogen-activated protein | no | no | 0.932 | 0.343 | 0.280 | 2e-18 | |
| O43318 | 606 | Mitogen-activated protein | no | no | 0.932 | 0.343 | 0.280 | 2e-18 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 124 bits (310), Expect = 7e-28, Method: Compositional matrix adjust.
Identities = 77/207 (37%), Positives = 102/207 (49%), Gaps = 48/207 (23%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++SR+ H N+V+FI ACK+P V I+TE + G LR YL P L I + ALDI+
Sbjct: 138 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDIS 197
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
R ME LHS G+IHRDLK NL+L D VK+ADFG + E+ GTYRWMAPE
Sbjct: 198 RGMEYLHSQGVIHRDLKSNNLLLN-DEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPE 256
Query: 120 NMRPS-------------------------------------AEN-----LPED----LA 133
++ AE LP LA
Sbjct: 257 MIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALA 316
Query: 134 LIVTSCWKEDPNERPNFSQIIQMLLHY 160
++ CW E+P++RP+FS I+ +L Y
Sbjct: 317 HLIKRCWSENPSKRPDFSNIVAVLEKY 343
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q66HA1|M3K11_RAT Mitogen-activated protein kinase kinase kinase 11 OS=Rattus norvegicus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 97.1 bits (240), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 61/214 (28%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ + + H N++ C +EP + +V E GG L + L R + HV + +A+ IA
Sbjct: 168 LFAMLAHPNIIALKAVCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIA 224
Query: 60 RAMECLHSHG---IIHRDLKPENLILTA-------DHKTVKLADFGLAREESLTEMMTAE 109
R M LH +IHRDLK N++L +HKT+K+ DFGLARE T M+A
Sbjct: 225 RGMHYLHCEALVPVIHRDLKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA- 283
Query: 110 TGTYRWMAPENMR----------------------------------------------P 123
GTY WMAPE ++ P
Sbjct: 284 AGTYAWMAPEVIKASTFSKGSDVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLP 343
Query: 124 SAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
PE A ++ CW +DP+ RP+F+ I+Q L
Sbjct: 344 IPSTCPEPFAQLMADCWAQDPHRRPDFASILQQL 377
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q16584|M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 97.1 bits (240), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 61/214 (28%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ + + H N++ C +EP + +V E GG L + L R + HV + +A+ IA
Sbjct: 167 LFAMLAHPNIIALKAVCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIA 223
Query: 60 RAMECLHSHG---IIHRDLKPENLILTA-------DHKTVKLADFGLAREESLTEMMTAE 109
R M LH +IHRDLK N++L +HKT+K+ DFGLARE T M+A
Sbjct: 224 RGMHYLHCEALVPVIHRDLKSNNILLLQPIESDDMEHKTLKITDFGLAREWHKTTQMSA- 282
Query: 110 TGTYRWMAPENMR----------------------------------------------P 123
GTY WMAPE ++ P
Sbjct: 283 AGTYAWMAPEVIKASTFSKGSDVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLP 342
Query: 124 SAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
PE A ++ CW +DP+ RP+F+ I+Q L
Sbjct: 343 IPSTCPEPFAQLMADCWAQDPHRRPDFASILQQL 376
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q80XI6|M3K11_MOUSE Mitogen-activated protein kinase kinase kinase 11 OS=Mus musculus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 97.1 bits (240), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 65/208 (31%), Positives = 91/208 (43%), Gaps = 61/208 (29%)
Query: 7 HRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECL 65
H N++ C +EP + +V E GG L + L R + HV + +A+ IAR M L
Sbjct: 174 HPNIIALKAVCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYL 230
Query: 66 HSHG---IIHRDLKPENLILTA-------DHKTVKLADFGLAREESLTEMMTAETGTYRW 115
H +IHRDLK N++L +HKT+K+ DFGLARE T M+A GTY W
Sbjct: 231 HCEALVPVIHRDLKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAW 289
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
MAPE ++ P P
Sbjct: 290 MAPEVIKASTFSKGSDVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCP 349
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQML 157
E A ++ CW +DP+ RP+F+ I+Q L
Sbjct: 350 EPFAQLMADCWAQDPHRRPDFASILQQL 377
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 95.5 bits (236), Expect = 2e-19, Method: Composition-based stats.
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 49/204 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++SR+RH N+V + AC P + +TE L GG+L L + + + +++ + A+ IA
Sbjct: 711 ILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK-MNMQLYKKLAIQIA 769
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+ M LH G+IHRD+K NL+L +H VK+ DFGL++ +S + MT G+ WM+PE
Sbjct: 770 QGMNYLHLSGVIHRDIKSLNLLLD-EHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPE 828
Query: 120 ---------------------------------------------NMRPSAENL-PEDLA 133
++RP N P L+
Sbjct: 829 LLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLS 888
Query: 134 LIVTSCWKEDPNERPNFSQIIQML 157
++ +CW +DP +RP+F++I+ +L
Sbjct: 889 HLIQACWHQDPLKRPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 95.1 bits (235), Expect = 3e-19, Method: Composition-based stats.
Identities = 68/209 (32%), Positives = 94/209 (44%), Gaps = 56/209 (26%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPR------CLDIHVAIGF 54
++ ++H NLV G P M IV E L G L + L++ +P LD + +
Sbjct: 1123 LLGSLQHPNLVTCYGYSLNP-MCIVMEFLPSGNLFE-LIHSKPSEQQQSIKLDSTLILAI 1180
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYR 114
A DIAR M+ LH+ IIHRDLK NL++ H +K+AD G+ARE S T+ MT GT
Sbjct: 1181 AFDIARGMQHLHTRNIIHRDLKSSNLLMD-KHFNIKIADLGIARETSFTQTMTT-IGTVA 1238
Query: 115 WMAPENMRPSAENL-------------------------PEDLALIVTS----------- 138
W APE +R + N P + ++V S
Sbjct: 1239 WTAPEILRHESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDNC 1298
Query: 139 ----------CWKEDPNERPNFSQIIQML 157
CW EDPN+RP+F +I L
Sbjct: 1299 DPNWKKLVVWCWSEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 72/208 (34%), Positives = 103/208 (49%), Gaps = 54/208 (25%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRC-LDIHVAIGFALDI 58
+M R+RH N+V F+GA + P + IVTE L G+L + L RP+ +D I ALD+
Sbjct: 717 IMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRIL--HRPKSHIDERRRIKMALDV 774
Query: 59 ARAMECLHSH--GIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET-GTYRW 115
A M CLH+ I+HRDLK NL L ++ VK+ DFGL+R + T + + T GT W
Sbjct: 775 AMGMNCLHTSTPTIVHRDLKTPNL-LVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEW 833
Query: 116 MAPENMR--PSAEN----------------------------------------LPEDL- 132
MAPE +R PS E +P++L
Sbjct: 834 MAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELD 893
Query: 133 ---ALIVTSCWKEDPNERPNFSQIIQML 157
I+ CW+ DPN RP+F+Q+ ++L
Sbjct: 894 PVVGRIILECWQTDPNLRPSFAQLTEVL 921
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q62073|M3K7_MOUSE Mitogen-activated protein kinase kinase kinase 7 OS=Mus musculus GN=Map3k7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 93.2 bits (230), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 74/264 (28%), Positives = 113/264 (42%), Gaps = 56/264 (21%)
Query: 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHV-AIGFALDIAR 60
+SRV H N+VK GAC PV +V E GG+L L P A+ + L ++
Sbjct: 81 LSRVNHPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 139
Query: 61 AMECLHS---HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ LHS +IHRDLKP NL+L A +K+ DFG A + + MT G+ WMA
Sbjct: 140 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMA 197
Query: 118 PENMR-----------------------------------------------PSAENLPE 130
PE P +NLP+
Sbjct: 198 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 257
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLHYIST-NSAPEPVILPRMFSSENAVLPPESPG 189
+ ++T CW +DP++RP+ +I++++ H + A EP+ P +S E S G
Sbjct: 258 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQYSDEGQSNSATSTG 317
Query: 190 TSSLMPPRDDSERNPNTRMEDQPG 213
+ + + S ++ +T ME P
Sbjct: 318 SFMDIASTNTSNKS-DTNMEQVPA 340
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q5RFL3|M3K7_PONAB Mitogen-activated protein kinase kinase kinase 7 OS=Pongo abelii GN=MAP3K7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 92.8 bits (229), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 74/264 (28%), Positives = 113/264 (42%), Gaps = 56/264 (21%)
Query: 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHV-AIGFALDIAR 60
+SRV H N+VK GAC PV +V E GG+L L P A+ + L ++
Sbjct: 81 LSRVNHPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 139
Query: 61 AMECLHS---HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ LHS +IHRDLKP NL+L A +K+ DFG A + + MT G+ WMA
Sbjct: 140 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMA 197
Query: 118 PENMR-----------------------------------------------PSAENLPE 130
PE P +NLP+
Sbjct: 198 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 257
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLHYIST-NSAPEPVILPRMFSSENAVLPPESPG 189
+ ++T CW +DP++RP+ +I++++ H + A EP+ P +S E S G
Sbjct: 258 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQYSDEGQSNSATSTG 317
Query: 190 TSSLMPPRDDSERNPNTRMEDQPG 213
+ + + S ++ +T ME P
Sbjct: 318 SFMDIASTNTSNKS-DTNMEQVPA 340
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O43318|M3K7_HUMAN Mitogen-activated protein kinase kinase kinase 7 OS=Homo sapiens GN=MAP3K7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 92.8 bits (229), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 74/264 (28%), Positives = 113/264 (42%), Gaps = 56/264 (21%)
Query: 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHV-AIGFALDIAR 60
+SRV H N+VK GAC PV +V E GG+L L P A+ + L ++
Sbjct: 81 LSRVNHPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 139
Query: 61 AMECLHS---HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ LHS +IHRDLKP NL+L A +K+ DFG A + + MT G+ WMA
Sbjct: 140 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMA 197
Query: 118 PENMR-----------------------------------------------PSAENLPE 130
PE P +NLP+
Sbjct: 198 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 257
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLHYIST-NSAPEPVILPRMFSSENAVLPPESPG 189
+ ++T CW +DP++RP+ +I++++ H + A EP+ P +S E S G
Sbjct: 258 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQYSDEGQSNSATSTG 317
Query: 190 TSSLMPPRDDSERNPNTRMEDQPG 213
+ + + S ++ +T ME P
Sbjct: 318 SFMDIASTNTSNKS-DTNMEQVPA 340
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 223 | ||||||
| 224055579 | 351 | predicted protein [Populus trichocarpa] | 1.0 | 0.635 | 0.706 | 1e-106 | |
| 224140853 | 351 | predicted protein [Populus trichocarpa] | 1.0 | 0.635 | 0.702 | 1e-105 | |
| 225456892 | 352 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.633 | 0.670 | 1e-102 | |
| 225452312 | 352 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.633 | 0.692 | 1e-102 | |
| 255560936 | 353 | protein kinase atn1, putative [Ricinus c | 1.0 | 0.631 | 0.675 | 1e-101 | |
| 449440628 | 353 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.631 | 0.663 | 3e-98 | |
| 356511702 | 346 | PREDICTED: serine/threonine-protein kina | 0.973 | 0.627 | 0.666 | 3e-96 | |
| 356516635 | 352 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.633 | 0.644 | 1e-95 | |
| 255540509 | 351 | protein kinase atn1, putative [Ricinus c | 0.995 | 0.632 | 0.644 | 2e-95 | |
| 357461809 | 352 | Serine/threonine protein kinase TNNI3K [ | 1.0 | 0.633 | 0.623 | 1e-92 |
| >gi|224055579|ref|XP_002298549.1| predicted protein [Populus trichocarpa] gi|222845807|gb|EEE83354.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 388 bits (997), Expect = e-106, Method: Compositional matrix adjust.
Identities = 195/276 (70%), Positives = 207/276 (75%), Gaps = 53/276 (19%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M+SRV+H+NLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCL++ VA GFALDIAR
Sbjct: 76 MLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLEMRVAFGFALDIAR 135
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE- 119
AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 136 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 195
Query: 120 ----------------------------------------------------NMRPSAEN 127
N+RPSAEN
Sbjct: 196 YSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 255
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPES 187
LPEDLALIVTSCWKEDPN RPNFSQIIQMLLHY+ST SAPEP I R+F+SENAV PPES
Sbjct: 256 LPEDLALIVTSCWKEDPNARPNFSQIIQMLLHYLSTISAPEPAIPARIFTSENAVFPPES 315
Query: 188 PGTSSLMPPRDDSERNPNTRMEDQPGGFFFCFKQCY 223
PGTSSLM RDDS P T++ED+P GFFFCF QCY
Sbjct: 316 PGTSSLMAVRDDSGETPRTQIEDKPRGFFFCFNQCY 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224140853|ref|XP_002323793.1| predicted protein [Populus trichocarpa] gi|222866795|gb|EEF03926.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 387 bits (994), Expect = e-105, Method: Compositional matrix adjust.
Identities = 194/276 (70%), Positives = 208/276 (75%), Gaps = 53/276 (19%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M+SRV+H+NLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLD+ +A+GFALDIAR
Sbjct: 76 MLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDMRLAVGFALDIAR 135
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE- 119
AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 136 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 195
Query: 120 ----------------------------------------------------NMRPSAEN 127
N+RPSAEN
Sbjct: 196 YSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 255
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPES 187
LPEDLALIVTSCWKEDPN RPNFSQIIQMLLHY+ST SAP+PVI R+F+SENAVLPPES
Sbjct: 256 LPEDLALIVTSCWKEDPNARPNFSQIIQMLLHYLSTISAPKPVIPARIFTSENAVLPPES 315
Query: 188 PGTSSLMPPRDDSERNPNTRMEDQPGGFFFCFKQCY 223
PGTSSLM RDD P T++ED+P FFFCF QCY
Sbjct: 316 PGTSSLMAVRDDLGETPRTQIEDKPKSFFFCFNQCY 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456892|ref|XP_002280504.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|147839295|emb|CAN63533.1| hypothetical protein VITISV_011081 [Vitis vinifera] gi|297733702|emb|CBI14949.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 375 bits (963), Expect = e-102, Method: Compositional matrix adjust.
Identities = 185/276 (67%), Positives = 202/276 (73%), Gaps = 53/276 (19%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M+SRV+H+NL KFIG CKEPVMVIVTELLLGGTLRKYLLNMRPRCLD +A+GFALDIAR
Sbjct: 77 MLSRVQHKNLAKFIGVCKEPVMVIVTELLLGGTLRKYLLNMRPRCLDARIAVGFALDIAR 136
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE- 119
AMECLHSHGIIHRDLKPENLILTADHKTVKL DFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 137 AMECLHSHGIIHRDLKPENLILTADHKTVKLVDFGLAREESLTEMMTAETGTYRWMAPEL 196
Query: 120 ----------------------------------------------------NMRPSAEN 127
N+RPSAEN
Sbjct: 197 YSTVTLRHGEKKHYNNKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 256
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPES 187
LPE+LA+I+TSCWKEDPN RPNFSQI+QMLLHY+ST S PEP I R+F+SEN +LPPES
Sbjct: 257 LPEELAIILTSCWKEDPNARPNFSQIVQMLLHYLSTISPPEPAIPSRVFASENTILPPES 316
Query: 188 PGTSSLMPPRDDSERNPNTRMEDQPGGFFFCFKQCY 223
PGTSSLM RDDS P +ME++P GFFFCF QCY
Sbjct: 317 PGTSSLMAVRDDSGETPKVKMENKPKGFFFCFNQCY 352
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452312|ref|XP_002272486.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|296087594|emb|CBI34850.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 375 bits (963), Expect = e-102, Method: Compositional matrix adjust.
Identities = 191/276 (69%), Positives = 202/276 (73%), Gaps = 53/276 (19%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M+SRV+H+NLVKFIGACKEPVMVIVTELLLGGTLRKYLLN+RPRCLD VA+GFALDIAR
Sbjct: 77 MLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNLRPRCLDTKVAVGFALDIAR 136
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE- 119
AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 137 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
Query: 120 ----------------------------------------------------NMRPSAEN 127
NMRPSAE+
Sbjct: 197 YSTVTLRHGEKKHYNHKVDAYSFAIVLWELVHNKLPFEGMSNLQAAYAAAFKNMRPSAED 256
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPES 187
LPEDLALIVTSCWKEDPN RPNFSQIIQMLLHY+ST S PEP++ PR+F+SENAVLPPES
Sbjct: 257 LPEDLALIVTSCWKEDPNTRPNFSQIIQMLLHYLSTISPPEPMVPPRVFTSENAVLPPES 316
Query: 188 PGTSSLMPPRDDSERNPNTRMEDQPGGFFFCFKQCY 223
PGTSSLM RD S P T ME P G F CF CY
Sbjct: 317 PGTSSLMAVRDGSGETPKTSMETNPRGCFSCFNHCY 352
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560936|ref|XP_002521481.1| protein kinase atn1, putative [Ricinus communis] gi|223539380|gb|EEF40971.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 372 bits (954), Expect = e-101, Method: Compositional matrix adjust.
Identities = 187/277 (67%), Positives = 208/277 (75%), Gaps = 54/277 (19%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M+SRV+H+NLVKFIGACKEPVMVIVTELLLGGTLRKYLLN+RPR L++HVAIGFALDIAR
Sbjct: 77 MLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNLRPRSLELHVAIGFALDIAR 136
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE- 119
AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 137 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
Query: 120 ----------------------------------------------------NMRPSAEN 127
N+RPSA++
Sbjct: 197 YSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSADD 256
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPES 187
LPE++A+IVTSCW+EDPN RPNF+QIIQMLL ++ST S PEPVI R+F+SENAVLPPES
Sbjct: 257 LPEEMAMIVTSCWQEDPNARPNFTQIIQMLLRFLSTISPPEPVIPARIFTSENAVLPPES 316
Query: 188 PGTSSLMPPRDDSERNPNTRMED-QPGGFFFCFKQCY 223
PGTSSLM RDDS P ++MED +P GFFFCF QCY
Sbjct: 317 PGTSSLMAVRDDSGETPKSKMEDNKPRGFFFCFNQCY 353
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440628|ref|XP_004138086.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449524138|ref|XP_004169080.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 363 bits (932), Expect = 3e-98, Method: Compositional matrix adjust.
Identities = 183/276 (66%), Positives = 199/276 (72%), Gaps = 53/276 (19%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M+SRV+H+NLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLD VA+GFALDIAR
Sbjct: 78 MLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDTRVAVGFALDIAR 137
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE- 119
AMECLHSHGIIHRDLKPENL+LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 138 AMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 197
Query: 120 ----------------------------------------------------NMRPSAEN 127
N+RPSAEN
Sbjct: 198 YSTVTLRQGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAEN 257
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPES 187
LPE+LA+I+TSCW+ED N RPNFSQIIQMLL+Y+ T S PEPVI R+F+SEN V PPES
Sbjct: 258 LPEELAIILTSCWQEDANARPNFSQIIQMLLNYLYTISPPEPVIPSRIFTSENTVFPPES 317
Query: 188 PGTSSLMPPRDDSERNPNTRMEDQPGGFFFCFKQCY 223
PGTSSLM RDDS P +ME+ P G FFC CY
Sbjct: 318 PGTSSLMAVRDDSGDTPKAKMENNPRGCFFCSNDCY 353
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511702|ref|XP_003524562.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 356 bits (914), Expect = 3e-96, Method: Compositional matrix adjust.
Identities = 184/276 (66%), Positives = 197/276 (71%), Gaps = 59/276 (21%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M+SRV+H+NLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRP+CLD+ VAIGFALDIAR
Sbjct: 77 MLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPKCLDMTVAIGFALDIAR 136
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE- 119
AMECLHSHGIIHRDLKP+NLILT DHK VKLADFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 137 AMECLHSHGIIHRDLKPDNLILTDDHKAVKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
Query: 120 ----------------------------------------------------NMRPSAEN 127
N RPSAE+
Sbjct: 197 YSTVTLRQGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNTRPSAED 256
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPES 187
LPEDLALIVTSCWKEDPN+RPNFSQIIQMLL Y+ST S PEPV+ R+ SSENAVLPPES
Sbjct: 257 LPEDLALIVTSCWKEDPNDRPNFSQIIQMLLRYLSTVSPPEPVVPLRITSSENAVLPPES 316
Query: 188 PGTSSLMPPRDDSERNPNTRMEDQPGGFFFCFKQCY 223
PGTS+LM RD S + GFFFCF QCY
Sbjct: 317 PGTSALMLGRDGSRETTTAK------GFFFCFNQCY 346
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516635|ref|XP_003526999.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 355 bits (910), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 178/276 (64%), Positives = 199/276 (72%), Gaps = 53/276 (19%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M+SRV+H+NLVKFIGACKEPVMVIVTELLLGGTLRKYL +MRP+CLD HVAIGFALDIAR
Sbjct: 77 MLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLFSMRPKCLDRHVAIGFALDIAR 136
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE- 119
AMECLHSHGIIHRDLKP+NL+LT D KTVKLADFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 137 AMECLHSHGIIHRDLKPDNLLLTEDQKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
Query: 120 ----------------------------------------------------NMRPSAEN 127
N+RPSAEN
Sbjct: 197 YSTVTLRQGEKKHYNHKVDAYSFAIVLWELLHNKVPFEGMSNLQAAYAAAFKNVRPSAEN 256
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPES 187
LPE+LA+I+TSCW+EDPN RPNF+QIIQMLL+Y+ T + PEP+I R+FSSEN VLPPES
Sbjct: 257 LPEELAVILTSCWQEDPNARPNFTQIIQMLLNYLYTVAPPEPMIPSRIFSSENTVLPPES 316
Query: 188 PGTSSLMPPRDDSERNPNTRMEDQPGGFFFCFKQCY 223
PGTSSLM RDD+ P + E +P GF CF QCY
Sbjct: 317 PGTSSLMAKRDDTGDTPRAKDEIKPNGFLCCFSQCY 352
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540509|ref|XP_002511319.1| protein kinase atn1, putative [Ricinus communis] gi|223550434|gb|EEF51921.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 354 bits (908), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 178/276 (64%), Positives = 199/276 (72%), Gaps = 54/276 (19%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M+SRV+H+NLVKF+GACKEPVMVIVTELL GGTLRKYLLNMRPRCL+ VAIGFALDIAR
Sbjct: 77 MLSRVQHKNLVKFVGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLETRVAIGFALDIAR 136
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE- 119
AMECLHSHGIIHRDLKPENL+LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 137 AMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
Query: 120 ----------------------------------------------------NMRPSAEN 127
N+RPSAE+
Sbjct: 197 YSTVTLRQGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAED 256
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPES 187
LPE+L++I+TSCWKEDPN RPNFSQII MLL++++ + PEP I R+F+SEN LPPES
Sbjct: 257 LPEELSIILTSCWKEDPNTRPNFSQIIHMLLNHLAVIAPPEPAIPHRIFTSENTFLPPES 316
Query: 188 PGTSSLMPPRDDSERNPNTRMEDQPGGFFFCFKQCY 223
PGTSSLM D E P +ME+QP G FFCFKQCY
Sbjct: 317 PGTSSLMAVHDTGE-TPKAKMENQPKGLFFCFKQCY 351
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461809|ref|XP_003601186.1| Serine/threonine protein kinase TNNI3K [Medicago truncatula] gi|355490234|gb|AES71437.1| Serine/threonine protein kinase TNNI3K [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 344 bits (883), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 172/276 (62%), Positives = 196/276 (71%), Gaps = 53/276 (19%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M+SRV+H+NLVKFIGACKEPVMVIVTELL GGTLRKYLLNMRP+CLD HVAIGFALDI+R
Sbjct: 77 MLSRVQHKNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPKCLDTHVAIGFALDISR 136
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE- 119
AMECLHSHGIIHRDLKP+NL+LT DH TVKLADFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 137 AMECLHSHGIIHRDLKPDNLLLTEDHGTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
Query: 120 ----------------------------------------------------NMRPSAEN 127
N+RP+A++
Sbjct: 197 YSTVTLRQGEKKHYNHKVDAYSFAIVFWELLHNKVPFEGMSNLQAAYAAAFKNVRPNADH 256
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPES 187
LPE+LA+I+TSCW+ED N RPNF+QIIQMLL+Y+ T S P P I R+F+SEN +LPPES
Sbjct: 257 LPEELAVILTSCWQEDANARPNFTQIIQMLLNYLYTVSPPTPAIPSRIFTSENTLLPPES 316
Query: 188 PGTSSLMPPRDDSERNPNTRMEDQPGGFFFCFKQCY 223
PGTSSLM RDD+ P + E +P GF CF QCY
Sbjct: 317 PGTSSLMAKRDDTGDTPRVKDEIKPNGFLCCFSQCY 352
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 223 | ||||||
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.533 | 0.343 | 0.815 | 2.2e-80 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.533 | 0.334 | 0.789 | 4.1e-77 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.533 | 0.337 | 0.781 | 5.2e-77 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.533 | 0.357 | 0.697 | 1.7e-41 | |
| TAIR|locus:2173674 | 405 | AT5G66710 [Arabidopsis thalian | 0.529 | 0.291 | 0.571 | 4.7e-32 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.744 | 0.440 | 0.463 | 9.8e-32 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.618 | 0.252 | 0.405 | 5e-28 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.627 | 0.340 | 0.436 | 1.2e-26 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.569 | 0.308 | 0.450 | 1.2e-24 | |
| UNIPROTKB|D4A600 | 518 | Map3k7 "Mitogen-activated prot | 0.515 | 0.222 | 0.352 | 1.3e-22 |
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 506 (183.2 bits), Expect = 2.2e-80, Sum P(2) = 2.2e-80
Identities = 97/119 (81%), Positives = 103/119 (86%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTEXXXXXXXXXXXXNMRPRCLDIHVAIGFALDIAR 60
M+SRV+H+NLVKFIGACKEPVMVIVTE N+RP CL+ VAIGFALDIAR
Sbjct: 71 MLSRVQHKNLVKFIGACKEPVMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALDIAR 130
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
MECLHSHGIIHRDLKPENL+LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 131 GMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 189
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 4.1e-77, Sum P(2) = 4.1e-77
Identities = 94/119 (78%), Positives = 105/119 (88%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTEXXXXXXXXXXXXNMRPRCLDIHVAIGFALDIAR 60
M+S+V+H+NLVKFIGACKEP+MVIVTE ++RP+ LDI +A+GFALDIAR
Sbjct: 77 MLSKVQHKNLVKFIGACKEPMMVIVTELLLGGTLRKYLVSLRPKRLDIRLAVGFALDIAR 136
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
AMECLHSHGIIHRDLKPENLIL+ADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 137 AMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 195
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 488 (176.8 bits), Expect = 5.2e-77, Sum P(2) = 5.2e-77
Identities = 93/119 (78%), Positives = 104/119 (87%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTEXXXXXXXXXXXXNMRPRCLDIHVAIGFALDIAR 60
M+SRV+H+NLVKFIGACKEP+MVIVTE ++RP LDI VA+G+ALDIAR
Sbjct: 77 MLSRVQHKNLVKFIGACKEPIMVIVTELLLGGTLRKYLVSLRPGSLDIRVAVGYALDIAR 136
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
AMECLHSHG+IHRDLKPE+LILTAD+KTVKLADFGLAREESLTEMMTAETGTYRWMAPE
Sbjct: 137 AMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 195
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 440 (159.9 bits), Expect = 1.7e-41, P = 1.7e-41
Identities = 83/119 (69%), Positives = 100/119 (84%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTEXXXXXXXXXXXXNMRPRCLDIHVAIGFALDIAR 60
MMSRV+H NLVKFIGACK+P+MVIVTE ++RP+ L + +A+ FALDIAR
Sbjct: 69 MMSRVQHHNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDIAR 128
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
A+ CLH++GIIHRDLKP+NL+LT +HK+VKLADFGLAREES+TEMMTAETGTYRWMAPE
Sbjct: 129 ALHCLHANGIIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAPE 187
|
|
| TAIR|locus:2173674 AT5G66710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 351 (128.6 bits), Expect = 4.7e-32, P = 4.7e-32
Identities = 68/119 (57%), Positives = 88/119 (73%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTEXXXXXXXXXXXXNMRPRCLDIHVAIGFALDIAR 60
++S+ RH N+V+FIGAC EP ++I+TE ++RP+ LD+ ++I FALDIAR
Sbjct: 123 LLSKFRHENIVRFIGACIEPKLMIITELMEGNTLQKFMLSVRPKPLDLKLSISFALDIAR 182
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
ME L+++GIIHRDLKP N++LT D K VKLADFGLAREE+ MT E GTYRWMAPE
Sbjct: 183 GMEFLNANGIIHRDLKPSNMLLTGDQKHVKLADFGLAREET-KGFMTFEAGTYRWMAPE 240
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 348 (127.6 bits), Expect = 9.8e-32, P = 9.8e-32
Identities = 82/177 (46%), Positives = 106/177 (59%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTEXXXXXXXXXXXXNMRPRCLDIHVAIGFALDIAR 60
++S ++H N+V+F+GAC EP ++IVTE N RP LD+ V++ FALDI+R
Sbjct: 100 VLSSMKHENIVRFVGACIEPQLMIVTELVRGGTLQRFMLNSRPSPLDLKVSLSFALDISR 159
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE- 119
AME LHS GIIHRDL P N+++T D K VKLADFGLARE++L M T E GTYRWMAPE
Sbjct: 160 AMEYLHSKGIIHRDLNPRNVLVTGDMKHVKLADFGLAREKTLGGM-TCEAGTYRWMAPEV 218
Query: 120 -NMRPS--AENLPEDLALIVTSC----WKEDPNERPNFSQIIQMLLHYISTNSAPEP 169
+ P E D + V S W N+ P FS+I + + Y N P
Sbjct: 219 CSREPLRIGEKKHYDQKIDVYSFALIFWSLLTNKTP-FSEIPSISIPYF-VNQGKRP 273
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 269 (99.8 bits), Expect = 5.0e-28, Sum P(2) = 5.0e-28
Identities = 58/143 (40%), Positives = 84/143 (58%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTEXXXXXXXXXXXXNMRPRC-LDIHVAIGFALDI 58
+M +VRH+N+V+F+GAC + P + IVTE + +C + + ALD+
Sbjct: 334 IMRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLH--KQKCAFKLQTLLKVALDV 391
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAP 118
A+ M LH + IIHRDLK NL++ +H VK+ADFG+AR + + +MTAETGTYRWMAP
Sbjct: 392 AKGMSYLHQNNIIHRDLKTANLLMD-EHGLVKVADFGVARVQIESGVMTAETGTYRWMAP 450
Query: 119 ENMRPSAENLPEDLALIVTSCWK 141
E + N D+ W+
Sbjct: 451 EVIEHKPYNHKADVFSYAIVLWE 473
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 300 (110.7 bits), Expect = 1.2e-26, P = 1.2e-26
Identities = 62/142 (43%), Positives = 89/142 (62%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTEXXXXXXXXXXXXNMRPRCLDIHVAIGFALDIA 59
M++ ++H N+V+FIGAC++P V IVTE + R + + +A+ ALD+A
Sbjct: 182 MLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 241
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
R M +H IHRDLK +NL+++AD K++K+ADFG+AR E TE MT ETGTYRWMAPE
Sbjct: 242 RGMAYVHGRNFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 300
Query: 120 NMRPSAENLPEDLALIVTSCWK 141
++ A N D+ W+
Sbjct: 301 MIQHRAYNQKVDVYSFGIVLWE 322
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 281 (104.0 bits), Expect = 1.2e-24, P = 1.2e-24
Identities = 59/131 (45%), Positives = 85/131 (64%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTEXXXXXXXXXXXXNMRPRCLDIHVAIGFALDIA 59
M++ ++H N+V+FIGAC +P V IVTE + R + + +A+ ALD+A
Sbjct: 183 MLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVA 242
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
R M +H IHRDLK +NL+++AD +++K+ADFG+AR E TE MT ETGTYRWMAPE
Sbjct: 243 RGMAYVHERNFIHRDLKSDNLLISAD-RSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 301
Query: 120 NM--RPSAENL 128
+ RP + +
Sbjct: 302 MIQHRPYTQKV 312
|
|
| UNIPROTKB|D4A600 Map3k7 "Mitogen-activated protein kinase kinase kinase 7" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 167 (63.8 bits), Expect = 1.3e-22, Sum P(2) = 1.3e-22
Identities = 43/122 (35%), Positives = 60/122 (49%)
Query: 2 MSRVRHRNLVKFIGACKEPVMVIVTEXXXXXXXXXXX-XNMRPRCLDIHVAIGFALDIAR 60
+SRV H N+VK GAC PV +++ P H A+ + L ++
Sbjct: 81 LSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH-AMSWCLQCSQ 139
Query: 61 AMECLHS---HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ LHS +IHRDLKP NL+L A +K+ DFG A + + MT G+ WMA
Sbjct: 140 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMA 197
Query: 118 PE 119
PE
Sbjct: 198 PE 199
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_I000876 | hypothetical protein (351 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 223 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-37 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-22 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-09 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-07 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-06 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.003 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 8e-46
Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 52/207 (25%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M ++ H N+VK +G C +EP+M IV E + GG L YL RP+ L + + FAL I
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLM-IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQI 112
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG--TYRWM 116
AR ME L S IHRDL N L ++ VK++DFGL+R+ + + G RWM
Sbjct: 113 ARGMEYLESKNFIHRDLAARN-CLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM 171
Query: 117 APE----------------------------------------------NMRPSAENLPE 130
APE P N P
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPP 231
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQML 157
+L ++ CW EDP +RP FS+++++L
Sbjct: 232 ELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-45
Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 55/208 (26%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA--IGFALD 57
+M ++ H N+VK +G C +E + IV E + GG L YL RP+ + ++ + FAL
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQ 110
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG--TYRW 115
IAR ME L S IHRDL N L ++ VK++DFGL+R+ + G RW
Sbjct: 111 IARGMEYLESKNFIHRDLAARN-CLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRW 169
Query: 116 MAPE----------------------------------------------NMRPSAENLP 129
MAPE P N P
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCP 229
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQML 157
+L ++ CW EDP +RP FS+++++L
Sbjct: 230 PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 8e-44
Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 17/173 (9%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++ H N+VK G + E + +V E GG+L+ L L + L I
Sbjct: 44 ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQIL 102
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWMAP 118
+E LHS+GIIHRDLKPEN++L +D+ VKLADFGL++ S ++ GT +MAP
Sbjct: 103 EGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162
Query: 119 ENMRPSAENLP--------------EDLALIVTSCWKEDPNERPNFSQIIQML 157
E + +L ++ ++DP +RP+ +I++ L
Sbjct: 163 EVLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 7e-42
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 58/210 (27%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M ++ H N+V+ +G C EP+ IVTE + GG L +L L + + AL I
Sbjct: 54 IMKKLSHPNIVRLLGVCTQGEPLY-IVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQI 111
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY---RW 115
A+ ME L S +HRDL N L ++ VK++DFGL+R+ + G +W
Sbjct: 112 AKGMEYLESKNFVHRDLAARN-CLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW 170
Query: 116 MAPE--------------------------------NM----------------RPSAEN 127
MAPE M RP EN
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRP--EN 228
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQML 157
P++L ++ CW DP +RP FS++++ L
Sbjct: 229 CPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 1e-41
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 60/215 (27%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRP-------RCLDIHVA 51
+M ++ H N+V+ +G C +EP+ +V E + GG L YL RP L +
Sbjct: 49 VMKKLGHPNVVRLLGVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL 107
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG 111
+ FA+ IA+ ME L S +HRDL N L + VK++DFGL+R+ + +TG
Sbjct: 108 LSFAIQIAKGMEYLASKKFVHRDLAARN-CLVGEDLVVKISDFGLSRDVYDDDYYRKKTG 166
Query: 112 TY---RWMAPENMR---------------------------------------------- 122
RWMAPE+++
Sbjct: 167 GKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL 226
Query: 123 PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
P E P++L ++ SCW+ DP +RP FS++++ L
Sbjct: 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 8e-37
Identities = 52/205 (25%), Positives = 80/205 (39%), Gaps = 52/205 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ +++H N+V+ ++ + +V E GG L L L A + I
Sbjct: 50 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQIL 107
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
A+E LHS GI+HRDLKPEN++L D VKLADFGLAR+ E +T GT +MAPE
Sbjct: 108 SALEYLHSKGIVHRDLKPENILLDEDG-HVKLADFGLARQLDPGEKLTTFVGTPEYMAPE 166
Query: 120 ------------------------------------------------NMRPSAENLPED 131
P ++ +
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPE 226
Query: 132 LALIVTSCWKEDPNERPNFSQIIQM 156
++ +DP +R + +Q
Sbjct: 227 AKDLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-32
Identities = 64/209 (30%), Positives = 92/209 (44%), Gaps = 57/209 (27%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ R+ H N+V+ I A ++ + +V E GG L YL R L A AL I
Sbjct: 51 ILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQIL 108
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAP 118
R +E LHS+GIIHRDLKPEN++L + VK+ADFGLA++ + +T GT +MAP
Sbjct: 109 RGLEYLHSNGIIHRDLKPENILLDENG-VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
Query: 119 E---------------------------NMRPSAENLPEDLALI---------------- 135
E S EN+ + L LI
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS 227
Query: 136 ---------VTSCWKEDPNERPNFSQIIQ 155
+ C +DP++RP +I+Q
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-28
Identities = 44/128 (34%), Positives = 68/128 (53%), Gaps = 9/128 (7%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
++S ++H N+V++ G+ +E + I E + GG+L LL + L V +
Sbjct: 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGK-LPEPVIRKYTRQ 109
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET---GTYR 114
I + LHS+GI+HRD+K N+++ +D VKLADFG A+ E GT
Sbjct: 110 ILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 115 WMAPENMR 122
WMAPE +R
Sbjct: 169 WMAPEVIR 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-24
Identities = 57/200 (28%), Positives = 82/200 (41%), Gaps = 52/200 (26%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M ++RH L++ C +EP+ IVTEL+ G+L +YL R L + I A +
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIY-IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR--EESLTEMMTAETGTYRWM 116
A M L + IHRDL N +L ++ K+ADFGLAR +E + E +W
Sbjct: 113 ASGMAYLEAQNYIHRDLAARN-VLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 117 APENMR----------------------------------------------PSAENLPE 130
APE P P+
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPK 231
Query: 131 DLALIVTSCWKEDPNERPNF 150
+L I+ CWKEDP++RP F
Sbjct: 232 ELYDIMLDCWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-23
Identities = 57/205 (27%), Positives = 82/205 (40%), Gaps = 50/205 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M + H ++VK IG E + IV EL G LR YL + LD+ I ++ ++
Sbjct: 60 IMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLST 118
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY--RWMAP 118
A+ L S +HRD+ N +L + VKL DFGL+R A G +WMAP
Sbjct: 119 ALAYLESKRFVHRDIAARN-VLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAP 177
Query: 119 E--NMR--------------------------------------------PSAENLPEDL 132
E N R P N P L
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 237
Query: 133 ALIVTSCWKEDPNERPNFSQIIQML 157
++T CW DP++RP F+++ L
Sbjct: 238 YSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 4e-23
Identities = 50/123 (40%), Positives = 70/123 (56%), Gaps = 9/123 (7%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++SR+ H +VK A + + +V E GG L +L + A +A +I
Sbjct: 46 ILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIV 103
Query: 60 RAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAET--GTYRWM 116
A+E LHS GII+RDLKPEN++L AD H +KL DFGLA+E S +E T GT ++
Sbjct: 104 LALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELS-SEGSRTNTFCGTPEYL 160
Query: 117 APE 119
APE
Sbjct: 161 APE 163
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-23
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 61/214 (28%)
Query: 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA--IGFALDIA 59
M+++ H +V+ IG CK +++V EL G L KYL R +I V+ A +A
Sbjct: 50 MAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRR----EIPVSDLKELAHQVA 105
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL---TEMMTAETG---TY 113
M L S +HRDL N++L H+ K++DFG++R +L ++ A T
Sbjct: 106 MGMAYLESKHFVHRDLAARNVLLVNRHQ-AKISDFGMSR--ALGAGSDYYRATTAGRWPL 162
Query: 114 RWMAPE--------------------------------NMR--------------PSAEN 127
+W APE M+ P E
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEE 222
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161
P+++ I+ SCWK P +RP FS++
Sbjct: 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-22
Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 56/204 (27%)
Query: 6 RHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAME 63
H N+VK IG C K+P+ IV EL+ GG+L +L + R L + + +LD A ME
Sbjct: 50 DHPNIVKLIGVCVQKQPIY-IVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGME 107
Query: 64 CLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT----YRWMAPE 119
L S IHRDL N ++ ++ +K++DFG++REE + T G +W APE
Sbjct: 108 YLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEE-GGIYTVSDGLKQIPIKWTAPE 165
Query: 120 NMR----------------------------------------------PSAENLPEDLA 133
+ P+ + PE++
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIY 225
Query: 134 LIVTSCWKEDPNERPNFSQIIQML 157
++ CW DP RP+FS+I L
Sbjct: 226 RLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-22
Identities = 47/122 (38%), Positives = 73/122 (59%), Gaps = 7/122 (5%)
Query: 1 MMSRVRHRNLVKFIGA--CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGF-ALD 57
++ + +H N+VK+ G+ K+ + IV E GG+L+ LL + L I + +
Sbjct: 50 ILKKCKHPNIVKYYGSYLKKDELW-IVMEFCSGGSLKD-LLKSTNQTLT-ESQIAYVCKE 106
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ + +E LHS+GIIHRD+K N++LT+D + VKL DFGL+ + S T+ GT WMA
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKARNTMVGTPYWMA 165
Query: 118 PE 119
PE
Sbjct: 166 PE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-22
Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 56/208 (26%)
Query: 2 MSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
M+ +RH NLV+ +G P+ IVTE + G+L YL + + + +GFALD+
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLY-IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY--RWMA 117
ME L +HRDL N +L ++ K++DFGLA+E S + ++G +W A
Sbjct: 113 EGMEYLEEKNFVHRDLAARN-VLVSEDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTA 167
Query: 118 PENMR----------------------------------------------PSAENLPED 131
PE +R + E P +
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPE 227
Query: 132 LALIVTSCWKEDPNERPNFSQIIQMLLH 159
+ ++ CW+ DP +RP F Q+ + L
Sbjct: 228 VYKVMKDCWELDPAKRPTFKQLREQLAL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-21
Identities = 42/132 (31%), Positives = 67/132 (50%), Gaps = 4/132 (3%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ + H LV + E M +V +LLLGG LR +L + +I
Sbjct: 53 ILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK--FSEEQVKFWICEIV 110
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
A+E LHS GIIHRD+KP+N++L V + DF +A + + + T+ +GT +MAPE
Sbjct: 111 LALEYLHSKGIIHRDIKPDNILLDE-QGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE 169
Query: 120 NMRPSAENLPED 131
+ ++ D
Sbjct: 170 VLCRQGYSVAVD 181
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-21
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 62/216 (28%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++H NLV+ +G C +EP I+TE + G L YL + ++ V + A I+
Sbjct: 55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT------- 112
AME L IHRDL N L ++ VK+ADFGL+R +MT +T T
Sbjct: 115 SAMEYLEKKNFIHRDLAARN-CLVGENHLVKVADFGLSR------LMTGDTYTAHAGAKF 167
Query: 113 -YRWMAPEN--------------------------MRP--------------------SA 125
+W APE+ M P
Sbjct: 168 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERP 227
Query: 126 ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161
E P + ++ +CW+ +P++RP+F++I Q
Sbjct: 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 8e-21
Identities = 60/225 (26%), Positives = 90/225 (40%), Gaps = 72/225 (32%)
Query: 1 MMSRV-RHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRP-----RCLDIHVAI 52
MM + +H+N++ +G C + P+ V+V E G LR +L RP D
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 53 G---------FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT 103
FA +AR ME L S IHRDL N+++T DH +K+ADFGLAR+
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKIADFGLARDIHHI 185
Query: 104 EMMTAETG---TYRWMAPENM--------------------------------------- 121
+ T +WMAPE +
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245
Query: 122 ---------RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
+P N ++L ++ CW E P++RP F Q+++ L
Sbjct: 246 LLKEGYRMEKPQ--NCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 9e-21
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 50/204 (24%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDI--HVAIGFALDI 58
+ ++ H N++K+ + +E + IV E GG L + + + + + + +
Sbjct: 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWMA 117
A++ LHS I+HRD+KP+N+ LT++ VKL DFG+++ S ++ GT +++
Sbjct: 113 CLALKYLHSRKILHRDIKPQNIFLTSNGL-VKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171
Query: 118 PE------------------------NMRP--SAENLPE-------------------DL 132
PE ++ ENL E +L
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSEL 231
Query: 133 ALIVTSCWKEDPNERPNFSQIIQM 156
+V+S ++DP ERP+ +QI+Q
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-20
Identities = 52/211 (24%), Positives = 78/211 (36%), Gaps = 58/211 (27%)
Query: 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLD---IHVAIGFALDI 58
M + H NL++ G +++VTEL G+L L +R L I +A+ I
Sbjct: 50 MHSLDHENLIRLYGVVLTHPLMMVTELAPLGSL---LDRLRKDALGHFLISTLCDYAVQI 106
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYR---- 114
A M L S IHRDL N++L +D VK+ DFGL R E +
Sbjct: 107 ANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA 165
Query: 115 WMAPENMR-----------------------------------------------PSAEN 127
W APE++R E
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA 225
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158
P+D+ ++ CW +P +RP F+ + + L
Sbjct: 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-20
Identities = 60/201 (29%), Positives = 80/201 (39%), Gaps = 54/201 (26%)
Query: 2 MSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
M ++RH LV+ C +EP+ IVTE + G+L +L + + L + + A IA
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRWM 116
M L S IHRDL N IL ++ K+ADFGLAR E TA G +W
Sbjct: 114 EGMAYLESRNYIHRDLAARN-ILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWT 171
Query: 117 APE--NMR--------------------------------------------PSAENLPE 130
APE N P N PE
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPE 231
Query: 131 DLALIVTSCWKEDPNERPNFS 151
+L ++ CW +DP ERP F
Sbjct: 232 ELYDLMLQCWDKDPEERPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 86.7 bits (213), Expect = 6e-20
Identities = 46/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 1 MMSRVRH-RNLVKFIGACKEP-VMVIVTELLLGGTLRKYL-LNMRPRCLDIHVAIGFALD 57
+++ + H N+VK ++ + +V E + GG+L L R L A+
Sbjct: 50 ILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQ 109
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-------ESLTEMMTAET 110
I A+E LHS GIIHRD+KPEN++L D + VKL DFGLA+ S+ + +
Sbjct: 110 ILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169
Query: 111 GTYRWMAPENMR 122
GT +MAPE +
Sbjct: 170 GTPGYMAPEVLL 181
|
Length = 384 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-19
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 55/209 (26%)
Query: 1 MMSRVRHRNLVKFIGACKEP--VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M+++RH NLV+ +G E + IVTE + G+L YL + L + F+LD+
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY--RWM 116
AME L ++ +HRDL N++++ D+ K++DFGL +E S T+ +TG +W
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ----DTGKLPVKWT 166
Query: 117 APENMR-------------------------------------PSAEN---------LPE 130
APE +R P E P
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLH 159
+ ++ CW D RP+F Q+ + L H
Sbjct: 227 VVYDVMKQCWHLDAATRPSFLQLREQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-19
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 58/211 (27%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
++ + H N+V+ IG C K+P+ IV EL+ GG +L PR L + I +
Sbjct: 46 ILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENA 103
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYR---- 114
A ME L S IHRDL N ++T + +K++DFG++REE + + A TG +
Sbjct: 104 AAGMEYLESKHCIHRDLAARNCLVT-EKNVLKISDFGMSREEE--DGVYASTGGMKQIPV 160
Query: 115 -WMAPENMR----------------------------------------------PSAEN 127
W APE + P E
Sbjct: 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPEL 220
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158
P+ + ++ CW+ DP +RP+FS + Q L
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-18
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 55/210 (26%)
Query: 1 MMSRV-RHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
+MS + H N+V +GAC P++VI TE G L +L R L + + F+
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVI-TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY---R 114
+A+ M L S IHRDL N++LT VK+ DFGLAR+ + +
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 115 WMAPENM-----------------------------------------------RPSAEN 127
WMAPE++ E+
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQML 157
P ++ I+ +CW DP +RP F QI+Q++
Sbjct: 269 APAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-18
Identities = 50/126 (39%), Positives = 68/126 (53%), Gaps = 13/126 (10%)
Query: 2 MSRVRHRNLVKFIGA--CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ ++H NLVK+ G +E V I E GGTL + L + R LD HV + L +
Sbjct: 53 LELLKHPNLVKYYGVEVHREKVY-IFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLL 109
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTV-KLADFGLA-----REESLTEMMTAETGTY 113
+ LHSHGI+HRD+KP N+ L DH V KL DFG A ++ E + + GT
Sbjct: 110 EGLAYLHSHGIVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167
Query: 114 RWMAPE 119
+MAPE
Sbjct: 168 AYMAPE 173
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-18
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 61/217 (28%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMR-----PRCLDIHVAIG 53
+MS H N+VK +G C EP +I+ EL+ GG L YL + R P L + +
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLD 110
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTAD----HKTVKLADFGLAREESLTEMMTAE 109
LD+A+ L IHRDL N +++ + VK+ DFGLAR+ ++ E
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170
Query: 110 TG---TYRWMAPENM--------------------------RP----------------- 123
RWMAPE++ +P
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG 230
Query: 124 ---SAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
EN P+ + ++T+CW +DP+ERP F +I ++L
Sbjct: 231 RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 8e-18
Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 21/132 (15%)
Query: 2 MSRVRHRNLVK----FIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
+S+ + +VK F G + +V E L GG L L N+ LD VA + +
Sbjct: 47 LSQAQSPYVVKLYYSFQGKKN---LYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAE 101
Query: 58 IARAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAE------- 109
I A+E LHS+GIIHRDLKP+N+++ ++ H +KL DFGL++ + +
Sbjct: 102 IVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKEDK 159
Query: 110 --TGTYRWMAPE 119
GT ++APE
Sbjct: 160 RIVGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 9e-18
Identities = 52/198 (26%), Positives = 79/198 (39%), Gaps = 51/198 (25%)
Query: 2 MSRVRHRNLVKFIGACK--EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ R+RH++L+ C EPV I+TEL+ G+L +L + + L + I A +A
Sbjct: 56 LKRLRHKHLISLFAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVA 114
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT-YRWMAP 118
M L IHRDL N IL + K+ADFGLAR ++++ Y+W AP
Sbjct: 115 EGMAYLEEQNSIHRDLAARN-ILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAP 173
Query: 119 E---------------------------------------------NMR-PSAENLPEDL 132
E R P P+++
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEI 233
Query: 133 ALIVTSCWKEDPNERPNF 150
I+ CW +P +RP+F
Sbjct: 234 YKIMLECWAAEPEDRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-17
Identities = 56/204 (27%), Positives = 77/204 (37%), Gaps = 53/204 (25%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++ H LV+ G C K+ + IVTE + G L YL R + D+
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVC 110
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRWM 116
M L S IHRDL N L D VK++DFGL+R L + T+ G+ RW
Sbjct: 111 EGMAYLESKQFIHRDLAARN-CLVDDQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWS 168
Query: 117 APE----------------------------------NMRPSAENLPEDLAL-------- 134
PE N + E + + L L
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASE 228
Query: 135 ----IVTSCWKEDPNERPNFSQII 154
I+ SCW E ERP F Q++
Sbjct: 229 KVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-17
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 55/205 (26%)
Query: 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARA 61
M+++ H+NLV+ +G + IV EL+ G L +L + + + F+LD+A
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112
Query: 62 MECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY--RWMAPE 119
ME L S ++HRDL N++++ D K++DFGLAR S M + +W APE
Sbjct: 113 MEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGS----MGVDNSKLPVKWTAPE 167
Query: 120 -----------------------------------------------NMRPSAENLPEDL 132
M P E P D+
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP-PEGCPADV 226
Query: 133 ALIVTSCWKEDPNERPNFSQIIQML 157
+++TSCW+ +P +RP+F ++ + L
Sbjct: 227 YVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-17
Identities = 46/123 (37%), Positives = 64/123 (52%), Gaps = 7/123 (5%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++ H NLV+ G C K+ + IVTE + G L YL + + L + D+
Sbjct: 52 VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVC 110
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRWM 116
AME L S+G IHRDL N L + VK++DFGLAR L + T+ GT +W
Sbjct: 111 EAMEYLESNGFIHRDLAARN-CLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWA 168
Query: 117 APE 119
PE
Sbjct: 169 PPE 171
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-17
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 53/204 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M+ V H ++V+ +G C + ++T+L+ G L Y+ N + + + + + IA+
Sbjct: 62 VMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAK 120
Query: 61 AMECLHSHGIIHRDLKPEN-LILTADHKTVKLADFGLARE-ESLTEMMTAETGTY--RWM 116
M L ++HRDL N L+ T H VK+ DFGLA+ + + AE G +WM
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 117 APENM--------------------------RPSA--------------ENLPE------ 130
A E++ +P E LP+
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTI 238
Query: 131 DLALIVTSCWKEDPNERPNFSQII 154
D+ +++ CW D RP F ++I
Sbjct: 239 DVYMVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-17
Identities = 50/209 (23%), Positives = 81/209 (38%), Gaps = 61/209 (29%)
Query: 9 NLVKFIGACK--EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHV--------AIGFALDI 58
++V+ +G +P +V++ EL+ G L+ YL + RP + I A +I
Sbjct: 70 HVVRLLGVVSTGQPTLVVM-ELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY---RW 115
A M L + +HRDL N ++ D TVK+ DFG+ R+ T+ RW
Sbjct: 129 ADGMAYLAAKKFVHRDLAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
MAPE+++ EN P
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCP 247
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLL 158
+ L ++ CW+ +P RP F +I+ L
Sbjct: 248 DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-17
Identities = 57/217 (26%), Positives = 82/217 (37%), Gaps = 66/217 (30%)
Query: 2 MSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
M + H N+++ G PVM I+TE + G+L K+L + + +G IA
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVM-IITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIA 116
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY------ 113
M+ L +HRDL N IL + K++DFGL+R +E TY
Sbjct: 117 SGMKYLSEMNYVHRDLAARN-ILVNSNLVCKVSDFGLSRRLEDSE------ATYTTKGGK 169
Query: 114 ---RWMAPE--------------------------------NMR--------------PS 124
RW APE +M P
Sbjct: 170 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP 229
Query: 125 AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161
+ P L ++ CW++D NERP FSQI+ L I
Sbjct: 230 PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-17
Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 20/178 (11%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++S+++H N+V+++G + E + I EL+ GG+L K L V + I
Sbjct: 55 LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQIL 112
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+E LH +HRD+K N IL + VKLADFG+A++ + G+ WMAPE
Sbjct: 113 LGLEYLHDRNTVHRDIKGAN-ILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171
Query: 120 NMRPSAE-NLPEDLALIVTSCWK------EDPNERPNFSQI--IQMLLHYISTNSAPE 168
+ L D+ W E +P +SQ+ + + + P
Sbjct: 172 VIAQQGGYGLAADI-------WSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP 222
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-17
Identities = 71/266 (26%), Positives = 107/266 (40%), Gaps = 72/266 (27%)
Query: 1 MMSRV-RHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHV------- 50
MM + +H+N++ +GAC + P+ V+V E G LR+YL RP +D
Sbjct: 70 MMKMIGKHKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPE 128
Query: 51 -------AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT 103
+ A +AR ME L S IHRDL N+++T D+ +K+ADFGLAR+
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN-VMKIADFGLARDVHNI 187
Query: 104 EMMTAETG---TYRWMAPENMR-------------------------------PSAE--- 126
+ T +WMAPE + P E
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247
Query: 127 ------------NLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPR 174
N +L +I+ CW P++RP F Q+++ L ++ S E + L
Sbjct: 248 LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSV 307
Query: 175 MFSSENAVLPPESPGTSSLMPPRDDS 200
F + P P + S DDS
Sbjct: 308 PFEQYS----PGCPDSPSSCSSGDDS 329
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 8e-17
Identities = 39/126 (30%), Positives = 66/126 (52%), Gaps = 7/126 (5%)
Query: 2 MSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ ++H N+VK+IG+ + + I+ E G+LR+ + P + + + +
Sbjct: 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQ 110
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA-REESLTEMMTAETGTYRWMAPE 119
+ LH G+IHRD+K N++ T D VKLADFG+A + +++ + GT WMAPE
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
Query: 120 --NMRP 123
M
Sbjct: 170 VIEMSG 175
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 9e-17
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 69/220 (31%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPR-----CLDIHVAIG 53
+MS+ H+N+V+ IG + P I+ EL+ GG L+ +L RPR L + +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTAD--HKTVKLADFGLAREESLTE------- 104
A D+A+ + L + IHRD+ N +LT + K+ADFG+AR+
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 105 -MMTAETGTYRWMAPENM-------------------------------RPSAE------ 126
M+ +WM PE R + E
Sbjct: 181 AMLPI-----KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235
Query: 127 ---------NLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
P + I+T CW+ P +RPNF+ I++ +
Sbjct: 236 GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-16
Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 7/122 (5%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ + H N++K + + + +V E + L K L+ R R L + + +
Sbjct: 51 LLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYK-LIKDRQRGLPESLIKSYLYQLL 108
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWM-A 117
+ + HSHGI+HRDLKPENL++ +KLADFGLAR S T T RW A
Sbjct: 109 QGLAFCHSHGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRA 166
Query: 118 PE 119
PE
Sbjct: 167 PE 168
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-16
Identities = 55/199 (27%), Positives = 80/199 (40%), Gaps = 51/199 (25%)
Query: 1 MMSRVRHRNLVK-FIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M +++H LV+ + +EP+ I+TE + G+L +L L I+ I A IA
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIA 112
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY--RWMA 117
M + IHRDL+ N IL ++ K+ADFGLAR E E + +W A
Sbjct: 113 EGMAFIERKNYIHRDLRAAN-ILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTA 171
Query: 118 PENMR----------------------------------------------PSAENLPED 131
PE + P +N PE+
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEE 231
Query: 132 LALIVTSCWKEDPNERPNF 150
L ++ CWKE P ERP F
Sbjct: 232 LYELMRLCWKEKPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 2e-16
Identities = 40/123 (32%), Positives = 66/123 (53%), Gaps = 8/123 (6%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M +H N+V + + + +V E + GG+L + R + +A ++
Sbjct: 68 IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-VCREVL 126
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWM 116
+ +E LHS +IHRD+K +N++L+ D +VKLADFG A + LT+ + GT WM
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQ--LTKEKSKRNSVVGTPYWM 183
Query: 117 APE 119
APE
Sbjct: 184 APE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-16
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 79/228 (34%)
Query: 1 MMSRVRHRNLVKFIGACK--EPVMVIVTELLLGGTLRKYLLNMRP--------------- 43
++ +V H +++K GAC P+++IV E G+LR +L R
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIV-EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSS 114
Query: 44 -------RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGL 96
R L + I FA I+R M+ L ++HRDL N +L A+ + +K++DFGL
Sbjct: 115 YLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN-VLVAEGRKMKISDFGL 173
Query: 97 ARE----------------------ESLT------------------EMMTAETGTYRWM 116
+R+ ESL E++T Y +
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233
Query: 117 APENM-----------RPSAENLPEDLALIVTSCWKEDPNERPNFSQI 153
APE + RP EN E++ ++ +CWK++P++RP F+ I
Sbjct: 234 APERLFNLLKTGYRMERP--ENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-16
Identities = 39/134 (29%), Positives = 69/134 (51%), Gaps = 21/134 (15%)
Query: 2 MSRVRHRNLVKFIGACKEP---VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+ + H N+VK+ G C++P + ++ E L G+LR YL R + +++ + F+ I
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQI 118
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY----- 113
+ M+ L S IHRDL N+++ ++ VK++DFGLA+ ++ + Y
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDL-VKISDFGLAK------VLPEDKDYYYVKEP 171
Query: 114 -----RWMAPENMR 122
W APE +R
Sbjct: 172 GESPIFWYAPECLR 185
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-16
Identities = 57/221 (25%), Positives = 82/221 (37%), Gaps = 73/221 (33%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPR--------------- 44
+MS ++H N+V +G C KE ++ E L G L ++L+ P
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 45 --CLD-IHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-- 99
C D +H+AI IA ME L SH +HRDL N L + TVK++DFGL+R+
Sbjct: 121 LDCSDFLHIAI----QIAAGMEYLSSHHFVHRDLAARN-CLVGEGLTVKISDFGLSRDIY 175
Query: 100 -ESLTEMMTAETGTYRWMAPE--------------------------------------- 119
+ + RWM PE
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235
Query: 120 -------NMRPSAENLPEDLALIVTSCWKEDPNERPNFSQI 153
+ P E+ P + ++ CW E P RP F I
Sbjct: 236 IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (184), Expect = 5e-16
Identities = 37/89 (41%), Positives = 50/89 (56%), Gaps = 7/89 (7%)
Query: 34 LRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLAD 93
L+KYL + RP L ++ + R + HSH I+HRDLKP+N+++ D +KLAD
Sbjct: 84 LKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLAD 141
Query: 94 FGLAREESLTEM-MTAETGT--YRWMAPE 119
FGLAR + T E T YR APE
Sbjct: 142 FGLARAFGIPLRTYTHEVVTLWYR--APE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 5e-16
Identities = 42/122 (34%), Positives = 67/122 (54%), Gaps = 10/122 (8%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ +RH LV G+ ++ + +V E + GG L +L + VA +A +
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVV 111
Query: 60 RAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLA-REESLTEMMTAETGTYRWMA 117
A+E LHS I++RDLKPENL+L +D + +K+ DFG A R + T + GT ++A
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGRTYTL---CGTPEYLA 166
Query: 118 PE 119
PE
Sbjct: 167 PE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 7e-16
Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 61/216 (28%)
Query: 2 MSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMR----PRCLDIHV 50
M H N++K IG C E P +++ + G L +LL R P L +
Sbjct: 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE----------- 99
+ F +DIA ME L + IHRDL N +L + TV +ADFGL+++
Sbjct: 115 LLKFMVDIALGMEYLSNRNFIHRDLAARNCML-REDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 100 -----------ESL----------------------TEMMTAETGT-----YRWMAPENM 121
ESL T T G Y ++ N
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233
Query: 122 RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
E+ ++L ++ SCW+ DP +RP F+++ ++L
Sbjct: 234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-15
Identities = 63/236 (26%), Positives = 96/236 (40%), Gaps = 72/236 (30%)
Query: 1 MMSRV-RHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRP-------------- 43
MM + +H+N++ +GAC + P+ VIV E G LR+YL RP
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPE 134
Query: 44 RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT 103
L + A +AR ME L S IHRDL N+++T D+ +K+ADFGLAR+
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHI 193
Query: 104 EMMTAETG---TYRWMAPENM--------------------------------------- 121
+ T +WMAPE +
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253
Query: 122 ---------RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168
+PS N +L +++ CW P++RP F Q+++ L ++ S E
Sbjct: 254 LLKEGHRMDKPS--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSNQE 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-15
Identities = 40/120 (33%), Positives = 63/120 (52%), Gaps = 2/120 (1%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ +V R +V A + + +V L+ GG L+ ++ N+ AI +A I
Sbjct: 46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQII 105
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+E LH I++RDLKPEN +L DH V+++D GLA E + + GT +MAPE
Sbjct: 106 CGLEHLHQRRIVYRDLKPEN-VLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-15
Identities = 32/74 (43%), Positives = 42/74 (56%), Gaps = 3/74 (4%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V E G L +Y+ LD +A +I A+E LHS GIIHRDLKPEN++L
Sbjct: 80 VLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK 137
Query: 85 DHKTVKLADFGLAR 98
D +K+ DFG A+
Sbjct: 138 D-MHIKITDFGTAK 150
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-15
Identities = 56/208 (26%), Positives = 78/208 (37%), Gaps = 49/208 (23%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M ++RH LV E + IVTE + G+L +L + L + + A IA
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY--RWMAP 118
M + IHRDL+ N IL D+ K+ADFGLAR E + + +W AP
Sbjct: 114 GMAYIERMNYIHRDLRAAN-ILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 119 ENM----------------------------------------------RPSAENLPEDL 132
E P + PE L
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL 232
Query: 133 ALIVTSCWKEDPNERPNFSQIIQMLLHY 160
++ CWK+DP+ERP F I L Y
Sbjct: 233 HELMKLCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-15
Identities = 53/206 (25%), Positives = 81/206 (39%), Gaps = 50/206 (24%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++H LV+ KE + I+TE + G+L +L + + + I F+ IA
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY--RWMA 117
M + IHRDL+ N +L ++ K+ADFGLAR E E + +W A
Sbjct: 114 EGMAYIERKNYIHRDLRAAN-VLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA 172
Query: 118 PENMR----------------------------------------------PSAENLPED 131
PE + P EN P++
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDE 232
Query: 132 LALIVTSCWKEDPNERPNFSQIIQML 157
L I+ +CWKE ERP F + +L
Sbjct: 233 LYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-15
Identities = 59/209 (28%), Positives = 81/209 (38%), Gaps = 51/209 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M ++RH LV+ E + IVTE + G+L +L + R L + + A +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRWMA 117
M + IHRDL+ N IL D K+ADFGLAR E TA G +W A
Sbjct: 114 GMAYIERMNYIHRDLRSAN-ILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTA 171
Query: 118 PE----------------------------------NMR------------PSAENLPED 131
PE N R P ++ P
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 231
Query: 132 LALIVTSCWKEDPNERPNFSQIIQMLLHY 160
L ++ CWK+DP ERP F + L Y
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 8e-15
Identities = 37/124 (29%), Positives = 63/124 (50%), Gaps = 9/124 (7%)
Query: 1 MMSRVRH---RNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFAL 56
++S++R N+ K+ G+ K P + I+ E GG++R M+ +
Sbjct: 52 LLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL---MKAGPIAEKYISVIIR 108
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRW 115
++ A++ +H G+IHRD+K N+++T VKL DFG+A + + GT W
Sbjct: 109 EVLVALKYIHKVGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYW 167
Query: 116 MAPE 119
MAPE
Sbjct: 168 MAPE 171
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-15
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 57/205 (27%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
++ + H N+VK IG C ++P+ IV EL+ GG +L + L + FALD
Sbjct: 45 ILKQYDHPNIVKLIGVCTQRQPIY-IVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDA 102
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG----TYR 114
A M L S IHRDL N L ++ +K++DFG++R+E + + + +G +
Sbjct: 103 AAGMAYLESKNCIHRDLAARN-CLVGENNVLKISDFGMSRQED--DGIYSSSGLKQIPIK 159
Query: 115 WMAPENM---RPSAEN-------------------------------------------L 128
W APE + R S+E+
Sbjct: 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKC 219
Query: 129 PEDLALIVTSCWKEDPNERPNFSQI 153
P+D+ ++ CW P RP FS++
Sbjct: 220 PDDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-14
Identities = 42/128 (32%), Positives = 58/128 (45%), Gaps = 18/128 (14%)
Query: 1 MMSRVRHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
++ ++RH N+V A + V V LL LL P L +
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL------ELLEASPGGLPPDAVRSYI 106
Query: 56 LDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY-- 113
+ +A+ HSH IIHRD+KPEN IL ++ +KL DFG AR +L + Y
Sbjct: 107 WQLLQAIAYCHSHNIIHRDIKPEN-ILVSESGVLKLCDFGFAR--ALRARPASPLTDYVA 163
Query: 114 -RWM-APE 119
RW APE
Sbjct: 164 TRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-14
Identities = 57/219 (26%), Positives = 86/219 (39%), Gaps = 71/219 (32%)
Query: 6 RHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAI----------- 52
+H+N++ +G C + P+ VIV E G LR++L RP D I
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 53 ---GFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE 109
A +AR ME L S IHRDL N+++T D+ +K+ADFGLAR +
Sbjct: 135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYYKKT 193
Query: 110 TG---TYRWMAPENM--------------------------------------------- 121
+ +WMAPE +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH 253
Query: 122 ---RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
+PS N +L +++ CW P +RP F Q+++ L
Sbjct: 254 RMDKPS--NCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-14
Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 21/187 (11%)
Query: 4 RVRHRNLVKFIGA-CKEPVMVIVTELLLGGTL---RKYLLNMRPRCLDIHVAIGFALDIA 59
+VK GA KE + IV E + GG+L K + + L A I
Sbjct: 55 SCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQIL 109
Query: 60 RAMECLHS-HGIIHRDLKPENLILTADHKTVKLADFGLAR--EESLTEMMTAETGTYRWM 116
+ ++ LH+ IIHRD+KP NL++ + VK+ADFG+++ E +L + T GT +M
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFV-GTVTYM 167
Query: 117 APENMRPSAENLPED---LALIVTSC-WKEDPNERPNFSQIIQMLLHYISTNSAPEPVIL 172
+PE ++ + + D L L + C + P P +++ I P
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-ICDGPPPSLP-- 224
Query: 173 PRMFSSE 179
FS E
Sbjct: 225 AEEFSPE 231
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-14
Identities = 38/124 (30%), Positives = 61/124 (49%), Gaps = 8/124 (6%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++H +V++ G ++ + I E + GG+++ L L V + I
Sbjct: 57 LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQIL 114
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE----ESLTEMMTAETGTYRW 115
+E LHS+ I+HRD+K N IL VKL DFG ++ S M + TGT W
Sbjct: 115 EGVEYLHSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 116 MAPE 119
M+PE
Sbjct: 174 MSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 40/101 (39%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFAL-DIARAMECLHSHGIIHRDLKPENL 80
+ I+ E GG+ L +P LD I F L ++ +E LH G IHRD+K N
Sbjct: 74 LWIIMEYCGGGSCLDLL---KPGKLD-ETYIAFILREVLLGLEYLHEEGKIHRDIKAAN- 128
Query: 81 ILTADHKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
IL ++ VKLADFG++ + + T M T GT WMAPE
Sbjct: 129 ILLSEEGDVKLADFGVSGQLTST-MSKRNTFVGTPFWMAPE 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 38/125 (30%), Positives = 62/125 (49%), Gaps = 9/125 (7%)
Query: 4 RVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRC-LDIHVAIGFALDIARA 61
+ +V F GA + I E + GG+L K L ++ R I I A + +
Sbjct: 55 KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKG 112
Query: 62 MECLHS-HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMT-AETGTYRWMAPE 119
+ LH H IIHRD+KP N+++ + +KL DFG++ + L + GT +MAPE
Sbjct: 113 LTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCDFGVSGQ--LVNSLAKTFVGTSSYMAPE 169
Query: 120 NMRPS 124
++ +
Sbjct: 170 RIQGN 174
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-14
Identities = 44/132 (33%), Positives = 65/132 (49%), Gaps = 12/132 (9%)
Query: 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFAL-DI 58
MS+ H N+VK+ + + +V L GG+L + + PR I L ++
Sbjct: 52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV 111
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET-------G 111
+ +E LHS+G IHRD+K N IL + +VK+ADFG++ SL + G
Sbjct: 112 LKGLEYLHSNGQIHRDIKAGN-ILLGEDGSVKIADFGVS--ASLADGGDRTRKVRKTFVG 168
Query: 112 TYRWMAPENMRP 123
T WMAPE M
Sbjct: 169 TPCWMAPEVMEQ 180
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-14
Identities = 38/121 (31%), Positives = 63/121 (52%), Gaps = 8/121 (6%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ V H +++ + + ++ E + GG L YL N + +A +I
Sbjct: 54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIV 111
Query: 60 RAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAETGTYRWMAP 118
A+E LHS I++RDLKPEN++L + H +KL DFG A++ L + GT ++AP
Sbjct: 112 CALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKK--LRDRTWTLCGTPEYLAP 167
Query: 119 E 119
E
Sbjct: 168 E 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 6e-14
Identities = 34/121 (28%), Positives = 56/121 (46%), Gaps = 6/121 (4%)
Query: 2 MSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ +H +VK + V+V E + +L R L + + +
Sbjct: 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSE--VLRDEERPLPEAQVKSYMRMLLK 110
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR--EESLTEMMTAETGTYRWMAP 118
+ +H++GI+HRDLKP NL L + +K+ADFGLAR E + + + T + AP
Sbjct: 111 GVAYMHANGIMHRDLKPANL-LISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
Query: 119 E 119
E
Sbjct: 170 E 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-14
Identities = 56/218 (25%), Positives = 85/218 (38%), Gaps = 59/218 (27%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLN--MRPRCLDIHVAIGFAL 56
+M H N++ +G C E ++V + G LR ++ + P D+ IGF L
Sbjct: 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGL 105
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---- 112
+A+ ME L S +HRDL N +L TVK+ADFGLAR+ E + T
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 113 -YRWMAPENMR----------------------------------------------PSA 125
+WMA E+++
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQP 224
Query: 126 ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163
E P+ L ++ SCW P RP FS+++ + ST
Sbjct: 225 EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-14
Identities = 46/206 (22%), Positives = 85/206 (41%), Gaps = 50/206 (24%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++S ++H N++ + + ++I E GGTL ++ + + + + + + I
Sbjct: 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV 111
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET--GTYRWMA 117
A+ +H GI+HRD+K N+ LT +KL DFG+++ +E AET GT +M+
Sbjct: 112 SAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILG-SEYSMAETVVGTPYYMS 169
Query: 118 PE-------NMRP-------------------SAENLPE-------------------DL 132
PE N + A N +L
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSEL 229
Query: 133 ALIVTSCWKEDPNERPNFSQIIQMLL 158
+V S ++DP +RP +++ L
Sbjct: 230 ISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-14
Identities = 57/212 (26%), Positives = 81/212 (38%), Gaps = 62/212 (29%)
Query: 7 HRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIG------------ 53
H N++ +GAC+ + + E G L +L R D AI
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 54 --FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG 111
FA D+AR M+ L IHRDL N IL ++ K+ADFGL+R + + T
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARN-ILVGENYVAKIADFGLSRGQEVYVKKTMGRL 185
Query: 112 TYRWMAPENMRPSA----------------------------------ENLPEDLAL--- 134
RWMA E++ S E LP+ L
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 245
Query: 135 ---------IVTSCWKEDPNERPNFSQIIQML 157
++ CW+E P ERP+F+QI+ L
Sbjct: 246 LNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-13
Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 68/223 (30%)
Query: 1 MMSRV-RHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
MM + +H+N++ +GAC + P+ VIV E G LR+YL RP ++ I D
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPD 131
Query: 58 --------------IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT 103
+AR ME L S IHRDL N+++T ++ +K+ADFGLAR+ +
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNI 190
Query: 104 EMMTAETG---TYRWMAPENMR-------------------------------PSAE--- 126
+ T +WMAPE + P E
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250
Query: 127 ------------NLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
N +L +++ CW P+ RP F Q+++ L
Sbjct: 251 LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-13
Identities = 51/210 (24%), Positives = 78/210 (37%), Gaps = 49/210 (23%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M ++RH LV+ E + IVTE + G+L +L + L + + A IA
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY--RWMAP 118
M + +HRDL+ N IL ++ K+ADFGLAR E + + +W AP
Sbjct: 114 GMAYVERMNYVHRDLRAAN-ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 119 ENM----------------------------------------------RPSAENLPEDL 132
E P PE L
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 232
Query: 133 ALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162
++ CW+++P ERP F + L Y +
Sbjct: 233 HDLMCQCWRKEPEERPTFEYLQAFLEDYFT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-13
Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 46/200 (23%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ + H N++++ ++ ++IV E GGTL +Y+ LD + F + I
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
A+ +H+ I+HRDLK +N++L VK+ DFG+++ S GT +++PE
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE 171
Query: 120 --NMRP------------------------SAENLP-------------------EDLAL 134
+P A NLP DL
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQ 231
Query: 135 IVTSCWKEDPNERPNFSQII 154
++ S DP++RP SQI+
Sbjct: 232 LILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-13
Identities = 37/110 (33%), Positives = 62/110 (56%), Gaps = 1/110 (0%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ +V L+ GG L+ ++ N+ R L++ I ++ I + LHS I++RD+KPEN++
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 82 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPED 131
L D +L+D GLA E + +T GT +MAPE ++ + P D
Sbjct: 128 LD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVD 176
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-13
Identities = 45/215 (20%), Positives = 85/215 (39%), Gaps = 60/215 (27%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLL-------NMRPRCLDIHVA 51
M ++ H+N+V+ +G C EP ++ E G L+++L ++P L
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEP-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE--MMTAE 109
+ IA M+ L + +HRDL N ++++ + VK++ L+++ +E +
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE-VKVSLLSLSKDVYNSEYYKLRNA 178
Query: 110 TGTYRWMAPENMR----------------------------------------------- 122
RW+APE ++
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238
Query: 123 PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
P E P L ++T CW +P +RP+FS+++ L
Sbjct: 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 25/187 (13%)
Query: 3 SRVRHRNLVKFI--GACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+R+ H N+V + G ++ V E + G TLR+ L L L +
Sbjct: 33 ARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGA--LPAGETGRLMLQVLD 90
Query: 61 AMECLHSHGIIHRDLKPENLILTA--DHKTVKLADFGLAR-----EESLTEMMTAET--- 110
A+ C H+ GI+HRDLKP+N++++ K+ DFG+ ++ +T T
Sbjct: 91 ALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL 150
Query: 111 GTYRWMAPENMRPSAENLPEDL---ALIVTSCWKEDPN-ERPNFSQIIQMLLHYISTNSA 166
GT + APE +R DL LI C + + ++I+ L +
Sbjct: 151 GTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQL-------S 203
Query: 167 PEPVILP 173
P V LP
Sbjct: 204 PVDVSLP 210
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 33/66 (50%), Positives = 46/66 (69%), Gaps = 9/66 (13%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR----EESLTEMMTAETGTY 113
+ R ++ LHSH I+HRDLKP+N+++T+D VK+ADFGLAR E +LT ++ T Y
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYSFEMALTSVVV--TLWY 172
Query: 114 RWMAPE 119
R APE
Sbjct: 173 R--APE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-13
Identities = 36/98 (36%), Positives = 57/98 (58%), Gaps = 1/98 (1%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ +V L+ GG L+ ++ NM D A+ +A +I +E LH I++RDLKPEN++
Sbjct: 75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134
Query: 82 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
L D+ ++++D GLA E E + GT +MAPE
Sbjct: 135 LD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-13
Identities = 51/218 (23%), Positives = 85/218 (38%), Gaps = 66/218 (30%)
Query: 1 MMSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMR------PRCLDIHVA 51
++ + H+N++ + C E P V+ + G L+ +L R P+ L
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWG-NLKLFLQQCRLGEANNPQALSTQQL 119
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE------ESLTEM 105
+ A+ IA M LH G+IH+D+ N ++ + VK+ D L+R+ L +
Sbjct: 120 VHMAIQIACGMSYLHKRGVIHKDIAARNCVI-DEELQVKITDNALSRDLFPMDYHCLGD- 177
Query: 106 MTAETGTYRWMAPENMR--------------------------PSAE------------- 126
E +WMA E++ P E
Sbjct: 178 --NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235
Query: 127 -------NLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
N P++L ++ CW DP ERP+FSQ++Q L
Sbjct: 236 YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-13
Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++++++H N+V F + +E + IV E GG L K + R + + + I+
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQIS 111
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWMAP 118
++ +H I+HRD+K +N+ L+ + KL DFG+AR+ E+ GT +++P
Sbjct: 112 LGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 119 ENMRPSAENLPEDL----ALIVTSCWKEDPNERPNFSQII----QMLLHYISTNSAPE-P 169
E + N D+ ++ C + P E N Q++ Q IS N + +
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLR 231
Query: 170 VILPRMFSSENAVLPPESPGTSSLM 194
++ ++F V P + P +S++
Sbjct: 232 SLISQLFK----VSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-13
Identities = 61/222 (27%), Positives = 87/222 (39%), Gaps = 70/222 (31%)
Query: 1 MMSRVRHRNLVKFIGAC---KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
++ ++H N+VK+ G C + +V E L G+LR YL R R D + +A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQ 116
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA------------RE------ 99
I + ME L S +HRDL N IL VK+ DFGL RE
Sbjct: 117 ICKGMEYLGSKRYVHRDLATRN-ILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI 175
Query: 100 -----ESLTE-------------MMTAETGTY------------RWMAPE---------- 119
ESLTE ++ E TY R M +
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235
Query: 120 ------NMR-PSAENLPEDLALIVTSCWKEDPNERPNFSQII 154
N R P+ P ++ I+ CW DP++RP+FS++
Sbjct: 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELA 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-13
Identities = 46/124 (37%), Positives = 63/124 (50%), Gaps = 10/124 (8%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLD---IHVAIGFAL 56
++S +H N+V A E + I+ E GG L +L + R L I L
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQML 113
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGL-AREESLTEMMTAETGTYRW 115
+ A+ LHSH +IHRDLK N++LT VKLADFG+ A+ +S + GT W
Sbjct: 114 E---ALNFLHSHKVIHRDLKAGNILLTL-DGDVKLADFGVSAKNKSTLQKRDTFIGTPYW 169
Query: 116 MAPE 119
MAPE
Sbjct: 170 MAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-13
Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 16/179 (8%)
Query: 2 MSRVRHRNLVKFIGACKEP---VMVIVTELLLGGTLRKYLLNMRPRCLDI--HVAIGFAL 56
+ +VK+ GA + + I E GG+L ++ R I V A
Sbjct: 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAE 112
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWM 116
+ + + LHS IIHRD+KP N++LT + VKL DFG++ E + T TGT +M
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ-VKLCDFGVSGELVNSLAGTF-TGTSFYM 170
Query: 117 APENMRPSAENLPED-------LALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168
APE ++ ++ D L + + + P P I LL YI PE
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI--ELLSYIVNMPNPE 227
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 5e-13
Identities = 41/125 (32%), Positives = 62/125 (49%), Gaps = 15/125 (12%)
Query: 7 HRNLVKFIGA-------CKEPVMVIVTELLLGGT---LRKYLLNMRPRCLDIHVAIGFAL 56
H N+ F GA + + +V EL GG+ L K L + + L I + L
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEW-IAYIL 119
Query: 57 -DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMT-AETGTYR 114
+ R + LH + +IHRD+K +N++LT + + VKL DFG++ + T GT
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPY 178
Query: 115 WMAPE 119
WMAPE
Sbjct: 179 WMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-13
Identities = 47/207 (22%), Positives = 78/207 (37%), Gaps = 58/207 (28%)
Query: 1 MMSRVRHRNLVK----FIGACKEPVMVIVTELLLGGTLRKYLLN--MRPRCLDIHVAIGF 54
+++ V H N++ F+ K + IV E G L K + + + +
Sbjct: 52 ILASVNHPNIISYKEAFLDGNK---LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMT-AETGTY 113
+ + R ++ LH I+HRDLK N IL + VK+ D G+++ L + M + GT
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSAN-ILLVANDLVKIGDLGISK--VLKKNMAKTQIGTP 165
Query: 114 RWMAPE--NMRP---------------------------SAENL---------------- 128
+MAPE RP S ++L
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIY 225
Query: 129 PEDLALIVTSCWKEDPNERPNFSQIIQ 155
+DL + S + P RPN +I+
Sbjct: 226 SQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-13
Identities = 47/125 (37%), Positives = 59/125 (47%), Gaps = 13/125 (10%)
Query: 1 MMSRVRHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
M+ ++RH NLV I + V V +L L KY P LD +
Sbjct: 53 MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLD-DLEKY-----PNGLDESRVRKYL 106
Query: 56 LDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYR 114
I R +E HSH IIHRD+KPEN IL + VKL DFG AR + E+ T T
Sbjct: 107 FQILRGIEFCHSHNIIHRDIKPEN-ILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW 165
Query: 115 WMAPE 119
+ APE
Sbjct: 166 YRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 7e-13
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 37/223 (16%)
Query: 2 MSRVRHRNLVKFIGACKEP---VMVIVTELLLGGTLRKYLLNMRP--RCLDIHVAIGFAL 56
+ ++H N+V++ + + IV E GG L + + + + ++
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 57 DIARAM-ECLH-----SHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
+ A+ EC H + ++HRDLKP N+ L A++ VKL DFGLA+ + A+T
Sbjct: 113 QLLLALYEC-HNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILG-HDSSFAKT 169
Query: 111 --GTYRWMAPENMRPSAENLPEDL----ALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164
GT +M+PE + + + D+ LI C P N Q+ +
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI------K 223
Query: 165 SAPEPVILPRMFSSE-NAVLPPESPGTSSLMPPRDDSERNPNT 206
I P +SSE N V+ M D +R P+T
Sbjct: 224 EGKFRRI-PYRYSSELNEVI--------KSMLNVDPDKR-PST 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-13
Identities = 36/128 (28%), Positives = 65/128 (50%), Gaps = 8/128 (6%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M+R+ H ++++ +GA C++ + E + GG++ L V I + +
Sbjct: 56 LMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLL 113
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE-----TGTYR 114
R + LH + IIHRD+K NL++ + + +++ADFG A + E GT
Sbjct: 114 RGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 115 WMAPENMR 122
+MAPE +R
Sbjct: 174 FMAPEVLR 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 7e-13
Identities = 44/133 (33%), Positives = 63/133 (47%), Gaps = 28/133 (21%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD-- 57
M+ RH N+V + G+ + + IV E GG+L+ DI+ L
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ-----------DIYQVTRGPLSEL 101
Query: 58 -IA-------RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE 109
IA + + LH G IHRD+K N++LT + VKLADFG++ + LT +
Sbjct: 102 QIAYVCRETLKGLAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQ--LTATIAKR 158
Query: 110 T---GTYRWMAPE 119
GT WMAPE
Sbjct: 159 KSFIGTPYWMAPE 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-12
Identities = 53/216 (24%), Positives = 82/216 (37%), Gaps = 61/216 (28%)
Query: 2 MSRVRHRNLVKFIGAC-------KEPVMVIVTELLLGGTLRKYLLNMR----PRCLDIHV 50
M H N++K IG + P+ +++ + G L +LL R P L +
Sbjct: 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE----------- 99
+ F +DIA ME L S IHRDL N +L + TV +ADFGL+++
Sbjct: 115 LVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVADFGLSKKIYSGDYYRQGC 173
Query: 100 -----------ESLT------------------EMMT---------AETGTYRWMAPENM 121
ESL E+MT + Y ++ N
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233
Query: 122 RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
+ ED+ ++ CW +P RP+F + L
Sbjct: 234 LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 1e-12
Identities = 41/131 (31%), Positives = 65/131 (49%), Gaps = 18/131 (13%)
Query: 1 MMSRVRHRNLVKFIGACKEPV------MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGF 54
++ +RH N++ + + P + IVTEL+ T ++ D H+ F
Sbjct: 52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQY-F 108
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR----EESLTEMMTAET 110
I R ++ LHS +IHRDLKP N+++ ++ +K+ DFGLAR +E +T
Sbjct: 109 LYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 111 GT--YRWMAPE 119
T YR APE
Sbjct: 168 VTRWYR--APE 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-12
Identities = 46/123 (37%), Positives = 64/123 (52%), Gaps = 9/123 (7%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVI--VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
++ +RH N++ P+ I VTELL GT LL RP L+ F I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRP--LEKQFIQYFLYQI 117
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAP 118
R ++ +HS G++HRDLKP N IL ++ +K+ DFGLAR + MT T + AP
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSN-ILINENCDLKICDFGLARIQD--PQMTGYVSTRYYRAP 174
Query: 119 ENM 121
E M
Sbjct: 175 EIM 177
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-12
Identities = 50/191 (26%), Positives = 90/191 (47%), Gaps = 15/191 (7%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++H N+V+++G C + + I E + GG++ L P L V + I
Sbjct: 55 LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQIL 112
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-------ESLTEMMTAETGT 112
+ LH++ ++HRD+K N++L + +KL DFG AR + + M+ + GT
Sbjct: 113 DGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171
Query: 113 YRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM-LLHYISTNSAPEPVI 171
WMAPE + S D+ I + + E +P + + ++ + YI + P
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVF-EMATGKPPLASMDRLAAMFYIGAHRGLMPR- 229
Query: 172 LPRMFSSENAV 182
LP F S A+
Sbjct: 230 LPDSF-SAAAI 239
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-12
Identities = 43/120 (35%), Positives = 61/120 (50%), Gaps = 9/120 (7%)
Query: 2 MSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ ++RH N +++ G C +E +V E LG ++ +P AI
Sbjct: 69 LQQLRHPNTIEYKG-CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI--CHGAL 125
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+ + LHSH IHRD+K N++LT + TVKLADFG A SL + GT WMAPE
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILLT-EPGTVKLADFGSA---SLVSPANSFVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-12
Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 11/99 (11%)
Query: 6 RHRNLVKFIGACKEPVMV-----IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
H N+VK KE V E + G L + + + + + V I +
Sbjct: 56 EHPNIVKL----KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE 99
+ +H HG HRDLKPENL+++ + VK+ADFGLARE
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVS-GPEVVKIADFGLARE 148
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-12
Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 15/152 (9%)
Query: 56 LDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRW 115
+ R ++ LHSH ++HRDLKP+N+++T+ + +KLADFGLAR S +T+ T +
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMALTSVVVTLWY 175
Query: 116 MAPENMRPSAENLPEDL---ALIVTSCWKEDPNERPNFSQIIQM-----LLHYISTNSAP 167
APE + S+ P DL I ++ P R + S + Q+ ++ P
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILDVIGLPGEEDWP 234
Query: 168 EPVILPRMFSSENAVLPPESPGTSSLMPPRDD 199
V LPR A + + D+
Sbjct: 235 RDVALPR-----QAFHSKSAQPIEKFVTDIDE 261
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-12
Identities = 31/67 (46%), Positives = 41/67 (61%), Gaps = 9/67 (13%)
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR------EESLTEMMTAETGTY 113
+A++ +HS +IHRDLKP N++L +D VKLADFGLAR E ++T T
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEENPENPVLTDYVAT- 175
Query: 114 RWM-APE 119
RW APE
Sbjct: 176 RWYRAPE 182
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-12
Identities = 53/207 (25%), Positives = 85/207 (41%), Gaps = 53/207 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++ H LV+ G C E + +V E + G L YL R + +G LD+
Sbjct: 52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVC 110
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRWM 116
M L S +IHRDL N L +++ VK++DFG+ R L + T+ TGT +W
Sbjct: 111 EGMAYLESSNVIHRDLAARN-CLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWS 168
Query: 117 APE-------------------------------NMRPSAENL---------------PE 130
+PE R ++E + +
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQ 228
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQML 157
+ ++ CWKE P +RP+FS ++ L
Sbjct: 229 SVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-12
Identities = 39/137 (28%), Positives = 72/137 (52%), Gaps = 7/137 (5%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRP--RCLDIHVAIGFALD 57
++ ++ H N++K++ + + + IV EL G L + + + + R + + +
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET--GTYRW 115
+ A+E +HS I+HRD+KP N+ +TA VKL D GL R S ++ A + GT +
Sbjct: 115 LCSALEHMHSKRIMHRDIKPANVFITATGV-VKLGDLGLGRFFS-SKTTAAHSLVGTPYY 172
Query: 116 MAPENMRPSAENLPEDL 132
M+PE + + N D+
Sbjct: 173 MSPERIHENGYNFKSDI 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-12
Identities = 27/75 (36%), Positives = 42/75 (56%), Gaps = 5/75 (6%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
+V E + GG L L+ A + ++ A++ +H G IHRD+KP+N+++
Sbjct: 78 LVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135
Query: 84 AD-HKTVKLADFGLA 97
AD H +KLADFGL
Sbjct: 136 ADGH--IKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 4e-12
Identities = 33/62 (53%), Positives = 41/62 (66%), Gaps = 4/62 (6%)
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWM-A 117
R +E LHS+ I+HRDLKP NL++ +D +KLADFGLAR S MT + T RW A
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVT-RWYRA 170
Query: 118 PE 119
PE
Sbjct: 171 PE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-12
Identities = 55/223 (24%), Positives = 80/223 (35%), Gaps = 71/223 (31%)
Query: 1 MMSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYL----------LNMRPRC-- 45
+++ +H N+VKF G C E P+MV E + G L K+L +
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVF--EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118
Query: 46 LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM 105
L + + A+ IA M L S +HRDL N L VK+ DFG++R+ T+
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRN-CLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 106 MTAETGTY---RWMAPENM----------------------------------------- 121
T RWM PE++
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237
Query: 122 -------RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
RP P ++ I+ CWK DP +R N I + L
Sbjct: 238 TQGRLLQRP--RTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-12
Identities = 37/96 (38%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 7 HRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPR-CLDIHVAIGFALDIARAM 62
H N+VK+ G C E + ++ E + G+LR YL P+ L++ + FA I M
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGM 120
Query: 63 ECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98
LHS IHRDL N++L D + VK+ DFGLA+
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-12
Identities = 45/127 (35%), Positives = 70/127 (55%), Gaps = 12/127 (9%)
Query: 1 MMSRVRHRNLVKFIGACKEPV------MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGF 54
M+ +H N++ + + P + +VTEL+ L K +++ +P D HV + F
Sbjct: 52 MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSD-HVKV-F 108
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE--MMTAETGT 112
I R ++ LHS GI+HRD+KP NL++ ++ +K+ DFGLAR E E MT E T
Sbjct: 109 LYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVT 167
Query: 113 YRWMAPE 119
+ APE
Sbjct: 168 QYYRAPE 174
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-12
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 75/215 (34%)
Query: 9 NLVKFIGACK--EPVMVIVTELLLGGTLRKYLLNMRPRCLD--------IHVAIGFALDI 58
++V+ +G +P +V++ EL+ G L+ YL ++RP + + I A +I
Sbjct: 70 HVVRLLGVVSKGQPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYR---- 114
A M L++ +HRDL N ++ D TVK+ DFG+ R+ ET YR
Sbjct: 129 ADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTRD-------IYETDYYRKGGK 180
Query: 115 ------WMAPENMRPSA------------------------------------------- 125
WMAPE+++
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240
Query: 126 ---ENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
+N PE + ++ CW+ +P RP F +I+ +L
Sbjct: 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-12
Identities = 29/55 (52%), Positives = 37/55 (67%), Gaps = 1/55 (1%)
Query: 65 LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
LHS GIIHRDLKP N+++ +D T+K+ DFGLAR + MMT T + APE
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-12
Identities = 34/65 (52%), Positives = 43/65 (66%), Gaps = 4/65 (6%)
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET--GTYR 114
+I+ A+E LH GII+RDLKPEN++L A VKL DFGL + ES+ E T GT
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCK-ESIHEGTVTHTFCGTIE 165
Query: 115 WMAPE 119
+MAPE
Sbjct: 166 YMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-12
Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 7/123 (5%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++ H LV+ G C ++ + IVTE + G L YL + + L + + D+
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVC 110
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRWM 116
ME L + IHRDL N ++++ VK++DFG+ R L + T+ +G +W
Sbjct: 111 EGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWS 168
Query: 117 APE 119
PE
Sbjct: 169 PPE 171
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-12
Identities = 55/205 (26%), Positives = 77/205 (37%), Gaps = 49/205 (23%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M ++H LVK + + I+TE + G+L +L + + I F+ IA
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY--RWMAP 118
M + IHRDL+ N IL + K+ADFGLAR E E + +W AP
Sbjct: 114 GMAFIEQRNYIHRDLRAAN-ILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172
Query: 119 ENMR----------------------------------------------PSAENLPEDL 132
E + P EN PE+L
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 232
Query: 133 ALIVTSCWKEDPNERPNFSQIIQML 157
I+ CWK P ERP F I +L
Sbjct: 233 YNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-12
Identities = 46/163 (28%), Positives = 64/163 (39%), Gaps = 53/163 (32%)
Query: 46 LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM 105
LD + F+ +A+ M L S IHRDL N++LT T K+ DFGLAR+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIR-NDS 268
Query: 106 MTAETGTYR----WMAPENM--------------------------RP------------ 123
G R WMAPE++ P
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328
Query: 124 ---------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
S E P ++ I+ SCW DP +RP F QI+Q++
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-11
Identities = 52/175 (29%), Positives = 83/175 (47%), Gaps = 16/175 (9%)
Query: 1 MMSRVRHRNLVKFIGA---CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
+M +H N+V ++ + E + +V E L GG+L + C+D +
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRE 123
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFG----LAREESLTEMMTAETGTY 113
+A+E LHS+ +IHRD+K +N++L D +VKL DFG + E+S M GT
Sbjct: 124 CLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTP 179
Query: 114 RWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168
WMAPE + A D+ + + E P ++ L+ I+TN PE
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-11
Identities = 37/123 (30%), Positives = 68/123 (55%), Gaps = 2/123 (1%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ +V R +V A + + + +V L+ GG L+ ++ +M + A+ +A +I
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEIC 112
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+E LH I++RDLKPEN++L DH ++++D GLA + + GT +MAPE
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 171
Query: 120 NMR 122
++
Sbjct: 172 VVK 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-11
Identities = 41/123 (33%), Positives = 64/123 (52%), Gaps = 9/123 (7%)
Query: 3 SRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGF-ALDIAR 60
S ++HRN+V+++G+ E I E + GG+L L + D I F I
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFG----LAREESLTEMMTAETGTYRWM 116
++ LH + I+HRD+K +N+++ VK++DFG LA TE TGT ++M
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TGTLQYM 176
Query: 117 APE 119
APE
Sbjct: 177 APE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-11
Identities = 41/104 (39%), Positives = 49/104 (47%), Gaps = 21/104 (20%)
Query: 26 TELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR--------AMECLHSHGIIHRDLKP 77
E LGG L L R R L F AR A E LH+ GII+RDLKP
Sbjct: 72 MEYCLGGELWTIL---RDRGL-------FDEYTARFYIACVVLAFEYLHNRGIIYRDLKP 121
Query: 78 ENLILTADHKT-VKLADFGLAREESLTEMMTAETGTYRWMAPEN 120
ENL+L D VKL DFG A++ + GT ++APE
Sbjct: 122 ENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEI 163
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 53/209 (25%), Positives = 77/209 (36%), Gaps = 62/209 (29%)
Query: 6 RHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA------------- 51
H N++ +GAC+ + I E G L +L R D A
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 52 -IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
+ FA D+A M+ L IHRDL N +L ++ K+ADFGL+R E + T
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHRDLAARN-VLVGENLASKIADFGLSRGEEVYVKKTMGR 179
Query: 111 GTYRWMAPENMRPSA----------------------------------ENLPEDLAL-- 134
RWMA E++ S E LP+ +
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239
Query: 135 ----------IVTSCWKEDPNERPNFSQI 153
++ CW++ P ERP F+QI
Sbjct: 240 PRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 2e-11
Identities = 38/123 (30%), Positives = 62/123 (50%), Gaps = 8/123 (6%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFAL-DI 58
++ + +VK+ G+ K + IV E G++ ++ + + L I L
Sbjct: 51 ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLT-EEEIAAILYQT 108
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET--GTYRWM 116
+ +E LHS+ IHRD+K N++L + KLADFG++ + + T M T GT WM
Sbjct: 109 LKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDT-MAKRNTVIGTPFWM 166
Query: 117 APE 119
APE
Sbjct: 167 APE 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-11
Identities = 57/210 (27%), Positives = 83/210 (39%), Gaps = 57/210 (27%)
Query: 1 MMSRVRHRNLVKFIGA---CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
+M + H N++ G K PVM IVTE + G+L +L + I + +G
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSK-PVM-IVTEYMENGSLDAFLRKHDGQFTVIQL-VGMLRG 114
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR--EESLTEMMTAETGT--Y 113
IA M+ L G +HRDL N IL + K++DFGL+R E+ T G
Sbjct: 115 IASGMKYLSDMGYVHRDLAARN-ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173
Query: 114 RWMAPENMR----------------------------------------------PSAEN 127
RW APE + P+ +
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMD 233
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQML 157
P L ++ CW++D NERP F QI+ +L
Sbjct: 234 CPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-11
Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V E + GG L ++ R D A +A +I ++ LH GII+RDLK +N++L +
Sbjct: 74 VMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS 131
Query: 85 D-HKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
+ H +K+ADFG+ + E + +T T GT ++APE
Sbjct: 132 EGH--IKIADFGMCK-EGILGGVTTSTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 39/124 (31%), Positives = 65/124 (52%), Gaps = 8/124 (6%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+++ + LVK + A ++ + + E + GG R L N+ L A + ++
Sbjct: 54 ILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMF 111
Query: 60 RAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAETGTYRWMAP 118
A++ LH G IHRDLKPEN ++ A H +KL DFGL++ + + G+ +MAP
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKG--IVTYANSVVGSPDYMAP 167
Query: 119 ENMR 122
E +R
Sbjct: 168 EVLR 171
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-11
Identities = 52/232 (22%), Positives = 83/232 (35%), Gaps = 77/232 (33%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPR-------------- 44
+M+ H N+VK +G C +P M ++ E + G L ++L + PR
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 45 --------CLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGL 96
+ I A +A M L +HRDL N L ++ VK+ADFGL
Sbjct: 120 CGLNPLPLSCTEQLCI--AKQVAAGMAYLSERKFVHRDLATRN-CLVGENMVVKIADFGL 176
Query: 97 AREESLTEMMTAETGTY---RWMAPE---------------------------------- 119
+R + A RWM PE
Sbjct: 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236
Query: 120 ------------NMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159
N+ +N P +L ++ CW + P++RP+F+ I ++L
Sbjct: 237 AHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-11
Identities = 32/98 (32%), Positives = 56/98 (57%), Gaps = 1/98 (1%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ +V ++ GG L+ ++ NM + A+ +A +I +E LH ++RDLKPEN++
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENIL 134
Query: 82 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
L D+ ++++D GLA + E + GT +MAPE
Sbjct: 135 LD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-11
Identities = 45/132 (34%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 7 HRNLVKFIGAC------KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
H N+V+ + C +E + +V E + LR YL + P L R
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEN 120
++ LH++ I+HRDLKPEN+++T+ VKLADFGLAR S +T T + APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 121 MRPSAENLPEDL 132
+ S P D+
Sbjct: 179 LLQSTYATPVDM 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-11
Identities = 36/141 (25%), Positives = 62/141 (43%), Gaps = 30/141 (21%)
Query: 2 MSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYL---------LNMRPRCLDIHVA 51
+SR+ N+ + +G C +P + ++ E + G L ++L L + L
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG 111
+ A IA M L S +HRDL N ++ ++ T+K+ADFG++R +
Sbjct: 133 LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY-TIKIADFGMSRN--------LYSS 183
Query: 112 TY-----------RWMAPENM 121
Y RWMA E++
Sbjct: 184 DYYRVQGRAPLPIRWMAWESV 204
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-11
Identities = 52/218 (23%), Positives = 83/218 (38%), Gaps = 66/218 (30%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRC-------------- 45
+M+ + H N+V +G +E + ++ E L G L ++L+ P
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 46 -LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE 104
LD + A+ IA ME L SH +H+DL N IL + VK++D GL+RE +
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN-ILIGEQLHVKISDLGLSREIYSAD 178
Query: 105 MMTAETGTY---RWMAPE------------------------------------------ 119
+ + RWM PE
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238
Query: 120 ----NMRPSAENLPEDLALIVTSCWKEDPNERPNFSQI 153
+ P +E+ P + ++T CW+E P+ RP F I
Sbjct: 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-11
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 1/98 (1%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ +V ++ GG L+ ++ NM D AI +A ++ +E L I++RDLKPEN++
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134
Query: 82 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
L D ++++D GLA + E + GT +MAPE
Sbjct: 135 LD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-11
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 4/99 (4%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++H+N+V+ + + +V E L+KY + +D + F +
Sbjct: 52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGD-IDPEIVKSFMFQLL 109
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98
+ + HSH ++HRDLKP+NL++ + +KLADFGLAR
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLIN-KNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-11
Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 63/210 (30%)
Query: 4 RVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--------RCLDIHVAIGF 54
++RH N+V++ E + IV +L+ G L ++ +++ R +I V +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 55 ALDIARAMECLHSHG-IIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY 113
AL LH I+HRDL P N++L D K V + DFGLA+++ +T+ GT
Sbjct: 125 AL------RYLHKEKRIVHRDLTPNNIMLGEDDK-VTITDFGLAKQKQPESKLTSVVGTI 177
Query: 114 RWMAPE---------------------------------NMRPSA--------ENLPE-- 130
+ PE NM A E LPE
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 131 ---DLALIVTSCWKEDPNERPNFSQIIQML 157
D+ ++TSC D RP+ Q+ M+
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-11
Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
+V E L GG+L + C+D + +A+E LHS+ +IHRD+K +N++L
Sbjct: 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 84 ADHKTVKLADFGLAREESLTEMMTAE-TGTYRWMAPENMRPSAENLPEDLALIVTSCWKE 142
D +VKL DFG + + + + GT WMAPE + A D+ + +
Sbjct: 151 MD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
Query: 143 DPNERPNFSQIIQMLLHYISTNSAPE 168
E P ++ L+ I+TN PE
Sbjct: 210 IEGEPPYLNENPLRALYLIATNGTPE 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 6e-11
Identities = 33/80 (41%), Positives = 42/80 (52%), Gaps = 11/80 (13%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLIL--TADHKTVKLADFGLAR----EESLTEMMT 107
F I R ++ +HS ++HRDLKP NL+L D +K+ DFGLAR E T +T
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLT 167
Query: 108 AETGTYRWM-APENMRPSAE 126
T RW APE M S
Sbjct: 168 EYVAT-RWYRAPEIMLNSKG 186
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-11
Identities = 28/67 (41%), Positives = 40/67 (59%), Gaps = 2/67 (2%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT-EMMTAETGT 112
F + R ++ +HS ++HRDLKP NL+L A+ +K+ DFGLAR S + MT T
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSEKGDFMTEYVVT 171
Query: 113 YRWMAPE 119
+ APE
Sbjct: 172 RWYRAPE 178
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-11
Identities = 31/64 (48%), Positives = 41/64 (64%), Gaps = 2/64 (3%)
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE-TGTYRW 115
++A A++ LHS GII+RDLKPEN IL + +KL DFGL++E E GT +
Sbjct: 106 ELALALDHLHSLGIIYRDLKPEN-ILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 164
Query: 116 MAPE 119
MAPE
Sbjct: 165 MAPE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-11
Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 4/100 (4%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYL-LNMRPRCLDIHVAIGFALDI 58
+M ++H N+V+ E +++V E + L+KY+ + LD + F +
Sbjct: 51 LMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL 109
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98
+ + H + ++HRDLKP+NL++ + +KLADFGLAR
Sbjct: 110 LKGIAFCHENRVLHRDLKPQNLLINKRGE-LKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-11
Identities = 37/112 (33%), Positives = 60/112 (53%), Gaps = 2/112 (1%)
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE-TGTYRW 115
+I + ++ LHS IHRD+K N++L+ + VKLADFG+A + + T++ GT W
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 116 MAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAP 167
MAPE ++ SA + D+ + + + E PN +L I N+ P
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP 219
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 31/65 (47%), Positives = 40/65 (61%), Gaps = 5/65 (7%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRW-M 116
I R ++ +HS GIIHRDLKP N+ + D + +K+ DFGLAR + MT T RW
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLAR--HTDDEMTGYVAT-RWYR 182
Query: 117 APENM 121
APE M
Sbjct: 183 APEIM 187
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-10
Identities = 43/165 (26%), Positives = 65/165 (39%), Gaps = 55/165 (33%)
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG 111
I ++ +AR ME L S IHRDL N IL +++ VK+ DFGLAR + + G
Sbjct: 176 ISYSFQVARGMEFLASRKCIHRDLAARN-ILLSENNVVKICDFGLAR-DIYKDPDYVRKG 233
Query: 112 TYR----WMAPEN----------------------------------------------- 120
R WMAPE+
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT 293
Query: 121 -MRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164
MR + E ++ I+ CW +P +RP FS+++++L + N
Sbjct: 294 RMR-APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-10
Identities = 37/121 (30%), Positives = 56/121 (46%), Gaps = 5/121 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
M+ +++H NLV I + + +V E L + L PR + H+
Sbjct: 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTL 110
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWM-AP 118
+A+ H H IHRD+KPEN+++T +KL DFG AR + + RW AP
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAP 169
Query: 119 E 119
E
Sbjct: 170 E 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 19/104 (18%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
+V E L GG L + + R ++ L + +A+ LH+ G+IHRD+K ++++LT
Sbjct: 93 VVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT 149
Query: 84 ADHKTVKLADFG--------LAREESLTEMMTAETGTYRWMAPE 119
+D VKL+DFG + R +SL GT WMAPE
Sbjct: 150 SD-GRVKLSDFGFCAQVSKEVPRRKSL-------VGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 49/205 (23%), Positives = 84/205 (40%), Gaps = 59/205 (28%)
Query: 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARA 61
M + H +V+ +G C + +VT+L G+L ++ R LD + + + IA+
Sbjct: 63 MGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKG 121
Query: 62 MECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA-------REESLTEMMTAETGTYR 114
M L H ++HR+L N++L +D V++ADFG+A ++ +E T +
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSI-VQIADFGVADLLYPDDKKYFYSEHKTP----IK 176
Query: 115 WMAPEN--------------------------------MRPS--------AENLPE---- 130
WMA E+ MRP E L +
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQIC 236
Query: 131 --DLALIVTSCWKEDPNERPNFSQI 153
D+ +++ CW D N RP F ++
Sbjct: 237 TIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-10
Identities = 54/171 (31%), Positives = 89/171 (52%), Gaps = 10/171 (5%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++S+ + K+ G+ K+ + I+ E L GG+ L P LD +I
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREIL 111
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE-TGTYRWMAP 118
+ ++ LHS IHRD+K N++L+ +H VKLADFG+A + + T++ GT WMAP
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 119 ENMRPSAENLPEDL-ALIVTSCWKEDPNERPNFSQIIQM-LLHYISTNSAP 167
E ++ SA + D+ +L +T+ E P S++ M +L I N+ P
Sbjct: 171 EVIKQSAYDSKADIWSLGITAI--ELAKGEPPHSELHPMKVLFLIPKNNPP 219
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-10
Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 8/97 (8%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
+V E L GG + + L A + ++ +E LH GIIHRD+KPENL++
Sbjct: 74 LVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131
Query: 84 AD-HKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
H +KL DFGL+R GT ++APE
Sbjct: 132 QTGH--LKLTDFGLSR---NGLENKKFVGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-10
Identities = 36/124 (29%), Positives = 64/124 (51%), Gaps = 9/124 (7%)
Query: 1 MMSRVRHRNLVKFIG-ACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ + H N+V+++G E + I E + GG++ L + + F +
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR--FEEQLVRFFTEQVL 118
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREE----SLTEMMTAETGTYRW 115
+ LHS GI+HRDLK +NL++ AD K++DFG++++ + M+ + G+ W
Sbjct: 119 EGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFW 176
Query: 116 MAPE 119
MAPE
Sbjct: 177 MAPE 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-10
Identities = 37/121 (30%), Positives = 61/121 (50%), Gaps = 3/121 (2%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++H N+V+ E + +V E L L+K++ + + + + I
Sbjct: 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAP 118
R + HSH ++HRDLKP+NL++ +KLADFGLAR + T E T + AP
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172
Query: 119 E 119
E
Sbjct: 173 E 173
|
Length = 294 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-10
Identities = 36/121 (29%), Positives = 62/121 (51%), Gaps = 4/121 (3%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ + H N+VK + E + +V E L L+K++ + + + + +
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL 110
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAP 118
+ + HSH ++HRDLKP+NL++ + +KLADFGLAR + T E T + AP
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169
Query: 119 E 119
E
Sbjct: 170 E 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-10
Identities = 43/124 (34%), Positives = 66/124 (53%), Gaps = 5/124 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++H LV + + + V + + GG L +L R RC A +A ++A
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAEVA 106
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE-TGTYRWMAP 118
A+ LHS II+RDLKPEN++L + V L DFGL +E E T+ GT ++AP
Sbjct: 107 SAIGYLHSLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAP 165
Query: 119 ENMR 122
E +R
Sbjct: 166 EVLR 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-10
Identities = 47/202 (23%), Positives = 86/202 (42%), Gaps = 51/202 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M+ + H +LV+ +G C P + +VT+L+ G L Y+ + + + + + + IA+
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAK 120
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR-EESLTEMMTAETGTY--RWMA 117
M L ++HRDL N+++ + + VK+ DFGLAR E + A+ G +WMA
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 118 PE----------------------------------------NMRPSAENLPE------D 131
E ++ E LP+ D
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID 239
Query: 132 LALIVTSCWKEDPNERPNFSQI 153
+ +++ CW D + RP F ++
Sbjct: 240 VYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 40/100 (40%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V + + GG L +L R R A +A +IA A+ LHS II+RDLKPEN++L
Sbjct: 74 VLDYVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL-- 129
Query: 85 DHKT-VKLADFGLAREESLTEMMTAE-TGTYRWMAPENMR 122
D + V L DFGL +E T+ GT ++APE +R
Sbjct: 130 DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-10
Identities = 37/122 (30%), Positives = 69/122 (56%), Gaps = 4/122 (3%)
Query: 1 MMSRVRHRNLVKFIGACK--EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
++S+++H N+V + + + + ++ IV GG L L + + L + + + + I
Sbjct: 52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI 111
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWMA 117
A A++ LH I+HRDLK +N+ LT + +K+ D G+AR E+ +M + GT +M+
Sbjct: 112 AMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIGTPYYMS 170
Query: 118 PE 119
PE
Sbjct: 171 PE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-10
Identities = 38/126 (30%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPR--CLDIHVAIGFALD 57
++++V R +V A + + +V ++ GG LR ++ N+ A +
Sbjct: 46 ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ 105
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMT-AETGTYRWM 116
I +E LH II+RDLKPEN++L + V+++D GLA E + T GT +M
Sbjct: 106 IISGLEHLHQRRIIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFM 164
Query: 117 APENMR 122
APE ++
Sbjct: 165 APELLQ 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-10
Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 5/145 (3%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
I+ E L GG+ L +P L+ +I + ++ LHS IHRD+K N++L+
Sbjct: 79 IIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS 135
Query: 84 ADHKTVKLADFGLAREESLTEMM-TAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKE 142
+ VKLADFG+A + + T++ GT WMAPE ++ SA + D+ + + +
Sbjct: 136 -EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194
Query: 143 DPNERPNFSQIIQMLLHYISTNSAP 167
E PN +L I NS P
Sbjct: 195 AKGEPPNSDLHPMRVLFLIPKNSPP 219
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-10
Identities = 32/76 (42%), Positives = 53/76 (69%), Gaps = 5/76 (6%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
+V E L+GG + K LL++ D +A+ + ++A A++ LH HGIIHRDLKP+N++++
Sbjct: 81 LVMEYLIGGDV-KSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS 138
Query: 84 AD-HKTVKLADFGLAR 98
+ H +KL DFGL++
Sbjct: 139 NEGH--IKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-10
Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 5/105 (4%)
Query: 19 EPVMVIVTELLLGGTLRKYLLNMR---PRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75
+P + +V E L L+K++ + R L F + + + H HG++HRDL
Sbjct: 78 KPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDL 136
Query: 76 KPENLILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPE 119
KP+NL++ +K+AD GL R S+ + T E T + APE
Sbjct: 137 KPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-10
Identities = 44/131 (33%), Positives = 65/131 (49%), Gaps = 25/131 (19%)
Query: 1 MMSRVRHRNLVKFIGA--CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
M+ +H N+V + G+ +E + I E GG+L+ DI+ G ++
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLW-ICMEYCGGGSLQ-----------DIYHVTGPLSEL 106
Query: 59 ARAMEC---------LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT-EMMTA 108
A C LHS G +HRD+K N++LT D+ VKLADFG+A + + T +
Sbjct: 107 QIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKS 165
Query: 109 ETGTYRWMAPE 119
GT WMAPE
Sbjct: 166 FIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 4e-10
Identities = 19/41 (46%), Positives = 30/41 (73%), Gaps = 1/41 (2%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98
+ ++ LHS+GI+HRD+K N+++ + +KLADFGLAR
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILIN-NDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-10
Identities = 29/55 (52%), Positives = 36/55 (65%), Gaps = 1/55 (1%)
Query: 65 LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
LHS GIIHRDLKP N+++ +D T+K+ DFGLAR MMT T + APE
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-10
Identities = 29/55 (52%), Positives = 37/55 (67%), Gaps = 1/55 (1%)
Query: 65 LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
LHS GIIHRDLKP N+++ +D T+K+ DFGLAR + MMT T + APE
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-10
Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 12/109 (11%)
Query: 2 MSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMR----PRCLDIHV 50
M H N+++ IG C + P V++ + G L +LL R P+ L +
Sbjct: 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQM 113
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE 99
+ F DIA ME L S IHRDL N +L ++ V +ADFGL+++
Sbjct: 114 LVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKK 161
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-10
Identities = 38/136 (27%), Positives = 70/136 (51%), Gaps = 5/136 (3%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRP--RCLDIHVAIGFALD 57
++ ++ H N++K+ + ++ + IV EL G L + + + + R + + +
Sbjct: 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR-EESLTEMMTAETGTYRWM 116
+ A+E +HS ++HRD+KP N+ +TA VKL D GL R S T + GT +M
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 117 APENMRPSAENLPEDL 132
+PE + + N D+
Sbjct: 174 SPERIHENGYNFKSDI 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-10
Identities = 30/69 (43%), Positives = 44/69 (63%), Gaps = 5/69 (7%)
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAET--GTY 113
+I A++ LH GII+RD+K EN++L ++ H V L DFGL++E E A + GT
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEEEERAYSFCGTI 170
Query: 114 RWMAPENMR 122
+MAPE +R
Sbjct: 171 EYMAPEVIR 179
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-10
Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 12/173 (6%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M +++ N+V F+ + + +V E L GG+L + C+D +
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECL 125
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFG----LAREESLTEMMTAETGTYRW 115
+A+E LH++ +IHRD+K +N++L D +VKL DFG + E+S M GT W
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYW 181
Query: 116 MAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168
MAPE + A D+ + + E P ++ L+ I+TN PE
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-10
Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
+V E L GG+L + C+D + +A++ LHS+ +IHRD+K +N++L
Sbjct: 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149
Query: 84 ADHKTVKLADFG----LAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSC 139
D +VKL DFG + E+S M GT WMAPE + A D+ +
Sbjct: 150 MD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 140 WKEDPNERPNFSQIIQMLLHYISTNSAPE 168
+ E P ++ L+ I+TN PE
Sbjct: 206 IEMVEGEPPYLNENPLRALYLIATNGTPE 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-10
Identities = 30/68 (44%), Positives = 40/68 (58%), Gaps = 2/68 (2%)
Query: 53 GFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETG 111
L + R ++ LH + IIHRDLK NL+LT D +K+ADFGLAR + MT +
Sbjct: 112 CLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVV 170
Query: 112 TYRWMAPE 119
T + APE
Sbjct: 171 TLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-10
Identities = 46/210 (21%), Positives = 87/210 (41%), Gaps = 65/210 (30%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M+ V + ++ + +G C + ++T+L+ G L Y+ + ++ + + + IA+
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAK 120
Query: 61 AMECLHSHGIIHRDLKPENLIL-TADHKTVKLADFGLAREESLTEMMTAETGTY------ 113
M L ++HRDL N+++ T H VK+ DFGLA+ ++ A+ Y
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAK------LLGADEKEYHAEGGK 172
Query: 114 ---RWMAPENM--------------------------RP--------------SAENLPE 130
+WMA E++ +P E LP+
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 232
Query: 131 ------DLALIVTSCWKEDPNERPNFSQII 154
D+ +I+ CW D + RP F ++I
Sbjct: 233 PPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-10
Identities = 46/164 (28%), Positives = 68/164 (41%), Gaps = 55/164 (33%)
Query: 46 LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM 105
L + I ++ +AR ME L S IHRDL N IL +++ VK+ DFGLAR + +
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARN-ILLSENNVVKICDFGLAR-DIYKDP 228
Query: 106 MTAETGTYR----WMAPEN----------------------------------------- 120
G+ R WMAPE+
Sbjct: 229 DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ 288
Query: 121 -------MRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
MR + EN ++ I+ +CW+ DP ERP FS ++++L
Sbjct: 289 RLKDGTRMR-APENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-10
Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 3/121 (2%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIA 59
++ ++H N+V + + + L L+KYL ++ + +D + + I
Sbjct: 52 LLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL 111
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAP 118
+ + HS ++HRDLKP+NL L + +KLADFGLAR + + T E T + AP
Sbjct: 112 QGILFCHSRRVLHRDLKPQNL-LIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAP 170
Query: 119 E 119
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-10
Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 2 MSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIA 59
+ R++H N +++ G +E +V E LG ++ +P + ++I AL
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL--- 135
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+ + LHSH +IHRD+K N++LT + VKLADFG A S+ + GT WMAPE
Sbjct: 136 QGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSA---SIASPANSFVGTPYWMAPE 191
Query: 120 NMRPSAENLPE---DLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAP 167
+ E + D+ + +C + + P F+ L++I+ N +P
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 242
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 8e-10
Identities = 31/75 (41%), Positives = 46/75 (61%), Gaps = 5/75 (6%)
Query: 25 VTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
V + GG L + LL +P +CL VA +A ++ A+E LH GI++RDLKPEN++L
Sbjct: 79 VMDYCPGGELFR-LLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH 137
Query: 84 AD-HKTVKLADFGLA 97
H + L+DF L+
Sbjct: 138 ESGH--IMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 31/78 (39%), Positives = 50/78 (64%), Gaps = 5/78 (6%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ +V E + GG L N+ +D+ + FA + A+E LH++GI+HRDLKP+NL+
Sbjct: 76 LCMVMEYVEGGDCATLLKNIGALPVDM-ARMYFA-ETVLALEYLHNYGIVHRDLKPDNLL 133
Query: 82 LTA-DHKTVKLADFGLAR 98
+T+ H +KL DFGL++
Sbjct: 134 ITSMGH--IKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-09
Identities = 26/65 (40%), Positives = 38/65 (58%), Gaps = 1/65 (1%)
Query: 34 LRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLAD 93
L+KY+ + LD + + + + + HSH ++HRDLKP+NL L +KLAD
Sbjct: 84 LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNL-LIDREGALKLAD 142
Query: 94 FGLAR 98
FGLAR
Sbjct: 143 FGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-09
Identities = 39/121 (32%), Positives = 60/121 (49%), Gaps = 9/121 (7%)
Query: 7 HRNLVKFIGAC--KEPV-----MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
HRN+ + GA K P + +V E G++ + N + L +I
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGL-AREESLTEMMTAETGTYRWMAP 118
R + LH+H +IHRD+K +N++LT ++ VKL DFG+ A+ + GT WMAP
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190
Query: 119 E 119
E
Sbjct: 191 E 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-09
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 31 GGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVK 90
T R L+N P L +GF+ +A ME L S +HRDL N +L + K VK
Sbjct: 222 ERTRRDTLINESP-ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN-VLICEGKLVK 279
Query: 91 LADFGLAREESLTEMMTAETGTY---RWMAPENM 121
+ DFGLAR+ ++ T+ +WMAPE++
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI 313
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-09
Identities = 44/179 (24%), Positives = 65/179 (36%), Gaps = 49/179 (27%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
IV E G L K L R R L F + I + LHS I+HRD+K NL L
Sbjct: 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD 135
Query: 84 ADHKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE---------------------- 119
A VK+ D G+A+ S A T GT +++PE
Sbjct: 136 AYDN-VKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE 193
Query: 120 -----------------------NMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155
P ++ + LA ++ C +D +RP+ Q+++
Sbjct: 194 CCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-09
Identities = 38/136 (27%), Positives = 70/136 (51%), Gaps = 5/136 (3%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRP--RCLDIHVAIGFALD 57
++ ++ H N++K++ + ++ + IV EL G L + + + R + + +
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR-EESLTEMMTAETGTYRWM 116
+ A+E +HS ++HRD+KP N+ +TA VKL D GL R S T + GT +M
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 117 APENMRPSAENLPEDL 132
+PE + + N D+
Sbjct: 174 SPERIHENGYNFKSDI 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-09
Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V E + GG L + R R D + +A ++ A+ LH HG+I+RDLK +N++L A
Sbjct: 74 VMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA 131
Query: 85 DHKTVKLADFGLAREESLTEMMTAE-TGTYRWMAPE 119
+ KLADFG+ +E L + T GT ++APE
Sbjct: 132 EGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-09
Identities = 55/208 (26%), Positives = 79/208 (37%), Gaps = 62/208 (29%)
Query: 7 HRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA-------------- 51
H N++ +GAC+ + + E G L +L R D A
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG 111
+ FA D+AR M+ L IHRDL N IL ++ K+ADFGL+R + + T
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARN-ILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 112 TYRWMAPENMRPSA----------------------------------ENLPEDLAL--- 134
RWMA E++ S E LP+ L
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 233
Query: 135 ---------IVTSCWKEDPNERPNFSQI 153
++ CW+E P ERP+F+QI
Sbjct: 234 LNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-09
Identities = 28/61 (45%), Positives = 40/61 (65%), Gaps = 4/61 (6%)
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET--GTYRWMAP 118
A+E LH + I++RDLKPEN++L A + L DFGL++ LT+ T T GT ++AP
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGH-IALCDFGLSKAN-LTDNKTTNTFCGTTEYLAP 165
Query: 119 E 119
E
Sbjct: 166 E 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-09
Identities = 52/211 (24%), Positives = 80/211 (37%), Gaps = 57/211 (27%)
Query: 1 MMSRVRHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M + H N++ G + PVM I+TE + G L +L + I + +G I
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSRPVM-IITEFMENGALDSFLRQNDGQFTVIQL-VGMLRGI 115
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR---EESLTEMMTAETG---T 112
A M+ L +HRDL N IL + K++DFGL+R +++ T+ G
Sbjct: 116 AAGMKYLSEMNYVHRDLAARN-ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 113 YRWMAPENMR----------------------------------------------PSAE 126
RW APE + P
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPM 234
Query: 127 NLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
+ P L ++ CW++D N RP F QI+ L
Sbjct: 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 2e-09
Identities = 29/55 (52%), Positives = 37/55 (67%), Gaps = 1/55 (1%)
Query: 65 LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
LHS GIIHRDLKP N+++ +D T+K+ DFGLAR + MMT T + APE
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-09
Identities = 43/210 (20%), Positives = 80/210 (38%), Gaps = 53/210 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M ++ + +V+ IG C+ ++V EL G L K+L + + + ++
Sbjct: 49 VMQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSM 106
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR----EESLTEMMTAETGTYRWM 116
M+ L +HRDL N++L H K++DFGL++ +E+ + T +W
Sbjct: 107 GMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWY 165
Query: 117 APENM--------------------------RP--------------------SAENLPE 130
APE M +P + P
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPP 225
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLHY 160
++ ++ CW +ERP F+ + L +Y
Sbjct: 226 EMYDLMKLCWTYGVDERPGFAVVELRLRNY 255
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-09
Identities = 29/70 (41%), Positives = 41/70 (58%), Gaps = 3/70 (4%)
Query: 50 VAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE 109
VA + ++ A E LHS II+RDLKPENL+L VK+ DFG A++ + +
Sbjct: 119 VAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKK--VPDRTFTL 175
Query: 110 TGTYRWMAPE 119
GT ++APE
Sbjct: 176 CGTPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-09
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V E L GG L ++ + D A +A +I ++ LH GII+RDLK +N++L
Sbjct: 74 VMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 85 DHKTVKLADFGLAREESLTEMMTAE-TGTYRWMAPE 119
D +K+ADFG+ +E E + GT ++APE
Sbjct: 132 DGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-09
Identities = 36/121 (29%), Positives = 66/121 (54%), Gaps = 11/121 (9%)
Query: 7 HRNLVKFIGACKEPV---MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAME 63
H N+VK+ G C E + ++ E L G+L++YL + + +++ + +A+ I + M+
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMD 123
Query: 64 CLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR-----EESLTEMMTAETGTYRWMAP 118
L S +HRDL N+++ ++H VK+ DFGL + +E T ++ + W AP
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDLDSPVF-WYAP 181
Query: 119 E 119
E
Sbjct: 182 E 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-09
Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 75/220 (34%)
Query: 1 MMSRVRHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLD--------IHV 50
+M ++V+ +G + P +VI+ EL+ G L+ YL ++RP + +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
I A +IA M L+++ +HRDL N ++ D TVK+ DFG+ R+ ET
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRD-------IYET 172
Query: 111 GTY----------RWMAPENMRPSA----------------------------------- 125
Y RWM+PE+++
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
Query: 126 -----------ENLPEDLALIVTSCWKEDPNERPNFSQII 154
+N P+ L ++ CW+ +P RP+F +II
Sbjct: 233 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-09
Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 2 MSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIA 59
+ +++H N +++ G KE +V E LG ++ +P + ++I AL
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL--- 131
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+ + LHSH +IHRD+K N++LT + VKLADFG A S + + GT WMAPE
Sbjct: 132 QGLAYLHSHNMIHRDIKAGNILLT-EPGQVKLADFGSA---SKSSPANSFVGTPYWMAPE 187
Query: 120 NMRPSAENLPE---DLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAP 167
+ E + D+ + +C + + P F+ L++I+ N +P
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 238
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-09
Identities = 25/63 (39%), Positives = 37/63 (58%), Gaps = 4/63 (6%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWM- 116
+ ++++ +H +GI HRD+KPEN+++ D +KLADFG R T T RW
Sbjct: 109 LLKSLDHMHRNGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYIST-RWYR 165
Query: 117 APE 119
APE
Sbjct: 166 APE 168
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-09
Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
++ + + GG L +L + R R + V I ++ +I A+E LH GII+RD+K EN++L
Sbjct: 82 LILDYINGGELFTHL-SQRERFKEQEVQI-YSGEIVLALEHLHKLGIIYRDIKLENILLD 139
Query: 84 ADHKTVKLADFGLARE--ESLTEMMTAETGTYRWMAPENMR 122
++ V L DFGL++E E E + GT +MAP+ +R
Sbjct: 140 SNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-09
Identities = 40/160 (25%), Positives = 64/160 (40%), Gaps = 54/160 (33%)
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG 111
+ F +AR ME L S +HRDL N++L A K VK+ DFGLAR+ ++
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 112 TY---RWMAPENM----------------------------------------------- 121
T+ +WMAPE++
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358
Query: 122 RPSAENLPEDLALIVTSCWKEDPNERPNF---SQIIQMLL 158
++ +++ I+ CW +P +RP+F S I++ LL
Sbjct: 359 MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-09
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
+V E L GG L + + R ++ L + RA+ LH+ G+IHRD+K ++++LT
Sbjct: 96 VVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 152
Query: 84 ADHKTVKLADFGL-AREESLTEMMTAETGTYRWMAPE 119
+D + +KL+DFG A+ + GT WMAPE
Sbjct: 153 SDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-09
Identities = 42/130 (32%), Positives = 62/130 (47%), Gaps = 23/130 (17%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
MM +H N+V + G+ + + I E GG+L+ DI+ G +
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQ-----------DIYHVTGPLSESQ 107
Query: 60 RAMEC---------LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT-EMMTAE 109
A LHS G +HRD+K N++LT D+ VKLADFG++ + + T +
Sbjct: 108 IAYVSRETLQGLYYLHSKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSF 166
Query: 110 TGTYRWMAPE 119
GT WMAPE
Sbjct: 167 IGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-09
Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 12/171 (7%)
Query: 2 MSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIA 59
+ ++RH N +++ G +E +V E LG ++ +P + ++I AL
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL--- 125
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+ + LHSH +IHRD+K N++L+ + VKL DFG A S+ GT WMAPE
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSA---SIMAPANXFVGTPYWMAPE 181
Query: 120 NMRPSAENLPE---DLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAP 167
+ E + D+ + +C + + P F+ L++I+ N +P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-09
Identities = 37/128 (28%), Positives = 65/128 (50%), Gaps = 13/128 (10%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++H N+V+++G+ + I E + GG++ LLN + + F I
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYG-AFEETLVRNFVRQIL 116
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYR----- 114
+ + LH+ GIIHRD+K N IL + +K++DFG++++ + T T R
Sbjct: 117 KGLNYLHNRGIIHRDIKGAN-ILVDNKGGIKISDFGISKKLEANSLSTK-TNGARPSLQG 174
Query: 115 ---WMAPE 119
WMAPE
Sbjct: 175 SVFWMAPE 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-09
Identities = 39/121 (32%), Positives = 59/121 (48%), Gaps = 9/121 (7%)
Query: 7 HRNLVKFIGAC--KEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
HRN+ + GA K P + +V E G++ + N + L +I
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGL-AREESLTEMMTAETGTYRWMAP 118
R + LH H +IHRD+K +N++LT ++ VKL DFG+ A+ + GT WMAP
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
Query: 119 E 119
E
Sbjct: 181 E 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-09
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
+V E L GG L + + R ++ L + +A+ LH+ G+IHRD+K ++++LT
Sbjct: 94 VVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT 150
Query: 84 ADHKTVKLADFGL-AREESLTEMMTAETGTYRWMAPE 119
D + VKL+DFG A+ + GT WMAPE
Sbjct: 151 HDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-09
Identities = 28/68 (41%), Positives = 40/68 (58%), Gaps = 4/68 (5%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREE-SLTEMMTAETG 111
+ +I A+ LHS +++RDLK ENL+L D H +K+ DFGL +E S M G
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCG 157
Query: 112 TYRWMAPE 119
T ++APE
Sbjct: 158 TPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 30/74 (40%), Positives = 40/74 (54%), Gaps = 8/74 (10%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR-----EESLTEMMTA 108
F I ++ +HS ++HRDLKP NL++ AD + +K+ DFGLAR MT
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGFSENPGENAGFMTE 168
Query: 109 ETGTYRWM-APENM 121
T RW APE M
Sbjct: 169 YVAT-RWYRAPEIM 181
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 6e-09
Identities = 27/74 (36%), Positives = 39/74 (52%), Gaps = 8/74 (10%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-----ESLTEMMTA 108
F + R ++ +HS +IHRDLKP NL++ D +++ DFG+AR MT
Sbjct: 112 FLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTE 170
Query: 109 ETGTYRWM-APENM 121
T RW APE +
Sbjct: 171 YVAT-RWYRAPELL 183
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-09
Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 3/121 (2%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++S ++H N+V++ + +E + IV + GG L K + R + + + I
Sbjct: 52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWMAP 118
A++ +H I+HRD+K +N+ LT D T+KL DFG+AR S E+ GT +++P
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170
Query: 119 E 119
E
Sbjct: 171 E 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-09
Identities = 36/119 (30%), Positives = 58/119 (48%), Gaps = 6/119 (5%)
Query: 3 SRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARA 61
+ RH LV + V V E GG L ++++ A+ +A +
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL---MMHIHTDVFSEPRAVFYAACVVLG 113
Query: 62 MECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE-TGTYRWMAPE 119
++ LH + I++RDLK +NL+L + VK+ADFGL +E T+ GT ++APE
Sbjct: 114 LQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-09
Identities = 46/136 (33%), Positives = 72/136 (52%), Gaps = 9/136 (6%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNM-RPRC-LDIHVAIGFALD 57
+++ H N+VK + A E + I+ E GG + +L + RP I V L+
Sbjct: 55 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE 114
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWM 116
A+ LH + IIHRDLK N++ T D +KLADFG++ + + T + + GT WM
Sbjct: 115 ---ALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170
Query: 117 APE-NMRPSAENLPED 131
APE M ++++ P D
Sbjct: 171 APEVVMCETSKDRPYD 186
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-09
Identities = 49/208 (23%), Positives = 77/208 (37%), Gaps = 53/208 (25%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M + H N+++ G K +I+TE + G L KYL + + +G IA
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIA 117
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETG---TYRW 115
M+ L +HRDL N IL + K++DFGL+R E E +G RW
Sbjct: 118 AGMKYLSDMNYVHRDLAARN-ILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
APE + P+ + P
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCP 236
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQML 157
+ ++ CW++D RP F I+ +L
Sbjct: 237 SAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-09
Identities = 30/70 (42%), Positives = 45/70 (64%), Gaps = 2/70 (2%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREE-SLTEMMTAETGT 112
+A +IA A+ LHS I++RDLKPEN++L + V L DFGL +E + ++ T GT
Sbjct: 101 YAAEIASALGYLHSINIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGT 159
Query: 113 YRWMAPENMR 122
++APE +R
Sbjct: 160 PEYLAPEVIR 169
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 33/135 (24%), Positives = 60/135 (44%), Gaps = 20/135 (14%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M+ ++H N++ + + + +V +++ L+K +++ + R + V L I
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKC-ILLQIL 129
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR---------------EESLTE 104
+ LH +HRDL P N+ + K+ADFGLAR E
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 105 MMTAETGTYRWMAPE 119
MT++ T + APE
Sbjct: 189 EMTSKVVTLWYRAPE 203
|
Length = 335 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-08
Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 10/126 (7%)
Query: 1 MMSRVRHRNLVKFIGACK---EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
++ ++H +V++ G + E + I E + GG+++ L L V +
Sbjct: 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQ 114
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM----MTAETGTY 113
I M LHS+ I+HRD+K N IL VKL DFG ++ M + + TGT
Sbjct: 115 ILEGMSYLHSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 114 RWMAPE 119
WM+PE
Sbjct: 174 YWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-08
Identities = 29/64 (45%), Positives = 38/64 (59%), Gaps = 3/64 (4%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
I R ++ +HS IIHRDLKP NL + D + +K+ DFGLAR + MT T + A
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTD--DEMTGYVATRWYRA 185
Query: 118 PENM 121
PE M
Sbjct: 186 PEIM 189
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-08
Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 4/99 (4%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ V E L GG L ++ + D+ A +A +I ++ LHS GI++RDLK +N++
Sbjct: 71 LFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128
Query: 82 LTADHKTVKLADFGLAREESLTEMMTAE-TGTYRWMAPE 119
L D +K+ADFG+ +E L + T GT ++APE
Sbjct: 129 LDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-08
Identities = 37/100 (37%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ V E + GG L ++ + R D A +A +I A+ LH GII+RDLK +N++
Sbjct: 71 LFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVL 128
Query: 82 LTADHKT-VKLADFGLAREESLTEMMTAE-TGTYRWMAPE 119
L DH+ KLADFG+ +E T+ GT ++APE
Sbjct: 129 L--DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-08
Identities = 17/37 (45%), Positives = 25/37 (67%), Gaps = 3/37 (8%)
Query: 65 LHSHGIIHRDLKPENLILTADHK---TVKLADFGLAR 98
LHS+ ++HRDLKP N+++ + VK+ D GLAR
Sbjct: 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 25/69 (36%), Positives = 42/69 (60%), Gaps = 2/69 (2%)
Query: 34 LRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLAD 93
L++Y+ + L +H F + R + H ++HRDLKP+NL+++ + +KLAD
Sbjct: 89 LKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLAD 146
Query: 94 FGLAREESL 102
FGLAR +S+
Sbjct: 147 FGLARAKSV 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-08
Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 4/99 (4%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ V E L GG L + + + R D++ A +A +I ++ LHS GII+RDLK +N++
Sbjct: 71 LFFVMEFLNGGDL-MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM 128
Query: 82 LTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPE 119
L D +K+ADFG+ +E + + GT ++APE
Sbjct: 129 LDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 31/73 (42%), Positives = 48/73 (65%), Gaps = 6/73 (8%)
Query: 50 VAIGFALDIARAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTA 108
A+ +A +IA + LHS GII+RDLK +N++L A+ H +K+ADFG+ + E++ T
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCK-ENIFGGKTT 158
Query: 109 ET--GTYRWMAPE 119
T GT ++APE
Sbjct: 159 RTFCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 36/135 (26%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPR----------CLDIH 49
+MSR+++ N+++ +G C + + ++TE + G L ++L + I
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 50 VAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE 109
+ A+ IA M+ L S +HRDL N ++ +H T+K+ADFG++R + +
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLV-GNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 110 TGTY---RWMAPENM 121
RWMA E++
Sbjct: 189 GRAVLPIRWMAWESI 203
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 10/126 (7%)
Query: 1 MMSRVRHRNLVKFIGACKEPV---MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
++ +RH +V++ G ++P + I E + GG+++ L L +V +
Sbjct: 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQ 114
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM----MTAETGTY 113
I + + LHS+ I+HRD+K N IL VKL DFG ++ M + + TGT
Sbjct: 115 ILQGVSYLHSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 114 RWMAPE 119
WM+PE
Sbjct: 174 YWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 39/121 (32%), Positives = 64/121 (52%), Gaps = 4/121 (3%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+++ H +VK +GA + + I+ E GG + +L + + + + +
Sbjct: 62 ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQML 120
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAP 118
A++ LHS IIHRDLK N++LT D +KLADFG++ + T + + GT WMAP
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGD-IKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
Query: 119 E 119
E
Sbjct: 180 E 180
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 27/64 (42%), Positives = 36/64 (56%), Gaps = 8/64 (12%)
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTV-KLADFGLARE-ESLTEMMTAETGT--YRW 115
+ LH + I+HRDLK NL+L ++ + K+ DFGLARE S + T T YR
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLN--NRGILKICDFGLAREYGSPLKPYTQLVVTLWYR- 173
Query: 116 MAPE 119
APE
Sbjct: 174 -APE 176
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 38/99 (38%), Positives = 54/99 (54%), Gaps = 4/99 (4%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ V + + GG L +L R RC A +A +IA A+ LHS I++RDLKPEN++
Sbjct: 71 LYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL 128
Query: 82 LTADHKTVKLADFGLAREESLTEMMTAE-TGTYRWMAPE 119
L + V L DFGL +E T+ GT ++APE
Sbjct: 129 LDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 40/128 (31%), Positives = 66/128 (51%), Gaps = 5/128 (3%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++H N+V E + +V E L L++YL N + +H F +
Sbjct: 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNC-GNLMSMHNVKIFMFQLL 113
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAP 118
R + H I+HRDLKP+NL++ + +KLADFGLAR +S+ T+ + E T + P
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 172
Query: 119 ENMRPSAE 126
+ + S E
Sbjct: 173 DVLLGSTE 180
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 26/71 (36%), Positives = 46/71 (64%), Gaps = 3/71 (4%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET--G 111
+ ++ A++ +HS G+IHRD+KP+N++L H +KLADFG + T M+ +T G
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 112 TYRWMAPENMR 122
T +++PE ++
Sbjct: 206 TPDYISPEVLK 216
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-08
Identities = 40/122 (32%), Positives = 60/122 (49%), Gaps = 8/122 (6%)
Query: 5 VRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRCL---DIHVAIGFALDIAR 60
++H NL++ +G C E ++V E G L+ YL + R L D A +IA
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY---RWMA 117
+ LH + IH DL N +LTAD TVK+ D+GL+ + + + RW+A
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIA 170
Query: 118 PE 119
PE
Sbjct: 171 PE 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 27/62 (43%), Positives = 39/62 (62%), Gaps = 3/62 (4%)
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
R ++ +HS GIIHRDLKP N+ + D + +++ DFGLAR+ + MT T + APE
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQAD--DEMTGYVATRWYRAPE 185
Query: 120 NM 121
M
Sbjct: 186 IM 187
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-08
Identities = 40/131 (30%), Positives = 65/131 (49%), Gaps = 8/131 (6%)
Query: 5 VRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMR---PRCLDIHVAIGFALDIAR 60
+ H N+++ +G C E + ++V E G L+ YL + R + V A ++A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE-MMTAETGTY--RWMA 117
+ LH IH DL N LTAD +VK+ D+GLA E+ + +T + RW+A
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLA 170
Query: 118 PENMRPSAENL 128
PE + ++L
Sbjct: 171 PELVEIRGQDL 181
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-08
Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ V E GG L +L R R A + +I A+E LHS +++RD+K ENL+
Sbjct: 70 LCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 127
Query: 82 LTADHKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
L D +K+ DFGL + E +++ T +T GT ++APE
Sbjct: 128 LDKDGH-IKITDFGLCK-EGISDGATMKTFCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 39/121 (32%), Positives = 61/121 (50%), Gaps = 8/121 (6%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+++ + H V G+ K E + +V E ++GG +L R + V +A I
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIV 141
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE-TGTYRWMAP 118
E L S I++RDLKPENL+L D +K+ DFG A+ + + T GT ++AP
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAK---VVDTRTYTLCGTPEYIAP 197
Query: 119 E 119
E
Sbjct: 198 E 198
|
Length = 340 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-08
Identities = 47/203 (23%), Positives = 78/203 (38%), Gaps = 51/203 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M+ V + + +G C + +VT+L+ G L Y+ + R + + + + IA+
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQIAK 120
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG---TYRWMA 117
M L ++HRDL N +L VK+ DFGLAR + E G +WMA
Sbjct: 121 GMSYLEEVRLVHRDLAARN-VLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 118 PEN--------------------------MRP--------------SAENLPE------D 131
E+ +P E LP+ D
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID 239
Query: 132 LALIVTSCWKEDPNERPNFSQII 154
+ +I+ CW D RP F +++
Sbjct: 240 VYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-08
Identities = 28/68 (41%), Positives = 42/68 (61%), Gaps = 3/68 (4%)
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE--ESLTEMMTAETGTYR 114
+I A+E LH GI++RD+K EN++L ++ V L DFGL++E E + GT
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 115 WMAPENMR 122
+MAPE +R
Sbjct: 172 YMAPEIIR 179
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-08
Identities = 40/136 (29%), Positives = 63/136 (46%), Gaps = 16/136 (11%)
Query: 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRC-----------LDI 48
+++ ++H ++VKF G C E +++V E + G L K+L P L
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 49 HVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTA 108
+ A IA M L S +HRDL N L ++ VK+ DFG++R+ T+
Sbjct: 120 SQMLHIAQQIAAGMVYLASQHFVHRDLATRN-CLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 109 ETGTY---RWMAPENM 121
T RWM PE++
Sbjct: 179 GGHTMLPIRWMPPESI 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-08
Identities = 42/165 (25%), Positives = 63/165 (38%), Gaps = 55/165 (33%)
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG 111
I ++ +A+ ME L S IHRDL N IL +++ VK+ DFGLAR + + G
Sbjct: 182 ICYSFQVAKGMEFLASRKCIHRDLAARN-ILLSENNVVKICDFGLAR-DIYKDPDYVRKG 239
Query: 112 TYR----WMAPE------------------------------------------------ 119
R WMAPE
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 299
Query: 120 NMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164
MR PE + + CW +P++RP FS++++ L + + N
Sbjct: 300 RMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 39/125 (31%), Positives = 61/125 (48%), Gaps = 9/125 (7%)
Query: 9 NLVKFIGAC-KEPVMVIVTELLLGG--TLRKYLLNMRPRCLDIHVAIGFALDIARAMECL 65
+VKF GA +E I EL+ KY+ + + + A+ +A+ L
Sbjct: 64 YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123
Query: 66 -HSHGIIHRDLKPENLILTADHKTVKLADFGLA--REESLTEMMTAETGTYRWMAPENMR 122
IIHRD+KP N IL + +KL DFG++ +S+ + T + G +MAPE +
Sbjct: 124 KEELKIIHRDVKPSN-ILLDRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERID 180
Query: 123 PSAEN 127
PSA +
Sbjct: 181 PSARD 185
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-08
Identities = 38/138 (27%), Positives = 64/138 (46%), Gaps = 18/138 (13%)
Query: 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRC-------------L 46
+++ ++H+++V+F G C E +++V E + G L ++L + P L
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119
Query: 47 DIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMM 106
+ + A IA M L S +HRDL N L VK+ DFG++R+ T+
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHFVHRDLATRN-CLVGQGLVVKIGDFGMSRDIYSTDYY 178
Query: 107 TAETGTY---RWMAPENM 121
T RWM PE++
Sbjct: 179 RVGGRTMLPIRWMPPESI 196
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-08
Identities = 51/222 (22%), Positives = 78/222 (35%), Gaps = 75/222 (33%)
Query: 1 MMSRVRHRNLVKFIG-ACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD-- 57
M SR++H N+V +G KE + ++ L ++L+ P H +G D
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSP-----HSDVGSTDDDK 115
Query: 58 -----------------IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE- 99
IA ME L SH ++H+DL N +L D VK++D GL RE
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN-VLVFDKLNVKISDLGLFREV 174
Query: 100 --ESLTEMMTAETGTYRWMAPE-------------------------------------- 119
++M RWM+PE
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234
Query: 120 --------NMRPSAENLPEDLALIVTSCWKEDPNERPNFSQI 153
+ P ++ P + ++ CW E P+ RP F I
Sbjct: 235 VIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-08
Identities = 40/122 (32%), Positives = 64/122 (52%), Gaps = 8/122 (6%)
Query: 1 MMSRVRHRNLVKFIGA--CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M +H+N+V+ + E + V++ E L GG L + R L+ +
Sbjct: 71 IMRDYQHQNVVEMYKSYLVGEELWVLM-EFLQGGALTDIVSQTR---LNEEQIATVCESV 126
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMA 117
+A+ LHS G+IHRD+K ++++LT D + VKL+DFG + S + GT WMA
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWMA 185
Query: 118 PE 119
PE
Sbjct: 186 PE 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-08
Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 7/121 (5%)
Query: 5 VRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRP--RCLDIHVAIGFALDIARA 61
++H N+++ +G C E + ++V E G L+ YL + R + + A +IA
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 62 MECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY---RWMAP 118
+ +H H +H DL N LT+D TVK+ D+G+ + + E RW+AP
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 119 E 119
E
Sbjct: 171 E 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-08
Identities = 32/123 (26%), Positives = 63/123 (51%), Gaps = 6/123 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M ++ + +V+ IG C+ +++V E+ GG L K+L + + + + ++
Sbjct: 48 IMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSM 106
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR----EESLTEMMTAETGTYRWM 116
M+ L +HRDL N++L H K++DFGL++ ++S + +A +W
Sbjct: 107 GMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARSAGKWPLKWY 165
Query: 117 APE 119
APE
Sbjct: 166 APE 168
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-08
Identities = 43/123 (34%), Positives = 61/123 (49%), Gaps = 12/123 (9%)
Query: 7 HRNLVKFIGA------CKEPVMVIVTELLLGGT---LRKYLLNMRPRCLDIHVAIGFALD 57
H N+VKF G + +V EL GG+ L K LL R LD +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYG 136
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWM 116
++ LH++ IIHRD+K N++LT + VKL DFG++ + + T + GT WM
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 195
Query: 117 APE 119
APE
Sbjct: 196 APE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-08
Identities = 37/100 (37%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ V E + GG L +L R R + +I A++ LHS I++RDLK ENL+
Sbjct: 70 LCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLM 127
Query: 82 LTADHKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
L D +K+ DFGL + E +T+ T +T GT ++APE
Sbjct: 128 LDKDGH-IKITDFGLCK-EGITDAATMKTFCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-08
Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN-LIL 82
+V E GG L LLN D +A + ++ A+ +H G +HRD+KPEN LI
Sbjct: 78 LVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID 136
Query: 83 TADHKTVKLADFGLAREESLTEMMTAE--TGTYRWMAPE 119
H +KLADFG A + +M+ ++ GT ++APE
Sbjct: 137 RTGH--IKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-08
Identities = 39/127 (30%), Positives = 63/127 (49%), Gaps = 12/127 (9%)
Query: 1 MMSRVRHRNLVKFIGACKEP---VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
++ + H +V++ G ++P + I E + GG+++ L + L +V +
Sbjct: 57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQ 114
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-----ESLTEMMTAETGT 112
I + LHS+ I+HRD+K N IL VKL DFG ++ S T M + TGT
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGAN-ILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGT 172
Query: 113 YRWMAPE 119
WM+PE
Sbjct: 173 PYWMSPE 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-08
Identities = 25/68 (36%), Positives = 39/68 (57%), Gaps = 1/68 (1%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY 113
F + R + +H I+HRDLKP+NL+++ D +KLADFGLAR +S+ +
Sbjct: 108 FLFQLLRGLSYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVT 166
Query: 114 RWMAPENM 121
W P ++
Sbjct: 167 LWYRPPDV 174
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-08
Identities = 39/156 (25%), Positives = 60/156 (38%), Gaps = 57/156 (36%)
Query: 55 ALDIARAMECLHSH-GIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMM--TAETG 111
A+ I +A+E LHS +IHRD+KP N +L + VKL DFG++ L + + T + G
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSN-VLINRNGQVKLCDFGISGY--LVDSVAKTIDAG 165
Query: 112 TYRWMAPENMRPS----------------------------------------------- 124
+MAPE + P
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS 225
Query: 125 ----AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156
AE + V C K++ ERPN+ +++Q
Sbjct: 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-08
Identities = 44/214 (20%), Positives = 80/214 (37%), Gaps = 66/214 (30%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+MS++ H++LVK G C ++V E + G L +L + +H + A +A
Sbjct: 54 LMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLAS 112
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKT------VKLADFGLAREESLTEMMTAETGTYR 114
A+ L ++H ++ +N+++ +KL+D G+ +T + R
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--------ITVLSREER 164
Query: 115 -----WMAPENMRPSAENL--------------------PEDL----------------- 132
W+APE +R +L E L
Sbjct: 165 VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224
Query: 133 ---------ALIVTSCWKEDPNERPNFSQIIQML 157
A ++ CW DP +RP+F I++ L
Sbjct: 225 LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 8e-08
Identities = 23/76 (30%), Positives = 32/76 (42%), Gaps = 14/76 (18%)
Query: 62 MECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121
+ LH + I+HRD+K N IL + +K+ADFGLAR Y P
Sbjct: 128 INYLHENHILHRDIKAAN-ILIDNQGILKIADFGLAR-------------PYDGPPPNPK 173
Query: 122 RPSAENLPEDLALIVT 137
+ L+VT
Sbjct: 174 GGGGGGTRKYTNLVVT 189
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-08
Identities = 29/82 (35%), Positives = 47/82 (57%), Gaps = 2/82 (2%)
Query: 46 LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL-TE 104
+ +H F I R + H ++HRDLKP+NL++ + +KLADFGLAR +S+ T+
Sbjct: 101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTK 159
Query: 105 MMTAETGTYRWMAPENMRPSAE 126
+ E T + P+ + S+E
Sbjct: 160 TYSNEVVTLWYRPPDVLLGSSE 181
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 6/103 (5%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ +V E + GG L ++ R R L A +A +I A+ LH GII+RDLK +N++
Sbjct: 71 LFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVL 128
Query: 82 LTADHKTVKLADFGLAREESLTEMMTAET--GTYRWMAPENMR 122
L AD +KL D+G+ + E L T T GT ++APE +R
Sbjct: 129 LDADGH-IKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILR 169
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 36/103 (34%), Positives = 58/103 (56%), Gaps = 6/103 (5%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ V E + GG L ++ R R L A ++ +I+ A+ LH GII+RDLK +N++
Sbjct: 71 LFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVL 128
Query: 82 LTADHKTVKLADFGLAREESLTEMMTAET--GTYRWMAPENMR 122
L A+ +KL D+G+ + E + T T GT ++APE +R
Sbjct: 129 LDAEGH-IKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILR 169
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-07
Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ +V + GG L +L R D+ A + ++ A+E LH +I+RDLKPEN++
Sbjct: 68 LYLVLAFINGGELFHHL--QREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENIL 125
Query: 82 LT-ADHKTVKLADFGLAR-EESLTEMMTAETGTYRWMAPE 119
L H + L DFGL + + GT ++APE
Sbjct: 126 LDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPE 163
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 19/139 (13%)
Query: 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYL----------LNMRPRC---- 45
+++ ++H ++VKF G C + +++V E + G L K+L ++ +PR
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 46 LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM 105
L + + A IA M L S +HRDL N L + VK+ DFG++R+ T+
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRN-CLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 106 MTAETGTY---RWMAPENM 121
T RWM PE++
Sbjct: 179 YRVGGHTMLPIRWMPPESI 197
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-07
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 6/164 (3%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++H N+V E + +V E L L++YL + +++H F +
Sbjct: 57 LLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC-GNSINMHNVKLFLFQLL 114
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAP 118
R + H ++HRDLKP+NL++ + +KLADFGLAR +S+ T+ + E T + P
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173
Query: 119 ENMRPSAENLPEDLALIVTSCWKEDPNERPNF-SQIIQMLLHYI 161
+ + S + + V + E RP F ++ LH+I
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 25/74 (33%), Positives = 44/74 (59%), Gaps = 3/74 (4%)
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
A + ++ A++ +HS G IHRD+KP+N++L +KLADFG + M+ +T
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTCMKMDANGMVRCDT 202
Query: 111 --GTYRWMAPENMR 122
GT +++PE ++
Sbjct: 203 AVGTPDYISPEVLK 216
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 20/37 (54%), Positives = 28/37 (75%), Gaps = 3/37 (8%)
Query: 61 AMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGL 96
A++ +H G IHRD+KP+NL+L A H +KL+DFGL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL-TEMMTAETGT 112
F + R + +H I+HRDLKP+NL+++ + +KLADFGLAR +S+ ++ ++E T
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE-LKLADFGLARAKSIPSQTYSSEVVT 166
Query: 113 YRWMAPENMRPSAENLPEDLALIVTSC 139
W P ++ A + L + C
Sbjct: 167 L-WYRPPDVLLGATDYSSALDIWGAGC 192
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 27/71 (38%), Positives = 47/71 (66%), Gaps = 4/71 (5%)
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
A+ +A +I+ + LH GII+RDLK +N++L ++ +K+ADFG+ + E + + +T T
Sbjct: 103 AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMCK-EHMVDGVTTRT 160
Query: 111 --GTYRWMAPE 119
GT ++APE
Sbjct: 161 FCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 36/99 (36%), Positives = 57/99 (57%), Gaps = 4/99 (4%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ V E + GG L Y + R + H A+ +A +IA + LHS GII+RDLK +N++
Sbjct: 76 LYFVMEYVNGGDL-MYQIQQVGRFKEPH-AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM 133
Query: 82 LTADHKTVKLADFGLAREESLTEMMTAE-TGTYRWMAPE 119
L ++ +K+ADFG+ +E + T GT ++APE
Sbjct: 134 LDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-07
Identities = 18/45 (40%), Positives = 29/45 (64%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98
F + R ++ +HS ++HRDLKP N+ + + +K+ DFGLAR
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 26/62 (41%), Positives = 33/62 (53%), Gaps = 5/62 (8%)
Query: 68 HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMM--TAETGTYRWMAPENMRPSA 125
HG+IHRD+KP N IL VKL DFG++ L + T G +MAPE + P
Sbjct: 134 HGVIHRDVKPSN-ILLDASGNVKLCDFGISGR--LVDSKAKTRSAGCAAYMAPERIDPPD 190
Query: 126 EN 127
N
Sbjct: 191 PN 192
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-07
Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 13/109 (11%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRP---------RCLDIH 49
+MSR++ N+++ + C +P+ +I TE + G L ++L P +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMI-TEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 50 VAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98
I A IA M+ L S +HRDL N L + T+K+ADFG++R
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRN-CLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-07
Identities = 37/113 (32%), Positives = 57/113 (50%), Gaps = 9/113 (7%)
Query: 10 LVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH 68
++ F GA E + I TE + GG+L Y R + HV A+ + + + L S
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSL 114
Query: 69 GIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121
I+HRD+KP N +L VKL DFG++ + + + GT +MAPE +
Sbjct: 115 KILHRDVKPSN-MLVNTRGQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERI 165
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 3e-07
Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 8/77 (10%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+IV E + G L+ + + L++ IG + + LHS GIIH DL N+I
Sbjct: 74 FIIVMEYIEGEPLKDLINSNGMEELELSREIGRL--VGK----LHSAGIIHGDLTTSNMI 127
Query: 82 LTADHKTVKLADFGLAR 98
L+ + L DFGLA
Sbjct: 128 LSGG--KIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-07
Identities = 30/94 (31%), Positives = 39/94 (41%), Gaps = 1/94 (1%)
Query: 39 LNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98
L R R L I A+ I + LH+ IIHRD+K EN I D V + D G A+
Sbjct: 147 LTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTEN-IFINDVDQVCIGDLGAAQ 205
Query: 99 EESLTEMMTAETGTYRWMAPENMRPSAENLPEDL 132
+ GT APE + N D+
Sbjct: 206 FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADI 239
|
Length = 357 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 26/62 (41%), Positives = 38/62 (61%), Gaps = 3/62 (4%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ + ++ +H+ GIIHRDLKP NL + D + +K+ DFGLAR+ MT T + A
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQTD--SEMTGYVVTRWYRA 183
Query: 118 PE 119
PE
Sbjct: 184 PE 185
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 24/60 (40%), Positives = 35/60 (58%), Gaps = 6/60 (10%)
Query: 65 LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE-----MMTAETGTYRWMAPE 119
+H + I+HRD+K N+++T D +KLADFGLAR SL++ T T + PE
Sbjct: 135 IHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-07
Identities = 29/71 (40%), Positives = 41/71 (57%), Gaps = 3/71 (4%)
Query: 27 ELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADH 86
E ++ G +K NM DI+V G + + LH GI+HRD+KPENL++T D
Sbjct: 289 EFMMAG--KKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG 346
Query: 87 KTVKLADFGLA 97
+ VK+ DFG A
Sbjct: 347 Q-VKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-07
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 8/86 (9%)
Query: 40 NMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE 99
+ P LD+ + F+ +A+ M+ L S IHRD+ N++LT D + K+ DFGLAR
Sbjct: 205 DSWP--LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLAR- 260
Query: 100 ESLTEMMTAETGTYR----WMAPENM 121
+ + + G R WMAPE++
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESI 286
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-07
Identities = 21/45 (46%), Positives = 32/45 (71%), Gaps = 1/45 (2%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98
F + RA++ +H+ + HRDLKP+N++ AD K +K+ DFGLAR
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-07
Identities = 26/66 (39%), Positives = 42/66 (63%), Gaps = 2/66 (3%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY 113
+A +I +E +H+ +++RDLKP N IL +H V+++D GLA + S + A GT+
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPAN-ILLDEHGHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 114 RWMAPE 119
+MAPE
Sbjct: 160 GYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-07
Identities = 27/55 (49%), Positives = 33/55 (60%), Gaps = 3/55 (5%)
Query: 65 LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+HS GIIHRDLKP NL + D + +K+ DFGLAR MT T + APE
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR--HADAEMTGYVVTRWYRAPE 184
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-07
Identities = 35/105 (33%), Positives = 58/105 (55%), Gaps = 4/105 (3%)
Query: 19 EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78
E + V E + GG L ++ R R L A ++ +I+ A+ LH GII+RDLK +
Sbjct: 68 ESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 125
Query: 79 NLILTADHKTVKLADFGLAREESLTEMMTAE-TGTYRWMAPENMR 122
N++L ++ +KL D+G+ +E T+ GT ++APE +R
Sbjct: 126 NVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 29/74 (39%), Positives = 43/74 (58%), Gaps = 10/74 (13%)
Query: 53 GFALDIAR----AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMM-- 106
F D+AR + LH I+HRD+KP NL++ + K VK+ADFG++R L + M
Sbjct: 168 QFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINS-AKNVKIADFGVSR--ILAQTMDP 224
Query: 107 -TAETGTYRWMAPE 119
+ GT +M+PE
Sbjct: 225 CNSSVGTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 18/40 (45%), Positives = 27/40 (67%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA 97
I A++ LHS GI+HRD+KP+N+I + + K+ D G A
Sbjct: 264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 1e-06
Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 11/77 (14%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
IV E + G K ++ ++ IG + + LH GI+H DL N+I
Sbjct: 72 KTIVMEYI-EGKPLKDVIE--EGNDELLREIGRL--VGK----LHKAGIVHGDLTTSNII 122
Query: 82 LTADHKTVKLADFGLAR 98
+ D + L DFGL +
Sbjct: 123 VRDD--KLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 24/71 (33%), Positives = 44/71 (61%), Gaps = 3/71 (4%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET--G 111
+ ++ A++ +HS G IHRD+KP+N++L +KLADFG + + M+ +T G
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVG 205
Query: 112 TYRWMAPENMR 122
T +++PE ++
Sbjct: 206 TPDYISPEVLK 216
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 25/66 (37%), Positives = 43/66 (65%), Gaps = 2/66 (3%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY 113
+A +I +E +H+ +++RDLKP N++L +H V+++D GLA + S + A GT+
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 114 RWMAPE 119
+MAPE
Sbjct: 160 GYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-06
Identities = 41/122 (33%), Positives = 62/122 (50%), Gaps = 10/122 (8%)
Query: 7 HRNLVKFIGAC-KEPV-----MVIVTELLLGGTLRKYLLNMRPRCLDIH-VAIGFALDIA 59
H N+VKF G K+ V + +V EL GG++ + R + I + L A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 60 -RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMA 117
++ LH + IHRD+K N++LT + VKL DFG++ + + T + GT WMA
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 118 PE 119
PE
Sbjct: 193 PE 194
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 20/45 (44%), Positives = 31/45 (68%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98
++ + RA+ +HS I HRDLKP+NL++ + T+KL DFG A+
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-06
Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 9/132 (6%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++++++H N+V F + + + + IV E GG L + + R + + + + +
Sbjct: 51 LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET--GTYRWMA 117
++ +H ++HRD+K +N+ LT + K VKL DFG AR + + A T GT ++
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFLTQNGK-VKLGDFGSARLLT-SPGAYACTYVGTPYYVP 168
Query: 118 PENMRPSAENLP 129
PE EN+P
Sbjct: 169 PEIW----ENMP 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 33/116 (28%), Positives = 56/116 (48%), Gaps = 19/116 (16%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLL---------NMRPRCLDIH- 49
++SR++ N+++ +G C E + ++TE + G L ++L N H
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 50 -------VAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98
+ AL IA M+ L S +HRDL N L ++ T+K+ADFG++R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN-CLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-06
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 21/83 (25%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR--------AMECLHSHGIIHRDL 75
++ E L GG L L+ D F+ D+ R A+E +H G IHRD+
Sbjct: 78 LIMEFLPGGDLMTMLIKY-----DT-----FSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 76 KPENLILTAD-HKTVKLADFGLA 97
KP+N+++ H +KL+DFGL+
Sbjct: 128 KPDNILIDRGGH--IKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 5e-06
Identities = 18/58 (31%), Positives = 28/58 (48%), Gaps = 3/58 (5%)
Query: 65 LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122
LH H IIH D+K EN++ + L D+GL + GT + +PE ++
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY---DGTLDYFSPEKIK 179
|
Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-06
Identities = 26/70 (37%), Positives = 41/70 (58%), Gaps = 7/70 (10%)
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY 113
+ + +A+ H + I+HRD+KPENL+++ + +KL DFG AR +L+E A Y
Sbjct: 105 YIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFAR--NLSEGSNANYTEY 161
Query: 114 ---RWM-APE 119
RW +PE
Sbjct: 162 VATRWYRSPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-06
Identities = 44/205 (21%), Positives = 77/205 (37%), Gaps = 51/205 (24%)
Query: 2 MSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ + H N+V+ G + M+IVTE + G L +L + L +G +A
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLAS 118
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG--TYRWMAP 118
M+ L G +H+ L +++ +D K++ F +E+ + T +G W AP
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 119 ENMR----------------------------------------------PSAENLPEDL 132
E ++ P+ N P L
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL 237
Query: 133 ALIVTSCWKEDPNERPNFSQIIQML 157
++ CW+++ ERP FSQI +L
Sbjct: 238 HQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 23/51 (45%), Positives = 29/51 (56%), Gaps = 9/51 (17%)
Query: 54 FALDIAR--------AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGL 96
F D+AR A+E +H G IHRD+KP+N IL +KL DFGL
Sbjct: 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDN-ILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 34/115 (29%), Positives = 58/115 (50%), Gaps = 6/115 (5%)
Query: 10 LVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS- 67
+V F GA E + + E + G+L + P ++I I A+ + + L++
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKI--AVAVVEGLTYLYNV 122
Query: 68 HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122
H I+HRD+KP N IL +KL DFG++ E + + GT +M+PE ++
Sbjct: 123 HRIMHRDIKPSN-ILVNSRGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQ 175
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 7/101 (6%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKPENL 80
+ V E GG L +L R R A + +I A++ LHS +++RDLK ENL
Sbjct: 70 LCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 127
Query: 81 ILTADHKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
+L D +K+ DFGL + E + + T +T GT ++APE
Sbjct: 128 MLDKDGH-IKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 24/75 (32%), Positives = 41/75 (54%), Gaps = 3/75 (4%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ V + + GG + L+ M +A + ++ A+E +H G IHRD+KP+N++
Sbjct: 76 LYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL 133
Query: 82 LTADHKTVKLADFGL 96
+ D +KL DFGL
Sbjct: 134 IDLDGH-IKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-05
Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 15/146 (10%)
Query: 65 LHSHGIIHRDLKPENLILTADHKTVKLADFGLAR-EESLTEMMTAETGTYRWMAPENMRP 123
+H I+HRDLK +N+ L + +K+ DFG++R ++ T TGT +M+PE ++
Sbjct: 122 MHQRRILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 124 SAENLPEDL----ALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSE 179
+ D+ ++ C E NF ++ + P P LP +S +
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV------LRIVEGPTPS-LPETYSRQ 232
Query: 180 -NAVLPPESPGTSSLMPPRDDSERNP 204
N+++ SL P + RNP
Sbjct: 233 LNSIMQSMLNKDPSLRPSAAEILRNP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-05
Identities = 35/118 (29%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 10 LVKFIGA-CKEPVMVIVTELLLGGTLRK-YLLNMRPRCLDIHVAIGFALDIARAMECL-H 66
+V F GA E + + E + G+L K Y + + V + + ++ L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 67 SHGIIHRDLKPENLILTADHKTVKLADFGLA--REESLTEMMTAETGTYRWMAPENMR 122
H IIHRD+KP N +L + VKL DFG++ SL + G +MAPE ++
Sbjct: 121 EHNIIHRDVKPTN-VLVNGNGQVKLCDFGVSGNLVASLAK---TNIGCQSYMAPERIK 174
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 27/75 (36%), Positives = 41/75 (54%), Gaps = 3/75 (4%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ ++ E L GG + L M+ L + + A++ +H G IHRD+KP+NL+
Sbjct: 76 LYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL 133
Query: 82 LTADHKTVKLADFGL 96
L A VKL+DFGL
Sbjct: 134 LDAKGH-VKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-05
Identities = 23/91 (25%), Positives = 34/91 (37%), Gaps = 11/91 (12%)
Query: 16 ACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75
+IV E + G L+ L D+ +G + + LH GI+H DL
Sbjct: 68 DVDPDNGLIVMEYIEGELLKDAL---EEARPDLLREVG--RLVGK----LHKAGIVHGDL 118
Query: 76 KPENLILTADHKTVKLADFGLAREESLTEMM 106
N+IL+ + DFGL E
Sbjct: 119 TTSNIILSGGR--IYFIDFGLGEFSDEVEDK 147
|
Length = 204 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 49/212 (23%), Positives = 82/212 (38%), Gaps = 61/212 (28%)
Query: 1 MMSRVRHRNLVKFIGAC---KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
MMS++ H++LV G C E +M V E + G+L Y L ++I + A
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIM--VQEYVKFGSLDTY-LKKNKNLINISWKLEVAKQ 108
Query: 58 IARAMECLHSHGIIHRDLKPENLILT--ADHKT-----VKLADFGLAREESLTEMMTAET 110
+A A+ L G+ H ++ +N++L D KT +KL+D G++ E++
Sbjct: 109 LAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI 168
Query: 111 GTYRWMAPENMR-PSAENLPED-------------------------------------- 131
W+ PE + P +L D
Sbjct: 169 ---PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLP 225
Query: 132 ------LALIVTSCWKEDPNERPNFSQIIQML 157
LA ++ C +P+ RP+F II+ L
Sbjct: 226 APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 3e-05
Identities = 25/83 (30%), Positives = 34/83 (40%), Gaps = 12/83 (14%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
IV E + GG K +L P + + + LH GI+H DL N I
Sbjct: 411 KTIVMEYI-GGKDLKDVLEGNPELVR---------KVGEIVAKLHKAGIVHGDLTTSNFI 460
Query: 82 LTADHKTVKLADFGLAREESLTE 104
+ D + L DFGL + L E
Sbjct: 461 VRDD-RLY-LIDFGLGKYSDLIE 481
|
Length = 535 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 26/84 (30%), Positives = 35/84 (41%), Gaps = 20/84 (23%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA----------------REES 101
I +E +HS G++HRDLKP+N IL V + D+G A
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDN-ILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 102 LTEMMTAE---TGTYRWMAPENMR 122
MT GT +MAPE +
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLL 204
|
Length = 932 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-05
Identities = 26/75 (34%), Positives = 41/75 (54%), Gaps = 3/75 (4%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ ++ E L GG + L M+ L + + A++ +H G IHRD+KP+NL+
Sbjct: 76 LYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLL 133
Query: 82 LTADHKTVKLADFGL 96
L + VKL+DFGL
Sbjct: 134 LDS-KGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-05
Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 8/126 (6%)
Query: 10 LVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDIARAMECLH 66
+V F GA + + I E + GG+L + L + P + V+I +A E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--- 121
Query: 67 SHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAE 126
H I+HRD+KP N IL +KL DFG++ + + M + GT +M+PE ++ +
Sbjct: 122 KHQIMHRDVKPSN-ILVNSRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 127 NLPEDL 132
++ D+
Sbjct: 180 SVQSDI 185
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-05
Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 15/87 (17%)
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEN 120
A+E +H G IHRD+KP+N+++ D +KL DFGL TG +RW
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLC------------TG-FRWTHDSK 158
Query: 121 MRPSAENLPEDLALIVTSCWKEDPNER 147
S +++ +D ++ ++ W + N R
Sbjct: 159 YYQSGDHVRQD-SMDFSNEWGDPANCR 184
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 21/52 (40%), Positives = 31/52 (59%), Gaps = 2/52 (3%)
Query: 68 HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
H I+HRD+KP N IL +KL DFG++ + + M + GT +M+PE
Sbjct: 119 HKIMHRDVKPSN-ILVNSRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 22/65 (33%), Positives = 38/65 (58%), Gaps = 2/65 (3%)
Query: 68 HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAEN 127
H I+HRD+KP N IL +KL DFG++ + + M + GT +M+PE ++ + +
Sbjct: 123 HKIMHRDVKPSN-ILVNSRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYS 180
Query: 128 LPEDL 132
+ D+
Sbjct: 181 VQSDI 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 21/64 (32%), Positives = 37/64 (57%), Gaps = 3/64 (4%)
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFG--LAREESLTEMMTAETGTYRWMAP 118
A++ +H G +HRD+KP+N++L + ++LADFG L T GT +++P
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDK-NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
Query: 119 ENMR 122
E ++
Sbjct: 173 EILQ 176
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 29/83 (34%), Positives = 36/83 (43%), Gaps = 10/83 (12%)
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEN 120
A+ LH GIIHRD+K EN+ L + + L DFG A + + Y W
Sbjct: 197 ALAYLHGRGIIHRDVKTENIFLD-EPENAVLGDFGAACK---LDAHPDTPQCYGWSGTLE 252
Query: 121 MRPSAENLPEDLALIVTSCWKED 143
N PE LAL C K D
Sbjct: 253 T-----NSPELLALD-PYCAKTD 269
|
Length = 392 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 5e-04
Identities = 15/41 (36%), Positives = 28/41 (68%), Gaps = 1/41 (2%)
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA 97
D+ +E +H HGI H D+KPEN+++ +++ + D+G+A
Sbjct: 134 DMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIA 173
|
Length = 294 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 6e-04
Identities = 22/59 (37%), Positives = 31/59 (52%), Gaps = 1/59 (1%)
Query: 39 LNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA 97
L R R L + A + A++ +H GIIHRD+K EN +L + + L DFG A
Sbjct: 250 LGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 6e-04
Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 4/100 (4%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ +V + +GG L L R L +A + ++ A++ +H +HRD+KP+N++
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134
Query: 82 LTADHKTVKLADFG--LAREESLTEMMTAETGTYRWMAPE 119
+ + ++LADFG L E T + GT +++PE
Sbjct: 135 MDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 7e-04
Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 4/103 (3%)
Query: 19 EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78
E + +V + +GG L L R L +A + ++ A+ +H +HRD+KP+
Sbjct: 73 ENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPD 131
Query: 79 NLILTADHKTVKLADFG--LAREESLTEMMTAETGTYRWMAPE 119
N++L + ++LADFG L + T + GT +++PE
Sbjct: 132 NVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 9e-04
Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 10/114 (8%)
Query: 18 KEPVMVIVTELLL----GGTLRKYLLNMRP--RCLDIHVAIGFALDIARAMECLHSHGII 71
+ P V++ L+L G LR+ + + R H A + + A+ +HS +I
Sbjct: 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMI 165
Query: 72 HRDLKPENLILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMR 122
HRD+K N++L ++ VKL DFG ++ + T ++ GT ++APE R
Sbjct: 166 HRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218
|
Length = 496 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 17/33 (51%), Positives = 21/33 (63%), Gaps = 1/33 (3%)
Query: 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98
H +HRD+K N IL + +KLADFGLAR
Sbjct: 133 HKKNFLHRDIKCSN-ILLNNKGQIKLADFGLAR 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.002
Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 11/93 (11%)
Query: 10 LVKFIGACKEPVMVIVTELLLGGTLRKYL---LNMRPRCLDIHVAIGFALDIARAMECLH 66
L K+I E + +V + GG L ++ LN+ C+ +A ++ A++ LH
Sbjct: 50 LHKYI--VSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-----RWAAEMVVALDALH 102
Query: 67 SHGIIHRDLKPENLILTADHKTVKLADFGLARE 99
GI+ RDL P N++L D ++L F E
Sbjct: 103 REGIVCRDLNPNNILLD-DRGHIQLTYFSRWSE 134
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 22/65 (33%), Positives = 39/65 (60%), Gaps = 4/65 (6%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT---EMMTAETGTYR 114
I A++ +HS ++HRDLK N+ L +KL DFG +++ S + ++ ++ GT
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 115 WMAPE 119
++APE
Sbjct: 237 YLAPE 241
|
Length = 478 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 19/37 (51%), Positives = 24/37 (64%), Gaps = 1/37 (2%)
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA 97
A+E +H +IHRD+K EN+ L D K V L DFG A
Sbjct: 279 AVEYIHDKKLIHRDIKLENIFLNCDGKIV-LGDFGTA 314
|
Length = 501 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 37.0 bits (85), Expect = 0.004
Identities = 20/62 (32%), Positives = 32/62 (51%), Gaps = 3/62 (4%)
Query: 40 NMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA---DHKTVKLADFGL 96
N +P L + I + LH++ ++HRDLKP N+++ + VK+AD G
Sbjct: 99 NKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158
Query: 97 AR 98
AR
Sbjct: 159 AR 160
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 223 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.98 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.95 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.95 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.95 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.95 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.95 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.95 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.95 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.95 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.95 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.95 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.94 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.94 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.94 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.94 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.94 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.94 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.94 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.94 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.94 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.94 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.94 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.94 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.94 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.94 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.94 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.94 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.94 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.94 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.94 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.94 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.94 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.94 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.93 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.93 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.93 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.93 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.93 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.93 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.93 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.93 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.93 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.93 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.93 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.93 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.93 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.93 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.93 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.93 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.93 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.93 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.93 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.93 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.93 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.93 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.93 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.93 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.93 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.92 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.92 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.92 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.92 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.92 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.92 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.92 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.92 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.92 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.92 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.92 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.92 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.92 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.91 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.91 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.91 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.91 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.91 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.91 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.9 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.9 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.9 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.9 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.9 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.89 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.89 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.88 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.88 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.88 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.87 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.86 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.86 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.85 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.84 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.83 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.83 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.8 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.79 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.75 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.75 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.74 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.71 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.61 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.59 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.57 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.57 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.56 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.48 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.44 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.44 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.31 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.29 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.28 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.18 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.16 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.15 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.12 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.07 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.86 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.82 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.65 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.36 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.2 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 97.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.9 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.77 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.69 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.45 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.3 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.28 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.2 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.16 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.68 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.54 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.17 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.02 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.76 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.62 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.56 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.4 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 95.18 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.67 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.67 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.57 | |
| PLN02236 | 344 | choline kinase | 94.53 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.41 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.34 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.23 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.99 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.94 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.85 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 93.84 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 93.47 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 93.42 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 93.06 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.99 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.92 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 92.87 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 91.97 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.57 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 91.53 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 91.49 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 91.3 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 90.54 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 90.39 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=256.13 Aligned_cols=157 Identities=27% Similarity=0.466 Sum_probs=137.7
Q ss_pred CCCCCCCCCccceEEEeecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||++|+|||||+++++|++. ..||||||++||.|.+.+..++. +.+..-..++.|++.|+.|||++||+||||||+|
T Consensus 229 ILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeN 306 (475)
T KOG0615|consen 229 ILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPEN 306 (475)
T ss_pred HHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcCcccccCCcce
Confidence 58999999999999999864 66999999999999999987665 8888889999999999999999999999999999
Q ss_pred EEEeCC---CCceEEccCccccccccccccccCCCccccccCCCCCCC--------------------------------
Q 027476 80 LILTAD---HKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS-------------------------------- 124 (223)
Q Consensus 80 ill~~~---~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------------------- 124 (223)
||+..+ . .+||+|||+|+.........+.+|||.|.|||++...
T Consensus 307 ILl~~~~e~~-llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 307 ILLSNDAEDC-LLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred EEeccCCcce-EEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 999765 4 7999999999988878888999999999999976511
Q ss_pred --------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 125 --------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 125 --------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
-..++.+..++|.+||..||++||++++++++ .++.
T Consensus 386 ~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h--pW~~ 441 (475)
T KOG0615|consen 386 TDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH--PWFK 441 (475)
T ss_pred CCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC--hhhh
Confidence 11244567789999999999999999999887 5554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=261.12 Aligned_cols=164 Identities=30% Similarity=0.487 Sum_probs=141.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|.++|+|||||+++++|+| +..|+|.|+|.+++|.+++++++. ++|.+++.++.||+.||.|||+++|+|||||..|
T Consensus 71 IHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~--ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGN 148 (592)
T KOG0575|consen 71 IHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKP--LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGN 148 (592)
T ss_pred HHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCC--CCcHHHHHHHHHHHHHHHHHHhcCceecccchhh
Confidence 4578999999999999998 578999999999999999986555 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCCCCCC------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPSAENL------------------------------ 128 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~------------------------------ 128 (223)
++++.+. .|||+|||+|...... +...+.+|||.|+|||++.....++
T Consensus 149 lfL~~~~-~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety 227 (592)
T KOG0575|consen 149 LFLNENM-NVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY 227 (592)
T ss_pred eeecCcC-cEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH
Confidence 9999887 8999999999876644 6677899999999999876444444
Q ss_pred --------------hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCCC
Q 027476 129 --------------PEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEP 169 (223)
Q Consensus 129 --------------~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~~ 169 (223)
+.+..+||.++|+.+|.+||++++++.+ .++.....|..
T Consensus 228 ~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h--~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 228 NKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH--PFFKSGFTPAR 280 (592)
T ss_pred HHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC--HhhhCCCcCCC
Confidence 4445568899999999999999999987 66655544443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=250.04 Aligned_cols=157 Identities=29% Similarity=0.495 Sum_probs=136.9
Q ss_pred CCCCCCCCCccceEEEeec-C-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-P-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKP 77 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp 77 (223)
|+++.+|||||.+||.|.+ + ...++||||.+|+|++++...+. +++....+++.++++||.|||+ ++|+||||||
T Consensus 130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKP 207 (364)
T KOG0581|consen 130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKP 207 (364)
T ss_pred HHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCH
Confidence 4678899999999999865 4 38999999999999999987644 9999999999999999999996 9999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC----------------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP---------------------------------- 123 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------------------------------- 123 (223)
+|||++..| .|||+|||+++...+. ..++.+||..|||||.+++
T Consensus 208 sNlLvNskG-eVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~ 285 (364)
T KOG0581|consen 208 SNLLVNSKG-EVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL 285 (364)
T ss_pred HHeeeccCC-CEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC
Confidence 999999988 8999999999876655 5578899999999995541
Q ss_pred ----------------CCCC-ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 124 ----------------SAEN-LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 124 ----------------~~~~-~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
.+.+ ++.++.+++..|++++|.+||++.|++++ .++..
T Consensus 286 ~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H--pfi~~ 340 (364)
T KOG0581|consen 286 DIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH--PFIKK 340 (364)
T ss_pred CHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC--HHHhh
Confidence 1333 77889999999999999999999999887 44443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=251.67 Aligned_cols=159 Identities=30% Similarity=0.454 Sum_probs=137.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||+.|+|||||.|++++++ +..|+|||||.||+|.+++...+. +++..+..++.||+.||++||+++|+||||||+|
T Consensus 62 iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQN 139 (429)
T KOG0595|consen 62 ILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENNIIHRDLKPQN 139 (429)
T ss_pred HHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcce
Confidence 5789999999999999975 678999999999999999998665 9999999999999999999999999999999999
Q ss_pred EEEeCC-C----CceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHH
Q 027476 80 LILTAD-H----KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQII 154 (223)
Q Consensus 80 ill~~~-~----~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~ 154 (223)
||++.. + ..+||+|||+|+.........+.+|++-|||||+++...++-.+|+|+++...|+.-.++-|.-++-.
T Consensus 140 iLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 140 ILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred EEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 999864 1 36899999999998888888889999999999999999999999999999887776666655443333
Q ss_pred HHHHHHh
Q 027476 155 QMLLHYI 161 (223)
Q Consensus 155 ~~L~~~~ 161 (223)
.+|...+
T Consensus 220 ~eL~~~~ 226 (429)
T KOG0595|consen 220 KELLLYI 226 (429)
T ss_pred HHHHHHH
Confidence 3333333
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=249.01 Aligned_cols=166 Identities=48% Similarity=0.831 Sum_probs=143.6
Q ss_pred CCCCCCCCCccceEEEeecC--ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKEP--VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG-IIHRDLKP 77 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp 77 (223)
+|++++|||||+++|+|.++ ..++||||+++|+|.+++.......+++..++.++.||+.||.|||+++ |||||||+
T Consensus 92 il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~ 171 (362)
T KOG0192|consen 92 LLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKS 171 (362)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccCh
Confidence 46789999999999999876 5899999999999999998754456999999999999999999999999 99999999
Q ss_pred CCEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC--CC------------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR--PS------------------------------ 124 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~------------------------------ 124 (223)
+|||++.+..++||+|||+++..... ...+...||+.|||||+++ ..
T Consensus 172 ~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 172 DNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred hhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 99999987558999999999866543 3334478999999999776 22
Q ss_pred ----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCC
Q 027476 125 ----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSA 166 (223)
Q Consensus 125 ----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~ 166 (223)
+..++..+..++..||..+|.+||++.+++..|+.+......
T Consensus 252 ~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 252 VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 334667788899999999999999999999999998876544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=242.01 Aligned_cols=162 Identities=35% Similarity=0.666 Sum_probs=140.9
Q ss_pred CCCCCCCCCccceEEEeecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||++|+|+|||+++++|..+ .++|||||++.|+|.++++......+...+.+.++.|||+||+||+++++|||||.+.|
T Consensus 254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARN 333 (468)
T KOG0197|consen 254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARN 333 (468)
T ss_pred HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhh
Confidence 58899999999999999874 59999999999999999998666779999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccccccc--CCCccccccCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTA--ETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE~~~----------------------------------- 122 (223)
|||+.+. .+||+|||+|+.......... ..-...|.|||.+.
T Consensus 334 iLV~~~~-~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e 412 (468)
T KOG0197|consen 334 ILVDEDL-VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE 412 (468)
T ss_pred eeeccCc-eEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH
Confidence 9999888 899999999995433332111 22345899999432
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.|..||+.+++++..||+.+|.+|||++.+...|.++...
T Consensus 413 v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 413 VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 66889999999999999999999999999999998887654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=234.93 Aligned_cols=162 Identities=27% Similarity=0.376 Sum_probs=142.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||.+++||+||+++..|++ .++|+|+||+.||.|..++.+++. +++..+.-++.+|+.||.|||++||+||||||+|
T Consensus 78 IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPEN 155 (357)
T KOG0598|consen 78 ILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPEN 155 (357)
T ss_pred HHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHH
Confidence 5778999999999999976 589999999999999999997766 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 80 LILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
||+|.+| +++|+|||+++.... .....+.+||+.|||||++...+++...|+|+++..++++-.+.+|...+-.....
T Consensus 156 ILLd~~G-Hi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~ 234 (357)
T KOG0598|consen 156 ILLDEQG-HIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY 234 (357)
T ss_pred eeecCCC-cEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH
Confidence 9999998 899999999995433 34456679999999999999999999999999999999999999997765544444
Q ss_pred HHhhcCC
Q 027476 159 HYISTNS 165 (223)
Q Consensus 159 ~~~~~~~ 165 (223)
+.+....
T Consensus 235 ~~I~~~k 241 (357)
T KOG0598|consen 235 DKILKGK 241 (357)
T ss_pred HHHhcCc
Confidence 4444333
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=228.24 Aligned_cols=166 Identities=27% Similarity=0.409 Sum_probs=144.8
Q ss_pred CCCCCCCCCccceEE-Eee-cCc-eEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cc
Q 027476 1 MMSRVRHRNLVKFIG-ACK-EPV-MVIVTELLLGGTLRKYLLN--MRPRCLDIHVAIGFALDIARAMECLHS--HG--II 71 (223)
Q Consensus 1 il~~l~Hpniv~l~~-~~~-~~~-~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~lH~--~~--iv 71 (223)
||++|+|||||++++ .|. ++. +++|||||.+|+|.+.++. ...+.+++..+|+++.|++.||.++|+ .+ |+
T Consensus 71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm 150 (375)
T KOG0591|consen 71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM 150 (375)
T ss_pred HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence 589999999999998 454 455 8899999999999999973 345679999999999999999999999 45 99
Q ss_pred cCCCCCCCEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCH
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
||||||.||+++.+| .|||+|||+++...... .....+|||.||+||.+...+++...|+|++++..+++-.-+-|+.
T Consensus 151 HRDIKPaNIFl~~~g-vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~ 229 (375)
T KOG0591|consen 151 HRDIKPANIFLTANG-VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY 229 (375)
T ss_pred eccCcchheEEcCCC-ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence 999999999999888 89999999999765543 3456789999999999999999999999999999988888888888
Q ss_pred HHHHHHHHHHhhcCCCC
Q 027476 151 SQIIQMLLHYISTNSAP 167 (223)
Q Consensus 151 ~~~~~~L~~~~~~~~~~ 167 (223)
.+-+..|.+-+.+...|
T Consensus 230 g~n~~~L~~KI~qgd~~ 246 (375)
T KOG0591|consen 230 GDNLLSLCKKIEQGDYP 246 (375)
T ss_pred cccHHHHHHHHHcCCCC
Confidence 88888888888776544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=232.86 Aligned_cols=152 Identities=28% Similarity=0.460 Sum_probs=134.7
Q ss_pred CCCCC-CCCccceEEEeecC--ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVR-HRNLVKFIGACKEP--VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~-Hpniv~l~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++|+ |||||+|.+++.|+ .+++||||| ..+|+++++.+ .+.+++..+..|+.||++||+|+|.+|+.|||+||+
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPE 139 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPE 139 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChh
Confidence 57888 99999999998653 689999999 68999999886 678999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC------------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
|||+.... .+||+|||+|+.......++..+.|.+|+|||++-
T Consensus 140 NiLi~~~~-~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq 218 (538)
T KOG0661|consen 140 NILISGND-VIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ 218 (538)
T ss_pred heEecccc-eeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH
Confidence 99999655 79999999999888877888889999999999432
Q ss_pred ---------------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 ---------------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 ---------------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....+.+.+..+++.+|+.+||.+||++.+.+++
T Consensus 219 i~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 219 IYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0012366788899999999999999999999876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=226.23 Aligned_cols=157 Identities=31% Similarity=0.553 Sum_probs=132.2
Q ss_pred CCCCCCCCCccceEEEe--ecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 1 MMSRVRHRNLVKFIGAC--KEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~--~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
||++|+|||||+++|.. .++ .+++.|||+++|+|.+++.+.+. .+++..+..+..|++.||.|||++|++||||||
T Consensus 67 iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~ 145 (313)
T KOG0198|consen 67 ILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKP 145 (313)
T ss_pred HHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCccc
Confidence 57889999999999974 333 58899999999999999998775 699999999999999999999999999999999
Q ss_pred CCEEEeC-CCCceEEccCcccccccc----ccccccCCCccccccCCCCCC-----------------------------
Q 027476 78 ENLILTA-DHKTVKLADFGLAREESL----TEMMTAETGTYRWMAPENMRP----------------------------- 123 (223)
Q Consensus 78 ~Nill~~-~~~~~kl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~----------------------------- 123 (223)
+|||++. ++ .+||+|||+++.... ........||+.|||||++..
T Consensus 146 ~NiLl~~~~~-~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 146 ANILLDPSNG-DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ceEEEeCCCC-eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 9999998 45 899999999986542 122334679999999997651
Q ss_pred -------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 124 -------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 124 -------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
.+..++.+.++++..|+..+|.+||++++++++..-
T Consensus 225 ~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 225 FFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred hcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 123455678889999999999999999999887433
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=218.85 Aligned_cols=145 Identities=32% Similarity=0.426 Sum_probs=133.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||+.+.||+++++++.|.+ +.++|||||+.||.|..++++.+. +++..++-++.||+.||+|||+++|++|||||+|
T Consensus 97 vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~iiYRDLKPEN 174 (355)
T KOG0616|consen 97 VLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPEN 174 (355)
T ss_pred HHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHH
Confidence 5788899999999999987 578999999999999999988665 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCH
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
||+|++| .+||+|||+|+..... ..+.+|||.|+|||.+...+++.+.|+|+|+...+++-.+.-|..
T Consensus 175 iLlD~~G-~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 175 LLLDQNG-HIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred eeeccCC-cEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 9999998 8999999999976654 467899999999999999999999999999998888888777754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=238.38 Aligned_cols=152 Identities=30% Similarity=0.528 Sum_probs=133.9
Q ss_pred CCCCCCCCCccceEEEe-ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||+..+|+|||++++.| .++++|+||||++||+|.+++.... +++.++..|.++++.||+|||.+||+|||||.+|
T Consensus 323 Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDn 399 (550)
T KOG0578|consen 323 VMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDN 399 (550)
T ss_pred HHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccce
Confidence 57889999999999987 4678999999999999999997643 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
|+++.++ .+||+|||++....... ...+.+|||.|||||++..
T Consensus 400 ILL~~~g-~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl 478 (550)
T KOG0578|consen 400 ILLTMDG-SVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 478 (550)
T ss_pred eEeccCC-cEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH
Confidence 9999988 79999999998765443 4467789999999996653
Q ss_pred ------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 ------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 ------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++..+.+|+.+||+.|+.+|+++.+++++
T Consensus 479 yLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 479 YLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 244566777889999999999999999999886
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=232.54 Aligned_cols=158 Identities=27% Similarity=0.481 Sum_probs=137.8
Q ss_pred CCCCCC-CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 1 MMSRVR-HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~-Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
++++++ ||||+++++++.. ..+++||||+.||+|.+++.+.+ .+.+.++..++.|+++|++|||++||+||||||+
T Consensus 72 ~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~E 149 (370)
T KOG0583|consen 72 ILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPE 149 (370)
T ss_pred HHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHH
Confidence 356777 9999999999964 57999999999999999998844 4999999999999999999999999999999999
Q ss_pred CEEEeCC-CCceEEccCcccccc-ccccccccCCCccccccCCCCCCC--------------------------------
Q 027476 79 NLILTAD-HKTVKLADFGLAREE-SLTEMMTAETGTYRWMAPENMRPS-------------------------------- 124 (223)
Q Consensus 79 Nill~~~-~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~-------------------------------- 124 (223)
||+++.+ + .+||+|||++... .......+.+||+.|+|||++...
T Consensus 150 Nilld~~~~-~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~ 228 (370)
T KOG0583|consen 150 NILLDGNEG-NLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV 228 (370)
T ss_pred HEEecCCCC-CEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH
Confidence 9999988 6 8999999999877 455667888999999999966522
Q ss_pred --------------CCCC-hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 125 --------------AENL-PEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 125 --------------~~~~-~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+..+ +.++..++.+|+..+|.+|+++.+++.+ .++..
T Consensus 229 ~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h--~w~~~ 280 (370)
T KOG0583|consen 229 PNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH--PWFQK 280 (370)
T ss_pred HHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC--hhhcc
Confidence 3345 7888999999999999999999999943 66654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=237.26 Aligned_cols=153 Identities=28% Similarity=0.480 Sum_probs=141.0
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||+.|.||||+++|+++++ .++|+|.||++||.|++++-..++ +++.++++++.||+.|+.|||..+|+||||||+|
T Consensus 65 iMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpEN 142 (786)
T KOG0588|consen 65 IMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFNICHRDLKPEN 142 (786)
T ss_pred HHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchh
Confidence 5788999999999999976 589999999999999999987666 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC-------------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
+++|..+ .+||+|||+|.....+....+.||++.|+|||+++
T Consensus 143 lLLd~~~-nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LL 221 (786)
T KOG0588|consen 143 LLLDVKN-NIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLL 221 (786)
T ss_pred hhhhccc-CEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHH
Confidence 9999888 59999999999887788888899999999999776
Q ss_pred --------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 --------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 --------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..+.+++.+..+|+.+|++.||.+|-++++|+++
T Consensus 222 lKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 222 LKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2356788889999999999999999999999987
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=225.54 Aligned_cols=153 Identities=25% Similarity=0.417 Sum_probs=138.5
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||+.|+||||+.++++|++ +.+.+||||..+|.|++++.+.+. +++.++.++++||++|+.|+|.++++|||||.+|
T Consensus 106 IMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLEN 183 (668)
T KOG0611|consen 106 IMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLEN 183 (668)
T ss_pred HHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhccceecccchhh
Confidence 5889999999999999976 689999999999999999998766 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAE--------------------------------- 126 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------------------- 126 (223)
||+|.++ .+||+|||++..+.......+++|++-|.+||.+.+.++
T Consensus 184 ILLD~N~-NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv 262 (668)
T KOG0611|consen 184 ILLDQNN-NIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV 262 (668)
T ss_pred eeecCCC-CeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH
Confidence 9999988 799999999998888888889999999999997654322
Q ss_pred -----------CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 127 -----------NLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 127 -----------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..+.|..-||.+||..+|++|.+++++..+
T Consensus 263 rQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 263 RQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred HHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 344567779999999999999999999765
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=218.45 Aligned_cols=153 Identities=24% Similarity=0.450 Sum_probs=136.1
Q ss_pred CCCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 1 MMSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
||+++ .||||+++.++|+. ...++|+|.|+.|.|.+++...-. +++++..++++|+..|+.|||.++||||||||+
T Consensus 75 ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpE 152 (411)
T KOG0599|consen 75 ILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPE 152 (411)
T ss_pred HHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChh
Confidence 45666 69999999999986 467899999999999999986544 999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC------------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
|||++.+. ++||+|||++.....++.....+|||+|+|||.+.
T Consensus 153 NILlddn~-~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 153 NILLDDNM-NIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred heeecccc-ceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 99999777 89999999999988888888999999999999553
Q ss_pred ------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 ------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 ------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+.-.+.+.+..+|+.+|++.||.+|-+.++.+++
T Consensus 232 kQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 232 KQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1223566778899999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=229.58 Aligned_cols=152 Identities=32% Similarity=0.475 Sum_probs=131.4
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|.+| .||.|++|+-.|+| ..+|+|+||+++|+|.++|.+.+. +++..++.++.||+.||+|||++|||||||||+|
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~GIIHRDlKPEN 204 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNGIIHRDLKPEN 204 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence 4566 89999999999987 479999999999999999987655 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc------------cc--ccCCCccccccCCCCC-----------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE------------MM--TAETGTYRWMAPENMR----------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~------------~~--~~~~gt~~y~aPE~~~----------------------- 122 (223)
||+|.|+ ++||+|||.|+...... .. ...+||..|++||.+.
T Consensus 205 ILLd~dm-hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG 283 (604)
T KOG0592|consen 205 ILLDKDG-HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAG 283 (604)
T ss_pred eeEcCCC-cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcC
Confidence 9999998 89999999998532111 11 3468999999999665
Q ss_pred ---------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 ---------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 ---------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..+.+.+.++.+|+.++|..+|.+|.+.++|.++
T Consensus 284 ~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 284 QPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 2356677778889999999999999999999776
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=231.34 Aligned_cols=155 Identities=28% Similarity=0.468 Sum_probs=137.6
Q ss_pred CCCCCCCCCccceEEEeec-Cc-eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PV-MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~-~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
++++++|||||.+.++|.+ +. .++||+||+||++.+.+.+.++..++++.+.+|+.|++.|+.|||+++|+|||||+.
T Consensus 56 lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~ 135 (426)
T KOG0589|consen 56 LLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCA 135 (426)
T ss_pred HHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhh
Confidence 4678999999999999965 45 789999999999999999888778999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC---------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
||++++++ .|||+|||+|+...... ...+.+||+.|++||.+.+.
T Consensus 136 Nifltk~~-~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 136 NIFLTKDK-KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred hhhccccC-ceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 99999988 68999999999877665 66778999999999966544
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++..++..|++.+|..||++.+++.+
T Consensus 215 i~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 ILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 44455566778999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=230.00 Aligned_cols=155 Identities=35% Similarity=0.669 Sum_probs=137.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++|+||||+.+.|+|.. +-+|||||||..|-|.++++.... ++......|..+|+.|+.|||.+.|+|||||.-||
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNi 243 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNI 243 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCce
Confidence 688999999999999976 568899999999999999987655 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------- 123 (223)
||..+. .|||+|||-++..........++||..|||||+++.
T Consensus 244 LIs~~d-~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG 322 (904)
T KOG4721|consen 244 LISYDD-VVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG 322 (904)
T ss_pred Eeeccc-eEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe
Confidence 999887 899999999987666555567789999999998763
Q ss_pred ---------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 124 ---------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 124 ---------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
.+.+++.-+.-|+.+||...|..||++.+++.+|.-
T Consensus 323 VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 323 VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 345566667778999999999999999999988753
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=225.10 Aligned_cols=160 Identities=36% Similarity=0.600 Sum_probs=130.6
Q ss_pred CCCCCCCCCccceEEEeec-C-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-P-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG---IIHRDL 75 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~dl 75 (223)
+|.+++|||+|+|+|+|.+ + +.++|+||+++|+|.+++.......++|..+++|+.++|.||+|||+.. |+||||
T Consensus 124 ~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDi 203 (361)
T KOG1187|consen 124 ILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDI 203 (361)
T ss_pred HHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCC
Confidence 4678999999999999975 4 3899999999999999998755326899999999999999999999864 999999
Q ss_pred CCCCEEEeCCCCceEEccCcccccccc-ccccccC-CCccccccCCCCC-------------------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESL-TEMMTAE-TGTYRWMAPENMR------------------------------- 122 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~------------------------------- 122 (223)
|++|||+|++. ..||+|||+|+.... ....... .||.+|++||+..
T Consensus 204 KssNILLD~~~-~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 204 KSSNILLDEDF-NAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred CHHHeeECCCC-CEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC
Confidence 99999999888 899999999975543 3322333 8999999999432
Q ss_pred -------------------------CC-C-CCC-----hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 123 -------------------------PS-A-ENL-----PEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 123 -------------------------~~-~-~~~-----~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
+. . ... -..+..++..|++.+|.+||++.+|+++|+...
T Consensus 283 ~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 283 PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 00 0 111 123567889999999999999999999986544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-33 Score=230.48 Aligned_cols=167 Identities=29% Similarity=0.426 Sum_probs=148.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|+++|+||||+.++++|+. .++|+|.||+.| +|..++...+. ++++.+..++.+++.||.|||+.+|+|||+||+|
T Consensus 54 i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqn 130 (808)
T KOG0597|consen 54 ILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQN 130 (808)
T ss_pred HHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcce
Confidence 5789999999999999975 689999999976 99999987665 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
|+++..+ .+|++|||+|+..... ...+...|||.|||||.+.+.+++...|+|++++.+++.-.++-|+.+.-+.+|-
T Consensus 131 iLl~~~~-~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv 209 (808)
T KOG0597|consen 131 ILLEKGG-TLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLV 209 (808)
T ss_pred eeecCCC-ceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHH
Confidence 9999877 8999999999976543 3445678999999999999999999999999999999999999999888777777
Q ss_pred HHhhcCCCCCCCC
Q 027476 159 HYISTNSAPEPVI 171 (223)
Q Consensus 159 ~~~~~~~~~~~~~ 171 (223)
+.+...+..+|..
T Consensus 210 ~~I~~d~v~~p~~ 222 (808)
T KOG0597|consen 210 KSILKDPVKPPST 222 (808)
T ss_pred HHHhcCCCCCccc
Confidence 7777666655543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=220.17 Aligned_cols=154 Identities=28% Similarity=0.496 Sum_probs=129.3
Q ss_pred CCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|+.++||||++++-.|. +..+|+||.||.+|++.++++..-+..+++..+..|++++++||.|||.+|.+|||||+.||
T Consensus 78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnI 157 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNI 157 (516)
T ss_pred hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccE
Confidence 67889999999999986 57899999999999999999987777799999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccc-cc---c-ccccCCCccccccCCCCCCC--CC---------------------------
Q 027476 81 ILTADHKTVKLADFGLAREES-LT---E-MMTAETGTYRWMAPENMRPS--AE--------------------------- 126 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~-~~---~-~~~~~~gt~~y~aPE~~~~~--~~--------------------------- 126 (223)
||+.+| .|||+|||...... .+ . ..++.+||+.|||||+++.. .+
T Consensus 158 Li~~dG-~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 158 LIDSDG-TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred EEcCCC-cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 999998 89999999765221 11 1 11567899999999984311 11
Q ss_pred ---------------------------CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 127 ---------------------------NLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 127 ---------------------------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.++..+..++..|++.||.+||++++++++
T Consensus 237 PmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 237 PMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred hHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 123346778999999999999999999754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-33 Score=216.02 Aligned_cols=118 Identities=30% Similarity=0.440 Sum_probs=102.6
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++|+|+|+|.|+++|.. ..+++|+|||+. ++.+-+.... ..++.+.+.+++.|++.|+.|+|+++++||||||+|
T Consensus 54 mLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPEN 131 (396)
T KOG0593|consen 54 MLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPEN 131 (396)
T ss_pred HHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhh
Confidence 4789999999999999965 678999999965 4445455433 349999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccc-cccccccCCCccccccCCCC
Q 027476 80 LILTADHKTVKLADFGLAREES-LTEMMTAETGTYRWMAPENM 121 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~ 121 (223)
|||+.++ .+||+|||+|+... .++.++..+.|.+|+|||.+
T Consensus 132 ILit~~g-vvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELL 173 (396)
T KOG0593|consen 132 ILITQNG-VVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELL 173 (396)
T ss_pred eEEecCC-cEEeccchhhHhhcCCcchhhhhhhhhhccChhhh
Confidence 9999988 89999999999776 56667778899999999943
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=223.50 Aligned_cols=160 Identities=34% Similarity=0.640 Sum_probs=142.7
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
||++++||||++|+|+|.+...|+|||.++.|.|..+++.++. .++......++.||+.||.|||+.++|||||...||
T Consensus 444 iMrnfdHphIikLIGv~~e~P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNi 522 (974)
T KOG4257|consen 444 IMRNFDHPHIIKLIGVCVEQPMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNI 522 (974)
T ss_pred HHHhCCCcchhheeeeeeccceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhhe
Confidence 5789999999999999999999999999999999999987654 489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCC--ccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETG--TYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g--t~~y~aPE~~~------------------------------------ 122 (223)
|+.+.. .|||+|||+++.......++...| ...|||||.+.
T Consensus 523 LVsSp~-CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV 601 (974)
T KOG4257|consen 523 LVSSPQ-CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV 601 (974)
T ss_pred eecCcc-eeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce
Confidence 999877 899999999997766655554444 34899999442
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
+.+.+|++.+++++.+||.++|.+||.+.++...|.++..
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 5688999999999999999999999999999888877665
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=221.84 Aligned_cols=152 Identities=30% Similarity=0.502 Sum_probs=128.0
Q ss_pred CCCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRC-LDIHVAIGFALDIARAMECLHSHGIIHRDLK 76 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~-l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 76 (223)
||++++|||||+|+++..+ ..+|||+|||..|.+...-. .+. +++.++++++.+++.||+|||.+||+|||||
T Consensus 161 ilKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIK 237 (576)
T KOG0585|consen 161 ILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIK 237 (576)
T ss_pred HHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccc
Confidence 5899999999999999966 47999999999998866432 233 8999999999999999999999999999999
Q ss_pred CCCEEEeCCCCceEEccCcccccc------ccccccccCCCccccccCCCCC----------------------------
Q 027476 77 PENLILTADHKTVKLADFGLAREE------SLTEMMTAETGTYRWMAPENMR---------------------------- 122 (223)
Q Consensus 77 p~Nill~~~~~~~kl~Dfg~a~~~------~~~~~~~~~~gt~~y~aPE~~~---------------------------- 122 (223)
|+|+||+.++ +|||+|||++... .........+|||.|+|||...
T Consensus 238 PsNLLl~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 238 PSNLLLSSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred hhheEEcCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 9999999987 8999999998754 2233344578999999999332
Q ss_pred ----------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 ----------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 ----------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+.......++.+||.++|++||++|.+..+|..+
T Consensus 317 ~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 317 LPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred CCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 1223456788999999999999999999999766
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=215.31 Aligned_cols=161 Identities=32% Similarity=0.619 Sum_probs=130.2
Q ss_pred CCCC-CCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcC------------------------------------
Q 027476 2 MSRV-RHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMR------------------------------------ 42 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~------------------------------------ 42 (223)
|+++ +||||++++++|.+ +.+++||||+++|+|.+++....
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (338)
T cd05102 64 LIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQAS 143 (338)
T ss_pred HHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCC
Confidence 4566 89999999998864 35889999999999999987532
Q ss_pred ------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 43 ------------------------PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 43 ------------------------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~ 222 (338)
T cd05102 144 VLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLAR 222 (338)
T ss_pred ccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeeccccc
Confidence 12478889999999999999999999999999999999999877 89999999997
Q ss_pred cccccc---ccccCCCccccccCCCCCC-----------------------------------------------CCCCC
Q 027476 99 EESLTE---MMTAETGTYRWMAPENMRP-----------------------------------------------SAENL 128 (223)
Q Consensus 99 ~~~~~~---~~~~~~gt~~y~aPE~~~~-----------------------------------------------~~~~~ 128 (223)
...... ......++..|+|||++.. .+..+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (338)
T cd05102 223 DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENA 302 (338)
T ss_pred ccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCC
Confidence 543221 1122345678999994421 12245
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 129 PEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 129 ~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.++.+++..||+.+|.+||++.++++.|++++..
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 66789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=204.37 Aligned_cols=152 Identities=30% Similarity=0.455 Sum_probs=129.7
Q ss_pred CCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 3 SRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+.|+||||++|.+.+. ++..|+|+|+++|+.|..-+-.+. .+++..+-.++.||++||.|+|.+||||||+||+|++
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nll 142 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLL 142 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhhee
Confidence 5689999999999886 467899999999999987765543 3889999999999999999999999999999999999
Q ss_pred EeCC--CCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHH---------------------------
Q 027476 82 LTAD--HKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDL--------------------------- 132 (223)
Q Consensus 82 l~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l--------------------------- 132 (223)
+-+. +.-+||+|||+|............+|||+|||||+++..+++.+.|+
T Consensus 143 LASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye 222 (355)
T KOG0033|consen 143 LASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYE 222 (355)
T ss_pred eeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHH
Confidence 9543 34699999999998887777778899999999998876655555554
Q ss_pred ---------------------HHHHHHhcccCCCCCCCHHHHHHH
Q 027476 133 ---------------------ALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 133 ---------------------~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+|+.+||..||.+|.++.|.+.+
T Consensus 223 ~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 223 QIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 458999999999999999888643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=227.13 Aligned_cols=162 Identities=31% Similarity=0.616 Sum_probs=140.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--------C----CCCHHHHHHHHHHHHHHHHHHHh
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--------R----CLDIHVAIGFALDIARAMECLHS 67 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------~----~l~~~~~~~i~~qi~~~l~~lH~ 67 (223)
+|+.|+|||||+|+|.|.+ +.++||+|||..|+|.++|....+ + .++..+.+.|+.||+.||+||-+
T Consensus 542 Lla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 542 LLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred HHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4678999999999999965 578999999999999999975432 2 28899999999999999999999
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccccccccccccC---CCccccccCCCCC----------------------
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE---TGTYRWMAPENMR---------------------- 122 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~---~gt~~y~aPE~~~---------------------- 122 (223)
+.+|||||...|+||+++. .|||+|||+++.....+.++.. .-...||+||.+.
T Consensus 622 ~~FVHRDLATRNCLVge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFs 700 (774)
T KOG1026|consen 622 HHFVHRDLATRNCLVGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFS 700 (774)
T ss_pred Ccccccchhhhhceeccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhc
Confidence 9999999999999999877 8999999999976655544432 2345899999332
Q ss_pred ------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+.++|.++++|+..||+.+|.+||++.+|...|+++...
T Consensus 701 yG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 701 YGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred cccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 56889999999999999999999999999999999998654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=218.14 Aligned_cols=158 Identities=23% Similarity=0.360 Sum_probs=131.0
Q ss_pred CCCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
||++|+||||++|.+...+ +.+|||+|||+ -+|.-++.... -.+++.++..++.|++.||+|||++||+|||||.
T Consensus 169 ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~ 246 (560)
T KOG0600|consen 169 ILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKG 246 (560)
T ss_pred HHHhcCCCcccceeeEEEecCCceEEEEEeccc-chhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccc
Confidence 6899999999999998854 47999999995 58888876532 3499999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccc--cccccCCCccccccCCCCC---------------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLT--EMMTAETGTYRWMAPENMR--------------------------------- 122 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~--------------------------------- 122 (223)
+|||||.+| .+||+|||+|+..... ..++..+.|.+|++||.+.
T Consensus 247 SNiLidn~G-~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE 325 (560)
T KOG0600|consen 247 SNILIDNNG-VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE 325 (560)
T ss_pred cceEEcCCC-CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence 999999888 8999999999954432 3456678899999999332
Q ss_pred -----------------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 123 -----------------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 123 -----------------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
.....++....+|+..+|.+||.+|.++.++++. +++
T Consensus 326 veQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s--eyF 403 (560)
T KOG0600|consen 326 VEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS--EYF 403 (560)
T ss_pred HHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC--ccc
Confidence 1123455667889999999999999999999865 566
Q ss_pred hc
Q 027476 162 ST 163 (223)
Q Consensus 162 ~~ 163 (223)
..
T Consensus 404 ~t 405 (560)
T KOG0600|consen 404 TT 405 (560)
T ss_pred cc
Confidence 33
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=211.93 Aligned_cols=153 Identities=28% Similarity=0.394 Sum_probs=128.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++.+.+ +..++||||+.|++|.+++...+. +++..+..++.||+.||+|||++||+||||||+|
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~N 125 (323)
T cd05571 48 VLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLEN 125 (323)
T ss_pred HHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHH
Confidence 3578899999999999865 578999999999999999876544 8999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
|+++.++ .+||+|||+++.... ........||+.|+|||.+..
T Consensus 126 Ill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~ 204 (323)
T cd05571 126 LMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204 (323)
T ss_pred EEECCCC-CEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH
Confidence 9999887 799999999875322 222334579999999995531
Q ss_pred ---------CCCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 124 ---------SAENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 124 ---------~~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
.+..++.++.+++..||+.+|.+|| ++.+++++
T Consensus 205 ~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 205 ELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1234667888999999999999999 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=213.49 Aligned_cols=165 Identities=35% Similarity=0.608 Sum_probs=139.3
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||++++|||||++||++.+ ..+++|||+|.||+|.+++++.+. .++..+...++.+.+.||+|||+++++||||.+.|
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARN 292 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARN 292 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHH
Confidence 4788999999999999965 578999999999999999998654 59999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccc-cCCCccccccCCCCC------------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMT-AETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+|++.++ .+||+|||+++......... ...-...|+|||.+.
T Consensus 293 cL~~~~~-~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v 371 (474)
T KOG0194|consen 293 CLYSKKG-VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV 371 (474)
T ss_pred heecCCC-eEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH
Confidence 9999777 78999999998654222222 122446899999543
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCC
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAP 167 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~ 167 (223)
+.+...+.++..++.+||..+|.+||++.++.+.++.+......+
T Consensus 372 ~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 372 KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 234567788899999999999999999999999999988765543
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=209.15 Aligned_cols=147 Identities=30% Similarity=0.396 Sum_probs=123.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||+++++.+.+ +..++||||+.+++|.+++..... +++..+..++.||+.||.|||++||+||||||+||
T Consensus 50 ~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NI 127 (323)
T cd05575 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENI 127 (323)
T ss_pred HhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHe
Confidence 467899999999999865 578999999999999999876543 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .+||+|||+++.... ........||+.|+|||.+...
T Consensus 128 ll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 206 (323)
T cd05575 128 LLDSQG-HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206 (323)
T ss_pred EECCCC-cEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 999887 899999999875322 2223345789999999954321
Q ss_pred ---------CCCChHHHHHHHHHhcccCCCCCCCHH
Q 027476 125 ---------AENLPEDLALIVTSCWKEDPNERPNFS 151 (223)
Q Consensus 125 ---------~~~~~~~l~~l~~~~l~~~p~~Rp~~~ 151 (223)
....+.++.+++.+|++.+|.+||+..
T Consensus 207 ~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 207 NILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 234567788899999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=208.87 Aligned_cols=149 Identities=29% Similarity=0.422 Sum_probs=125.5
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +.+++||||+.+++|.+++.+... +++..++.++.|++.||.|||++|++||||||+|
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 128 (318)
T cd05582 51 ILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN 128 (318)
T ss_pred HHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHH
Confidence 3678899999999999975 578999999999999999976543 8999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC------------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
|+++.++ .+||+|||+++..... .......|++.|+|||.+.
T Consensus 129 il~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 207 (318)
T cd05582 129 ILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM 207 (318)
T ss_pred eEECCCC-cEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH
Confidence 9999887 7999999998754333 2233457899999999442
Q ss_pred --------CCCCCChHHHHHHHHHhcccCCCCCCCHHH
Q 027476 123 --------PSAENLPEDLALIVTSCWKEDPNERPNFSQ 152 (223)
Q Consensus 123 --------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~ 152 (223)
..+..++.++.+++..||+.+|.+||++.+
T Consensus 208 ~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 208 TMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 113346778899999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=207.92 Aligned_cols=153 Identities=28% Similarity=0.413 Sum_probs=126.0
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++||||+++++.|.+ +.+++||||+.+++|.+++..... +++..++.++.|++.||.|||++|++||||||+|
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~N 125 (323)
T cd05595 48 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 125 (323)
T ss_pred HHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHH
Confidence 3577899999999999865 578999999999999998876543 8999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
|+++.++ .+||+|||+++.... ........|++.|+|||.+...
T Consensus 126 Ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~ 204 (323)
T cd05595 126 LMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 204 (323)
T ss_pred EEEcCCC-CEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999877 899999999875322 2222345789999999966422
Q ss_pred ----------CCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 125 ----------AENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 125 ----------~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
+..++.++.+++..||+.+|.+|+ ++.+++++
T Consensus 205 ~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 205 ELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 234566777888899999999997 67777654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=211.30 Aligned_cols=151 Identities=26% Similarity=0.386 Sum_probs=126.5
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++.+.+ +..++||||+.|++|.+++..... +++..+..++.|++.||+|||++||+||||||+|
T Consensus 71 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~N 148 (329)
T PTZ00263 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPEN 148 (329)
T ss_pred HHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 3678899999999999865 578999999999999999986544 8999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
|+++.++ .+||+|||+++..... .....|++.|+|||.+...
T Consensus 149 Ill~~~~-~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 225 (329)
T PTZ00263 149 LLLDNKG-HVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE 225 (329)
T ss_pred EEECCCC-CEEEeeccCceEcCCC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9999887 8999999999764332 2345789999999955311
Q ss_pred ---------CCCChHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 027476 125 ---------AENLPEDLALIVTSCWKEDPNERPN-----FSQIIQM 156 (223)
Q Consensus 125 ---------~~~~~~~l~~l~~~~l~~~p~~Rp~-----~~~~~~~ 156 (223)
+..++.++.+++..||+.+|.+|++ +++++.+
T Consensus 226 ~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 226 KILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 2335667889999999999999986 5776654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=205.24 Aligned_cols=156 Identities=20% Similarity=0.309 Sum_probs=132.0
Q ss_pred CCCCCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRD 74 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~d 74 (223)
+|++++||||++++|++.+ ...++||||+.||+|.+++.+.. .+++...+.++.|++.||.|||+ .+++|||
T Consensus 71 ~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrd 148 (283)
T PHA02988 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKN 148 (283)
T ss_pred HHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCc
Confidence 4678999999999999855 35789999999999999998654 38999999999999999999998 4999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-------------------------------
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------- 123 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------- 123 (223)
|||+||+++.++ .+||+|||+++...... ....|+..|+|||.+..
T Consensus 149 lkp~nill~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 149 LTSVSFLVTENY-KLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred CChhhEEECCCC-cEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 999999999887 89999999987543322 23468899999995521
Q ss_pred -----------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 124 -----------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 124 -----------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
.+..++..+.+++.+||+.+|.+||+++++++.|+.+.
T Consensus 226 ~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 226 TTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 12246778889999999999999999999999988764
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=220.70 Aligned_cols=154 Identities=23% Similarity=0.339 Sum_probs=128.7
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
+|++++||||++++++|.+ +.+++||||++||+|.+++.+. ....+++..+..++.|++.||.|||+++|+||||||
T Consensus 118 ~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp 197 (478)
T PTZ00267 118 CLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS 197 (478)
T ss_pred HHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCH
Confidence 3678999999999999864 6789999999999999988642 233589999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCC-------------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRP------------------------------- 123 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~------------------------------- 123 (223)
+||+++.++ .+||+|||+++...... .....+||+.|+|||++..
T Consensus 198 ~NIll~~~~-~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 198 ANIFLMPTG-IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred HhEEECCCC-cEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999887 89999999998643321 2334579999999995431
Q ss_pred --------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 124 --------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 124 --------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
.+..++.++.+++..||+.+|.+||++++++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 277 REIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 12346678889999999999999999998864
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=200.48 Aligned_cols=156 Identities=27% Similarity=0.510 Sum_probs=131.2
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++++.++..++||||+.+++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus 50 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nil 127 (257)
T cd05116 50 MQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVL 127 (257)
T ss_pred HHhCCCCCcceEEEEEcCCCcEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEE
Confidence 56789999999999998888899999999999999997644 3899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccc----cccCCCccccccCCCCC-----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
++.++ .+||+|||+++....... .....++..|+|||.+.
T Consensus 128 l~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 206 (257)
T cd05116 128 LVTQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206 (257)
T ss_pred EcCCC-eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99877 899999999875432221 11223457899999432
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
..+..++.++++++.+||+.+|.+||++++|.+.|++.
T Consensus 207 ~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 207 VTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 12345678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=204.78 Aligned_cols=157 Identities=29% Similarity=0.551 Sum_probs=127.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHH
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP-----------------RCLDIHVAIGFALDIARAM 62 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-----------------~~l~~~~~~~i~~qi~~~l 62 (223)
+|++++||||+++++++.+ +..++||||+.+++|.+++..... ..+++..++.++.|++.||
T Consensus 72 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 151 (304)
T cd05096 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGM 151 (304)
T ss_pred HHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 3678899999999999965 578999999999999999864321 2368889999999999999
Q ss_pred HHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCC----------------
Q 027476 63 ECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRP---------------- 123 (223)
Q Consensus 63 ~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~---------------- 123 (223)
.|||+.|++||||||+||+++.++ .+||+|||+++...... ......++..|+|||.+..
T Consensus 152 ~~lH~~~ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 230 (304)
T cd05096 152 KYLSSLNFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL 230 (304)
T ss_pred HHHHHCCccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence 999999999999999999999877 89999999997543222 1223345788999994321
Q ss_pred --------------------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 124 --------------------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 124 --------------------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
.+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 231 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 01234567889999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=205.05 Aligned_cols=153 Identities=29% Similarity=0.411 Sum_probs=127.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++.+.+ +..++||||+.+++|.+++..... +++..+..++.||+.||+|||++||+||||||+|
T Consensus 48 ~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~N 125 (328)
T cd05593 48 VLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLEN 125 (328)
T ss_pred HHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHH
Confidence 3678899999999999865 578999999999999998876543 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
|+++.++ .+||+|||+++.... ........||+.|+|||.+..
T Consensus 126 Ill~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~ 204 (328)
T cd05593 126 LMLDKDG-HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204 (328)
T ss_pred eEECCCC-cEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH
Confidence 9999877 899999999875322 222334579999999995531
Q ss_pred ---------CCCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 124 ---------SAENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 124 ---------~~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
.+..++.++.+++.+||+.+|.+|+ ++.+++++
T Consensus 205 ~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 205 ELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1234567888999999999999997 78888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=224.74 Aligned_cols=167 Identities=34% Similarity=0.615 Sum_probs=141.3
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR-----PRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+|++++|||||+++|+|-+ ...++++|||+||+|..+|++.+ ...++..+.+.++.|||+|+.||+++++||||
T Consensus 748 ~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRD 827 (1025)
T KOG1095|consen 748 LMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRD 827 (1025)
T ss_pred HHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcc
Confidence 5889999999999999965 56889999999999999998752 34599999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCcccccccccccccc---CCCccccccCCCCC-----------------------------
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTA---ETGTYRWMAPENMR----------------------------- 122 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~---~~gt~~y~aPE~~~----------------------------- 122 (223)
|...|+|++... .|||+|||+|+.....+.+.. ..-...|||||.+.
T Consensus 828 LAaRNCLL~~~r-~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 828 LAARNCLLDERR-VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred hhhhheeecccC-cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence 999999999886 899999999994433332221 12345899999443
Q ss_pred -----------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCC
Q 027476 123 -----------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168 (223)
Q Consensus 123 -----------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~ 168 (223)
+.+..|+..+++++.+||+.+|++||++..+++.+..++.......
T Consensus 907 ~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 907 SRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred CcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 4577899999999999999999999999999999888876654433
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=192.68 Aligned_cols=164 Identities=26% Similarity=0.331 Sum_probs=144.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
-+.|+||||+++|++|-| ...|+++||..+|+|...+.......+++...+.++.|++.||.|+|.++|+||||||+|+
T Consensus 76 qs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenl 155 (281)
T KOG0580|consen 76 QSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENL 155 (281)
T ss_pred ecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHh
Confidence 467899999999999976 5789999999999999999977777799999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
|++.++ .+|++|||-+.... .....+.+||..|.+||...+...+...|+|.++..|++.-.+.-|+-++....+-+-
T Consensus 156 Llg~~~-~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr 233 (281)
T KOG0580|consen 156 LLGSAG-ELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR 233 (281)
T ss_pred ccCCCC-CeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH
Confidence 999988 89999999876554 3334678999999999999999999999999999999999999999887776666665
Q ss_pred hhcCCCC
Q 027476 161 ISTNSAP 167 (223)
Q Consensus 161 ~~~~~~~ 167 (223)
+......
T Consensus 234 I~k~~~~ 240 (281)
T KOG0580|consen 234 IRKVDLK 240 (281)
T ss_pred HHHcccc
Confidence 5544333
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=204.60 Aligned_cols=121 Identities=30% Similarity=0.478 Sum_probs=104.1
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|+||+++++.+.+ +..++||||+.+|+|.+++.......+++..++.++.|++.||.|||+.|++||||||+|
T Consensus 53 il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~N 132 (285)
T cd05631 53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPEN 132 (285)
T ss_pred HHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHH
Confidence 3677899999999999865 578999999999999988876554568999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
|+++.++ .+||+|||++.............|+..|+|||.+.
T Consensus 133 ill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~ 174 (285)
T cd05631 133 ILLDDRG-HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN 174 (285)
T ss_pred EEECCCC-CEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhc
Confidence 9999877 79999999997654333334567899999999664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=207.96 Aligned_cols=147 Identities=24% Similarity=0.356 Sum_probs=126.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||...++|+||+|+..|++ ..+|+||||++||++..+|.+.+. |++..+..++.+++.|++.+|+.|++||||||+|
T Consensus 194 iL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdN 271 (550)
T KOG0605|consen 194 ILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDN 271 (550)
T ss_pred HhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcCcccccCChhh
Confidence 3555789999999999987 478999999999999999987655 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc----------------------ccc--------------------------cccCCC
Q 027476 80 LILTADHKTVKLADFGLAREESL----------------------TEM--------------------------MTAETG 111 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~----------------------~~~--------------------------~~~~~g 111 (223)
+|||..| ++||+|||++..... .+. ....+|
T Consensus 272 lLiD~~G-HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVG 350 (550)
T KOG0605|consen 272 LLIDAKG-HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVG 350 (550)
T ss_pred eeecCCC-CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccC
Confidence 9999998 899999999852100 000 011369
Q ss_pred ccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCH
Q 027476 112 TYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 112 t~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
||.|+|||++.+..++...|+|+|++.|++.--+-+|+-
T Consensus 351 TPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~ 389 (550)
T KOG0605|consen 351 TPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFC 389 (550)
T ss_pred CccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999999988888777743
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=206.71 Aligned_cols=151 Identities=27% Similarity=0.357 Sum_probs=124.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||+++++.+.+ +..++||||+.|++|.+++..... +++..+..++.||+.||.|||++||+||||||+||
T Consensus 50 l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Ni 127 (325)
T cd05602 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI 127 (325)
T ss_pred HHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence 467899999999999865 578999999999999999976543 88999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .+||+|||+++.... ........||+.|+|||++...
T Consensus 128 li~~~~-~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (325)
T cd05602 128 LLDSQG-HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206 (325)
T ss_pred EECCCC-CEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999887 899999999875322 2223445799999999954311
Q ss_pred ---------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 125 ---------AENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 125 ---------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
...++.++.+++.+|++.+|.+|++..+.+.
T Consensus 207 ~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 207 NILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 2345677888999999999999998764433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=208.46 Aligned_cols=152 Identities=24% Similarity=0.377 Sum_probs=125.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++.+.+ +..++||||+.+|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|
T Consensus 46 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~N 123 (312)
T cd05585 46 VLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRDLKPEN 123 (312)
T ss_pred HHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHH
Confidence 3567899999999999865 578999999999999999976543 8999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
|+++.++ .+||+|||+++.... ........||+.|+|||.+..
T Consensus 124 ili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~ 202 (312)
T cd05585 124 ILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY 202 (312)
T ss_pred eEECCCC-cEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH
Confidence 9999887 899999999875322 222334579999999995531
Q ss_pred ---------CCCCChHHHHHHHHHhcccCCCCCCCH---HHHHH
Q 027476 124 ---------SAENLPEDLALIVTSCWKEDPNERPNF---SQIIQ 155 (223)
Q Consensus 124 ---------~~~~~~~~l~~l~~~~l~~~p~~Rp~~---~~~~~ 155 (223)
.+..++.++.+++..||+.+|.+||+. .+++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 203 RKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 123456778899999999999999864 45443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=194.20 Aligned_cols=159 Identities=25% Similarity=0.342 Sum_probs=133.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|+.++|+||+.++++|-+ +.+.+|+||+ ..+|+..+++. ...++...+..++.++++||+|||++.|+||||||.|+
T Consensus 55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNL 132 (318)
T KOG0659|consen 55 LQELKHPNIIELIDVFPHKSNLSLVFEFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNL 132 (318)
T ss_pred HHHccCcchhhhhhhccCCCceEEEEEec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccce
Confidence 678899999999999965 5788999999 57999998764 45699999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc-cccCCCccccccCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
|++.+| .+||+|||+|+....... ....+.|.+|+|||.+-
T Consensus 133 Lis~~g-~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL 211 (318)
T KOG0659|consen 133 LISSDG-QLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL 211 (318)
T ss_pred EEcCCC-cEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH
Confidence 999988 899999999997654433 23347899999999221
Q ss_pred ------------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCC
Q 027476 123 ------------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165 (223)
Q Consensus 123 ------------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~ 165 (223)
......+.+..+++..++..+|.+|.++.|++++ ..+.+.+
T Consensus 212 ~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P 288 (318)
T KOG0659|consen 212 SKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLP 288 (318)
T ss_pred HHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCC
Confidence 0123456778999999999999999999999987 6766543
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=205.18 Aligned_cols=148 Identities=30% Similarity=0.381 Sum_probs=123.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||+++++.+.+ +..++||||+.|++|..++..... +++..+..++.||+.||.|||++|++||||||+||
T Consensus 50 l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NI 127 (325)
T cd05604 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSINIVYRDLKPENI 127 (325)
T ss_pred HHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence 467899999999998865 678999999999999998876544 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .+||+|||+++.... ........|++.|+|||.+...
T Consensus 128 ll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~ 206 (325)
T cd05604 128 LLDSQG-HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206 (325)
T ss_pred EECCCC-CEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH
Confidence 999887 899999999875322 2223445799999999954321
Q ss_pred ---------CCCChHHHHHHHHHhcccCCCCCCCHHH
Q 027476 125 ---------AENLPEDLALIVTSCWKEDPNERPNFSQ 152 (223)
Q Consensus 125 ---------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~ 152 (223)
....+.++++++..|++.+|.+||+..+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 207 NILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 2235567788999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=198.63 Aligned_cols=159 Identities=25% Similarity=0.558 Sum_probs=130.4
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++++++||||++++++++.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||
T Consensus 48 ~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 126 (257)
T cd05115 48 IMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNV 126 (257)
T ss_pred HHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheE
Confidence 367899999999999998888999999999999999987533 3589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc----cccCCCccccccCCCCCC---------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMRP--------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--------------------------------- 123 (223)
+++.++ .+||+|||++........ .....++..|+|||.+..
T Consensus 127 l~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 205 (257)
T cd05115 127 LLVNQH-YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP 205 (257)
T ss_pred EEcCCC-cEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 999777 899999999874332211 111223568999994321
Q ss_pred -------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 124 -------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 124 -------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
.+..++.++.+++..||..+|.+||++.++.+.|+.++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 206 EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 12234678889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=198.56 Aligned_cols=159 Identities=32% Similarity=0.597 Sum_probs=132.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +.++++|||+.+++|.+++.......+++..++.++.|++.||.|||++|++||||||+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~ni 135 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135 (263)
T ss_pred HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence 567899999999999864 6788999999999999999876555689999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccc--cCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMT--AETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+++.++ .+||+|||++.......... ...++..|+|||.+.
T Consensus 136 l~~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~ 214 (263)
T cd05052 136 LVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 214 (263)
T ss_pred EEcCCC-cEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999877 89999999987654322211 123456799999432
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
..+..++.++++++.+||+.+|.+||++.++.+.|+.++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 215 YELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 113345678899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=200.06 Aligned_cols=172 Identities=30% Similarity=0.438 Sum_probs=140.6
Q ss_pred CCCCCCCCC-ccceEEEeec-C------ceEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027476 1 MMSRVRHRN-LVKFIGACKE-P------VMVIVTELLLGGTLRKYLLNMRP--RCLDIHVAIGFALDIARAMECLHSHGI 70 (223)
Q Consensus 1 il~~l~Hpn-iv~l~~~~~~-~------~~~lv~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~i 70 (223)
+|++|+|+| |++|++++.. + .+++|+||+ ..+|.+++..... ..++...+..++.||+.||+|||+++|
T Consensus 63 llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~I 141 (323)
T KOG0594|consen 63 LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGI 141 (323)
T ss_pred HHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 467899999 9999999843 3 678999999 6899999987653 358889999999999999999999999
Q ss_pred ccCCCCCCCEEEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCC-CCCChHHHHHHHHHhcccCCCCCC
Q 027476 71 IHRDLKPENLILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPS-AENLPEDLALIVTSCWKEDPNERP 148 (223)
Q Consensus 71 vH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~l~~l~~~~l~~~p~~Rp 148 (223)
+||||||+||+|++++ .+||+|||+|+.... ....+..++|.+|+|||++.+. .++.+.|+|++++-..++-- .||
T Consensus 142 lHRDLKPQNlLi~~~G-~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~-~~~ 219 (323)
T KOG0594|consen 142 LHRDLKPQNLLISSSG-VLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT-RRP 219 (323)
T ss_pred ecccCCcceEEECCCC-cEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh-CCC
Confidence 9999999999999987 899999999997653 3346677899999999998876 78899999998876655543 333
Q ss_pred ---CHHHHHHHHHHHhhcCCCCCCCCCCccc
Q 027476 149 ---NFSQIIQMLLHYISTNSAPEPVILPRMF 176 (223)
Q Consensus 149 ---~~~~~~~~L~~~~~~~~~~~~~~~~~~~ 176 (223)
-..+ .+.|..++...+.|....+|...
T Consensus 220 LFpG~se-~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 220 LFPGDSE-IDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred CCCCCcH-HHHHHHHHHHcCCCCccCCCCcc
Confidence 2223 66778888888888776666543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=218.56 Aligned_cols=162 Identities=25% Similarity=0.332 Sum_probs=138.1
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
+||.+++++..|+. .++|+||||+.||++..++.. +.+++..+.-++++|+.||+|||++||+|||||.+|||+|.
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~ 503 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDT 503 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcc
Confidence 79999999999975 689999999999995544432 34999999999999999999999999999999999999999
Q ss_pred CCCceEEccCccccccc-cccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 85 DHKTVKLADFGLAREES-LTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+| ++||+|||+++..- ......+.+|||.|||||++.+..++.+.|+|.++..++++-.++-|.-.+--+.+.+.+..
T Consensus 504 eG-h~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~ 582 (694)
T KOG0694|consen 504 EG-HVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN 582 (694)
T ss_pred cC-cEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 99 89999999999654 45566789999999999999999999999999999999999999998775555555555555
Q ss_pred CCCCCCCC
Q 027476 164 NSAPEPVI 171 (223)
Q Consensus 164 ~~~~~~~~ 171 (223)
..+.-|..
T Consensus 583 d~~~yP~~ 590 (694)
T KOG0694|consen 583 DEVRYPRF 590 (694)
T ss_pred CCCCCCCc
Confidence 44444433
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=203.48 Aligned_cols=151 Identities=25% Similarity=0.366 Sum_probs=124.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.|++|...+.. +.+++..++.++.|++.||.|||++|++||||||+||
T Consensus 56 ~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Ni 132 (324)
T cd05589 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNL 132 (324)
T ss_pred ccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence 457889999999999975 578999999999999988854 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRP------------------------------------ 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~------------------------------------ 123 (223)
+++.++ .+||+|||+++.... ........|++.|+|||.+..
T Consensus 133 ll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~ 211 (324)
T cd05589 133 LLDTEG-FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211 (324)
T ss_pred EECCCC-cEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999887 899999999874322 222344579999999995531
Q ss_pred --------CCCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 124 --------SAENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 124 --------~~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
.+..++.++.+++.+||+.+|.+|| ++.+++++
T Consensus 212 ~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 212 SIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1234567788899999999999999 45555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=209.32 Aligned_cols=132 Identities=23% Similarity=0.297 Sum_probs=105.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++|+||||++++++|.. ...++|+|++ +++|.+++..... +++..++.++.|++.||.|||++||+||||||+|
T Consensus 136 il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~N 212 (391)
T PHA03212 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRN--IAICDILAIERSVLRAIQYLHENRIIHRDIKAEN 212 (391)
T ss_pred HHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHh
Confidence 4678999999999999865 5688999999 5789888876543 8999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc--cccccCCCccccccCCCCCCCCCCChHHHHHHH
Q 027476 80 LILTADHKTVKLADFGLAREESLT--EMMTAETGTYRWMAPENMRPSAENLPEDLALIV 136 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~ 136 (223)
|+++.++ .+||+|||+++..... .......||+.|+|||++.....+...|+|+++
T Consensus 213 Ill~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 270 (391)
T PHA03212 213 IFINHPG-DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAG 270 (391)
T ss_pred EEEcCCC-CEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHH
Confidence 9999887 7999999998743221 122345799999999976544444444444443
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=198.11 Aligned_cols=159 Identities=26% Similarity=0.503 Sum_probs=132.1
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++++.+...++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||+
T Consensus 63 l~~l~h~~iv~~~~~~~~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nil 141 (279)
T cd05111 63 MGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141 (279)
T ss_pred HhcCCCCCcceEEEEECCCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEE
Confidence 46789999999999988777889999999999999997643 34899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCC-----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
++.++ .+||+|||+++...... ......++..|++||.+..
T Consensus 142 i~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~ 220 (279)
T cd05111 142 LKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV 220 (279)
T ss_pred EcCCC-cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99877 89999999997543221 1223456778999995421
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
.+..++.+++.++..||..+|.+||++.++.+.|..+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 221 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 122345678889999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=206.68 Aligned_cols=152 Identities=29% Similarity=0.404 Sum_probs=127.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~N 79 (223)
+++++||||+++++.+.+ +.+++||||+.+++|.+++..... +++..+..++.|++.||.|||+ .||+||||||+|
T Consensus 49 l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~N 126 (325)
T cd05594 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN 126 (325)
T ss_pred HHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCe
Confidence 567899999999999865 578999999999999998876543 8999999999999999999997 799999999999
Q ss_pred EEEeCCCCceEEccCccccccc-cccccccCCCccccccCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREES-LTEMMTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
|+++.++ .+||+|||+++... .........||+.|+|||++..
T Consensus 127 Ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~ 205 (325)
T cd05594 127 LMLDKDG-HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 205 (325)
T ss_pred EEECCCC-CEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH
Confidence 9999887 89999999987432 2222334579999999995431
Q ss_pred ---------CCCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 124 ---------SAENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 124 ---------~~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
.+..++.++.+++.+||+.+|.+|+ ++.+++++
T Consensus 206 ~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 206 ELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1334677889999999999999996 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=203.59 Aligned_cols=160 Identities=24% Similarity=0.493 Sum_probs=132.6
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||++++|+|..+..++|+||+.+|+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+
T Consensus 63 l~~l~h~niv~~~g~~~~~~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nil 141 (316)
T cd05108 63 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVL 141 (316)
T ss_pred HHhCCCCCCCeEEEEEcCCCceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheE
Confidence 57889999999999998878889999999999999997643 34899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCcccccccccccc---ccCCCccccccCCCCCC-----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEMM---TAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
++.++ .+||+|||+++........ ....++..|++||.+..
T Consensus 142 l~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~ 220 (316)
T cd05108 142 VKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 220 (316)
T ss_pred ecCCC-cEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99877 7999999999865432221 12234668999994421
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
.+..++.++..++..||+.+|.+||++.+++..+......
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 221 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 1233556788899999999999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=206.05 Aligned_cols=153 Identities=31% Similarity=0.423 Sum_probs=127.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++.+.+ +..++||||+.|++|.+++...+. +++..+..++.|++.||.|||++||+||||||+|
T Consensus 53 il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N 130 (323)
T cd05584 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQGIIYRDLKPEN 130 (323)
T ss_pred HHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 3678999999999999865 578999999999999999976544 8899999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
|+++.++ .+||+|||+++.... ........|++.|+|||.+..
T Consensus 131 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~ 209 (323)
T cd05584 131 ILLDAQG-HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI 209 (323)
T ss_pred eEECCCC-CEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999887 899999999874322 222234579999999995531
Q ss_pred ---------CCCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 124 ---------SAENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 124 ---------~~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
.+..++.++.+++.+||+.+|.+|| ++++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 210 DKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1234567788999999999999999 77777664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=201.35 Aligned_cols=155 Identities=37% Similarity=0.695 Sum_probs=124.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||++++|++.+ +..++|+||+++|+|.+++.......+++..++.|+.|++.||.|||+++++|+||+++||
T Consensus 55 l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~ni 134 (259)
T PF07714_consen 55 LRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNI 134 (259)
T ss_dssp HHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 467899999999999974 5789999999999999999987455699999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
+++.++ .+||+|||++...... ...........|+|||.+.
T Consensus 135 ll~~~~-~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~ 213 (259)
T PF07714_consen 135 LLDSNG-QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE 213 (259)
T ss_dssp EEETTT-EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH
T ss_pred cccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999888 8999999999865221 1223335677899999332
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
..+..++.++++++..||..+|.+||++.++++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 214 IIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 23456788999999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=202.27 Aligned_cols=139 Identities=30% Similarity=0.437 Sum_probs=112.2
Q ss_pred CCCCCCCccceEEEee------cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 027476 3 SRVRHRNLVKFIGACK------EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLK 76 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 76 (223)
++++||||++++++|. +..+++||||+. ++|.+++.......+++..++.++.|++.||.|||++|++|||||
T Consensus 59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk 137 (290)
T cd07862 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137 (290)
T ss_pred cccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 4568999999999884 235889999995 699999977555568999999999999999999999999999999
Q ss_pred CCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccC
Q 027476 77 PENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKED 143 (223)
Q Consensus 77 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~ 143 (223)
|+||+++.++ .+||+|||+++............|++.|+|||.+.....+...|+|+++..+++.-
T Consensus 138 p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 203 (290)
T cd07862 138 PQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203 (290)
T ss_pred HHHEEEcCCC-CEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHH
Confidence 9999999887 89999999998654444444567899999999776555555556665555555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=202.40 Aligned_cols=147 Identities=29% Similarity=0.353 Sum_probs=121.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||+++++.+.+ +..++||||++|++|.+.+..... +++..+..++.||+.||.|||+.||+||||||+||
T Consensus 50 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NI 127 (321)
T cd05603 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENI 127 (321)
T ss_pred HHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence 567899999999998865 578999999999999998876443 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .+||+|||+++.... ........|++.|+|||.+...
T Consensus 128 ll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 206 (321)
T cd05603 128 LLDSQG-HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206 (321)
T ss_pred EECCCC-CEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 999887 899999999875322 2223345789999999955321
Q ss_pred ---------CCCChHHHHHHHHHhcccCCCCCCCHH
Q 027476 125 ---------AENLPEDLALIVTSCWKEDPNERPNFS 151 (223)
Q Consensus 125 ---------~~~~~~~l~~l~~~~l~~~p~~Rp~~~ 151 (223)
+...+.++.+++.+|++.+|.+|++..
T Consensus 207 ~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 207 NILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 223456678899999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=197.79 Aligned_cols=157 Identities=27% Similarity=0.505 Sum_probs=128.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||
T Consensus 60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~ni 138 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKV 138 (266)
T ss_pred HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhE
Confidence 567899999999999865 57899999999999999987643 3589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccc--cCCCccccccCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMT--AETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
+++.++ .+|++|||.+.......... ...++..|+|||.+..
T Consensus 139 li~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~ 217 (266)
T cd05064 139 LVNSDL-VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV 217 (266)
T ss_pred EEcCCC-cEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 999877 89999999876432221111 2235678999994421
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
.+..++..+.+++..||+.+|.+||+++++.+.|.++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 218 IKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1234567788899999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=204.86 Aligned_cols=118 Identities=25% Similarity=0.462 Sum_probs=101.0
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~ 78 (223)
+|++++||||+++++++.+ +..++||||+++++|.+++..... +++..+..++.|++.||.|||++ +++||||||+
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~ 133 (331)
T cd06649 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPS 133 (331)
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChh
Confidence 3678899999999999864 678999999999999999976544 89999999999999999999986 6999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
||+++.++ .+||+|||++...... ......|++.|+|||.+.
T Consensus 134 Nil~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~ 175 (331)
T cd06649 134 NILVNSRG-EIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQ 175 (331)
T ss_pred hEEEcCCC-cEEEccCccccccccc-ccccCCCCcCcCCHhHhc
Confidence 99999887 7999999998754322 223457899999999543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=209.22 Aligned_cols=159 Identities=32% Similarity=0.593 Sum_probs=128.8
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC-------------------------------------
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR------------------------------------- 42 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------------------------------------- 42 (223)
|+++ +|+||+++++.|.+ +..++||||+.+|+|.+++....
T Consensus 95 l~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred HHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 5567 89999999999865 57899999999999999986421
Q ss_pred -------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEE
Q 027476 43 -------------------------------PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKL 91 (223)
Q Consensus 43 -------------------------------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl 91 (223)
...+++..+++++.|++.||.|||++|++||||||+||+++.++ .+||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL 253 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKI 253 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEE
Confidence 12378899999999999999999999999999999999999776 8999
Q ss_pred ccCccccccccccc---cccCCCccccccCCCCCC---------------------------------------------
Q 027476 92 ADFGLAREESLTEM---MTAETGTYRWMAPENMRP--------------------------------------------- 123 (223)
Q Consensus 92 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--------------------------------------------- 123 (223)
+|||+++....... .....++..|+|||++..
T Consensus 254 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~ 333 (374)
T cd05106 254 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333 (374)
T ss_pred eeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC
Confidence 99999875432211 112235568999994421
Q ss_pred --CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 124 --SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 124 --~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
.+...+.++.+++.+||+.+|.+||++.++++.|++++
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 01224678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=198.67 Aligned_cols=157 Identities=34% Similarity=0.618 Sum_probs=130.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--------------RCLDIHVAIGFALDIARAMECLH 66 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~lH 66 (223)
+++++||||+++++++.+ +..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 567899999999999865 578999999999999999976422 45889999999999999999999
Q ss_pred hCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC---------------------
Q 027476 67 SHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR--------------------- 122 (223)
Q Consensus 67 ~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~--------------------- 122 (223)
++|++|+||||+||+++.++ .+||+|||+++...... ......+++.|+|||.+.
T Consensus 142 ~~~i~H~dlkp~Nil~~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~ 220 (283)
T cd05048 142 SHHFVHRDLAARNCLVGEGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIF 220 (283)
T ss_pred hCCeeccccccceEEEcCCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHH
Confidence 99999999999999999877 79999999987543221 122345678899999432
Q ss_pred -------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 123 -------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 123 -------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
..+..++.++.+++..||+.+|.+||++.++.++|++
T Consensus 221 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 221 SYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1123567788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=197.57 Aligned_cols=156 Identities=28% Similarity=0.433 Sum_probs=132.4
Q ss_pred CCCCccceEEEeecC-----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 6 RHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 6 ~Hpniv~l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
.|||||+++++|++. -+.+|||.++||.|.+.+.+++.+.+++.++..|++||+.|+.|||+.+|.||||||+|+
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENL 192 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENL 192 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhe
Confidence 699999999998542 367999999999999999999988999999999999999999999999999999999999
Q ss_pred EEeCCC--CceEEccCccccccccccccccCCCccccccCCCCCCCC---------------------------------
Q 027476 81 ILTADH--KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA--------------------------------- 125 (223)
Q Consensus 81 ll~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------------------- 125 (223)
|..... ..+||+|||+|+.........+.+.|+.|.|||++.+..
T Consensus 193 Lyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais 272 (400)
T KOG0604|consen 193 LYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 272 (400)
T ss_pred eeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC
Confidence 996433 379999999999876666667788999999999664211
Q ss_pred -------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 126 -------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 126 -------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..++.+..++|..+|..+|.+|.++.+++++ .++..
T Consensus 273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h--pwi~~ 327 (400)
T KOG0604|consen 273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH--PWINQ 327 (400)
T ss_pred hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC--chhcc
Confidence 1245567789999999999999999999876 55443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=212.63 Aligned_cols=161 Identities=35% Similarity=0.662 Sum_probs=138.3
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++++-+|.||+-+.|+|..+.+.+|.-+|+|.+|+.++...+ ..++....+.|+.|++.|+.|||.++|+|||||..||
T Consensus 441 ~lkkTRH~NIlLFMG~~~~p~~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNI 519 (678)
T KOG0193|consen 441 VLKKTRHENILLFMGACMNPPLAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNI 519 (678)
T ss_pred HHhhcchhhheeeehhhcCCceeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccce
Confidence 367889999999999999888899999999999999998654 3389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc---ccccccCCCccccccCCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESL---TEMMTAETGTYRWMAPENMRP---------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~---------------------------------- 123 (223)
++.+++ .|||+|||++..... ........|...|||||+++.
T Consensus 520 Fl~~~~-kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~ 598 (678)
T KOG0193|consen 520 FLHEDL-KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR 598 (678)
T ss_pred EEccCC-cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh
Confidence 999877 899999999974332 222344568889999996651
Q ss_pred ------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 124 ------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 124 ------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
...+++.++..|+..||..++++||.+.+++..|+.++..
T Consensus 599 dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 599 DQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred hheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1245777899999999999999999999999999988763
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=216.52 Aligned_cols=163 Identities=27% Similarity=0.452 Sum_probs=133.5
Q ss_pred CCCCCC-CCCccceEEE-ee----c---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 027476 1 MMSRVR-HRNLVKFIGA-CK----E---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG-- 69 (223)
Q Consensus 1 il~~l~-Hpniv~l~~~-~~----~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~-- 69 (223)
+|++|+ |+|||.+++. .. + -+++++||||.||.|-+++..+....|++.++++|+.++|+|+.+||...
T Consensus 87 ~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pP 166 (738)
T KOG1989|consen 87 IMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPP 166 (738)
T ss_pred HHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCc
Confidence 477886 9999999993 31 1 25789999999999999998766666999999999999999999999998
Q ss_pred cccCCCCCCCEEEeCCCCceEEccCcccccccccc----------ccccCCCccccccCCCCC-----------------
Q 027476 70 IIHRDLKPENLILTADHKTVKLADFGLAREESLTE----------MMTAETGTYRWMAPENMR----------------- 122 (223)
Q Consensus 70 ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~----------~~~~~~gt~~y~aPE~~~----------------- 122 (223)
|+|||||-+||||+.++ ..||||||.|....... ..-....|+.|+|||.+.
T Consensus 167 iIHRDLKiENvLls~~g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALG 245 (738)
T KOG1989|consen 167 IIHRDLKIENVLLSADG-NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALG 245 (738)
T ss_pred cchhhhhhhheEEcCCC-CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHH
Confidence 99999999999999888 89999999987322111 001124689999999432
Q ss_pred ----------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 ----------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 ----------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
+....++..+..||..||+.+|.+||++-+++..+.++....
T Consensus 246 clLYkLCy~t~PFe~sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 246 CLLYKLCYFTTPFEESGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred HHHHHHHHhCCCcCcCcceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 223567788999999999999999999999999988876543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=201.58 Aligned_cols=123 Identities=30% Similarity=0.492 Sum_probs=105.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++.+++ ..+++||||+.|++|.+++.......+++..++.++.|++.||+|||+.|++||||||+|
T Consensus 46 il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~N 125 (277)
T cd05607 46 ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPEN 125 (277)
T ss_pred HHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHh
Confidence 3678899999999999875 578999999999999998876555568999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 124 (223)
|+++.++ .++|+|||++.............|+..|+|||.+...
T Consensus 126 ili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 169 (277)
T cd05607 126 VLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE 169 (277)
T ss_pred EEEcCCC-CEEEeeceeeeecCCCceeeccCCCCCccCHHHHccC
Confidence 9999877 7999999998765443333445789999999965433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=198.20 Aligned_cols=163 Identities=27% Similarity=0.353 Sum_probs=134.8
Q ss_pred CCCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
+|.+++|||||.+-++... +.+|+|||||+ .+|..++...+ +.+...++..+..|+++|++|||.+.|+|||||+
T Consensus 128 iLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~ 205 (419)
T KOG0663|consen 128 ILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKT 205 (419)
T ss_pred HHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccch
Confidence 4678899999999998754 46999999995 69999988755 5599999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC----------------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR---------------------------------- 122 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~---------------------------------- 122 (223)
+|+|++..| .+||+|||+|+.+... ...+..+.|.+|+|||.+-
T Consensus 206 SNLLm~~~G-~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~ 284 (419)
T KOG0663|consen 206 SNLLLSHKG-ILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI 284 (419)
T ss_pred hheeeccCC-cEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH
Confidence 999999887 8999999999987655 3356678899999999321
Q ss_pred ---------------------------------CC----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 123 ---------------------------------PS----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 123 ---------------------------------~~----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
.. ...++..-.+|+..++.+||.+|-|+++.+++ .
T Consensus 285 dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~ 362 (419)
T KOG0663|consen 285 DQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--E 362 (419)
T ss_pred HHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--c
Confidence 00 11144667789999999999999999999887 7
Q ss_pred HhhcCCCCC
Q 027476 160 YISTNSAPE 168 (223)
Q Consensus 160 ~~~~~~~~~ 168 (223)
++...+.|.
T Consensus 363 ~F~e~P~p~ 371 (419)
T KOG0663|consen 363 YFRETPLPI 371 (419)
T ss_pred ccccCCCCC
Confidence 776655443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=208.22 Aligned_cols=158 Identities=35% Similarity=0.597 Sum_probs=127.7
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC-------------------------------------
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR------------------------------------- 42 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------------------------------------- 42 (223)
|+.+ +||||++++++|.+ +..++||||++||+|.+++....
T Consensus 92 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (375)
T cd05104 92 LSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDM 171 (375)
T ss_pred HHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhc
Confidence 4566 89999999999975 57899999999999999986432
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCC
Q 027476 43 ------------------------------------PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADH 86 (223)
Q Consensus 43 ------------------------------------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~ 86 (223)
...+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~ 251 (375)
T cd05104 172 KPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR 251 (375)
T ss_pred CCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC
Confidence 12478899999999999999999999999999999999999766
Q ss_pred CceEEccCccccccccccc---cccCCCccccccCCCCCC----------------------------------------
Q 027476 87 KTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP---------------------------------------- 123 (223)
Q Consensus 87 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---------------------------------------- 123 (223)
.+||+|||+++....... .....++..|+|||.+..
T Consensus 252 -~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~ 330 (375)
T cd05104 252 -ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330 (375)
T ss_pred -cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH
Confidence 899999999975432221 112334567999994421
Q ss_pred -------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 124 -------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 124 -------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
.+...+.++.+++..||+.+|.+||++.++++.|++.
T Consensus 331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0123456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=213.30 Aligned_cols=154 Identities=29% Similarity=0.497 Sum_probs=130.3
Q ss_pred CCCCCCCCCccceEEEe-ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||+.++||+||+|++.| .++.+|++.|||.||-.+.++-..+ ..+++.++.-+++|++.||.|||+++|+|||||+.|
T Consensus 82 ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGN 160 (1187)
T KOG0579|consen 82 ILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGN 160 (1187)
T ss_pred hhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccc
Confidence 67889999999999865 6789999999999999999987754 459999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCC-----CCCCCChHHH---------------------
Q 027476 80 LILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMR-----PSAENLPEDL--------------------- 132 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~l--------------------- 132 (223)
||++.+| .++|+|||++..... ......+.|||.|||||++. ..++++..|+
T Consensus 161 iL~TldG-dirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln 239 (1187)
T KOG0579|consen 161 ILLTLDG-DIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN 239 (1187)
T ss_pred eEEEecC-cEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence 9999999 799999998764332 23345678999999999764 3444554444
Q ss_pred --------------------------HHHHHHhcccCCCCCCCHHHHHHH
Q 027476 133 --------------------------ALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 133 --------------------------~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+++..||..+|..||++++++++
T Consensus 240 pMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 240 PMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 457889999999999999999753
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=207.85 Aligned_cols=158 Identities=30% Similarity=0.482 Sum_probs=135.7
Q ss_pred CCCCCC-CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 1 MMSRVR-HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~-Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
||++++ ||||+.+.++|++ ..+++|||++.||.|.+.+... . +++..+..++.|++.++.|||+.||+||||||+
T Consensus 88 il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpE 164 (382)
T KOG0032|consen 88 ILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPE 164 (382)
T ss_pred HHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHH
Confidence 477887 9999999999986 5789999999999999999876 2 999999999999999999999999999999999
Q ss_pred CEEEeCCC---CceEEccCccccccccccccccCCCccccccCCCCCCCC------------------------------
Q 027476 79 NLILTADH---KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA------------------------------ 125 (223)
Q Consensus 79 Nill~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------------------ 125 (223)
|+|+.... ..+|++|||++............+||+.|+|||++...+
T Consensus 165 N~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~ 244 (382)
T KOG0032|consen 165 NLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF 244 (382)
T ss_pred HeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh
Confidence 99996542 279999999999877666677889999999999765322
Q ss_pred ------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 126 ------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 126 ------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
.+++..+.+++..++..+|.+|+++.+++++ .++..
T Consensus 245 ~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H--pWi~~ 298 (382)
T KOG0032|consen 245 EIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH--PWIKS 298 (382)
T ss_pred HHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC--ccccC
Confidence 3355667778999999999999999999886 44443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=204.62 Aligned_cols=150 Identities=28% Similarity=0.435 Sum_probs=127.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++.+.+ +..++||||++|++|.+++..... +++..+..++.|++.||.|||++|++||||||+||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 132 (333)
T cd05600 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF 132 (333)
T ss_pred HHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 567889999999999975 578999999999999999976543 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS------------------------------------ 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------------------------ 124 (223)
+++.++ .+||+|||++..... ......|++.|+|||.+...
T Consensus 133 l~~~~~-~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 209 (333)
T cd05600 133 LIDASG-HIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209 (333)
T ss_pred EECCCC-CEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH
Confidence 999887 899999999975433 23456799999999954311
Q ss_pred ----------C------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------A------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------~------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+ ..++.++++++.+||..+|.+||++++++++
T Consensus 210 i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 210 LKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 1336788999999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=195.07 Aligned_cols=159 Identities=30% Similarity=0.541 Sum_probs=131.9
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++.+.++..++||||+.+++|.+++.......+++..++.++.|++.||.|+|+.+++|+||||+||+
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nil 134 (262)
T cd05071 55 MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 134 (262)
T ss_pred HHhCCCCCcceEEEEECCCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEE
Confidence 56789999999999988778899999999999999998655556899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCcccccccccccc--ccCCCccccccCCCCCCC-----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEMM--TAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
++.++ .+||+|||.++........ ....++..|++||.....
T Consensus 135 l~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~ 213 (262)
T cd05071 135 VGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 213 (262)
T ss_pred EcCCC-cEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH
Confidence 99877 7999999998754332211 123456789999954211
Q ss_pred -----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 125 -----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 125 -----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
...++.++.+++.+|++.+|.+||+++++.+.|++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 214 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 1235577888999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=206.76 Aligned_cols=137 Identities=23% Similarity=0.319 Sum_probs=110.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++|+|++ .++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 110 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 187 (357)
T PHA03209 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTEN 187 (357)
T ss_pred HHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 3678999999999999865 5688999999 568888886533 358999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhc
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCW 140 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l 140 (223)
|+++.++ .+||+|||+++............||..|+|||++.....+...|+|+++..++
T Consensus 188 ill~~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ 247 (357)
T PHA03209 188 IFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLF 247 (357)
T ss_pred EEECCCC-CEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHH
Confidence 9999877 79999999997543333334567899999999876655555556555544444
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=196.67 Aligned_cols=161 Identities=29% Similarity=0.546 Sum_probs=133.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--------------RCLDIHVAIGFALDIARAMECLH 66 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~lH 66 (223)
+++++|+||+++++++.+ +..++||||+.+++|.+++..... ..+++..++.++.|++.||+|||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 578899999999999965 578999999999999999975431 34899999999999999999999
Q ss_pred hCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC---------------------
Q 027476 67 SHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR--------------------- 122 (223)
Q Consensus 67 ~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~--------------------- 122 (223)
++|++||||||+||+++.++ .++|+|||++....... ......++..|+|||.+.
T Consensus 141 ~~~i~H~dlkp~Nil~~~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 219 (291)
T cd05094 141 SQHFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219 (291)
T ss_pred hCCeeecccCcceEEEccCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999877 89999999987543222 122345678899999432
Q ss_pred -------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 -------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 -------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+...+.++.+++.+||+.+|.+||++.++++.|+++...
T Consensus 220 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 220 TYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred hCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11233567789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=203.85 Aligned_cols=117 Identities=25% Similarity=0.448 Sum_probs=100.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~N 79 (223)
|++++||||++++++|.+ +..++||||+.+++|.+++...+. +++..+..++.|++.||.|||+. +++|+||||+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~N 134 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 134 (333)
T ss_pred HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhh
Confidence 578899999999999865 678999999999999999976544 89999999999999999999985 79999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
|+++.++ .+||+|||++...... ......|+..|+|||.+.
T Consensus 135 ili~~~~-~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~ 175 (333)
T cd06650 135 ILVNSRG-EIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQ 175 (333)
T ss_pred EEEcCCC-CEEEeeCCcchhhhhh-ccccCCCCccccCHHHhc
Confidence 9999877 7999999998754322 223457899999999553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=213.13 Aligned_cols=161 Identities=29% Similarity=0.574 Sum_probs=140.5
Q ss_pred CCCCCCCCCccceEEEeecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||.+++||||++|.|+.... ...+|.|||++|+|+.+|+.+.++ ++.-++..++++|+.|++||-+.++|||||.+.|
T Consensus 683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARN 761 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARN 761 (996)
T ss_pred hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhh
Confidence 68999999999999999764 577999999999999999987755 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc--ccccCCCc--cccccCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE--MMTAETGT--YRWMAPENMR--------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt--~~y~aPE~~~--------------------------------- 122 (223)
|||+.+- .+|++|||+++...+.. ..++..|. ..|.|||.+.
T Consensus 762 ILVNsnL-vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 762 ILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred eeeccce-EEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 9999887 89999999999654332 22333333 4899999332
Q ss_pred -------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 -------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 -------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+.+||..+++|+..||+++-.+||.+.+++..|.+++++
T Consensus 841 QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 841 QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 56788999999999999999999999999999999999875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=204.20 Aligned_cols=118 Identities=28% Similarity=0.407 Sum_probs=98.2
Q ss_pred CCCCCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 1 MMSRVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+|++++||||+++++++.. ...++||||+ +++|.+++..... +++..+..++.|++.||.|||++|++|||
T Consensus 52 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~d 128 (338)
T cd07859 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTANVFHRD 128 (338)
T ss_pred HHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 3678899999999998742 2479999999 5799998876544 99999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR 122 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~ 122 (223)
|||+||+++.++ .+||+|||+++...... ......|++.|+|||++.
T Consensus 129 lkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 179 (338)
T cd07859 129 LKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179 (338)
T ss_pred CCHHHeEECCCC-cEEEccCccccccccccCccccccCCCCCCCcCCHHHHh
Confidence 999999999887 89999999997532211 123457899999999654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=197.16 Aligned_cols=161 Identities=29% Similarity=0.528 Sum_probs=133.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR-----------PRCLDIHVAIGFALDIARAMECLHSHG 69 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~l~~lH~~~ 69 (223)
+++++||||+++++++.+ +..++|+||+.+++|.+++.... ...+++..++.++.|++.||+|||++|
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 578899999999999965 67899999999999999997543 134899999999999999999999999
Q ss_pred cccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC-----------------------
Q 027476 70 IIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP----------------------- 123 (223)
Q Consensus 70 ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~----------------------- 123 (223)
++||||||+||+++.++ .+||+|||+++....... .....++..|+|||.+..
T Consensus 141 i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g 219 (288)
T cd05093 141 FVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYG 219 (288)
T ss_pred eeecccCcceEEEccCC-cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999877 899999999875432221 122345778999994431
Q ss_pred -----------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 124 -----------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 124 -----------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
.+...+.++.+++.+||+.+|.+||++.++.+.|+++...
T Consensus 220 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 220 KQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1224567889999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=195.42 Aligned_cols=153 Identities=25% Similarity=0.426 Sum_probs=122.1
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++||||+++++++.+ +..++||||+++++|..++.... +.+++..+..++.|++.||+|||+++++||||||+|
T Consensus 69 ~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~N 147 (274)
T cd05076 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKN 147 (274)
T ss_pred HHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCccc
Confidence 3578899999999999965 57889999999999999886533 348999999999999999999999999999999999
Q ss_pred EEEeCCC------CceEEccCccccccccccccccCCCccccccCCCCCCC-----------------------------
Q 027476 80 LILTADH------KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS----------------------------- 124 (223)
Q Consensus 80 ill~~~~------~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------------- 124 (223)
|+++.++ ..+|++|||++...... ....++..|+|||.+...
T Consensus 148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 148 ILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred EEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 9997543 14899999987643221 223567889999955321
Q ss_pred ----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 125 ----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 125 ----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
+.....++.+++.+||+.+|.+||++.++++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 225 RTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred cChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111234677888899999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=193.93 Aligned_cols=157 Identities=31% Similarity=0.575 Sum_probs=130.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 578899999999999865 57899999999999999997643 3589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-cc--ccCCCccccccCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MM--TAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~--~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
+++.++ .++|+|||+++...... .. ....++..|+|||.+.
T Consensus 138 li~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~ 216 (266)
T cd05033 138 LVNSNL-VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD 216 (266)
T ss_pred EEcCCC-CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH
Confidence 999877 79999999998653111 11 1223456899999432
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
+.+..++.++.+++.+||+.+|.+||++++++++|.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 217 VIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11234567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=203.19 Aligned_cols=95 Identities=26% Similarity=0.546 Sum_probs=86.7
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++.+.+ +.+++||||++||+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~N 131 (376)
T cd05598 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDN 131 (376)
T ss_pred HHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHH
Confidence 3678899999999999975 57899999999999999997654 38999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccc
Q 027476 80 LILTADHKTVKLADFGLAR 98 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~ 98 (223)
|+++.++ .+||+|||++.
T Consensus 132 ill~~~~-~ikL~DFG~a~ 149 (376)
T cd05598 132 ILIDRDG-HIKLTDFGLCT 149 (376)
T ss_pred EEECCCC-CEEEEeCCCCc
Confidence 9999887 89999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=210.25 Aligned_cols=162 Identities=33% Similarity=0.595 Sum_probs=142.0
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||+.|+|||+|+|+|+|.. ..+|||.|||..|+|.+++++.....++.-..+.++.||.+|++||..++++||||.+.|
T Consensus 316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARN 395 (1157)
T KOG4278|consen 316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 395 (1157)
T ss_pred HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence 5889999999999999974 689999999999999999998887778888999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCC---CccccccCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAET---GTYRWMAPENM----------------------------------- 121 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~---gt~~y~aPE~~----------------------------------- 121 (223)
+|+.++. .||++|||+++...... ++... ....|.|||.+
T Consensus 396 CLVgEnh-iVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS 473 (1157)
T KOG4278|consen 396 CLVGENH-IVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 473 (1157)
T ss_pred ccccccc-eEEeeccchhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence 9999887 89999999999765433 23333 34589999933
Q ss_pred -----------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 122 -----------RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 122 -----------~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
+..+.+|+..++.|+..||++.|.+||+++++.+.++.++...
T Consensus 474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 2568899999999999999999999999999999988877543
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=196.85 Aligned_cols=159 Identities=34% Similarity=0.644 Sum_probs=130.4
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--------------RPRCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~l~~l 65 (223)
++++ +|+||+++++++.+ +..+++|||+.+++|.+++... ....+++..++.++.|++.||+||
T Consensus 69 l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 148 (293)
T cd05053 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL 148 (293)
T ss_pred HHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 4566 79999999999865 5789999999999999999652 234589999999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCC--------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMR-------------------- 122 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-------------------- 122 (223)
|+.+++||||||+||+++.++ .+||+|||+++....... .....++..|+|||.+.
T Consensus 149 H~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 227 (293)
T cd05053 149 ASKKCIHRDLAARNVLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227 (293)
T ss_pred HHCCccccccceeeEEEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHH
Confidence 999999999999999999877 899999999975433221 11223457899999432
Q ss_pred --------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 123 --------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 123 --------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
..+...+.++.+++.+||..+|.+||++.++++.|.+++
T Consensus 228 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 228 FTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred hcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 112345578899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=202.87 Aligned_cols=152 Identities=26% Similarity=0.364 Sum_probs=124.1
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|+++ +||||+++++++.+ +.+++||||+.+|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~N 135 (332)
T cd05614 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLEN 135 (332)
T ss_pred HHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHH
Confidence 4556 59999999998865 578899999999999999976544 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
|+++.++ .+||+|||+++...... ......||+.|+|||.+...
T Consensus 136 ili~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 214 (332)
T cd05614 136 ILLDSEG-HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214 (332)
T ss_pred eEECCCC-CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC
Confidence 9999887 89999999987543221 12345789999999954311
Q ss_pred ----------------CCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 125 ----------------AENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 125 ----------------~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
+..++..+.+++.+||+.+|.+|| ++++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 215 TQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 123456678899999999999999 66677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=203.14 Aligned_cols=95 Identities=27% Similarity=0.531 Sum_probs=86.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++.+.+ +.+++||||++||+|.+++.+... +++..+..++.|++.||+|||+.||+||||||+|
T Consensus 54 il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~N 131 (381)
T cd05626 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDN 131 (381)
T ss_pred HHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHH
Confidence 3678899999999999975 578999999999999999976544 8999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccc
Q 027476 80 LILTADHKTVKLADFGLAR 98 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~ 98 (223)
|+++.++ .+||+|||+++
T Consensus 132 ili~~~~-~~kL~DFGl~~ 149 (381)
T cd05626 132 ILIDLDG-HIKLTDFGLCT 149 (381)
T ss_pred EEECCCC-CEEEeeCcCCc
Confidence 9999877 89999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=205.66 Aligned_cols=145 Identities=26% Similarity=0.390 Sum_probs=127.1
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++.++||||+++++++.+ +..++||||+.+|+|.+++..... +++..+..++.|++.||.|||++|++||||||+|
T Consensus 84 ~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~N 161 (340)
T PTZ00426 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPEN 161 (340)
T ss_pred HHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHH
Confidence 3577899999999999975 578999999999999999986554 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCH
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
|+++.++ .+||+|||+++..... .....||+.|+|||++.....+...|+|+++..++++-.+..|..
T Consensus 162 ILl~~~~-~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 229 (340)
T PTZ00426 162 LLLDKDG-FIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY 229 (340)
T ss_pred EEECCCC-CEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCC
Confidence 9999877 8999999999754322 234579999999999988888889999999999998887777753
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=194.26 Aligned_cols=158 Identities=30% Similarity=0.527 Sum_probs=130.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++|+||+++++.+.+ +..+++|||+.+++|.+++.......+++..++.++.|++.||+|||+.+++|+||||+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~n 133 (261)
T cd05072 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAAN 133 (261)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhh
Confidence 3578899999999998865 568999999999999999987655568999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMRP---------------------------------- 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~---------------------------------- 123 (223)
|+++.++ .+||+|||++........ .....++..|+|||.+..
T Consensus 134 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~ 212 (261)
T cd05072 134 VLVSESL-MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212 (261)
T ss_pred EEecCCC-cEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH
Confidence 9999877 899999999975433221 122345678999994321
Q ss_pred ------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 124 ------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 124 ------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
....++.++.+++.+|+..+|.+||+++++.+.|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 213 VMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122356788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=193.99 Aligned_cols=152 Identities=26% Similarity=0.437 Sum_probs=125.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+|+|.+++...+. .+++..++.++.|++.||+|||++|++||||||+||
T Consensus 53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~ni 131 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNV 131 (258)
T ss_pred HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 567899999999999865 678999999999999999976443 489999999999999999999999999999999999
Q ss_pred EEeCCCCc-------eEEccCccccccccccccccCCCccccccCCCCCCC-----------------------------
Q 027476 81 ILTADHKT-------VKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS----------------------------- 124 (223)
Q Consensus 81 ll~~~~~~-------~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------------- 124 (223)
+++.++.. ++++|||++...... ....++..|+|||++...
T Consensus 132 li~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 132 LLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred EEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 99876532 799999988654322 234678899999965421
Q ss_pred ----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 125 ----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 125 ----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
+.....++.+++.+||+.+|.+||+++++++.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 209 LDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ccHHHHHHHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112335677899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=195.01 Aligned_cols=152 Identities=24% Similarity=0.412 Sum_probs=121.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ ...++||||+.+++|..++.... ..+++..++.++.|++.||+|||+++++||||||+||
T Consensus 58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 136 (262)
T cd05077 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNI 136 (262)
T ss_pred HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccE
Confidence 567899999999999865 57889999999999999886533 3489999999999999999999999999999999999
Q ss_pred EEeCCCC------ceEEccCccccccccccccccCCCccccccCCCCCC-CCC---------------------------
Q 027476 81 ILTADHK------TVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP-SAE--------------------------- 126 (223)
Q Consensus 81 ll~~~~~------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~--------------------------- 126 (223)
+++.++. .++++|||++...... ....++..|+|||.+.. ...
T Consensus 137 ll~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 137 LLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred EEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 9986542 2899999998654321 23457888999996531 111
Q ss_pred -----------------CChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 127 -----------------NLPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 127 -----------------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
....++.+++.+||+.+|.+||++.++++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 214 TLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred chhHHHHHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1235567788888888888888888887765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=194.91 Aligned_cols=159 Identities=31% Similarity=0.580 Sum_probs=127.9
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--------------PRCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~l 65 (223)
++++ +||||+++++++.+ +..++||||+++++|.+++.... ...+++..++.++.|++.||+||
T Consensus 49 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l 128 (270)
T cd05047 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 128 (270)
T ss_pred HHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567 79999999999965 57899999999999999997532 12478999999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC----------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP---------------------- 123 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------------------- 123 (223)
|+.|++|+||||+||+++.++ .+||+|||++..............+..|+|||++..
T Consensus 129 H~~~i~H~dikp~nili~~~~-~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~ 207 (270)
T cd05047 129 SQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 207 (270)
T ss_pred HHCCEeecccccceEEEcCCC-eEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcC
Confidence 999999999999999999877 899999999864322111112234567999994321
Q ss_pred ------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 124 ------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 124 ------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
.+...+.++.+++.+||..+|.+||++.++++.|.+++
T Consensus 208 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 208 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 12234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=193.91 Aligned_cols=156 Identities=33% Similarity=0.612 Sum_probs=128.5
Q ss_pred CCCCCCCCCccceEEEee--cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACK--EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
++++++|+||+++++++. ++..++|+||+.+++|.+++.+.....+++..++.++.|++.||+|||++|++||||||+
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ 131 (256)
T cd05082 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAAR 131 (256)
T ss_pred HHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchh
Confidence 367889999999999763 356899999999999999998766556899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
||+++.++ .+||+|||+++...... ....++..|+|||.+...
T Consensus 132 nil~~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~ 208 (256)
T cd05082 132 NVLVSEDN-VAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208 (256)
T ss_pred eEEEcCCC-cEEecCCccceeccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999877 89999999987543221 223445689999943211
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
+..++..+.+++.+||+.+|.+||+++++.+.|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 209 VPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 12345678899999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=210.03 Aligned_cols=153 Identities=28% Similarity=0.457 Sum_probs=132.0
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++++||.++|+.+.. ..+|++||||.||++.+.++.... +++.++..++++++.||.|+|.++.+|||||+.|
T Consensus 64 ~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaan 141 (467)
T KOG0201|consen 64 VLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAAN 141 (467)
T ss_pred HHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhcceecccccccc
Confidence 3678899999999999865 579999999999999999976443 5899999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccc-cccCCCccccccCCCCCCCCCCChHH---------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMAPENMRPSAENLPED--------------------------- 131 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~--------------------------- 131 (223)
|++..++ .+||+|||++.+...... ..+.+||+.|||||++....++..+|
T Consensus 142 il~s~~g-~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl 220 (467)
T KOG0201|consen 142 ILLSESG-DVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL 220 (467)
T ss_pred eeEeccC-cEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE
Confidence 9999887 799999999987655443 36789999999999888555555555
Q ss_pred ------------------HHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 132 ------------------LALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 132 ------------------l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+.+++..|+.++|..||++.+++++
T Consensus 221 flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 221 FLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred EeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 4558899999999999999999765
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=197.24 Aligned_cols=161 Identities=32% Similarity=0.633 Sum_probs=131.9
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--------------RCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~l 65 (223)
++.+ +||||+++++++.+ +..++||||+.+++|.+++..... ..+++..++.++.|++.||.||
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L 153 (304)
T cd05101 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL 153 (304)
T ss_pred HHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence 4567 79999999999965 578899999999999999976421 3478889999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC-------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP------------------- 123 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------------- 123 (223)
|++|++||||||+||+++.++ .+||+|||+++....... .....++..|+|||.+..
T Consensus 154 H~~givH~dlkp~Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 232 (304)
T cd05101 154 ASQKCIHRDLAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232 (304)
T ss_pred HHCCeeecccccceEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHH
Confidence 999999999999999999777 899999999975432211 122345678999995421
Q ss_pred ---------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 124 ---------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 124 ---------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
.+..++.++.+++.+||+.+|.+||++.++++.|++++..
T Consensus 233 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 233 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1233557788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=193.87 Aligned_cols=157 Identities=31% Similarity=0.592 Sum_probs=130.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+++++|.+++.+.....+++..++.++.|++.||.|||++|++|+||||+||
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~ni 135 (261)
T cd05148 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNI 135 (261)
T ss_pred HhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceE
Confidence 678999999999999865 5788999999999999999876656689999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc-cccCCCccccccCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
+++.++ .+||+|||.+........ .....++..|++||.+.
T Consensus 136 lv~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~ 214 (261)
T cd05148 136 LVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214 (261)
T ss_pred EEcCCc-eEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 999877 899999999875432221 11234566899999432
Q ss_pred ---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 123 ---------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 123 ---------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
+.+..++.++.+++.+||+.+|.+||+++++.+.|+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 215 DQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1123456778899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=193.56 Aligned_cols=158 Identities=32% Similarity=0.543 Sum_probs=130.8
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++++++||||+++++++.++..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Ni 133 (260)
T cd05069 54 IMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANI 133 (260)
T ss_pred HHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence 36788999999999998877889999999999999999875555689999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
+++.++ .++|+|||++........ .....++..|+|||....
T Consensus 134 ll~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 212 (260)
T cd05069 134 LVGDNL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV 212 (260)
T ss_pred EEcCCC-eEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999877 899999999875432221 112345678999994321
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
.+...+..+.+++.+||..+|.+||+++++.+.|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 213 LEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122356678899999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=192.67 Aligned_cols=119 Identities=24% Similarity=0.429 Sum_probs=100.6
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++||||+++++++..+..++||||+.+++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni 132 (259)
T cd05037 54 LMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI 132 (259)
T ss_pred HHHcCCCcchhheeeEEecCCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence 3678899999999999876778999999999999999976542 489999999999999999999999999999999999
Q ss_pred EEeCCCC------ceEEccCccccccccccccccCCCccccccCCCCCC
Q 027476 81 ILTADHK------TVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP 123 (223)
Q Consensus 81 ll~~~~~------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 123 (223)
+++.++. .+||+|||++..... .....++..|+|||.+..
T Consensus 133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~ 178 (259)
T cd05037 133 LVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRN 178 (259)
T ss_pred EEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcC
Confidence 9986652 499999999875433 223356778999997654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=193.56 Aligned_cols=160 Identities=33% Similarity=0.571 Sum_probs=133.3
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++++.++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+||+
T Consensus 61 l~~~~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nil 139 (270)
T cd05056 61 MRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVL 139 (270)
T ss_pred HHhCCCCchhceeEEEcCCCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEE
Confidence 57889999999999998888899999999999999997643 34899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccccc--cCCCccccccCCCCC-------------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEMMT--AETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~------------------------------------- 122 (223)
++.++ .+||+|||+++......... ...++..|+|||.+.
T Consensus 140 i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~ 218 (270)
T cd05056 140 VSSPD-CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI 218 (270)
T ss_pred EecCC-CeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99877 89999999987543332211 223456899999432
Q ss_pred ---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ---------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ---------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++..+.+++.+|+..+|.+||++.++++.|.++...
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 219 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11234567899999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=206.98 Aligned_cols=145 Identities=24% Similarity=0.345 Sum_probs=125.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+.+ ..+++||||++||+|.+++.+.+. +++..+..++.|++.||+|||++||+||||||+||
T Consensus 55 l~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NI 132 (363)
T cd05628 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL 132 (363)
T ss_pred HHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence 567899999999999976 578999999999999999986544 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc------------------------------------ccccCCCccccccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE------------------------------------MMTAETGTYRWMAPENMRPS 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~ 124 (223)
+++.++ .+||+|||+++...... .....+||+.|+|||.+...
T Consensus 133 Li~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~ 211 (363)
T cd05628 133 LLDSKG-HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT 211 (363)
T ss_pred EECCCC-CEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC
Confidence 999887 89999999986432110 01234799999999999988
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCC
Q 027476 125 AENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 125 ~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
..+...|+|+++..++++-.++.|.
T Consensus 212 ~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 212 GYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred CCCCchhhhhhHHHHHHHHhCCCCC
Confidence 8889999999999988887777774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=193.20 Aligned_cols=158 Identities=31% Similarity=0.540 Sum_probs=130.9
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++++++|+||+++++++.++..+++|||+.+++|.+++.......+++..++.++.|++.||.|||+.+++|+||||+||
T Consensus 54 ~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Ni 133 (260)
T cd05070 54 IMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANI 133 (260)
T ss_pred HHHhcCCCceEEEEeEECCCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceE
Confidence 36789999999999998877889999999999999999875555689999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccccc--ccCCCccccccCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMM--TAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
+++.++ .++|+|||++......... ....++..|+|||.+..
T Consensus 134 li~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~ 212 (260)
T cd05070 134 LVGDGL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV 212 (260)
T ss_pred EEeCCc-eEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999877 8999999999754332211 12235568999994321
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
.+...+..+.+++.+|+..+|.+||+++++.+.|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 213 LEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 123456778899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=198.35 Aligned_cols=162 Identities=30% Similarity=0.575 Sum_probs=130.5
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--------------PRCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~l 65 (223)
+.++ +||||+++++++.+ +.+++||||+++++|.+++.... ...+++..++.++.|++.||+||
T Consensus 61 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 140 (303)
T cd05088 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 140 (303)
T ss_pred HHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH
Confidence 4567 89999999999965 57899999999999999997543 13588999999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC-----------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR----------------------- 122 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----------------------- 122 (223)
|++|++||||||+||+++.++ .+||+|||+++............++..|+|||.+.
T Consensus 141 H~~gi~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 219 (303)
T cd05088 141 SQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 219 (303)
T ss_pred HhCCccccccchheEEecCCC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhc
Confidence 999999999999999999877 79999999986432211112223456799999322
Q ss_pred -----------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 -----------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 -----------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+...+.++.+++.+||+.+|.+||+++++++.|..+....
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 220 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred CCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 012235678889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=191.78 Aligned_cols=156 Identities=32% Similarity=0.583 Sum_probs=126.1
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~n 124 (252)
T cd05084 46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARN 124 (252)
T ss_pred HHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence 3678899999999999865 57889999999999999987533 348999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccc---cCCCccccccCCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMT---AETGTYRWMAPENMRP--------------------------------- 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~--------------------------------- 123 (223)
|+++.++ .+||+|||++.......... ....+..|+|||.+..
T Consensus 125 il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~ 203 (252)
T cd05084 125 CLVTEKN-VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ 203 (252)
T ss_pred EEEcCCC-cEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH
Confidence 9999877 79999999987533221111 1122456999995431
Q ss_pred -------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 124 -------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 124 -------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
.+..++..+.+++.+|++.+|.+||++.++.+.|+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 204 QTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 12334667888999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=192.64 Aligned_cols=156 Identities=33% Similarity=0.587 Sum_probs=130.4
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++++..+..++||||+.+++|.+++.... .+++..++.++.|++.||+|||+.+++|+||||+||+
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nil 127 (257)
T cd05060 50 MAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVL 127 (257)
T ss_pred HHhcCCCCeeeEEEEEcCCceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEE
Confidence 57789999999999998888999999999999999998755 4899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCcccccccccccc-c---cCCCccccccCCCCC-----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEMM-T---AETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~~-~---~~~gt~~y~aPE~~~----------------------------------- 122 (223)
++.++ .+||+|||+++........ . ...++..|+|||.+.
T Consensus 128 i~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~ 206 (257)
T cd05060 128 LVNRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206 (257)
T ss_pred EcCCC-cEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99877 8999999998754322211 1 112346799999432
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
..+..++..+++++.+||..+|.+||++.++.+.|++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 207 VIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11334567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=196.98 Aligned_cols=164 Identities=34% Similarity=0.626 Sum_probs=132.7
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--------------PRCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~l 65 (223)
++++ +||||++++++|.+ +..++++||+.+++|.+++.... ...+++..++.++.|++.||.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred HHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 4567 79999999999865 56899999999999999997532 12478899999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC-------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP------------------- 123 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------------- 123 (223)
|++|++||||||+||+++.++ .+||+|||+++....... .....++..|+|||.+..
T Consensus 151 H~~givH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 229 (334)
T cd05100 151 ASQKCIHRDLAARNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229 (334)
T ss_pred HHCCeeccccccceEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHH
Confidence 999999999999999999877 899999999875432211 112234567999995421
Q ss_pred ---------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCC
Q 027476 124 ---------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSA 166 (223)
Q Consensus 124 ---------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~ 166 (223)
.+..++.++.+++.+||+.+|.+||++.++++.|.++......
T Consensus 230 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 230 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 1234566788999999999999999999999999998865443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=195.69 Aligned_cols=162 Identities=30% Similarity=0.552 Sum_probs=130.4
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--------------PRCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~l 65 (223)
++++ +||||+++++++.+ +..++|+||+++++|.+++.... ...+++..++.++.|++.||+||
T Consensus 56 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l 135 (297)
T cd05089 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL 135 (297)
T ss_pred HHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4566 79999999999865 57899999999999999997532 13488999999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC----------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP---------------------- 123 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------------------- 123 (223)
|++|++||||||+||+++.++ .+||+|||++..............+..|+|||.+..
T Consensus 136 H~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~ 214 (297)
T cd05089 136 SEKQFIHRDLAARNVLVGENL-ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSL 214 (297)
T ss_pred HHCCcccCcCCcceEEECCCC-eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 999999999999999999877 799999999864322111111223457999994321
Q ss_pred ------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 124 ------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 124 ------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
.+..++.++.+++.+||+.+|.+||+++++++.|..+....
T Consensus 215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 215 GGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 12246678899999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-28 Score=190.99 Aligned_cols=160 Identities=33% Similarity=0.588 Sum_probs=129.7
Q ss_pred CCCCCCCCCccceEEEee--cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACK--EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++.++||||+++++++. ++..++|+||+.+++|.+++.+.. ...++..+..++.|++.||.|||+.+++||||||+
T Consensus 49 ~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~ 127 (262)
T cd05058 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAAR 127 (262)
T ss_pred HHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcc
Confidence 367899999999999774 346789999999999999987643 33678888999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc-----ccccCCCccccccCCCCCC------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE-----MMTAETGTYRWMAPENMRP------------------------------ 123 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~------------------------------ 123 (223)
||+++.++ .+||+|||+++...... ......++..|+|||.+..
T Consensus 128 nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 206 (262)
T cd05058 128 NCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206 (262)
T ss_pred eEEEcCCC-cEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999877 79999999987543211 1122345678999994421
Q ss_pred ----------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 124 ----------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 124 ----------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
.+...+..+.+++..||+.+|.+||++.++++.|++++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 207 DSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 012246788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=199.10 Aligned_cols=132 Identities=23% Similarity=0.349 Sum_probs=103.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.++++..+... ...+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 131 (287)
T cd07848 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENL 131 (287)
T ss_pred HHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 578899999999999864 678999999988777655433 23499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCCCCCCChHHHHHHH
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRPSAENLPEDLALIV 136 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~ 136 (223)
+++.++ .+||+|||++....... ......|++.|+|||++.....+...|+|+++
T Consensus 132 ll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 188 (287)
T cd07848 132 LISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVG 188 (287)
T ss_pred EEcCCC-cEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHH
Confidence 999877 89999999997643221 22345689999999966543333333333333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=195.19 Aligned_cols=161 Identities=30% Similarity=0.598 Sum_probs=131.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHH
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR----------------------PRCLDIHVAIGFALDI 58 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~----------------------~~~l~~~~~~~i~~qi 58 (223)
+++++||||+++++.+.+ +..++++||+.+++|.+++.... ...+++..++.++.|+
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 578899999999999864 57889999999999999986421 1247899999999999
Q ss_pred HHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCC-------------
Q 027476 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMR------------- 122 (223)
Q Consensus 59 ~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~------------- 122 (223)
+.||.|||+.+++||||||+||+++.++ .+||+|||+++....... .....++..|+|||.+.
T Consensus 137 ~~~l~~LH~~~ivH~dikp~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 215 (290)
T cd05045 137 SRGMQYLAEMKLVHRDLAARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSF 215 (290)
T ss_pred HHHHHHHHHCCeehhhhhhheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHH
Confidence 9999999999999999999999999777 899999999875422211 12234567899999432
Q ss_pred ---------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ---------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ---------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++..||+.+|.+||++.++++.|++++..
T Consensus 216 G~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 216 GVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11234567889999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=198.48 Aligned_cols=155 Identities=29% Similarity=0.433 Sum_probs=127.5
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++||||+++++.+.+ +..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+|
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N 132 (285)
T cd05605 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPEN 132 (285)
T ss_pred HHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHH
Confidence 3577899999999999865 578999999999999998876554569999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
|+++.++ .++|+|||++.............|++.|+|||.+...
T Consensus 133 il~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~ 211 (285)
T cd05605 133 ILLDDYG-HIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE 211 (285)
T ss_pred EEECCCC-CEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH
Confidence 9999877 8999999998765433333445789999999955311
Q ss_pred -------------CCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 125 -------------AENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 125 -------------~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
+..++..+.+++..||..+|.+|| ++++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 212 EVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 123556678888999999999999 67777554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=191.98 Aligned_cols=157 Identities=33% Similarity=0.554 Sum_probs=129.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 134 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNV 134 (261)
T ss_pred HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceE
Confidence 568899999999998864 5789999999999999999876545689999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccc--cCCCccccccCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMT--AETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
+++.++ .+||+|||++.......... ....+..|+|||.+..
T Consensus 135 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 213 (261)
T cd05068 135 LVGENN-ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV 213 (261)
T ss_pred EEcCCC-CEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999887 79999999987654222111 1123457999995431
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
.+...+.++.+++.+|++.+|.+||+++++.+.|++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 214 LQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 123456778899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=194.08 Aligned_cols=158 Identities=30% Similarity=0.553 Sum_probs=128.6
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHH
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR---------------PRCLDIHVAIGFALDIARAMEC 64 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~---------------~~~l~~~~~~~i~~qi~~~l~~ 64 (223)
++++++||||+++++++.+ +..++||||+.+++|.+++.... ...+++..++.++.|++.||+|
T Consensus 60 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 139 (283)
T cd05090 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEY 139 (283)
T ss_pred HHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 3678999999999999865 57899999999999999986322 1347899999999999999999
Q ss_pred HHhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCC------------------
Q 027476 65 LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRP------------------ 123 (223)
Q Consensus 65 lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~------------------ 123 (223)
||++|++|+||||+||+++.++ .+||+|||+++...... ......++..|+|||.+..
T Consensus 140 lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 218 (283)
T cd05090 140 LSSHFFVHKDLAARNILIGEQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWE 218 (283)
T ss_pred HHhcCeehhccccceEEEcCCC-cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHH
Confidence 9999999999999999999877 79999999997543221 1223345678999995421
Q ss_pred ----------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 124 ----------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 124 ----------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
.+..++.++.+++.+||+.+|.+||++.++.++|..
T Consensus 219 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 219 IFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 123456778899999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=204.34 Aligned_cols=159 Identities=31% Similarity=0.583 Sum_probs=129.3
Q ss_pred CCCCC-CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC-------------------------------------
Q 027476 2 MSRVR-HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR------------------------------------- 42 (223)
Q Consensus 2 l~~l~-Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------------------------------------- 42 (223)
|++++ ||||++++++|.+ +..++||||+++|+|.+++....
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (400)
T cd05105 94 MTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN 173 (400)
T ss_pred HHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence 56675 9999999999965 57899999999999999886431
Q ss_pred ---------------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 027476 43 ---------------------------------------------------------PRCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 43 ---------------------------------------------------------~~~l~~~~~~~i~~qi~~~l~~l 65 (223)
...+++..++.++.|++.||.||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 253 (400)
T cd05105 174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL 253 (400)
T ss_pred cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 12478889999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC-------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP------------------- 123 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------------- 123 (223)
|+.+++|+||||+||+++.++ .+||+|||+++....... .....++..|+|||.+..
T Consensus 254 H~~~ivH~dikp~Nill~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~el 332 (400)
T cd05105 254 ASKNCVHRDLAARNVLLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332 (400)
T ss_pred HhCCeeCCCCChHhEEEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHH
Confidence 999999999999999999877 899999999875432211 122346778999994421
Q ss_pred ----------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 124 ----------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 124 ----------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
.+..++.++.+++.+||+.+|.+||++.++.+.|++++
T Consensus 333 lt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 333 FSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 12235667889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-28 Score=190.49 Aligned_cols=155 Identities=28% Similarity=0.546 Sum_probs=125.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~n 130 (256)
T cd05114 52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN 130 (256)
T ss_pred HHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcce
Confidence 3678899999999999865 57899999999999999987543 248999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccccc--ccCCCccccccCCCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMM--TAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
|+++.++ .+||+|||.++........ ....++..|+|||.+...
T Consensus 131 i~i~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05114 131 CLVSSTG-VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209 (256)
T ss_pred EEEcCCC-eEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999877 8999999998754322221 122345689999965311
Q ss_pred -------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 125 -------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 125 -------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
+...+.++.+++.+||+.+|.+||+++++++.|
T Consensus 210 ~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 210 VVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 122445678889999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-28 Score=191.03 Aligned_cols=156 Identities=32% Similarity=0.560 Sum_probs=129.4
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++.+.+...++|+||+++++|.+++.+.....+++..++.++.|++.||+|||++|++|+||||+||+
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil 129 (257)
T cd05040 50 MHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNIL 129 (257)
T ss_pred HhhcCCCCccceeEEEcCCeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEE
Confidence 67899999999999987788899999999999999998755345899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccc----cccCCCccccccCCCCCC----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMRP---------------------------------- 123 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~---------------------------------- 123 (223)
++.++ .+||+|||+++....... .....++..|+|||.+..
T Consensus 130 ~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 208 (257)
T cd05040 130 LASDD-KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208 (257)
T ss_pred EecCC-EEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99887 899999999875433211 112356778999994421
Q ss_pred -------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 124 -------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 124 -------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
.+...+.++.+++..||+.+|.+||++.++++.|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 209 ILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12234577888999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-28 Score=193.01 Aligned_cols=156 Identities=30% Similarity=0.587 Sum_probs=126.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--------RCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
++.++||||+++++++.+ ...++||||+.+++|.+++.+... ..+++..++.++.|++.||.|||+.|++|
T Consensus 63 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH 142 (277)
T cd05062 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVH 142 (277)
T ss_pred HHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 567899999999999865 578999999999999999875321 23678899999999999999999999999
Q ss_pred CCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC--------------------------
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP-------------------------- 123 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-------------------------- 123 (223)
+||||+||+++.++ .+||+|||+++....... .....++..|+|||.+..
T Consensus 143 ~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p 221 (277)
T cd05062 143 RDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 221 (277)
T ss_pred CCcchheEEEcCCC-CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCC
Confidence 99999999999877 799999999875432221 112345678999995421
Q ss_pred --------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 124 --------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 124 --------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
.+..++..+.+++.+||+.+|.+||++.++++.|+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 222 YQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 12345567888999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=198.46 Aligned_cols=152 Identities=28% Similarity=0.399 Sum_probs=129.8
Q ss_pred CCCCCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 1 MMSRVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+|+.++|+||+.+.+++.. +..|+|+|+| +.+|.+.++.+.. ++...+.-++.|++.||+|+|+.+|+|||
T Consensus 74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAnViHRD 150 (359)
T KOG0660|consen 74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSANVIHRD 150 (359)
T ss_pred HHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcccccccc
Confidence 4678899999999999832 3689999999 7899999987655 99999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCcccccccc---ccccccCCCccccccCCCCC-----------------------------
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESL---TEMMTAETGTYRWMAPENMR----------------------------- 122 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~----------------------------- 122 (223)
|||+|++++.++ .+||+|||+|+.... ....+..+.|.+|+|||.+.
T Consensus 151 LKPsNll~n~~c-~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 151 LKPSNLLLNADC-DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred cchhheeeccCC-CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 999999999999 799999999997643 44456678899999999321
Q ss_pred -----------------------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 123 -----------------------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 123 -----------------------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
....+.+++..+|+.+||..||.+|+|+++.++
T Consensus 230 G~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 230 GKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 002345667888999999999999999999988
Q ss_pred H
Q 027476 156 M 156 (223)
Q Consensus 156 ~ 156 (223)
+
T Consensus 310 h 310 (359)
T KOG0660|consen 310 H 310 (359)
T ss_pred C
Confidence 7
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-28 Score=190.72 Aligned_cols=156 Identities=34% Similarity=0.649 Sum_probs=130.3
Q ss_pred CCCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++|+||+++++++. ++..++||||+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||||+|
T Consensus 53 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~N 132 (256)
T cd05039 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARN 132 (256)
T ss_pred HHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccce
Confidence 357889999999999987 4678999999999999999987665569999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
|+++.++ .+||+|||.++...... .....+..|+|||.+...
T Consensus 133 ili~~~~-~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 209 (256)
T cd05039 133 VLVSEDL-VAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209 (256)
T ss_pred EEEeCCC-CEEEccccccccccccc--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999877 79999999997653222 123445679999954311
Q ss_pred -----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 125 -----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 125 -----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
+..++.++.+++.+||..+|.+||++++++++|+.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 210 PHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 12346778899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=200.16 Aligned_cols=144 Identities=27% Similarity=0.400 Sum_probs=125.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +.+++||||+.+++|.+++...+. +++..+..++.|++.||+|||++|++||||||+|
T Consensus 54 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 131 (291)
T cd05612 54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPEN 131 (291)
T ss_pred HHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 3678899999999998865 578999999999999999976544 8999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
|+++.++ .+||+|||+++..... .....|++.|+|||.+.....+...|+|+++..+++.-.++.|.
T Consensus 132 Ili~~~~-~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf 198 (291)
T cd05612 132 ILLDKEG-HIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198 (291)
T ss_pred eEECCCC-CEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999877 8999999998754322 23457899999999999888899999999999988887777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=204.20 Aligned_cols=149 Identities=27% Similarity=0.477 Sum_probs=121.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|+||+++++++.+ +.+++||||+.+++|.+. ...++..+..++.||+.||.|||++|++||||||+|
T Consensus 125 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 198 (353)
T PLN00034 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSN 198 (353)
T ss_pred HHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHH
Confidence 3678899999999999965 578899999999998653 226778889999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
|+++.++ .+||+|||+++...... ......|+..|+|||.+...
T Consensus 199 Ill~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 277 (353)
T PLN00034 199 LLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277 (353)
T ss_pred EEEcCCC-CEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999877 89999999987543221 22345789999999975210
Q ss_pred -------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++.+++..||+.+|.+||++.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 278 QGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12345677888999999999999999999876
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=191.76 Aligned_cols=155 Identities=29% Similarity=0.471 Sum_probs=130.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++.+.+ +..++|+||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni 132 (256)
T cd08220 53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNI 132 (256)
T ss_pred HhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 678899999999998864 6789999999999999999876555689999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------- 123 (223)
+++.++..+||+|||.+.............++..|+|||.+..
T Consensus 133 l~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 212 (256)
T cd08220 133 LLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK 212 (256)
T ss_pred EEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence 9987665789999999986554443344578899999995531
Q ss_pred --------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 --------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 --------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+++..||+.+|.+||++++++++
T Consensus 213 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 213 IMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 123456778889999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-29 Score=200.10 Aligned_cols=160 Identities=23% Similarity=0.363 Sum_probs=132.3
Q ss_pred CCCCCCCCCccceEEEeec---C-c--eEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 1 MMSRVRHRNLVKFIGACKE---P-V--MVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---~-~--~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
||++++|||||+|..+|.. + . ..+||||+ ..||.+.++.. ....++.-.+.-+..||.+||.|||+.||+|
T Consensus 70 im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcH 148 (364)
T KOG0658|consen 70 IMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICH 148 (364)
T ss_pred HHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCccc
Confidence 5788999999999988832 2 2 34999999 57999999741 2344888899999999999999999999999
Q ss_pred CCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC------------------------------
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR------------------------------ 122 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------------------------------ 122 (223)
|||||+|+|+|.+.+.+||+|||.|+.....+.......|..|+|||.+-
T Consensus 149 RDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 149 RDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred CCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 99999999999987799999999999877776666677889999999221
Q ss_pred --------------------------------------C------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 123 --------------------------------------P------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 123 --------------------------------------~------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
. .....++|+.+|+.++++.+|.+|.+..+++.+
T Consensus 229 ~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h-- 306 (364)
T KOG0658|consen 229 DSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH-- 306 (364)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc--
Confidence 0 123467899999999999999999999998876
Q ss_pred HHhhc
Q 027476 159 HYIST 163 (223)
Q Consensus 159 ~~~~~ 163 (223)
..+..
T Consensus 307 ~fFde 311 (364)
T KOG0658|consen 307 PFFDE 311 (364)
T ss_pred hhhHH
Confidence 44443
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=192.53 Aligned_cols=158 Identities=30% Similarity=0.546 Sum_probs=126.8
Q ss_pred CCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027476 2 MSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNM----RPRCLDIHVAIGFALDIARAMECLHSHGI 70 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~i 70 (223)
+++++|+||+++++.+.+ ...++++||+.+|+|.+++... ....+++..++.++.|++.||+|||++++
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 133 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSF 133 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 567899999999997632 2468999999999999987532 22458999999999999999999999999
Q ss_pred ccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC------------------------
Q 027476 71 IHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP------------------------ 123 (223)
Q Consensus 71 vH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------------------ 123 (223)
+||||||+||+++.++ .+||+|||+++....... .....+++.|++||....
T Consensus 134 ~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~ 212 (272)
T cd05075 134 IHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212 (272)
T ss_pred eccccchhheEEcCCC-CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCC
Confidence 9999999999999877 799999999986433221 112235667999994321
Q ss_pred ----------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 124 ----------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 124 ----------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
.+..++.++.+++.+||+.+|.+||+++++++.|+++
T Consensus 213 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 213 TPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1234557788999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=193.61 Aligned_cols=156 Identities=31% Similarity=0.578 Sum_probs=127.7
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++||||+++++++.+ ...++||||+.+++|.+++... .+++..++.++.|++.||.|||++|++|+||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~ 136 (283)
T cd05080 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAAR 136 (283)
T ss_pred HHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChh
Confidence 678899999999998753 3578999999999999999753 3999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccc----cccCCCccccccCCCCCCC------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMRPS------------------------------ 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~------------------------------ 124 (223)
||+++.++ .+||+|||+++....... .....++..|+|||.+...
T Consensus 137 Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 215 (283)
T cd05080 137 NVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK 215 (283)
T ss_pred eEEEcCCC-cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999877 899999999875432221 1122355678999943200
Q ss_pred ------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 125 ------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 125 ------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
+..++..+.+++..||+.+|.+||+++++++.|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 216 KFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1234578899999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=198.23 Aligned_cols=148 Identities=27% Similarity=0.391 Sum_probs=122.6
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
+||||+++++++.+ +.+++||||+.|++|.+++.+... +++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~ 131 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS 131 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC
Confidence 79999999999875 578999999999999999876543 999999999999999999999999999999999999998
Q ss_pred CCCceEEccCcccccccc-ccccccCCCccccccCCCCCCC---------------------------------------
Q 027476 85 DHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPS--------------------------------------- 124 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~--------------------------------------- 124 (223)
++ .+||+|||+++.... ........|++.|+|||.+...
T Consensus 132 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~ 210 (318)
T cd05570 132 EG-HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210 (318)
T ss_pred CC-cEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 87 899999999874321 2222344689999999965422
Q ss_pred -----CCCChHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 027476 125 -----AENLPEDLALIVTSCWKEDPNERPNF-----SQIIQM 156 (223)
Q Consensus 125 -----~~~~~~~l~~l~~~~l~~~p~~Rp~~-----~~~~~~ 156 (223)
+..++.++.+++.+||+.+|.+||++ .+++++
T Consensus 211 ~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 211 DEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 22356677788899999999999998 776554
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=195.38 Aligned_cols=158 Identities=34% Similarity=0.620 Sum_probs=129.5
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++ +||||+++++++.+ +..++||||+.+++|.+++.......+++..++.++.|++.||.|||+++++|+||||+|
T Consensus 92 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N 171 (302)
T cd05055 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 171 (302)
T ss_pred HHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccce
Confidence 5677 79999999999865 578999999999999999976554558999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCCC--------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRPS-------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~-------------------------------- 124 (223)
|+++.++ .+|++|||+++...... ......++..|+|||.+...
T Consensus 172 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~ 250 (302)
T cd05055 172 VLLTHGK-IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250 (302)
T ss_pred EEEcCCC-eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence 9999776 89999999987543221 11223456789999954211
Q ss_pred ---------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 125 ---------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 125 ---------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
+...+.++.+++.+|+..+|.+||++.++++.|.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 251 SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 113456788899999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=193.40 Aligned_cols=157 Identities=28% Similarity=0.501 Sum_probs=128.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--------------PRCLDIHVAIGFALDIARAMECLH 66 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH 66 (223)
+++++||||+++++++.+ +..++++||+.+++|.+++.... ...+++..++.++.|++.||.|+|
T Consensus 62 ~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred HhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 567899999999999965 57889999999999999985321 134888999999999999999999
Q ss_pred hCCcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCC---------------------
Q 027476 67 SHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMR--------------------- 122 (223)
Q Consensus 67 ~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~--------------------- 122 (223)
++|++||||||+||+++.++ .+||+|||+++....... .....+++.|+|||.+.
T Consensus 142 ~~gi~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 220 (283)
T cd05091 142 SHHVVHKDLATRNVLVFDKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220 (283)
T ss_pred HcCccccccchhheEecCCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence 99999999999999999777 799999999875432221 22334678899999432
Q ss_pred -------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 123 -------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 123 -------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
..+.+++.++.+++..||+.+|.+||+++++++.|+.
T Consensus 221 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 221 SYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1134577788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=190.43 Aligned_cols=155 Identities=33% Similarity=0.650 Sum_probs=128.6
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++.+.++..++||||+.+++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||+
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nil 132 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132 (254)
T ss_pred HHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEE
Confidence 56789999999999998778899999999999999998765556899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccccccCCCccccccCCCCCC--------------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP-------------------------------------- 123 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------------------------------------- 123 (223)
++.++ .+||+|||++...... ......+..|+|||.+..
T Consensus 133 i~~~~-~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 209 (254)
T cd05083 133 VSEDG-VAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC 209 (254)
T ss_pred EcCCC-cEEECCCccceecccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 99877 7999999998753321 122334567999994421
Q ss_pred --------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 124 --------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 124 --------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
.+..++..+.+++.+||+.+|.+||+++++++.|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 210 VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122355678889999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=206.68 Aligned_cols=152 Identities=28% Similarity=0.414 Sum_probs=136.7
Q ss_pred CCCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|+.|+|||||+++++.+ ...+|+||||+.+|.+++++.+.+. +.+..+..++.|+++|++|||+++|+|||||++|
T Consensus 108 imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eN 185 (596)
T KOG0586|consen 108 IMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAEN 185 (596)
T ss_pred HHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhh
Confidence 478899999999999986 5789999999999999999988665 7789999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
|+++.+. .+||+|||++..........+.+|++.|+|||++.+.
T Consensus 186 ilL~~~m-nikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr 264 (596)
T KOG0586|consen 186 ILLDENM-NIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR 264 (596)
T ss_pred ccccccc-ceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc
Confidence 9999887 7999999999988888888889999999999965522
Q ss_pred ----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 125 ----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 125 ----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
+..++.|..+++++++..+|.+|++.+++..
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 4446677889999999999999999999865
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=190.96 Aligned_cols=154 Identities=31% Similarity=0.524 Sum_probs=124.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++..... .+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 131 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNC 131 (256)
T ss_pred HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceE
Confidence 678899999999999865 568999999999999999876433 589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccccc--ccCCCccccccCCCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMM--TAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
+++.++ .+||+|||.++........ ....++..|++||.+...
T Consensus 132 li~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05113 132 LVDDQG-CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET 210 (256)
T ss_pred EEcCCC-CEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 999877 8999999998754332211 122355679999954311
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 211 VEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 122445678888899999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=195.57 Aligned_cols=136 Identities=32% Similarity=0.448 Sum_probs=108.2
Q ss_pred CCCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 027476 3 SRVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLK 76 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 76 (223)
++++||||+++++++.+ ...++|+||+. ++|.+++.......+++..+..++.|++.||.|||++|++|||||
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik 135 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 135 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 34689999999998743 24789999996 589998876555569999999999999999999999999999999
Q ss_pred CCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhc
Q 027476 77 PENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCW 140 (223)
Q Consensus 77 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l 140 (223)
|+||+++.++ .+||+|||+++............++..|+|||++.....+...|+|+++..++
T Consensus 136 p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 198 (288)
T cd07863 136 PENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 198 (288)
T ss_pred HHHEEECCCC-CEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHH
Confidence 9999999887 79999999997654333334457899999999776554444555555444433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=197.07 Aligned_cols=137 Identities=26% Similarity=0.365 Sum_probs=105.5
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++||||+++++++.+ ...++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~N 133 (303)
T cd07869 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQN 133 (303)
T ss_pred HHhhCCCCCcCeEEEEEecCCeEEEEEECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 3678899999999999965 5789999999 578888776543 348999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCC-CCCChHHHHHHHHHhc
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPS-AENLPEDLALIVTSCW 140 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~l~~l~~~~l 140 (223)
|+++.++ .+||+|||+++..... .......+++.|+|||.+... ..+...|+|+++..++
T Consensus 134 ill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 195 (303)
T cd07869 134 LLISDTG-ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFV 195 (303)
T ss_pred EEECCCC-CEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHH
Confidence 9999877 7999999998753322 222345688999999966432 2333344444443333
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=193.12 Aligned_cols=156 Identities=28% Similarity=0.537 Sum_probs=128.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP-------------RCLDIHVAIGFALDIARAMECLHS 67 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-------------~~l~~~~~~~i~~qi~~~l~~lH~ 67 (223)
+++++|+||+++++++.+ +..+++|||+.+++|.+++..... ..+++..++.++.|++.||+|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 578899999999999875 568999999999999999976432 248899999999999999999999
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCC----------------------
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMR---------------------- 122 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~---------------------- 122 (223)
.|++|+||||+||+++.++ .+||+|||++........ .....+++.|+|||.+.
T Consensus 141 ~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 219 (280)
T cd05092 141 LHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219 (280)
T ss_pred CCeecccccHhhEEEcCCC-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHc
Confidence 9999999999999999777 899999999874432211 12233567899999432
Q ss_pred ------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 123 ------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 123 ------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
..+..++..+++++.+||+.+|.+||+++++.+.|+
T Consensus 220 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 220 YGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 112346678899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=197.92 Aligned_cols=160 Identities=31% Similarity=0.611 Sum_probs=128.7
Q ss_pred CCCC-CCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcCC-----------------------------------
Q 027476 2 MSRV-RHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRP----------------------------------- 43 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~----------------------------------- 43 (223)
++++ +|+||++++++|.. ..+++++||+.+++|.+++.....
T Consensus 64 ~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (337)
T cd05054 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSA 143 (337)
T ss_pred HHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccc
Confidence 4566 79999999998853 468899999999999999864321
Q ss_pred ------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 44 ------------------------RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 44 ------------------------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
..+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~ 222 (337)
T cd05054 144 SSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARD 222 (337)
T ss_pred ccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchh
Confidence 2589999999999999999999999999999999999999877 799999999975
Q ss_pred cccccc---cccCCCccccccCCCCCCC-----------------------------------------------CCCCh
Q 027476 100 ESLTEM---MTAETGTYRWMAPENMRPS-----------------------------------------------AENLP 129 (223)
Q Consensus 100 ~~~~~~---~~~~~gt~~y~aPE~~~~~-----------------------------------------------~~~~~ 129 (223)
...... .....++..|+|||++... +...+
T Consensus 223 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (337)
T cd05054 223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYAT 302 (337)
T ss_pred cccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 432211 1223456789999943211 11234
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 130 ~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
.++.+++.+||+.+|.+||++.+++++|.+++.
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 577889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=195.00 Aligned_cols=162 Identities=33% Similarity=0.644 Sum_probs=131.9
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--------------RCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~l 65 (223)
++++ +||||+++++++.+ +..++||||+.+++|.+++..... ..+++..++.++.|++.||+||
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 156 (307)
T cd05098 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL 156 (307)
T ss_pred HHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 4456 79999999999865 578999999999999999976432 2488999999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCC--------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMR-------------------- 122 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-------------------- 122 (223)
|++|++||||||+||+++.++ .+||+|||+++....... .....+++.|+|||.+.
T Consensus 157 H~~gi~H~dlkp~Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el 235 (307)
T cd05098 157 ASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235 (307)
T ss_pred HHCCcccccccHHheEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999887 899999999875432211 11123456899999432
Q ss_pred --------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 --------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 --------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+...+.++.+++..||..+|.+||++.++++.|.+++...
T Consensus 236 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 236 FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 112345678899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=196.11 Aligned_cols=147 Identities=25% Similarity=0.315 Sum_probs=126.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||+.++||.++.||..|+. ...|+|||||+||+|..+++++..+.+++..++-++.+++.||+|||..|||+|||||+|
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPEN 209 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPEN 209 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcce
Confidence 6788999999999999975 578899999999999999999888999999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccc-----------------------------------ccc---------------------
Q 027476 80 LILTADHKTVKLADFGLAREE-----------------------------------SLT--------------------- 103 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~-----------------------------------~~~--------------------- 103 (223)
|||.++| ++-|+||.++..- ...
T Consensus 210 ILvredG-HIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~ 288 (459)
T KOG0610|consen 210 ILVREDG-HIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPT 288 (459)
T ss_pred eEEecCC-cEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCC
Confidence 9999998 8999999987410 000
Q ss_pred -cccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCC
Q 027476 104 -EMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERP 148 (223)
Q Consensus 104 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp 148 (223)
...+..+||-.|+|||++++...+...|+|.++.-++++-.+.=|
T Consensus 289 ~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TP 334 (459)
T KOG0610|consen 289 GARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTP 334 (459)
T ss_pred CccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 001223688899999999999999999999999877776665544
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=190.24 Aligned_cols=154 Identities=27% Similarity=0.410 Sum_probs=127.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+.+ +..++||||++|++|.+++.......+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~ni 132 (256)
T cd08529 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNL 132 (256)
T ss_pred HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence 578899999999999865 5789999999999999999876455699999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .++|+|||+++...... ......+++.|+|||++...
T Consensus 133 li~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 211 (256)
T cd08529 133 FLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL 211 (256)
T ss_pred EEeCCC-CEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999877 79999999987543322 22344688899999954321
Q ss_pred ----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++.+++.+||+.+|.+||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 212 KIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 12345677888888998899999988888754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=191.87 Aligned_cols=159 Identities=25% Similarity=0.486 Sum_probs=130.4
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
++.++||||+++++++.....++++||+++|+|.+++.... +.+++..++.++.|++.||+|||+++++||||||+||+
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil 141 (279)
T cd05109 63 MAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVL 141 (279)
T ss_pred HHhcCCCCCceEEEEEcCCCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 46789999999999998878889999999999999987633 34899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC-----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
++.++ .+||+|||+++....... .....++..|++||.+..
T Consensus 142 ~~~~~-~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 220 (279)
T cd05109 142 VKSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220 (279)
T ss_pred EcCCC-cEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 98777 799999999975532221 112234678999994421
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
.+..++.++.+++..||+.+|.+||++.++++.|..+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 221 PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 122345678889999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=192.62 Aligned_cols=157 Identities=27% Similarity=0.585 Sum_probs=129.3
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++||||+++.+++.+ ...++||||++|++|.+++.+.. ..+++..++.++.|++.||+|||++|++||||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~ 138 (284)
T cd05079 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR 138 (284)
T ss_pred HHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchh
Confidence 678899999999998864 35789999999999999986543 34899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccc----cccCCCccccccCCCCCC-------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMRP------------------------------- 123 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~------------------------------- 123 (223)
||+++.++ .+||+|||+++....... .....++..|+|||.+..
T Consensus 139 Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 139 NVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred eEEEcCCC-CEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 99999877 799999999875432211 123346677999994321
Q ss_pred -----------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 124 -----------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 124 -----------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
.+..++.++.+++.+||+.+|.+||+++++++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1223557888999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=195.20 Aligned_cols=162 Identities=31% Similarity=0.609 Sum_probs=131.1
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--------------PRCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~l 65 (223)
++++ +||||+++++++.+ +.+++||||+.+++|.+++.... ...+++..+..++.|++.||.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 150 (314)
T cd05099 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150 (314)
T ss_pred HHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH
Confidence 4556 69999999999875 56899999999999999997632 13489999999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC-------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP------------------- 123 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------------- 123 (223)
|++|++||||||+||+++.++ .+||+|||+++....... .....++..|+|||.+..
T Consensus 151 H~~gi~H~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el 229 (314)
T cd05099 151 ESRRCIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229 (314)
T ss_pred HHCCeeeccccceeEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHH
Confidence 999999999999999999877 899999999975432211 112234467999994321
Q ss_pred ---------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 124 ---------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 124 ---------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
.+..++.++++++.+||..+|.+||++.++++.|.++....
T Consensus 230 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 230 FTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 12345668899999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=197.38 Aligned_cols=152 Identities=24% Similarity=0.361 Sum_probs=125.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+.+ +..++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NI 133 (330)
T cd05601 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133 (330)
T ss_pred HHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHhe
Confidence 567899999999999875 57899999999999999997652 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
+++.++ .+||+|||++........ .....||+.|+|||.+..
T Consensus 134 ll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 134 LIDRTG-HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred EECCCC-CEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 999887 899999999975433221 223468999999996420
Q ss_pred -------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 -------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 -------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.....+.++.+++..|+. +|.+||++++++.+
T Consensus 213 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 213 TSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 011356778889999998 99999999998765
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=197.82 Aligned_cols=154 Identities=27% Similarity=0.423 Sum_probs=132.0
Q ss_pred CCCCCCCCCccceEEEe-ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||++++.|+||++||.| .+..+|+|||||-.|++.++++.+ .+.+++.++..+++.-++||+|||...-+|||||+.|
T Consensus 81 IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGN 159 (502)
T KOG0574|consen 81 IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGN 159 (502)
T ss_pred HHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhccccc
Confidence 57889999999999976 567899999999889999998763 4569999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccc-cccCCCccccccCCCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
||++.+| +.||+|||+|.+...... .++..||+.|||||++...
T Consensus 160 ILLNT~G-~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI 238 (502)
T KOG0574|consen 160 ILLNTDG-IAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI 238 (502)
T ss_pred EEEcccc-hhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee
Confidence 9999988 899999999987665433 3567899999999966422
Q ss_pred -------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++-+++..||-+.|++|-++.+++++
T Consensus 239 FMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 239 FMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred EeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 33455566679999999999999999888764
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=193.81 Aligned_cols=156 Identities=29% Similarity=0.567 Sum_probs=128.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR---------PRCLDIHVAIGFALDIARAMECLHSHGII 71 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~l~~lH~~~iv 71 (223)
|++++||||+++++++.+ +..++|+||+.+++|.+++.+.. ...+++..++.++.|++.||.|||+.|++
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~ 152 (296)
T cd05051 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV 152 (296)
T ss_pred HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Confidence 678899999999999865 67899999999999999997644 12589999999999999999999999999
Q ss_pred cCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCC-------------------------
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRP------------------------- 123 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~------------------------- 123 (223)
|+||||+||+++.++ .++|+|||+++...... ......++..|+|||.+..
T Consensus 153 H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 231 (296)
T cd05051 153 HRDLATRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231 (296)
T ss_pred ccccchhceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence 999999999999887 89999999987543221 1223346778999994321
Q ss_pred -----------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 124 -----------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 124 -----------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
.+..++.++.+++.+||+.+|.+||++.++++.|+
T Consensus 232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 232 QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 01223578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=192.79 Aligned_cols=156 Identities=31% Similarity=0.556 Sum_probs=128.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--------PRCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
|++++||||+++++++.+ +..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+.+++|
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 142 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVH 142 (277)
T ss_pred HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 567899999999999865 57899999999999999997532 124788999999999999999999999999
Q ss_pred CCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCC---------------------------
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMR--------------------------- 122 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~--------------------------- 122 (223)
+||||+||+++.++ .+||+|||+++....... .....++..|+|||.+.
T Consensus 143 ~di~p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 221 (277)
T cd05032 143 RDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221 (277)
T ss_pred cccChheEEEcCCC-CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCC
Confidence 99999999999887 799999999875433221 12334677899999432
Q ss_pred -------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 123 -------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 123 -------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
..+..++.++.+++..||+.+|.+||++.++++.|+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 222 YQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 113345678889999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=206.25 Aligned_cols=154 Identities=28% Similarity=0.512 Sum_probs=129.0
Q ss_pred CCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 3 SRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLN-MRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~-~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++|+|.|||+++|.+.+ +.+-+.||-++||+|.++++. +++-.=++...--+.+||++||.|||++.|||||||-+|+
T Consensus 627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNV 706 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNV 706 (1226)
T ss_pred HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcE
Confidence 57899999999999965 556699999999999999974 4442237888888999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
+|+.-.+.+||+|||-++.... .....+..||..|||||++.
T Consensus 707 LvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA 786 (1226)
T KOG4279|consen 707 LVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA 786 (1226)
T ss_pred EEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH
Confidence 9987777999999998875433 33345678999999999664
Q ss_pred ------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 ------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 ------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+.+..++++...+|.+|++.+|.+||++.++++.
T Consensus 787 AMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 787 AMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred hhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 2345566677789999999999999999999753
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=191.05 Aligned_cols=158 Identities=29% Similarity=0.500 Sum_probs=130.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++||||+++++.+.+ +..++|+||+.+++|.+++... ....+++..++.++.|++.||.|||+++++|+||||+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ 135 (267)
T cd08228 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPA 135 (267)
T ss_pred HHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHH
Confidence 578899999999998864 6789999999999999988642 2345899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccc-cccCCCccccccCCCCCCC---------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
||+++.++ .++|+|||++........ .....+++.|+|||.+...
T Consensus 136 nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 214 (267)
T cd08228 136 NVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF 214 (267)
T ss_pred HEEEcCCC-CEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH
Confidence 99999877 799999999875433221 2234688899999954210
Q ss_pred ---------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 125 ---------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 125 ---------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
....+.++.+++.+||..+|.+||+++++++.++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 215 SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 113446789999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=194.63 Aligned_cols=121 Identities=31% Similarity=0.458 Sum_probs=101.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
+|++++|+||+++.+++.+ +..++||||+++|+|.+.+... ....+++..++.++.|++.||.|||++||+||||||
T Consensus 46 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 125 (280)
T cd05608 46 ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKP 125 (280)
T ss_pred HHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 3678899999999998865 5789999999999999887542 234589999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCC
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMR 122 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~ 122 (223)
+||+++.++ .+||+|||++....... ......|++.|+|||.+.
T Consensus 126 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 170 (280)
T cd05608 126 ENVLLDNDG-NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170 (280)
T ss_pred HHEEECCCC-CEEEeeCccceecCCCCccccccCCCcCccCHHHhc
Confidence 999999877 79999999987543322 223457899999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=188.93 Aligned_cols=154 Identities=24% Similarity=0.418 Sum_probs=128.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++.+.+ +..++|+||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~ni 131 (255)
T cd08219 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131 (255)
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceE
Confidence 567899999999999865 5789999999999999998765556689999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRP------------------------------------ 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------------------------------------ 123 (223)
+++.++ .++++|||.+....... ......+++.|+|||++..
T Consensus 132 li~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~ 210 (255)
T cd08219 132 FLTQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL 210 (255)
T ss_pred EECCCC-cEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH
Confidence 999877 89999999987543322 2234568889999995431
Q ss_pred ---------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 ---------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 ---------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+++.+||+.+|.+||++.+++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 KVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 123355678889999999999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=200.83 Aligned_cols=115 Identities=33% Similarity=0.471 Sum_probs=95.7
Q ss_pred CCCCCCCCccceEEEeecC-------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKEP-------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
++.++||||+++++++... ..++||||+. ++|.+.+.. .+++..+..++.|++.||.|||++||+|||
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrD 148 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 148 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 5678999999999988432 4789999995 566666532 288999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
|||+||+++.++ .+||+|||+++............||+.|+|||.+.
T Consensus 149 lkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~ 195 (359)
T cd07876 149 LKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195 (359)
T ss_pred CCHHHEEECCCC-CEEEecCCCccccccCccCCCCcccCCCCCchhcc
Confidence 999999999887 89999999997654433344567899999999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=202.55 Aligned_cols=151 Identities=26% Similarity=0.460 Sum_probs=126.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|+.++||||+++++.+.+ +..++||||+.+++|.+++... ..+++..++.++.|++.||+|||+.|++||||||+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NI 132 (350)
T cd05573 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNI 132 (350)
T ss_pred HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 567899999999999875 5789999999999999999875 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc------------------------------ccccCCCccccccCCCCCC-------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE------------------------------MMTAETGTYRWMAPENMRP------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~------- 123 (223)
+++.++ .+||+|||++....... ......||+.|+|||.+..
T Consensus 133 ll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 211 (350)
T cd05573 133 LIDADG-HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC 211 (350)
T ss_pred EECCCC-CEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCce
Confidence 999887 89999999987543322 1234468999999994421
Q ss_pred -----------------------------------------CCCCChHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 027476 124 -----------------------------------------SAENLPEDLALIVTSCWKEDPNERPN-FSQIIQM 156 (223)
Q Consensus 124 -----------------------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~-~~~~~~~ 156 (223)
....++.++.+++..|+. +|.+||+ +++++++
T Consensus 212 DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 212 DWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred eeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 112247888999999997 9999998 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=192.18 Aligned_cols=157 Identities=31% Similarity=0.595 Sum_probs=126.4
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++||||+++.+++.. ..+++|+||+++++|.+++.+.. ..+++..++.++.|++.||.|||++|++||||||+
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ 137 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATR 137 (284)
T ss_pred HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHh
Confidence 578899999999998732 46889999999999999997543 34899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccccc----ccCCCccccccCCCCCCC------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMM----TAETGTYRWMAPENMRPS------------------------------ 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~------------------------------ 124 (223)
||+++.++ .+||+|||+++........ ....++..|+|||.+...
T Consensus 138 nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 138 NILVESEN-RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred hEEECCCC-eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 99999877 7999999998854322111 111234468999943211
Q ss_pred -------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 125 -------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 125 -------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
+..++.++.+++.+||..+|.+||++.++++.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 217 EFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 123456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=189.31 Aligned_cols=155 Identities=25% Similarity=0.461 Sum_probs=128.0
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|+||+++++++.+ +..+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus 52 ~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~n 131 (256)
T cd08221 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLN 131 (256)
T ss_pred HHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHh
Confidence 3678899999999999865 578899999999999999987655568999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
|+++.++ .+||+|||++....... ......+++.|+|||.+...
T Consensus 132 i~~~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~ 210 (256)
T cd08221 132 IFLTKAG-LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV 210 (256)
T ss_pred EEEeCCC-CEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999877 79999999987543322 22345688999999955322
Q ss_pred -----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....+.++.+++.+||+.+|.+||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 211 VKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 12245677788888888889889888888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=190.06 Aligned_cols=157 Identities=29% Similarity=0.544 Sum_probs=128.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+++++|.+++.... ..+++.+++.++.|++.||.|||+.+++|+||||+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni 137 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137 (267)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence 567899999999999864 57889999999999999997643 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--c--ccCCCccccccCCCCCC---------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--M--TAETGTYRWMAPENMRP--------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~--~~~~gt~~y~aPE~~~~--------------------------------- 123 (223)
+++.++ .++|+|||++........ . ....++..|++||.+..
T Consensus 138 li~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 138 LVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred EECCCC-eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 999877 899999999875432211 1 11223567999994421
Q ss_pred -------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 124 -------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 124 -------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
....++.++.+++.+|++.+|.+||++.++++.|.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 217 DVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1223466788999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=190.16 Aligned_cols=152 Identities=25% Similarity=0.469 Sum_probs=123.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ ...++|+||+++++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 135 (263)
T cd06625 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANI 135 (263)
T ss_pred HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 578899999999999965 578999999999999999976544 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccccc----ccCCCccccccCCCCCCC--------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMM----TAETGTYRWMAPENMRPS-------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~-------------------------------- 124 (223)
+++.++ .++|+|||+++........ ....++..|+|||.+...
T Consensus 136 lv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 214 (263)
T cd06625 136 LRDSAG-NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214 (263)
T ss_pred EEcCCC-CEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence 999877 8999999998753321111 234578899999965422
Q ss_pred --------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 --------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 --------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++.+++..||..+|.+||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 215 AIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 22445667778888888888888888887654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=204.95 Aligned_cols=159 Identities=27% Similarity=0.546 Sum_probs=136.0
Q ss_pred CCCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|.+|+||||++|+|+|. |+.+++|+||+++|+|.+++.++....+......+|+.||++||+||.+.++|||||.+.|
T Consensus 588 iLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rN 667 (807)
T KOG1094|consen 588 ILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRN 667 (807)
T ss_pred HHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccc
Confidence 478999999999999995 6789999999999999999998765555666778899999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccc---cCCCccccccCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMT---AETGTYRWMAPENM----------------------------------- 121 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~----------------------------------- 121 (223)
+|++.+. ++||+|||+++.......+. ..+-...|||+|.+
T Consensus 668 cLv~~e~-~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 668 CLVDGEF-TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred eeecCcc-cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 9999888 89999999999654443322 23445789999922
Q ss_pred -------------------CCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 122 -------------------RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 122 -------------------~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
...+.-++..+++++..||..+-.+||+++++...|++.
T Consensus 747 e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 747 EQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 144667889999999999999999999999999998874
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=190.15 Aligned_cols=158 Identities=32% Similarity=0.549 Sum_probs=130.9
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++++++|+||+++++++.++..+++|||+.+++|.+++.......+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni 133 (260)
T cd05067 54 LMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANI 133 (260)
T ss_pred HHHhcCCcCeeeEEEEEccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhE
Confidence 36788999999999998888899999999999999998776555689999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
+++.++ .++|+|||++........ .....++..|+|||.+..
T Consensus 134 ~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 212 (260)
T cd05067 134 LVSETL-CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212 (260)
T ss_pred EEcCCC-CEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 999877 899999999875442221 122345678999994421
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
.+...+.++.+++.+||..+|.+||+++++...|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 213 IQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 112345678999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=189.36 Aligned_cols=155 Identities=37% Similarity=0.699 Sum_probs=129.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR-------PRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
++.++|+||+++++++.+ ...++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+
T Consensus 50 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 129 (262)
T cd00192 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHR 129 (262)
T ss_pred HhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence 567899999999999865 57899999999999999998752 2459999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCCC---------------------------
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMRP--------------------------- 123 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~--------------------------- 123 (223)
||||+||+++.++ .+||+|||.+...... .......++..|+|||.+..
T Consensus 130 di~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 208 (262)
T cd00192 130 DLAARNCLVGEDL-VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY 208 (262)
T ss_pred ccCcceEEECCCC-cEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCC
Confidence 9999999999887 8999999999865432 12233457889999994431
Q ss_pred -------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 124 -------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 124 -------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
.+..++.++.+++.+||..+|.+||++.+++++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 209 PGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1234567888899999999999999999998876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=190.13 Aligned_cols=159 Identities=26% Similarity=0.538 Sum_probs=131.5
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
|++++||||+++++++.+...++|+||+.+++|.+++..... .+++..++.++.|++.||+|||+++++|+||||+||+
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil 141 (279)
T cd05057 63 MASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVL 141 (279)
T ss_pred HHhCCCCCcceEEEEEecCceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEE
Confidence 567899999999999988889999999999999999976433 3899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccccc---cCCCccccccCCCCC------------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEMMT---AETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~------------------------------------ 122 (223)
++.++ .+||+|||+++......... ...++..|+|||.+.
T Consensus 142 ~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 220 (279)
T cd05057 142 VKTPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220 (279)
T ss_pred EcCCC-eEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 99777 79999999997543222111 122356799999432
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
..+..++.++.+++..||..+|.+||++.++++.|.++..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 221 PDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1122355678889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=197.42 Aligned_cols=121 Identities=15% Similarity=0.266 Sum_probs=98.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++.++||||++++++|.+ +..++||||+++++|.+++.......+++..++.++.|++.||+|||+++++||||||+|
T Consensus 52 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~N 131 (327)
T cd08227 52 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASH 131 (327)
T ss_pred HHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhh
Confidence 3567899999999999864 678999999999999999976544558999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc--------ccccCCCccccccCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTE--------MMTAETGTYRWMAPENMR 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~ 122 (223)
|+++.++ .+++.||+.+....... ......++..|+|||++.
T Consensus 132 il~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (327)
T cd08227 132 ILISVDG-KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQ 181 (327)
T ss_pred EEEecCC-cEEEcccchhhccccccccccccccccccccceecccChHHhh
Confidence 9999877 79999998654321110 112234677899999653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=202.71 Aligned_cols=136 Identities=24% Similarity=0.305 Sum_probs=107.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.. +..++|||++ +++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 139 il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~N 215 (392)
T PHA03207 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTEN 215 (392)
T ss_pred HHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence 4678999999999998864 5789999999 57888888543 349999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCCCCCCChHHHHHHHHHhc
Q 027476 80 LILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRPSAENLPEDLALIVTSCW 140 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l 140 (223)
|+++.++ .+||+|||+++....... .....||+.|+|||.+.....+...|+|+++..++
T Consensus 216 ill~~~~-~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ 278 (392)
T PHA03207 216 IFLDEPE-NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLF 278 (392)
T ss_pred EEEcCCC-CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHH
Confidence 9999887 899999999875433221 22456899999999765444444444444443333
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=205.19 Aligned_cols=146 Identities=23% Similarity=0.337 Sum_probs=122.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +.+++||||++||+|.+++...+. +++..+..++.|++.||+|||+.||+||||||+|
T Consensus 54 il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~N 131 (377)
T cd05629 54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDN 131 (377)
T ss_pred HHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 3567899999999999976 578999999999999999976543 8999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc------------------------------------------------ccccCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTE------------------------------------------------MMTAETG 111 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~------------------------------------------------~~~~~~g 111 (223)
|+++.++ .+||+|||+++...... .....+|
T Consensus 132 Ill~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (377)
T cd05629 132 ILIDRGG-HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVG 210 (377)
T ss_pred EEECCCC-CEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCC
Confidence 9999877 89999999985321100 0012468
Q ss_pred ccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 112 TYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 112 t~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
|+.|+|||++.....+...|+|+++..+++.-.+..|.
T Consensus 211 t~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf 248 (377)
T cd05629 211 TPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPF 248 (377)
T ss_pred CccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCC
Confidence 99999999998888888899999998888877666663
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=198.50 Aligned_cols=142 Identities=27% Similarity=0.333 Sum_probs=122.9
Q ss_pred CCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEe
Q 027476 5 VRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83 (223)
Q Consensus 5 l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 83 (223)
.+||||+++++++.+ +.+++||||+.|++|.+++..... +++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~ 130 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD 130 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC
Confidence 379999999999975 578999999999999999876544 99999999999999999999999999999999999999
Q ss_pred CCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 84 ADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 84 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
.++ .+||+|||+++.... ........||+.|+|||.+.....+...|+|+++..+++.-.++.|.
T Consensus 131 ~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf 196 (320)
T cd05590 131 HEG-HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196 (320)
T ss_pred CCC-cEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCC
Confidence 887 899999999875322 22234457999999999999888888999999999988887766663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=201.30 Aligned_cols=152 Identities=22% Similarity=0.388 Sum_probs=124.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|+.++||||+++++++.+ +..++||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 96 il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~N 172 (370)
T cd05596 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 172 (370)
T ss_pred HHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 3577899999999999875 5689999999999999998653 38899999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRP---------------------------------- 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~---------------------------------- 123 (223)
|+++.++ .+||+|||++....... ......||+.|+|||.+..
T Consensus 173 ILl~~~~-~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 173 MLLDKSG-HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred EEEcCCC-CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 9999887 89999999987543221 2234579999999995421
Q ss_pred ------------------CCCCChHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 027476 124 ------------------SAENLPEDLALIVTSCWKEDPNE--RPNFSQIIQM 156 (223)
Q Consensus 124 ------------------~~~~~~~~l~~l~~~~l~~~p~~--Rp~~~~~~~~ 156 (223)
....++.++.+++..|++.+|.+ |+++++++++
T Consensus 252 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 252 LVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 01135677888888899888877 8888888765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=197.51 Aligned_cols=143 Identities=27% Similarity=0.325 Sum_probs=123.2
Q ss_pred CCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q 027476 4 RVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL 82 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill 82 (223)
..+||||+++++++.+ +.+++||||+.||+|.+++..... +++..+..++.|++.||.|||++||+||||||+||++
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill 129 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE
Confidence 3589999999999865 578999999999999999876543 9999999999999999999999999999999999999
Q ss_pred eCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 83 TADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 83 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+.++ .+||+|||+++.... ........||+.|+|||.+.....+...|+|+++..+++.-.++.|.
T Consensus 130 ~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf 196 (316)
T cd05592 130 DKDG-HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196 (316)
T ss_pred CCCC-CEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCC
Confidence 9887 899999999975332 22234457999999999999888888999999999888877666663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=199.62 Aligned_cols=154 Identities=26% Similarity=0.456 Sum_probs=134.5
Q ss_pred CCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|+.++|||||+||++.. +-.+|+|+|.=.+|+|.++|-+...+ +.+....+++.||+.|+.|+|+..+|||||||+|+
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~G-l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENV 149 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEG-LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENV 149 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhcc-ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCccee
Confidence 46679999999999985 45899999999999999999876543 99999999999999999999999999999999998
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS------------------------------------ 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------------------------ 124 (223)
.+.+.-+-|||.|||++..+..+....+.+|+..|-|||.+.+.
T Consensus 150 VFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT 229 (864)
T KOG4717|consen 150 VFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT 229 (864)
T ss_pred EEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh
Confidence 87665558999999999988888888899999999999965422
Q ss_pred ---------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ---------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ---------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+.-++.+.++||..||..+|.+|.+.++|...
T Consensus 230 mImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 230 MIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 22345677889999999999999999999754
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=190.21 Aligned_cols=156 Identities=32% Similarity=0.549 Sum_probs=127.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR------------PRCLDIHVAIGFALDIARAMECLHSH 68 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------------~~~l~~~~~~~i~~qi~~~l~~lH~~ 68 (223)
|++++|+||+++++++.+ ...++||||+++++|.+++...+ ...+++..+..++.|++.||.|||++
T Consensus 62 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 141 (280)
T cd05049 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ 141 (280)
T ss_pred HHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 577899999999999865 57899999999999999997543 23478999999999999999999999
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCCC---------------------
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRPS--------------------- 124 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~--------------------- 124 (223)
|++||||||+||+++.++ .+||+|||+++...... ......+++.|+|||.+...
T Consensus 142 ~i~h~dlkp~nili~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~ 220 (280)
T cd05049 142 HFVHRDLATRNCLVGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220 (280)
T ss_pred CeeccccccceEEEcCCC-eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhc
Confidence 999999999999999887 89999999987532221 11233456789999954311
Q ss_pred -------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 125 -------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 125 -------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
+..++..+.+++..||+.+|.+||+++++++.|+
T Consensus 221 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 221 GKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 2345677888999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=189.56 Aligned_cols=158 Identities=32% Similarity=0.582 Sum_probs=127.9
Q ss_pred CCCCCCCCccceEEEeecC-------ceEEEEEcCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027476 2 MSRVRHRNLVKFIGACKEP-------VMVIVTELLLGGTLRKYLLNM----RPRCLDIHVAIGFALDIARAMECLHSHGI 70 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~i 70 (223)
|++++||||+++++++.+. ..++++||+.+++|.+++... ....+++..++.++.|++.||.|||++++
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i 134 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNF 134 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 5678999999999987432 268999999999999998543 22358999999999999999999999999
Q ss_pred ccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC------------------------
Q 027476 71 IHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP------------------------ 123 (223)
Q Consensus 71 vH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------------------ 123 (223)
+||||||+||+++.++ .+||+|||+++....... .....++..|+|||.+..
T Consensus 135 ~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~ 213 (273)
T cd05035 135 IHRDLAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213 (273)
T ss_pred eccccchheEEECCCC-eEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCC
Confidence 9999999999999877 899999999875432221 111234568999995421
Q ss_pred ----------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 124 ----------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 124 ----------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
.+..++.++.+++.+||+.+|.+||++.++++.|+++
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 214 TPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1234567888999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-29 Score=222.72 Aligned_cols=153 Identities=29% Similarity=0.454 Sum_probs=129.6
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||..|+|||+|+++|+-.+ +..++.||||+||+|.+.+...+. .++.....+..|++.|+.|||+.|||||||||.|
T Consensus 1287 vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aN 1364 (1509)
T KOG4645|consen 1287 VLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPAN 1364 (1509)
T ss_pred HHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccc
Confidence 3567899999999999865 578899999999999999876443 7888888889999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-----cccccCCCccccccCCCCC--------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT-----EMMTAETGTYRWMAPENMR-------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~-------------------------------- 122 (223)
|+++.+| .+|++|||.|...... ......+||+.|||||++.
T Consensus 1365 I~Ld~~g-~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1365 ILLDFNG-LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred eeeecCC-cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence 9999888 8999999999865433 2334568999999999664
Q ss_pred -----------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 -----------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 -----------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+.|..++..-.+++.+|++.||.+|.++.|++++
T Consensus 1444 ~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1444 LDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2355577778889999999999999888887765
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=188.34 Aligned_cols=154 Identities=34% Similarity=0.611 Sum_probs=124.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||++|++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni 131 (256)
T cd05059 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNC 131 (256)
T ss_pred HHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhE
Confidence 577899999999999865 57889999999999999997643 3589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccccc--ccCCCccccccCCCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMM--TAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
+++.++ .+||+|||+++........ ....++..|+|||.+...
T Consensus 132 ~i~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05059 132 LVGEDN-VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210 (256)
T ss_pred EECCCC-cEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH
Confidence 999877 7999999998754332211 111234579999954311
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
+..++..+.+++.+||..+|.+||++.++++.|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 211 VESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 223456788888899999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=188.60 Aligned_cols=119 Identities=29% Similarity=0.482 Sum_probs=98.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
++.++||||+++++.|.+ ...++||||+.+|+|.+++.+.. ....++..++.++.|++.||+|||+.+++|+||||+
T Consensus 49 ~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~ 128 (268)
T cd05086 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALR 128 (268)
T ss_pred HhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccc
Confidence 567899999999999975 57899999999999999997643 234677888899999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccc---cccccCCCccccccCCCC
Q 027476 79 NLILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENM 121 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~ 121 (223)
||+++.++ .+||+|||++...... .......++..|+|||++
T Consensus 129 nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 173 (268)
T cd05086 129 NCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173 (268)
T ss_pred eEEEcCCc-cEEecccccccccCcchhhhcccCCcCcccccCchhc
Confidence 99999877 8999999998642211 112234678899999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=186.91 Aligned_cols=155 Identities=32% Similarity=0.604 Sum_probs=126.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||.|+|++|++|+||||+||
T Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~ni 124 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNC 124 (250)
T ss_pred HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheE
Confidence 567899999999999865 57899999999999999987543 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccccc--ccCCCccccccCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMM--TAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
+++.++ .+||+|||++......... ....++..|+|||.+..
T Consensus 125 li~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~ 203 (250)
T cd05085 125 LVGENN-VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA 203 (250)
T ss_pred EEcCCC-eEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 999877 7999999998753322111 11234567999994321
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
.+..++.++.+++.+|+..+|.+||++.++.+.|.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 204 REQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12345678889999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=190.80 Aligned_cols=153 Identities=28% Similarity=0.427 Sum_probs=124.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+.+ +.+++|+||+.+++|.+++..... +++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 137 (267)
T cd06646 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANI 137 (267)
T ss_pred HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 567899999999999864 578999999999999999876543 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCC---C--------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRP---S-------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~---~-------------------------------- 124 (223)
+++.++ .+||+|||++....... ......++..|+|||.+.. .
T Consensus 138 ll~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~ 216 (267)
T cd06646 138 LLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred EECCCC-CEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh
Confidence 999877 79999999987543221 1233468889999995420 0
Q ss_pred -----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 125 -----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 125 -----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
...++..+.+++.+||..+|.+||+++++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 217 ALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred hheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 012346678889999999999999998887653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=188.15 Aligned_cols=157 Identities=28% Similarity=0.536 Sum_probs=128.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++.+++.+ +..++||||+.+++|.+++.... +.+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni 138 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNI 138 (268)
T ss_pred HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 678899999999999865 57899999999999999987643 4589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cc--cCCCccccccCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MT--AETGTYRWMAPENMR---------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~--~~~gt~~y~aPE~~~---------------------------------- 122 (223)
+++.++ .+||+|||++........ .. ....+..|++||.+.
T Consensus 139 li~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~ 217 (268)
T cd05063 139 LVNSNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217 (268)
T ss_pred EEcCCC-cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence 999877 799999999875432111 11 112345799999432
Q ss_pred ------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 123 ------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 123 ------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
+....++.++++++.+||+.+|.+||++.++++.|.++
T Consensus 218 ~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 218 EVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11234567788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=200.93 Aligned_cols=115 Identities=34% Similarity=0.480 Sum_probs=96.1
Q ss_pred CCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
++.++||||+++++++.. ...++||||+. ++|.+.+.. .+++..+..++.|++.||.|||++||+|||
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrD 144 (355)
T cd07874 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 144 (355)
T ss_pred HHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 567899999999998843 24689999995 567776643 288999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
|||+||+++.++ .+||+|||+++............||..|+|||.+.
T Consensus 145 ikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~ 191 (355)
T cd07874 145 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191 (355)
T ss_pred CChHHEEECCCC-CEEEeeCcccccCCCccccCCccccCCccCHHHHc
Confidence 999999999887 89999999998654444444567899999999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=204.97 Aligned_cols=146 Identities=23% Similarity=0.369 Sum_probs=123.3
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++.+.+ +.+++||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 54 il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~N 131 (382)
T cd05625 54 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDN 131 (382)
T ss_pred HHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 3678899999999999975 57899999999999999997654 48999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc------------------------------------------------cccccCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLT------------------------------------------------EMMTAETG 111 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~------------------------------------------------~~~~~~~g 111 (223)
|+++.++ .+||+|||++...... ......+|
T Consensus 132 ILl~~~g-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (382)
T cd05625 132 ILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVG 210 (382)
T ss_pred EEECCCC-CEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccc
Confidence 9999887 8999999997521100 00112468
Q ss_pred ccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 112 TYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 112 t~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
|+.|+|||++.....+...|+|+++..+++.-.++.|.
T Consensus 211 t~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf 248 (382)
T cd05625 211 TPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248 (382)
T ss_pred CcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCC
Confidence 99999999999888889999999998888777776664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=197.98 Aligned_cols=144 Identities=26% Similarity=0.370 Sum_probs=122.6
Q ss_pred CCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 3 SRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 3 ~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++ +||||+++++++.+ +.+++||||++|++|.+++...+. +++..++.++.|++.||.|||++|++||||||+||
T Consensus 50 ~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 127 (329)
T cd05588 50 ETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK--LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV 127 (329)
T ss_pred HhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence 345 79999999999975 578999999999999998876543 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccc-cccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREES-LTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+++.++ .+||+|||+++... .........||+.|+|||++.....+...|+|+++..+++.-.++.|.
T Consensus 128 li~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf 196 (329)
T cd05588 128 LLDAEG-HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196 (329)
T ss_pred EECCCC-CEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCc
Confidence 999877 89999999987422 222234457999999999999888888999999998888776655553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=189.89 Aligned_cols=159 Identities=28% Similarity=0.501 Sum_probs=130.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++||||+++++++.+ +..+++|||+.+++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ 135 (267)
T cd08229 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPA 135 (267)
T ss_pred HHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 567899999999998864 5789999999999999988642 2345899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC---------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
||+++.++ .++|+|||++....... ......++..|+|||.+...
T Consensus 136 nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08229 136 NVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred HEEEcCCC-CEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence 99999877 89999999987543322 12234688899999954211
Q ss_pred ---------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 125 ---------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 125 ---------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
....+.++.+++.+||..+|.+||++.++++.+.++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1134567889999999999999999999999888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=192.90 Aligned_cols=160 Identities=26% Similarity=0.527 Sum_probs=130.9
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++++.++..++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+++++|+||||+||+
T Consensus 63 ~~~l~h~niv~~~~~~~~~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nil 141 (303)
T cd05110 63 MASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVL 141 (303)
T ss_pred HHhCCCCCcccEEEEEcCCCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceee
Confidence 56789999999999998777889999999999999987643 34899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCCC----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
++.++ .+||+|||+++....... .....++..|++||.+...
T Consensus 142 l~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~ 220 (303)
T cd05110 142 VKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220 (303)
T ss_pred ecCCC-ceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 98777 799999999975432221 1123356789999944311
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+..++.++..++..||..+|.+||+++++++.|.++...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 221 PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 122456778889999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=203.22 Aligned_cols=145 Identities=23% Similarity=0.365 Sum_probs=122.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|+.++||||+++++.+.+ +.+++||||+.||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~N 131 (364)
T cd05599 54 ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDN 131 (364)
T ss_pred HHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHH
Confidence 3567899999999999975 578999999999999999976544 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc---------------------------------------ccccCCCccccccCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTE---------------------------------------MMTAETGTYRWMAPEN 120 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~ 120 (223)
|+++.++ .+||+|||++....... .....+||+.|+|||+
T Consensus 132 Il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 210 (364)
T cd05599 132 LLLDAKG-HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210 (364)
T ss_pred eEECCCC-CEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHH
Confidence 9999888 89999999986432110 0012368999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcccCCCCCC
Q 027476 121 MRPSAENLPEDLALIVTSCWKEDPNERP 148 (223)
Q Consensus 121 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rp 148 (223)
+.....+...|+|+++..+++.-.+..|
T Consensus 211 ~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 211 FLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred HcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 9988888899999999888777655555
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=188.64 Aligned_cols=157 Identities=28% Similarity=0.505 Sum_probs=126.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++.+++.+ +..++||||+.+++|.+++.... +.+++..++.++.|++.||.|||++|++|+||||+||
T Consensus 59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 578899999999999865 56899999999999999987643 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccccc---c-cCC--CccccccCCCCCC-------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMM---T-AET--GTYRWMAPENMRP------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~---~-~~~--gt~~y~aPE~~~~------------------------------- 123 (223)
+++.++ .+||+|||++......... . ... .+..|++||.+..
T Consensus 138 li~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 138 LVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred EEcCCC-cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 999777 8999999998743322111 1 111 2357999994421
Q ss_pred ---------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 124 ---------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 124 ---------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
.+..++.++.+++..||+.+|.+||++++++..|+++
T Consensus 217 ~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 217 NQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1234566788899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=190.12 Aligned_cols=119 Identities=32% Similarity=0.491 Sum_probs=97.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP---RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
++.++||||+++++.+.+ +..++||||+.+|+|.+++..... ...++..+..++.|++.||+|||+++++||||||
T Consensus 49 ~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp 128 (269)
T cd05042 49 YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLAL 128 (269)
T ss_pred HHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccH
Confidence 467899999999999865 578999999999999999976432 2356788899999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCC
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENM 121 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~ 121 (223)
+||+++.++ .+||+|||++....... ......++..|+|||++
T Consensus 129 ~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05042 129 RNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174 (269)
T ss_pred hheEecCCC-cEEEeccccccccccchheeccCCCCCcccccCHHHH
Confidence 999999887 89999999986432211 11223456789999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=204.82 Aligned_cols=155 Identities=25% Similarity=0.379 Sum_probs=122.7
Q ss_pred CCCCCCCCCccceEEEeec---------CceEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027476 1 MMSRVRHRNLVKFIGACKE---------PVMVIVTELLLGGTLRKYLLN--MRPRCLDIHVAIGFALDIARAMECLHSHG 69 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---------~~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ 69 (223)
+|++++||||+++++++.. ..+++||||+. ++|.+++.. .....+++..++.++.|++.||.|||++|
T Consensus 112 il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~ 190 (440)
T PTZ00036 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF 190 (440)
T ss_pred HHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4678999999999887621 13568999995 578777653 22345999999999999999999999999
Q ss_pred cccCCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-C-----------------------
Q 027476 70 IIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS-A----------------------- 125 (223)
Q Consensus 70 ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~----------------------- 125 (223)
|+||||||+||+++.++..+||+|||+++............||+.|+|||++.+. .
T Consensus 191 IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~p 270 (440)
T PTZ00036 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI 270 (440)
T ss_pred EecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999876657999999999865444434455789999999954310 0
Q ss_pred --------------------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 126 --------------------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 126 --------------------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
...+.++.+|+.+||+.+|.+||++.++++
T Consensus 271 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 271 FSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 013456778999999999999999999987
Q ss_pred H
Q 027476 156 M 156 (223)
Q Consensus 156 ~ 156 (223)
+
T Consensus 351 h 351 (440)
T PTZ00036 351 D 351 (440)
T ss_pred C
Confidence 6
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=190.92 Aligned_cols=157 Identities=28% Similarity=0.525 Sum_probs=126.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP----------RCLDIHVAIGFALDIARAMECLHSHG 69 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~----------~~l~~~~~~~i~~qi~~~l~~lH~~~ 69 (223)
+|++++|+||+++++++.. +..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+.|
T Consensus 70 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 149 (295)
T cd05097 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN 149 (295)
T ss_pred HHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC
Confidence 3678999999999999864 678999999999999999865321 13688999999999999999999999
Q ss_pred cccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCCC----------------------
Q 027476 70 IIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRPS---------------------- 124 (223)
Q Consensus 70 ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------------------- 124 (223)
++|+||||+||+++.++ .+||+|||++........ .....++..|+|||.+...
T Consensus 150 i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~ 228 (295)
T cd05097 150 FVHRDLATRNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC 228 (295)
T ss_pred eeccccChhhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcC
Confidence 99999999999999777 799999999875432211 1223456789999943210
Q ss_pred --------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 125 --------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 125 --------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
+...+..+.+++.+||+.+|.+||+++++++.|+
T Consensus 229 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 229 KEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1224567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=195.82 Aligned_cols=143 Identities=26% Similarity=0.348 Sum_probs=122.9
Q ss_pred CCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q 027476 4 RVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL 82 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill 82 (223)
.++||||+++++++.+ +..++||||+.|++|.+++..... +++..+..++.|++.||+|||++||+||||||+||++
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~ 129 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence 3589999999999865 578999999999999999876543 8999999999999999999999999999999999999
Q ss_pred eCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 83 TADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 83 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+.++ .+||+|||+++.... ........||+.|+|||.+.....+...|+|+++..+++.-.++.|.
T Consensus 130 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf 196 (316)
T cd05620 130 DRDG-HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196 (316)
T ss_pred CCCC-CEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCC
Confidence 9887 899999999874321 22234457899999999999888888999999999888877666663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=195.48 Aligned_cols=146 Identities=21% Similarity=0.261 Sum_probs=109.5
Q ss_pred CCCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027476 1 MMSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMR-------PRCLDIHVAIGFALDIARAMECLHSHGI 70 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~~lH~~~i 70 (223)
+|++++||||+++++++.+ ...++|+||+ +++|.+++.... ...+++..+..++.|++.||.|||++||
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i 129 (317)
T cd07868 51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWV 129 (317)
T ss_pred HHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 3678899999999998843 4578999999 568888875321 2348999999999999999999999999
Q ss_pred ccCCCCCCCEEEeC---CCCceEEccCcccccccccc----ccccCCCccccccCCCCCCC-CCCChHHHHHHHHHhccc
Q 027476 71 IHRDLKPENLILTA---DHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMRPS-AENLPEDLALIVTSCWKE 142 (223)
Q Consensus 71 vH~dlkp~Nill~~---~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~l~~l~~~~l~~ 142 (223)
+||||||+||+++. ....+||+|||+++...... ......||+.|+|||.+... ..+...|+|+++..+++.
T Consensus 130 vHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 209 (317)
T cd07868 130 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209 (317)
T ss_pred EcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHH
Confidence 99999999999942 22379999999997543221 12345789999999977543 345556666665555554
Q ss_pred CCCCC
Q 027476 143 DPNER 147 (223)
Q Consensus 143 ~p~~R 147 (223)
-..+.
T Consensus 210 ~~g~~ 214 (317)
T cd07868 210 LTSEP 214 (317)
T ss_pred HhCCC
Confidence 44433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=195.58 Aligned_cols=147 Identities=24% Similarity=0.351 Sum_probs=121.9
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
+||||+++++.+.+ +.+++||||+.+++|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~ 131 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA 131 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 79999999999875 578999999999999999876544 999999999999999999999999999999999999998
Q ss_pred CCCceEEccCcccccccc-ccccccCCCccccccCCCCCCC---------------------------------------
Q 027476 85 DHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPS--------------------------------------- 124 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~--------------------------------------- 124 (223)
++ .+||+|||+++.... ........||+.|+|||.+...
T Consensus 132 ~~-~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~ 210 (330)
T cd05586 132 TG-HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA 210 (330)
T ss_pred CC-CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH
Confidence 87 799999999875322 2223455799999999954310
Q ss_pred -------CCCChHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 027476 125 -------AENLPEDLALIVTSCWKEDPNERP----NFSQIIQ 155 (223)
Q Consensus 125 -------~~~~~~~l~~l~~~~l~~~p~~Rp----~~~~~~~ 155 (223)
...++.++.+++.+||+.+|.+|| ++.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 211 FGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 113567788899999999999998 4566654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=193.51 Aligned_cols=155 Identities=26% Similarity=0.430 Sum_probs=127.1
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++|+||+++++.+.+ +..++||||+.|++|.+++.......+++..+..++.|++.||.|||+.+++||||||+|
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~N 132 (285)
T cd05630 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPEN 132 (285)
T ss_pred HHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHH
Confidence 3578899999999998864 678999999999999999876555569999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
|+++.++ .++|+|||++.............|+..|+|||.+...
T Consensus 133 il~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~ 211 (285)
T cd05630 133 ILLDDHG-HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 211 (285)
T ss_pred EEECCCC-CEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH
Confidence 9999877 7999999998754433333445789999999955321
Q ss_pred -------------CCCChHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 027476 125 -------------AENLPEDLALIVTSCWKEDPNERPN-----FSQIIQM 156 (223)
Q Consensus 125 -------------~~~~~~~l~~l~~~~l~~~p~~Rp~-----~~~~~~~ 156 (223)
...++.++.+++..||+.+|.+||+ +++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 212 EVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1234556778888888888888888 6777664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=189.64 Aligned_cols=159 Identities=31% Similarity=0.591 Sum_probs=128.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--------RCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
+++++||||+++++++.+ +..++||||+.+|+|.+++..... ...++..+..++.|++.||.|||+++++|
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H 142 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVH 142 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence 567899999999999865 578999999999999999975321 23567888999999999999999999999
Q ss_pred CCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC--------------------------
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP-------------------------- 123 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-------------------------- 123 (223)
|||||+||+++.++ .+||+|||+++....... .....++..|+|||.+..
T Consensus 143 ~dikp~nili~~~~-~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p 221 (288)
T cd05061 143 RDLAARNCMVAHDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 221 (288)
T ss_pred CCCChheEEEcCCC-cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCC
Confidence 99999999999877 899999999875332211 112245678999995421
Q ss_pred --------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 124 --------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 124 --------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
.+...+..+.+++.+|++.+|.+||++.++++.|++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 222 YQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 12234677899999999999999999999999888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=203.10 Aligned_cols=152 Identities=26% Similarity=0.473 Sum_probs=128.5
Q ss_pred CCCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG--IIHRDL 75 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~dl 75 (223)
+|+.|+||||+++++++.+ ..+.+|+|.+..|+|..++++.+. ++.+.+..|++||++||.|||++. |+||||
T Consensus 94 lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDL 171 (632)
T KOG0584|consen 94 LLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDL 171 (632)
T ss_pred HHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCcccccc
Confidence 5889999999999999965 247799999999999999998766 999999999999999999999986 999999
Q ss_pred CCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-------------------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS------------------------------- 124 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------------------- 124 (223)
|=+||+|+.+.+.|||+|+|+|........ ....|||.|||||.....
T Consensus 172 KCDNIFinG~~G~VKIGDLGLAtl~r~s~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A 250 (632)
T KOG0584|consen 172 KCDNIFVNGNLGEVKIGDLGLATLLRKSHA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA 250 (632)
T ss_pred ccceEEEcCCcCceeecchhHHHHhhcccc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHH
Confidence 999999998877999999999986544333 347899999999944310
Q ss_pred -----------CCC----ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -----------AEN----LPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -----------~~~----~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
|.. -.++++.+|.+|+.. ..+|+++.++++.
T Consensus 251 QIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 251 QIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 000 124678899999999 9999999999865
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=196.48 Aligned_cols=143 Identities=27% Similarity=0.367 Sum_probs=123.5
Q ss_pred CC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 4 RV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 4 ~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
++ +||||+++++++.+ +.+++||||++|++|.+++...+. +++..++.++.|++.||+|||++|++||||||+||+
T Consensus 51 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil 128 (327)
T cd05617 51 QASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVL 128 (327)
T ss_pred hhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 44 79999999999865 578999999999999998876544 999999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccc-cccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 82 LTADHKTVKLADFGLAREES-LTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
++.++ .+||+|||+++... .........||+.|+|||.+.....+...|+|+++..+++.-.++.|.
T Consensus 129 i~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf 196 (327)
T cd05617 129 LDADG-HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196 (327)
T ss_pred EeCCC-CEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCC
Confidence 99887 79999999987432 222334567999999999999888899999999999888877766665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=186.38 Aligned_cols=158 Identities=33% Similarity=0.548 Sum_probs=130.1
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++++++|+||+++.+++.+...+++|||+.+++|.+++.......+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 54 ~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 133 (260)
T cd05073 54 VMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 133 (260)
T ss_pred HHHhcCCCCcceEEEEEcCCCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceE
Confidence 36789999999999998878889999999999999999875555689999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
+++.++ .+||+|||.+........ .....++..|+|||.+..
T Consensus 134 ~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~ 212 (260)
T cd05073 134 LVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 212 (260)
T ss_pred EEcCCC-cEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999877 899999999875432221 112235677999995431
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
.....+.++.+++.+|++.+|.+||++.++.+.|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 213 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 122344678889999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=205.77 Aligned_cols=148 Identities=29% Similarity=0.445 Sum_probs=126.2
Q ss_pred CCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++|||+|.+-|+|. +...|+||||| -|+-.+++.-.+ +++-+.++..|..+.+.||.|||+.+.+|||||+.||
T Consensus 80 L~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNI 157 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNI 157 (948)
T ss_pred HHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccce
Confidence 57899999999999996 55789999999 568888776533 4489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------- 123 (223)
|++..+ .|||+|||.|.... ..+.++|||.|||||++..
T Consensus 158 LLse~g-~VKLaDFGSAsi~~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA 233 (948)
T KOG0577|consen 158 LLSEPG-LVKLADFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 233 (948)
T ss_pred EecCCC-eeeeccccchhhcC---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH
Confidence 999887 89999999987543 2356799999999996630
Q ss_pred ------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 124 ------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 124 ------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
....++..+.+++..||++-|.+||+.++++.
T Consensus 234 LYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 234 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 12346677889999999999999999998865
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=188.77 Aligned_cols=117 Identities=32% Similarity=0.487 Sum_probs=100.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||+++++.+.+ +..++|+||+.+++|.+++...+. +++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 60 ~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 137 (267)
T cd06645 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANI 137 (267)
T ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 567899999999998864 678999999999999999876544 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENM 121 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~ 121 (223)
+++.++ .+||+|||++...... .......|+..|+|||.+
T Consensus 138 li~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 178 (267)
T cd06645 138 LLTDNG-HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178 (267)
T ss_pred EECCCC-CEEECcceeeeEccCcccccccccCcccccChhhh
Confidence 999877 7999999998654322 112344688999999965
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=189.46 Aligned_cols=153 Identities=28% Similarity=0.443 Sum_probs=125.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||+++++.+.+ +..++|+||+.+++|..++.+.. ..+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 56 l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~ni 134 (282)
T cd06643 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134 (282)
T ss_pred HHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccE
Confidence 567899999999998864 67899999999999999876532 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
+++.++ .+||+|||++...... .......++..|+|||.+.
T Consensus 135 li~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 213 (282)
T cd06643 135 LFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213 (282)
T ss_pred EEccCC-CEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence 999877 8999999998754322 1223446889999999652
Q ss_pred ---------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 ---------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 ---------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..+..++.++.+++..||+.+|.+||++++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 214 MRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112355678889999999999999999888755
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=188.85 Aligned_cols=157 Identities=32% Similarity=0.597 Sum_probs=124.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP-----RCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
+++++|+||+++++++.+ +..++||||+.|++|.+++..... ..+++..++.++.||+.||+|||+++++|+||
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dl 142 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDI 142 (277)
T ss_pred HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 578899999999998754 578899999999999999976432 24899999999999999999999999999999
Q ss_pred CCCCEEEeCCC--CceEEccCccccccccccc---cccCCCccccccCCCCCCC--------------------------
Q 027476 76 KPENLILTADH--KTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRPS-------------------------- 124 (223)
Q Consensus 76 kp~Nill~~~~--~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-------------------------- 124 (223)
||+||+++.++ ..+||+|||+++....... ......+..|+|||++...
T Consensus 143 kp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf 222 (277)
T cd05036 143 AARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222 (277)
T ss_pred chheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 99999998653 3699999999875432211 1122335679999954311
Q ss_pred --------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 125 --------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 125 --------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
+..++..+.+++.+|++.+|.+||++.+++++|+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 223 PGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2234567788889999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=188.45 Aligned_cols=152 Identities=24% Similarity=0.528 Sum_probs=124.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++|+||+++++|.+++..... +++..+..++.|++.||+|||+.|++||||+|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~ni 137 (267)
T cd06628 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANI 137 (267)
T ss_pred HHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHE
Confidence 578899999999999865 578899999999999999976543 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-------ccccCCCccccccCCCCCCC-----------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-------MMTAETGTYRWMAPENMRPS----------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~----------------------------- 124 (223)
+++.++ .+||+|||.++...... ......|+..|+|||.+...
T Consensus 138 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 138 LVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred EEcCCC-CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 999877 79999999987543211 11223578899999954321
Q ss_pred ----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 217 QLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 23356677888899999999999998888753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=192.73 Aligned_cols=116 Identities=27% Similarity=0.466 Sum_probs=99.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~N 79 (223)
+++++||||+++++.|.+ +.+++||||++|++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+|
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~n 130 (308)
T cd06615 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSN 130 (308)
T ss_pred HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHH
Confidence 567899999999999864 68899999999999999997654 38999999999999999999997 589999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 121 (223)
|+++.++ .+||+|||++...... ......++..|+|||.+
T Consensus 131 il~~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~ 170 (308)
T cd06615 131 ILVNSRG-EIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERL 170 (308)
T ss_pred EEEecCC-cEEEccCCCccccccc-ccccCCCCcCccChhHh
Confidence 9999877 7999999998754322 22345788999999954
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=206.09 Aligned_cols=150 Identities=29% Similarity=0.420 Sum_probs=132.6
Q ss_pred CCCCCCCCCccceEEEeecC-------ceEEEEEcCCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 1 MMSRVRHRNLVKFIGACKEP-------VMVIVTELLLGGTLRKYLLN-MRPRCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~-------~~~lv~e~~~~~sL~~~l~~-~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
||++|+|+|||+++++-++. ...+|||||.||+|+..+.+ .....+++.+++.++..++.||.|||++||+|
T Consensus 64 ilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvH 143 (732)
T KOG4250|consen 64 ILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVH 143 (732)
T ss_pred HHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCcee
Confidence 57899999999999986442 36799999999999999974 23345999999999999999999999999999
Q ss_pred CCCCCCCEEEeCC--C-CceEEccCccccccccccccccCCCccccccCCCCC-CCCCCChHHHHHHHHHhcccCCCCCC
Q 027476 73 RDLKPENLILTAD--H-KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR-PSAENLPEDLALIVTSCWKEDPNERP 148 (223)
Q Consensus 73 ~dlkp~Nill~~~--~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~l~~l~~~~l~~~p~~Rp 148 (223)
|||||.||++... | ..-||+|||.|+...........+||..|++||... ...++...|+|+++...++.-.+.+|
T Consensus 144 RDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 144 RDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred ccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 9999999998532 2 267999999999988888888899999999999998 58889999999999999999999998
Q ss_pred CH
Q 027476 149 NF 150 (223)
Q Consensus 149 ~~ 150 (223)
+.
T Consensus 224 F~ 225 (732)
T KOG4250|consen 224 FI 225 (732)
T ss_pred CC
Confidence 65
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=198.81 Aligned_cols=115 Identities=35% Similarity=0.480 Sum_probs=96.6
Q ss_pred CCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
++.++||||+++++++.. ...++||||+. ++|.+.+.. .+++..+..++.|++.||.|||++||+|||
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 151 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCC
Confidence 567899999999998742 24789999995 577777743 288999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
|||+||+++.++ .+||+|||+++............+|..|+|||++.
T Consensus 152 lkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~ 198 (364)
T cd07875 152 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198 (364)
T ss_pred CCHHHEEECCCC-cEEEEeCCCccccCCCCcccCCcccCCcCCHHHHh
Confidence 999999999887 89999999998654444444567899999999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=194.20 Aligned_cols=163 Identities=25% Similarity=0.316 Sum_probs=145.6
Q ss_pred CCCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|+..+||.+..|-..|+ ++.+|+||||+.||.|.-++.+.+. +++...+.+..+|+.||.|||+++||+||||.+|
T Consensus 221 VL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~--FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLEN 298 (516)
T KOG0690|consen 221 VLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERV--FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLEN 298 (516)
T ss_pred HHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhc--ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhh
Confidence 467789999999977775 5789999999999999999987554 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccc-ccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 80 LILTADHKTVKLADFGLAREE-SLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
.++|++| ++||+|||+++.. ......++.+|||.|+|||++....++...|+|-++..|+++--++-|..++-.+.|.
T Consensus 299 LlLDkDG-HIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF 377 (516)
T KOG0690|consen 299 LLLDKDG-HIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF 377 (516)
T ss_pred heeccCC-ceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHH
Confidence 9999999 8999999999843 4455667899999999999999999999999999999999999999999988888887
Q ss_pred HHhhcCCC
Q 027476 159 HYISTNSA 166 (223)
Q Consensus 159 ~~~~~~~~ 166 (223)
+++.....
T Consensus 378 eLIl~ed~ 385 (516)
T KOG0690|consen 378 ELILMEDL 385 (516)
T ss_pred HHHHhhhc
Confidence 77765433
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=187.12 Aligned_cols=157 Identities=36% Similarity=0.666 Sum_probs=126.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR-----PRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
|++++||||+++++++.+ +..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl 132 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDL 132 (269)
T ss_pred HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 678899999999999865 57899999999999999997532 234789999999999999999999999999999
Q ss_pred CCCCEEEeCCC----CceEEccCccccccccccc---cccCCCccccccCCCCCC-------------------------
Q 027476 76 KPENLILTADH----KTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP------------------------- 123 (223)
Q Consensus 76 kp~Nill~~~~----~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------------------- 123 (223)
||+||+++.++ ..++|+|||+++....... .....++..|+|||.+..
T Consensus 133 ~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~ 212 (269)
T cd05044 133 AARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212 (269)
T ss_pred ChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCC
Confidence 99999998654 2699999999875432211 122345678999994321
Q ss_pred ---------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 124 ---------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 124 ---------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
.+...+.++++++.+||+.+|.+||+++++.+.|+
T Consensus 213 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 213 PYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 12245677899999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=200.86 Aligned_cols=145 Identities=25% Similarity=0.359 Sum_probs=124.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+.+++||||+++++.+.+ +.+++||||++||+|.+++.+... +++..+..++.|++.||.|||++||+||||||+||
T Consensus 55 l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NI 132 (360)
T cd05627 55 LVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNL 132 (360)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence 567899999999999875 578999999999999999976544 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc------------------------------------ccccCCCccccccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE------------------------------------MMTAETGTYRWMAPENMRPS 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~ 124 (223)
+++.++ .+||+|||+++...... .....+||+.|+|||++...
T Consensus 133 li~~~~-~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 211 (360)
T cd05627 133 LLDAKG-HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT 211 (360)
T ss_pred EECCCC-CEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC
Confidence 999887 89999999986432110 01134699999999999988
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCC
Q 027476 125 AENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 125 ~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
..+...|+|+++..++++-.++.|.
T Consensus 212 ~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 212 GYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred CCCCcceeccccceeeecccCCCCC
Confidence 8889999999999888887777764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=197.54 Aligned_cols=159 Identities=31% Similarity=0.571 Sum_probs=128.8
Q ss_pred CCCCC-CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC------------------------------------
Q 027476 2 MSRVR-HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP------------------------------------ 43 (223)
Q Consensus 2 l~~l~-Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------ 43 (223)
|.++. ||||+++++++.+ +..++|+||+.+|+|.+++...+.
T Consensus 94 l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (401)
T cd05107 94 MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSE 173 (401)
T ss_pred HHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhc
Confidence 55676 9999999999965 578999999999999999965321
Q ss_pred ------------------------------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 027476 44 ------------------------------------------------------------RCLDIHVAIGFALDIARAME 63 (223)
Q Consensus 44 ------------------------------------------------------------~~l~~~~~~~i~~qi~~~l~ 63 (223)
..+++..++.++.|++.||.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 253 (401)
T cd05107 174 SDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGME 253 (401)
T ss_pred cCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 23677888999999999999
Q ss_pred HHHhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCC-----------------
Q 027476 64 CLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRP----------------- 123 (223)
Q Consensus 64 ~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~----------------- 123 (223)
|||+.+++||||||+||+++.++ .+||+|||+++...... ......++..|+|||.+..
T Consensus 254 ~LH~~~ivHrdlkp~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~ 332 (401)
T cd05107 254 FLASKNCVHRDLAARNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLW 332 (401)
T ss_pred HHhcCCcCcccCCcceEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHH
Confidence 99999999999999999999776 89999999987532211 1122356788999994321
Q ss_pred ------------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 124 ------------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 124 ------------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
.+..++.++.+++..||+.+|.+||+++++++.|++++
T Consensus 333 e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 333 EIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 12234577889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=186.06 Aligned_cols=154 Identities=27% Similarity=0.479 Sum_probs=124.5
Q ss_pred CCCCCCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++|+||+++++.+.. +.+++||||+++++|.+++.......+++.+++.++.|++.||.+||+.|++|+||||+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~n 132 (257)
T cd08223 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQN 132 (257)
T ss_pred HHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchh
Confidence 567899999999998753 357899999999999999987555568999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPSA--------------------------------- 125 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--------------------------------- 125 (223)
|+++.++ .++|+|||++...... .......+++.|+|||.+....
T Consensus 133 il~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~ 211 (257)
T cd08223 133 VFLTRTN-IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV 211 (257)
T ss_pred EEEecCC-cEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 9999877 8999999998754322 2223456889999999554222
Q ss_pred ------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...+.++.+++.+|++.+|.+||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 212 YRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2344567777888888888888888777653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=201.75 Aligned_cols=144 Identities=24% Similarity=0.359 Sum_probs=121.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||+++++.+.+ +..++||||+.||+|.+++... .+++..+..++.|++.||+|||++||+||||||+||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NI 173 (370)
T cd05621 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNM 173 (370)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence 567899999999999975 5789999999999999998653 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCCCC----CCChHHHHHHHHHhcccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRPSA----ENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+++.++ .+||+|||++....... ......||+.|+|||++.... .+...|+|+++..+++.-.++.|.
T Consensus 174 Ll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf 247 (370)
T cd05621 174 LLDKHG-HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247 (370)
T ss_pred EECCCC-CEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence 999887 89999999997643222 123557999999999987543 566789999998888877776664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=187.62 Aligned_cols=160 Identities=28% Similarity=0.544 Sum_probs=130.9
Q ss_pred CCCCCCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 2 MSRVRHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRP------RCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
+++++||||+++++++.+ ...++++||+.+++|.+++..... ..+++..++.++.|++.||+|||+.+++|+
T Consensus 62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 141 (280)
T cd05043 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHK 141 (280)
T ss_pred HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 567899999999998754 568899999999999999875422 458999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC---------------------------
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP--------------------------- 123 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--------------------------- 123 (223)
||||+||+++.++ .+||+|||+++....... .....++..|+|||.+..
T Consensus 142 di~p~nil~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 220 (280)
T cd05043 142 DIAARNCVIDEEL-QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220 (280)
T ss_pred ccCHhhEEEcCCC-cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCc
Confidence 9999999999877 899999999975432211 122345678999994321
Q ss_pred -------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 124 -------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 124 -------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
....++.++.+++.+||..+|.+||++.++++.|..+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 221 VEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 112346778999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=188.46 Aligned_cols=154 Identities=27% Similarity=0.476 Sum_probs=123.7
Q ss_pred CCCC-CCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 2 MSRV-RHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
++++ +|+||+++++.+.+ ..+++||||+.+++|.+++.......+++..+..++.|++.||.|||+++++|+
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~ 135 (272)
T cd06637 56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR 135 (272)
T ss_pred HHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence 3455 79999999998853 357899999999999999987555568999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCC-----C-----------------------
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRP-----S----------------------- 124 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~----------------------- 124 (223)
||||+||+++.++ .+||+|||++...... .......|+..|+|||++.. .
T Consensus 136 dl~~~nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~ 214 (272)
T cd06637 136 DIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214 (272)
T ss_pred CCCHHHEEECCCC-CEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999887 7999999998754322 22234568899999996531 0
Q ss_pred -----------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -----------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -----------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++.+||..+|.+||++.+++++
T Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 215 PLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 11244567778888888888888888887653
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=192.79 Aligned_cols=142 Identities=27% Similarity=0.359 Sum_probs=123.2
Q ss_pred CCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEe
Q 027476 5 VRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83 (223)
Q Consensus 5 l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 83 (223)
++||||+++++++.+ +.+++||||++||+|.+++..... +++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~ 130 (316)
T cd05619 53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD 130 (316)
T ss_pred cCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC
Confidence 589999999999865 578899999999999999976443 89999999999999999999999999999999999999
Q ss_pred CCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 84 ADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 84 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
.++ .+||+|||+++.... ........||+.|+|||.+.....+...|+|+++..+++.-.++.|.
T Consensus 131 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf 196 (316)
T cd05619 131 TDG-HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196 (316)
T ss_pred CCC-CEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 887 899999999874322 12233457899999999999888899999999999988888777774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=187.09 Aligned_cols=119 Identities=33% Similarity=0.494 Sum_probs=97.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP---RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
+++++||||+++++.+.+ ...++||||+++++|.+++..... ...++..+..++.|++.||.|||+.+++|+||||
T Consensus 49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp 128 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLAL 128 (269)
T ss_pred HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCc
Confidence 577899999999999865 568899999999999999975332 2467778889999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCC
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENM 121 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~ 121 (223)
+||+++.++ .+||+|||+++....... .....++..|+|||.+
T Consensus 129 ~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05087 129 RNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174 (269)
T ss_pred ceEEEcCCC-cEEECCccccccccCcceeecCCCcCCcccccCHhHh
Confidence 999999877 899999999874332211 1233567889999965
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=190.81 Aligned_cols=121 Identities=28% Similarity=0.456 Sum_probs=103.5
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|+||+++.+.+.+ +..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+|
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~N 132 (285)
T cd05632 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPEN 132 (285)
T ss_pred HHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHH
Confidence 3678899999999988864 578899999999999998876555569999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
|+++.++ .+||+|||++.............|+..|+|||.+.
T Consensus 133 ili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~ 174 (285)
T cd05632 133 ILLDDYG-HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN 174 (285)
T ss_pred EEECCCC-CEEEecCCcceecCCCCcccCCCCCcCccChHHhc
Confidence 9999877 79999999987543333334457899999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=187.96 Aligned_cols=157 Identities=27% Similarity=0.554 Sum_probs=127.7
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP-------RCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
++++++|+||+++++++.+ +..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+++|
T Consensus 61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H 140 (275)
T cd05046 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVH 140 (275)
T ss_pred HHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCccc
Confidence 3678899999999999975 578999999999999999976541 14899999999999999999999999999
Q ss_pred CCCCCCCEEEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCCC--------------------------
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRPS-------------------------- 124 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-------------------------- 124 (223)
+||||+||+++.++ .++++|||++....... ......++..|++||.+...
T Consensus 141 ~dlkp~Nili~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~ 219 (275)
T cd05046 141 RDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219 (275)
T ss_pred CcCccceEEEeCCC-cEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999887 79999999986432221 12233456789999954211
Q ss_pred ---------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 125 ---------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 125 ---------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
...++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 220 YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 2345567888999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=185.91 Aligned_cols=157 Identities=34% Similarity=0.570 Sum_probs=128.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ ...++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~ni 134 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNI 134 (261)
T ss_pred HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheE
Confidence 578899999999999875 6789999999999999999876655699999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
+++.++ .+||+|||++........ .....++..|+|||.+..
T Consensus 135 li~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 213 (261)
T cd05034 135 LVGENL-VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV 213 (261)
T ss_pred EEcCCC-CEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999887 899999999875432211 112234567999994321
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
.+...+.++.+++.+|+..+|.+||+++++.+.|+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 214 LEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 123345678889999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=193.91 Aligned_cols=160 Identities=29% Similarity=0.594 Sum_probs=127.0
Q ss_pred CCCC-CCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcC------------------------------------
Q 027476 2 MSRV-RHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMR------------------------------------ 42 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~------------------------------------ 42 (223)
|+++ +||||+++++++.+ ...++||||+.+|+|.+++....
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (343)
T cd05103 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITS 143 (343)
T ss_pred HHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccc
Confidence 4566 78999999998853 46789999999999999986432
Q ss_pred -----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEcc
Q 027476 43 -----------------------------PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLAD 93 (223)
Q Consensus 43 -----------------------------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~D 93 (223)
...+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~d 222 (343)
T cd05103 144 SQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICD 222 (343)
T ss_pred ccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEe
Confidence 12368888999999999999999999999999999999999877 899999
Q ss_pred Cccccccccccc---cccCCCccccccCCCCCCC----------------------------------------------
Q 027476 94 FGLAREESLTEM---MTAETGTYRWMAPENMRPS---------------------------------------------- 124 (223)
Q Consensus 94 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------------------------------------------- 124 (223)
||++........ .....++..|+|||.+...
T Consensus 223 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 302 (343)
T cd05103 223 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302 (343)
T ss_pred cccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC
Confidence 999875422211 1123356679999944211
Q ss_pred -CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 125 -AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 125 -~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
+...+.++.+++..||+.+|.+||++.+++++|+.++.
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11234578889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=190.29 Aligned_cols=166 Identities=25% Similarity=0.376 Sum_probs=129.6
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++||||+++++++.+ +..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~N 133 (288)
T cd07871 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQN 133 (288)
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 3578899999999999865 56889999996 59999886543 348999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCC-CCCCChHHHHHHHHHhcccCCCCCCCH-HHHHHH
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRP-SAENLPEDLALIVTSCWKEDPNERPNF-SQIIQM 156 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~~l~~l~~~~l~~~p~~Rp~~-~~~~~~ 156 (223)
|+++.++ .+||+|||+++..... .......+++.|+|||.+.+ ...+...|+|+++..+++.-.++.|.. ....+.
T Consensus 134 il~~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 212 (288)
T cd07871 134 LLINEKG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212 (288)
T ss_pred EEECCCC-CEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999887 7999999998754322 22234568999999998865 457888999999999998887777743 223333
Q ss_pred HHHHhhcCCCCCC
Q 027476 157 LLHYISTNSAPEP 169 (223)
Q Consensus 157 L~~~~~~~~~~~~ 169 (223)
+..+....+.+..
T Consensus 213 ~~~~~~~~~~~~~ 225 (288)
T cd07871 213 LHLIFRLLGTPTE 225 (288)
T ss_pred HHHHHHHhCCCCh
Confidence 3344433333333
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=194.48 Aligned_cols=142 Identities=27% Similarity=0.356 Sum_probs=122.8
Q ss_pred CCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEe
Q 027476 5 VRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83 (223)
Q Consensus 5 l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 83 (223)
.+||||+++++++.+ +.+++||||+.+++|...+..... +++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~ 130 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD 130 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence 389999999999975 578999999999999999876544 89999999999999999999999999999999999999
Q ss_pred CCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 84 ADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 84 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
.++ .+||+|||++..... ........|++.|+|||.+.....+...|+|+++..+++.-.++.|.
T Consensus 131 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf 196 (321)
T cd05591 131 AEG-HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF 196 (321)
T ss_pred CCC-CEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCC
Confidence 887 899999999875322 22233456899999999999888888999999999988887777663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=185.70 Aligned_cols=146 Identities=29% Similarity=0.381 Sum_probs=114.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++||||+++++.+.+ +..+++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+++++|+||+|+|
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~n 131 (262)
T cd06613 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGAN 131 (262)
T ss_pred HHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhh
Confidence 3678999999999998865 57899999999999999987642 348999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC---CCCChHHHHHHHHHhcccCCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS---AENLPEDLALIVTSCWKEDPNERP 148 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~---~~~~~~~l~~l~~~~l~~~p~~Rp 148 (223)
|+++.++ .+||+|||++....... ......++..|++||.+... ..+...|+|+++..+++.-..+.|
T Consensus 132 i~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p 203 (262)
T cd06613 132 ILLTEDG-DVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203 (262)
T ss_pred EEECCCC-CEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCC
Confidence 9999877 79999999987543322 22345688899999987544 444555555555555544444333
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-27 Score=188.09 Aligned_cols=157 Identities=30% Similarity=0.554 Sum_probs=127.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--------------------CCCCHHHHHHHHHHHHH
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--------------------RCLDIHVAIGFALDIAR 60 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~l~~~~~~~i~~qi~~ 60 (223)
+++++||||+++++++.+ +..++|+||+.+++|.+++..... ..+++..++.++.|++.
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 567899999999999865 578999999999999999974321 23788899999999999
Q ss_pred HHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC--------------
Q 027476 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP-------------- 123 (223)
Q Consensus 61 ~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-------------- 123 (223)
||.|||+++++||||||+||+++.++ .++|+|||++........ ......+..|+|||.+..
T Consensus 142 aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 220 (288)
T cd05050 142 GMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGV 220 (288)
T ss_pred HHHHHHhCCeecccccHhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHH
Confidence 99999999999999999999999887 799999999875432211 112234567999994320
Q ss_pred --------------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 124 --------------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 124 --------------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
.+..++.++.+++.+||+.+|.+||++.++++.|++
T Consensus 221 il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 221 VLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 123456789999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=184.62 Aligned_cols=158 Identities=30% Similarity=0.519 Sum_probs=130.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++|+||+++++.+.+ +..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.|++|+||+|+
T Consensus 56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ 135 (267)
T cd08224 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPA 135 (267)
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChh
Confidence 578899999999999865 5788999999999999998653 2345899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC---------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
||+++.++ .++|+|||++....... ......++..|+|||.+...
T Consensus 136 nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08224 136 NVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred hEEECCCC-cEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH
Confidence 99999877 79999999987543322 12334678899999954211
Q ss_pred --------------CC-CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 125 --------------AE-NLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 125 --------------~~-~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
+. ..+.++.+++.+||..+|.+||++.++++.|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 215 SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11 4455788999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=187.40 Aligned_cols=156 Identities=30% Similarity=0.575 Sum_probs=125.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP---------RCLDIHVAIGFALDIARAMECLHSHGII 71 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---------~~l~~~~~~~i~~qi~~~l~~lH~~~iv 71 (223)
|++++|+||+++++++.+ +..++||||+.+++|.+++..... ..+++..++.++.|++.||+|||+.|++
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~ 152 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFV 152 (296)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 568899999999999865 578999999999999999876432 2477889999999999999999999999
Q ss_pred cCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC--------------------------
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR-------------------------- 122 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-------------------------- 122 (223)
|+||||+||+++.++ .++|+|||+++...... ......++..|++||...
T Consensus 153 H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~ 231 (296)
T cd05095 153 HRDLATRNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE 231 (296)
T ss_pred cccCChheEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCC
Confidence 999999999999777 89999999987543221 111223456788888221
Q ss_pred ----------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 123 ----------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 123 ----------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
+.+..++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 232 QPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 112335577889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=210.09 Aligned_cols=156 Identities=22% Similarity=0.430 Sum_probs=126.4
Q ss_pred CCCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------
Q 027476 1 MMSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDIARAMECLHSH------- 68 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~------- 68 (223)
+|++|+||||++++++|.+ ..+|+||||+.+++|.+++.... ...+++..++.|+.||+.||.|||+.
T Consensus 65 IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k 144 (1021)
T PTZ00266 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGE 144 (1021)
T ss_pred HHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccC
Confidence 4678999999999998843 45899999999999999987532 24599999999999999999999984
Q ss_pred CcccCCCCCCCEEEeCC----------------CCceEEccCccccccccccccccCCCccccccCCCCCCC--------
Q 027476 69 GIIHRDLKPENLILTAD----------------HKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS-------- 124 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~----------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------- 124 (223)
+|+||||||+||||+.+ ...+||+|||++.............||+.|+|||++...
T Consensus 145 ~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KS 224 (1021)
T PTZ00266 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKS 224 (1021)
T ss_pred CceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchh
Confidence 49999999999999642 124899999999865444444456799999999965210
Q ss_pred ---------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ---------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ---------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....+.++.+|+..||+.+|.+||++.+++.+
T Consensus 225 DVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 225 DMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 12345678889999999999999999999864
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=196.29 Aligned_cols=142 Identities=26% Similarity=0.363 Sum_probs=122.5
Q ss_pred CCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEe
Q 027476 5 VRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83 (223)
Q Consensus 5 l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 83 (223)
.+||||+++++++.+ +.+++||||+.+++|..++..... +++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~ 130 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 130 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC
Confidence 489999999999865 678999999999999998876544 99999999999999999999999999999999999999
Q ss_pred CCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 84 ADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 84 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
.++ .+||+|||+++.... ........||+.|+|||++.....+...|+|+++..+++.-.++.|.
T Consensus 131 ~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf 196 (329)
T cd05618 131 SEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196 (329)
T ss_pred CCC-CEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCC
Confidence 887 899999999875322 22233457899999999999888888999999998888877666664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=189.33 Aligned_cols=152 Identities=33% Similarity=0.573 Sum_probs=124.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.+||+.|++|+||||+||
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NI 129 (260)
T PF00069_consen 52 LRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKP--LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENI 129 (260)
T ss_dssp HHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSS--BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 456789999999999964 678899999999999999985444 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccc-ccccccccCCCccccccCCCCC-CCCCCC------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREE-SLTEMMTAETGTYRWMAPENMR-PSAENL------------------------------ 128 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~------------------------------ 128 (223)
+++.++ .++|+|||.+... ..........++..|+|||.+. ....+.
T Consensus 130 l~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~ 208 (260)
T PF00069_consen 130 LLDENG-EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL 208 (260)
T ss_dssp EESTTS-EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH
T ss_pred cccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhh
Confidence 999777 8999999998752 2233345567899999999765 222222
Q ss_pred ---------------------hHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 129 ---------------------PEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 129 ---------------------~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...+.+++..||+.+|.+||++.+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 209 EIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2566778888888888888888887653
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=188.50 Aligned_cols=119 Identities=30% Similarity=0.497 Sum_probs=99.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++||||+++++++.+ +..++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||||+|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~n 131 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQN 131 (285)
T ss_pred HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHH
Confidence 567899999999999865 67899999996 689888865432 568999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMR 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~ 122 (223)
|+++.++ .+||+|||++....... ......+++.|+|||.+.
T Consensus 132 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 174 (285)
T cd07861 132 LLIDNKG-VIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL 174 (285)
T ss_pred EEEcCCC-cEEECcccceeecCCCcccccCCcccccccChHHhc
Confidence 9999887 89999999987543221 123345788999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-28 Score=196.15 Aligned_cols=149 Identities=26% Similarity=0.364 Sum_probs=136.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||.+++.+.||.+-..|+. +.+++|+..|.||+|.-+|.+.+...+++..++-++.+|+.||++||+.+||+|||||+|
T Consensus 238 iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeN 317 (591)
T KOG0986|consen 238 ILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPEN 317 (591)
T ss_pred HHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhh
Confidence 4678899999999888865 689999999999999999998887779999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCH
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
||+|..| +++|+|+|+|............+||.+|||||++....++.++|+|++++.++++-.++-|+-
T Consensus 318 ILLDd~G-hvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr 387 (591)
T KOG0986|consen 318 ILLDDHG-HVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFR 387 (591)
T ss_pred eeeccCC-CeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchh
Confidence 9999887 899999999998777777777799999999999999999999999999999998888877754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=201.92 Aligned_cols=154 Identities=27% Similarity=0.404 Sum_probs=126.4
Q ss_pred CCCCCCCCccceEEEeecC---------ceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027476 2 MSRVRHRNLVKFIGACKEP---------VMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDIARAMECLHSHGI 70 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~---------~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~i 70 (223)
|..++|+||+++++.+... .+++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+.+|
T Consensus 85 l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~I 164 (496)
T PTZ00283 85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHM 164 (496)
T ss_pred HhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 4678999999998876321 2679999999999999987532 3458999999999999999999999999
Q ss_pred ccCCCCCCCEEEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCCC------------------------
Q 027476 71 IHRDLKPENLILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMRP------------------------ 123 (223)
Q Consensus 71 vH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~------------------------ 123 (223)
+||||||+||+++.++ .+||+|||+++..... .......||+.|+|||.+..
T Consensus 165 iHrDLKP~NILl~~~~-~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~ 243 (496)
T PTZ00283 165 IHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243 (496)
T ss_pred ecCCCCHHHEEEeCCC-CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 9999999999999887 8999999998754321 22234579999999995542
Q ss_pred ---------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 ---------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 ---------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+++..||+.+|.+||++.+++++
T Consensus 244 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 244 PFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 233566778889999999999999999998764
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=197.84 Aligned_cols=144 Identities=24% Similarity=0.347 Sum_probs=121.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||+++++.+.+ +..++||||+.||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI 173 (371)
T cd05622 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173 (371)
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 567899999999999875 5789999999999999998653 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCCCC----CCChHHHHHHHHHhcccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRPSA----ENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+++.++ .+||+|||+++...... ......||+.|+|||++.... .+...|+|+++..++++-.++.|.
T Consensus 174 ll~~~~-~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 174 LLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred EECCCC-CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 999887 89999999997543222 223457999999999987543 567889999998888777666664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=198.60 Aligned_cols=157 Identities=22% Similarity=0.296 Sum_probs=130.7
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++|+|+||+++++++.. +..++|||++ .++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 213 iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~N 290 (461)
T PHA03211 213 LLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTEN 290 (461)
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHH
Confidence 4678999999999999864 5788999999 578988886533 359999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCCCCCCChHHHHHHHHHhccc------------CC
Q 027476 80 LILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKE------------DP 144 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~------------~p 144 (223)
|+++.++ .+||+|||+++...... ......||+.|+|||++.....+...|+|+++..+++. .+
T Consensus 291 ILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~ 369 (461)
T PHA03211 291 VLVNGPE-DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369 (461)
T ss_pred EEECCCC-CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccc
Confidence 9999877 79999999987543221 12245699999999999998889999999999888875 35
Q ss_pred CCCCCHHHHHHHHHHH
Q 027476 145 NERPNFSQIIQMLLHY 160 (223)
Q Consensus 145 ~~Rp~~~~~~~~L~~~ 160 (223)
.++|...++.+.++..
T Consensus 370 ~~~~~~~~l~~~i~~~ 385 (461)
T PHA03211 370 ERRPYDAQILRIIRQA 385 (461)
T ss_pred ccCCcHHHHHHHHHhh
Confidence 6677777877776654
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=190.75 Aligned_cols=120 Identities=20% Similarity=0.365 Sum_probs=100.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++|+||+++++++.+ +..+++|||+.+++|.+++.......+++..+..++.|++.||+|||+++|+|+||||+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Ni 132 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHI 132 (314)
T ss_pred HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceE
Confidence 567899999999998865 5789999999999999999876555689999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--------ccccCCCccccccCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--------MMTAETGTYRWMAPENMR 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~ 122 (223)
+++.++ .+||+|||.+....... ......++..|+|||.+.
T Consensus 133 li~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (314)
T cd08216 133 LLSGDG-KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181 (314)
T ss_pred EEecCC-ceEEecCccceeeccccccccccccccccccccccccCHHHhc
Confidence 999777 79999999886432111 112335677899999654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=189.14 Aligned_cols=151 Identities=28% Similarity=0.497 Sum_probs=124.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++.+.+ ...++||||++|++|.+++.+. .+++.++..++.|++.||.|||+.|++|+||||+||
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Ni 147 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 567899999999998864 5789999999999999998652 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRP------------------------------------ 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------------------------------------ 123 (223)
+++.++ .+||+|||++....... ......+++.|+|||.+..
T Consensus 148 ll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~ 226 (296)
T cd06654 148 LLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (296)
T ss_pred EEcCCC-CEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH
Confidence 999877 89999999987533221 1233468889999994321
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+...+..+.+++.+||..+|.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 122345678889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=190.72 Aligned_cols=143 Identities=20% Similarity=0.249 Sum_probs=106.8
Q ss_pred CCCCCCCCCccceEEEee---cCceEEEEEcCCCCCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027476 1 MMSRVRHRNLVKFIGACK---EPVMVIVTELLLGGTLRKYLLNM-------RPRCLDIHVAIGFALDIARAMECLHSHGI 70 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~---~~~~~lv~e~~~~~sL~~~l~~~-------~~~~l~~~~~~~i~~qi~~~l~~lH~~~i 70 (223)
+|++++||||+++++++. +...++|+||+. ++|.+++... ....+++..++.++.|++.||.|||+.++
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i 129 (317)
T cd07867 51 LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWV 129 (317)
T ss_pred HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 367889999999999884 346889999985 6888877532 12348899999999999999999999999
Q ss_pred ccCCCCCCCEEEe----CCCCceEEccCcccccccccc----ccccCCCccccccCCCCCCC-CCCChHHHHHHHHHhcc
Q 027476 71 IHRDLKPENLILT----ADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMRPS-AENLPEDLALIVTSCWK 141 (223)
Q Consensus 71 vH~dlkp~Nill~----~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~l~~l~~~~l~ 141 (223)
+||||||+||++. .++ .+||+|||+++...... ......+|+.|+|||.+... ..+...|+|+++..+++
T Consensus 130 vH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 208 (317)
T cd07867 130 LHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 208 (317)
T ss_pred EcCCCCHHHEEEccCCCCCC-cEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHH
Confidence 9999999999993 334 79999999998543221 12344688999999977542 34455566655555444
Q ss_pred cCCC
Q 027476 142 EDPN 145 (223)
Q Consensus 142 ~~p~ 145 (223)
.-.+
T Consensus 209 l~tg 212 (317)
T cd07867 209 LLTS 212 (317)
T ss_pred HHhC
Confidence 4433
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=191.79 Aligned_cols=141 Identities=25% Similarity=0.317 Sum_probs=122.5
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
+|++|+++++++.+ +.+++||||+.+|+|.+.+..... +++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 136 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC
Confidence 68999999999865 578999999999999999876544 899999999999999999999999999999999999998
Q ss_pred CCCceEEccCcccccccc-ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 85 DHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
++ .+||+|||+++.... ........||+.|+|||.+.....+...|+|+++..+++.-.++.|.
T Consensus 137 ~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf 201 (323)
T cd05616 137 EG-HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201 (323)
T ss_pred CC-cEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCC
Confidence 87 899999999875332 22234557999999999999988899999999999988887777764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=188.08 Aligned_cols=155 Identities=28% Similarity=0.514 Sum_probs=128.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +.+++|+||+.+++|.+++... .+++.++..++.|++.||.|||+.|++|+||||+||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Ni 146 (296)
T cd06655 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNV 146 (296)
T ss_pred HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 567899999999999865 5789999999999999988653 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRP------------------------------------ 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------------------------------------ 123 (223)
+++.++ .+||+|||++....... ......++..|+|||.+..
T Consensus 147 li~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~ 225 (296)
T cd06655 147 LLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (296)
T ss_pred EECCCC-CEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999877 89999999987543222 1233468889999995431
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
.+..++..+.+++.+||..+|.+||++.+++++ .++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~--~~~~ 273 (296)
T cd06655 226 LIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH--PFLK 273 (296)
T ss_pred HHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC--hHhh
Confidence 123455678889999999999999999999876 4443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=191.73 Aligned_cols=145 Identities=25% Similarity=0.317 Sum_probs=122.1
Q ss_pred CCCCCC-CCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRH-RNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~H-pniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++.++| ++|+++++++.+ +..++||||+.||+|.+++..... +++..++.++.|++.||.|||++||+||||||+|
T Consensus 54 l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~N 131 (324)
T cd05587 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDN 131 (324)
T ss_pred HHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHH
Confidence 345555 568888888865 578999999999999999876544 8999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
|+++.++ .+||+|||+++.... ........||+.|+|||.+.....+...|+|+++..+++.-.++.|.
T Consensus 132 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf 201 (324)
T cd05587 132 VMLDAEG-HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201 (324)
T ss_pred eEEcCCC-CEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCC
Confidence 9999887 899999999874321 22233457999999999999888888999999999988887777764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=184.99 Aligned_cols=151 Identities=31% Similarity=0.593 Sum_probs=121.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++|+||+++.+++.+ +..++|+||+.+++|.+++.+... +++..+..++.|++.||+|||+.+++|+||+|+||
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 133 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNV 133 (265)
T ss_pred HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhE
Confidence 567899999999999965 578899999999999999976543 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc-------ccccccCCCccccccCCCCCCCC----------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESL-------TEMMTAETGTYRWMAPENMRPSA---------------------------- 125 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~---------------------------- 125 (223)
+++.++ .++|+|||++..... ........++..|+|||.+....
T Consensus 134 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 134 MLMPNG-IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred EECCCC-eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 999877 899999999874321 11122346888999999654222
Q ss_pred -------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 126 -------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 126 -------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
..++.++.+++.+||+.+|.+||++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 213 RLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 224455667777777777777777777654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=183.17 Aligned_cols=155 Identities=39% Similarity=0.757 Sum_probs=126.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ +..+++|||+++++|.+++.......+++..++.++.|++.||.|||+.+++|+||||+||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~ni 134 (258)
T smart00219 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNC 134 (258)
T ss_pred HHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceE
Confidence 567899999999999865 6789999999999999999765444489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccc--cCCCccccccCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMT--AETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
+++.++ .++|+|||++.......... ...+++.|++||.+..
T Consensus 135 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~ 213 (258)
T smart00219 135 LVGENL-VVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV 213 (258)
T ss_pred EEccCC-eEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999877 89999999997554332211 1236788999994421
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
.+...+.++.+++.+|+..+|.+||++.++++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 214 LEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1223567788889999999999999998887653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=183.81 Aligned_cols=152 Identities=28% Similarity=0.437 Sum_probs=122.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+.+ ...++++||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni 130 (256)
T cd06612 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNI 130 (256)
T ss_pred HHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence 567899999999999865 57899999999999999987533 4589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCCCCC--------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPSAEN-------------------------------- 127 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-------------------------------- 127 (223)
+++.++ .++|+|||++....... ......++..|++||.+.....+
T Consensus 131 ~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~ 209 (256)
T cd06612 131 LLNEEG-QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209 (256)
T ss_pred EECCCC-cEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh
Confidence 999887 79999999987654332 22334578899999965432222
Q ss_pred ---------------ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 128 ---------------LPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 128 ---------------~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
++.++.+++..||+.+|.+||++.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 210 MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 3345667777777777777777777764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=184.06 Aligned_cols=154 Identities=29% Similarity=0.475 Sum_probs=128.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++|+||+.+++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~ni 132 (256)
T cd08218 53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 132 (256)
T ss_pred HHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 678999999999999865 5789999999999999999765555589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc-cccCCCccccccCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMAPENMRP------------------------------------ 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~------------------------------------ 123 (223)
+++.++ .++|+|||++........ .....|++.|+|||.+..
T Consensus 133 l~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~ 211 (256)
T cd08218 133 FLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211 (256)
T ss_pred EEcCCC-CEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHH
Confidence 999877 799999999875433221 223457888999995431
Q ss_pred ---------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 ---------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 ---------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+++.+||+.+|.+||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 212 KIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 123456778899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=187.37 Aligned_cols=118 Identities=32% Similarity=0.486 Sum_probs=100.0
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++|+||+++++++.+ +..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~n 132 (298)
T cd07841 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNN 132 (298)
T ss_pred HHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhh
Confidence 3678899999999999975 5789999999 999999997654 359999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENM 121 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~ 121 (223)
|+++.++ .++|+|||++...... .......+++.|+|||.+
T Consensus 133 ill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 174 (298)
T cd07841 133 LLIASDG-VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL 174 (298)
T ss_pred EEEcCCC-CEEEccceeeeeccCCCccccccccceeeeCHHHH
Confidence 9999877 8999999999754432 222334567889999955
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=186.87 Aligned_cols=154 Identities=28% Similarity=0.458 Sum_probs=123.0
Q ss_pred CCCC-CCCCccceEEEee------cCceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 2 MSRV-RHRNLVKFIGACK------EPVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~------~~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
++++ +||||+++++.+. ++..++||||++|++|.+++... ....+++..+..++.|++.||.|||+.+++|
T Consensus 68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 147 (286)
T cd06638 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIH 147 (286)
T ss_pred HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 4456 6999999999873 23589999999999999987632 2245899999999999999999999999999
Q ss_pred CCCCCCCEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCC----------------------------
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRP---------------------------- 123 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~---------------------------- 123 (223)
|||||+||+++.++ .+||+|||++....... ......|++.|+|||.+..
T Consensus 148 ~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~ 226 (286)
T cd06638 148 RDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226 (286)
T ss_pred cCCCHHhEEECCCC-CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCC
Confidence 99999999999887 79999999987543221 2234468899999995420
Q ss_pred ------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 ------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 ------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+++.+||+.+|.+||++.+++++
T Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 227 PPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 011234568889999999999999999998865
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=186.64 Aligned_cols=151 Identities=27% Similarity=0.418 Sum_probs=123.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++.+.. +..++||||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus 46 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~N 125 (277)
T cd05577 46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPEN 125 (277)
T ss_pred HHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 3678899999999999865 678999999999999999987664569999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
|+++.++ .+||+|||++.............++..|++||.+...
T Consensus 126 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 204 (277)
T cd05577 126 VLLDDHG-NVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204 (277)
T ss_pred EEECCCC-CEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH
Confidence 9999877 8999999998754433333345678899999954311
Q ss_pred -------------CCCChHHHHHHHHHhcccCCCCCCCHHH
Q 027476 125 -------------AENLPEDLALIVTSCWKEDPNERPNFSQ 152 (223)
Q Consensus 125 -------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~ 152 (223)
+...+.++.+++.+||+.+|.+||++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 205 ELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 1234567788888899899999984433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=181.87 Aligned_cols=155 Identities=34% Similarity=0.615 Sum_probs=125.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ ...++|+||+.+++|.+++.... ..+++..++.++.+++.||.|||+++++||||||+||
T Consensus 46 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~ni 124 (251)
T cd05041 46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNC 124 (251)
T ss_pred HHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceE
Confidence 578899999999999865 57899999999999999987643 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccccc---ccCCCccccccCCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMM---TAETGTYRWMAPENMRP---------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~---------------------------------- 123 (223)
+++.++ .+||+|||++......... .....+..|+|||.+..
T Consensus 125 li~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~ 203 (251)
T cd05041 125 LVGENN-VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203 (251)
T ss_pred EEcCCC-cEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH
Confidence 999877 8999999998754321111 11223567999995421
Q ss_pred ------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 124 ------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 124 ------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
.+...+.++.+++.+||..+|.+||+++++++.|+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 204 TRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 12234567888999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=207.24 Aligned_cols=161 Identities=25% Similarity=0.363 Sum_probs=127.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR---------PRCLDIHVAIGFALDIARAMECLHSHGII 71 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~---------~~~l~~~~~~~i~~qi~~~l~~lH~~~iv 71 (223)
+++++||||+++++++.+ +..++||||++|++|.+++.... ...+++..++.++.|++.||+|||++||+
T Consensus 56 Ls~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GII 135 (932)
T PRK13184 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVL 135 (932)
T ss_pred HHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 567899999999999965 57899999999999999986421 12356778899999999999999999999
Q ss_pred cCCCCCCCEEEeCCCCceEEccCccccccccc-------------------cccccCCCccccccCCCCCCCCC------
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLT-------------------EMMTAETGTYRWMAPENMRPSAE------ 126 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~------ 126 (223)
||||||+||+++.++ .+||+|||+++..... .......||+.|+|||.+.....
T Consensus 136 HRDLKPeNILLd~dg-~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDI 214 (932)
T PRK13184 136 HRDLKPDNILLGLFG-EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI 214 (932)
T ss_pred ccCCchheEEEcCCC-CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHH
Confidence 999999999999887 7999999999754110 00112468999999995542211
Q ss_pred -----------------------------------------CChHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHhhc
Q 027476 127 -----------------------------------------NLPEDLALIVTSCWKEDPNERP-NFSQIIQMLLHYIST 163 (223)
Q Consensus 127 -----------------------------------------~~~~~l~~l~~~~l~~~p~~Rp-~~~~~~~~L~~~~~~ 163 (223)
.++..+.+++.+|++.+|.+|+ +++++.+.|+..+..
T Consensus 215 WSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 215 YALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred HHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 3455677888999999999996 667788888887654
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=186.55 Aligned_cols=154 Identities=32% Similarity=0.496 Sum_probs=126.1
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++||||+++++.+.+ +..++||||+.+++|.+++.+.. ..+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~n 133 (280)
T cd06611 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGN 133 (280)
T ss_pred HHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhh
Confidence 3578899999999999864 57899999999999999987643 349999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCC-----C------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMR-----P------------------------------ 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~------------------------------ 123 (223)
|+++.++ .++|+|||++....... ......+++.|++||.+. .
T Consensus 134 ili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 134 ILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred EEECCCC-CEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 9999877 89999999886543221 123346888999999542 0
Q ss_pred -----------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 -----------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 -----------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+++..||+.+|.+||++++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 213 PMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 012345678889999999999999999988765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=186.88 Aligned_cols=118 Identities=30% Similarity=0.398 Sum_probs=99.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+++++|..++.... .+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~ni 131 (286)
T cd07847 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENI 131 (286)
T ss_pred HHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhE
Confidence 567899999999999865 57889999999998888775533 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMR 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~ 122 (223)
+++.++ .+||+|||++....... ......++..|+|||.+.
T Consensus 132 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 173 (286)
T cd07847 132 LITKQG-QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173 (286)
T ss_pred EEcCCC-cEEECccccceecCCCcccccCcccccccCCHHHHh
Confidence 999887 89999999987544332 223345778899999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=200.72 Aligned_cols=121 Identities=22% Similarity=0.289 Sum_probs=97.0
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP---RCLDIHVAIGFALDIARAMECLHSHGIIHRDLK 76 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 76 (223)
+|++++||||+++++++.+ +..++|+|++ +++|.+++..... .......+..++.|++.||+|||++||+|||||
T Consensus 216 il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLK 294 (501)
T PHA03210 216 ALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK 294 (501)
T ss_pred HHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 3678899999999999975 5688999998 5678887754321 123466788899999999999999999999999
Q ss_pred CCCEEEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCC
Q 027476 77 PENLILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRP 123 (223)
Q Consensus 77 p~Nill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~ 123 (223)
|+|||++.++ .+||+|||+++...... ......||..|+|||.+..
T Consensus 295 P~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 342 (501)
T PHA03210 295 LENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342 (501)
T ss_pred HHHEEECCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC
Confidence 9999999887 79999999997654322 1224579999999996653
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=186.06 Aligned_cols=153 Identities=29% Similarity=0.472 Sum_probs=121.7
Q ss_pred CCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+. ++..++||||+.+++|..++.+.. ..+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Ni 141 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNV 141 (292)
T ss_pred HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceE
Confidence 56789999999999885 567899999999999998876533 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCC-----C------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRP-----S------------------------------ 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~------------------------------ 124 (223)
+++.++ .+||+|||++...... .......+++.|+|||.+.. .
T Consensus 142 li~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 220 (292)
T cd06644 142 LLTLDG-DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220 (292)
T ss_pred EEcCCC-CEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH
Confidence 999777 8999999988653221 12233467889999996521 1
Q ss_pred -----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++.+++.+||+.+|.+||++++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 221 MRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11233567778888888888888888877654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=195.55 Aligned_cols=118 Identities=36% Similarity=0.551 Sum_probs=97.5
Q ss_pred CCCCCCCCCccceEEEeecC------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 1 MMSRVRHRNLVKFIGACKEP------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+|+.++||||+++++++.++ ..++|+||+. ++|.+.+.... .+++..+..++.|++.||.|||++|++|||
T Consensus 52 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~d 128 (372)
T cd07853 52 MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRD 128 (372)
T ss_pred HHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 35678999999999998643 5789999995 68888876543 499999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCC
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMR 122 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~ 122 (223)
|||+||+++.++ .+||+|||+++...... ......+++.|+|||.+.
T Consensus 129 lkp~Nili~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 177 (372)
T cd07853 129 IKPGNLLVNSNC-VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177 (372)
T ss_pred CChHHEEECCCC-CEEeccccceeecccCccccCCCCCcCCCcCCHHHHc
Confidence 999999999887 89999999997543221 223346788999999553
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-27 Score=187.05 Aligned_cols=153 Identities=27% Similarity=0.454 Sum_probs=124.6
Q ss_pred CCC-CCCCccceEEEee-------cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 3 SRV-RHRNLVKFIGACK-------EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 3 ~~l-~Hpniv~l~~~~~-------~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+++ +|+||+++++++. +..++++|||+.+++|.+++.......+++..++.++.|++.||.|||+.|++|+|
T Consensus 67 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~d 146 (282)
T cd06636 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRD 146 (282)
T ss_pred HHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 445 7999999999883 24678999999999999999876656689999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCC-----C------------------------
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRP-----S------------------------ 124 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~------------------------ 124 (223)
|||+||+++.++ .++|+|||++...... .......|+..|+|||.+.. .
T Consensus 147 l~~~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p 225 (282)
T cd06636 147 IKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225 (282)
T ss_pred CCHHHEEECCCC-CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCC
Confidence 999999999877 7999999998754321 12234568899999996520 0
Q ss_pred ----------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++.+||+.+|.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 226 LCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 11245678899999999999999999988753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=181.29 Aligned_cols=154 Identities=31% Similarity=0.576 Sum_probs=120.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ ...++|+||+.+++|.+++.... ..++++.++.++.|++.||.|||+.+++|+||||+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni 131 (256)
T cd05112 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNC 131 (256)
T ss_pred HHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceE
Confidence 578899999999999865 57889999999999999987643 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCCCCCCC-------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMRPSAEN------------------------------- 127 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~------------------------------- 127 (223)
+++.++ .+||+|||++........ .....++..|+|||.+.....+
T Consensus 132 ~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05112 132 LVGENQ-VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210 (256)
T ss_pred EEcCCC-eEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 999776 899999999875432211 1122345689999965422222
Q ss_pred ---------------ChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 128 ---------------LPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 128 ---------------~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
.+..+.+++.+||+.+|.+||++.+++++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 211 VETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 345566777777777777777777777665
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=189.74 Aligned_cols=151 Identities=27% Similarity=0.452 Sum_probs=121.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++.+.+ +..++||||+.+++|.+++... .+++..++.++.|++.||.|||++|++||||||+||
T Consensus 73 l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni 149 (292)
T cd06658 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSI 149 (292)
T ss_pred HHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 567899999999998865 6789999999999999988542 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCCCC---------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPSAE--------------------------------- 126 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--------------------------------- 126 (223)
+++.++ .++|+|||++....... ......|+..|+|||.+.....
T Consensus 150 ll~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~ 228 (292)
T cd06658 150 LLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR 228 (292)
T ss_pred EEcCCC-CEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999877 89999999986432211 1233468889999996542222
Q ss_pred --------------CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 127 --------------NLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 127 --------------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..+..+.+++..||..+|.+||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 229 RIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 234556677788888888888888888764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=185.45 Aligned_cols=154 Identities=27% Similarity=0.465 Sum_probs=123.7
Q ss_pred CCCC-CCCCccceEEEeecC-------ceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 027476 2 MSRV-RHRNLVKFIGACKEP-------VMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDIARAMECLHSHGII 71 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~iv 71 (223)
++++ +|+||+++++++.+. .+++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+.+++
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~ 135 (275)
T cd06608 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVI 135 (275)
T ss_pred HHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 4556 799999999998542 3799999999999999987533 45699999999999999999999999999
Q ss_pred cCCCCCCCEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCC--------------------------
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPS-------------------------- 124 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-------------------------- 124 (223)
|+||+|+||+++.++ .+||+|||++...... .......++..|+|||.+...
T Consensus 136 H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g 214 (275)
T cd06608 136 HRDIKGQNILLTKNA-EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214 (275)
T ss_pred cCCCCHHHEEEccCC-eEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhC
Confidence 999999999999877 8999999998754322 122344688899999954210
Q ss_pred --------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 --------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 --------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++.+||..+|.+||++.+++++
T Consensus 215 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 215 KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11134567889999999999999999988753
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=183.90 Aligned_cols=154 Identities=28% Similarity=0.494 Sum_probs=122.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCL--DIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l--~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++|+||+++++++.+ +..++|+||+.+++|.+++.... ..+ ++..+..++.|++.||.|||++|++||||||+
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~ 137 (268)
T cd06624 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGD 137 (268)
T ss_pred HHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 567899999999999865 57889999999999999997642 224 88889999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC---------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
||+++.+...++|+|||++....... ......+++.|+|||.+...
T Consensus 138 nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~ 217 (268)
T cd06624 138 NVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP 217 (268)
T ss_pred HEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99998744489999999986543211 12234578899999954211
Q ss_pred ----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+...+.++.+++.+||+.+|.+||++.+++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 218 QAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 12244567788888888888888888888754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=188.99 Aligned_cols=117 Identities=29% Similarity=0.511 Sum_probs=97.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Ni 135 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL 135 (309)
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 567899999999999864 67899999996 58888876543 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENM 121 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~ 121 (223)
+++.++ .+||+|||+++...... ......+++.|+|||.+
T Consensus 136 ll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 176 (309)
T cd07872 136 LINERG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176 (309)
T ss_pred EECCCC-CEEECccccceecCCCccccccccccccccCCHHH
Confidence 999877 89999999987543222 22334678999999954
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=185.60 Aligned_cols=153 Identities=27% Similarity=0.515 Sum_probs=122.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ +.+++|+||+.+++|.+++.+... +++..++.++.|++.||.|||++|++|+||+|+||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~ni 134 (268)
T cd06630 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANL 134 (268)
T ss_pred HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 567899999999999975 578999999999999999976543 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-----ccccCCCccccccCCCCCCCC------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-----MMTAETGTYRWMAPENMRPSA------------------------------ 125 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------------------------------ 125 (223)
+++.++..+||+|||++....... ......++..|+|||.+....
T Consensus 135 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 214 (268)
T cd06630 135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS 214 (268)
T ss_pred EEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Confidence 998776569999999987543321 112346788999999543221
Q ss_pred -------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 -------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 -------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...+.++.+++.+|++.+|.+||++.+++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 215 NHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred chHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1234567777888888888888888777643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=176.12 Aligned_cols=158 Identities=23% Similarity=0.380 Sum_probs=131.2
Q ss_pred CCCCCCCccceEEEee----c--CceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Q 027476 3 SRVRHRNLVKFIGACK----E--PVMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDIARAMECLHSHG--IIH 72 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~----~--~~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH 72 (223)
++++||||++++++.. | ...|++++|...|||.+.+...+ +..+++.++++|+.++++||++||+.. +.|
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH 152 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAH 152 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccc
Confidence 6789999999998872 2 24899999999999999997543 346999999999999999999999998 999
Q ss_pred CCCCCCCEEEeCCCCceEEccCcccccccccc----------ccccCCCccccccCCCCC--------------------
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESLTE----------MMTAETGTYRWMAPENMR-------------------- 122 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~----------~~~~~~gt~~y~aPE~~~-------------------- 122 (223)
|||||.||++...+ .++|.|||.+....... .......|..|+|||.+.
T Consensus 153 ~DiKP~NILls~~~-~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL 231 (302)
T KOG2345|consen 153 RDIKPANILLSDSG-LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL 231 (302)
T ss_pred cCCCcceeEecCCC-ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence 99999999999766 89999999987532211 112235789999999432
Q ss_pred -------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 123 -------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 123 -------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
+....++..+.+++..|++.+|.+||++.+++..+.+++
T Consensus 232 Ya~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 232 YAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 233458889999999999999999999999999988764
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=182.60 Aligned_cols=155 Identities=28% Similarity=0.505 Sum_probs=128.7
Q ss_pred CCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCC
Q 027476 3 SRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPE 78 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~ 78 (223)
+.++||||+++++++.+ +..++||||++|++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|.
T Consensus 64 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ 143 (269)
T cd08528 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN 143 (269)
T ss_pred hcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHH
Confidence 35799999999998865 6789999999999999988542 23458999999999999999999996 78999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
||+++.++ .+||+|||.+.............++..|++||.+...
T Consensus 144 nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~ 222 (269)
T cd08528 144 NIMLGEDD-KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA 222 (269)
T ss_pred HEEECCCC-cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH
Confidence 99999887 8999999999865544334455788899999954311
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
...++.++.+++.+||+.+|.+||++.++..++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 223 TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1135678889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=181.61 Aligned_cols=151 Identities=29% Similarity=0.554 Sum_probs=122.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ +.+++++||+++++|.+++.+... +++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni 133 (258)
T cd06632 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANI 133 (258)
T ss_pred HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 577899999999999865 578999999999999999976543 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS------------------------------------ 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------------------------ 124 (223)
+++.++ .+||+|||++.............++..|++||.+...
T Consensus 134 ~~~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~ 212 (258)
T cd06632 134 LVDTNG-VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF 212 (258)
T ss_pred EECCCC-CEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH
Confidence 999877 8999999998764433333455688899999954322
Q ss_pred -----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 125 -----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 125 -----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
+..++.++.+++.+||+.+|.+||++++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 213 KIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1233455667777777777777777777764
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=189.52 Aligned_cols=141 Identities=23% Similarity=0.312 Sum_probs=120.9
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
+|++|+++++++.+ +.+++||||++||+|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 56888899998865 578999999999999999876544 999999999999999999999999999999999999998
Q ss_pred CCCceEEccCccccccccc-cccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 85 DHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
++ .+||+|||+++..... .......||+.|+|||.+.....+...|+|+++..+++.-.++.|.
T Consensus 137 ~~-~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf 201 (323)
T cd05615 137 EG-HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201 (323)
T ss_pred CC-CEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCC
Confidence 87 7999999998753222 2223456899999999999888888999999999888887777664
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=185.24 Aligned_cols=151 Identities=29% Similarity=0.471 Sum_probs=125.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+.+ +..++|+||+.+++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni 132 (277)
T cd06642 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANV 132 (277)
T ss_pred HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheE
Confidence 578899999999999865 578999999999999998864 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPSA---------------------------------- 125 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---------------------------------- 125 (223)
+++.++ .++|+|||++....... ......++..|+|||.+....
T Consensus 133 ~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06642 133 LLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF 211 (277)
T ss_pred EEeCCC-CEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh
Confidence 999877 89999999987544322 122345788999999543211
Q ss_pred -----------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 -----------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 -----------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...+.++.+++.+||+.+|.+||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 212 LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred hhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1245667889999999999999999999875
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=185.52 Aligned_cols=119 Identities=21% Similarity=0.379 Sum_probs=100.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++|+||+++++.+.+ +.+++||||+.+|+|.+++.+.. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Ni 133 (332)
T cd05623 55 LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133 (332)
T ss_pred HhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence 467899999999999875 57899999999999999997633 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMR 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~ 122 (223)
+++.++ .+||+|||++....... ......||+.|+|||++.
T Consensus 134 li~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 134 LMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred EECCCC-CEEEeecchheecccCCcceecccccCccccCHHHHh
Confidence 999877 89999999987532221 123357999999999653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=182.84 Aligned_cols=154 Identities=26% Similarity=0.468 Sum_probs=126.9
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCcc
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLH-----SHGII 71 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH-----~~~iv 71 (223)
+++++||||+++++.+.. ...++++||+.+++|.+++... ....+++..++.++.|++.||.||| +.+++
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~ 132 (265)
T cd08217 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVL 132 (265)
T ss_pred HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcce
Confidence 578899999999997742 3578999999999999998753 2345899999999999999999999 88999
Q ss_pred cCCCCCCCEEEeCCCCceEEccCccccccccccc-cccCCCccccccCCCCCCC--------------------------
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMAPENMRPS-------------------------- 124 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~-------------------------- 124 (223)
|+||||+||+++.++ .+||+|||++........ .....+++.|++||.+...
T Consensus 133 h~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 211 (265)
T cd08217 133 HRDLKPANIFLDANN-NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211 (265)
T ss_pred ecCCCHHHEEEecCC-CEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCccc
Confidence 999999999999877 899999999886544332 3345689999999955321
Q ss_pred -------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+...+.++.+++.+|++.+|.+||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 212 ARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 23455778889999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=185.50 Aligned_cols=147 Identities=28% Similarity=0.497 Sum_probs=119.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++.+.. +..++|+||+++++|..+. .+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 126 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNM 126 (279)
T ss_pred HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHE
Confidence 577899999999998864 6788999999999997642 278999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAE---------------------------------- 126 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---------------------------------- 126 (223)
+++.++ .++|+|||++...... ......++..|+|||.+.....
T Consensus 127 ll~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~ 204 (279)
T cd06619 127 LVNTRG-QVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM 204 (279)
T ss_pred EECCCC-CEEEeeCCcceecccc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc
Confidence 999887 8999999998754322 2344578999999996542211
Q ss_pred -------------------CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 127 -------------------NLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 127 -------------------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..+.++.+++.+|++.+|.+||++++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 205 PLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred hHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 234567778888888888888888887765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=192.47 Aligned_cols=115 Identities=30% Similarity=0.505 Sum_probs=97.1
Q ss_pred CCCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 1 MMSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
+|++++||||+++++++.. ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 142 (343)
T cd07878 67 LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHR 142 (343)
T ss_pred HHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 3678899999999998742 2468999988 8899988754 239999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
||||+||+++.++ .+||+|||+++..... .....|++.|+|||.+.
T Consensus 143 dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~ 188 (343)
T cd07878 143 DLKPSNVAVNEDC-ELRILDFGLARQADDE--MTGYVATRWYRAPEIML 188 (343)
T ss_pred cCChhhEEECCCC-CEEEcCCccceecCCC--cCCccccccccCchHhc
Confidence 9999999999887 8999999999864332 23457899999999664
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=184.92 Aligned_cols=149 Identities=23% Similarity=0.332 Sum_probs=120.4
Q ss_pred CCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q 027476 4 RVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL 82 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill 82 (223)
..+||||+.+++.+. ++..++||||+.+++|.+++...+. +++..+..++.|++.||+|||+.+++|+||||+||++
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~ 130 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL 130 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE
Confidence 357999999999886 4678999999999999999876544 9999999999999999999999999999999999999
Q ss_pred eCCCCceEEccCccccccccccccccCCCccccccCCCCCC-C-------------------------------------
Q 027476 83 TADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP-S------------------------------------- 124 (223)
Q Consensus 83 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~------------------------------------- 124 (223)
+.++ .++|+|||++....... .....|+..|+|||.+.. .
T Consensus 131 ~~~~-~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 208 (279)
T cd05633 131 DEHG-HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208 (279)
T ss_pred CCCC-CEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH
Confidence 9877 89999999987543222 233468999999996531 1
Q ss_pred ----------CCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 125 ----------AENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 125 ----------~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
+..++.++.+++..||..+|.+|| ++++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 209 RMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 123455677788888888888888 47776654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=186.71 Aligned_cols=155 Identities=28% Similarity=0.450 Sum_probs=124.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||+++++.+.+ +..++||||++|++|.+++...+ .+++..+..++.|++.||.|||+.+++||||||+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NI 132 (305)
T cd05609 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNL 132 (305)
T ss_pred HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHE
Confidence 567899999999999865 56889999999999999997654 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc----------------ccccCCCccccccCCCCCCC--------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE----------------MMTAETGTYRWMAPENMRPS-------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~-------------------- 124 (223)
+++.++ .+||+|||+++...... ......++..|+|||.+...
T Consensus 133 ll~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~ 211 (305)
T cd05609 133 LITSMG-HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV 211 (305)
T ss_pred EECCCC-CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHh
Confidence 999877 89999999886311000 01123577889999954311
Q ss_pred ---------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 125 ---------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 125 ---------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
...++.++.+++.+||+.+|.+||+..++.+.|+.
T Consensus 212 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 212 GCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11356778899999999999999987666555555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=184.37 Aligned_cols=117 Identities=32% Similarity=0.496 Sum_probs=100.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++|+||+ +++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 130 (286)
T cd07832 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANL 130 (286)
T ss_pred HHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHE
Confidence 567899999999999875 5788999999 999999987543 4599999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENM 121 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~ 121 (223)
+++.++ .++|+|||++....... ......++..|+|||.+
T Consensus 131 ~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 172 (286)
T cd07832 131 LISADG-VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172 (286)
T ss_pred EEcCCC-cEEEeeeeecccccCCCCCccccccCcccccCceee
Confidence 999877 79999999987654332 23345688999999965
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=186.92 Aligned_cols=151 Identities=28% Similarity=0.496 Sum_probs=124.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++|+||+++++.+.+ +..++||||+++++|.+++.+. .+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Ni 146 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNI 146 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 567899999999999865 5789999999999999998652 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .++|+|||++....... ......+++.|+|||.+...
T Consensus 147 li~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~ 225 (297)
T cd06656 147 LLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (297)
T ss_pred EECCCC-CEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee
Confidence 999877 89999999987543222 12234678899999943211
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+...+..+.+++.+||+.+|.+||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 226 LIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred eeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12345667889999999999999999998875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=183.10 Aligned_cols=151 Identities=29% Similarity=0.417 Sum_probs=122.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+.+ ...++|+||+.+++|.+++.+... +++..+..++.|++.||.|+|+++++|+||+|+||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~ni 124 (262)
T cd05572 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENL 124 (262)
T ss_pred HHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHE
Confidence 567899999999999865 578999999999999999976544 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA----------------------------------- 125 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------------------- 125 (223)
+++.++ .++|+|||++.............++..|++||.+....
T Consensus 125 lv~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 203 (262)
T cd05572 125 LLDSNG-YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY 203 (262)
T ss_pred EEcCCC-CEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH
Confidence 999887 89999999998655433333456888999999543211
Q ss_pred -------------CCChHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 027476 126 -------------ENLPEDLALIVTSCWKEDPNERPN-----FSQIIQ 155 (223)
Q Consensus 126 -------------~~~~~~l~~l~~~~l~~~p~~Rp~-----~~~~~~ 155 (223)
...+.++.+++.+||+.+|.+||+ ++++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 204 NDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 123456777888888888888887 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=182.86 Aligned_cols=151 Identities=29% Similarity=0.474 Sum_probs=124.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.|++|.+++... .+++..+..++.|++.||+|||+.+++|+||+|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Ni 132 (277)
T cd06640 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANV 132 (277)
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhE
Confidence 567899999999999865 5789999999999999998652 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc-cccCCCccccccCCCCCCCCC---------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMAPENMRPSAE--------------------------------- 126 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~--------------------------------- 126 (223)
+++.++ .++|+|||++........ .....++..|+|||.+.....
T Consensus 133 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06640 133 LLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211 (277)
T ss_pred EEcCCC-CEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh
Confidence 999877 899999999875433221 223457888999996532111
Q ss_pred ------------CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 127 ------------NLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 127 ------------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.++.++.+++..||+.+|.+||++++++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 212 LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 234567788899999999999999999766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=181.87 Aligned_cols=155 Identities=26% Similarity=0.494 Sum_probs=126.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++.+.+ +..++|+||+.+++|.+++.+.....+++..+..++.|++.||.|||+.+++|+||||+||
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni 132 (257)
T cd08225 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNI 132 (257)
T ss_pred HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence 577899999999999865 5789999999999999999875555689999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++..+||+|||.+....... ......|++.|+|||.+...
T Consensus 133 l~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 212 (257)
T cd08225 133 FLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212 (257)
T ss_pred EEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 999876567999999987543322 12234688899999954321
Q ss_pred ----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....+.++.+++.+||+.+|.+||++.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 213 KICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 12345677888889999999999998888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=183.31 Aligned_cols=144 Identities=25% Similarity=0.424 Sum_probs=113.0
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++||||+++++++.+ +..++++||+.+++|.+++..... +++..++.++.|++.||+|||+.+++|+||||+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~ 135 (266)
T cd06651 58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGA 135 (266)
T ss_pred HHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 567899999999998854 457899999999999999976544 899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccc----cccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCC
Q 027476 79 NLILTADHKTVKLADFGLAREESLT----EMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERP 148 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp 148 (223)
||+++.++ .+||+|||+++..... .......++..|+|||.+.....+...|+|+++..+++.-.++.|
T Consensus 136 nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~p 208 (266)
T cd06651 136 NILRDSAG-NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208 (266)
T ss_pred HEEECCCC-CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCC
Confidence 99999877 7999999998743221 111234578899999987655555555666655555544444433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=191.68 Aligned_cols=146 Identities=21% Similarity=0.321 Sum_probs=121.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ +.+++||||+.|++|.+++.+.. ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 133 (331)
T cd05597 55 LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV 133 (331)
T ss_pred HHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHE
Confidence 456799999999999875 57899999999999999997532 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCCC-----CCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMRP-----SAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+++.++ .+||+|||++........ .....||+.|+|||++.. ...+...|+|+++..+++.--++.|.
T Consensus 134 ll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf 208 (331)
T cd05597 134 LLDKNG-HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208 (331)
T ss_pred EECCCC-CEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCC
Confidence 999887 899999999875432221 123468999999999863 33456789999998888877776664
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=200.61 Aligned_cols=150 Identities=27% Similarity=0.462 Sum_probs=130.6
Q ss_pred CCCCCccceEEEe------ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 5 VRHRNLVKFIGAC------KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 5 l~Hpniv~l~~~~------~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
-+|||++.++|+| .++.+|+|||||.|||..++++...+..+.|..+.-|+++++.|+.+||.+.++|||||-.
T Consensus 73 ~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~ 152 (953)
T KOG0587|consen 73 SHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQ 152 (953)
T ss_pred cCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCc
Confidence 3799999999987 3457999999999999999999877778999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCC-----------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
|||++.++ .|||.|||++.+...+. ...+..||+.|||||++.
T Consensus 153 NiLLT~e~-~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 153 NVLLTENA-EVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred eEEEeccC-cEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 99999988 79999999988655433 345678999999999664
Q ss_pred -----------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 123 -----------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 123 -----------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
..+..++.++.++|..|+.++..+||++.++++
T Consensus 232 HPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 232 HPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred chhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 113446677889999999999999999988864
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=187.71 Aligned_cols=151 Identities=27% Similarity=0.446 Sum_probs=123.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.. +..++|+||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Ni 148 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSI 148 (297)
T ss_pred HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHe
Confidence 567899999999998864 678999999999999998754 2389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPSA---------------------------------- 125 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---------------------------------- 125 (223)
+++.++ .+||+|||++....... ......++..|+|||.+....
T Consensus 149 ll~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 227 (297)
T cd06659 149 LLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 227 (297)
T ss_pred EEccCC-cEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999887 89999999986433221 223456889999999654211
Q ss_pred -------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 -------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 -------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...+.++.+++..||+.+|.+||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 228 RLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1345567788888999999999998888875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=181.78 Aligned_cols=157 Identities=29% Similarity=0.616 Sum_probs=127.4
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++||||+++++++.+ ...++||||+++++|.+++..... .+++..++.++.|++.||+|||+.|++|+||||+
T Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ 138 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAAR 138 (284)
T ss_pred HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 578899999999998864 368899999999999999976542 4899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccc----cccCCCccccccCCCCCCC------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMRPS------------------------------ 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~------------------------------ 124 (223)
||+++.++ .++|+|||.+........ .....++..|++||.+...
T Consensus 139 nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 217 (284)
T cd05038 139 NILVESED-LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA 217 (284)
T ss_pred hEEEcCCC-CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccc
Confidence 99999887 899999999976542211 1122345568899833200
Q ss_pred ------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 125 ------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 125 ------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
+..++..+.+++.+||+.+|.+||++.+++++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 218 EFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred hhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 123456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=186.97 Aligned_cols=154 Identities=26% Similarity=0.424 Sum_probs=124.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++.+.+ ...++||||+.|++|.+++.......+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 134 (316)
T cd05574 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENI 134 (316)
T ss_pred HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHe
Confidence 567899999999999865 5689999999999999999865555699999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc------------------------------ccccCCCccccccCCCCCCC------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE------------------------------MMTAETGTYRWMAPENMRPS------ 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~------ 124 (223)
+++.++ .++|+|||++....... ......|+..|+|||.+...
T Consensus 135 li~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 213 (316)
T cd05574 135 LLHESG-HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV 213 (316)
T ss_pred EEcCCC-CEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchH
Confidence 999877 79999999886432111 01123578899999954211
Q ss_pred ----------------------------------------CCCChHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 027476 125 ----------------------------------------AENLPEDLALIVTSCWKEDPNERPN----FSQIIQM 156 (223)
Q Consensus 125 ----------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~----~~~~~~~ 156 (223)
....+.++.+++.+||+.+|.+||+ +++++.+
T Consensus 214 Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 214 DWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 1124677889999999999999999 5665553
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=183.96 Aligned_cols=154 Identities=28% Similarity=0.460 Sum_probs=121.1
Q ss_pred CCCC-CCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 2 MSRV-RHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
++++ +||||+++++++.. +.+++|+||+.|++|.+++... ....+++..++.++.|++.||+|||+.+++|
T Consensus 72 l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH 151 (291)
T cd06639 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIH 151 (291)
T ss_pred HHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3455 79999999998853 2479999999999999988642 2345899999999999999999999999999
Q ss_pred CCCCCCCEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC---------------------------
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS--------------------------- 124 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~--------------------------- 124 (223)
+||||+||+++.++ .+||+|||++....... ......|+..|+|||.+...
T Consensus 152 ~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~ 230 (291)
T cd06639 152 RDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230 (291)
T ss_pred cCCCHHHEEEcCCC-CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCC
Confidence 99999999999877 79999999987543322 22344688899999964210
Q ss_pred -------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 231 PPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11233456778888888888888888888764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=182.41 Aligned_cols=151 Identities=30% Similarity=0.478 Sum_probs=126.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++.+++.+ ...++|+||+.+++|.+++... .+++..++.++.|++.||.|||+.+++|+||+|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 129 (274)
T cd06609 53 LSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANI 129 (274)
T ss_pred HHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 567899999999998864 5788999999999999998764 489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .++|+|||+++..... .......++..|++||.+...
T Consensus 130 ~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~ 208 (274)
T cd06609 130 LLSEEG-DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF 208 (274)
T ss_pred EECCCC-CEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 999877 7999999999765433 222345688899999954311
Q ss_pred ----------CC-CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------AE-NLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------~~-~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.. .++.++.+++.+||..+|.+||++++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 209 LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01 156778899999999999999999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=181.28 Aligned_cols=152 Identities=27% Similarity=0.507 Sum_probs=122.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++|+||+.+++|.+++.+.. .+++..+..++.|++.||.|||+.+++|+||+|+||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~ni 139 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNL 139 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhE
Confidence 578899999999999875 57889999999999999997754 489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCCCC--------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRPSA-------------------------------- 125 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-------------------------------- 125 (223)
+++.++ .++|+|||+++...... ......++..|+|||.+....
T Consensus 140 l~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 218 (272)
T cd06629 140 LVDADG-ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218 (272)
T ss_pred EEcCCC-eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH
Confidence 999877 89999999987543211 122345788999999543111
Q ss_pred --------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 --------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 --------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++..||..+|.+||++++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 219 AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1234567778888888888888888887654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=183.92 Aligned_cols=119 Identities=29% Similarity=0.513 Sum_probs=100.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+. ++|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~ni 131 (284)
T cd07860 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 131 (284)
T ss_pred HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 578899999999999865 57899999995 6899988765556699999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 122 (223)
+++.++ .+||+|||++...... .......++..|+|||.+.
T Consensus 132 ll~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 173 (284)
T cd07860 132 LINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173 (284)
T ss_pred EECCCC-CEEEeeccchhhcccCccccccccccccccCCeEEe
Confidence 999887 8999999998754322 1223345688999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=189.60 Aligned_cols=114 Identities=34% Similarity=0.487 Sum_probs=95.9
Q ss_pred CCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+++++||||++++++|.. ...++||||+. ++|.+.+... +++..+..++.|++.||+|||++|++|||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~d 143 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRD 143 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence 567899999999998842 24689999994 6888887542 88999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCC
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 121 (223)
|||+||+++.++ .+||+|||+++............++..|+|||.+
T Consensus 144 lkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 189 (353)
T cd07850 144 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 189 (353)
T ss_pred CCHHHEEECCCC-CEEEccCccceeCCCCCCCCCCcccccccCHHHH
Confidence 999999999887 7999999999865443333445678899999954
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=184.90 Aligned_cols=138 Identities=25% Similarity=0.408 Sum_probs=106.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++|+||+. ++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~ni 130 (284)
T cd07839 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNL 130 (284)
T ss_pred HHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 567899999999999865 57899999995 68888776533 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCC-CCCChHHHHHHHHHhccc
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPS-AENLPEDLALIVTSCWKE 142 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~l~~l~~~~l~~ 142 (223)
+++.++ .+||+|||+++..... .......++..|+|||.+.+. ..+...|+|+++..+++.
T Consensus 131 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 193 (284)
T cd07839 131 LINKNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193 (284)
T ss_pred EEcCCC-cEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHH
Confidence 999887 8999999998754322 122334678899999976432 223444454444444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-27 Score=191.55 Aligned_cols=146 Identities=20% Similarity=0.302 Sum_probs=120.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++.+.+ +..++||||+.||+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 55 l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Ni 133 (331)
T cd05624 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133 (331)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHE
Confidence 456799999999999975 57899999999999999997633 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCCC-----CCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMRP-----SAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+++.++ .+||+|||++........ .....|++.|+|||.+.. ...+...|+|+++..+++.-.++.|.
T Consensus 134 ll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf 208 (331)
T cd05624 134 LLDMNG-HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208 (331)
T ss_pred EEcCCC-CEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCc
Confidence 999877 799999999875433221 123569999999998865 34556778998888777766666553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-27 Score=179.35 Aligned_cols=151 Identities=25% Similarity=0.461 Sum_probs=127.6
Q ss_pred CCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCE
Q 027476 3 SRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPENL 80 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Ni 80 (223)
+.-+.|+||+.+|+|. +...++.||.| ...++.+++.- .+.+++..+-++...+++||.||.+ ++|+|||+||+||
T Consensus 146 ~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNI 223 (391)
T KOG0983|consen 146 KSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 223 (391)
T ss_pred hccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccce
Confidence 3446899999999995 56788999998 56666666553 3459999999999999999999986 5899999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCC--------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR-------------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-------------------------------------- 122 (223)
|+|..| .+|++|||++.........+...|.+.|||||.+.
T Consensus 224 LlDe~G-niKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe 302 (391)
T KOG0983|consen 224 LLDERG-NIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE 302 (391)
T ss_pred EEccCC-CEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH
Confidence 999888 89999999998877777777789999999999553
Q ss_pred -------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 -------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 -------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+....++.++.+++..||.+|+.+||...+++++
T Consensus 303 ~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 303 VLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1123478899999999999999999999999876
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=183.41 Aligned_cols=153 Identities=25% Similarity=0.487 Sum_probs=124.7
Q ss_pred CCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMR-PRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~ 78 (223)
+++++||||+++++.+. ++..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~ 132 (286)
T cd06622 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPT 132 (286)
T ss_pred HHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHH
Confidence 56789999999999886 467899999999999999887532 2358999999999999999999997 59999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
||+++.++ .+||+|||++...... ......++..|+|||.+...
T Consensus 133 nil~~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 133 NVLVNGNG-QVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred HEEECCCC-CEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 99999876 8999999998754322 22344678899999965210
Q ss_pred --------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 --------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 --------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++.+++.+||+.+|.+||++++++.+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 211 TYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred chhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 12245667888999999999999999988875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-26 Score=182.17 Aligned_cols=151 Identities=27% Similarity=0.462 Sum_probs=122.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.. +..++|+||+.|++|.+++.. ..+++..++.++.|++.||+|||++|++||||+|+||
T Consensus 70 l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Ni 146 (285)
T cd06648 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSI 146 (285)
T ss_pred HHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhE
Confidence 567899999999998864 678999999999999999876 2389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCCCC---------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPSAE--------------------------------- 126 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--------------------------------- 126 (223)
+++.++ .++|+|||.+....... ......|++.|+|||.+.....
T Consensus 147 l~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~ 225 (285)
T cd06648 147 LLTSDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK 225 (285)
T ss_pred EEcCCC-cEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH
Confidence 999877 89999999876433221 1223468899999996532211
Q ss_pred --------------CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 127 --------------NLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 127 --------------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.++.++.+++.+||+.+|.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 226 RIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 145677788888888888888888888754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=183.93 Aligned_cols=117 Identities=29% Similarity=0.526 Sum_probs=97.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Ni 135 (301)
T cd07873 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL 135 (301)
T ss_pred HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHE
Confidence 578899999999999965 57899999996 69999887643 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENM 121 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~ 121 (223)
+++.++ .+||+|||++....... ......+++.|+|||.+
T Consensus 136 l~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~ 176 (301)
T cd07873 136 LINERG-ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL 176 (301)
T ss_pred EECCCC-cEEECcCcchhccCCCCCcccccceeecccCcHHH
Confidence 999887 89999999987543221 22334568899999943
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-26 Score=182.06 Aligned_cols=143 Identities=29% Similarity=0.381 Sum_probs=125.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|.||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~ni 132 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENL 132 (290)
T ss_pred HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 678899999999999875 57889999999999999997754 499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+++.++ .+||+|||++...... .....+++.|+|||.+.....+...|+|+++..+++.-.++.|.
T Consensus 133 li~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 198 (290)
T cd05580 133 LLDSDG-YIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198 (290)
T ss_pred EECCCC-CEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 999887 8999999998765433 23456889999999998887888899999998888877777663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=181.46 Aligned_cols=120 Identities=30% Similarity=0.449 Sum_probs=98.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+. ++|.+++.......+++..++.++.||+.||+|||+++++|+||+|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~ni 133 (294)
T PLN00009 55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNL 133 (294)
T ss_pred HHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceE
Confidence 578899999999999965 57899999995 6888888765554578899999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 122 (223)
+++.++..+||+|||++...... .......+++.|+|||.+.
T Consensus 134 ll~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 176 (294)
T PLN00009 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176 (294)
T ss_pred EEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHh
Confidence 99865557999999999754322 1223346788999999653
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=178.84 Aligned_cols=133 Identities=20% Similarity=0.303 Sum_probs=109.3
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
+||||+++++.+.+ +..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~ 144 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC
Confidence 79999999999864 67899999999999999998754 4999999999999999999999999999999999999997
Q ss_pred CCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccC
Q 027476 85 DHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKED 143 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~ 143 (223)
++..++|+|||++...... ....++..|+|||++.....+...|+|+++..+++.-
T Consensus 145 ~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 200 (267)
T PHA03390 145 AKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELL 200 (267)
T ss_pred CCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 7657999999998754322 2346889999999876555555556666555444333
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-26 Score=179.58 Aligned_cols=147 Identities=26% Similarity=0.359 Sum_probs=119.8
Q ss_pred CCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 3 SRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+.++|+||+++++.+.+ +..++|+||+.+++|.+++..... +++..+..++.|++.||.|||+.+++|+||+|+||+
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil 129 (260)
T cd05611 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLL 129 (260)
T ss_pred hcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 45689999999999975 578999999999999999976544 899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCC------------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA------------------------------------ 125 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------------------------ 125 (223)
++.++ .+||+|||+++.... .....++..|++||.+....
T Consensus 130 ~~~~~-~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 205 (260)
T cd05611 130 IDQTG-HLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205 (260)
T ss_pred ECCCC-cEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99877 799999999875432 23346788999999543211
Q ss_pred ------------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 126 ------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 126 ------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
..++.++.+++.+||+.+|.+||++.++.+
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 206 LSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred HhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 135667788888888888888886644433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-26 Score=182.59 Aligned_cols=118 Identities=27% Similarity=0.367 Sum_probs=99.0
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++||||+++++++.+ +..++|+||+. ++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~ 135 (293)
T cd07843 58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTS 135 (293)
T ss_pred HHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHH
Confidence 567899999999998853 57899999996 59999887643 35899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC
Q 027476 79 NLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 122 (223)
||+++.++ .+||+|||++...... .......+++.|+|||.+.
T Consensus 136 nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 179 (293)
T cd07843 136 NLLLNNRG-ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLL 179 (293)
T ss_pred HEEECCCC-cEEEeecCceeeccCCccccccccccccccCchhhc
Confidence 99999877 8999999998865433 2223445788999999664
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=178.11 Aligned_cols=151 Identities=34% Similarity=0.562 Sum_probs=121.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ +..++|+||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 53 ~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~ni 130 (264)
T cd06626 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANI 130 (264)
T ss_pred HHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 567899999999999865 57899999999999999997643 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc-----cccCCCccccccCCCCCCCC---C--------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM-----MTAETGTYRWMAPENMRPSA---E-------------------------- 126 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~---~-------------------------- 126 (223)
+++.++ .+||+|||++........ .....++..|++||.+.... .
T Consensus 131 l~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 131 FLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred EECCCC-CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 999877 899999999875433221 12346788999999654221 1
Q ss_pred ----------------------CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 127 ----------------------NLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 127 ----------------------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
.++..+.+++..||+.+|.+||++++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 210 DNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 12456677888888888888888877754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=179.85 Aligned_cols=121 Identities=35% Similarity=0.540 Sum_probs=100.2
Q ss_pred CCCCCCCccceEEEeecC-c-----eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 027476 3 SRVRHRNLVKFIGACKEP-V-----MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLK 76 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~-~-----~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 76 (223)
++++||||+++++++.+. . .+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.+++|+||+
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~ 134 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLK 134 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence 456799999999998643 3 889999995 589998876554459999999999999999999999999999999
Q ss_pred CCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCC
Q 027476 77 PENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA 125 (223)
Q Consensus 77 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 125 (223)
|+||+++.++ .+||+|||++.............++..|+|||.+....
T Consensus 135 ~~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~ 182 (287)
T cd07838 135 PQNILVTSDG-QVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS 182 (287)
T ss_pred hhhEEEccCC-CEEEeccCcceeccCCcccccccccccccChHHhccCC
Confidence 9999999887 89999999987654443333445788999999665433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=195.21 Aligned_cols=155 Identities=34% Similarity=0.596 Sum_probs=134.6
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
|-+|+|||+++|||+..+....||+|.++.|+|.+.+.+.....+-......++.||+.||.||.++++|||||...|++
T Consensus 165 M~~L~H~hliRLyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNll 244 (1039)
T KOG0199|consen 165 MLKLQHPHLIRLYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLL 244 (1039)
T ss_pred HHhccCcceeEEeeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhe
Confidence 66899999999999999988999999999999999998855567889999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccccccC----CCccccccCCCCC-----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEMMTAE----TGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~----~gt~~y~aPE~~~----------------------------------- 122 (223)
+-... .|||+|||+.+.....+..... .-...|+|||.++
T Consensus 245 laspr-tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q 323 (1039)
T KOG0199|consen 245 LASPR-TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ 323 (1039)
T ss_pred ecccc-eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH
Confidence 98766 8999999999976544332222 2346899999553
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
+.+..|+.||++++..||..+|.+||++..+.+.+
T Consensus 324 IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 324 ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 45778999999999999999999999999997543
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=181.62 Aligned_cols=150 Identities=29% Similarity=0.440 Sum_probs=123.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+.+ ...++|+||+.|++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni 131 (258)
T cd05578 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNI 131 (258)
T ss_pred HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence 578999999999998865 57899999999999999997753 489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS------------------------------------ 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------------------------ 124 (223)
+++.++ .++|+|||++.............|+..|+|||.+...
T Consensus 132 l~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 210 (258)
T cd05578 132 LLDEQG-HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210 (258)
T ss_pred EEcCCC-CEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH
Confidence 999887 7999999998765444333455688899999954311
Q ss_pred -----------CCCChHHHHHHHHHhcccCCCCCCCH--HHHH
Q 027476 125 -----------AENLPEDLALIVTSCWKEDPNERPNF--SQII 154 (223)
Q Consensus 125 -----------~~~~~~~l~~l~~~~l~~~p~~Rp~~--~~~~ 154 (223)
+...+.++.+++.+||+.+|.+||+. .++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 211 RAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 22355678888888888888888887 4443
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=179.06 Aligned_cols=154 Identities=30% Similarity=0.509 Sum_probs=126.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|+.++|+||+++++.+.+ +..++|+|++.+++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~n 132 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGN 132 (267)
T ss_pred HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence 567899999999998864 678999999999999999976543 568999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccc-----cccCCCccccccCCCCCCC-C----------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEM-----MTAETGTYRWMAPENMRPS-A---------------------------- 125 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~---------------------------- 125 (223)
|+++.++ .++|+|||++........ .....|+..|++||.+... .
T Consensus 133 i~~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 133 ILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred EEEcCCC-CEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 9999877 799999999875433221 1334688899999954311 0
Q ss_pred ----------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ----------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ----------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++..||+.+|.+||++++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 212 PMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred hhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1345677889999999999999998888764
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=177.38 Aligned_cols=159 Identities=30% Similarity=0.540 Sum_probs=125.2
Q ss_pred CCCCCCCCCccceEEEeecC-------ceEEEEEcCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027476 1 MMSRVRHRNLVKFIGACKEP-------VMVIVTELLLGGTLRKYLLNMR----PRCLDIHVAIGFALDIARAMECLHSHG 69 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~ 69 (223)
+|++++||||+++++++... ..++++||+.+++|.+++.... ...+++..++.++.|++.||+|||+.|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 133 (273)
T cd05074 54 CMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN 133 (273)
T ss_pred HHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 36789999999999987431 2368899999999998875321 224799999999999999999999999
Q ss_pred cccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCC-----------------------
Q 027476 70 IIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRP----------------------- 123 (223)
Q Consensus 70 ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~----------------------- 123 (223)
++||||||+||+++.++ .+||+|||+++....... .....+++.|++||.+..
T Consensus 134 i~H~dikp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g 212 (273)
T cd05074 134 FIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRG 212 (273)
T ss_pred EeecccchhhEEEcCCC-CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCC
Confidence 99999999999999777 799999999875432221 122345567899994321
Q ss_pred -----------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 124 -----------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 124 -----------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
.+...+.++.+++.+||..+|.+||++.++.+.|+++
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 213 QTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1123557788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=192.24 Aligned_cols=114 Identities=23% Similarity=0.353 Sum_probs=93.1
Q ss_pred CCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEE
Q 027476 6 RHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPENLIL 82 (223)
Q Consensus 6 ~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill 82 (223)
+|.+|++++++|.+ +.+++|||++ |++|.+++.+.+. +++..+..++.||+.||+|||+ .||+||||||+|||+
T Consensus 189 ~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl 265 (467)
T PTZ00284 189 DRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGP--FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILM 265 (467)
T ss_pred cCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE
Confidence 56678999998864 4688999988 8899998876543 9999999999999999999998 599999999999999
Q ss_pred eCCCC---------------ceEEccCccccccccccccccCCCccccccCCCCCCC
Q 027476 83 TADHK---------------TVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS 124 (223)
Q Consensus 83 ~~~~~---------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 124 (223)
+.++. .+||+|||.+.... .......||+.|+|||++...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~ 320 (467)
T PTZ00284 266 ETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGL 320 (467)
T ss_pred ecCCcccccccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcC
Confidence 86542 49999999876432 223456799999999966533
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=183.35 Aligned_cols=118 Identities=34% Similarity=0.492 Sum_probs=99.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++|+||+.+++|.++..... .+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni 131 (286)
T cd07846 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI 131 (286)
T ss_pred HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 567899999999999965 57899999999999988775533 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 122 (223)
+++.++ .++|+|||++...... .......++..|+|||.+.
T Consensus 132 ~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 173 (286)
T cd07846 132 LVSQSG-VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173 (286)
T ss_pred EECCCC-cEEEEeeeeeeeccCCccccCcccceeeccCcHHhc
Confidence 999877 8999999998754322 2223346788999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-26 Score=181.54 Aligned_cols=136 Identities=27% Similarity=0.355 Sum_probs=105.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ +..++|+||+.++.+..+.... ..+++..++.++.|++.||.|||+.+++|+||+|+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni 131 (288)
T cd07833 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI 131 (288)
T ss_pred HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 567899999999999865 5789999999887776655443 3389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCCC-CCCChHHHHHHHHHhc
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRPS-AENLPEDLALIVTSCW 140 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~l~~l~~~~l 140 (223)
+++.++ .+||+|||++....... ......++..|+|||.+... ..+...|+|+++..++
T Consensus 132 ~~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~ 193 (288)
T cd07833 132 LVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMA 193 (288)
T ss_pred EECCCC-CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHH
Confidence 999877 89999999987544332 22345678899999976544 3334444444443333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=180.07 Aligned_cols=116 Identities=28% Similarity=0.358 Sum_probs=99.1
Q ss_pred CCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 3 SRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+..+||||+++.+.+.+ +..++||||+.|++|.+++.... .+++..+..++.|++.||.|||+.+++||||||+||+
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nil 129 (278)
T cd05606 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 129 (278)
T ss_pred HhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEE
Confidence 34579999999998875 57889999999999999887644 4999999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 82 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
++.++ .+||+|||++....... .....|+..|+|||.+.
T Consensus 130 i~~~~-~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~ 168 (278)
T cd05606 130 LDEHG-HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQ 168 (278)
T ss_pred ECCCC-CEEEccCcCccccCccC-CcCcCCCcCCcCcHHhc
Confidence 99877 79999999987543222 23457899999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=176.28 Aligned_cols=154 Identities=30% Similarity=0.526 Sum_probs=127.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++|||++++.+.+.+ +..++|+||+++++|.+++.+.. ...+++..++.++.+++.||.|||+.|++|+||+|+
T Consensus 53 l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~ 132 (258)
T cd08215 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQ 132 (258)
T ss_pred HHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChH
Confidence 567899999999998865 57889999999999999998643 356999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC---------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
||+++.++ .++|+|||.+....... ......|++.|+|||.....
T Consensus 133 nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 211 (258)
T cd08215 133 NIFLTSNG-LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL 211 (258)
T ss_pred HeEEcCCC-cEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH
Confidence 99999777 89999999987544332 22334678899999954311
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++.+++.+||..+|.+||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 212 ALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 22456778889999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=180.47 Aligned_cols=118 Identities=32% Similarity=0.511 Sum_probs=101.3
Q ss_pred CCCCC-CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVR-HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~-Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++ ||||+++++.+.+ +..++||||+ +++|.+++.......+++..++.++.|++.+|.|||++|++|+||+|+|
T Consensus 51 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~n 129 (283)
T cd07830 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPEN 129 (283)
T ss_pred HHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhh
Confidence 45677 9999999998865 5789999999 8899999887654568999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 121 (223)
|+++.++ .++|+|||++.............++..|+|||.+
T Consensus 130 i~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 170 (283)
T cd07830 130 LLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEIL 170 (283)
T ss_pred EEEcCCC-CEEEeecccceeccCCCCcCCCCCcccccCceee
Confidence 9999877 8999999999765444334455688899999955
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=166.51 Aligned_cols=173 Identities=26% Similarity=0.403 Sum_probs=148.5
Q ss_pred CCCCCCCCCccceEEEe-ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|+.++|.|||++++.. .++.+-+|+||| ..+|..+..... +.++.+.+..++.|++.||.|+|+++++|||+||+|
T Consensus 54 llkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqn 131 (292)
T KOG0662|consen 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQN 131 (292)
T ss_pred HHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcce
Confidence 46789999999999987 467889999999 679999887643 459999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-CCCChHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS-AENLPEDLALIVTSCWKEDPNERPNF--SQIIQ 155 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~l~~l~~~~l~~~p~~Rp~~--~~~~~ 155 (223)
.+|+.+| .+|++|||+++...... ..+..+.|.+|.+|.++-+. -++.+.|+|+-++..-+..-..||-+ .++.+
T Consensus 132 llin~ng-elkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd 210 (292)
T KOG0662|consen 132 LLINRNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_pred EEeccCC-cEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH
Confidence 9999988 89999999999776554 45667889999999987654 57888999999988888888889855 68899
Q ss_pred HHHHHhhcCCCCCCCCCCccc
Q 027476 156 MLLHYISTNSAPEPVILPRMF 176 (223)
Q Consensus 156 ~L~~~~~~~~~~~~~~~~~~~ 176 (223)
.|..++...+.+....+|...
T Consensus 211 qlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 211 QLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred HHHHHHHHhCCCccccCCccc
Confidence 999999988888776666543
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=179.48 Aligned_cols=153 Identities=29% Similarity=0.453 Sum_probs=122.5
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLK 76 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 76 (223)
+++++||||++++++|.+ +.+++||||++|++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~ 132 (287)
T cd06621 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIK 132 (287)
T ss_pred HHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 678899999999998843 3689999999999999987542 23458999999999999999999999999999999
Q ss_pred CCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCC-------------------------------
Q 027476 77 PENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA------------------------------- 125 (223)
Q Consensus 77 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------------------- 125 (223)
|+||+++.++ .++|+|||++....... .....++..|++||.+....
T Consensus 133 ~~nil~~~~~-~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 210 (287)
T cd06621 133 PSNILLTRKG-QVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP 210 (287)
T ss_pred HHHEEEecCC-eEEEeeccccccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC
Confidence 9999999877 79999999987543222 12345778899999442110
Q ss_pred -------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 -------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 -------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...+..+.+++.+||+.+|.+||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 211 LGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1123467889999999999999999988875
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=178.86 Aligned_cols=151 Identities=30% Similarity=0.467 Sum_probs=125.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+.+ +..++||||+.+++|.+++... .+++..+..++.|++.|+.|||+.|++|+||+|+||
T Consensus 56 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni 132 (277)
T cd06641 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 132 (277)
T ss_pred HHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhE
Confidence 567899999999999865 5789999999999999998642 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .++|+|||++....... ......++..|++||.+...
T Consensus 133 ~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 211 (277)
T cd06641 133 LLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF 211 (277)
T ss_pred EECCCC-CEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH
Confidence 999877 79999999987543322 12234678899999954311
Q ss_pred ----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++.+||+.+|.+||++.+++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 212 LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 12345678899999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=180.26 Aligned_cols=153 Identities=31% Similarity=0.503 Sum_probs=123.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKP 77 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp 77 (223)
++.++||||+++++++.+ +..++||||+. ++|.+++... ....+++..++.++.|++.||+|||++ +++||||||
T Consensus 54 ~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp 132 (283)
T cd06617 54 MRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKP 132 (283)
T ss_pred HHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCH
Confidence 355789999999999864 67899999995 7888887642 234589999999999999999999997 999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC---------------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
+||+++.++ .+||+|||++.............++..|+|||.+.+.
T Consensus 133 ~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (283)
T cd06617 133 SNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK 211 (283)
T ss_pred HHEEECCCC-CEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc
Confidence 999999887 8999999998764433222335678899999954210
Q ss_pred ------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++..||..+|.+||++++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 212 TPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred cCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01245678899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-26 Score=180.15 Aligned_cols=152 Identities=28% Similarity=0.504 Sum_probs=121.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~N 79 (223)
+++++||||+++++.+.. +..++++||+.+++|.+++.... ..+++..+..++.|++.||.|+|+ .|++|+||||+|
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~n 131 (265)
T cd06605 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131 (265)
T ss_pred HHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHH
Confidence 567899999999998864 67899999999999999997653 458999999999999999999999 999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCC--------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAEN-------------------------------- 127 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-------------------------------- 127 (223)
|+++.++ .++|+|||.+........ ....++..|++||.+.....+
T Consensus 132 i~~~~~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 209 (265)
T cd06605 132 ILVNSRG-QIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209 (265)
T ss_pred EEECCCC-CEEEeecccchhhHHHHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH
Confidence 9999877 799999999875432222 226788899999954322222
Q ss_pred -------------------ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 128 -------------------LPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 128 -------------------~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
++.++.+++..||..+|.+||++.+++.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 210 FELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 34556777777777777777777777654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=181.58 Aligned_cols=118 Identities=29% Similarity=0.423 Sum_probs=96.2
Q ss_pred CCCCCCCCccceEEEeecC---------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 2 MSRVRHRNLVKFIGACKEP---------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~---------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
+++++||||+++++++... ..++||||+. ++|.+.+.... ..+++.+++.++.|++.||.|||++|++|
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H 142 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILH 142 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 5788999999999988432 3589999995 68888876533 34899999999999999999999999999
Q ss_pred CCCCCCCEEEeCCCCceEEccCccccccccccc-----cccCCCccccccCCCCC
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESLTEM-----MTAETGTYRWMAPENMR 122 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~ 122 (223)
+||||+||+++.++ .+||+|||++........ .....++..|+|||.+.
T Consensus 143 ~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (310)
T cd07865 143 RDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL 196 (310)
T ss_pred cCCCHHHEEECCCC-cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhc
Confidence 99999999999877 899999999875432221 12345778899999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=176.36 Aligned_cols=132 Identities=21% Similarity=0.226 Sum_probs=106.2
Q ss_pred CCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q 027476 4 RVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL 82 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill 82 (223)
...||||+++++++.+ +..++||||+.|++|.+++.+... +++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 41 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~ 118 (237)
T cd05576 41 PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL 118 (237)
T ss_pred hcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence 3469999999998865 578999999999999999876544 9999999999999999999999999999999999999
Q ss_pred eCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhc
Q 027476 83 TADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCW 140 (223)
Q Consensus 83 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l 140 (223)
+.++ .++++|||.+...... .....++..|+|||.......+...|+|+++..++
T Consensus 119 ~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ 173 (237)
T cd05576 119 DDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEETEACDWWSLGAILF 173 (237)
T ss_pred cCCC-CEEEecccchhccccc--cccCCcCccccCCcccCCCCCCchhhHHHHHHHHH
Confidence 9887 7999999987654322 22345677899999776554455555555544433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=183.38 Aligned_cols=119 Identities=18% Similarity=0.306 Sum_probs=96.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||++++++|.. +..++|+||+.+++|.+++.+.....+++..+..++.|++.||+|||++|++||||||+||
T Consensus 53 ~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Ni 132 (328)
T cd08226 53 SHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHI 132 (328)
T ss_pred HHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 456899999999999975 5789999999999999999876555699999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-c-------cccCCCccccccCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-M-------MTAETGTYRWMAPENM 121 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~-------~~~~~gt~~y~aPE~~ 121 (223)
+++.++ .++++||+.+....... . .....++..|++||++
T Consensus 133 ll~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (328)
T cd08226 133 LISGDG-LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL 180 (328)
T ss_pred EEeCCC-cEEEechHHHhhhhccCccccccccccccccCccCccChhhh
Confidence 999877 89999998653221100 0 0112345679999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=181.46 Aligned_cols=151 Identities=29% Similarity=0.507 Sum_probs=124.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+.+ +..++|+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||||+||
T Consensus 70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Ni 146 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 146 (293)
T ss_pred HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHE
Confidence 577899999999999865 5789999999999999998653 378999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .+||+|||++....... ......+++.|++||.+...
T Consensus 147 li~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~ 225 (293)
T cd06647 147 LLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (293)
T ss_pred EEcCCC-CEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee
Confidence 999877 89999999886443222 22334688899999954211
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....+..+.+++..||+.+|.+||++++++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 226 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11234568889999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=177.18 Aligned_cols=153 Identities=27% Similarity=0.441 Sum_probs=124.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++|+||+++.+++.+ ...++|+||+++++|.+++.+.. ...+++..++.++.|++.||.|||+.|++|+||+|.
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ 132 (256)
T cd08530 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSA 132 (256)
T ss_pred HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcc
Confidence 578899999999998864 67899999999999999986522 245899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCC---------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA--------------------------------- 125 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------------------- 125 (223)
||+++.++ .+||+|||++...... ......++..|++||.+....
T Consensus 133 ni~~~~~~-~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (256)
T cd08530 133 NILLVAND-LVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210 (256)
T ss_pred eEEEecCC-cEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999876 7999999999765443 333456788999999543221
Q ss_pred ------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...+.++.+++..|+..+|.+||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 211 YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2344567778888888888888888887654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=192.60 Aligned_cols=163 Identities=28% Similarity=0.273 Sum_probs=136.4
Q ss_pred CCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCC-
Q 027476 8 RNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTAD- 85 (223)
Q Consensus 8 pniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~- 85 (223)
-|||+++++|.. ++.|+|+|.+ ..+|.++++.++...++...++.++.||+.||.+||+.+|||+||||+||||..-
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK 326 (586)
T ss_pred eeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC
Confidence 489999999975 7999999999 7899999999998889999999999999999999999999999999999999543
Q ss_pred CCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCH-HHHHHHHHHHhhcC
Q 027476 86 HKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNF-SQIIQMLLHYISTN 164 (223)
Q Consensus 86 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~-~~~~~~L~~~~~~~ 164 (223)
...|||+|||.+........ +...+..|+|||++.+.+++.+-|+|+|++.+-++-.+.-... +.-.+.|..++...
T Consensus 327 r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred cCceeEEecccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 24799999999987655433 5677889999999999999999999999999888888765332 23345555666666
Q ss_pred CCCCCCCCC
Q 027476 165 SAPEPVILP 173 (223)
Q Consensus 165 ~~~~~~~~~ 173 (223)
+.|++..+.
T Consensus 405 G~Pp~~mL~ 413 (586)
T KOG0667|consen 405 GLPPPKMLD 413 (586)
T ss_pred CCCCHHHHH
Confidence 666655444
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-26 Score=179.45 Aligned_cols=152 Identities=30% Similarity=0.472 Sum_probs=120.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+.+ +..++++||+.+++|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 47 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~ni 124 (265)
T cd05579 47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNI 124 (265)
T ss_pred HHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHe
Confidence 567899999999998865 57899999999999999998755 489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc---------ccccCCCccccccCCCCCCCCCC------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE---------MMTAETGTYRWMAPENMRPSAEN------------------------ 127 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~------------------------ 127 (223)
+++.++ .++|+|||++....... ......++..|++||.......+
T Consensus 125 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 125 LIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred EEcCCC-CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 999887 89999999987533221 12234577889999954322111
Q ss_pred ----------------------ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 128 ----------------------LPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 128 ----------------------~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..+.+++.+||+.+|.+||++.++.+.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 204 ETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred CCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence 25667778888888888888887444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=178.61 Aligned_cols=145 Identities=24% Similarity=0.398 Sum_probs=113.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++|+||+++++++.+ +..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||||+|
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~n 133 (291)
T cd07844 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQN 133 (291)
T ss_pred HHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHH
Confidence 3678899999999999875 57899999996 59999887643 358999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCC-CCCCChHHHHHHHHHhcccCCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRP-SAENLPEDLALIVTSCWKEDPNERP 148 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~~l~~l~~~~l~~~p~~Rp 148 (223)
|+++.++ .+||+|||+++...... ......++..|+|||.+.. ...+...|+|+++..+++.-.++.|
T Consensus 134 il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~ 203 (291)
T cd07844 134 LLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203 (291)
T ss_pred EEEcCCC-CEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999887 79999999987543211 1223356788999997754 3345566777766666655444333
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=179.47 Aligned_cols=156 Identities=26% Similarity=0.468 Sum_probs=125.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++.+.+ +..++||||+++++|.+++... .+++..++.++.|++.||+|||+.|++|+||+|+||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Ni 147 (292)
T cd06657 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSI 147 (292)
T ss_pred HHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 567899999999999864 6789999999999999987542 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPSA---------------------------------- 125 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---------------------------------- 125 (223)
+++.++ .++|+|||++....... ......+++.|++||.+....
T Consensus 148 lv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~ 226 (292)
T cd06657 148 LLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK 226 (292)
T ss_pred EECCCC-CEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999887 79999999886543221 123346788999999543111
Q ss_pred -------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 126 -------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 126 -------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
...+.++.+++.+||+.+|.+||++++++.+ .++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~--~~~~~ 275 (292)
T cd06657 227 MIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAK 275 (292)
T ss_pred HHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC--hHHhc
Confidence 1245667788888999999999999888775 44443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=190.13 Aligned_cols=147 Identities=22% Similarity=0.381 Sum_probs=124.3
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||..-+.+-||+||..|+| +.+|+||+|++||++..+|.+.+- +++..++.++.++..|+++.|..|++||||||+|
T Consensus 682 ILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDN 759 (1034)
T KOG0608|consen 682 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDN 759 (1034)
T ss_pred hHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhccceecccCccc
Confidence 4566678899999999987 579999999999999999987654 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-------------------------------------------cccccCCCccccc
Q 027476 80 LILTADHKTVKLADFGLAREESLT-------------------------------------------EMMTAETGTYRWM 116 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-------------------------------------------~~~~~~~gt~~y~ 116 (223)
||||.+| ++||+|||++.-+... ......+||+.|+
T Consensus 760 ILIDrdG-HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyi 838 (1034)
T KOG0608|consen 760 ILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYI 838 (1034)
T ss_pred eEEccCC-ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCccc
Confidence 9999999 8999999998521000 0001236999999
Q ss_pred cCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCH
Q 027476 117 APENMRPSAENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 117 aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
|||++....++-.-|+|+.+..++++.-++-|+.
T Consensus 839 apevl~r~g~~q~cdwws~gvil~em~~g~~pf~ 872 (1034)
T KOG0608|consen 839 APEVLARTGYTQLCDWWSVGVILYEMLVGQPPFL 872 (1034)
T ss_pred ChHHhcccCccccchhhHhhHHHHHHhhCCCCcc
Confidence 9999999999999999999888887776665543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-25 Score=178.93 Aligned_cols=118 Identities=34% Similarity=0.433 Sum_probs=97.3
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++|+||+++++++.+ +..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 137 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVS 137 (309)
T ss_pred HHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 568899999999999854 35799999995 58988887533 45899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCC
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMR 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~ 122 (223)
||+++.++ .+||+|||++....... ......++..|+|||.+.
T Consensus 138 nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 181 (309)
T cd07845 138 NLLLTDKG-CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181 (309)
T ss_pred HEEECCCC-CEEECccceeeecCCccCCCCcccccccccChhhhc
Confidence 99999877 89999999987654321 222334578899999653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=190.02 Aligned_cols=130 Identities=28% Similarity=0.412 Sum_probs=109.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||.+++||.||.+.-.|+. +..++|||-+ +|+..+.|.....+.+++.....++.||+.||.|||.++|+|+||||+|
T Consensus 616 ILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPEN 694 (888)
T KOG4236|consen 616 ILQNLHHPGIVNLECMFETPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPEN 694 (888)
T ss_pred HHHhcCCCCeeEEEEeecCCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchh
Confidence 5789999999999998875 5789999999 5565565555555679999999999999999999999999999999999
Q ss_pred EEEeCCC--CceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHH
Q 027476 80 LILTADH--KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPED 131 (223)
Q Consensus 80 ill~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 131 (223)
||+.... ..+||+|||+|+...........+||+.|+|||+++...++.+-|
T Consensus 695 VLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLD 748 (888)
T KOG4236|consen 695 VLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLD 748 (888)
T ss_pred eeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcccccccc
Confidence 9997543 489999999999887777778889999999999887544443333
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=174.68 Aligned_cols=153 Identities=33% Similarity=0.579 Sum_probs=125.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ +..++++||+.+++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||
T Consensus 51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni 129 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANI 129 (253)
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHE
Confidence 567899999999999864 57899999999999999987653 3589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA----------------------------------- 125 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------------------- 125 (223)
+++.++ .++|+|||.+.............++..|++||.+....
T Consensus 130 ~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 208 (253)
T cd05122 130 LLTSDG-EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208 (253)
T ss_pred EEccCC-eEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 999877 89999999987654433234456888999999543111
Q ss_pred ------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++..+.+++..||+.+|.+||++.+++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 209 IATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1125677888889999999999998888753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=175.79 Aligned_cols=152 Identities=28% Similarity=0.491 Sum_probs=125.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~N 79 (223)
+++++|+||+++++++.+ +..++|+||+.+++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~n 130 (264)
T cd06623 53 LRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSN 130 (264)
T ss_pred HHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHH
Confidence 457889999999999865 67899999999999999998653 49999999999999999999999 999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccccc-ccCCCccccccCCCCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMM-TAETGTYRWMAPENMRPSA--------------------------------- 125 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~--------------------------------- 125 (223)
|+++.++ .++|+|||++......... ....++..|+|||.+....
T Consensus 131 i~~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~ 209 (264)
T cd06623 131 LLINSKG-EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF 209 (264)
T ss_pred EEECCCC-CEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH
Confidence 9999877 8999999998765433322 2446788999999543221
Q ss_pred ---------------CC-ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ---------------EN-LPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ---------------~~-~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.. ++..+.+++..|+..+|.+||++.+++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 210 ELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 45678888888888888888888888765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=178.22 Aligned_cols=153 Identities=28% Similarity=0.506 Sum_probs=126.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++.+.. +..++|+||+.+++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni 147 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNI 147 (286)
T ss_pred HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhE
Confidence 567899999999998864 67899999999999999998754 3599999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .++|+|||++....... ......++..|++||.+...
T Consensus 148 ~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~ 226 (286)
T cd06614 148 LLSKDG-SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF 226 (286)
T ss_pred EEcCCC-CEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999877 89999999876433221 12334578899999954311
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++.+||+.+|.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 227 LITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11256678899999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=178.99 Aligned_cols=151 Identities=28% Similarity=0.507 Sum_probs=123.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~N 79 (223)
++.++||||+++++.+.+ +.+++|+||+++++|.+++...+ .+++..+..++.+++.||.|||+ .+++|+||||+|
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~n 134 (284)
T cd06620 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSN 134 (284)
T ss_pred HHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHH
Confidence 567899999999999865 67899999999999999987644 38999999999999999999997 689999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA---------------------------------- 125 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------------------- 125 (223)
|+++.++ .++|+|||++...... ......|+..|+|||++....
T Consensus 135 il~~~~~-~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~ 212 (284)
T cd06620 135 ILVNSRG-QIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212 (284)
T ss_pred EEECCCC-cEEEccCCcccchhhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh
Confidence 9999877 8999999998643222 123457889999999543110
Q ss_pred -----------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 -----------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 -----------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++.+|++.+|.+||++.+++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 213 DDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0144567788899999999999999888875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=178.45 Aligned_cols=137 Identities=30% Similarity=0.436 Sum_probs=106.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++++||+ +++|.+++.......+++..++.++.|++.||+|||+++++|+||+|+||
T Consensus 52 l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~ni 130 (283)
T cd07835 52 LKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNL 130 (283)
T ss_pred HHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHE
Confidence 567899999999999865 5789999999 57999998776544589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-CCCChHHHHHHHHHhc
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS-AENLPEDLALIVTSCW 140 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~l~~l~~~~l 140 (223)
+++.++ .++|+|||++....... ......++..|+|||.+... ..+...|+|+++..++
T Consensus 131 l~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~ 191 (283)
T cd07835 131 LIDREG-ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFA 191 (283)
T ss_pred EEcCCC-cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHH
Confidence 999877 89999999987543221 12233568899999976432 2233444444443333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-25 Score=173.48 Aligned_cols=152 Identities=34% Similarity=0.584 Sum_probs=127.0
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++||||+++++.+.+ +.+++|+||+.+++|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||+|+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ 130 (260)
T cd06606 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGA 130 (260)
T ss_pred HHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHH
Confidence 567899999999999865 46889999999999999998755 4999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCCC-------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRPS------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~------------------------------- 124 (223)
||+++.++ .++|+|||.+........ .....++..|++||.+...
T Consensus 131 ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (260)
T cd06606 131 NILVDSDG-VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP 209 (260)
T ss_pred HEEEcCCC-CEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Confidence 99999877 799999999886554432 3445688899999954311
Q ss_pred ----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+...+.++.+++.+|++.+|.+||++.+++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 210 MAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 22345678888999999999999998888754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-25 Score=173.52 Aligned_cols=151 Identities=31% Similarity=0.575 Sum_probs=123.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ +..++++||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 130 (254)
T cd06627 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANI 130 (254)
T ss_pred HHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHE
Confidence 567899999999998865 57889999999999999997753 499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc-cccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .++|+|||.+........ .....++..|++||.....
T Consensus 131 ~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~ 209 (254)
T cd06627 131 LTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF 209 (254)
T ss_pred EECCCC-CEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 999877 899999999985543322 2334678899999955322
Q ss_pred ----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 125 ----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 125 ----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
+...+..+.+++.+||..+|.+||++.+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 210 RIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1234566778888888888888888887764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=184.40 Aligned_cols=152 Identities=26% Similarity=0.418 Sum_probs=123.2
Q ss_pred CCCCCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
+|++++||||+++++++.. ...++|+||+ +++|.+++..... +++..++.++.|++.||.|||+.|++||||
T Consensus 57 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dl 133 (334)
T cd07855 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSANVIHRDL 133 (334)
T ss_pred HHHhcCCCCccCHHHhccccCCCCceEEEEEehh-hhhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 3678899999999998742 3588999999 5689998875443 999999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCccccccccccc-----cccCCCccccccCCCCCCC--------------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTEM-----MTAETGTYRWMAPENMRPS-------------------------- 124 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------------------------- 124 (223)
||+||+++.++ .+||+|||++........ .....++..|+|||.+...
T Consensus 134 kp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf 212 (334)
T cd07855 134 KPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212 (334)
T ss_pred CHHHEEEcCCC-cEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc
Confidence 99999999887 899999999875432211 1234688899999954210
Q ss_pred --------------------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHH
Q 027476 125 --------------------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQII 154 (223)
Q Consensus 125 --------------------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~ 154 (223)
....+.++.+++..||+.+|.+||++++++
T Consensus 213 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 213 PGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred CCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 012456788899999999999999999988
Q ss_pred HH
Q 027476 155 QM 156 (223)
Q Consensus 155 ~~ 156 (223)
.+
T Consensus 293 ~~ 294 (334)
T cd07855 293 QH 294 (334)
T ss_pred hC
Confidence 76
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-25 Score=177.49 Aligned_cols=144 Identities=24% Similarity=0.338 Sum_probs=112.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ +..++|+||+. ++|.+.+.... ..+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 134 (291)
T cd07870 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL 134 (291)
T ss_pred HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence 567899999999999875 57889999995 77777765433 3478889999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-CCCChHHHHHHHHHhcccCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS-AENLPEDLALIVTSCWKEDPNERP 148 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~l~~l~~~~l~~~p~~Rp 148 (223)
+++.++ .+||+|||+++...... ......+++.|+|||.+... ..+...|+|+++..+++.-.+..|
T Consensus 135 l~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~ 203 (291)
T cd07870 135 LISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203 (291)
T ss_pred EEcCCC-cEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999887 89999999987533221 22334578899999987643 345566777777666665555444
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=183.76 Aligned_cols=151 Identities=28% Similarity=0.422 Sum_probs=124.5
Q ss_pred CCCCCCCCccceEEEeecC------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKEP------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
+++++||||+++.+++.+. ..++||||+. ++|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dl 129 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDL 129 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 5678999999999988543 5899999996 68999887644 4999999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCCCC-C-------------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMRPS-A------------------------- 125 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~------------------------- 125 (223)
||+||+++.++ .++|+|||++....... ......++..|+|||.+... .
T Consensus 130 kp~nili~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 130 KPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred CHHHEEEcCCC-CEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 99999999887 89999999998654432 22344678899999965422 1
Q ss_pred --------------------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 126 --------------------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 126 --------------------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
...+.++++++..||+.+|.+||++++++.
T Consensus 209 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 209 GRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred CCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 113456778999999999999999999987
Q ss_pred H
Q 027476 156 M 156 (223)
Q Consensus 156 ~ 156 (223)
+
T Consensus 289 ~ 289 (330)
T cd07834 289 H 289 (330)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=180.86 Aligned_cols=135 Identities=22% Similarity=0.285 Sum_probs=102.4
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMR---PRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
+++++||||+++++++.+ +..++||||+. ++|.+.+.... ...+++..++.++.|++.||.|||+.+++||||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dl 134 (316)
T cd07842 56 LRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDL 134 (316)
T ss_pred HHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCC
Confidence 577899999999999854 45899999995 57777765322 235899999999999999999999999999999
Q ss_pred CCCCEEEeC----CCCceEEccCcccccccccc----ccccCCCccccccCCCCCCC-CCCChHHHHHHHHH
Q 027476 76 KPENLILTA----DHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMRPS-AENLPEDLALIVTS 138 (223)
Q Consensus 76 kp~Nill~~----~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~l~~l~~~ 138 (223)
||+||+++. ++ .+||+|||++....... ......++..|+|||.+... ..+...|+|+++..
T Consensus 135 kp~Nil~~~~~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~ 205 (316)
T cd07842 135 KPANILVMGEGPERG-VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCI 205 (316)
T ss_pred CHHHEEEcCCCCccc-eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHH
Confidence 999999998 66 89999999987543221 12234678899999965432 23334444444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=165.61 Aligned_cols=160 Identities=27% Similarity=0.384 Sum_probs=130.8
Q ss_pred CCCCCCCCccceEEEe-ecCceEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCC
Q 027476 2 MSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLN--MRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKP 77 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp 77 (223)
++....|.+|.++|.+ .++..|+.||.| ..||+.+..+ ..++.+++..+-+|+..++.||.|||++ .++|||+||
T Consensus 99 ~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKP 177 (282)
T KOG0984|consen 99 MRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKP 177 (282)
T ss_pred ccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCc
Confidence 4556789999999965 568999999999 6788887653 2345699999999999999999999986 899999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC----CCCChHHHHHHHHHhcccCCCCCC--CHH
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS----AENLPEDLALIVTSCWKEDPNERP--NFS 151 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~l~~l~~~~l~~~p~~Rp--~~~ 151 (223)
+|||++.+| +||++|||++....+....+...|...|||||.+.+. .+++..|+|+|+..+++.-..+-| +..
T Consensus 178 sNiLIn~~G-qVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 178 SNILINYDG-QVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ceEEEccCC-cEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 999999998 8999999999876655555556899999999987643 677889999999999988776665 444
Q ss_pred HHHHHHHHHhhc
Q 027476 152 QIIQMLLHYIST 163 (223)
Q Consensus 152 ~~~~~L~~~~~~ 163 (223)
.-.+.|.+....
T Consensus 257 tpF~qLkqvVee 268 (282)
T KOG0984|consen 257 TPFQQLKQVVEE 268 (282)
T ss_pred CHHHHHHHHhcC
Confidence 445666666544
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=175.69 Aligned_cols=152 Identities=27% Similarity=0.474 Sum_probs=124.6
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
.||||+++++.+.+ +..++||||+.|++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~ 136 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN 136 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC
Confidence 49999999998865 5789999999999999998653 4899999999999999999999999999999999999998
Q ss_pred CCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC---------------------------------------
Q 027476 85 DHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS--------------------------------------- 124 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~--------------------------------------- 124 (223)
++ .++|+|||++....... ......|+..|+|||.+...
T Consensus 137 ~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~ 215 (277)
T cd06917 137 TG-NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP 215 (277)
T ss_pred CC-CEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc
Confidence 77 89999999987543322 12334688899999943210
Q ss_pred -------CC-CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 125 -------AE-NLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 125 -------~~-~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
.. ..+.++.+++..||+.+|.+||++.+++.+ .++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~--~~~~~ 260 (277)
T cd06917 216 KSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS--KWIKA 260 (277)
T ss_pred cCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC--hHhhc
Confidence 01 256678899999999999999999999875 55443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=176.19 Aligned_cols=116 Identities=28% Similarity=0.454 Sum_probs=96.4
Q ss_pred CCCC-CCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
++++ +|+||+++++++.+ +.+++|+||+. ++|.+.+.... ..+++..++.++.|++.||.|||+.|++|+||||
T Consensus 51 l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p 128 (282)
T cd07831 51 LRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKP 128 (282)
T ss_pred HhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCH
Confidence 4455 59999999999864 56899999996 58888876533 3589999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCC
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 121 (223)
+||+++. + .+||+|||+++............++..|+|||.+
T Consensus 129 ~ni~l~~-~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 170 (282)
T cd07831 129 ENILIKD-D-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECL 170 (282)
T ss_pred HHEEEcC-C-CeEEEecccccccccCCCcCCCCCCcccCChhHh
Confidence 9999998 5 8999999999865443333445678899999954
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=176.90 Aligned_cols=140 Identities=26% Similarity=0.393 Sum_probs=108.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR-PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++||||+++++.+.+ +..++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||||+|
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~n 130 (284)
T cd07836 52 MKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQN 130 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHH
Confidence 567899999999999875 67899999997 58888886543 2458999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-CCCChHHHHHHHHHhcccC
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS-AENLPEDLALIVTSCWKED 143 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~l~~l~~~~l~~~ 143 (223)
|+++.++ .++|+|||++....... ......++..|++||.+... ..+...|+|+++..+++.-
T Consensus 131 i~~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~ 195 (284)
T cd07836 131 LLINKRG-ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195 (284)
T ss_pred EEECCCC-cEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999877 79999999987543221 12334578899999976442 2344555555554444443
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-25 Score=175.94 Aligned_cols=153 Identities=28% Similarity=0.465 Sum_probs=122.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++||||+++++.+.+ ...++|+||+.+++|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~ 135 (260)
T cd08222 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAK 135 (260)
T ss_pred HHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChh
Confidence 567899999999998864 5788999999999999988642 2345899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCC---------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
||+++. + .+||+|||++...... .......++..|++||.+...
T Consensus 136 nili~~-~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~ 213 (260)
T cd08222 136 NIFLKN-N-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV 213 (260)
T ss_pred heEeec-C-CEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 999984 4 6999999998754322 222344678899999954311
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++.+++.+||..+|.+||++++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 214 VLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 22345677888888888899999988888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=177.56 Aligned_cols=141 Identities=27% Similarity=0.373 Sum_probs=127.4
Q ss_pred CCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
+||.+|-+..+|+ +..+++|.||+.||+|.-++++++. ++++.+..+..+|+.||.|||++||++||||..|+++|.
T Consensus 309 n~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rgiiyrdlkldnvllda 386 (593)
T KOG0695|consen 309 NNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDA 386 (593)
T ss_pred CCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEcc
Confidence 6899999999885 5789999999999999988887665 999999999999999999999999999999999999999
Q ss_pred CCCceEEccCcccccc-ccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 85 DHKTVKLADFGLAREE-SLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
.+ ++||+|+|+++.. ......++.+|||.|+|||.+++..+.++.|+|.++..|+++-.++-|.
T Consensus 387 eg-hikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspf 451 (593)
T KOG0695|consen 387 EG-HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 451 (593)
T ss_pred CC-ceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCc
Confidence 98 8999999999853 3345567889999999999999999999999999999999887777663
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=175.68 Aligned_cols=142 Identities=20% Similarity=0.288 Sum_probs=109.4
Q ss_pred CCCCCCCccceEEEeecC-----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 3 SRVRHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
..++|+||+++++.+... ..++++|++ ..++.+.+..... .++..+..++.|++.||.|||+.+++||||||
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp 154 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKC--KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKP 154 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhcc--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 457899999999876432 246888887 5677777765432 67888999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccc--------cccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCC
Q 027476 78 ENLILTADHKTVKLADFGLAREESLT--------EMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERP 148 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp 148 (223)
+||+++.++ .++|+|||+++..... .......||+.|+|||.......+...|+|+++..++++-..+.|
T Consensus 155 ~Nill~~~~-~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P 232 (294)
T PHA02882 155 ENIMVDGNN-RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232 (294)
T ss_pred HHEEEcCCC-cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999777 7999999999754211 111234699999999988776667777777777666666555555
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=188.01 Aligned_cols=149 Identities=26% Similarity=0.377 Sum_probs=123.9
Q ss_pred CCCCCccceEEEeecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE-
Q 027476 5 VRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL- 82 (223)
Q Consensus 5 l~Hpniv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill- 82 (223)
-+||||+++.+.+.++ +.|+|||.+.|+-+.+.+...+. ...++..|+.+|+.|+.|||++|+|||||||+|||+
T Consensus 373 ~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~ 449 (612)
T KOG0603|consen 373 RDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD 449 (612)
T ss_pred cCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec
Confidence 3799999999999875 79999999999988888866443 337778899999999999999999999999999999
Q ss_pred eCCCCceEEccCccccccccccccccCCCccccccCCCCCCCC-------------------------------------
Q 027476 83 TADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA------------------------------------- 125 (223)
Q Consensus 83 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------------------------- 125 (223)
+..+ +++|+|||.++..... ..+.+-|..|.|||++....
T Consensus 450 ~~~g-~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i 526 (612)
T KOG0603|consen 450 GSAG-HLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI 526 (612)
T ss_pred CCCC-cEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence 4666 8999999999875544 34557788999999665322
Q ss_pred ------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 126 ------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 126 ------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
..++....+|+.+||+.+|.+|+++.++..+ .++
T Consensus 527 ~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h--~w~ 566 (612)
T KOG0603|consen 527 QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH--PWF 566 (612)
T ss_pred cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC--cch
Confidence 4566667778999999999999999999876 554
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=182.93 Aligned_cols=151 Identities=26% Similarity=0.369 Sum_probs=122.8
Q ss_pred CCCCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
|++++|+||+++++++.. ...++|+||+ +++|.+++.... .+++..+..++.|++.||.|||+++++|+||
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl 134 (337)
T cd07858 58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDL 134 (337)
T ss_pred HHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 567899999999998743 2479999999 578999887644 4999999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCC------------------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPS------------------------------ 124 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~------------------------------ 124 (223)
||+||+++.++ .+||+|||++...... .......++..|+|||.+...
T Consensus 135 kp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 135 KPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred CHHHEEEcCCC-CEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999877 8999999999755432 222334678889999944210
Q ss_pred ----------------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..+.+.++.+++.+||+.+|.+||++++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 214 YVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 01345567789999999999999999999877
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=183.69 Aligned_cols=151 Identities=23% Similarity=0.392 Sum_probs=119.6
Q ss_pred CCCC-CCCCccceEEEe-ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|.+| .|.+||+|+++- .|+.+||||||= ..+|..+|.+.... ++.-.++.+..||+.|+.++|..||||.||||.|
T Consensus 413 L~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPAN 490 (677)
T KOG0596|consen 413 LNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPAN 490 (677)
T ss_pred HHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCccc
Confidence 4566 599999999987 478899999987 67999999875543 3433788899999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRP--------------------------------- 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~--------------------------------- 123 (223)
+++- .| ++||+|||+|....... .....+||+.||+||.+..
T Consensus 491 FLlV-kG-~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYg 568 (677)
T KOG0596|consen 491 FLLV-KG-RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYG 568 (677)
T ss_pred EEEE-ee-eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhc
Confidence 9998 45 79999999998654332 2234589999999994431
Q ss_pred -------------------------CCCCChH-HHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 -------------------------SAENLPE-DLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 -------------------------~~~~~~~-~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.++-.+. ++.+++..||..||.+||+..+++++
T Consensus 569 ktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 569 KTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 0111112 27789999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=202.58 Aligned_cols=152 Identities=24% Similarity=0.376 Sum_probs=121.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLH---SHGIIHRDLKP 77 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp 77 (223)
|++++||||++++|+|.+ +..++||||+++|+|.+++.. +++..+.+++.|++.||+||| +.+++||||||
T Consensus 737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp 811 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811 (968)
T ss_pred HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCH
Confidence 678899999999999965 578999999999999999953 899999999999999999999 66999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCC------------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAEN------------------------------ 127 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~------------------------------ 127 (223)
+||+++.++ ..++. ||....... .....+++.|+|||++.....+
T Consensus 812 ~Nil~~~~~-~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~ 886 (968)
T PLN00113 812 EKIIIDGKD-EPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886 (968)
T ss_pred HhEEECCCC-ceEEE-ecccccccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence 999999766 56654 555433221 1233678999999955421110
Q ss_pred --------------------------------ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 128 --------------------------------LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 128 --------------------------------~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
...++.+++.+||+.+|.+||+++++++.|+++...
T Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 012355778899999999999999999999987653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=181.46 Aligned_cols=160 Identities=24% Similarity=0.297 Sum_probs=137.1
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
+-|.++++..+|+. +.+|+||||+.||+|.-++++.+. +.+..+.-++.+|+-||-+||++||++||||.+||+++.
T Consensus 408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~ 485 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 485 (683)
T ss_pred CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEecc
Confidence 46778888888865 689999999999999999987665 899999999999999999999999999999999999999
Q ss_pred CCCceEEccCcccccccc-ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 85 DHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+| ++||+|||+++.... .....+.+||+.|+|||.+.-++++.+.|+|+++..++++-.++-|.-.+--+.|.+.+..
T Consensus 486 eG-HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e 564 (683)
T KOG0696|consen 486 EG-HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME 564 (683)
T ss_pred CC-ceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 98 899999999985332 3345678999999999999999999999999999999999999999776655555555554
Q ss_pred CCCCC
Q 027476 164 NSAPE 168 (223)
Q Consensus 164 ~~~~~ 168 (223)
....-
T Consensus 565 hnvsy 569 (683)
T KOG0696|consen 565 HNVSY 569 (683)
T ss_pred ccCcC
Confidence 44333
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=173.75 Aligned_cols=146 Identities=25% Similarity=0.393 Sum_probs=123.6
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++||||+++++++.+ ..+++||||++|++|.+++.+... +++..+..++.|++.||.|||+++++|+||||+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ 135 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGA 135 (265)
T ss_pred HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 567899999999998864 357799999999999999876543 899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccc----cccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCH
Q 027476 79 NLILTADHKTVKLADFGLAREESLT----EMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
||+++.++ .++|+|||+++..... .......++..|+|||.+.....+...|+|+++..+++.--++.|..
T Consensus 136 nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 136 NILRDSVG-NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred HEEecCCC-CEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 99999877 8999999998753321 11223458889999999988878888999999999888887777753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=173.22 Aligned_cols=147 Identities=35% Similarity=0.458 Sum_probs=120.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++.+.+ +..++||||+.+++|.+++..... +++..+..++.|++.||.|+|+.+++|+||+|+||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni 124 (250)
T cd05123 47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGR--FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENI 124 (250)
T ss_pred HHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceE
Confidence 567899999999998865 578999999999999999986543 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .++|+|||++...... .......++..|++||.....
T Consensus 125 ~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~ 203 (250)
T cd05123 125 LLDADG-HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203 (250)
T ss_pred EEcCCC-cEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999877 8999999998764432 223445688899999955422
Q ss_pred ---------CCCChHHHHHHHHHhcccCCCCCCCHH
Q 027476 125 ---------AENLPEDLALIVTSCWKEDPNERPNFS 151 (223)
Q Consensus 125 ---------~~~~~~~l~~l~~~~l~~~p~~Rp~~~ 151 (223)
+...+.++.+++.+||..+|.+||++.
T Consensus 204 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 204 KILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 223356677777888888888888773
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=176.48 Aligned_cols=120 Identities=28% Similarity=0.437 Sum_probs=94.8
Q ss_pred CCCC-CCCCccceEEEeec-Cc-----eEEEEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 027476 2 MSRV-RHRNLVKFIGACKE-PV-----MVIVTELLLGGTLRKYLLNMR---PRCLDIHVAIGFALDIARAMECLHSHGII 71 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~-----~~lv~e~~~~~sL~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~iv 71 (223)
++++ +||||+++++++.. +. .++||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++|++
T Consensus 54 l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~ 132 (295)
T cd07837 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVM 132 (295)
T ss_pred HHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 4556 57999999998854 23 7899999975 8988886532 23589999999999999999999999999
Q ss_pred cCCCCCCCEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 122 (223)
||||||+||+++.++..+||+|||+++..... .......+++.|+|||.+.
T Consensus 133 H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 184 (295)
T cd07837 133 HRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLL 184 (295)
T ss_pred ecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhh
Confidence 99999999999983448999999998754322 1122335678899999653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-26 Score=189.29 Aligned_cols=146 Identities=27% Similarity=0.355 Sum_probs=133.2
Q ss_pred CCCCCCCCCccceEEEeecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||.+.+.|.||++|..|.++ ..|++||-|-||.|...+++++. ++......++..+++|++|||++||++|||||+|
T Consensus 473 Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPEN 550 (732)
T KOG0614|consen 473 IMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPEN 550 (732)
T ss_pred HHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcCceeccCChhh
Confidence 35567899999999999775 67899999999999999987665 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
.+++.+| -+||.|||+|+.........+.+||+.|.|||.+.....+.+.|.|+|+..++++-.+.-|+
T Consensus 551 llLd~~G-y~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPF 619 (732)
T KOG0614|consen 551 LLLDNRG-YLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPF 619 (732)
T ss_pred eeeccCC-ceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCC
Confidence 9999988 79999999999988888888999999999999999999999999999998888877776653
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=177.69 Aligned_cols=149 Identities=30% Similarity=0.462 Sum_probs=121.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||+++.++|.+ +..++|+||+. |+|.+++.... +.+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 69 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nI 146 (307)
T cd06607 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNI 146 (307)
T ss_pred HHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccE
Confidence 567899999999999865 57889999995 67777775432 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC---C---------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP---S--------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~--------------------------------- 124 (223)
+++.++ .+||+|||++..... .....++..|+|||.+.. .
T Consensus 147 l~~~~~-~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~ 222 (307)
T cd06607 147 LLTEPG-TVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (307)
T ss_pred EECCCC-CEEEeecCcceecCC---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH
Confidence 999887 799999998865332 233467889999996520 0
Q ss_pred -------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++.+||..+|.+||++.+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 223 LYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01234567889999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=175.78 Aligned_cols=138 Identities=26% Similarity=0.343 Sum_probs=108.3
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|+++ +|+||+++++.++. +..++|+||+++++|.+++..... +++..+..++.|++.||.|||+.|++||||+|+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~n 135 (290)
T cd05613 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLEN 135 (290)
T ss_pred HHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 4567 69999999999875 567899999999999999976544 8999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCCC--CCCChHHHHHHHHHhccc
Q 027476 80 LILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRPS--AENLPEDLALIVTSCWKE 142 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~~l~~l~~~~l~~ 142 (223)
|+++.++ .+||+|||++....... ......|+..|++||.+... ..+...|+|+++..+++.
T Consensus 136 il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~l 201 (290)
T cd05613 136 ILLDSNG-HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201 (290)
T ss_pred eEECCCC-CEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHH
Confidence 9999887 89999999987543221 12234688899999976532 223344555555444433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=176.67 Aligned_cols=155 Identities=26% Similarity=0.367 Sum_probs=122.6
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++ +||||+++++.+.. ...++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+|
T Consensus 58 l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~n 135 (288)
T cd05583 58 LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLEN 135 (288)
T ss_pred HHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 4566 69999999998865 56889999999999999987644 38999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
|+++.++ .++|+|||+++....... .....|+..|++||.+...
T Consensus 136 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 136 ILLDSEG-HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred eEECCCC-CEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 9999877 799999999875433221 1234578899999954311
Q ss_pred -----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 125 -----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 125 -----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
+..++.++.+++.+||+.+|.+||++.++.+.|+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 215 NSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred chHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11234567778888888888888887766665544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-25 Score=176.85 Aligned_cols=153 Identities=26% Similarity=0.452 Sum_probs=118.6
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYL---LNMRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDL 75 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l---~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~dl 75 (223)
+.++ +|+||+++++++.+ +..+++|||+. +++.++. .......+++..+..++.|++.||+|||+. +++||||
T Consensus 56 l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dl 134 (288)
T cd06616 56 VMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDV 134 (288)
T ss_pred HHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCC
Confidence 3455 49999999998754 57889999984 5665543 222335599999999999999999999975 9999999
Q ss_pred CCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-------------------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS------------------------------- 124 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------------------- 124 (223)
||+||+++.++ .+||+|||+++............|+..|+|||.+...
T Consensus 135 kp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 135 KPSNILLDRNG-NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred CHHHEEEccCC-cEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 99999999877 7999999998754433333444688899999954321
Q ss_pred ----------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++.+||+.+|.+||++++++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 214 NSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred chHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01245567888999999999999999888765
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=199.00 Aligned_cols=146 Identities=25% Similarity=0.355 Sum_probs=125.3
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
+.+=|+.++..|+| .++|+||||++||+|-.++.+.. .+++..++.++.+|+.||.-+|+.|+|||||||+|||+|.
T Consensus 133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 133 NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK 210 (1317)
T ss_pred CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc
Confidence 45567888888876 57899999999999999998766 4999999999999999999999999999999999999999
Q ss_pred CCCceEEccCcccccccc--ccccccCCCccccccCCCCCCC-----CCCChHHHHHHHHHhcccCCCCCCCHHHHH
Q 027476 85 DHKTVKLADFGLAREESL--TEMMTAETGTYRWMAPENMRPS-----AENLPEDLALIVTSCWKEDPNERPNFSQII 154 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~ 154 (223)
.| ++||+|||.+-.... .......+|||.|++||+++.. .++..-|+|+++..++++-.++=|+.++-+
T Consensus 211 ~G-HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl 286 (1317)
T KOG0612|consen 211 SG-HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL 286 (1317)
T ss_pred cC-cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH
Confidence 88 899999998865442 2334567899999999988743 455667999999999999999999876543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=176.36 Aligned_cols=117 Identities=26% Similarity=0.357 Sum_probs=95.1
Q ss_pred CCCCCCCCccceEEEeecC-----------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027476 2 MSRVRHRNLVKFIGACKEP-----------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGI 70 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~-----------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i 70 (223)
+++++||||+++++++.+. .+++|+||+.+ ++.+.+... ...+++..++.++.|++.||.|||+.|+
T Consensus 60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i 137 (302)
T cd07864 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNF 137 (302)
T ss_pred HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 5678999999999988542 58899999965 777777653 3358999999999999999999999999
Q ss_pred ccCCCCCCCEEEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCC
Q 027476 71 IHRDLKPENLILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENM 121 (223)
Q Consensus 71 vH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~ 121 (223)
+|+||||+||+++.++ .+||+|||++....... ......++..|++||.+
T Consensus 138 ~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 189 (302)
T cd07864 138 LHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELL 189 (302)
T ss_pred ecCCCCHHHEEECCCC-cEEeCcccccccccCCcccccccceeccCccChHHh
Confidence 9999999999999877 89999999987543222 12223457789999955
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=180.66 Aligned_cols=115 Identities=32% Similarity=0.499 Sum_probs=94.5
Q ss_pred CCCCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
+++++||||+++++++.. ...++|+||+. ++|.+.+.. +.+++..++.++.|++.||.|||+.|++||||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dl 132 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDL 132 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 577899999999988743 24789999995 588887754 34899999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCccccccccccc----cccCCCccccccCCCC
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENM 121 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~ 121 (223)
||+||+++.++ .+||+|||++........ .....|+..|+|||.+
T Consensus 133 kp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (336)
T cd07849 133 KPSNLLLNTNC-DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181 (336)
T ss_pred CHHHEEECCCC-CEEECcccceeeccccccccCCcCCcCcCCCccChHHh
Confidence 99999999887 799999999875432211 1234678899999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=171.91 Aligned_cols=146 Identities=25% Similarity=0.417 Sum_probs=124.0
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++|+||+++++.+.+ +.+++++||+.+++|.+++..... +++..+..++.|++.||.|||+.|++|+||||+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ 135 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGA 135 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 567899999999998854 357899999999999999976544 899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccc----cccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCH
Q 027476 79 NLILTADHKTVKLADFGLAREESLT----EMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
||+++.++ .++|+|||+++..... .......++..|+|||.+.....+...|+|+++..+++.-.++.|..
T Consensus 136 ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 136 NILRDSAG-NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred HEEEcCCC-CEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999877 7999999999754321 11123468899999999988877888999999999988888777743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=174.83 Aligned_cols=153 Identities=29% Similarity=0.470 Sum_probs=124.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|||++++++++.+ ...++||||+. |+|.+.+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Ni 156 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 156 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccE
Confidence 567899999999999865 57889999996 57877775432 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------- 123 (223)
+++.++ .+||+|||++..... .....++..|+|||.+..
T Consensus 157 l~~~~~-~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 232 (317)
T cd06635 157 LLTEPG-QVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232 (317)
T ss_pred EECCCC-CEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 999877 899999998864332 234468889999996520
Q ss_pred ------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 124 ------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 124 ------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
....++..+.+++.+||+.+|.+||++.++++++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred HHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 0112445678899999999999999999998875543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=178.04 Aligned_cols=117 Identities=28% Similarity=0.453 Sum_probs=96.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.. +..++||||+. ++|.+++..... +++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~ni 150 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR--LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANI 150 (335)
T ss_pred HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHe
Confidence 577899999999999864 57889999995 699998876443 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc---------------ccccccCCCccccccCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESL---------------TEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~ 122 (223)
+++.++ .+||+|||++..... ........++..|+|||.+.
T Consensus 151 ll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 206 (335)
T PTZ00024 151 FINSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM 206 (335)
T ss_pred EECCCC-CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcc
Confidence 999877 899999999875431 11112234678899999654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-25 Score=175.60 Aligned_cols=118 Identities=31% Similarity=0.484 Sum_probs=98.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++|+||+++++++.+ +..++|+||+. ++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||||+||
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ni 129 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENL 129 (283)
T ss_pred HHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHE
Confidence 567899999999998865 57899999996 58888887643 4589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMR 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~ 122 (223)
+++.++ .+||+|||.+....... ......++..|+|||.+.
T Consensus 130 li~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 171 (283)
T cd05118 130 LINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171 (283)
T ss_pred EECCCC-cEEEeeeeeeEecCCCcccccCccCcccccCcHHHh
Confidence 999877 79999999987544332 223345778899999554
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=178.66 Aligned_cols=115 Identities=34% Similarity=0.480 Sum_probs=95.8
Q ss_pred CCCC-CCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
++++ +||||++++++|.. ...++||||+. ++|.+++... .+++..++.++.|++.||.|||+.|++|+||||
T Consensus 60 l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p 135 (337)
T cd07852 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKP 135 (337)
T ss_pred HHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 4677 99999999998853 25799999996 6999988654 488999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCcccccccccc------ccccCCCccccccCCCC
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTE------MMTAETGTYRWMAPENM 121 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~ 121 (223)
+||+++.++ .+||+|||++....... ......|+..|+|||.+
T Consensus 136 ~nill~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 184 (337)
T cd07852 136 SNILLNSDC-RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL 184 (337)
T ss_pred HHEEEcCCC-cEEEeeccchhccccccccccCcchhcccccccccCceee
Confidence 999999888 89999999987543221 12234688899999954
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=175.94 Aligned_cols=151 Identities=30% Similarity=0.494 Sum_probs=119.6
Q ss_pred CCCCC-CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVR-HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~-Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++ ||||+++++++.+ +..++||||+.+++|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus 55 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~n 132 (280)
T cd05581 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPEN 132 (280)
T ss_pred HHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 45677 9999999999865 57899999999999999998754 49999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc---------------------ccccCCCccccccCCCCCCCC-------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE---------------------MMTAETGTYRWMAPENMRPSA------------- 125 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~~~------------- 125 (223)
|+++.++ .++++|||++....... ......++..|++||.+....
T Consensus 133 i~i~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~ 211 (280)
T cd05581 133 ILLDKDM-HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCI 211 (280)
T ss_pred eEECCCC-CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHH
Confidence 9999877 79999999987543221 112235778999999554322
Q ss_pred -------------------------------CCChHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 027476 126 -------------------------------ENLPEDLALIVTSCWKEDPNERPNF----SQIIQ 155 (223)
Q Consensus 126 -------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~----~~~~~ 155 (223)
...+.++.+++..||+.+|.+||++ +++++
T Consensus 212 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 212 IYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 2334556677777777777777777 55543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=173.26 Aligned_cols=137 Identities=24% Similarity=0.309 Sum_probs=106.5
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++|+||+++++++.+ +..++|+||+. ++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|+
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~ 129 (287)
T cd07840 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGS 129 (287)
T ss_pred HHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHH
Confidence 567899999999999864 47899999996 58998887642 35899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCC-CCCCChHHHHHHHHHhcc
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRP-SAENLPEDLALIVTSCWK 141 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~~l~~l~~~~l~ 141 (223)
||+++.++ .+||+|||++....... ......++..|+|||.+.. ...+...|+|+++..+++
T Consensus 130 nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~e 194 (287)
T cd07840 130 NILINNDG-VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAE 194 (287)
T ss_pred HeEEcCCC-CEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHH
Confidence 99999887 89999999987554332 1233456788999996543 223344455554444443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=189.29 Aligned_cols=159 Identities=31% Similarity=0.643 Sum_probs=132.6
Q ss_pred CCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC------------C--CCCCHHHHHHHHHHHHHHHHHHH
Q 027476 3 SRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR------------P--RCLDIHVAIGFALDIARAMECLH 66 (223)
Q Consensus 3 ~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------------~--~~l~~~~~~~i~~qi~~~l~~lH 66 (223)
+.+ +|+||+.++|.|.+ +..++|+||+..|+|.++++..+ . ..++....+.++.||+.|++||+
T Consensus 356 ~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~ 435 (609)
T KOG0200|consen 356 KELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA 435 (609)
T ss_pred HHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh
Confidence 344 79999999999975 67899999999999999998765 0 13889999999999999999999
Q ss_pred hCCcccCCCCCCCEEEeCCCCceEEccCccccccccccccc--cCCC--ccccccCCCCC--------------------
Q 027476 67 SHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMT--AETG--TYRWMAPENMR-------------------- 122 (223)
Q Consensus 67 ~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~g--t~~y~aPE~~~-------------------- 122 (223)
+.+++||||.+.||++..+. .+||+|||+|+......... ...+ ...|||||.+.
T Consensus 436 ~~~~vHRDLAaRNVLi~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Ei 514 (609)
T KOG0200|consen 436 SVPCVHRDLAARNVLITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEI 514 (609)
T ss_pred hCCccchhhhhhhEEecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHH
Confidence 99999999999999999876 89999999998544333222 2222 34699999432
Q ss_pred ---------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 ---------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 ---------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
..+..++.+++.++..||+.+|.+||++.++.+.+...+.
T Consensus 515 fsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 515 FTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred hhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 3466678899999999999999999999999999988644
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=185.84 Aligned_cols=145 Identities=25% Similarity=0.341 Sum_probs=123.1
Q ss_pred CCCCCC---CCCccceEEEeecC-ceEEEEEcC-CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 1 MMSRVR---HRNLVKFIGACKEP-VMVIVTELL-LGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 1 il~~l~---Hpniv~l~~~~~~~-~~~lv~e~~-~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
||+.++ |+||++++++|+++ .+|++||-- +|-+|.++|..... +++.++.-|+.|++.|+++||++|||||||
T Consensus 619 Ila~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~ivhrdi 696 (772)
T KOG1152|consen 619 ILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQGIVHRDI 696 (772)
T ss_pred HHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccCceeccc
Confidence 455665 99999999999875 677888865 45688999876555 999999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCC-CChHHHHHHHHHhcccCCCCCCC
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAE-NLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
|-+|+.++.+| .+||+|||.+.....+. ....+||..|+|||++.+..+ +-+.|+|.++..++.....+-|.
T Consensus 697 kdenvivd~~g-~~klidfgsaa~~ksgp-fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 697 KDENVIVDSNG-FVKLIDFGSAAYTKSGP-FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ccccEEEecCC-eEEEeeccchhhhcCCC-cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99999999988 89999999987554433 356789999999999998875 67899999998888776666654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=173.84 Aligned_cols=149 Identities=29% Similarity=0.476 Sum_probs=120.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|||++++++++.+ ...++||||+. ++|.+.+.... ..+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus 75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~ni 152 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 152 (313)
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhE
Confidence 577899999999999875 56889999995 67877776533 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC---C---------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP---S--------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~--------------------------------- 124 (223)
+++.++ .+||+|||++.... ......|+..|+|||.+.. .
T Consensus 153 li~~~~-~~kL~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~ 228 (313)
T cd06633 153 LLTEPG-QVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 228 (313)
T ss_pred EECCCC-CEEEeecCCCcccC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999877 79999999886432 2234568889999997520 0
Q ss_pred -------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++..+.+++.+||+.+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 229 LYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01234567888899999999999998888755
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=175.47 Aligned_cols=116 Identities=30% Similarity=0.423 Sum_probs=93.7
Q ss_pred CCCC-CCCCccceEEEee---c--CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRV-RHRNLVKFIGACK---E--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~---~--~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
++++ +||||+++++.+. + ...++++||+ +++|.+.+.... .+++..++.++.|++.||+|||+.|++||||
T Consensus 55 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dl 131 (332)
T cd07857 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDL 131 (332)
T ss_pred HHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 3456 6999999998752 1 3477888888 579999887544 3899999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCcccccccccc-----ccccCCCccccccCCCC
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTE-----MMTAETGTYRWMAPENM 121 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~ 121 (223)
||+||+++.++ .+||+|||+++...... ......|+..|+|||.+
T Consensus 132 kp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 181 (332)
T cd07857 132 KPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181 (332)
T ss_pred CHHHeEEcCCC-CEEeCcCCCceecccccccccccccCcccCccccCcHHH
Confidence 99999999877 89999999997543211 12234688999999954
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=172.44 Aligned_cols=148 Identities=30% Similarity=0.512 Sum_probs=119.4
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEe
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPENLILT 83 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~ 83 (223)
.||||+++++++.+ ...++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+ .|++||||+|+||+++
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~ 149 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD 149 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc
Confidence 59999999999865 5789999998 568888776533 358999999999999999999997 5999999999999999
Q ss_pred CCCCceEEccCccccccccccccccCCCccccccCCCCCCCC--------------------------------------
Q 027476 84 ADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA-------------------------------------- 125 (223)
Q Consensus 84 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------------------------------- 125 (223)
.++ .+||+|||++.............++..|+|||.+....
T Consensus 150 ~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 228 (296)
T cd06618 150 ASG-NVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228 (296)
T ss_pred CCC-CEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH
Confidence 877 89999999987544333333445788899999653110
Q ss_pred --------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 --------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 --------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++.+||..+|.+||++++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1245567889999999999999999999766
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=172.07 Aligned_cols=149 Identities=28% Similarity=0.443 Sum_probs=121.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+|++++.+++.+ ...++|+||+. ++|.+.+.... ..+++..+..++.|++.||.|||+.+++||||+|+||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 146 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146 (308)
T ss_pred HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhE
Confidence 577899999999998865 57889999995 68888775433 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------- 123 (223)
+++.++ .+||+|||++..... .....++..|+|||.+..
T Consensus 147 l~~~~~-~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 222 (308)
T cd06634 147 LLSEPG-LVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (308)
T ss_pred EECCCC-cEEECCcccceeecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH
Confidence 999877 899999999865332 233467889999995410
Q ss_pred ------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 ------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 ------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....++..+.+++.+||..+|.+||++++++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 011345567889999999999999999999866
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=171.48 Aligned_cols=118 Identities=33% Similarity=0.486 Sum_probs=98.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ +..++|+||+. ++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||
T Consensus 52 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni 129 (282)
T cd07829 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNI 129 (282)
T ss_pred HHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheE
Confidence 567899999999999865 57899999996 69999998753 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMR 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~ 122 (223)
+++.++ .++|+|||++....... ......++..|+|||.+.
T Consensus 130 ~~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 171 (282)
T cd07829 130 LINRDG-VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILL 171 (282)
T ss_pred EEcCCC-CEEEecCCcccccCCCccccCccccCcCcCChHHhc
Confidence 999877 89999999987543322 223345677899999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-24 Score=175.10 Aligned_cols=114 Identities=32% Similarity=0.471 Sum_probs=94.6
Q ss_pred CCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+++++||||+++++++.. +..+++++++ +++|.+++... .+++..++.++.|++.||+|||+.|++|||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~d 145 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRD 145 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 567899999999998743 2367788877 88998887642 389999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
|||+||+++.++ .+||+|||+++.... ......++..|+|||.+.
T Consensus 146 lkp~NIll~~~~-~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~ 190 (345)
T cd07877 146 LKPSNLAVNEDC-ELKILDFGLARHTDD--EMTGYVATRWYRAPEIML 190 (345)
T ss_pred CChHHEEEcCCC-CEEEecccccccccc--cccccccCCCccCHHHHh
Confidence 999999999887 899999999875432 223446788999999653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=171.18 Aligned_cols=119 Identities=28% Similarity=0.454 Sum_probs=100.3
Q ss_pred CCCCCCCCCccceEEEee-c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCC
Q 027476 1 MMSRVRHRNLVKFIGACK-E-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH--GIIHRDLK 76 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~-~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlk 76 (223)
|-+.|+||.||++|++|. | ..+|-|+|||+|.+|+-+++.++- +++++++.|+.||+.||.||.+. -|+|-|||
T Consensus 520 IHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLK 597 (775)
T KOG1151|consen 520 IHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLK 597 (775)
T ss_pred hhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccC
Confidence 346799999999999994 4 578999999999999999987655 99999999999999999999986 49999999
Q ss_pred CCCEEEeCC--CCceEEccCccccccccc--------cccccCCCccccccCCCC
Q 027476 77 PENLILTAD--HKTVKLADFGLAREESLT--------EMMTAETGTYRWMAPENM 121 (223)
Q Consensus 77 p~Nill~~~--~~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~ 121 (223)
|.|||+... ++.+||+|||+++..... +..+...||.+|++||.+
T Consensus 598 PgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcF 652 (775)
T KOG1151|consen 598 PGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECF 652 (775)
T ss_pred CccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCccee
Confidence 999999643 247999999999864332 223456799999999944
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=172.08 Aligned_cols=156 Identities=29% Similarity=0.435 Sum_probs=126.0
Q ss_pred CCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------C
Q 027476 4 RVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH---------G 69 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---------~ 69 (223)
.++|+||+++++.-+. .++|+|++|.+.|+|.++++.+ .++|....+++..++.||+|||+. .
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~ 336 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPP 336 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCc
Confidence 5799999999987532 3799999999999999999764 499999999999999999999973 4
Q ss_pred cccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCCCC----------------------
Q 027476 70 IIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMRPS---------------------- 124 (223)
Q Consensus 70 ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~---------------------- 124 (223)
|+|||||..||||..|. ...|+|||+|........ ....+||..|||||++.+.
T Consensus 337 IaHRDlkSkNVLvK~Dl-TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLW 415 (534)
T KOG3653|consen 337 IAHRDLKSKNVLVKNDL-TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLW 415 (534)
T ss_pred cccccccccceEEccCC-cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHH
Confidence 99999999999999888 899999999986543322 1235899999999955311
Q ss_pred -------------------------------------------C---------CCChHHHHHHHHHhcccCCCCCCCHHH
Q 027476 125 -------------------------------------------A---------ENLPEDLALIVTSCWKEDPNERPNFSQ 152 (223)
Q Consensus 125 -------------------------------------------~---------~~~~~~l~~l~~~~l~~~p~~Rp~~~~ 152 (223)
. ..-..-+.+.+..||..|++.|.|+.=
T Consensus 416 Ei~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 416 EIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred HHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 0 011123566888999999999999998
Q ss_pred HHHHHHHHhhc
Q 027476 153 IIQMLLHYIST 163 (223)
Q Consensus 153 ~~~~L~~~~~~ 163 (223)
+.+.+.++...
T Consensus 496 v~eR~~~l~~~ 506 (534)
T KOG3653|consen 496 VEERMAELMML 506 (534)
T ss_pred HHHHHHHHhcc
Confidence 88888877644
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=170.02 Aligned_cols=114 Identities=32% Similarity=0.518 Sum_probs=96.5
Q ss_pred CCCCccceEEEeecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
.|+||++|+++|+++ .+|+|||-+.||+|..+|.++.. +++.++.++.++|+.||+|||.+||.||||||+|||-..
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCES 211 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecC
Confidence 599999999999864 78999999999999999988766 999999999999999999999999999999999999864
Q ss_pred CC--CceEEccCccccccccc--------cccccCCCccccccCCCC
Q 027476 85 DH--KTVKLADFGLAREESLT--------EMMTAETGTYRWMAPENM 121 (223)
Q Consensus 85 ~~--~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~ 121 (223)
.+ .-|||+||.+....... ....+.+|+..|||||++
T Consensus 212 pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVV 258 (463)
T KOG0607|consen 212 PNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVV 258 (463)
T ss_pred CCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHH
Confidence 43 15899999987632211 122345789999999944
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=177.59 Aligned_cols=113 Identities=33% Similarity=0.506 Sum_probs=95.5
Q ss_pred CCCCCCCCccceEEEeec-C------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKE-P------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+++++||||+++.+++.. + ..++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.|++|+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~d 143 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRD 143 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 567899999999987743 2 378999999 7899998865 3499999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCC
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 121 (223)
|||+||+++.++ .+||+|||++...... .....++..|+|||.+
T Consensus 144 lkp~Nill~~~~-~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~ 187 (343)
T cd07851 144 LKPSNIAVNEDC-ELKILDFGLARHTDDE--MTGYVATRWYRAPEIM 187 (343)
T ss_pred CCHHHeEECCCC-CEEEcccccccccccc--ccCCcccccccCHHHH
Confidence 999999999877 7999999998754322 2344678889999954
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-24 Score=177.04 Aligned_cols=116 Identities=28% Similarity=0.399 Sum_probs=93.7
Q ss_pred CCCCCCCCccceEEEeec---------------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRVRHRNLVKFIGACKE---------------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLH 66 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---------------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH 66 (223)
+++++||||+++++.+.. ...++|+||+. ++|.+++... .+++..++.++.|++.||.|||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH 131 (342)
T cd07854 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH 131 (342)
T ss_pred HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH
Confidence 678899999999987643 24689999996 6898887542 3899999999999999999999
Q ss_pred hCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCC
Q 027476 67 SHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENM 121 (223)
Q Consensus 67 ~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~ 121 (223)
+.|++||||||+||+++.++..+||+|||.++...... ......++..|+|||.+
T Consensus 132 ~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 190 (342)
T cd07854 132 SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL 190 (342)
T ss_pred hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHH
Confidence 99999999999999998665579999999987543211 11223578899999954
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=172.49 Aligned_cols=113 Identities=35% Similarity=0.560 Sum_probs=94.6
Q ss_pred CCCCCCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++||||+++.++|.. ...++|+||+ +++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+|
T Consensus 63 l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~N 138 (328)
T cd07856 63 LKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSN 138 (328)
T ss_pred HHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 567899999999998854 4688999998 67999888642 37888899999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 121 (223)
|+++.++ .+||+|||.+..... ......++..|+|||.+
T Consensus 139 ili~~~~-~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~ 177 (328)
T cd07856 139 ILINENC-DLKICDFGLARIQDP--QMTGYVSTRYYRAPEIM 177 (328)
T ss_pred EeECCCC-CEEeCccccccccCC--CcCCCcccccccCceee
Confidence 9999877 799999999875322 12334678889999965
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=173.61 Aligned_cols=114 Identities=29% Similarity=0.492 Sum_probs=95.5
Q ss_pred CCCCCCCCCccceEEEeecC-------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 1 MMSRVRHRNLVKFIGACKEP-------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
+|++++||||+++++++..+ .+++||||+ +++|.+++.. ..+++..++.++.|++.||.|||+.|++||
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~ 142 (343)
T cd07880 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHR 142 (343)
T ss_pred HHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 36788999999999988532 358999999 8899988864 248999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCC
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 121 (223)
||||+||+++.++ .+||+|||++...... .....+++.|++||.+
T Consensus 143 dlkp~Nill~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~ 187 (343)
T cd07880 143 DLKPGNLAVNEDC-ELKILDFGLARQTDSE--MTGYVVTRWYRAPEVI 187 (343)
T ss_pred CCCHHHEEEcCCC-CEEEeecccccccccC--ccccccCCcccCHHHH
Confidence 9999999999877 7999999998754322 2234678889999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.5e-24 Score=171.93 Aligned_cols=118 Identities=27% Similarity=0.370 Sum_probs=94.3
Q ss_pred CCCCCCCCccceEEEeec---------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 2 MSRVRHRNLVKFIGACKE---------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
+++++||||+++++++.+ ..+++|+||+. ++|.+.+... ...+++..+..++.|++.||.|||++|++|
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H 138 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILH 138 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 567899999999987632 23689999995 5777776543 235999999999999999999999999999
Q ss_pred CCCCCCCEEEeCCCCceEEccCccccccccccc------------cccCCCccccccCCCCC
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESLTEM------------MTAETGTYRWMAPENMR 122 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~gt~~y~aPE~~~ 122 (223)
+||||+||+++.++ .+||+|||+++....... .....+++.|+|||.+.
T Consensus 139 ~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (311)
T cd07866 139 RDIKAANILIDNQG-ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL 199 (311)
T ss_pred CCCCHHHEEECCCC-CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhh
Confidence 99999999999887 899999999875332111 12235678899999654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=169.95 Aligned_cols=115 Identities=36% Similarity=0.538 Sum_probs=99.3
Q ss_pred CCCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 1 MMSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
++..++|+||++++.+|.- ...|+|||++ ..+|.+.+... ++-+.+..++.|++.|++|+|+.||+||
T Consensus 68 l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~IihR 142 (369)
T KOG0665|consen 68 LMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSAGIIHR 142 (369)
T ss_pred hhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcceeec
Confidence 3567899999999999942 3579999999 67999988732 7888899999999999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCC
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 121 (223)
||||+||++..++ .+||.|||+|+.....-..+..+.+..|.|||++
T Consensus 143 dLkPsnivv~~~~-~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevi 189 (369)
T KOG0665|consen 143 DLKPSNIVVNSDC-TLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVI 189 (369)
T ss_pred ccCcccceecchh-heeeccchhhcccCcccccCchhheeeccCchhe
Confidence 9999999999988 8999999999976655455667889999999944
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=185.47 Aligned_cols=160 Identities=27% Similarity=0.534 Sum_probs=135.5
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|.+++|||+++|+++|..+...+|++|+++|+|.++++.++ ..+-.+..+.|..||++||.|||++++|||||.+.||
T Consensus 751 ~masldHpnl~RLLgvc~~s~~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNV 829 (1177)
T KOG1025|consen 751 RMASLDHPNLLRLLGVCMLSTLQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNV 829 (1177)
T ss_pred HHhcCCCchHHHHhhhcccchHHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhhe
Confidence 478999999999999999888999999999999999998755 3488899999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccC--CCccccccCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAE--TGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~--~gt~~y~aPE~~~----------------------------------- 122 (223)
||.+-+ ++||.|||+++...... ..... .-.+.|||-|.++
T Consensus 830 LVksP~-hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 830 LVKSPN-HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred eecCCC-eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 999877 89999999998544322 22222 2345778877332
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
..+..++.|+|.++.+||..++..||+++++...+.+..+
T Consensus 909 I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 909 IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 4577889999999999999999999999999888777654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=182.47 Aligned_cols=149 Identities=25% Similarity=0.450 Sum_probs=115.7
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL 82 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill 82 (223)
+|||||++++.-.+ +..|++.|.| .-+|.+++... ..........+..+.|+++||++||+.+||||||||+||||
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI 639 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILI 639 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEE
Confidence 69999999998765 5789999999 68999999873 11111113456788999999999999999999999999999
Q ss_pred eC---CC-CceEEccCccccccccccc----cccCCCccccccCCCCCCCCCC---------------------------
Q 027476 83 TA---DH-KTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMRPSAEN--------------------------- 127 (223)
Q Consensus 83 ~~---~~-~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~--------------------------- 127 (223)
+. ++ .+++|+|||+++....... ..+..||-+|+|||.++.....
T Consensus 640 ~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 640 SVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred EccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence 86 23 4799999999986543321 3456799999999965421100
Q ss_pred -------------------ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 128 -------------------LPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 128 -------------------~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
...+..+||.+|+..+|..||++.+|+.
T Consensus 720 ~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 720 ERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred HhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0015678999999999999999999964
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-24 Score=193.20 Aligned_cols=152 Identities=22% Similarity=0.336 Sum_probs=111.9
Q ss_pred CCCCC-CCccceEEEee-------c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 3 SRVRH-RNLVKFIGACK-------E-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 3 ~~l~H-pniv~l~~~~~-------~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
+.++| +||+++++.|. + ..++.++||+ +++|.+++... ...+++.+++.++.||+.||.|||++||+||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 55677 79999999871 1 2466788887 77999999753 3449999999999999999999999999999
Q ss_pred CCCCCCEEEeCCC------------------CceEEccCccccccccc-----------------cccccCCCccccccC
Q 027476 74 DLKPENLILTADH------------------KTVKLADFGLAREESLT-----------------EMMTAETGTYRWMAP 118 (223)
Q Consensus 74 dlkp~Nill~~~~------------------~~~kl~Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aP 118 (223)
||||+||||+..+ ..+|++|||+++..... ......+||+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999995422 25677777777532110 001123578899999
Q ss_pred CCCCCCCCCChHHH-------------------------------------------HHHHHHhcccCCCCCCCHHHHHH
Q 027476 119 ENMRPSAENLPEDL-------------------------------------------ALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 119 E~~~~~~~~~~~~l-------------------------------------------~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
|++....++...|+ ..++..||+.+|.+||++.++++
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 97764433333333 34566789999999999999875
Q ss_pred H
Q 027476 156 M 156 (223)
Q Consensus 156 ~ 156 (223)
+
T Consensus 265 h 265 (793)
T PLN00181 265 S 265 (793)
T ss_pred c
Confidence 3
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=172.74 Aligned_cols=113 Identities=29% Similarity=0.437 Sum_probs=92.8
Q ss_pred CCCCCCCCccceEEEeecC-------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKEP-------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+++++||||+++++++... .+++|+||+. .+|.++.. ..+++..+..++.|++.||.|||+.|++|||
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~d 142 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRD 142 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 5678999999999988532 4689999995 57776652 2389999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
|||+||+++.++ .+||+|||+++.... ......++..|+|||.+.
T Consensus 143 lkp~NIll~~~~-~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~ 187 (342)
T cd07879 143 LKPGNLAVNEDC-ELKILDFGLARHADA--EMTGYVVTRWYRAPEVIL 187 (342)
T ss_pred CCHHHEEECCCC-CEEEeeCCCCcCCCC--CCCCceeeecccChhhhc
Confidence 999999999887 899999999875432 123346788899999653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=168.48 Aligned_cols=118 Identities=24% Similarity=0.362 Sum_probs=98.4
Q ss_pred CCCCCCCCCccceEEEee--cCceEEEEEcCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 1 MMSRVRHRNLVKFIGACK--EPVMVIVTELLLGGTLRKYLLNM---RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
+++.|+||||+.|..+|. +...++++||.+ -+|.++|+-. ..+.++...+..++.||+.|+.|||++=|+||||
T Consensus 80 L~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDL 158 (438)
T KOG0666|consen 80 LLRELKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDL 158 (438)
T ss_pred HHHHhcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccC
Confidence 367899999999999883 568999999996 5888888632 2245999999999999999999999999999999
Q ss_pred CCCCEEEeCCC---CceEEccCcccccccccc----ccccCCCccccccCC
Q 027476 76 KPENLILTADH---KTVKLADFGLAREESLTE----MMTAETGTYRWMAPE 119 (223)
Q Consensus 76 kp~Nill~~~~---~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE 119 (223)
||.||+|..++ ++|||+|||+++...+.- .....+.|.+|+|||
T Consensus 159 KPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE 209 (438)
T KOG0666|consen 159 KPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE 209 (438)
T ss_pred CcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChH
Confidence 99999998772 389999999999654432 233456799999999
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=187.66 Aligned_cols=133 Identities=28% Similarity=0.434 Sum_probs=105.2
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccccc
Q 027476 21 VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREE 100 (223)
Q Consensus 21 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 100 (223)
.+||=||||+..+|.+++.++.... .....|++++||+.||.|+|++|++||||||.||+++.++ .|||+|||+|...
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDL 747 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCC-Ceeecccccchhh
Confidence 3688999999988888887755311 5788999999999999999999999999999999999887 7999999999741
Q ss_pred c-------------------cccccccCCCccccccCCCCCCCC---CCChH----------------------------
Q 027476 101 S-------------------LTEMMTAETGTYRWMAPENMRPSA---ENLPE---------------------------- 130 (223)
Q Consensus 101 ~-------------------~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~---------------------------- 130 (223)
. .....+..+||.-|+|||.+.... ++-..
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~ 827 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTN 827 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhccCCchHHHHHHHHh
Confidence 0 011234557999999999665322 22222
Q ss_pred ------------------HHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 131 ------------------DLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 131 ------------------~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
.-.++|.++++.+|.+||++.+++.
T Consensus 828 LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 828 LRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 2356899999999999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-24 Score=163.53 Aligned_cols=162 Identities=23% Similarity=0.369 Sum_probs=127.5
Q ss_pred CCCCCCCCCccceEEEeec---------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 027476 1 MMSRVRHRNLVKFIGACKE---------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGII 71 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iv 71 (223)
||..|+|+|++.+++.|.. ..+++||.+|+ .+|..++.+.. ..++..++.+++.++..||.|+|...|+
T Consensus 69 iL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kil 146 (376)
T KOG0669|consen 69 ILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKIL 146 (376)
T ss_pred HHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHH
Confidence 4667899999999998821 24899999995 68888887643 3499999999999999999999999999
Q ss_pred cCCCCCCCEEEeCCCCceEEccCccccccccccc-----cccCCCccccccCCCCC------------------------
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLTEM-----MTAETGTYRWMAPENMR------------------------ 122 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~------------------------ 122 (223)
|||+|+.|++|+.++ .+||+|||+++..+.... ++..+.|.+|++||.+.
T Consensus 147 HRDmKaaNvLIt~dg-ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtr 225 (376)
T KOG0669|consen 147 HRDMKAANVLITKDG-ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTR 225 (376)
T ss_pred hhcccHhhEEEcCCc-eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHcc
Confidence 999999999999888 899999999986543322 33445699999999221
Q ss_pred --------------------------------------------------------CCCCCChHHHHHHHHHhcccCCCC
Q 027476 123 --------------------------------------------------------PSAENLPEDLALIVTSCWKEDPNE 146 (223)
Q Consensus 123 --------------------------------------------------------~~~~~~~~~l~~l~~~~l~~~p~~ 146 (223)
-.++...++..+|+..++..||.+
T Consensus 226 spimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~k 305 (376)
T KOG0669|consen 226 SPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTK 305 (376)
T ss_pred CccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCccc
Confidence 012223346778999999999999
Q ss_pred CCCHHHHHHHHHHHhhcCCCC
Q 027476 147 RPNFSQIIQMLLHYISTNSAP 167 (223)
Q Consensus 147 Rp~~~~~~~~L~~~~~~~~~~ 167 (223)
|+..++++.+ .++...+.|
T Consensus 306 R~~ad~alnh--~~F~kdp~p 324 (376)
T KOG0669|consen 306 RIDADQALNH--DFFWKDPMP 324 (376)
T ss_pred CcchHhhhch--hhhhcCCcc
Confidence 9999999877 444444333
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-23 Score=161.11 Aligned_cols=151 Identities=34% Similarity=0.512 Sum_probs=127.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+||+++++++.+ ...++++||+.+++|.+++..... +++..++.++.+++.++.+||+.+++|+||+|+||
T Consensus 41 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni 118 (244)
T smart00220 41 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENI 118 (244)
T ss_pred HHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHe
Confidence 467799999999999865 678999999999999999977554 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS------------------------------------ 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------------------------ 124 (223)
+++.++ .++|+|||.+.............++..|++||.....
T Consensus 119 ~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~ 197 (244)
T smart00220 119 LLDEDG-HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK 197 (244)
T ss_pred EECCCC-cEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999877 8999999999865544344556788899999944210
Q ss_pred -----C-----CC--ChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 125 -----A-----EN--LPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 125 -----~-----~~--~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
. .. ++.++.+++.+|+..+|.+||++.++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 198 KIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0 00 6678889999999999999999999875
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-24 Score=163.29 Aligned_cols=160 Identities=26% Similarity=0.386 Sum_probs=133.7
Q ss_pred CCCCCCCCccceEEEe-ecCceEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCC
Q 027476 2 MSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLN---MRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLK 76 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~---~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlk 76 (223)
++.=+.||||++||.+ .++.-|+.||.| ..||+.+.+. .....++++-+-+|..-.+.||.||-. .+|+|||+|
T Consensus 117 mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvK 195 (361)
T KOG1006|consen 117 MKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVK 195 (361)
T ss_pred HhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCC
Confidence 4455789999999965 788999999999 6788776542 233459999999999999999999975 589999999
Q ss_pred CCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCC--CCChHHHHHHHHHhcccCCCCCC--CHHH
Q 027476 77 PENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA--ENLPEDLALIVTSCWKEDPNERP--NFSQ 152 (223)
Q Consensus 77 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~l~~l~~~~l~~~p~~Rp--~~~~ 152 (223)
|+|||++..| .+||+|||++.........+...|...|||||.+.+.. +++..|+|+|+..+++.-.+.=| -+..
T Consensus 196 PSNILldr~G-~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 196 PSNILLDRHG-DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred hhheEEecCC-CEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 9999999888 79999999998776666666778999999999998654 67889999999999998888877 5567
Q ss_pred HHHHHHHHhhc
Q 027476 153 IIQMLLHYIST 163 (223)
Q Consensus 153 ~~~~L~~~~~~ 163 (223)
+.++|......
T Consensus 275 vfeql~~Vv~g 285 (361)
T KOG1006|consen 275 VFEQLCQVVIG 285 (361)
T ss_pred HHHHHHHHHcC
Confidence 88888776543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-23 Score=178.53 Aligned_cols=103 Identities=25% Similarity=0.299 Sum_probs=80.3
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 19 EPVMVIVTELLLGGTLRKYLLNMRPR------------------CLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 19 ~~~~~lv~e~~~~~sL~~~l~~~~~~------------------~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+..+++|+||+.+++|.+++...... ......+..++.|++.||.|||+++|+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 35789999999999999998753211 012344667999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc--cccccCCCccccccCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLT--EMMTAETGTYRWMAPENM 121 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~ 121 (223)
|++.+...+||+|||+++..... .......+++.|+|||.+
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 329 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence 99865448999999999754322 222445789999999943
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-23 Score=174.98 Aligned_cols=152 Identities=30% Similarity=0.436 Sum_probs=128.4
Q ss_pred CCCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++..+||||+.++|.+- +...|++||||.||+|++...--+ .+++.++..+.++.+.||+|||+.|-+|||||-.|
T Consensus 65 ~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGan 142 (829)
T KOG0576|consen 65 MLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGAN 142 (829)
T ss_pred eeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccc
Confidence 467889999999999984 678999999999999999876544 49999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCC------------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
|+++..+ .+|++|||.+....... ..+...||+.|||||+..
T Consensus 143 illtd~g-DvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 143 ILLTDEG-DVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred eeecccC-ceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 9999887 79999999987654332 235568999999999321
Q ss_pred ----------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 123 ----------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 123 ----------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
......+.-+.+++..++.++|.+||+.+.+++
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 223446677889999999999999999987753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-22 Score=150.09 Aligned_cols=153 Identities=33% Similarity=0.549 Sum_probs=125.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++|++|+++++++.. ...++++|++.|++|.+++.... ..+++..++.++.+++.++.+||+.|++|+||+|.||
T Consensus 45 ~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni 123 (215)
T cd00180 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENI 123 (215)
T ss_pred HHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhE
Confidence 567899999999999975 67889999999999999987642 3489999999999999999999999999999999999
Q ss_pred EEeC-CCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-CCCChHHH-------------HHHHHHhcccCC
Q 027476 81 ILTA-DHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS-AENLPEDL-------------ALIVTSCWKEDP 144 (223)
Q Consensus 81 ll~~-~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~l-------------~~l~~~~l~~~p 144 (223)
+++. ++ .++|+|||.+....... ......+...|++||..... ......|+ .+++..|++.+|
T Consensus 124 ~~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l~~~~~~l~~~l~~~p 202 (215)
T cd00180 124 LLDSDNG-KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDP 202 (215)
T ss_pred EEeCCCC-cEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHHHHHHHHHHHHhhCCc
Confidence 9997 55 89999999987544332 12334578899999988765 44444454 456678899999
Q ss_pred CCCCCHHHHHHH
Q 027476 145 NERPNFSQIIQM 156 (223)
Q Consensus 145 ~~Rp~~~~~~~~ 156 (223)
.+||++.++++.
T Consensus 203 ~~R~~~~~l~~~ 214 (215)
T cd00180 203 EKRPSAKEILEH 214 (215)
T ss_pred ccCcCHHHHhhC
Confidence 999999888754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=162.54 Aligned_cols=154 Identities=30% Similarity=0.472 Sum_probs=124.6
Q ss_pred CCCCCccceEEEee-c-C---ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------Ccc
Q 027476 5 VRHRNLVKFIGACK-E-P---VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH--------GII 71 (223)
Q Consensus 5 l~Hpniv~l~~~~~-~-~---~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--------~iv 71 (223)
|+|+||+.+++.=. + + .+|+|.+|-+.|||.|++.+ ..++.+..++++..++.||++||.. .|.
T Consensus 262 LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIA 338 (513)
T KOG2052|consen 262 LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIA 338 (513)
T ss_pred hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhh
Confidence 68999999998652 2 2 58999999999999999976 3499999999999999999999963 499
Q ss_pred cCCCCCCCEEEeCCCCceEEccCccccccccc-----cccccCCCccccccCCCCC------------------------
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLT-----EMMTAETGTYRWMAPENMR------------------------ 122 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~------------------------ 122 (223)
|||||..||||.+++ .+-|+|+|+|...... ...+..+||..|||||++.
T Consensus 339 HRDlKSKNILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlW 417 (513)
T KOG2052|consen 339 HRDLKSKNILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLW 417 (513)
T ss_pred ccccccccEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHH
Confidence 999999999999888 8999999999754322 2234568999999999543
Q ss_pred ------------------------------------------CCCC------CChHHHHHHHHHhcccCCCCCCCHHHHH
Q 027476 123 ------------------------------------------PSAE------NLPEDLALIVTSCWKEDPNERPNFSQII 154 (223)
Q Consensus 123 ------------------------------------------~~~~------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~ 154 (223)
+... ..-..+..++..||..+|.-|-++-.+.
T Consensus 418 EiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 418 EIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred HHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 0000 1112366789999999999999999998
Q ss_pred HHHHHHhh
Q 027476 155 QMLLHYIS 162 (223)
Q Consensus 155 ~~L~~~~~ 162 (223)
+.|.++..
T Consensus 498 Ktl~~l~~ 505 (513)
T KOG2052|consen 498 KTLAKLSN 505 (513)
T ss_pred HHHHHHhc
Confidence 88888763
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=160.68 Aligned_cols=110 Identities=25% Similarity=0.317 Sum_probs=93.5
Q ss_pred ccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCC---
Q 027476 10 LVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTAD--- 85 (223)
Q Consensus 10 iv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~--- 85 (223)
++.+.++|+ .++.++|+|.+ |-|+.+++.+++-..++...+..++.|++.+++|||+.+++|-||||+||++.+.
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence 456667785 58999999999 8899999999888889999999999999999999999999999999999998431
Q ss_pred ----------------CCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 86 ----------------HKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 86 ----------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
...|+|+|||.|..... .....+.|..|+|||++.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViL 282 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVIL 282 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceecc--CcceeeeccccCCchhee
Confidence 12589999999976443 336678899999999654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=151.98 Aligned_cols=145 Identities=19% Similarity=0.317 Sum_probs=123.2
Q ss_pred CCCCCC-CCCccceEEEeecC---ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 027476 1 MMSRVR-HRNLVKFIGACKEP---VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLK 76 (223)
Q Consensus 1 il~~l~-Hpniv~l~~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 76 (223)
||..|. ||||++|+++..|+ ...+|+||+.+.+...+... ++...+.-++.|++.||.|||+.||.|||+|
T Consensus 85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVK 159 (338)
T KOG0668|consen 85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVK 159 (338)
T ss_pred HHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCC
Confidence 345564 99999999998763 57799999999888887643 7888889999999999999999999999999
Q ss_pred CCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-CCCCChHHHHHHHHHhcccCCCCCCCH
Q 027476 77 PENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP-SAENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 77 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
|.|++||.....++|+|+|+|-........+..+.+..|--||.+.. ..++++-|+|++++..-.+--.++|++
T Consensus 160 PhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 160 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred cceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 99999998877899999999987766666666677778889998765 457899999999998777777777765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=174.54 Aligned_cols=117 Identities=30% Similarity=0.494 Sum_probs=100.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||+++++++.+ +.+++||||+.|++|.+++...+ .+++..++.++.||+.||.|||.++|+||||||+||
T Consensus 58 l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NI 135 (669)
T cd05610 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNM 135 (669)
T ss_pred HHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHE
Confidence 467899999999998864 67899999999999999997644 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENM 121 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~ 121 (223)
|++.++ .+||+|||+++...... ......+|+.|++||..
T Consensus 136 Ll~~~g-~vkL~DFGls~~~~~~~~~~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 136 LISNEG-HIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKND 176 (669)
T ss_pred EEcCCC-CEEEEeCCCCccccCCcccccccccCccccCcccc
Confidence 999877 89999999998654322 23345788999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=164.81 Aligned_cols=112 Identities=29% Similarity=0.374 Sum_probs=87.3
Q ss_pred ccceEEEee---------cCceEEEEEcCCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHH
Q 027476 10 LVKFIGACK---------EPVMVIVTELLLGGTLRKYLLNMRP----------------------RCLDIHVAIGFALDI 58 (223)
Q Consensus 10 iv~l~~~~~---------~~~~~lv~e~~~~~sL~~~l~~~~~----------------------~~l~~~~~~~i~~qi 58 (223)
+++++++|. ++..++|+||+.+++|.+++..... ..+++..+..++.|+
T Consensus 239 ~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql 318 (507)
T PLN03224 239 CAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQV 318 (507)
T ss_pred hhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHH
Confidence 366777653 2468999999999999999864211 124677889999999
Q ss_pred HHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccccccc--CCCccccccCCCCC
Q 027476 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTA--ETGTYRWMAPENMR 122 (223)
Q Consensus 59 ~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE~~~ 122 (223)
+.||.|||+.+|+||||||+||+++.++ .+||+|||++........... ..+++.|+|||.+.
T Consensus 319 ~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 319 LTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred HHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 9999999999999999999999999877 799999999875433222222 23478999999764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=149.31 Aligned_cols=161 Identities=27% Similarity=0.475 Sum_probs=133.2
Q ss_pred CCCCCCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 2 MSRVRHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLN------MRPRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~------~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
+..+.|||+.++.+++.+ ...++++.++.-|+|..++.. ...+.++..+...++.|++.|++|||++|++|.
T Consensus 341 ly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHk 420 (563)
T KOG1024|consen 341 LYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHK 420 (563)
T ss_pred HhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 456789999999998843 467899999988999999973 234568888999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC----------------------------
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR---------------------------- 122 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~---------------------------- 122 (223)
||.+.|.+|+..- +|||+|=.+++..-..+ .....-....||++|.+.
T Consensus 421 DiAaRNCvIdd~L-qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Py 499 (563)
T KOG1024|consen 421 DIAARNCVIDDQL-QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPY 499 (563)
T ss_pred hhhhhcceehhhe-eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCc
Confidence 9999999999765 89999999988432211 122233456899999332
Q ss_pred ------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
.++.+||+++..++..||...|++||+++|++.-|.++..+
T Consensus 500 aeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 500 AEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred cccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 45889999999999999999999999999999999887654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-22 Score=155.71 Aligned_cols=117 Identities=32% Similarity=0.548 Sum_probs=95.9
Q ss_pred CCCCCCCCccceEEEeecC------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKEP------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
|..++|.||+..+++.+-. ++|++.|.+ ..+|..++-. ++.++.+.+.-++.||+.||+|||+.+|+||||
T Consensus 106 LcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDI 182 (449)
T KOG0664|consen 106 LSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDI 182 (449)
T ss_pred HHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccC
Confidence 4567999999999887532 467888888 5678777654 455999999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCC
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMR 122 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~ 122 (223)
||.|.++++++ .+||+|||+++...... ..+..+.|-.|+|||.++
T Consensus 183 KPGNLLVNSNC-vLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLM 230 (449)
T KOG0664|consen 183 KPGNLLVNSNC-ILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLM 230 (449)
T ss_pred CCccEEeccCc-eEEecccccccccchhhhhhhHHHHHHHHhccHHHhh
Confidence 99999999998 89999999999765433 234456788999999543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=140.56 Aligned_cols=146 Identities=34% Similarity=0.445 Sum_probs=122.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|+|++++++++.. ...++++||+.+++|.+++...... +++..++.++.+++.++.+||+.+++|+|+++.||
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni 129 (225)
T smart00221 51 LKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENI 129 (225)
T ss_pred HHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 456799999999999865 6789999999999999999764432 78999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCC-CCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENM-RPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+++.++ .++|+|||.+....... ......++..|++||.+ .....+...|+|.++..+++.--++-|.
T Consensus 130 ~v~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf 200 (225)
T smart00221 130 LLGMDG-LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPF 200 (225)
T ss_pred EEcCCC-CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCc
Confidence 999876 89999999987654332 22345678889999998 5666667899999998888877766665
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=154.33 Aligned_cols=111 Identities=24% Similarity=0.272 Sum_probs=85.3
Q ss_pred CCCCCCCCCccc-eEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCC
Q 027476 1 MMSRVRHRNLVK-FIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL-KPE 78 (223)
Q Consensus 1 il~~l~Hpniv~-l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl-kp~ 78 (223)
+|++++|+||+. +++. +..++||||++|++|... .. .. ...++.|++.||.|||++||+|||| ||+
T Consensus 74 iL~~L~h~~iv~~l~~~---~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~ 141 (365)
T PRK09188 74 ALKTVRGIGVVPQLLAT---GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQ 141 (365)
T ss_pred HHHhccCCCCCcEEEEc---CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcc
Confidence 467889999985 4432 467999999999999732 11 11 1467889999999999999999999 999
Q ss_pred CEEEeCCCCceEEccCcccccccccc---------ccccCCCccccccCCCCCCC
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE---------MMTAETGTYRWMAPENMRPS 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~ 124 (223)
||+++.++ .+||+|||+++...... ......+++.|++||.+.+.
T Consensus 142 NILv~~~~-~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 142 NWLMGPDG-EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eEEEcCCC-CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99998777 79999999998543221 11345678889999977643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-20 Score=155.38 Aligned_cols=139 Identities=23% Similarity=0.288 Sum_probs=119.5
Q ss_pred CCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCC
Q 027476 8 RNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTAD 85 (223)
Q Consensus 8 pniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~ 85 (223)
-|+++|+..|. .+++|||+|.+ ..+|.+++++-+. -.|....+..++.|+..||..|-..||+|.||||.||||++.
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES 572 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC
Confidence 46778887775 47999999999 7899999987543 348999999999999999999999999999999999999988
Q ss_pred CCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCC
Q 027476 86 HKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERP 148 (223)
Q Consensus 86 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp 148 (223)
...+||||||.|......+. +....+-.|.|||.+.+.+++++-|+|++++.++++-.++=.
T Consensus 573 k~iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred cceeeeccCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 87999999999987654443 333456789999999999999999999999999998877754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=133.86 Aligned_cols=109 Identities=29% Similarity=0.419 Sum_probs=87.8
Q ss_pred CCCCccceEEE-ee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE-
Q 027476 6 RHRNLVKFIGA-CK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL- 82 (223)
Q Consensus 6 ~Hpniv~l~~~-~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill- 82 (223)
.|.||+.-|+. |+ .+.+++++||++.|+|.+-+.. ..+.+....+++.|+++|+.|||++++||||||.+||||
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif 155 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIF 155 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEe
Confidence 48899988764 44 3578899999999999998865 338899999999999999999999999999999999998
Q ss_pred eCCCCceEEccCccccccccccccccCCCccccccCC
Q 027476 83 TADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119 (223)
Q Consensus 83 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE 119 (223)
+.|..+|||+|||..+........ .--+..|.+||
T Consensus 156 ~~df~rvKlcDFG~t~k~g~tV~~--~~~~~~y~~pe 190 (378)
T KOG1345|consen 156 DADFYRVKLCDFGLTRKVGTTVKY--LEYVNNYHAPE 190 (378)
T ss_pred cCCccEEEeeecccccccCceehh--hhhhcccCCcH
Confidence 445568999999998765433221 22345677888
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=128.96 Aligned_cols=116 Identities=22% Similarity=0.198 Sum_probs=90.4
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccccccCCC
Q 027476 32 GTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETG 111 (223)
Q Consensus 32 ~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 111 (223)
|+|.+++...+ ..+++..++.++.|++.||.|||+++ ||+||+++.++ .+|+ ||+++..... ...|
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeeccc----cCCC
Confidence 68999997633 34999999999999999999999998 99999999877 7888 9998754332 2368
Q ss_pred ccccccCCCCCCCCCCCh----------------------------------------------------H--HHHHHHH
Q 027476 112 TYRWMAPENMRPSAENLP----------------------------------------------------E--DLALIVT 137 (223)
Q Consensus 112 t~~y~aPE~~~~~~~~~~----------------------------------------------------~--~l~~l~~ 137 (223)
++.|+|||++....++.. . ++.+++.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 899999996642211111 1 4677888
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHh
Q 027476 138 SCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 138 ~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
+||..+|.+||++.++++++....
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 888888888888888888776654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-19 Score=155.70 Aligned_cols=155 Identities=26% Similarity=0.378 Sum_probs=123.0
Q ss_pred CCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 3 SRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
.+++|||++..+..+.+ ....-+||||++ +|..++..... ++..++..++.|++.|++|+|+.|+.|||+|++|++
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll 452 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLL 452 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEE
Confidence 46899999887776654 344445999999 99999987533 889999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccc-----cccccCCCccccccCCCCCCCC-------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLT-----EMMTAETGTYRWMAPENMRPSA------------------------------- 125 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~------------------------------- 125 (223)
++.++ .+||+|||.+...... ......+|+..|+|||++.+..
T Consensus 453 ~~~~g-~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 453 VTENG-ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred EecCC-ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 99888 8999999998744322 2345668999999999554210
Q ss_pred -----------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 126 -----------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 126 -----------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..++..-+.++.++++.+|.+|-+++++++. .++..
T Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d--~W~~~ 590 (601)
T KOG0590|consen 532 DNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND--EWIRS 590 (601)
T ss_pred ccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC--hHhhh
Confidence 0123345668999999999999999999875 55543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.5e-18 Score=137.92 Aligned_cols=88 Identities=27% Similarity=0.483 Sum_probs=80.6
Q ss_pred CCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
.+.||+++.+++. ++...+|+||++.....++... ++..++..++..++.||.++|.+|||||||||+|++.+.
T Consensus 93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~ 167 (418)
T KOG1167|consen 93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR 167 (418)
T ss_pred cchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc
Confidence 4789999999985 4688999999999999998865 789999999999999999999999999999999999987
Q ss_pred CCCceEEccCcccc
Q 027476 85 DHKTVKLADFGLAR 98 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~ 98 (223)
..++-.|.|||+|.
T Consensus 168 ~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQ 181 (418)
T ss_pred ccCCceEEechhHH
Confidence 77788999999996
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.5e-18 Score=139.01 Aligned_cols=77 Identities=30% Similarity=0.481 Sum_probs=69.5
Q ss_pred CCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCC
Q 027476 6 RHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPEN 79 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~N 79 (223)
.-.+||+|++.|.. .+.+||+|++ |.+|..+|.....+.++...+..|+.||+.||.|||. .||+|-||||+|
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPEN 218 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPEN 218 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcce
Confidence 34679999999953 3799999999 9999999998887889999999999999999999997 589999999999
Q ss_pred EEEe
Q 027476 80 LILT 83 (223)
Q Consensus 80 ill~ 83 (223)
||+.
T Consensus 219 vLl~ 222 (590)
T KOG1290|consen 219 VLLC 222 (590)
T ss_pred eeee
Confidence 9984
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-18 Score=129.96 Aligned_cols=92 Identities=20% Similarity=0.156 Sum_probs=70.3
Q ss_pred CCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCCEE
Q 027476 3 SRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECL-HSHGIIHRDLKPENLI 81 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~l-H~~~ivH~dlkp~Nil 81 (223)
.++.++++........ ...++||||+.|+++....... ..+++..+..++.|++.+|.++ |+.||+||||||+||+
T Consensus 74 ~~l~~~~v~~p~~~~~-~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIl 150 (190)
T cd05147 74 KRLVTAGIPCPEPILL-KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLL 150 (190)
T ss_pred HHHHHCCCCCCcEEEe-cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence 3445555533222222 2348999999888776554332 3489999999999999999999 7999999999999999
Q ss_pred EeCCCCceEEccCccccc
Q 027476 82 LTADHKTVKLADFGLARE 99 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~ 99 (223)
++ ++ .++|+|||++..
T Consensus 151 i~-~~-~v~LiDFG~a~~ 166 (190)
T cd05147 151 YH-DG-KLYIIDVSQSVE 166 (190)
T ss_pred EE-CC-cEEEEEcccccc
Confidence 98 45 799999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=135.41 Aligned_cols=140 Identities=26% Similarity=0.339 Sum_probs=114.2
Q ss_pred CCccceEEEee-c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCC
Q 027476 8 RNLVKFIGACK-E-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTAD 85 (223)
Q Consensus 8 pniv~l~~~~~-~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~ 85 (223)
.++..+++.+. . ...++||+.+ |.+|.++......+.++...++.++.|++.+|+++|+.|++||||||+|++++..
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~ 158 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQS 158 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCC
Confidence 58888888883 4 4678999988 9999998876666779999999999999999999999999999999999999865
Q ss_pred C----CceEEccCcccc--cccccc--------c-cccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCC
Q 027476 86 H----KTVKLADFGLAR--EESLTE--------M-MTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERP 148 (223)
Q Consensus 86 ~----~~~kl~Dfg~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp 148 (223)
. ..++|.|||+++ ...... . .....||..|+++........+..+|+++++-.+++..-..-|
T Consensus 159 ~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LP 236 (322)
T KOG1164|consen 159 SRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLP 236 (322)
T ss_pred CCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCC
Confidence 3 469999999998 321111 1 1234599999999999999999999999977776666555444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.5e-17 Score=130.68 Aligned_cols=148 Identities=26% Similarity=0.384 Sum_probs=113.0
Q ss_pred CCCCccceEEEeecC----------------------------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHH
Q 027476 6 RHRNLVKFIGACKEP----------------------------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57 (223)
Q Consensus 6 ~Hpniv~l~~~~~~~----------------------------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~q 57 (223)
+|||||++.++|.+. .+|+||... ..||.+++..+. .+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 799999998876321 258899888 579999997644 566677789999
Q ss_pred HHHHHHHHHhCCcccCCCCCCCEEEeCCC---CceEEccCcccccccc-------ccccccCCCccccccCCCCC-----
Q 027476 58 IARAMECLHSHGIIHRDLKPENLILTADH---KTVKLADFGLAREESL-------TEMMTAETGTYRWMAPENMR----- 122 (223)
Q Consensus 58 i~~~l~~lH~~~ivH~dlkp~Nill~~~~---~~~kl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~----- 122 (223)
+++|+.|||.+||.|||+|.+||++.-+. ..+.|+|||.+-.... ........|....||||+..
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999999999999999999999995433 3688999997742211 11122345777889999322
Q ss_pred -----------------------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 123 -----------------------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 123 -----------------------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
..+..++.++++++-.+++.+|.+|++..-...
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 346678899999999999999999998765544
Q ss_pred HH
Q 027476 156 ML 157 (223)
Q Consensus 156 ~L 157 (223)
.|
T Consensus 510 vl 511 (598)
T KOG4158|consen 510 VL 511 (598)
T ss_pred HH
Confidence 43
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.4e-17 Score=125.34 Aligned_cols=94 Identities=19% Similarity=0.121 Sum_probs=71.9
Q ss_pred CCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEE
Q 027476 3 SRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPENLI 81 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil 81 (223)
.++.|++|.....+... ..++||||+.|+++....... ..++...+..++.|++.++.++|+ .||+||||||+||+
T Consensus 74 ~~l~~~~i~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 74 KRLYEAGVPVPEPILLK-KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred HHHHhCCCCCceEEEec-CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 34566766443333222 348999999888654432222 237889999999999999999999 99999999999999
Q ss_pred EeCCCCceEEccCccccccc
Q 027476 82 LTADHKTVKLADFGLAREES 101 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~ 101 (223)
++ ++ .++|+|||++....
T Consensus 151 l~-~~-~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DG-KPYIIDVSQAVELD 168 (190)
T ss_pred EE-CC-CEEEEEcccceecC
Confidence 98 55 79999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=128.85 Aligned_cols=147 Identities=31% Similarity=0.448 Sum_probs=118.0
Q ss_pred CCCCCCC-CccceEEEeecC-ceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHR-NLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hp-niv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
++.+.|+ +|+++.+.+... ..+++++++.++++.+++..... ..++......++.|++.++.|+|+.+++|||+||+
T Consensus 51 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~ 130 (384)
T COG0515 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPE 130 (384)
T ss_pred HHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence 4567777 799999999654 46999999999999977765431 24899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc-------ccccCCCccccccCCCCCC---CCCCChHHHHHHHHHhcccCCCCCC
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE-------MMTAETGTYRWMAPENMRP---SAENLPEDLALIVTSCWKEDPNERP 148 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~~l~~l~~~~l~~~p~~Rp 148 (223)
||+++..+..++++|||+++...... ......|+..|++||.+.. .......|+|+++..++.......|
T Consensus 131 nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p 210 (384)
T COG0515 131 NILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210 (384)
T ss_pred HeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 99999776459999999987443322 2356689999999999987 5778889999877655544444443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.5e-17 Score=125.20 Aligned_cols=87 Identities=11% Similarity=0.174 Sum_probs=69.0
Q ss_pred CCCCccceEEEeecC----c-eEEEEEc--CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCcccCCCCC
Q 027476 6 RHRNLVKFIGACKEP----V-MVIVTEL--LLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAM-ECLHSHGIIHRDLKP 77 (223)
Q Consensus 6 ~Hpniv~l~~~~~~~----~-~~lv~e~--~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l-~~lH~~~ivH~dlkp 77 (223)
+||||++++|+++++ . +.+|+|| +.++||.+++.+. .+++. ..++.|++.++ +|||+++|+||||||
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp 133 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKP 133 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence 689999999999754 2 3378999 5579999999663 26655 35678888777 999999999999999
Q ss_pred CCEEEeCCC---CceEEccCccc
Q 027476 78 ENLILTADH---KTVKLADFGLA 97 (223)
Q Consensus 78 ~Nill~~~~---~~~kl~Dfg~a 97 (223)
+||+++..+ ..++|+||+-+
T Consensus 134 ~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 134 QNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHEEEeccCCCCCcEEEEECCCC
Confidence 999997532 27999995433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-16 Score=120.98 Aligned_cols=87 Identities=18% Similarity=0.260 Sum_probs=71.2
Q ss_pred CCCCC-CCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCC
Q 027476 1 MMSRV-RHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL-KPE 78 (223)
Q Consensus 1 il~~l-~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl-kp~ 78 (223)
+|++| +|++|++++++ +..+++|||+.|.+|.+.+.. . ...++.|++.+|+++|++||+|||| ||+
T Consensus 54 iL~~L~~~~~vP~ll~~---~~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~ 121 (218)
T PRK12274 54 ALRQLDGLPRTPRLLHW---DGRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEA 121 (218)
T ss_pred HHHhcCCCCCCCEEEEE---cCEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcc
Confidence 35678 45889999886 356899999999999764321 1 1357789999999999999999999 799
Q ss_pred CEEEeCCCCceEEccCcccccc
Q 027476 79 NLILTADHKTVKLADFGLAREE 100 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~ 100 (223)
||+++.++ .++|+|||++...
T Consensus 122 NILv~~~g-~i~LIDFG~A~~~ 142 (218)
T PRK12274 122 NWLVQEDG-SPAVIDFQLAVRG 142 (218)
T ss_pred eEEEcCCC-CEEEEECCCceec
Confidence 99999877 7999999999743
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.2e-16 Score=131.62 Aligned_cols=160 Identities=35% Similarity=0.550 Sum_probs=126.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGI-IHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i-vH~dlkp~N 79 (223)
|+++.|.|+.+++|.+.+ +..+.|.+||..|+|.+.+... ...+++.....++++++.||.|+|+..| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 688999999999999865 6788999999999999999873 3448999999999999999999998766 999999999
Q ss_pred EEEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMRP--------------------------------- 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~--------------------------------- 123 (223)
.++|... .+||+|||+....... ..........-|.|||.++.
T Consensus 80 Clvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 80 CLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred ceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999877 8999999998754321 11111123345777773320
Q ss_pred --------------------------C---CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 124 --------------------------S---AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 124 --------------------------~---~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
. ......++..++..||..+|.+||+++++...++.....
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 0 012334678899999999999999999999888777654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.3e-15 Score=116.06 Aligned_cols=149 Identities=22% Similarity=0.265 Sum_probs=99.2
Q ss_pred CCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+..+.|++|.....++. .+..++||||++|++|.+++.... . .+..++.+++.+|.++|+.|++|+|++|.||
T Consensus 53 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Ni 126 (211)
T PRK14879 53 MSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNM 126 (211)
T ss_pred HHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccE
Confidence 34567788776665553 456789999999999999986522 2 7788999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
+++ ++ .++|+|||.+......... +...+...+.+.........+++.....-+.. ....+.+++.+.+.++
T Consensus 127 l~~-~~-~~~liDf~~a~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~f~~gY~~--~~~~~~~~~~~~~~~i 198 (211)
T PRK14879 127 ILS-GG-KIYLIDFGLAEFSKDLEDR----AVDLHVLLRSLESTHPDWAEELFEAFLEGYRE--VMGEKAEEVLERVKEI 198 (211)
T ss_pred EEE-CC-CEEEEECCcccCCCcHHhh----hccHHHHHHHhhccCcchHHHHHHHHHHHHHH--hhcccHHHHHHHHHHH
Confidence 999 55 7999999998753221111 11111111222222223334444443333332 1236888888888887
Q ss_pred hhcC
Q 027476 161 ISTN 164 (223)
Q Consensus 161 ~~~~ 164 (223)
....
T Consensus 199 ~~~~ 202 (211)
T PRK14879 199 RLRG 202 (211)
T ss_pred HHhc
Confidence 6544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6e-15 Score=117.15 Aligned_cols=159 Identities=20% Similarity=0.323 Sum_probs=124.9
Q ss_pred CCCCccceEEEeecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
.-+.|..++.|..++ +-.+|+|.+ |-+|++++.- .+..++.+.++.++.|++.-++|+|++.+|+|||||+|+||..
T Consensus 82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGr 159 (449)
T KOG1165|consen 82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGR 159 (449)
T ss_pred CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecC
Confidence 457888888888765 557999998 9999997754 5566999999999999999999999999999999999999964
Q ss_pred CC----CceEEccCcccccccccc--------ccccCCCccccccCCCCCC-----------------------------
Q 027476 85 DH----KTVKLADFGLAREESLTE--------MMTAETGTYRWMAPENMRP----------------------------- 123 (223)
Q Consensus 85 ~~----~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~----------------------------- 123 (223)
.+ ..+.++|||+|+...+.. ..+...||..||+--...+
T Consensus 160 p~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 160 PGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred CCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 33 379999999998654432 2345579999998762211
Q ss_pred -----------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCC
Q 027476 124 -----------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSA 166 (223)
Q Consensus 124 -----------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~ 166 (223)
...++|.++...+...-.++-.+-|..+-+...+..++...+.
T Consensus 240 KA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 240 KADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred cCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 1245666777777777888889999999888888777765544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.3e-16 Score=118.99 Aligned_cols=115 Identities=16% Similarity=0.199 Sum_probs=83.3
Q ss_pred CCCCCCCCccceEEEeec---------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 2 MSRVRHRNLVKFIGACKE---------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
+.++.|++|..+.+++.. +..++||||++|.+|.++.. +++ ....+++.+|..+|+.|++|
T Consensus 89 l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H 158 (232)
T PRK10359 89 TDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVS 158 (232)
T ss_pred HHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCcc
Confidence 456789999999887642 24789999999999988731 333 24569999999999999999
Q ss_pred CCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHh
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSC 139 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~ 139 (223)
||+||+||+++.++ ++|+|||..+.......... .+.....+..+|+|+++..+
T Consensus 159 ~Dikp~Nili~~~g--i~liDfg~~~~~~e~~a~d~-----------~vler~y~~~~di~~lg~~~ 212 (232)
T PRK10359 159 GDPHKGNFIVSKNG--LRIIDLSGKRCTAQRKAKDR-----------IDLERHYGIKNEIKDLGYYL 212 (232)
T ss_pred CCCChHHEEEeCCC--EEEEECCCcccccchhhHHH-----------HHHHhHhcccccccceeEee
Confidence 99999999998765 99999998764422111110 22233344567777776543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.1e-15 Score=128.07 Aligned_cols=87 Identities=26% Similarity=0.348 Sum_probs=74.4
Q ss_pred CCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++|++|+....++. +...++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||
T Consensus 390 l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NI 459 (535)
T PRK09605 390 LSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNF 459 (535)
T ss_pred HHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHE
Confidence 56788999988766654 356789999999999999875 3467899999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccc
Q 027476 81 ILTADHKTVKLADFGLAREE 100 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~ 100 (223)
+++ ++ .++|+|||+++..
T Consensus 460 Ll~-~~-~~~liDFGla~~~ 477 (535)
T PRK09605 460 IVR-DD-RLYLIDFGLGKYS 477 (535)
T ss_pred EEE-CC-cEEEEeCcccccC
Confidence 995 45 7999999999764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.3e-16 Score=132.35 Aligned_cols=143 Identities=27% Similarity=0.320 Sum_probs=116.1
Q ss_pred CCCC-CCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 3 SRVR-HRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 3 ~~l~-Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
..++ ||.++++...++ +...++++++..||.|...+.+... +++.....+..+++-+++++|+.+++|||+|++||
T Consensus 51 ~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~iiyrd~k~eni 128 (612)
T KOG0603|consen 51 AFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLGIAYRDYKLENV 128 (612)
T ss_pred hhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccce
Confidence 3444 999999988875 6789999999999999998876554 88888899999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHH
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQI 153 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~ 153 (223)
+++.+| ++++.|||+.+........ +||..|||||++. ......|+|+++..+++.-.+-=|...++
T Consensus 129 lld~~G-hi~~tdfglske~v~~~~~---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~ 195 (612)
T KOG0603|consen 129 LLLLEG-HIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT 195 (612)
T ss_pred eecccC-ccccCCchhhhHhHhhhhc---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH
Confidence 999998 8999999998865433322 8999999999998 45566677776666665555555544433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=5e-15 Score=113.26 Aligned_cols=142 Identities=20% Similarity=0.260 Sum_probs=91.0
Q ss_pred CCCCCCCccceEEEe-ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 3 SRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+.++|+++.....++ .++..++||||++|++|.+.+..... .++.+++.+|.++|+.|++|+|++|.||+
T Consensus 52 ~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil 122 (199)
T TIGR03724 52 SRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAGIVHGDLTTSNII 122 (199)
T ss_pred HHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCCeecCCCCcceEE
Confidence 445666654433333 34567899999999999998754211 78999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 82 LTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
++ ++ .++++|||++........ .+...|..++.+.....+...+++.....-+. ..+....++.+.+.++.
T Consensus 123 ~~-~~-~~~liDfg~a~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~fl~~Y~---~~~~~~~~~~~~i~~~~ 193 (199)
T TIGR03724 123 VR-DD-KLYLIDFGLGKYSDEIED----KAVDLHVLKRSLESTHPDKAEELFEAFLEGYR---EEFGEAKDVLERVKEIE 193 (199)
T ss_pred EE-CC-cEEEEECCCCcCCCcHHh----hhchHHHHHHHHhhhCchhHHHHHHHHHHHHH---hhcccHHHHHHHHHHHH
Confidence 99 55 799999999875322111 11111222222222233334455554444443 34555555666666654
Q ss_pred h
Q 027476 162 S 162 (223)
Q Consensus 162 ~ 162 (223)
.
T Consensus 194 ~ 194 (199)
T TIGR03724 194 L 194 (199)
T ss_pred h
Confidence 3
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-15 Score=118.18 Aligned_cols=77 Identities=25% Similarity=0.247 Sum_probs=64.3
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 20 PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG-IIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~-ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
...++||||+.|++|........ .+....+..++.|++.+|.+||+.| ++||||||+||+++ ++ .++|+|||.+.
T Consensus 121 ~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~-~i~LiDFg~a~ 196 (237)
T smart00090 121 RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DG-KVVIIDVSQSV 196 (237)
T ss_pred cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC-CEEEEEChhhh
Confidence 34589999999988877553322 2666777899999999999999999 99999999999999 55 79999999886
Q ss_pred cc
Q 027476 99 EE 100 (223)
Q Consensus 99 ~~ 100 (223)
..
T Consensus 197 ~~ 198 (237)
T smart00090 197 EL 198 (237)
T ss_pred cc
Confidence 43
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.5e-15 Score=114.69 Aligned_cols=153 Identities=28% Similarity=0.515 Sum_probs=118.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG--IIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~ 78 (223)
|+-+.||||+.++|.|+. +.+.++..|++.|+|+..+.+...-..+..++.+++.+++.|++|||+.. |.---|...
T Consensus 241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~ 320 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSK 320 (448)
T ss_pred eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccc
Confidence 455689999999999987 57889999999999999999877667888999999999999999999974 444578888
Q ss_pred CEEEeCCCCceEEc--cCccccccccccccccCCCccccccCCCCCCC--------------------------------
Q 027476 79 NLILTADHKTVKLA--DFGLAREESLTEMMTAETGTYRWMAPENMRPS-------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------------------- 124 (223)
.+++|++- ..+|. |--++- ......-.+.||+||.+...
T Consensus 321 hvmidedl-tarismad~kfsf------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 321 HVMIDEDL-TARISMADTKFSF------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred eEEecchh-hhheecccceeee------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 99999765 44443 321111 11223457899999955422
Q ss_pred -----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 125 -----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 125 -----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
+.+.+..+..++..|+..||.+||.++.++-.|++.+
T Consensus 394 pmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 394 PMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred chhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 4455566777889999999999999999888777653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.4e-14 Score=107.88 Aligned_cols=155 Identities=23% Similarity=0.335 Sum_probs=116.7
Q ss_pred ceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCC--CCc
Q 027476 12 KFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTAD--HKT 88 (223)
Q Consensus 12 ~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~--~~~ 88 (223)
.+..++.+ ..-.+||+.+ |-||++++.-. ...++...++-.+-|++.-++|+|.++++||||||+|+|..-+ ...
T Consensus 75 ~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~k 152 (341)
T KOG1163|consen 75 HIRHYGTEKDYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNK 152 (341)
T ss_pred hhhhhccccccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccce
Confidence 34444444 4567999999 99999987542 3449999999999999999999999999999999999998643 347
Q ss_pred eEEccCcccccccccc--------ccccCCCccccccCCCCC--------------------------------------
Q 027476 89 VKLADFGLAREESLTE--------MMTAETGTYRWMAPENMR-------------------------------------- 122 (223)
Q Consensus 89 ~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-------------------------------------- 122 (223)
+.++|||+++...+.. ......||..|++-....
T Consensus 153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK 232 (341)
T KOG1163|consen 153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK 232 (341)
T ss_pred EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence 9999999998643322 123446888887655110
Q ss_pred --------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCC
Q 027476 123 --------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168 (223)
Q Consensus 123 --------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~ 168 (223)
....++|.++...+..|-...-.+.|...-+.+...-++.......
T Consensus 233 yEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~ 292 (341)
T KOG1163|consen 233 YEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQY 292 (341)
T ss_pred HHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccC
Confidence 1134677888889999999999999999888887777776655443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-15 Score=126.92 Aligned_cols=110 Identities=31% Similarity=0.472 Sum_probs=89.3
Q ss_pred ceEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 21 VMVIVTELLLGGTLRKYLLNMR-PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 21 ~~~lv~e~~~~~sL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.+++.|++|.-.+|.+++.... ....++.....++.|++.|++| ++.+|+|+||.||+...++ .+||.|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhhhheee
Confidence 3689999999999999997433 3457788889999999999999 9999999999999998777 899999999875
Q ss_pred ccccc-------ccccCCCccccccCCCCCCCCCCChHHHHH
Q 027476 100 ESLTE-------MMTAETGTYRWMAPENMRPSAENLPEDLAL 134 (223)
Q Consensus 100 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~ 134 (223)
..... ..+...||..||+||.+.+..++...|+++
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIya 447 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYA 447 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhh
Confidence 44333 345568999999999888665555555444
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.6e-14 Score=113.61 Aligned_cols=90 Identities=23% Similarity=0.265 Sum_probs=70.2
Q ss_pred CCCCCCCCc--cceEEEeec--C---ceEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 2 MSRVRHRNL--VKFIGACKE--P---VMVIVTELLLG-GTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 2 l~~l~Hpni--v~l~~~~~~--~---~~~lv~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
+.+|+|++| ++.+++... . ..++|+|+++| .+|.+++.+. .+++.. +.+++.+|.+||+.||+|+
T Consensus 94 l~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~Hr 166 (239)
T PRK01723 94 LAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHA 166 (239)
T ss_pred HHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCC
Confidence 445677774 667766432 2 23599999997 6999988652 255543 5689999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccc
Q 027476 74 DLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
||||.|||++.++ .++|+|||.+..
T Consensus 167 Dlkp~NILv~~~~-~v~LIDfg~~~~ 191 (239)
T PRK01723 167 DLNAHNILLDPDG-KFWLIDFDRGEL 191 (239)
T ss_pred CCCchhEEEcCCC-CEEEEECCCccc
Confidence 9999999999777 799999998865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.9e-14 Score=107.85 Aligned_cols=73 Identities=21% Similarity=0.228 Sum_probs=61.4
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 20 PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
...++||||+.|++|.+.... .....++.+++.++.++|+.|++|+||||.||+++.++ .++|+|||++..
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-~~~liDfg~~~~ 174 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-KIYIIDWPQMVS 174 (198)
T ss_pred CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-cEEEEECCcccc
Confidence 356899999999999775421 33467889999999999999999999999999999877 899999999864
Q ss_pred cc
Q 027476 100 ES 101 (223)
Q Consensus 100 ~~ 101 (223)
..
T Consensus 175 ~~ 176 (198)
T cd05144 175 TD 176 (198)
T ss_pred CC
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.6e-14 Score=129.42 Aligned_cols=149 Identities=20% Similarity=0.255 Sum_probs=114.4
Q ss_pred CCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q 027476 4 RVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL 82 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill 82 (223)
.++|||++.+.-.-. +...|||-+|+ ..+|.|.+..+.. +..-+...|+-|++.||.-+|..||.|||||.+||||
T Consensus 77 l~~~pn~lPfqk~~~t~kAAylvRqyv-khnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi 153 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI 153 (1431)
T ss_pred hhcCCcccchHHHHHhhHHHHHHHHHH-hhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE
Confidence 358999998877654 45567888998 5799999876554 8888889999999999999999999999999999999
Q ss_pred eCCCCceEEccCcccccccccc--------ccccCCCccccccCCCCCCCC-----------------------------
Q 027476 83 TADHKTVKLADFGLAREESLTE--------MMTAETGTYRWMAPENMRPSA----------------------------- 125 (223)
Q Consensus 83 ~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~----------------------------- 125 (223)
++-+ -+.|+||..-+....++ ...+...-..|+|||.+-...
T Consensus 154 TSWN-W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf 232 (1431)
T KOG1240|consen 154 TSWN-WLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELF 232 (1431)
T ss_pred eeec-hhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHH
Confidence 9876 69999998776432221 222333445799999543210
Q ss_pred -------------------C---------CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 -------------------E---------NLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 -------------------~---------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
. -....++.++..|++.+|.+|-++++.++.
T Consensus 233 ~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 233 LEGRPLFTLSQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hcCCCcccHHHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 011246789999999999999999999875
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.7e-13 Score=123.67 Aligned_cols=115 Identities=27% Similarity=0.301 Sum_probs=93.3
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC------CCCceEEc
Q 027476 19 EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA------DHKTVKLA 92 (223)
Q Consensus 19 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~------~~~~~kl~ 92 (223)
.+.-++|+||.+.|||.+++... +.+++..++.++.|++..++.||..+||||||||+|++|.. +...++|+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CCcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 34568999999999999999744 45999999999999999999999999999999999999953 23369999
Q ss_pred cCcccccc---ccccccccCCCccccccCCCCCCCCCCChHHHHHH
Q 027476 93 DFGLAREE---SLTEMMTAETGTYRWMAPENMRPSAENLPEDLALI 135 (223)
Q Consensus 93 Dfg~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l 135 (223)
|||.+... ......+..++|-.+-.+|...+.+.++-.|+.-|
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGl 889 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGL 889 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHH
Confidence 99988632 23334456677888888998888887777775443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.31 E-value=4e-12 Score=101.47 Aligned_cols=113 Identities=20% Similarity=0.264 Sum_probs=70.8
Q ss_pred eEEEEEcCCCCCHHHHHHh---cCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcc
Q 027476 22 MVIVTELLLGGTLRKYLLN---MRPR--CLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGL 96 (223)
Q Consensus 22 ~~lv~e~~~~~sL~~~l~~---~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~ 96 (223)
.+++|+-+ -++|.+++.. .... .+.....+.+..|+++.+++||+.|++|+||+|+|++++.+| .++|+||+.
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G-~v~Lg~F~~ 191 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDG-GVFLGDFSS 191 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS--EEE--GGG
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCC-CEEEcChHH
Confidence 46788877 6788888642 2211 133444455668999999999999999999999999999988 899999998
Q ss_pred ccccccccccccCCCccccccCCCCCC--------CCCCChHHHHHHHHH
Q 027476 97 AREESLTEMMTAETGTYRWMAPENMRP--------SAENLPEDLALIVTS 138 (223)
Q Consensus 97 a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~l~~l~~~ 138 (223)
.......... ...+..|.+||.... ...+...|.|+|+..
T Consensus 192 ~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 192 LVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp EEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred HeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 7654433222 334567888885432 234555666666543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=8.2e-12 Score=94.43 Aligned_cols=74 Identities=27% Similarity=0.288 Sum_probs=58.1
Q ss_pred ceEEEEEcCCCCCHHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 21 VMVIVTELLLGGTLRKY-LLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 21 ~~~lv~e~~~~~sL~~~-l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
..++||||+.|+++... +.... .. ..+..++.+++.++.++|. .+++|+||||+||+++ ++ .++++|||.+.
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-~~~liDfg~a~ 162 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-KVYIIDVPQAV 162 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-cEEEEECcccc
Confidence 45899999998543221 11111 11 5678899999999999999 9999999999999999 66 79999999986
Q ss_pred cc
Q 027476 99 EE 100 (223)
Q Consensus 99 ~~ 100 (223)
..
T Consensus 163 ~~ 164 (187)
T cd05119 163 EI 164 (187)
T ss_pred cc
Confidence 54
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.6e-12 Score=91.69 Aligned_cols=87 Identities=18% Similarity=0.243 Sum_probs=71.1
Q ss_pred CCCCC--CCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Q 027476 3 SRVRH--RNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH---GIIHRDLK 76 (223)
Q Consensus 3 ~~l~H--pniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlk 76 (223)
+.++| .+++++++++.. +..++++||+.|+.+..+ +......++.+++.+|.++|.. +++|+|++
T Consensus 46 ~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~ 116 (155)
T cd05120 46 QLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLH 116 (155)
T ss_pred HHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCC
Confidence 34444 578888887754 578999999988877653 4556677889999999999985 69999999
Q ss_pred CCCEEEeCCCCceEEccCccccc
Q 027476 77 PENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 77 p~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
|.||+++..+ .++++|||.+..
T Consensus 117 ~~Nil~~~~~-~~~l~Df~~~~~ 138 (155)
T cd05120 117 PGNILVDDGK-ILGIIDWEYAGY 138 (155)
T ss_pred cceEEEECCc-EEEEEecccccC
Confidence 9999999756 899999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.6e-12 Score=114.26 Aligned_cols=95 Identities=35% Similarity=0.492 Sum_probs=79.4
Q ss_pred HHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccccccc---------------cc-ccccCCCccccccCCC
Q 027476 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL---------------TE-MMTAETGTYRWMAPEN 120 (223)
Q Consensus 57 qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~---------------~~-~~~~~~gt~~y~aPE~ 120 (223)
+++.+++|+|+.||+|||+||+|.+|+.-| ++|++|||+.+.... .+ ..+..+||+.|+|||+
T Consensus 151 dmvla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hhhHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 347899999999999999999999999888 899999999873210 00 1234589999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcccCCCCCCCHHH
Q 027476 121 MRPSAENLPEDLALIVTSCWKEDPNERPNFSQ 152 (223)
Q Consensus 121 ~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~ 152 (223)
+-...++-+.|+|.++...++.+...=|.+.+
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 99999999999999998888888887776665
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=1e-10 Score=88.74 Aligned_cols=84 Identities=15% Similarity=0.139 Sum_probs=62.1
Q ss_pred CccceEEEeecCceEEEEEcCCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCCEEEeCCC
Q 027476 9 NLVKFIGACKEPVMVIVTELLLGGTLRK-YLLNMRPRCLDIHVAIGFALDIARAMECL-HSHGIIHRDLKPENLILTADH 86 (223)
Q Consensus 9 niv~l~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~l~~~~~~~i~~qi~~~l~~l-H~~~ivH~dlkp~Nill~~~~ 86 (223)
++.+++++ ...++||||+.++.+.. .+++ ..++......+..+++.+|..+ |..|++|+||++.||+++. +
T Consensus 89 ~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~-~ 161 (197)
T cd05146 89 PCPEVVVL---KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD-G 161 (197)
T ss_pred CCCeEEEe---cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC-C
Confidence 34455544 45679999996543322 2222 1255666778889999999998 8999999999999999974 4
Q ss_pred CceEEccCcccccc
Q 027476 87 KTVKLADFGLAREE 100 (223)
Q Consensus 87 ~~~kl~Dfg~a~~~ 100 (223)
.++|+|||.+...
T Consensus 162 -~v~iIDF~qav~~ 174 (197)
T cd05146 162 -KVWFIDVSQSVEP 174 (197)
T ss_pred -cEEEEECCCceeC
Confidence 6999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.9e-11 Score=101.58 Aligned_cols=132 Identities=17% Similarity=0.184 Sum_probs=100.1
Q ss_pred CCCCCCCCccceEEEee-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLH-SHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~N 79 (223)
|+.++||||+++++.++ ++..|+|+|-+ ..|..++++ +....+...+.||+.||.||| +.+++|++|..+.
T Consensus 63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~S 135 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDS 135 (690)
T ss_pred hhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeee
Confidence 57899999999999986 56899999998 588888876 446777778899999999998 5689999999999
Q ss_pred EEEeCCCCceEEccCccccccccccc-cccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccC
Q 027476 80 LILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKED 143 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~ 143 (223)
|+|+..| ..||++|.++........ .......-.|..|+.+.+.. ++.|.|.|++.|++.-
T Consensus 136 VfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ 197 (690)
T KOG1243|consen 136 VFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELF 197 (690)
T ss_pred EEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHh
Confidence 9999988 899999988764433221 11111223456666555443 6778888877776543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.9e-10 Score=85.18 Aligned_cols=70 Identities=30% Similarity=0.455 Sum_probs=58.8
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 20 PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
+...++|||++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||+++.+ .+.++|||++..
T Consensus 72 ~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 72 DNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred CCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence 4567999999999999988764 14567777788889999999999999999999854 499999999874
Q ss_pred c
Q 027476 100 E 100 (223)
Q Consensus 100 ~ 100 (223)
.
T Consensus 141 s 141 (204)
T COG3642 141 S 141 (204)
T ss_pred c
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.6e-12 Score=110.02 Aligned_cols=141 Identities=22% Similarity=0.284 Sum_probs=108.3
Q ss_pred CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCEEEeC
Q 027476 7 HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLH-SHGIIHRDLKPENLILTA 84 (223)
Q Consensus 7 Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~ 84 (223)
|.|++.+++...+ +..+++.+|..|+++.+.+........+....-.++.|+..++.|+| ..++.|+|+||+|.+++.
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~ 159 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE 159 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc
Confidence 9999999999876 46789999999999999883222213677777889999999999999 999999999999999997
Q ss_pred CCCceEEccCcccccccc----ccccccCCC-ccccccCCCCCCC-CCCChHHHHHHHHHhcccCCCCC
Q 027476 85 DHKTVKLADFGLAREESL----TEMMTAETG-TYRWMAPENMRPS-AENLPEDLALIVTSCWKEDPNER 147 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~~~~----~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~~l~~l~~~~l~~~p~~R 147 (223)
.+...|+.|||+|..... .......+| ++.|+|||...+. -..-+.|+|+.+.......+.+=
T Consensus 160 s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~ 228 (601)
T KOG0590|consen 160 SGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGEL 228 (601)
T ss_pred CCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCC
Confidence 664699999999985544 122334578 9999999988763 34455566666555544444443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5e-11 Score=95.10 Aligned_cols=151 Identities=23% Similarity=0.381 Sum_probs=106.0
Q ss_pred CCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Q 027476 4 RVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDIARAMECLHSHG--IIHR 73 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~ 73 (223)
++-|-||++++.++.+ ....++.||+..|++.+++++.+ ...+......+|+-||+.||.|||+.. ++|+
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg 202 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG 202 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence 4579999999988754 24689999999999999998532 345888999999999999999999975 9999
Q ss_pred CCCCCCEEEeCCCCceEEccCcccc---c--cccccccccCCCccccccCCCCCCCCCC---------------------
Q 027476 74 DLKPENLILTADHKTVKLADFGLAR---E--ESLTEMMTAETGTYRWMAPENMRPSAEN--------------------- 127 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~---~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~--------------------- 127 (223)
++.-..|++..++ -+|+.--.-.. . ...........+.++|.+||.=.-...+
T Consensus 203 nlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 203 NLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred CcchhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 9999999999777 67765321110 0 0011111223456788888821100000
Q ss_pred --------------------ChHH-HHHHHHHhcccCCCCCCCHHHHHH
Q 027476 128 --------------------LPED-LALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 128 --------------------~~~~-l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
...+ -+.++..|++-.|..||++..++.
T Consensus 282 ~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 282 STNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred cCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhc
Confidence 0001 134778999999999999998854
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.6e-10 Score=98.51 Aligned_cols=77 Identities=26% Similarity=0.349 Sum_probs=59.5
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 20 PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR-AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~-~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
...++||||++|++|.+.......+ .+ ...++.+++. .+..+|..|++|+|++|.||+++.++ .++++|||++.
T Consensus 231 ~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g-~i~liDfG~~~ 305 (437)
T TIGR01982 231 SERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDG-KIIALDFGIVG 305 (437)
T ss_pred CCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCC-cEEEEeCCCee
Confidence 3568999999999999876532211 22 2345555555 46789999999999999999998777 79999999997
Q ss_pred ccc
Q 027476 99 EES 101 (223)
Q Consensus 99 ~~~ 101 (223)
...
T Consensus 306 ~l~ 308 (437)
T TIGR01982 306 RLS 308 (437)
T ss_pred ECC
Confidence 544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.3e-10 Score=88.06 Aligned_cols=78 Identities=22% Similarity=0.235 Sum_probs=65.2
Q ss_pred ceEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCC------CCceEEcc
Q 027476 21 VMVIVTELLLGG-TLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTAD------HKTVKLAD 93 (223)
Q Consensus 21 ~~~lv~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~------~~~~kl~D 93 (223)
..++|+|++++. +|.+++........+......++.+++..+.-||..||+|+|++++||+++.+ ...+.++|
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 468999999875 89999865333346677788999999999999999999999999999999852 23799999
Q ss_pred Ccccc
Q 027476 94 FGLAR 98 (223)
Q Consensus 94 fg~a~ 98 (223)
|+.+.
T Consensus 189 l~r~~ 193 (268)
T PRK15123 189 LHRAQ 193 (268)
T ss_pred CCccc
Confidence 99875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.9e-10 Score=81.81 Aligned_cols=80 Identities=28% Similarity=0.376 Sum_probs=65.1
Q ss_pred CceEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCce--EEccCcc
Q 027476 20 PVMVIVTELLLG-GTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTV--KLADFGL 96 (223)
Q Consensus 20 ~~~~lv~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~--kl~Dfg~ 96 (223)
..-.++|||++| .++.+++...............++..+-..+.-||.++++|+||..+||++..++..+ .++|||+
T Consensus 83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecc
Confidence 455799999976 5888888765544344455578899999999999999999999999999998777544 8999999
Q ss_pred ccc
Q 027476 97 ARE 99 (223)
Q Consensus 97 a~~ 99 (223)
+..
T Consensus 163 s~~ 165 (229)
T KOG3087|consen 163 SSV 165 (229)
T ss_pred hhc
Confidence 864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.5e-10 Score=85.99 Aligned_cols=77 Identities=27% Similarity=0.292 Sum_probs=58.2
Q ss_pred ccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCCEEEeC
Q 027476 10 LVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGI-----IHRDLKPENLILTA 84 (223)
Q Consensus 10 iv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i-----vH~dlkp~Nill~~ 84 (223)
+.+++.+.. ...++||||++|.++.+. . .. ...++.+++.+|..||+.++ +|+|++|.||+++
T Consensus 55 ~P~~~~~~~-~~~~lv~e~i~G~~l~~~--~-----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~- 122 (170)
T cd05151 55 GPKLYYFDP-ETGVLITEFIEGSELLTE--D-----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD- 122 (170)
T ss_pred CCceEEEeC-CCCeEEEEecCCCccccc--c-----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-
Confidence 345555543 335799999999888653 0 11 13356789999999999885 9999999999999
Q ss_pred CCCceEEccCccccc
Q 027476 85 DHKTVKLADFGLARE 99 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~ 99 (223)
++ .++++|||.+..
T Consensus 123 ~~-~~~liDf~~a~~ 136 (170)
T cd05151 123 DG-RLWLIDWEYAGM 136 (170)
T ss_pred CC-eEEEEecccccC
Confidence 55 699999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.8e-09 Score=80.75 Aligned_cols=87 Identities=28% Similarity=0.339 Sum_probs=70.0
Q ss_pred cceEEEeec-----CceEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 11 VKFIGACKE-----PVMVIVTELLLG-GTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 11 v~l~~~~~~-----~~~~lv~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
.+.+++.+. ...++|+|+++| .+|.+++..... .+......++.+++..+.-||..||+|+|+++.|||++.
T Consensus 76 P~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~ 153 (206)
T PF06293_consen 76 PEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDP 153 (206)
T ss_pred CcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeC
Confidence 445555543 135899999988 489999876444 667778889999999999999999999999999999986
Q ss_pred CC--CceEEccCccccc
Q 027476 85 DH--KTVKLADFGLARE 99 (223)
Q Consensus 85 ~~--~~~kl~Dfg~a~~ 99 (223)
++ ..+.++||+.++.
T Consensus 154 ~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 154 DDGQYRFYLIDLDRMRF 170 (206)
T ss_pred CCCceeEEEEcchhcee
Confidence 64 3689999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3e-09 Score=90.75 Aligned_cols=148 Identities=28% Similarity=0.346 Sum_probs=113.0
Q ss_pred CCCCccceEEEeecC-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCcccCCCCCCCE
Q 027476 6 RHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR----AMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 6 ~Hpniv~l~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~----~l~~lH~~~ivH~dlkp~Ni 80 (223)
.|+|.++.+..++++ ..++=+|++ +.+|.++..... ..++...++..+.+... ||.++|+.+++|-|+||.||
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i 253 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANI 253 (524)
T ss_pred ccccccccCcccccCCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhhe
Confidence 488889977777765 455666666 789988886533 33788888999999988 99999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccccc------ccCCCccccccCCCCCC-------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMM------TAETGTYRWMAPENMRP------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~------------------------------- 123 (223)
+...+....+++|||+.......... ....|...|++||...+
T Consensus 254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~ 333 (524)
T KOG0601|consen 254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS 333 (524)
T ss_pred ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence 99988448999999998865544322 12256778999994431
Q ss_pred -------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 124 -------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 124 -------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
.....+.++...+..+++.++..|++.+.+..
T Consensus 334 ~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 12234456677888999999999998877754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.7e-08 Score=83.33 Aligned_cols=156 Identities=15% Similarity=0.198 Sum_probs=108.1
Q ss_pred CCCCCCCCccceEEEee-----cCceEEEEEcCCC-CCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHH
Q 027476 2 MSRVRHRNLVKFIGACK-----EPVMVIVTELLLG-GTLRKYLLNMR-------------PRCLDIHVAIGFALDIARAM 62 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~-----~~~~~lv~e~~~~-~sL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~l 62 (223)
.+++.|+|||++.++|. |..+++|++|.++ ++|.++..... +...++..+|.++.|+..||
T Consensus 327 wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL 406 (655)
T KOG3741|consen 327 WKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAAL 406 (655)
T ss_pred HHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHH
Confidence 36789999999998873 4568999999987 68888765322 12478899999999999999
Q ss_pred HHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc--ccc--------c--------CCCccc----cccCCC
Q 027476 63 ECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE--MMT--------A--------ETGTYR----WMAPEN 120 (223)
Q Consensus 63 ~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~--~~~--------~--------~~gt~~----y~aPE~ 120 (223)
.++|+.|+.-+-|.+.+|+++.+. +++|+-.|+........ ... . ..|+.. =+.-+.
T Consensus 407 ~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d~~~~le~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s 485 (655)
T KOG3741|consen 407 YSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQEDPTEPLESQQQNDLRDLGLLLLALATGTENSNRTDSTQSS 485 (655)
T ss_pred HHHHhcCceeecccHhHeEeeCcc-eEEEecccceeeecCCCCcchhHHhhhhHHHHHHHHHHHhhcccccccccchHHH
Confidence 999999999999999999999766 78888777654221111 000 0 011100 000001
Q ss_pred -CCCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 121 -MRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 121 -~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
+......++.|++.++.-....++.+ -++.+++.++-.
T Consensus 486 ~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~ 524 (655)
T KOG3741|consen 486 HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGS 524 (655)
T ss_pred HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence 12234567889999998888888886 567777655433
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.81 E-value=8e-09 Score=89.66 Aligned_cols=75 Identities=20% Similarity=0.276 Sum_probs=52.0
Q ss_pred CceEEEEEcCCCCCHHHHH--HhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCC---CceEEc
Q 027476 20 PVMVIVTELLLGGTLRKYL--LNMRP--RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADH---KTVKLA 92 (223)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~l--~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~---~~~kl~ 92 (223)
...++||||+.|+.+.++- ...+. ..+.+..+..++.| +...|++|+|+||.||+++.++ +.++++
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~ll 306 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFRDGFFHADMHPGNIFVSYDPPENPRYIAL 306 (537)
T ss_pred CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEE
Confidence 4567999999999998753 22110 01223333333333 4568999999999999998765 379999
Q ss_pred cCccccccc
Q 027476 93 DFGLAREES 101 (223)
Q Consensus 93 Dfg~a~~~~ 101 (223)
|||++...+
T Consensus 307 DFGivg~l~ 315 (537)
T PRK04750 307 DFGIVGSLN 315 (537)
T ss_pred ecceEEECC
Confidence 999987543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.3e-08 Score=76.96 Aligned_cols=83 Identities=27% Similarity=0.269 Sum_probs=52.6
Q ss_pred CccceEEEeecCceEEEEEcCC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCcccCCCCCCCEEEeCC
Q 027476 9 NLVKFIGACKEPVMVIVTELLL--GGTLRKYLLNMRPRCLDIHVAIGFALDIARAMEC-LHSHGIIHRDLKPENLILTAD 85 (223)
Q Consensus 9 niv~l~~~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~-lH~~~ivH~dlkp~Nill~~~ 85 (223)
++.+++++. ...+||||+. |..+..+.... ++......++.+++..+.. +|..|++|+||.+.||+++.+
T Consensus 71 ~vP~p~~~~---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~ 143 (188)
T PF01163_consen 71 PVPKPYDYN---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG 143 (188)
T ss_dssp SS--EEEEE---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT
T ss_pred cCCcEEEEe---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc
Confidence 345555442 3479999998 65665543321 2234456677788885555 579999999999999999965
Q ss_pred CCceEEccCcccccc
Q 027476 86 HKTVKLADFGLAREE 100 (223)
Q Consensus 86 ~~~~kl~Dfg~a~~~ 100 (223)
.+.++|||.+...
T Consensus 144 --~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 --KVYIIDFGQAVDS 156 (188)
T ss_dssp --CEEE--GTTEEET
T ss_pred --eEEEEecCcceec
Confidence 6999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.1e-08 Score=74.79 Aligned_cols=67 Identities=27% Similarity=0.415 Sum_probs=53.4
Q ss_pred ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 21 VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 21 ~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
..+++|||++|..|.+... +++ .+...+.+++.-+|+.|++|+|..|+|++++.+ .++++||+..+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~~k~~ 183 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECccccc
Confidence 4679999999988877532 333 244567788999999999999999999999854 499999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.3e-07 Score=69.44 Aligned_cols=79 Identities=16% Similarity=0.154 Sum_probs=65.1
Q ss_pred ceEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCC-ceEEccCcccc
Q 027476 21 VMVIVTELLLG-GTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHK-TVKLADFGLAR 98 (223)
Q Consensus 21 ~~~lv~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~-~~kl~Dfg~a~ 98 (223)
..++|+|-+.| .+|.+++.+..-...+......++.+++..+.-||+.|+.|+|+.+.||+++.++. .++++||.-++
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 35799998854 68999887654445688888899999999999999999999999999999985552 49999997655
Q ss_pred c
Q 027476 99 E 99 (223)
Q Consensus 99 ~ 99 (223)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.1e-07 Score=73.42 Aligned_cols=89 Identities=27% Similarity=0.396 Sum_probs=65.7
Q ss_pred CCccceEEEeec----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh----------------
Q 027476 8 RNLVKFIGACKE----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS---------------- 67 (223)
Q Consensus 8 pniv~l~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---------------- 67 (223)
.++.+++.+..+ +..++||||++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~ 133 (223)
T cd05154 57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGG 133 (223)
T ss_pred CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCc
Confidence 446777777754 256899999999988775432 226667777777777777777773
Q ss_pred ----------------------------------------CCcccCCCCCCCEEEeCC-CCceEEccCccccc
Q 027476 68 ----------------------------------------HGIIHRDLKPENLILTAD-HKTVKLADFGLARE 99 (223)
Q Consensus 68 ----------------------------------------~~ivH~dlkp~Nill~~~-~~~~kl~Dfg~a~~ 99 (223)
..++|+|+++.||+++.+ ++.+.|+||+.+..
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 134 YLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236999999999999873 22689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.4e-07 Score=80.74 Aligned_cols=91 Identities=25% Similarity=0.296 Sum_probs=75.6
Q ss_pred CCCCccceEEEe-ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
.|.+++.+...+ +....++=-|||.++++...+. -...+++..++++..|++.++.++|+..++|+|+||+||++..
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~ 401 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN 401 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc
Confidence 577777766655 4466778899999998887763 2344889999999999999999999999999999999999987
Q ss_pred CCCceEEccCcccc
Q 027476 85 DHKTVKLADFGLAR 98 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~ 98 (223)
++...++.|||.+.
T Consensus 402 ~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 402 DGFFSKLGDFGCWT 415 (524)
T ss_pred chhhhhcccccccc
Confidence 64478999999885
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.7e-07 Score=83.72 Aligned_cols=140 Identities=26% Similarity=0.270 Sum_probs=106.6
Q ss_pred CCCccceEEEe-ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCC
Q 027476 7 HRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTAD 85 (223)
Q Consensus 7 Hpniv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~ 85 (223)
||-++...-.+ .....++|++|+.|++|...+..... .+.+-....+..+..+++|||...+.|+|++|.|+++..+
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~ 940 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD 940 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccchhhcccccccchhhccc
Confidence 35555444333 23467899999999999999887553 6777777888899999999999999999999999999988
Q ss_pred CCceEEccCccccccc-------c------------------c-------cccccCCCccccccCCCCCCCCCCChHHHH
Q 027476 86 HKTVKLADFGLAREES-------L------------------T-------EMMTAETGTYRWMAPENMRPSAENLPEDLA 133 (223)
Q Consensus 86 ~~~~kl~Dfg~a~~~~-------~------------------~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~ 133 (223)
+ +.++.|||...... . . .......||+.|.+||..........+++|
T Consensus 941 g-h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~ 1019 (1205)
T KOG0606|consen 941 G-HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWW 1019 (1205)
T ss_pred C-CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhh
Confidence 8 89999998432100 0 0 011234689999999999999999999999
Q ss_pred HHHHHhcccCCCCCCC
Q 027476 134 LIVTSCWKEDPNERPN 149 (223)
Q Consensus 134 ~l~~~~l~~~p~~Rp~ 149 (223)
..+...++.....-|.
T Consensus 1020 ~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred hhhhhhhhhhcCCCCC
Confidence 9888877766655543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.36 E-value=7.9e-07 Score=67.36 Aligned_cols=92 Identities=21% Similarity=0.243 Sum_probs=71.1
Q ss_pred CCCCCC-CCccceEEEeecCceEEEEEcCCCCCHHHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Q 027476 2 MSRVRH-RNLVKFIGACKEPVMVIVTELLLGGTLRKY---LLNMRPRCLDIHVAIGFALDIARAMECLHS---HGIIHRD 74 (223)
Q Consensus 2 l~~l~H-pniv~l~~~~~~~~~~lv~e~~~~~sL~~~---l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~d 74 (223)
|+.+++ +++.+++|+|. .++|.||...+++... +... ..-+|..+.+++.+++..+.+++. ..+.-.|
T Consensus 13 l~~l~~~~~~pk~lG~CG---~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcD 87 (188)
T PF12260_consen 13 LQLLQGSEPFPKLLGSCG---RFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLGFFYLCD 87 (188)
T ss_pred HHHcCCCCCCCCeeeECC---CEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEee
Confidence 344544 59999999994 3689999977665421 1111 126899999999999999999987 3466799
Q ss_pred CCCCCEEEeCCCCceEEccCccccc
Q 027476 75 LKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
++++|+.++.++ ++|++|...+..
T Consensus 88 v~~~nfgv~~~~-~lk~iDld~v~~ 111 (188)
T PF12260_consen 88 VSPDNFGVNDDG-RLKLIDLDDVFV 111 (188)
T ss_pred cchHHeEEeCCC-cEEEEechhcch
Confidence 999999999877 799999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.3e-06 Score=67.44 Aligned_cols=71 Identities=24% Similarity=0.287 Sum_probs=54.4
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 20 PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
+...+|||+++|..|...- ++.+..-.++..|+.-+..+...|+||+|+.+-||+++.+| .+.++||--+.
T Consensus 180 nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg-~~~vIDwPQ~v 250 (304)
T COG0478 180 NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG-DIVVIDWPQAV 250 (304)
T ss_pred ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC-CEEEEeCcccc
Confidence 4568999999997776532 22334445666666667777799999999999999999988 69999996553
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00015 Score=60.73 Aligned_cols=97 Identities=16% Similarity=0.233 Sum_probs=71.2
Q ss_pred eEEEEEcCCCC-CHHHHHH----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcc
Q 027476 22 MVIVTELLLGG-TLRKYLL----NMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGL 96 (223)
Q Consensus 22 ~~lv~e~~~~~-sL~~~l~----~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~ 96 (223)
.-+.|..+.|. .+..++. ++.....+|...++.++.++.+..-||+.|.+-+|+.++|+|++.++ .|.|.|=..
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDs 163 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDS 163 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEcccc
Confidence 55778777664 2333322 12223478999999999999999999999999999999999999777 788887443
Q ss_pred ccccccccccccCCCccccccCC
Q 027476 97 AREESLTEMMTAETGTYRWMAPE 119 (223)
Q Consensus 97 a~~~~~~~~~~~~~gt~~y~aPE 119 (223)
-..-.+...+...+|...|.+||
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPE 186 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPE 186 (637)
T ss_pred eeeccCCceEecccCccccCCHH
Confidence 22223344445567889999999
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=97.95 E-value=1e-05 Score=72.93 Aligned_cols=64 Identities=16% Similarity=0.112 Sum_probs=40.4
Q ss_pred ccCCCCCC-CEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCCCCCCChHHHHHH
Q 027476 71 IHRDLKPE-NLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRPSAENLPEDLALI 135 (223)
Q Consensus 71 vH~dlkp~-Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l 135 (223)
.+++..|. |++++.++ ..++.|||.++...... ......||+.|+|||++....++...|+|++
T Consensus 499 ~~~~~~p~~~~~~~p~~-~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSl 566 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQ-VKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWAL 566 (669)
T ss_pred CCCCCCCCCceeECCcc-ccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHH
Confidence 44566666 45555444 68889999887543221 2234579999999997765545544554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.90 E-value=2.8e-06 Score=73.91 Aligned_cols=130 Identities=21% Similarity=0.221 Sum_probs=89.3
Q ss_pred CCCCCCCCC-ccceEEEee-cCceEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 1 MMSRVRHRN-LVKFIGACK-EPVMVIVTELLLGG-TLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 1 il~~l~Hpn-iv~l~~~~~-~~~~~lv~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
+|.+++||| .+..++.++ +...+++++++.++ +-...... ..-.+.+-+...+.+.-..+++++|+.--+|+|
T Consensus 286 LLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d--- 361 (829)
T KOG0576|consen 286 LLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD--- 361 (829)
T ss_pred HHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc---
Confidence 467889999 666677665 45788999999776 22111110 001133444455566677899999998878998
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHH
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVT 137 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~ 137 (223)
||+..+ + ..|.+||+..........-+...+++.+++||+.......--.+.+.+..
T Consensus 362 -~~l~s~-~-~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~ 418 (829)
T KOG0576|consen 362 -NILGSE-E-EVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAV 418 (829)
T ss_pred -cccccc-c-ccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCc
Confidence 777764 4 68999999988766555556678999999999887766555555555443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=4.3e-05 Score=59.68 Aligned_cols=75 Identities=23% Similarity=0.248 Sum_probs=53.6
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEeCCCCceEEccCcccccc
Q 027476 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPENLILTADHKTVKLADFGLAREE 100 (223)
Q Consensus 22 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 100 (223)
-.+||||+... - .---..+.-.++..+...+..+++..+.-|.. .++||+||..-|||+. ++ .+.|+|||-|...
T Consensus 141 nVLvMEfIg~~-g-~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~-~p~iID~~QaV~~ 216 (268)
T COG1718 141 NVLVMEFIGDD-G-LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG-EPYIIDVSQAVTI 216 (268)
T ss_pred CeEEEEeccCC-C-CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-eEEEEECcccccc
Confidence 46999999432 1 00000011113444677888899999998877 8999999999999999 55 6999999987643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=9.3e-05 Score=64.30 Aligned_cols=77 Identities=19% Similarity=0.274 Sum_probs=56.1
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 20 PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
+...++|||+.|-.+.+...-.. ..++.+.+...+.++ -+..+-..|++|+|..|.||+++.++ ++.+.|||+...
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~ 314 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDG-RIVLLDFGIVGR 314 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecCC-cEEEEcCcceec
Confidence 46789999999999988843222 236655544433333 23344458999999999999999988 899999999875
Q ss_pred c
Q 027476 100 E 100 (223)
Q Consensus 100 ~ 100 (223)
.
T Consensus 315 l 315 (517)
T COG0661 315 L 315 (517)
T ss_pred C
Confidence 4
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.69 E-value=7.3e-05 Score=65.67 Aligned_cols=100 Identities=21% Similarity=0.372 Sum_probs=73.2
Q ss_pred HHHHHHHHHHHHHhC-CcccCCCCCCCEEEeCCCCceEEccCccccccccccc-----cc-----cCCCccccccCCCCC
Q 027476 54 FALDIARAMECLHSH-GIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM-----MT-----AETGTYRWMAPENMR 122 (223)
Q Consensus 54 i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-----~~-----~~~gt~~y~aPE~~~ 122 (223)
=+.+++.|+.|+|.. ++||++|.|++|.++..+ .+||+.|+.+........ +. -......|.|||++.
T Consensus 104 nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhhcccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345677999999964 899999999999999888 799999998764332111 11 112456899999442
Q ss_pred -------------------------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHH
Q 027476 123 -------------------------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQI 153 (223)
Q Consensus 123 -------------------------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~ 153 (223)
....+++.++.+=+.+++..+...||++..+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 2235677888888889999999999966555
Q ss_pred H
Q 027476 154 I 154 (223)
Q Consensus 154 ~ 154 (223)
.
T Consensus 263 ~ 263 (700)
T KOG2137|consen 263 L 263 (700)
T ss_pred h
Confidence 3
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00074 Score=53.15 Aligned_cols=29 Identities=21% Similarity=0.247 Sum_probs=25.2
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
.++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~-~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGK-FSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCc-EEEEEEccccc
Confidence 489999999999999755 68899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00058 Score=59.45 Aligned_cols=77 Identities=19% Similarity=0.259 Sum_probs=52.7
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC---CCCceEEccCcc
Q 027476 20 PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA---DHKTVKLADFGL 96 (223)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~---~~~~~kl~Dfg~ 96 (223)
....++|||++|..+.+.-.- ....++...+..-+.+... .-+-..|++|+|=.|.||+++. .+..+.+.|||+
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl 351 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGL 351 (538)
T ss_pred cceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccc
Confidence 367899999999877665321 1122666654444443322 2233568999999999999984 244899999998
Q ss_pred ccc
Q 027476 97 ARE 99 (223)
Q Consensus 97 a~~ 99 (223)
...
T Consensus 352 ~~~ 354 (538)
T KOG1235|consen 352 YAV 354 (538)
T ss_pred ccc
Confidence 764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.002 Score=50.26 Aligned_cols=28 Identities=25% Similarity=0.292 Sum_probs=24.1
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
.++|+|+.|.||+++.++ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~--~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG--TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC--cEEEechhcC
Confidence 468999999999998654 8999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00081 Score=62.26 Aligned_cols=31 Identities=26% Similarity=0.618 Sum_probs=25.0
Q ss_pred CcccCCCCCCCEEEeCCC-CceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTADH-KTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~-~~~kl~Dfg~a~~ 99 (223)
.++|+|+++.||+++.++ ..+-|.||+++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 499999999999998533 2468999998863
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.001 Score=52.08 Aligned_cols=30 Identities=30% Similarity=0.443 Sum_probs=24.8
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
+++|+|+.+.||+++.++ ...|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGR-LSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCC-EEEEEeCcccCc
Confidence 489999999999998543 567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0059 Score=46.65 Aligned_cols=83 Identities=25% Similarity=0.346 Sum_probs=58.9
Q ss_pred CCCCCCccceEEEeec-CceEEEEEcCCC------CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 027476 4 RVRHRNLVKFIGACKE-PVMVIVTELLLG------GTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLK 76 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~-~~~~lv~e~~~~------~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 76 (223)
...+.+|.+++|+.+. -..-+|+|.+.+ .||.+++.+.. ++. ...+ .+-.-.+||-+.+|+.+|++
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~ 145 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQ---ALDEFKRYLLDHHIVIRDLN 145 (199)
T ss_pred CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHH---HHHHHHHHHHHcCCeecCCC
Confidence 3467889999999864 467788887644 47888885532 555 3333 33444568889999999999
Q ss_pred CCCEEEeCCC--C-ceEEcc
Q 027476 77 PENLILTADH--K-TVKLAD 93 (223)
Q Consensus 77 p~Nill~~~~--~-~~kl~D 93 (223)
|+||++.... . .+.|+|
T Consensus 146 ~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 146 PHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cccEEEEecCCCceEEEEEe
Confidence 9999997543 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0042 Score=58.20 Aligned_cols=118 Identities=18% Similarity=0.209 Sum_probs=80.0
Q ss_pred CCCCCCCCccceEEEeec----C-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE----P-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLK 76 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~----~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 76 (223)
+.++.|+|++.++.+..+ + ...+..+++...++...+..... ++...++.+..++..||.|+|+....|.-+.
T Consensus 236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~ 313 (1351)
T KOG1035|consen 236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSLSLEHVVLS 313 (1351)
T ss_pred HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHhccceeEEe
Confidence 457799999999887633 2 23466789999999888876544 8999999999999999999999865555554
Q ss_pred CC---CEEEeCCCCceEEc--cCccccccccccccccCCCccccccCCCCC
Q 027476 77 PE---NLILTADHKTVKLA--DFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 77 p~---Nill~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
.+ +...+.++ .+.++ ||+..+.............+..+.++|...
T Consensus 314 ~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~ 363 (1351)
T KOG1035|consen 314 ASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLK 363 (1351)
T ss_pred cccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccc
Confidence 44 23333333 45555 888776554444333333445566666443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0022 Score=52.40 Aligned_cols=70 Identities=26% Similarity=0.312 Sum_probs=52.0
Q ss_pred CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 20 PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 20 ~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
+..++|||++.|-.|.+.-.- .+... +...+..-+.-|..+|+||+|..--||+++.++ .++++||--..
T Consensus 181 ~RH~Vvmelv~g~Pl~~v~~v-----~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~-~i~vIDFPQmv 250 (465)
T KOG2268|consen 181 NRHCVVMELVDGYPLRQVRHV-----EDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD-KIVVIDFPQMV 250 (465)
T ss_pred cceeeHHHhhcccceeeeeec-----CChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCC-CEEEeechHhh
Confidence 456899999999888775322 23333 333444455667889999999999999999777 79999997543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.00052 Score=65.83 Aligned_cols=158 Identities=12% Similarity=-0.051 Sum_probs=106.3
Q ss_pred CCCCCCCccceEEEee---cCceEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC-----Cccc
Q 027476 3 SRVRHRNLVKFIGACK---EPVMVIVTELLLGGTLRKYLLNMRP--RCLDIHVAIGFALDIARAMECLHSH-----GIIH 72 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~-----~ivH 72 (223)
+..+|+++.....-.. +.+-+.+++|+.+|.+.+.+.+... ..++..-+...-.+.+.+..-+|+. -.+|
T Consensus 1284 ~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~ 1363 (2724)
T KOG1826|consen 1284 REAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVS 1363 (2724)
T ss_pred hhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchh
Confidence 3457777776655432 2356889999999999999976432 2345555554445557777777764 2799
Q ss_pred CCCCCCCEEEeCCCCceEEccCcccc-ccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCHH
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAR-EESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNFS 151 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~ 151 (223)
+++|+-|.+|..+. .+|++++|+.+ ............+++-|+.++.......+...|++......+...-..-+...
T Consensus 1364 ~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1364 KSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred hhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence 99999999998776 79999999998 44444445566788889999988777666667777755555544444444444
Q ss_pred HHHHHHHHHh
Q 027476 152 QIIQMLLHYI 161 (223)
Q Consensus 152 ~~~~~L~~~~ 161 (223)
.+...+...+
T Consensus 1443 flq~~Lkgii 1452 (2724)
T KOG1826|consen 1443 FLQPALKGII 1452 (2724)
T ss_pred HHHHHHcCcc
Confidence 4444444433
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.015 Score=47.52 Aligned_cols=31 Identities=35% Similarity=0.633 Sum_probs=26.8
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.+++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDS-VKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCc-eEEEeecccccC
Confidence 5799999999999999766 678999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.026 Score=46.26 Aligned_cols=31 Identities=32% Similarity=0.555 Sum_probs=26.0
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.+++|+|+.+.||+++.+. ...|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence 3799999999999998544 568999998864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.039 Score=46.02 Aligned_cols=69 Identities=19% Similarity=0.301 Sum_probs=53.9
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 22 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.|++|++- |++|.. ++ ...++++..++.+.+..+.-+..+ ..-|||+.-.||+|+ +| .|.|+||-+++.
T Consensus 301 ~yl~~kdh-gt~is~-ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDfklsRl 370 (488)
T COG5072 301 LYLHFKDH-GTPISI-IK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDFKLSRL 370 (488)
T ss_pred EEEEEecC-Cceeee-ee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEeeeeec
Confidence 45777766 666643 21 256888899999988877777654 689999999999999 66 799999999984
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.025 Score=45.71 Aligned_cols=31 Identities=32% Similarity=0.542 Sum_probs=26.3
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.+++|+|+.|.||+++.++ .+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDE-LSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence 4699999999999999765 578999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.041 Score=44.81 Aligned_cols=29 Identities=28% Similarity=0.517 Sum_probs=25.0
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
.+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence 47899999999999986 4 58999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.023 Score=44.31 Aligned_cols=30 Identities=30% Similarity=0.490 Sum_probs=25.2
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
+++|+|+.+.||+++.+++.+.++||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 589999999999999732379999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.012 Score=45.32 Aligned_cols=32 Identities=28% Similarity=0.445 Sum_probs=20.6
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
..++|+|+.+.||+++..++.+.|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 35999999999999993333568999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.05 Score=44.18 Aligned_cols=30 Identities=30% Similarity=0.416 Sum_probs=26.0
Q ss_pred CcccCCCCCCCEEEeCC----CCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTAD----HKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~----~~~~kl~Dfg~a~~ 99 (223)
+++|+|+.+.||+++.+ + .++++||..+..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~-~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETK-KLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCC-cEEEEeeCCCCC
Confidence 57999999999999874 5 799999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.13 Score=42.10 Aligned_cols=29 Identities=14% Similarity=0.230 Sum_probs=25.4
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
+++|+|+.++|++++.++ .+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-GGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-CEEEEEhhhcc
Confidence 699999999999998776 68999997664
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.028 Score=45.25 Aligned_cols=31 Identities=26% Similarity=0.534 Sum_probs=25.6
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.++|+|+++.||+++.++....|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999986453567999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.047 Score=45.42 Aligned_cols=31 Identities=23% Similarity=0.543 Sum_probs=26.4
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.++|+|+++.||+++.+.+.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999986444799999998864
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.097 Score=40.82 Aligned_cols=80 Identities=21% Similarity=0.270 Sum_probs=51.6
Q ss_pred HHHHHHHHh--CCcccCCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHH
Q 027476 59 ARAMECLHS--HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIV 136 (223)
Q Consensus 59 ~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~ 136 (223)
+.+|.-.|+ .+.+|||-.|+||+-|+.| .+||.|=+..-.. +..|.--|+ ...+..++...++
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G-~lKlVDP~~Ll~~-----------~V~~vN~~Y---~~lT~~aE~~~fv 215 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFG-YLKLVDPVCLLEN-----------QVNMVNIEY---ESLTQEAEVKVFV 215 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCC-CEEecChhhhhhh-----------eeeEEeeec---cccChHHHHHHHH
Confidence 456777784 4799999999999999988 7999997643210 111111111 1123446777888
Q ss_pred HHhcccCCCCCC-CHHHH
Q 027476 137 TSCWKEDPNERP-NFSQI 153 (223)
Q Consensus 137 ~~~l~~~p~~Rp-~~~~~ 153 (223)
..|++.....|- ..+++
T Consensus 216 ~s~l~~v~~~~~~~~~ei 233 (308)
T PF07387_consen 216 KSCLKLVEKQRSAETEEI 233 (308)
T ss_pred HHHHHHHHHHhcCcHhhh
Confidence 888887666663 44555
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.057 Score=44.62 Aligned_cols=30 Identities=37% Similarity=0.592 Sum_probs=25.6
Q ss_pred cccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 70 IIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 70 ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
++|+|+.+.||+++.++..+.++||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999997652389999998763
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.044 Score=41.38 Aligned_cols=28 Identities=29% Similarity=0.506 Sum_probs=24.1
Q ss_pred cccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 70 IIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 70 ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.+|+|+.|.|++++.++ ++++||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~--~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG--LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC--EEEEeCCcccC
Confidence 69999999999998554 89999998864
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.1 Score=41.87 Aligned_cols=45 Identities=31% Similarity=0.358 Sum_probs=31.9
Q ss_pred HHHHHHHHHHHHHhC--CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 54 FALDIARAMECLHSH--GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 54 i~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.+..+-.++.-.+.. -++|+|+.+.|++.+..+ .++|+||.-|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence 333444444444433 489999999999998756 799999987753
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.94 E-value=0.095 Score=43.20 Aligned_cols=51 Identities=24% Similarity=0.335 Sum_probs=33.7
Q ss_pred HHHHHHHHHHHHHHHHHHh----CCcccCCCCCCCEEEeCCCC-----------------ceEEccCccccc
Q 027476 49 HVAIGFALDIARAMECLHS----HGIIHRDLKPENLILTADHK-----------------TVKLADFGLARE 99 (223)
Q Consensus 49 ~~~~~i~~qi~~~l~~lH~----~~ivH~dlkp~Nill~~~~~-----------------~~kl~Dfg~a~~ 99 (223)
+-+..++.||+.-.-.+.+ .+.+|-||||+|||+-.... +.+|.||.+++.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 4455667788665434433 36899999999999953221 356777777664
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.85 E-value=0.13 Score=39.17 Aligned_cols=31 Identities=32% Similarity=0.508 Sum_probs=25.0
Q ss_pred CCcccCCCCCCCEEEeCCCC----ceEEccCcccc
Q 027476 68 HGIIHRDLKPENLILTADHK----TVKLADFGLAR 98 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~----~~kl~Dfg~a~ 98 (223)
..++|||+.+.||++..++. .+.++||..++
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 35899999999999975442 58999998764
|
subfamily of choline kinases |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=93.84 E-value=0.048 Score=43.22 Aligned_cols=29 Identities=31% Similarity=0.521 Sum_probs=25.0
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.++|+|+.+.||+++.++ ++++||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC--CEEEeccccCc
Confidence 489999999999998654 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.47 E-value=0.23 Score=37.26 Aligned_cols=68 Identities=28% Similarity=0.273 Sum_probs=45.6
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-CCCEEEeCCCCceEEccCccccc
Q 027476 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLK-PENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 22 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk-p~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.++.|||+.|..|.+.-... +.+. +..++..---|-..||-|+.|. |...++..++ .+.|+||..|+.
T Consensus 87 ~~i~me~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 87 DFIRMEYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 35669999998998865431 2233 3344444444566799999887 5555555455 799999998874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=93.42 E-value=0.22 Score=38.13 Aligned_cols=55 Identities=33% Similarity=0.467 Sum_probs=40.0
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccc
Q 027476 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA 97 (223)
Q Consensus 22 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a 97 (223)
+.||.||++... .+.. +-+.+|.+-|..+|..||+-+|+++.|.. + -||+|||.+
T Consensus 152 ~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 152 RAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKILHKLGIVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred EEEEEeecCCcc-----------ccch----hHHHHHHHHHHHHHHCCeeeccCcccccc---C---CEEEecccC
Confidence 357888776544 1222 23456777788999999999999999974 2 389999864
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.06 E-value=0.13 Score=48.83 Aligned_cols=31 Identities=23% Similarity=0.341 Sum_probs=25.5
Q ss_pred CCcccCCCCCCCEEEeCCC----CceEEccCcccc
Q 027476 68 HGIIHRDLKPENLILTADH----KTVKLADFGLAR 98 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~----~~~kl~Dfg~a~ 98 (223)
.+++|+|+.+.||+++.+. ....|+|||.+.
T Consensus 208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred ccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 5799999999999998652 235899999875
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.99 E-value=0.12 Score=42.75 Aligned_cols=52 Identities=23% Similarity=0.329 Sum_probs=32.9
Q ss_pred HHHHHHHHHHHHHHHHHHh----CCcccCCCCCCCEEEeCCCC-----------------ceEEccCcccccc
Q 027476 49 HVAIGFALDIARAMECLHS----HGIIHRDLKPENLILTADHK-----------------TVKLADFGLAREE 100 (223)
Q Consensus 49 ~~~~~i~~qi~~~l~~lH~----~~ivH~dlkp~Nill~~~~~-----------------~~kl~Dfg~a~~~ 100 (223)
+-+..++.||+.-.--+.+ .+.+|-||||+|||+-.... .++|.||.+++..
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3445566777543211322 36899999999999943211 4678888877643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.92 E-value=0.057 Score=41.48 Aligned_cols=30 Identities=40% Similarity=0.602 Sum_probs=19.7
Q ss_pred CcccCCCCCCCEEE-eCCCCceEEccCccccc
Q 027476 69 GIIHRDLKPENLIL-TADHKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill-~~~~~~~kl~Dfg~a~~ 99 (223)
.+.|+|+.+.||++ +.++ .++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDG-EVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSS-CEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCC-eEEEecHHHHhh
Confidence 47999999999999 5455 799999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.87 E-value=0.25 Score=41.50 Aligned_cols=73 Identities=22% Similarity=0.232 Sum_probs=53.3
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 22 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
..+||+++-+.....- ..+.-.++...+..+-.|++.-+.-|.. .++||.||.--|+|+- +| .+.|+|.+-+.
T Consensus 239 hVLVM~FlGrdgw~aP--kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG-~lyiIDVSQSV 312 (520)
T KOG2270|consen 239 HVLVMEFLGRDGWAAP--KLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG-KLYIIDVSQSV 312 (520)
T ss_pred ceEeeeeccCCCCcCc--ccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC-EEEEEEccccc
Confidence 4699999932111110 0112237778888888899998888864 6899999999999997 55 79999998765
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=91.97 E-value=0.32 Score=40.21 Aligned_cols=30 Identities=30% Similarity=0.457 Sum_probs=25.6
Q ss_pred cccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 70 IIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 70 ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
+.|+|+.+.||+++.+++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 699999999999975544799999998864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.57 E-value=0.15 Score=48.66 Aligned_cols=32 Identities=34% Similarity=0.516 Sum_probs=26.2
Q ss_pred CCcccCCCCCCCEEEeCCC--CceEEccCccccc
Q 027476 68 HGIIHRDLKPENLILTADH--KTVKLADFGLARE 99 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~--~~~kl~Dfg~a~~ 99 (223)
.+++|+|+.+.||+++.++ ...-|+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998764 3456999998763
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.53 E-value=0.13 Score=42.34 Aligned_cols=30 Identities=30% Similarity=0.533 Sum_probs=26.6
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.++|+|+.+.|++++.++ -+-++||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence 489999999999999877 599999998864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=91.49 E-value=0.16 Score=40.75 Aligned_cols=30 Identities=13% Similarity=0.080 Sum_probs=26.9
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 127 NLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 127 ~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..+.+..+++.+|++.+|.+||++++++++
T Consensus 256 ~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 256 RLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 467889999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=91.30 E-value=0.34 Score=41.07 Aligned_cols=29 Identities=28% Similarity=0.450 Sum_probs=24.7
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
..++||||.|.||+++.+ .+|++|...+-
T Consensus 227 ~aLlHGDlHtGSI~v~~~--~~kvIDpEFAf 255 (409)
T PRK12396 227 QALIHGDLHTGSVFVKND--STKVIDPEFAF 255 (409)
T ss_pred hhhccCcCCCCCEEecCC--ceEEEcccccc
Confidence 469999999999999965 48999977764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.54 E-value=0.38 Score=39.72 Aligned_cols=29 Identities=28% Similarity=0.353 Sum_probs=24.2
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.+++|+|+.+.||+++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D--GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C--CcEEEeCCCCCC
Confidence 3689999999999995 3 378999998763
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=90.39 E-value=0.46 Score=38.38 Aligned_cols=29 Identities=38% Similarity=0.604 Sum_probs=24.1
Q ss_pred cccCCCCCCCEEEeCCCC----ceEEccCcccc
Q 027476 70 IIHRDLKPENLILTADHK----TVKLADFGLAR 98 (223)
Q Consensus 70 ivH~dlkp~Nill~~~~~----~~kl~Dfg~a~ 98 (223)
++|||++..||++..++. .+++.||..++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 899999999999976542 58999997664
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 223 | ||||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-08 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-06 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-05 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-05 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-05 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-05 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-05 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-05 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-05 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-05 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-05 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-05 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 7e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-05 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 7e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 7e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-05 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-04 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-04 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 3e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 3e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-04 |
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 4e-67
Identities = 68/253 (26%), Positives = 105/253 (41%), Gaps = 58/253 (22%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRC-LDIHVAIGFALDIA 59
+SRV H N+VK GAC PV +V E GG+L L P A+ + L +
Sbjct: 54 QLSRVNHPNIVKLYGACLNPVC-LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 60 RAMECLHSH---GIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWM 116
+ + LHS +IHRDLKP NL+L A +K+ DFG A + + MT G+ WM
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWM 170
Query: 117 APE----------------------------------------------NMRPS-AENLP 129
APE RP +NLP
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPESPG 189
+ + ++T CW +DP++RP+ +I++++ H + + P + +++ LPP G
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE---PLQYPCQHS-LPPGEDG 286
Query: 190 TSSLMPPRDDSER 202
+ R
Sbjct: 287 RVEPYVDFAEFYR 299
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 3e-66
Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 53/220 (24%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRC-LDIHVAIGFALDI 58
+M R+RH N+V F+GA + P + IVTE L G+L + L R LD + A D+
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 59 ARAMECLHSHG--IIHRDLKPENLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRW 115
A+ M LH+ I+HR+LK NL++ TVK+ DFGL+R ++ T + GT W
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW 205
Query: 116 MAPE---------------------------------------------NMRPSA-ENLP 129
MAPE R NL
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEP 169
+A I+ CW +P +RP+F+ I+ +L + ++ P P
Sbjct: 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRP-LIKSAVPPP 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 6e-65
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 60/213 (28%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+MS + H N+VK G P +V E + G L LL+ + + V + LDIA
Sbjct: 76 IMSNLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIAL 133
Query: 61 AMECLHSHG--IIHRDLKPENLILTADHK----TVKLADFGLAREESLTEMMTAETGTYR 114
+E + + I+HRDL+ N+ L + + K+ADFGL+++ ++ G ++
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQ 191
Query: 115 WMAPE-------------------------------------------------NMRPS- 124
WMAPE +RP+
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 125 AENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
E+ P L ++ CW DP +RP+FS I++ L
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-64
Identities = 59/214 (27%), Positives = 88/214 (41%), Gaps = 61/214 (28%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ + ++H N++ G C KEP + +V E GG L + L + + + + +A+ IA
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIA 115
Query: 60 RAMECLHSHG---IIHRDLKPENLILT-------ADHKTVKLADFGLAREESLTEMMTAE 109
R M LH IIHRDLK N+++ +K +K+ DFGLARE T M+A
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA- 174
Query: 110 TGTYRWMAPE---------------------------------------------NMRPS 124
G Y WMAPE +
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234
Query: 125 -AENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
PE A ++ CW DP+ RP+F+ I+ L
Sbjct: 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 4e-64
Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 58/213 (27%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
++ + RH N++ F+G P + IVT+ G +L +L + ++ I A AR
Sbjct: 73 VLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTAR 131
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMA 117
M+ LH+ IIHRDLK N I + TVK+ DFGLA E+S +G+ WMA
Sbjct: 132 GMDYLHAKSIIHRDLKSNN-IFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 118 PE-------------------------------------------------NMRPSA--- 125
PE ++ P
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 126 -ENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
N P+ + ++ C K+ +ERP+F +I+ +
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 4e-62
Identities = 39/211 (18%), Positives = 72/211 (34%), Gaps = 59/211 (27%)
Query: 1 MMSRVRHRNLVKFIGACKEPV---MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
+ H N++ +GAC+ P ++T + G+L L +D A+ FALD
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 58 IARAMECLHSHG--IIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRW 115
+AR M LH+ I L ++++ + T +++ + W
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQ----SPGRMYAPAW 174
Query: 116 MAPE------------------------------------------------NMRPSA-E 126
+APE +RP+
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234
Query: 127 NLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
+ ++ ++ C EDP +RP F I+ +L
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-56
Identities = 52/238 (21%), Positives = 87/238 (36%), Gaps = 68/238 (28%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ RH N+V F+GAC P + I+T L G TL + + + LD++ A +I
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIV 140
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREES------------------ 101
+ M LH+ GI+H+DLK +N+ D+ V + DFGL
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 102 ----------------------------------LTEMMTAETGTYR--------WMAPE 119
E+ E ++ W
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW-PFKTQPAEAIIWQMGT 257
Query: 120 NMRP--SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN-SAPEPVILPR 174
M+P S + ++++ I+ CW + ERP F++++ ML N P +
Sbjct: 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-56
Identities = 59/233 (25%), Positives = 82/233 (35%), Gaps = 65/233 (27%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M + H N++KFIG K+ + +TE + GGTLR + +M + + FA DIA
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIA 118
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM-------------- 105
M LHS IIHRDL N L ++K V +ADFGLAR +
Sbjct: 119 SGMAYLHSMNIIHRDLNSHN-CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 106 -MTAETGTYRWMAPE--------------------------------------------- 119
G WMAPE
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237
Query: 120 -NMRPSA-ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPV 170
+ N P I C DP +RP+F ++ L + P+
Sbjct: 238 GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-42
Identities = 37/137 (27%), Positives = 56/137 (40%), Gaps = 22/137 (16%)
Query: 1 MMSRVRHRNLVKFIGAC-----KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
+RH N++ FI + + ++T G+L YL + LD +
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIV 111
Query: 56 LDIARAMECLHS--------HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMM- 106
L IA + LH I HRDLK +N+++ + +AD GLA S +
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQL 170
Query: 107 ----TAETGTYRWMAPE 119
GT R+MAPE
Sbjct: 171 DVGNNPRVGTKRYMAPE 187
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-05
Identities = 10/45 (22%), Positives = 21/45 (46%), Gaps = 6/45 (13%)
Query: 119 ENMRPS------AENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
+ RP+ ++ LA ++ CW ++P+ R +I + L
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-41
Identities = 35/137 (25%), Positives = 56/137 (40%), Gaps = 22/137 (16%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-----MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
+RH N++ FI A + + ++T+ G+L YL + LD + A
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLA 140
Query: 56 LDIARAMECLHSH--------GIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM-- 105
+ LH+ I HRDLK +N+++ + T +AD GLA +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEV 199
Query: 106 ---MTAETGTYRWMAPE 119
GT R+M PE
Sbjct: 200 DIPPNTRVGTKRYMPPE 216
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-05
Identities = 10/64 (15%), Positives = 23/64 (35%), Gaps = 6/64 (9%)
Query: 100 ESLTEMMTAETGTYRWMAPENMRPS------AENLPEDLALIVTSCWKEDPNERPNFSQI 153
L + + + +RPS ++ + ++T CW +P R ++
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 154 IQML 157
+ L
Sbjct: 323 KKTL 326
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 54/217 (24%), Positives = 83/217 (38%), Gaps = 52/217 (23%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++RH LV+ +EP+ IVTE + G+L +L + L + + A IA
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT--YRWMA 117
M + +HRDL+ N IL ++ K+ADFGLAR E + +W A
Sbjct: 291 SGMAYVERMNYVHRDLRAAN-ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349
Query: 118 PENMR----------------------------------------------PSAENLPED 131
PE P PE
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409
Query: 132 LALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168
L ++ CW+++P ERP F + L Y T++ P+
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF-TSTEPQ 445
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 57/212 (26%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M+++RH NLV+ +G ++ + IVTE + G+L YL + L + F+LD+
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRW 115
AME L + +HRDL N +L ++ K++DFGL +E S + + +W
Sbjct: 299 CEAMEYLEGNNFVHRDLAARN-VLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKW 352
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
APE +R + + P
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 412
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161
+ ++ +CW D RP F Q+ + L H
Sbjct: 413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-39
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 54/221 (24%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M ++H NLV+ +G C + P I+TE + G L YL + + V + A I
Sbjct: 62 VMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRW 115
+ AME L IHRDL N L ++ VK+ADFGL+R + + TA G +W
Sbjct: 121 SSAMEYLEKKNFIHRDLAARN-CLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKW 178
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
APE++ E P
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 238
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPV 170
E + ++ +CW+ +P++RP+F++I Q +S + V
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-39
Identities = 56/213 (26%), Positives = 86/213 (40%), Gaps = 53/213 (24%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M +++H+ LV+ +EP+ I+TE + G+L +L L I+ + A IA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRWM 116
M + IHRDL+ N IL +D + K+ADFGLAR E TA G +W
Sbjct: 120 EGMAFIEERNYIHRDLRAAN-ILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWT 177
Query: 117 APENMR----------------------------------------------PSAENLPE 130
APE + +N PE
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163
+L ++ CWKE P +RP F + +L + +
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-39
Identities = 47/262 (17%), Positives = 92/262 (35%), Gaps = 56/262 (21%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ + H ++V+ +G C + +VT+ L G+L ++ R L + + + + IA
Sbjct: 68 AIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIA 125
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRWM 116
+ M L HG++HR+L N +L V++ADFG+A + + +WM
Sbjct: 126 KGMYYLEEHGMVHRNLAARN-VLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 117 APE--------------------------------NMR--------------PSAENLPE 130
A E +R +
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI 244
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPESPGT 190
D+ +++ CW D N RP F ++ P ++ + S PE G
Sbjct: 245 DVYMVMVKCWMIDENIRPTFKELANEFTRMARD---PPRYLVIKRESGPGIAPGPEPHGL 301
Query: 191 SSLMPPRDDSERNPNTRMEDQP 212
++ + E + ++ +
Sbjct: 302 TNKKLEEVELEPELDLDLDLEA 323
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-39
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 54/216 (25%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M ++H NLV+ +G C + P I+TE + G L YL + + V + A I
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 327
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRW 115
+ AME L IHR+L N L ++ VK+ADFGL+R + + TA G +W
Sbjct: 328 SSAMEYLEKKNFIHRNLAARN-CLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKW 385
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
APE++ E P
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP 445
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165
E + ++ +CW+ +P++RP+F++I Q +S
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-39
Identities = 54/208 (25%), Positives = 82/208 (39%), Gaps = 54/208 (25%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
++ + H N+V+ IG C K+P+ IV EL+ GG +L R L + + D
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDA 222
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRW 115
A ME L S IHRDL N L + +K++DFG++REE+ + +W
Sbjct: 223 AAGMEYLESKCCIHRDLAARN-CLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
APE + P E P
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP 341
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQML 157
+ + ++ CW +P +RP+FS I Q L
Sbjct: 342 DAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-39
Identities = 60/215 (27%), Positives = 82/215 (38%), Gaps = 53/215 (24%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++H LVK KEP+ I+TE + G+L +L + + I F+ IA
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRWM 116
M + IHRDL+ N IL + K+ADFGLAR E TA G +W
Sbjct: 295 EGMAFIEQRNYIHRDLRAAN-ILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWT 352
Query: 117 APENMR----------------------------------------------PSAENLPE 130
APE + P EN PE
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE 412
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165
+L I+ CWK P ERP F I +L + +
Sbjct: 413 ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-38
Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 57/214 (26%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M+++RH NLV+ +G ++ + IVTE + G+L YL + L + F+LD+
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRW 115
AME L + +HRDL N +L ++ K++DFGL +E S + + +W
Sbjct: 127 CEAMEYLEGNNFVHRDLAARN-VLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKW 180
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
APE +R + + P
Sbjct: 181 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 240
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163
+ ++ +CW D RP+F Q+ + L H +
Sbjct: 241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-38
Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 1 MMSRVRHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
+ ++H N+++FIGA K + ++T G+L +L + + + A
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIA 127
Query: 56 LDIARAMECLHSH----------GIIHRDLKPENLILTADHKTVKLADFGLAR---EESL 102
+AR + LH I HRD+K +N++L + T +ADFGLA
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKS 186
Query: 103 TEMMTAETGTYRWMAPE 119
+ GT R+MAPE
Sbjct: 187 AGDTHGQVGTRRYMAPE 203
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-38
Identities = 37/137 (27%), Positives = 56/137 (40%), Gaps = 22/137 (16%)
Query: 1 MMSRVRHRNLVKFIGACK-----EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
+RH N++ FI A + +V++ G+L YL + + I A
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLA 145
Query: 56 LDIARAMECLHSH--------GIIHRDLKPENLILTADHKTVKLADFGLAREES-----L 102
L A + LH I HRDLK +N+++ + T +AD GLA +
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTI 204
Query: 103 TEMMTAETGTYRWMAPE 119
GT R+MAPE
Sbjct: 205 DIAPNHRVGTKRYMAPE 221
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 10/51 (19%), Positives = 20/51 (39%), Gaps = 6/51 (11%)
Query: 113 YRWMAPENMRPSAEN------LPEDLALIVTSCWKEDPNERPNFSQIIQML 157
+ + + +RP+ N +A I+ CW + R +I + L
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-38
Identities = 43/211 (20%), Positives = 75/211 (35%), Gaps = 53/211 (25%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M+ V + ++ + +G C V ++T+L+ G L Y+ + + + + + IA
Sbjct: 70 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIA 127
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRWM 116
+ M L ++HRDL N +L + VK+ DFGLA+ E G +WM
Sbjct: 128 KGMNYLEDRRLVHRDLAARN-VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 117 APE--------------------------------NMR--------------PSAENLPE 130
A E + P
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 246
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161
D+ +I+ CW D + RP F ++I
Sbjct: 247 DVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-38
Identities = 54/217 (24%), Positives = 83/217 (38%), Gaps = 52/217 (23%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++RH LV+ +EP+ IVTE + G+L +L + L + + A IA
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT--YRWMA 117
M + +HRDL+ N IL ++ K+ADFGLAR E + +W A
Sbjct: 374 SGMAYVERMNYVHRDLRAAN-ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432
Query: 118 PENMR----------------------------------------------PSAENLPED 131
PE P PE
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 492
Query: 132 LALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168
L ++ CW+++P ERP F + L Y T++ P+
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF-TSTEPQ 528
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-38
Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 55/226 (24%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M + H N++ IG E + ++ + G L +++ + + + I F L +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQV 133
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY----- 113
AR ME L +HRDL N + + TVK+ADFGLAR+ E + + +
Sbjct: 134 ARGMEYLAEQKFVHRDLAARN-CMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 114 RWMAPENMR----------------------------------------------PSAEN 127
+W A E+++ P E
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY 252
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILP 173
P+ L ++ CW+ DP RP F ++ + +S V LP
Sbjct: 253 CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP 298
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-38
Identities = 51/267 (19%), Positives = 95/267 (35%), Gaps = 63/267 (23%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M+ V + ++ + +G C V ++T+L+ G L Y+ + + + + + IA
Sbjct: 70 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIA 127
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRWM 116
+ M L ++HRDL N +L + VK+ DFGLA+ E G +WM
Sbjct: 128 KGMNYLEDRRLVHRDLAARN-VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 117 APE--------------------------------NMR--------------PSAENLPE 130
A E + P
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 246
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPESPGT 190
D+ +I+ CW D + RP F ++I P+ ++ + + P +S
Sbjct: 247 DVYMIMVKCWMIDADSRPKFRELIIEFSKMA---RDPQRYLVIQGDERMHLPSPTDSNFY 303
Query: 191 SSLMPPRDDSERNPNTRMED----QPG 213
+LM D+ + + ++ Q G
Sbjct: 304 RALM---DEEDMDDVVDADEYLIPQQG 327
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-37
Identities = 56/216 (25%), Positives = 79/216 (36%), Gaps = 55/216 (25%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M + H LV+ G C + P+ I+TE + G L YL MR R + D+
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRPIF-IITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDV 129
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRW 115
AME L S +HRDL N L D VK++DFGL+R E T+ G+ RW
Sbjct: 130 CEAMEYLESKQFLHRDLAARN-CLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRW 187
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
PE +
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 247
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165
E + I+ SCW E +ERP F ++ +L + S
Sbjct: 248 EKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-37
Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 55/218 (25%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
M + H ++VK IG + PV I+ EL G LR +L + LD+ I +A ++
Sbjct: 69 TMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLS 126
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY--RWMA 117
A+ L S +HRD+ N +L + + VKL DFGL+R + A G +WMA
Sbjct: 127 TALAYLESKRFVHRDIAARN-VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185
Query: 118 PENMR----------------------------------------------PSAENLPED 131
PE++ P N P
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 245
Query: 132 LALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEP 169
L ++T CW DP+ RP F+++ L + +
Sbjct: 246 LYSLMTKCWAYDPSRRPRFTELKAQLSTIL---EEEKA 280
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-37
Identities = 51/221 (23%), Positives = 82/221 (37%), Gaps = 55/221 (24%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M H N++ +G C E ++V + G LR ++ N + IGF L +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 137
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY----- 113
A+ M+ L S +HRDL N + + TVK+ADFGLAR+ E + T
Sbjct: 138 AKGMKYLASKKFVHRDLAARN-CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 114 RWMAPENMR----------------------------------------------PSAEN 127
+WMA E+++ E
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 256
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168
P+ L ++ CW RP+FS+++ + ST
Sbjct: 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-36
Identities = 49/214 (22%), Positives = 80/214 (37%), Gaps = 55/214 (25%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M ++ H LV+ G C + P+ +VTE + G L YL R +G LD+
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDV 113
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRW 115
M L +IHRDL N L +++ +K++DFG+ R + T+ TGT +W
Sbjct: 114 CEGMAYLEEACVIHRDLAARN-CLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKW 171
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
+PE
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS 231
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163
+ I+ CW+E P +RP FS++++ L +
Sbjct: 232 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-36
Identities = 54/212 (25%), Positives = 84/212 (39%), Gaps = 52/212 (24%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M + H ++VK IG +EP I+ EL G L YL + L + + ++L I
Sbjct: 66 IMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQIC 123
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY--RWMA 117
+AM L S +HRD+ N IL A + VKL DFGL+R + A +WM+
Sbjct: 124 KAMAYLESINCVHRDIAVRN-ILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 182
Query: 118 PENMR----------------------------------------------PSAENLPED 131
PE++ P + P
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV 242
Query: 132 LALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163
L ++T CW DP++RP F++++ L
Sbjct: 243 LYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-36
Identities = 52/211 (24%), Positives = 74/211 (35%), Gaps = 55/211 (26%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
M ++ H LVKF G C + P+ IVTE + G L YL + L+ + D+
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIY-IVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDV 113
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT---YRW 115
M L SH IHRDL N L VK++DFG+ R + + GT +W
Sbjct: 114 CEGMAFLESHQFIHRDLAARN-CLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKW 171
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
APE
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLAS 231
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160
+ + I+ SCW E P +RP F Q++ +
Sbjct: 232 DTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 55/210 (26%), Positives = 84/210 (40%), Gaps = 52/210 (24%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
M + H ++VK IG + PV I+ EL G LR +L + LD+ I +A ++
Sbjct: 444 TMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLS 501
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY--RWMA 117
A+ L S +HRD+ N +L + + VKL DFGL+R + A G +WMA
Sbjct: 502 TALAYLESKRFVHRDIAARN-VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 118 PENMR----------------------------------------------PSAENLPED 131
PE++ P N P
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620
Query: 132 LALIVTSCWKEDPNERPNFSQIIQMLLHYI 161
L ++T CW DP+ RP F+++ L +
Sbjct: 621 LYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-36
Identities = 57/236 (24%), Positives = 92/236 (38%), Gaps = 72/236 (30%)
Query: 1 MMSRV-RHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA------ 51
MM + +H+N++ +GAC P+ VI E G LR+YL RP ++
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 52 --------IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT 103
+ +AR ME L S IHRDL N +L ++ +K+ADFGLAR+ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN-VLVTENNVMKIADFGLARDINNI 210
Query: 104 EMMTAETGT---YRWMAPENM--------------------------------------- 121
+ T +WMAPE +
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270
Query: 122 ---------RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168
+P N +L +++ CW P++RP F Q+++ L ++ + E
Sbjct: 271 LLKEGHRMDKP--ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 63/261 (24%), Positives = 98/261 (37%), Gaps = 77/261 (29%)
Query: 1 MMSRV-RHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA------ 51
MM + +H+N++ +GAC P+ VI E G LR+YL RP L+
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 52 --------IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT 103
+ A +AR ME L S IHRDL N +L + +K+ADFGLAR+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN-VLVTEDNVMKIADFGLARDIHHI 244
Query: 104 EMMTAETGT---YRWMAPENM--------------------------------------- 121
+ T +WMAPE +
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304
Query: 122 ---------RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVIL 172
+P N +L +++ CW P++RP F Q+++ L ++ S E +
Sbjct: 305 LLKEGHRMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE---M 359
Query: 173 PRMFSSENAVLPPESPGTSSL 193
+ + P T +L
Sbjct: 360 GYYHHHHHH--DYDIPTTENL 378
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-36
Identities = 52/229 (22%), Positives = 85/229 (37%), Gaps = 55/229 (24%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M H N++ +G C E ++V + G LR ++ N + IGF L +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 201
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY----- 113
A+ M+ L S +HRDL N + + TVK+ADFGLAR+ E + T
Sbjct: 202 AKGMKFLASKKFVHRDLAARN-CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 114 RWMAPENMR----------------------------------------------PSAEN 127
+WMA E+++ E
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 320
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMF 176
P+ L ++ CW RP+FS+++ + ST V + +
Sbjct: 321 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATY 369
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-36
Identities = 54/241 (22%), Positives = 91/241 (37%), Gaps = 58/241 (24%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M + H N+++ G +P+M I+TE + G L K+L + +G I
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMM-IITEYMENGALDKFLREKDGE-FSVLQLVGMLRGI 156
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGT---YR 114
A M+ L + +HRDL N IL + K++DFGL+R E E +G R
Sbjct: 157 AAGMKYLANMNYVHRDLAARN-ILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 115 WMAPE--------------------------------NMR--------------PSAENL 128
W APE + P+ +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 275
Query: 129 PEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPESP 188
P + ++ CW+++ RP F+ I+ +L I AP+ + F ++ P +
Sbjct: 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLI---RAPDSLKTLADFDPRVSIRLPSTS 332
Query: 189 G 189
G
Sbjct: 333 G 333
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-36
Identities = 57/234 (24%), Positives = 88/234 (37%), Gaps = 71/234 (30%)
Query: 1 MMSRV-RHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA------ 51
++S + H N+V +GAC P +VI TE G L +L R + +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVI-TEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 52 ----------IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREES 101
+ F+ +A+ M L S IHRDL N IL + K+ DFGLAR+
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN-ILLTHGRITKICDFGLARDIK 196
Query: 102 LTEMMTAETGT---YRWMAPENMR------------------------------------ 122
+ +WMAPE++
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165
S E+ P ++ I+ +CW DP +RP F QI+Q++ IS ++
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-36
Identities = 57/236 (24%), Positives = 92/236 (38%), Gaps = 72/236 (30%)
Query: 1 MMSRV-RHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA------ 51
MM + +H+N++ +GAC P+ VI E G LR+YL RP ++
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 52 --------IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT 103
+ +AR ME L S IHRDL N +L ++ +K+ADFGLAR+ +
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN-VLVTENNVMKIADFGLARDINNI 256
Query: 104 EMMTAETGT---YRWMAPENM--------------------------------------- 121
+ T +WMAPE +
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316
Query: 122 ---------RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168
+P N +L +++ CW P++RP F Q+++ L ++ + E
Sbjct: 317 LLKEGHRMDKP--ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 370
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 8e-36
Identities = 36/143 (25%), Positives = 57/143 (39%), Gaps = 28/143 (19%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV------IVTELLLGGTLRKYLLNMRPRCLDIHVAIGF 54
+ + H N+ +FI + +V E G+L KYL D +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRL 116
Query: 55 ALDIARAMECLHS---------HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM 105
A + R + LH+ I HRDL N+++ D T ++DFGL+ + +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRL 175
Query: 106 ---------MTAETGTYRWMAPE 119
+E GT R+MAPE
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPE 198
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 7e-05
Identities = 9/59 (15%), Positives = 15/59 (25%), Gaps = 7/59 (11%)
Query: 119 ENMRP-------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPV 170
E RP L + CW +D R + + + + V
Sbjct: 268 EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-35
Identities = 51/230 (22%), Positives = 78/230 (33%), Gaps = 67/230 (29%)
Query: 1 MMSRV-RHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA------ 51
+MS + +H N+V +GAC PV+VI TE G L +L
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVI-TEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 52 ------IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM 105
+ F+ +A+ M L S IHRD+ N +L + K+ DFGLAR+
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARN-VLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 106 MTAETGT---YRWMAPENMR---------------------------------------- 122
+ +WMAPE++
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279
Query: 123 -------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165
P+++ I+ +CW +P RP F QI L +
Sbjct: 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-35
Identities = 45/237 (18%), Positives = 82/237 (34%), Gaps = 70/237 (29%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRC------------- 45
+++ ++H+++V+F G C P++++ E + G L ++L + P
Sbjct: 96 LLTMLQHQHIVRFFGVCTEGRPLLMV-FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 46 LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM 105
L + + A +A M L +HRDL N L VK+ DFG++R+ T+
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRN-CLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 106 MTAETGTY---RWMAPENM----------------------------------------- 121
T RWM PE++
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273
Query: 122 -------RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVI 171
RP P ++ I+ CW+ +P +R + + L V+
Sbjct: 274 TQGRELERP--RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVL 328
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-35
Identities = 42/216 (19%), Positives = 79/216 (36%), Gaps = 54/216 (25%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++ + +V+ IG C E +M +V E+ GG L K+L+ R + + ++
Sbjct: 63 IMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVS 120
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMM-TAETGT---YRW 115
M+ L +HRDL N +L + K++DFGL++ + TA + +W
Sbjct: 121 MGMKYLEEKNFVHRDLAARN-VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
APE + P
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 239
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165
+L +++ CW +RP+F + Q + + +
Sbjct: 240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-35
Identities = 57/247 (23%), Positives = 97/247 (39%), Gaps = 65/247 (26%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA------- 51
+M ++V+ +G +P +VI EL+ G L+ YL ++RP + V
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVI-MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 52 -IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
I A +IA M L+++ +HRDL N + A+ TVK+ DFG+ R+ T+
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARN-CMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 111 GTY---RWMAPENMR--------------------------------------------- 122
RWM+PE+++
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258
Query: 123 -PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENA 181
+N P+ L ++ CW+ +P RP+F +II + + P + +S EN
Sbjct: 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME----PGFREVSFYYSEENK 314
Query: 182 VLPPESP 188
+ PE
Sbjct: 315 LPEPEEL 321
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-35
Identities = 53/221 (23%), Positives = 80/221 (36%), Gaps = 58/221 (26%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M + H N+++ G M IVTE + G+L +L + I +G +
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGV 160
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGT---YR 114
M L G +HRDL N +L + K++DFGL+R E + TG R
Sbjct: 161 GAGMRYLSDLGYVHRDLAARN-VLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 115 WMAPENMR----------------------------------------------PSAENL 128
W APE + P+
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGC 279
Query: 129 PEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEP 169
P L ++ CW +D +RP FSQI+ +L I +PE
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI---RSPES 317
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-35
Identities = 52/232 (22%), Positives = 92/232 (39%), Gaps = 79/232 (34%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA------- 51
++ +V H +++K GAC P+++IV E G+LR +L R +
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 52 ---------------IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGL 96
I FA I++ M+ L ++HRDL N IL A+ + +K++DFGL
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN-ILVAEGRKMKISDFGL 196
Query: 97 AREESLTEMMTAETGT---YRWMAPENM-------------------------------- 121
+R+ + + +WMA E++
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 122 ----------------RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
RP +N E++ ++ CWK++P++RP F+ I + L
Sbjct: 257 PPERLFNLLKTGHRMERP--DNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-35
Identities = 48/222 (21%), Positives = 81/222 (36%), Gaps = 60/222 (27%)
Query: 1 MMSRVRHRNLVKFIGAC------KEPVMVIVTELLLGGTLRKYLLNMRPRC----LDIHV 50
M H N+++ +G C P +++ + G L YLL R + +
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
+ F +DIA ME L + +HRDL N + D TV +ADFGL+++ +
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARN-CMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207
Query: 111 GT---YRWMAPENMR--------------------------------------------- 122
+W+A E++
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267
Query: 123 -PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163
E+ ++L I+ SCW+ DP +RP FS + L + +
Sbjct: 268 LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-35
Identities = 53/242 (21%), Positives = 82/242 (33%), Gaps = 76/242 (31%)
Query: 1 MMSRV-RHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA------ 51
MM+++ H N+V +GAC P+ +I E G L YL + R + + +
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLI-FEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 52 ---------------IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGL 96
+ FA +A+ ME L +HRDL N +L K VK+ DFGL
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN-VLVTHGKVVKICDFGL 218
Query: 97 AREESLTEMMTAETGT---YRWMAPE--------------------------------NM 121
AR+ +WMAPE +
Sbjct: 219 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278
Query: 122 RPSAE---------------NLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSA 166
A E++ +I+ SCW D +RP+F + L ++
Sbjct: 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338
Query: 167 PE 168
Sbjct: 339 AM 340
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-35
Identities = 51/215 (23%), Positives = 80/215 (37%), Gaps = 59/215 (27%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRC-----LDIHVAIG 53
++S+ H+N+V+ IG P I+ EL+ GG L+ +L RPR L + +
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 54 FALDIARAMECLHSHGIIHRDLKPEN--LILTADHKTVKLADFGLAREESLTEMMTAETG 111
A DIA + L + IHRD+ N L + K+ DFG+AR+
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 112 TY---RWMAPENMR---------------------------------------------- 122
+WM PE
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264
Query: 123 PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
+N P + I+T CW+ P +RPNF+ I++ +
Sbjct: 265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-35
Identities = 47/230 (20%), Positives = 81/230 (35%), Gaps = 61/230 (26%)
Query: 1 MMSRVRHRNLVKFIGAC-------KEPVMVIVTELLLGGTLRKYLLNMRP----RCLDIH 49
M H ++ K +G + P+ +++ + G L +LL R L +
Sbjct: 78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 50 VAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE 109
+ F +DIA ME L S IHRDL N + A+ TV +ADFGL+R+ +
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARN-CMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 110 TGT---YRWMAPENMR-------------------------------------------- 122
+ +W+A E++
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256
Query: 123 --PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPV 170
E++ ++ CW DP +RP+F+ + L + + S
Sbjct: 257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-35
Identities = 54/236 (22%), Positives = 89/236 (37%), Gaps = 70/236 (29%)
Query: 1 MMSRV-RHRNLVKFIGAC---KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA----- 51
++ + H N+V +GAC P+MVI E G L YL + R + VA
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVI-VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 52 ---------IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL 102
I ++ +A+ ME L S IHRDL N IL ++ VK+ DFGLAR+
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN-ILLSEKNVVKICDFGLARDIYK 200
Query: 103 TEMMTAETGT---YRWMAPENMR------------------------------------- 122
+ +WMAPE +
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260
Query: 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168
+ + ++ + CW +P++RP FS++++ L + + N+ +
Sbjct: 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-35
Identities = 44/211 (20%), Positives = 73/211 (34%), Gaps = 55/211 (26%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++ + +V+ IG C E M +V E+ G L KYL R + I ++
Sbjct: 71 VMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVS 127
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGT---YRW 115
M+ L +HRDL N +L K++DFGL++ + A+T +W
Sbjct: 128 MGMKYLEESNFVHRDLAARN-VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
APE + P
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 246
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160
++ ++ CW D RP F+ + L +Y
Sbjct: 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-35
Identities = 51/215 (23%), Positives = 80/215 (37%), Gaps = 59/215 (27%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRC-----LDIHVAIG 53
++S+ H+N+V+ IG P I+ EL+ GG L+ +L RPR L + +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 54 FALDIARAMECLHSHGIIHRDLKPEN--LILTADHKTVKLADFGLAREESLTEMMTAETG 111
A DIA + L + IHRD+ N L + K+ DFG+AR+
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 112 TY---RWMAPENMR---------------------------------------------- 122
+WM PE
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305
Query: 123 PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
+N P + I+T CW+ P +RPNF+ I++ +
Sbjct: 306 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-34
Identities = 53/232 (22%), Positives = 86/232 (37%), Gaps = 71/232 (30%)
Query: 1 MMSRV-RHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA------ 51
++ ++ H N++ +GAC + + + E G L +L R D A
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 52 --------IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT 103
+ FA D+AR M+ L IHRDL N IL ++ K+ADFGL+R +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN-ILVGENYVAKIADFGLSRGQ--- 192
Query: 104 EMMTAETGT---YRWMAPENMR-------------------------------------- 122
E+ +T RWMA E++
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252
Query: 123 --------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSA 166
N +++ ++ CW+E P ERP+F+QI+ L +
Sbjct: 253 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-34
Identities = 49/209 (23%), Positives = 73/209 (34%), Gaps = 55/209 (26%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
M + HRNL++ G P+ +VTEL G+L L + + +A+ +A
Sbjct: 74 AMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVA 131
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGT---YRW 115
M L S IHRDL N +L A VK+ DFGL R + + + W
Sbjct: 132 EGMGYLESKRFIHRDLAARN-LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 116 MAPE--------------------------------NMR---------------PSAENL 128
APE + P E+
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250
Query: 129 PEDLALIVTSCWKEDPNERPNFSQIIQML 157
P+D+ ++ CW P +RP F + L
Sbjct: 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-34
Identities = 59/245 (24%), Positives = 89/245 (36%), Gaps = 56/245 (22%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M + H N+++ G +PVM IVTE + G+L +L + + +G I
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVM-IVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGI 156
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGT---YR 114
A M+ L G +HRDL N IL + K++DFGL R E E G R
Sbjct: 157 ASGMKYLSDMGYVHRDLAARN-ILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 115 WMAPE--------------------------------NMR--------------PSAENL 128
W +PE M P +
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275
Query: 129 PEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPESP 188
P L ++ CW++D N RP F QI+ +L I N +I N +L +
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI-RNPGSLKIITSAAARPSNLLLDQSNV 334
Query: 189 GTSSL 193
++
Sbjct: 335 DITTF 339
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-34
Identities = 50/230 (21%), Positives = 85/230 (36%), Gaps = 71/230 (30%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRC------------- 45
+++ ++H ++VKF G C +P++ +V E + G L K+L P
Sbjct: 70 LLTNLQHEHIVKFYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 46 -LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE 104
L + + A IA M L S +HRDL N L + VK+ DFG++R+ T+
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRN-CLVGANLLVKIGDFGMSRDVYSTD 187
Query: 105 MMTAETGTY---RWMAPENM---------------------------------------- 121
T RWM PE++
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 247
Query: 122 --------RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163
RP P+++ ++ CW+ +P +R N +I ++L
Sbjct: 248 ITQGRVLERP--RVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-34
Identities = 48/225 (21%), Positives = 79/225 (35%), Gaps = 67/225 (29%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRC------------- 45
+ +R++H N+V +G +P+ ++ G L ++L+ P
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 46 -LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE 104
L+ + IA ME L SH ++H+DL N +L D VK++D GL RE +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN-VLVYDKLNVKISDLGLFREVYAAD 182
Query: 105 MMTAETGTY---RWMAPENMR--------------------------------------- 122
+ RWMAPE +
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 123 -------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160
P ++ P + ++ CW E P+ RP F I L +
Sbjct: 243 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-33
Identities = 51/245 (20%), Positives = 84/245 (34%), Gaps = 79/245 (32%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA------- 51
+M+ + N+VK +G C +P+ ++ E + G L ++L +M P +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 52 ---------------IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGL 96
+ A +A M L +HRDL N L ++ VK+ADFGL
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN-CLVGENMVVKIADFGL 220
Query: 97 AREESLTEMMTAETGTY---RWMAPENM-------------------------------- 121
+R + A+ RWM PE++
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280
Query: 122 ----------------RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165
P EN P +L ++ CW + P +RP+F I ++L
Sbjct: 281 AHEEVIYYVRDGNILACP--ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338
Query: 166 APEPV 170
V
Sbjct: 339 GTVGV 343
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-32
Identities = 56/252 (22%), Positives = 85/252 (33%), Gaps = 71/252 (28%)
Query: 1 MMSRVRHRNLVKFIGAC----KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFAL 56
++ + +VK+ G ++ + +V E L G LR +L R R LD + ++
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSS 134
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE----------------- 99
I + ME L S +HRDL N IL VK+ADFGLA+
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARN-ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 100 ------ES------------------LTEMMT-------AETGTYRWMAPENMRPSAENL 128
ES L E+ T R M E P+ L
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 129 ----------------PEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVIL 172
P ++ ++ CW P +RP+FS + L S + E
Sbjct: 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 313
Query: 173 PRMFSSENAVLP 184
++ L
Sbjct: 314 TAHPEGKHHSLS 325
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 44/228 (19%), Positives = 82/228 (35%), Gaps = 67/228 (29%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
MMS++ H++LV G C + + +V E + G+L YL + ++I + A +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQL 122
Query: 59 ARAMECLHSHGIIHRDL-------KPENLILTADHKTVKLADFGLAREESLTEMMTAETG 111
A AM L + +IH ++ E T + +KL+D G++
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLPKD 175
Query: 112 TY----RWMAPENMR-----------------------------PSAEN----------- 127
W+ PE + + ++
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH 235
Query: 128 -LPE----DLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPV 170
LP +LA ++ +C +P+ RP+F II+ L + + P
Sbjct: 236 QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS 283
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 42/220 (19%), Positives = 80/220 (36%), Gaps = 53/220 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M ++ + +V+ IG C+ +++V E+ GG L K+L+ R + + ++
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSM 447
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMM-TAETGT---YRWM 116
M+ L +HR+L N +L + K++DFGL++ + TA + +W
Sbjct: 448 GMKYLEEKNFVHRNLAARN-VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 506
Query: 117 APENMR----------------------------------------------PSAENLPE 130
APE + P
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 566
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLHYI-STNSAPEP 169
+L +++ CW +RP+F + Q + S S E
Sbjct: 567 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-32
Identities = 49/235 (20%), Positives = 83/235 (35%), Gaps = 72/235 (30%)
Query: 1 MMSRVRHRNLVKFIGAC----KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFAL 56
++ ++H N+VK+ G C + + ++ E L G+LR YL + R +D + +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTS 121
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE----------------- 99
I + ME L + IHRDL N IL + VK+ DFGL +
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRN-ILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 100 ------ES------------------LTEMMTAETGTYRWMAPENMR------------- 122
ES L E+ T + A
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSA 166
P + P+++ +I+T CW + N+RP+F + + +
Sbjct: 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-31
Identities = 44/225 (19%), Positives = 83/225 (36%), Gaps = 71/225 (31%)
Query: 1 MMSRVRHRNLVKFIGAC----KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFAL 56
++ + H N+VK+ G C + ++ E L G+L++YL + + +++ + +A+
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAV 133
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE----------------- 99
I + M+ L S +HRDL N +L VK+ DFGL +
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARN-VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 100 ------ES------------------LTEMMT--------------AETGTYRWMAPENM 121
E L E++T T+ M +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 122 R---------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
P N P+++ ++ CW+ P+ R +F +I+
Sbjct: 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-31
Identities = 49/226 (21%), Positives = 82/226 (36%), Gaps = 72/226 (31%)
Query: 1 MMSRVRHRNLVKFIGAC----KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFAL 56
++ ++H N+VK+ G C + + ++ E L G+LR YL + R +D + +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTS 152
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE----------------- 99
I + ME L + IHRDL N IL + VK+ DFGL +
Sbjct: 153 QICKGMEYLGTKRYIHRDLATRN-ILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 100 ------ES------------------LTEMMTAETGTYRWMAPENMR------------- 122
ES L E+ T + A
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
P + P+++ +I+T CW + N+RP+F + +
Sbjct: 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-31
Identities = 46/237 (19%), Positives = 80/237 (33%), Gaps = 73/237 (30%)
Query: 1 MMSRVRHRNLVKFIGAC----KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFAL 56
++ + H +++K+ G C + +V E + G+LR YL + + FA
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQ-LVMEYVPLGSLRDYLPRHSIGLAQL---LLFAQ 141
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE----------------- 99
I M LH+ IHRDL N +L + + VK+ DFGLA+
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARN-VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 100 ------ES------------------LTEMMT-------AETGTYRWMAPENMRPSAENL 128
E L E++T T + + + L
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260
Query: 129 ----------------PEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEP 169
P ++ ++ +CW+ + + RP F +I +L P
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-31
Identities = 46/214 (21%), Positives = 78/214 (36%), Gaps = 58/214 (27%)
Query: 1 MMSRVRHRNLVKFIGA-----------------CKEPVMVIVTELLLGGTLRKYLLNMRP 43
++++ H N+V + G K + I E GTL +++ R
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 44 RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT 103
LD +A+ I + ++ +HS +I+RDLKP N+ L K VK+ DFGL
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKND 175
Query: 104 EMMTAETGTYRWMAPE----------------------------------------NMRP 123
T GT R+M+PE
Sbjct: 176 GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI 235
Query: 124 SAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
++ + ++ + P +RPN S+I++ L
Sbjct: 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-29
Identities = 32/126 (25%), Positives = 53/126 (42%), Gaps = 7/126 (5%)
Query: 1 MMSRVRHRNLVK---FIGACKEPVMVIVTELLLGGTLRKYLL-NMRPRCLDIHVAIGFAL 56
++ ++ H+N+VK V++ E G+L L L +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTA---DHKTVKLADFGLAREESLTEMMTAETGTY 113
D+ M L +GI+HR++KP N++ KL DFG ARE E + GT
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 114 RWMAPE 119
++ P+
Sbjct: 180 EYLHPD 185
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 52/245 (21%), Positives = 101/245 (41%), Gaps = 54/245 (22%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+++ ++H N+V++ + +E + IV + GG L K + + + + + I
Sbjct: 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWMAP 118
A++ +H I+HRD+K +N+ LT D TV+L DFG+AR S E+ A GT +++P
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSP 194
Query: 119 E--NMRP------------------------SAENLPE-------------------DLA 133
E +P A ++ DL
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLR 254
Query: 134 LIVTSCWKEDPNERPNFSQIIQM------LLHYISTNSAPEPVILPRMFSSENAVLPPES 187
+V+ +K +P +RP+ + I++ + ++S E L + +P +
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314
Query: 188 PGTSS 192
P +
Sbjct: 315 PASGQ 319
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 6e-28
Identities = 32/126 (25%), Positives = 53/126 (42%), Gaps = 7/126 (5%)
Query: 1 MMSRVRHRNLVK---FIGACKEPVMVIVTELLLGGTLRKYLL-NMRPRCLDIHVAIGFAL 56
++ ++ H+N+VK V++ E G+L L L +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTAD---HKTVKLADFGLAREESLTEMMTAETGTY 113
D+ M L +GI+HR++KP N++ KL DFG ARE E + GT
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 114 RWMAPE 119
++ P+
Sbjct: 180 EYLHPD 185
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-27
Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 4/120 (3%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+H V+ A +E ++ + TEL G +L+++ L G+ D
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA-WGASLPEAQVWGYLRDTL 167
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
A+ LHS G++H D+KP N+ L KL DFGL E + G R+MAPE
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-26
Identities = 42/126 (33%), Positives = 68/126 (53%), Gaps = 10/126 (7%)
Query: 1 MMSRVRHRNLVKFIGAC-----KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
M+ ++H N+V+F + + +V+VTEL+ GTL+ YL R + + I V +
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWC 135
Query: 56 LDIARAMECLHSHG--IIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY 113
I + ++ LH+ IIHRDLK +N+ +T +VK+ D GLA + + GT
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTP 194
Query: 114 RWMAPE 119
+MAPE
Sbjct: 195 EFMAPE 200
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 41/129 (31%), Positives = 59/129 (45%), Gaps = 10/129 (7%)
Query: 1 MMSRVRHRNLVKFI-------GACKEPVMVIVTELLLGGTLRKYLLNM-RPRCLDIHVAI 52
+M ++ H N+V + ++ E GG LRKYL L
Sbjct: 65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 53 GFALDIARAMECLHSHGIIHRDLKPENLILTA--DHKTVKLADFGLAREESLTEMMTAET 110
DI+ A+ LH + IIHRDLKPEN++L K+ D G A+E E+ T
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184
Query: 111 GTYRWMAPE 119
GT +++APE
Sbjct: 185 GTLQYLAPE 193
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-26
Identities = 35/148 (23%), Positives = 59/148 (39%), Gaps = 31/148 (20%)
Query: 1 MMSRVRHRNLVKFIGA--------------CKEPVMVIVTELLLGGTLRKYLLNMRPRCL 46
+++ + H+ +V++ A K+ + I E GTL + +
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQ 113
Query: 47 DIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR-------- 98
I A+ +HS GIIHRDLKP N+ + VK+ DFGLA+
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDI 172
Query: 99 -------EESLTEMMTAETGTYRWMAPE 119
++ +T+ GT ++A E
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATE 200
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 7e-25
Identities = 37/224 (16%), Positives = 67/224 (29%), Gaps = 68/224 (30%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-----MVIVTELLLGGTLRKYLLNMRPR--CLDIHVAIG 53
M H N+++ + C ++ GTL + ++ + L +
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR----------EESLT 103
L I R +E +H+ G HRDLKP N++L + L D G +
Sbjct: 139 LLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 104 EMMTAETGTYRWMAP------------------------------------ENMR----- 122
+ A+ T + AP +
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
Query: 123 ---------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
P + L ++ S DP++RP+ ++ L
Sbjct: 258 LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-25
Identities = 27/125 (21%), Positives = 57/125 (45%), Gaps = 11/125 (8%)
Query: 1 MMSRVRHRNL--VKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
+++++ + ++ + +V E L +L + +D + +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKN 135
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR---EESLTEMMTAETGTYR 114
+ A+ +H HGI+H DLKP N ++ +KL DFG+A ++ + + ++ GT
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 115 WMAPE 119
+M PE
Sbjct: 194 YMPPE 198
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 9e-25
Identities = 46/224 (20%), Positives = 71/224 (31%), Gaps = 71/224 (31%)
Query: 2 MSRVRHRNLVKFIGACKE-------------PVMVIVTELLLGGTLRKYLLNMRPRC-LD 47
++++ H +V++ A E + I +L L+ ++ +
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 48 IHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR--------- 98
V + L IA A+E LHS G++HRDLKP N+ T D VK+ DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQ 175
Query: 99 ----EESLTEMMTAETGTYRWMAPE----------------------------------- 119
T + GT +M+PE
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVR 235
Query: 120 --------NMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155
P ++V P ERP II+
Sbjct: 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-25
Identities = 32/126 (25%), Positives = 58/126 (46%), Gaps = 15/126 (11%)
Query: 2 MSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTL------RKYLLNMRPRCLDIHVAIGF 54
++ RHRN++ + + +V++ E + G + + LN R + +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER-------EIVSY 107
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLIL-TADHKTVKLADFGLAREESLTEMMTAETGTY 113
+ A++ LHSH I H D++PEN+I T T+K+ +FG AR+ +
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167
Query: 114 RWMAPE 119
+ APE
Sbjct: 168 EYYAPE 173
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-24
Identities = 28/125 (22%), Positives = 57/125 (45%), Gaps = 11/125 (8%)
Query: 1 MMSRVRHRNL--VKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
+++++ + ++ + +V E L +L + +D + +
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKN 116
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAET--GTYR 114
+ A+ +H HGI+H DLKP N ++ +KL DFG+A + + T + ++ GT
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 115 WMAPE 119
+M PE
Sbjct: 175 YMPPE 179
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-24
Identities = 39/129 (30%), Positives = 66/129 (51%), Gaps = 15/129 (11%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLL--NMRPRCLD----IHVAIG 53
+S RH +LV IG C E M+++ + + G L+++L ++ + + + IG
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR---EESLTEMMTAET 110
AR + LH+ IIHRD+K N IL ++ K+ DFG+++ E T + T
Sbjct: 148 ----AARGLHYLHTRAIIHRDVKSIN-ILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 111 GTYRWMAPE 119
GT ++ PE
Sbjct: 203 GTLGYIDPE 211
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-24
Identities = 37/127 (29%), Positives = 55/127 (43%), Gaps = 16/127 (12%)
Query: 2 MSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTL-----RKYLLNMRPRCLDIHVAIGFA 55
+ +RH N++ + +V++ EL+ GG L K L A F
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-------EATQFL 114
Query: 56 LDIARAMECLHSHGIIHRDLKPENLIL---TADHKTVKLADFGLAREESLTEMMTAETGT 112
I + LHS I H DLKPEN++L + +KL DFG+A + GT
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 174
Query: 113 YRWMAPE 119
++APE
Sbjct: 175 PEFVAPE 181
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-24
Identities = 31/98 (31%), Positives = 55/98 (56%), Gaps = 5/98 (5%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
+V E + G TL +Y+ + P L + AI F I ++ H I+HRD+KP+N+++
Sbjct: 88 LVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID 145
Query: 84 ADHKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
++ +K+ DFG+A+ S T + GT ++ +PE
Sbjct: 146 SNKT-LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-24
Identities = 54/227 (23%), Positives = 87/227 (38%), Gaps = 61/227 (26%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
IV E + G TLR + P + AI D +A+ H +GIIHRD+KP N++++
Sbjct: 93 IVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 84 ADHKTVKLADFGLAREESLTEMMTAET----GTYRWMAPENMR----------------- 122
A + VK+ DFG+AR + + +T GT ++++PE R
Sbjct: 151 ATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 123 -----------------------------PSAEN--LPEDLALIVTSCWKEDPNERP-NF 150
PSA + L DL +V ++P R
Sbjct: 210 YEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 269
Query: 151 SQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPESPGTSSLMPPR 197
+++ L+ + P +L +E L + G S PR
Sbjct: 270 AEMRADLVRVHNGEPPEAPKVLT---DAERTSLLSSAAGNLS--GPR 311
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-24
Identities = 40/127 (31%), Positives = 60/127 (47%), Gaps = 15/127 (11%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTL------RKYLLNMRPRCLDIHVAIG 53
+M+++ H NL++ A + +V+V E + GG L Y L I
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL-------DTIL 191
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLIL-TADHKTVKLADFGLAREESLTEMMTAETGT 112
F I + +H I+H DLKPEN++ D K +K+ DFGLAR E + GT
Sbjct: 192 FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT 251
Query: 113 YRWMAPE 119
++APE
Sbjct: 252 PEFLAPE 258
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-24
Identities = 27/125 (21%), Positives = 56/125 (44%), Gaps = 11/125 (8%)
Query: 1 MMSRVRHRNL--VKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
+++++ + ++ + +V E L +L + +D + +
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKN 163
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAET--GTYR 114
+ A+ +H HGI+H DLKP N ++ +KL DFG+A + + T + ++ G
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 115 WMAPE 119
+M PE
Sbjct: 222 YMPPE 226
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-24
Identities = 37/129 (28%), Positives = 56/129 (43%), Gaps = 18/129 (13%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTL------RKYLLNMRPRCLDIHVAIG 53
++ +V H N++ + +V++ EL+ GG L ++ L A
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE--------ATS 119
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLIL---TADHKTVKLADFGLAREESLTEMMTAET 110
F I + LH+ I H DLKPEN++L +KL DFGLA E
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 111 GTYRWMAPE 119
GT ++APE
Sbjct: 180 GTPEFVAPE 188
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-24
Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 15/127 (11%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTL------RKYLLNMRPRCLDIHVAIG 53
+M+++ H L+ A ++ MV++ E L GG L Y ++ I
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA-------EVIN 153
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLIL-TADHKTVKLADFGLAREESLTEMMTAETGT 112
+ ++ +H H I+H D+KPEN++ T +VK+ DFGLA + + E++ T T
Sbjct: 154 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 213
Query: 113 YRWMAPE 119
+ APE
Sbjct: 214 AEFAAPE 220
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-24
Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 5/124 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTL--RKYLLNMRPRCLDIHVAIGFALD 57
++ + H N++K ++ + IV E GG L R R + L
Sbjct: 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 58 IARAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLAREESLTEMMTAETGTYRW 115
+ A+ HS ++H+DLKPEN++ + H +K+ DFGLA E T GT +
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALY 192
Query: 116 MAPE 119
MAPE
Sbjct: 193 MAPE 196
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-24
Identities = 35/127 (27%), Positives = 54/127 (42%), Gaps = 16/127 (12%)
Query: 2 MSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTL-----RKYLLNMRPRCLDIHVAIGFA 55
+ ++H N++ + ++++ EL+ GG L K L A F
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-------EATEFL 120
Query: 56 LDIARAMECLHSHGIIHRDLKPENLIL---TADHKTVKLADFGLAREESLTEMMTAETGT 112
I + LHS I H DLKPEN++L +K+ DFGLA + GT
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 180
Query: 113 YRWMAPE 119
++APE
Sbjct: 181 PEFVAPE 187
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 9e-24
Identities = 35/121 (28%), Positives = 60/121 (49%), Gaps = 3/121 (2%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
MS +RH LV A ++ MV++ E + GG L + + + + + A+ + +
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVC 265
Query: 60 RAMECLHSHGIIHRDLKPENLIL-TADHKTVKLADFGLAREESLTEMMTAETGTYRWMAP 118
+ + +H + +H DLKPEN++ T +KL DFGL + + TGT + AP
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
Query: 119 E 119
E
Sbjct: 326 E 326
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 9e-24
Identities = 46/212 (21%), Positives = 74/212 (34%), Gaps = 57/212 (26%)
Query: 1 MMSRVRHRNLVKFIGACKEP---VMVIVTELLLGGTLRKYLLNMRP--RCLDIHVAIGFA 55
++ ++H N+V++ + + IV E GG L + + LD +
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 56 LDIARAMECLHS-----HGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAE 109
+ A++ H H ++HRDLKP N+ L VKL DFGLAR T
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTF 176
Query: 110 TGTYRWMAPE--NMRP------------------------SAENLPE------------- 130
GT +M+PE N +A + E
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236
Query: 131 ------DLALIVTSCWKEDPNERPNFSQIIQM 156
+L I+T RP+ +I++
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-23
Identities = 41/127 (32%), Positives = 65/127 (51%), Gaps = 6/127 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRC-LDIHVAIGFALDI 58
+M++ +H NLV+ +G + + +V + G+L L + L H+ A
Sbjct: 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 142
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR---EESLTEMMTAETGTYRW 115
A + LH + IHRD+K N IL + T K++DFGLAR + + T M + GT +
Sbjct: 143 ANGINFLHENHHIHRDIKSAN-ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAY 201
Query: 116 MAPENMR 122
MAPE +R
Sbjct: 202 MAPEALR 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-23
Identities = 38/127 (29%), Positives = 56/127 (44%), Gaps = 16/127 (12%)
Query: 2 MSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTL-----RKYLLNMRPRCLDIHVAIGFA 55
+ +V H N++ + +V++ EL+ GG L +K L+ A F
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-------EATSFI 121
Query: 56 LDIARAMECLHSHGIIHRDLKPENLIL---TADHKTVKLADFGLAREESLTEMMTAETGT 112
I + LH+ I H DLKPEN++L +KL DFGLA E GT
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 113 YRWMAPE 119
++APE
Sbjct: 182 PEFVAPE 188
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-23
Identities = 46/207 (22%), Positives = 81/207 (39%), Gaps = 53/207 (25%)
Query: 2 MSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDI 58
+ ++ H N++K+ + E + IV EL G L + + + + R + + + +
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWMA 117
A+E +HS ++HRD+KP N+ +TA VKL D GL R S T + GT +M+
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 204
Query: 118 PE------------------------NMRP----SAENLPE------------------- 130
PE ++ NL
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264
Query: 131 -DLALIVTSCWKEDPNERPNFSQIIQM 156
+L +V C DP +RP+ + + +
Sbjct: 265 EELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-23
Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 4/121 (3%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
++ ++ H ++K IV EL+ GG L ++ + L + +
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLL 250
Query: 61 AMECLHSHGIIHRDLKPENLILTADHK--TVKLADFGLAREESLTEMMTAETGTYRWMAP 118
A++ LH +GIIHRDLKPEN++L++ + +K+ DFG ++ T +M GT ++AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 119 E 119
E
Sbjct: 311 E 311
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 4e-23
Identities = 37/124 (29%), Positives = 62/124 (50%), Gaps = 15/124 (12%)
Query: 2 MSRVRHRNLVK------FIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
++ V H ++V+ +PV IV E + G +L++ + L + AI +
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYL 188
Query: 56 LDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRW 115
L+I A+ LHS G+++ DLKPEN++LT + +KL D G + + GT +
Sbjct: 189 LEILPALSYLHSIGLVYNDLKPENIMLTEEQ--LKLIDLGAVSRINSFGYL---YGTPGF 243
Query: 116 MAPE 119
APE
Sbjct: 244 QAPE 247
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-23
Identities = 37/130 (28%), Positives = 57/130 (43%), Gaps = 23/130 (17%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGF-----A 55
+ ++ H N++K ++ IV EL GG L D + A
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-----------FDEIIKRKRFSEHDA 123
Query: 56 LDIAR----AMECLHSHGIIHRDLKPENLILTADHK--TVKLADFGLAREESLTEMMTAE 109
I + + +H H I+HRDLKPEN++L + K +K+ DFGL+ M
Sbjct: 124 ARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
Query: 110 TGTYRWMAPE 119
GT ++APE
Sbjct: 184 IGTAYYIAPE 193
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-23
Identities = 34/122 (27%), Positives = 59/122 (48%), Gaps = 5/122 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M + H N+++ ++ + +V EL GG L + +++ R A D+
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVL 116
Query: 60 RAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
A+ H + HRDLKPEN + + +KL DFGLA +MM + GT +++
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 118 PE 119
P+
Sbjct: 177 PQ 178
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 6e-23
Identities = 41/127 (32%), Positives = 64/127 (50%), Gaps = 17/127 (13%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTL------RKYLLNMRPRCLDIHVAIGF 54
+++H N+V+ + +E +V +L+ GG L R++ A
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHC 110
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLAREESLTEMMTAETGT 112
I ++ HS+GI+HR+LKPENL+L A VKLADFGLA E + +E GT
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 170
Query: 113 YRWMAPE 119
+++PE
Sbjct: 171 PGYLSPE 177
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-23
Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83
+ L+ G L L P L A+ I A++ H+ G HRD+KPEN++++
Sbjct: 111 VDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168
Query: 84 ADHKTVKLADFGLAR---EESLTEMMTAETGTYRWMAPE 119
AD L DFG+A +E LT++ GT +MAPE
Sbjct: 169 ADDF-AYLVDFGIASATTDEKLTQLGNT-VGTLYYMAPE 205
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 9e-23
Identities = 41/128 (32%), Positives = 61/128 (47%), Gaps = 17/128 (13%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTL------RKYLLNMRPRCLDIHVAIG 53
++ R+ H N++K + P + +V EL+ GG L + Y A
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE--------RDAAD 152
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLAREESLTEMMTAETG 111
I A+ LH +GI+HRDLKPENL+ A +K+ADFGL++ +M G
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212
Query: 112 TYRWMAPE 119
T + APE
Sbjct: 213 TPGYCAPE 220
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-22
Identities = 41/127 (32%), Positives = 64/127 (50%), Gaps = 17/127 (13%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTL------RKYLLNMRPRCLDIHVAIGF 54
+++H N+V+ + +E +V +L+ GG L R++ A
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHC 133
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLAREESLTEMMTAETGT 112
I ++ HS+GI+HR+LKPENL+L A VKLADFGLA E + +E GT
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGT 193
Query: 113 YRWMAPE 119
+++PE
Sbjct: 194 PGYLSPE 200
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-22
Identities = 32/219 (14%), Positives = 64/219 (29%), Gaps = 67/219 (30%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLL--NMRPRCLDIHVAIGFALD 57
+H ++V++ A E M+I E GG+L + L
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 58 IARAMECLHSHGIIHRDLKPENLILTAD------------------HKTVKLADFGLARE 99
+ R + +HS ++H D+KP N+ ++ K+ D G
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182
Query: 100 ESLTEMMTAETGTYRWMAPE---------------------------------------- 119
++ E G R++A E
Sbjct: 183 -RISSPQV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240
Query: 120 ---NMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155
+ + L ++ ++ DP RP+ +++
Sbjct: 241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-22
Identities = 36/121 (29%), Positives = 62/121 (51%), Gaps = 4/121 (3%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
++ ++ H ++K IV EL+ GG L ++ + L + +
Sbjct: 68 ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLL 125
Query: 61 AMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLAREESLTEMMTAETGTYRWMAP 118
A++ LH +GIIHRDLKPEN++L+ + +K+ DFG ++ T +M GT ++AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 119 E 119
E
Sbjct: 186 E 186
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-22
Identities = 34/122 (27%), Positives = 58/122 (47%), Gaps = 9/122 (7%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ S +RH N+++ G + V ++ E GT+ + L + D + ++A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELA 119
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET--GTYRWMA 117
A+ HS +IHRD+KPENL+L + +K+ADFG + GT ++
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWS---VHAPSSRRTDLCGTLDYLP 175
Query: 118 PE 119
PE
Sbjct: 176 PE 177
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-22
Identities = 36/121 (29%), Positives = 58/121 (47%), Gaps = 5/121 (4%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ ++ H N++K ++ IV EL GG L ++ + H A +
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFS 132
Query: 61 AMECLHSHGIIHRDLKPENLILTADHK--TVKLADFGLAREESLTEMMTAETGTYRWMAP 118
+ +H H I+HRDLKPEN++L + K +K+ DFGL+ M GT ++AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 119 E 119
E
Sbjct: 193 E 193
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-22
Identities = 32/122 (26%), Positives = 62/122 (50%), Gaps = 5/122 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++ H N++K ++ +V E+ GG L +++ + A +
Sbjct: 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVL 136
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHK--TVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ +H + I+HRDLKPENL+L + K +++ DFGL+ ++ M + GT ++A
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 118 PE 119
PE
Sbjct: 197 PE 198
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-22
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 3/97 (3%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+++H ++++ ++ V +V E+ G + +YL N R + + A F I
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIIT 123
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA 97
M LHSHGI+HRDL NL+LT + +K+ADFGLA
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLA 159
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 3e-22
Identities = 32/136 (23%), Positives = 52/136 (38%), Gaps = 17/136 (12%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRP---RCLDIHVAIGFAL 56
+ +KF A V+V EL GTL + + + + + I FA+
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTA----------DHKTVKLADFGLAREESL---T 103
+ +E +H IIH D+KP+N IL + L D G + + L
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 104 EMMTAETGTYRWMAPE 119
+ TA+ T + E
Sbjct: 240 TIFTAKCETSGFQCVE 255
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-22
Identities = 34/122 (27%), Positives = 65/122 (53%), Gaps = 3/122 (2%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIG-FALDI 58
+ ++H+N+V+++G+ E + I E + GG+L L + D IG + I
Sbjct: 72 LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWMA 117
++ LH + I+HRD+K +N+++ +K++DFG ++ + TGT ++MA
Sbjct: 132 LEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 191
Query: 118 PE 119
PE
Sbjct: 192 PE 193
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-22
Identities = 27/127 (21%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLN------MRPRCLDIHVAIG 53
+++ +++ + G V I+ E + ++ K+ + I V
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 54 FALDIARAMECLHSH-GIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT 112
+ + +H+ I HRD+KP N+++ + VKL+DFG + ++ + GT
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNILMDK-NGRVKLSDFGESEYMVDKKIKGSR-GT 213
Query: 113 YRWMAPE 119
Y +M PE
Sbjct: 214 YEFMPPE 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-22
Identities = 35/122 (28%), Positives = 58/122 (47%), Gaps = 5/122 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ + H N++K ++ +V E GG L +++ + A +
Sbjct: 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVL 146
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHK--TVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ LH H I+HRDLKPENL+L + K +K+ DFGL+ + M GT ++A
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206
Query: 118 PE 119
PE
Sbjct: 207 PE 208
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-22
Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ + +V GA +E V I ELL GG+L + + M L A+ +
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQAL 160
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFG----LAREESLTEMMTAET--GTY 113
+E LH+ I+H D+K +N++L++D L DFG L + ++T + GT
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 114 RWMAPE 119
MAPE
Sbjct: 221 THMAPE 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-22
Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 5/122 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ + H N++K ++ +VTE GG L + ++N D A I
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQIL 156
Query: 60 RAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ LH H I+HRD+KPEN++L +K+ DFGL+ S + GT ++A
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216
Query: 118 PE 119
PE
Sbjct: 217 PE 218
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-22
Identities = 26/122 (21%), Positives = 53/122 (43%), Gaps = 4/122 (3%)
Query: 2 MSRVRHR-NLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ + ++ + ++++ E GG + L + + I I
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141
Query: 60 RAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ LH + I+H DLKP+N++L+ +K+ DFG++R+ + GT ++A
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLA 201
Query: 118 PE 119
PE
Sbjct: 202 PE 203
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 5e-22
Identities = 40/190 (21%), Positives = 60/190 (31%), Gaps = 58/190 (30%)
Query: 24 IVTELLLGGTLRKYLLNMRPRC-LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL 82
I +L L+ ++ + V + + IA A+E LHS G++HRDLKP N+
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF 197
Query: 83 TADHKTVKLADFGLAR-------------EESLTEMMTAETGTYRWMAPENMR------- 122
T D VK+ DFGL T + GT +M+PE +
Sbjct: 198 TMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256
Query: 123 ------------------------------------PSAENLPEDLALIVTSCWKEDPNE 146
++V P E
Sbjct: 257 VDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316
Query: 147 RPNFSQIIQM 156
RP + II+
Sbjct: 317 RPEATDIIEN 326
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 6e-22
Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 24/131 (18%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGF----- 54
++ +++H N+V + +V +L+ GG L D + G
Sbjct: 59 VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL-----------FDRILERGVYTEKD 107
Query: 55 ----ALDIARAMECLHSHGIIHRDLKPENLIL--TADHKTVKLADFGLAREESLTEMMTA 108
+ A++ LH +GI+HRDLKPENL+ ++ + + DFGL++ E +M+
Sbjct: 108 ASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMST 166
Query: 109 ETGTYRWMAPE 119
GT ++APE
Sbjct: 167 ACGTPGYVAPE 177
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-22
Identities = 32/124 (25%), Positives = 54/124 (43%), Gaps = 6/124 (4%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLN--MRPRCLDIHVAIGFALDI 58
++H ++V+ + M+ +V E + G L ++ VA + I
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 59 ARAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLARE-ESLTEMMTAETGTYRW 115
A+ H + IIHRD+KP ++L + VKL FG+A + + GT +
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 116 MAPE 119
MAPE
Sbjct: 200 MAPE 203
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-22
Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 5/120 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ S +RH N+++ + + ++ E G L K L + D + F ++A
Sbjct: 67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELA 124
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
A+ H +IHRD+KPENL++ +K+ADFG + T GT ++ PE
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGY-KGELKIADFGWSVHAPSLRRRTM-CGTLDYLPPE 182
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-21
Identities = 34/120 (28%), Positives = 51/120 (42%), Gaps = 4/120 (3%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ H N+++ + +V +L+ G L YL L +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALL 134
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+ LH I+HRDLKPEN IL D +KL DFG + + E + GT ++APE
Sbjct: 135 EVICALHKLNIVHRDLKPEN-ILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 3e-21
Identities = 37/181 (20%), Positives = 67/181 (37%), Gaps = 51/181 (28%)
Query: 35 RKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADF 94
+ ++ L + I ++ +A+ ME L S IHRDL N IL ++ VK+ DF
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN-ILLSEKNVVKICDF 237
Query: 95 GLAREESLTEMMTAETGT---YRWMAPENMR----------------------------- 122
GLAR+ + +WMAPE +
Sbjct: 238 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297
Query: 123 ------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164
+ + ++ + CW +P++RP FS++++ L + + N
Sbjct: 298 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357
Query: 165 S 165
+
Sbjct: 358 A 358
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-05
Identities = 25/86 (29%), Positives = 35/86 (40%), Gaps = 10/86 (11%)
Query: 1 MMSRVRHRNLVKFIGAC---KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
++ H N+V +GAC P+MVIV E G L YL + R + +
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVP------YKTK 131
Query: 58 IARAMECLHSHGIIHRDLKPENLILT 83
AR + G I DLK +T
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSIT 157
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-21
Identities = 39/131 (29%), Positives = 58/131 (44%), Gaps = 22/131 (16%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDI--------HVA 51
+ ++H N+V+ + E ++ +L+ GG L DI A
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----------FEDIVAREYYSEADA 112
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLARE-ESLTEMMTA 108
I A+ H G++HR+LKPENL+L VKLADFGLA E E +
Sbjct: 113 SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 109 ETGTYRWMAPE 119
GT +++PE
Sbjct: 173 FAGTPGYLSPE 183
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-21
Identities = 31/129 (24%), Positives = 56/129 (43%), Gaps = 22/129 (17%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGF----- 54
+ H +++ I + + + +V +L+ G L D
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-----------FDYLTEKVALSEKE 201
Query: 55 ----ALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
+ A+ LH++ I+HRDLKPEN++L D+ ++L+DFG + E +
Sbjct: 202 TRSIMRSLLEAVSFLHANNIVHRDLKPENILL-DDNMQIRLSDFGFSCHLEPGEKLRELC 260
Query: 111 GTYRWMAPE 119
GT ++APE
Sbjct: 261 GTPGYLAPE 269
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-21
Identities = 38/122 (31%), Positives = 64/122 (52%), Gaps = 8/122 (6%)
Query: 2 MSRVRHRNLVKF---IGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+ ++ H N+VK + E + +V EL+ G + + L A + D+
Sbjct: 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---LSEDQARFYFQDL 146
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET-GTYRWMA 117
+ +E LH IIHRD+KP NL++ D +K+ADFG++ E ++ + + T GT +MA
Sbjct: 147 IKGIEYLHYQKIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSDALLSNTVGTPAFMA 205
Query: 118 PE 119
PE
Sbjct: 206 PE 207
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-21
Identities = 31/123 (25%), Positives = 52/123 (42%), Gaps = 11/123 (8%)
Query: 6 RHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMEC 64
H N++++ K+ I EL TL++Y+ + I +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAH 133
Query: 65 LHSHGIIHRDLKPENLILTADHKT----VKLADFGLAR----EESLTEMMTAETGTYRWM 116
LHS I+HRDLKP N++++ + ++DFGL + + GT W+
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 117 APE 119
APE
Sbjct: 194 APE 196
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 5e-21
Identities = 49/266 (18%), Positives = 81/266 (30%), Gaps = 78/266 (29%)
Query: 1 MMSRVRHRNLVKFIGACKEPVM--------VIVTELLLGGTLRKYLLNMRPR-CLDIHVA 51
M H N+V+F A ++ L G L ++L M R L
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138
Query: 52 IGFALDIARAMECLHSHG--IIHRDLKPENLILTADHKTVKLADFGLAR----------- 98
+ RA++ +H IIHRDLK ENL+L+ T+KL DFG A
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-TIKLCDFGSATTISHYPDYSWS 197
Query: 99 --EESLTEMMTAETGTYRWMAPE------------------------------------- 119
+L E T + PE
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257
Query: 120 NMR--------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVI 171
+R P + ++ + + +P ER + ++++ L + +
Sbjct: 258 KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP 317
Query: 172 LPRMFSSENAVLPPESPGTSSLMPPR 197
+ L ++ G S R
Sbjct: 318 ITE--------LLEQNGGYGSATLSR 335
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-21
Identities = 36/126 (28%), Positives = 54/126 (42%), Gaps = 8/126 (6%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-----IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
++V + + I+ E + GG L + + A
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 56 LDIARAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLAREESLTEMMTAETGTY 113
DI A++ LHSH I HRD+KPENL+ T +KL DFG A+E + + T T
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTP 193
Query: 114 RWMAPE 119
++APE
Sbjct: 194 YYVAPE 199
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-21
Identities = 39/121 (32%), Positives = 60/121 (49%), Gaps = 6/121 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M + H LV + ++ M +V +LLLGG LR Y L + F ++
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR-YHLQ-QNVHFKEETVKLFICELV 125
Query: 60 RAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAETGTYRWMAP 118
A++ L + IIHRD+KP+N++L H V + DF +A +T GT +MAP
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRETQITTMAGTKPYMAP 183
Query: 119 E 119
E
Sbjct: 184 E 184
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-21
Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 9/124 (7%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+MSR+ H VK ++ + G L KY+ + D + +I
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIV 140
Query: 60 RAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLARE-ESLTEMMTAET--GTYRW 115
A+E LH GIIHRDLKPEN++L D H +++ DFG A+ ++ A + GT ++
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 116 MAPE 119
++PE
Sbjct: 199 VSPE 202
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 8e-21
Identities = 34/137 (24%), Positives = 59/137 (43%), Gaps = 24/137 (17%)
Query: 6 RHRNLVKFIGACKEPVMV-IVTELLLGGTL-----RKYLLNMRPRCLDIHVAIGFALDIA 59
H N++++ + + I EL L K + + + + I IA
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 60 RAMECLHSHGIIHRDLKPENLILT------------ADHKTVKLADFGLAR-----EESL 102
+ LHS IIHRDLKP+N++++ A++ + ++DFGL + + S
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 103 TEMMTAETGTYRWMAPE 119
+ +GT W APE
Sbjct: 186 RTNLNNPSGTSGWRAPE 202
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-20
Identities = 36/126 (28%), Positives = 56/126 (44%), Gaps = 7/126 (5%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-----IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
+ ++V+ + + IV E L GG L + + + A
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 167
Query: 56 LDIARAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLAREESLTEMMTAETGTY 113
I A++ LHS I HRD+KPENL+ T + +KL DFG A+E + +T T
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 227
Query: 114 RWMAPE 119
++APE
Sbjct: 228 YYVAPE 233
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-20
Identities = 33/124 (26%), Positives = 63/124 (50%), Gaps = 7/124 (5%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ +H N++ + V +VTEL+ GG L +L R + A I
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL--RQKFFSEREASAVLFTIT 126
Query: 60 RAMECLHSHGIIHRDLKPENLILT---ADHKTVKLADFGLARE-ESLTEMMTAETGTYRW 115
+ +E LH+ G++HRDLKP N++ + +++++ DFG A++ + ++ T +
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF 186
Query: 116 MAPE 119
+APE
Sbjct: 187 VAPE 190
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-20
Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 4/97 (4%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ H+++V F G ++ V +V EL +L + R + L A + I
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL 126
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA 97
+ LH + +IHRDLK NL L + VK+ DFGLA
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLA 162
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 9e-20
Identities = 42/127 (33%), Positives = 60/127 (47%), Gaps = 9/127 (7%)
Query: 1 MMSRVRHRNLVKFIGACKEPVM-VIVTELLLGGTLRKYLLNMRPRC--LDIHVAIGFALD 57
M+S HRNL++ G C P ++V + G++ L LD AL
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 58 IARAMECLHSHG---IIHRDLKPENLILTADHKTVKLADFGLAR--EESLTEMMTAETGT 112
AR + LH H IIHRD+K N++L + + DFGLA+ + T + TA GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGT 198
Query: 113 YRWMAPE 119
+APE
Sbjct: 199 IGHIAPE 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-20
Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 4/97 (4%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ H+++V F G ++ V +V EL +L + R + L A + I
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL 152
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA 97
+ LH + +IHRDLK NL L + VK+ DFGLA
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLA 188
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 9e-20
Identities = 23/132 (17%), Positives = 54/132 (40%), Gaps = 12/132 (9%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFAL-DI 58
+ H N+V + + + +VT + G+ + + ++ +AI + L +
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELAIAYILQGV 137
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA--------REESLTEMMTAET 110
+A++ +H G +HR +K + IL + V L+ R+ + +
Sbjct: 138 LKALDYIHHMGYVHRSVKASH-ILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 111 GTYRWMAPENMR 122
W++PE ++
Sbjct: 197 KVLPWLSPEVLQ 208
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-19
Identities = 35/133 (26%), Positives = 53/133 (39%), Gaps = 25/133 (18%)
Query: 1 MMSRVR-HRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGF---- 54
+ H N+VK + + +V ELL GG L +
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL-----------FERIKKKKHFSET 106
Query: 55 -----ALDIARAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLARE-ESLTEMM 106
+ A+ +H G++HRDLKPENL+ T D+ +K+ DFG AR + +
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166
Query: 107 TAETGTYRWMAPE 119
T + APE
Sbjct: 167 KTPCFTLHYAAPE 179
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-19
Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 14/139 (10%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVA-----IGF 54
MS+ H N+V + + + + +V +LL GG++ + ++ + I
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 55 AL-DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFG----LAREESLTEMMTAE 109
L ++ +E LH +G IHRD+K N IL + +V++ADFG LA +T +
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGN-ILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 110 T--GTYRWMAPENMRPSAE 126
T GT WMAPE M
Sbjct: 185 TFVGTPCWMAPEVMEQVRG 203
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-19
Identities = 37/140 (26%), Positives = 58/140 (41%), Gaps = 32/140 (22%)
Query: 1 MMSRVR-HRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGF---- 54
M+ + + HRN+++ I +E +V E + GG++ L
Sbjct: 63 MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI-----------LSHIHKRRHFNEL 111
Query: 55 -----ALDIARAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLAR--------E 99
D+A A++ LH+ GI HRDLKPEN++ VK+ DF L
Sbjct: 112 EASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 100 ESLTEMMTAETGTYRWMAPE 119
T + G+ +MAPE
Sbjct: 172 PISTPELLTPCGSAEYMAPE 191
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-19
Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 12/129 (9%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLD-IHVAIGFALDI 58
++S+ + K+ G+ K+ + I+ E L GG+ + P LD +A +I
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL---LEPGPLDETQIAT-ILREI 128
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET---GTYRW 115
+ ++ LHS IHRD+K N++L+ + VKLADFG+A LT+ GT W
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVA--GQLTDTQIKRNTFVGTPFW 185
Query: 116 MAPENMRPS 124
MAPE ++ S
Sbjct: 186 MAPEVIKQS 194
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-19
Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLD-IHVAIGFALDI 58
+M + ++VK+ G+ K + IV E G++ ++ +R + L +A
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQST 134
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET---GTYRW 115
+ +E LH IHRD+K N++L + KLADFG+A + LT+ M GT W
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQ--LTDTMAKRNTVIGTPFW 191
Query: 116 MAPE 119
MAPE
Sbjct: 192 MAPE 195
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-19
Identities = 36/124 (29%), Positives = 64/124 (51%), Gaps = 10/124 (8%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLD-IHVAIGFALDI 58
+++ H +VK +GA + + I+ E GG + ++ R L + + +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQM 126
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMT-AET--GTYRW 115
A+ LHS IIHRDLK N+++T + ++LADFG++ + + + ++ GT W
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLEGD-IRLADFGVSAK--NLKTLQKRDSFIGTPYW 183
Query: 116 MAPE 119
MAPE
Sbjct: 184 MAPE 187
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-19
Identities = 32/129 (24%), Positives = 52/129 (40%), Gaps = 5/129 (3%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ +V+ G + I EL+ + P I + + I
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM--TVAIV 134
Query: 60 RAMECLHS-HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAP 118
+A+ L HG+IHRD+KP N IL + +KL DFG++ + G +MAP
Sbjct: 135 KALYYLKEKHGVIHRDVKPSN-ILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAP 193
Query: 119 ENMRPSAEN 127
E + P
Sbjct: 194 ERIDPPDPT 202
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-19
Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 15/130 (11%)
Query: 1 MMSRVRHRNLVKFIGA-------CKEPVMVIVTELLLGGTLRKYLLNMRPRCLD-IHVAI 52
+ HRN+ + GA + + +V E G++ + N + L +A
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 53 GFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET-- 110
+I R + LH H +IHRD+K +N++LT + + VKL DFG++ + L +
Sbjct: 134 -ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQ--LDRTVGRRNTF 189
Query: 111 -GTYRWMAPE 119
GT WMAPE
Sbjct: 190 IGTPYWMAPE 199
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 6e-19
Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 3/96 (3%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V L+ GG L+ ++ +M A+ +A +I +E LH I++RDLKPEN++L
Sbjct: 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD 321
Query: 85 D-HKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
H ++++D GLA + + GT +MAPE
Sbjct: 322 HGH--IRISDLGLAVHVPEGQTIKGRVGTVGYMAPE 355
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 7e-19
Identities = 35/128 (27%), Positives = 62/128 (48%), Gaps = 10/128 (7%)
Query: 1 MMSRVRHRNLVKFIGA-CKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ +V F GA + + I E + GG+L + L I + ++ +
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV--SIAVI 141
Query: 60 RAMECLHS-HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET--GTYRWM 116
+ + L H I+HRD+KP N IL +KL DFG++ + L + M A + GT +M
Sbjct: 142 KGLTYLREKHKIMHRDVKPSN-ILVNSRGEIKLCDFGVSGQ--LIDSM-ANSFVGTRSYM 197
Query: 117 APENMRPS 124
+PE ++ +
Sbjct: 198 SPERLQGT 205
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-19
Identities = 39/124 (31%), Positives = 65/124 (52%), Gaps = 12/124 (9%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLD-IHVAIGFALDI 58
+M ++ N+V ++ + + +V E L GG+L + C+D +A +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAA-VCREC 125
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET---GTYRW 115
+A+E LHS+ +IHRD+K +N++L D VKL DFG + +T + + GT W
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQ--ITPEQSKRSTMVGTPYW 182
Query: 116 MAPE 119
MAPE
Sbjct: 183 MAPE 186
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 9e-19
Identities = 40/123 (32%), Positives = 61/123 (49%), Gaps = 13/123 (10%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLD-IHVAIGFALDI 58
+ ++RH N +++ G +E +V E LG LL + + L + +A
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGA 163
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET--GTYRWM 116
+ + LHSH +IHRD+K N++L+ VKL DFG A + M A + GT WM
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSA-----SIMAPANSFVGTPYWM 217
Query: 117 APE 119
APE
Sbjct: 218 APE 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-18
Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKY-LLNMRPRCLDIHVAIGFALDI 58
M V V F GA +E + I EL+ + Y + + + + + A+ I
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 59 ARAMECLHS-HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET--GTYRW 115
+A+E LHS +IHRD+KP N +L VK+ DFG++ L + + + G +
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSN-VLINALGQVKMCDFGISGY--LVDDVAKDIDAGCKPY 175
Query: 116 MAPE 119
MAPE
Sbjct: 176 MAPE 179
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-18
Identities = 27/123 (21%), Positives = 60/123 (48%), Gaps = 7/123 (5%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ + + A ++ + +V + +GG L LL+ L +A + ++
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMARFYLAEMV 185
Query: 60 RAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAET--GTYRWM 116
A++ +H +HRD+KP+N+++ + H ++LADFG + + + GT ++
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 117 APE 119
+PE
Sbjct: 244 SPE 246
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-18
Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 7/106 (6%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-----IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
+ ++V+ + + IV E L GG L + + + A
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 56 LDIARAMECLHSHGIIHRDLKPENLILT--ADHKTVKLADFGLARE 99
I A++ LHS I HRD+KPENL+ T + +KL DFG A+E
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-18
Identities = 29/65 (44%), Positives = 40/65 (61%), Gaps = 5/65 (7%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAET--GTYR 114
I A+E LH GII+RD+K EN++L ++ H V L DFGL++E E A GT
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 115 WMAPE 119
+MAP+
Sbjct: 226 YMAPD 230
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-18
Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V E +GG L LL+ + +A + +I A++ +H G +HRD+KP+N++L
Sbjct: 139 VMEYYVGGDLL-TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR 197
Query: 85 D-HKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
H ++LADFG + + + GT +++PE
Sbjct: 198 CGH--IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-18
Identities = 36/172 (20%), Positives = 61/172 (35%), Gaps = 45/172 (26%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTL------------------------- 34
+M ++ H N+ + ++ + +V EL GG L
Sbjct: 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 35 -------------RKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ I A+ LH+ GI HRD+KPEN +
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 82 LTADHK-TVKLADFGLAR-----EESLTEMMTAETGTYRWMAPENMRPSAEN 127
+ + +KL DFGL++ MT + GT ++APE + + E+
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 3e-18
Identities = 19/101 (18%), Positives = 35/101 (34%), Gaps = 6/101 (5%)
Query: 30 LGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTV 89
G L + + L H + L + R + LH +G++H L+P +++L V
Sbjct: 189 FGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-V 245
Query: 90 KLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPE 130
L F + + + + PE A
Sbjct: 246 FLTGFEHLVRDG---ARVVSSVSRGFEPPELEARRATISYH 283
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-18
Identities = 35/133 (26%), Positives = 63/133 (47%), Gaps = 16/133 (12%)
Query: 1 MMSRVRHRNLVKFI-------GACKEPVMVIVTELLLGGTLRKYL---LNMRPRCLDIHV 50
+M ++ H N+V+ E + +V + + T+ + + I+V
Sbjct: 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYV 158
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
+ + + R++ +HS GI HRD+KP+NL+L D +KL DFG A++ E +
Sbjct: 159 KL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 111 GT--YRWMAPENM 121
+ YR APE +
Sbjct: 218 CSRYYR--APELI 228
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-18
Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ V LVK + K+ + +V E + GG + +L R A +A I
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIV 151
Query: 60 RAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAET--GTYRWM 116
E LHS +I+RDLKPENL++ + +++ DFG A+ T GT +
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVK----GRTWTLCGTPEAL 205
Query: 117 APE 119
APE
Sbjct: 206 APE 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-18
Identities = 29/101 (28%), Positives = 54/101 (53%), Gaps = 9/101 (8%)
Query: 2 MSRVRHRNLVKF---IGACKEPVMVIVTELLLGGT--LRKYLLNMRPRCLDIHVAIGFAL 56
+ R+RH+N+++ + ++ M +V E + G + + R + A G+
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFC 116
Query: 57 DIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA 97
+ +E LHS GI+H+D+KP NL+LT T+K++ G+A
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVA 156
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 5e-18
Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 25 VTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL 82
V ++ GG +R ++ N+ AI + I +E LH II+RDLKPEN++L
Sbjct: 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 83 TAD-HKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
D + V+++D GLA E + GT +MAPE
Sbjct: 323 DDDGN--VRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPE 359
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 5e-18
Identities = 39/123 (31%), Positives = 65/123 (52%), Gaps = 12/123 (9%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
M+S V H +++ G ++ + ++ + + GG L L + + VA +A ++
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVC 116
Query: 60 RAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAET--GTYRWM 116
A+E LHS II+RDLKPEN++L + H +K+ DFG A+ T GT ++
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVP----DVTYTLCGTPDYI 170
Query: 117 APE 119
APE
Sbjct: 171 APE 173
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-18
Identities = 36/124 (29%), Positives = 63/124 (50%), Gaps = 12/124 (9%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLD-IHVAIGFALDI 58
+M +H N+V+ + + ++ E L GG L + L+ +A +
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQVRLNEEQIAT-VCEAV 150
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET---GTYRW 115
+A+ LH+ G+IHRD+K ++++LT D + VKL+DFG +++ + GT W
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGFC--AQISKDVPKRKSLVGTPYW 207
Query: 116 MAPE 119
MAPE
Sbjct: 208 MAPE 211
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-18
Identities = 38/133 (28%), Positives = 60/133 (45%), Gaps = 5/133 (3%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLR--KYLLNMRPRCLDIHVAIGFALD 57
+M +V+F GA +E I EL+ + KY+ ++ + + L
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 58 IARAMECLHS-HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWM 116
+A+ L IIHRD+KP N IL +KL DFG++ + + T + G +M
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSN-ILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYM 192
Query: 117 APENMRPSAENLP 129
APE + PSA
Sbjct: 193 APERIDPSASRQG 205
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-18
Identities = 34/133 (25%), Positives = 60/133 (45%), Gaps = 16/133 (12%)
Query: 1 MMSRVRHRNLVKFI-------GACKEPVMVIVTELLLGGTLRKYL---LNMRPRCLDIHV 50
+M V+H N+V E + +V E + T+ + ++ + +
Sbjct: 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLI 143
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAE- 109
+ + + R++ +HS GI HRD+KP+NL+L +KL DFG A+ E +
Sbjct: 144 KL-YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202
Query: 110 -TGTYRWMAPENM 121
+ YR APE +
Sbjct: 203 CSRYYR--APELI 213
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 8e-18
Identities = 18/94 (19%), Positives = 34/94 (36%), Gaps = 6/94 (6%)
Query: 30 LGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTV 89
G L + + L H + L + R + LH +G++H L+P +++L V
Sbjct: 194 FGEVLLSHSSTHKS--LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GV 250
Query: 90 KLADFGLAREESLTEMMTAETGTYRWMAPENMRP 123
L F + ++ + PE
Sbjct: 251 FLTGFEHLVRDG-ASAVSPIGRGF--APPETTAE 281
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 1e-17
Identities = 32/65 (49%), Positives = 45/65 (69%), Gaps = 6/65 (9%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAET--GTYR 114
+A A++ LHS GII+RDLKPEN++L + H +KL DFGL++ ES+ A + GT
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSK-ESIDHEKKAYSFCGTVE 191
Query: 115 WMAPE 119
+MAPE
Sbjct: 192 YMAPE 196
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V E GG L +L R R A + +I A+E LHS +++RD+K ENL+L
Sbjct: 83 VMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK 140
Query: 85 D-HKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
D H +K+ DFGL +E +++ T +T GT ++APE
Sbjct: 141 DGH--IKITDFGLCKEG-ISDGATMKTFCGTPEYLAPE 175
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-17
Identities = 37/119 (31%), Positives = 57/119 (47%), Gaps = 4/119 (3%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M + H N+VK + + ++ E GG + YL + + A I
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVS 125
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
A++ H I+HRDLK ENL+L AD +K+ADFG + E ++ + A G + APE
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAAPE 183
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V E + GG L ++ R R L A ++ +I+ A+ LH GII+RDLK +N++L +
Sbjct: 88 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 145
Query: 85 D-HKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
+ H +KL D+G+ +E L T T GT ++APE
Sbjct: 146 EGH--IKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPE 180
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-17
Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 9/123 (7%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
M+ +++H NLV + + + + +V E T+ L + R + H+
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPEHLVKSITWQTL 112
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL-TEMMTAETGT--YRWM 116
+A+ H H IHRD+KPEN+++T +KL DFG AR + ++ E T YR
Sbjct: 113 QAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYR-- 169
Query: 117 APE 119
+PE
Sbjct: 170 SPE 172
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 1e-17
Identities = 32/65 (49%), Positives = 41/65 (63%), Gaps = 6/65 (9%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAET--GTYR 114
I+ A+ LH GII+RDLKPEN++L H VKL DFGL + ES+ + T GT
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCK-ESIHDGTVTHTFCGTIE 186
Query: 115 WMAPE 119
+MAPE
Sbjct: 187 YMAPE 191
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-17
Identities = 44/127 (34%), Positives = 61/127 (48%), Gaps = 12/127 (9%)
Query: 1 MMSRVRHRNLVKFI------GACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGF 54
+ H N+V+ + +E + +V E + LR YL P L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT-- 112
R ++ LH++ I+HRDLKPEN+++T TVKLADFGLAR S +T T
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 113 YRWMAPE 119
YR APE
Sbjct: 185 YR--APE 189
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-17
Identities = 38/120 (31%), Positives = 57/120 (47%), Gaps = 5/120 (4%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLL-GGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+SRV H N++K + + +V E G L ++ PR LD +A +
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPR-LDEPLASYIFRQLV 140
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
A+ L IIHRD+K EN+++ D T+KL DFG A ++ GT + APE
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE 199
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-17
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V E L GG L ++ D+ A +A +I ++ LHS GI++RDLK +N++L
Sbjct: 96 VMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 153
Query: 85 D-HKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
D H +K+ADFG+ +E + T GT ++APE
Sbjct: 154 DGH--IKIADFGMCKEN-MLGDAKTNTFCGTPDYIAPE 188
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V E + GG L ++ R R L A ++ +I+ A+ LH GII+RDLK +N++L +
Sbjct: 131 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 188
Query: 85 D-HKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
+ H +KL D+G+ +E L T T GT ++APE
Sbjct: 189 EGH--IKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPE 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-17
Identities = 35/123 (28%), Positives = 64/123 (52%), Gaps = 9/123 (7%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M+ +V+ A ++ + +V E + GG L + N + A + ++
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVV 178
Query: 60 RAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAET--GTYRWM 116
A++ +HS G IHRD+KP+N++L H +KLADFG + + M+ +T GT ++
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 117 APE 119
+PE
Sbjct: 237 SPE 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-17
Identities = 39/98 (39%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V + + GG L +L R RC A +A +IA A+ LHS I++RDLKPEN++L +
Sbjct: 117 VLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS 174
Query: 85 D-HKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
H + L DFGL +E + T T GT ++APE
Sbjct: 175 QGH--IVLTDFGLCKEN-IEHNSTTSTFCGTPEYLAPE 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-17
Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 8/98 (8%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V E + GG L ++ + R D A +A +I A+ LH GII+RDLK +N++L
Sbjct: 102 VMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH 159
Query: 85 D-HKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
+ H KLADFG+ +E + +T T GT ++APE
Sbjct: 160 EGH--CKLADFGMCKEG-ICNGVTTATFCGTPDYIAPE 194
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (192), Expect = 4e-17
Identities = 15/84 (17%), Positives = 25/84 (29%), Gaps = 3/84 (3%)
Query: 42 RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREES 101
I + R L S G++H P+NL + D + L D +
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGDVSALWKVG 245
Query: 102 LTEMMTAETGTYRWMAPENMRPSA 125
A + + E + S
Sbjct: 246 --TRGPASSVPVTYAPREFLNAST 267
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-17
Identities = 28/119 (23%), Positives = 55/119 (46%), Gaps = 10/119 (8%)
Query: 7 HRNLVKFIGACKEPVM---VIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAME 63
N++ K+PV +V E + ++ D + + +I +A++
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRF-YMYEILKALD 144
Query: 64 CLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWM-APENM 121
HS GI+HRD+KP N+++ +H+ ++L D+GLA + + R+ PE +
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPELL 202
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 5e-17
Identities = 39/127 (30%), Positives = 60/127 (47%), Gaps = 12/127 (9%)
Query: 1 MMSRVRHRNLVKFI------GACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGF 54
+ H N+V+ +E + +V E + L YL + +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM 125
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT-- 112
+ R ++ LHSH ++HRDLKP+N+++T +KLADFGLAR S +T+ T
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 113 YRWMAPE 119
YR APE
Sbjct: 185 YR--APE 189
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-17
Identities = 34/98 (34%), Positives = 59/98 (60%), Gaps = 8/98 (8%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V E + GG L ++ + A+ +A +IA + L S GII+RDLK +N++L +
Sbjct: 99 VMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 156
Query: 85 D-HKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
+ H +K+ADFG+ + E++ + +T +T GT ++APE
Sbjct: 157 EGH--IKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPE 191
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-17
Identities = 44/123 (35%), Positives = 63/123 (51%), Gaps = 9/123 (7%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++RH NLV + CK + +V E + T+ L + P LD V + I
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQII 134
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESL-TEMMTAETGT--YRWM 116
+ HSH IIHRD+KPEN++++ VKL DFG AR + E+ E T YR
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYR-- 191
Query: 117 APE 119
APE
Sbjct: 192 APE 194
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 9e-17
Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 6/96 (6%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
+ +L+ GG L +L +A +I +E +H+ +++RDLKP N++L
Sbjct: 270 ILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 327
Query: 85 D-HKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
H V+++D GLA + S + + GT+ +MAPE
Sbjct: 328 HGH--VRISDLGLACDFSKKKPHAS-VGTHGYMAPE 360
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-16
Identities = 33/129 (25%), Positives = 56/129 (43%), Gaps = 13/129 (10%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV------IVTELLLGGTLRKYLLNMRPRCLDIHVAIGF 54
+++ H N++ +VTEL+ L + + + R H+ F
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY-F 139
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT-- 112
I + LH G++HRDL P N++L ++ + + DF LARE++ T
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDFNLAREDTADANKTHYVTHRW 198
Query: 113 YRWMAPENM 121
YR APE +
Sbjct: 199 YR--APELV 205
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-16
Identities = 28/66 (42%), Positives = 41/66 (62%), Gaps = 4/66 (6%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT--YRW 115
+ RA+ +HS GI HRD+KP+NL++ + T+KL DFG A++ +E A + YR
Sbjct: 150 LFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR- 208
Query: 116 MAPENM 121
APE M
Sbjct: 209 -APELM 213
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-16
Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 6/89 (6%)
Query: 34 LRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLAD 93
L+K++ + + + + + + + HSH ++HRDLKP+NL++ + +KLAD
Sbjct: 88 LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLAD 146
Query: 94 FGLAREESL-TEMMTAETGT--YRWMAPE 119
FGLAR + T E T YR APE
Sbjct: 147 FGLARAFGVPVRTYTHEVVTLWYR--APE 173
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-16
Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 7/122 (5%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ H N+VKF G +E + + E GG L + + A F +
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA---REESLTEMMTAETGTYRWMA 117
+ LH GI HRD+KPENL+L +K++DFGLA R + ++ GT ++A
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 118 PE 119
PE
Sbjct: 176 PE 177
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 3e-16
Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84
V E + GG L ++ + A+ +A +IA + L S GII+RDLK +N++L +
Sbjct: 420 VMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 477
Query: 85 D-HKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
+ H +K+ADFG+ +E + + +T +T GT ++APE
Sbjct: 478 EGH--IKIADFGMCKEN-IWDGVTTKTFCGTPDYIAPE 512
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-16
Identities = 37/119 (31%), Positives = 57/119 (47%), Gaps = 4/119 (3%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ RH +++K P +V E + GG L Y+ ++ A I
Sbjct: 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILS 122
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
A++ H H ++HRDLKPEN++L A K+ADFGL+ S E + G+ + APE
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRTSCGSPNYAAPE 180
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-16
Identities = 32/97 (32%), Positives = 46/97 (47%), Gaps = 4/97 (4%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ H N+VKF G +E + + E GG L + + A F +
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA 97
+ LH GI HRD+KPENL+L +K++DFGLA
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLA 152
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-16
Identities = 36/120 (30%), Positives = 53/120 (44%), Gaps = 4/120 (3%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+RH N+V+F P + I+ E GG L + + N R A F +
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN-AGR-FSEDEARFFFQQLLS 127
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKT-VKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+ HS I HRDLK EN +L +K+ DFG ++ L + GT ++APE
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-15
Identities = 27/195 (13%), Positives = 63/195 (32%), Gaps = 32/195 (16%)
Query: 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+SR+ + + + ++V E + GG+L++ AI +A
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAA 140
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREES-----------LTEMMTAE 109
A + H G+ P + ++ D V LA + + L ++
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPATMPDANPQDDIRGIGASLYALLVNR 199
Query: 110 ------------TGTYRWMAPENMRPSAEN--LPEDLALIVTSCWKEDPNERPNFSQIIQ 155
R A + + P+ + +P ++ + + D R S ++
Sbjct: 200 WPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSA-STLLN 258
Query: 156 MLLHYISTNSAPEPV 170
++ + E +
Sbjct: 259 LMQQATAVADRTEVL 273
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 27/122 (22%), Positives = 52/122 (42%), Gaps = 7/122 (5%)
Query: 2 MSRVRHR--NLVKFIGACKEPVM-VIVTELLLG-GTLRKYLLNMRPRCLDIHVAIGFALD 57
+ +V +++ + + P V++ E L ++ L +A F
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQ 157
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ A+ H+ G++HRD+K EN+++ + +KL DFG T + GT +
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSP 216
Query: 118 PE 119
PE
Sbjct: 217 PE 218
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-15
Identities = 38/119 (31%), Positives = 59/119 (49%), Gaps = 5/119 (4%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ +RH +++K P + +V E GG L Y++ + + F I
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIIC 119
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
A+E H H I+HRDLKPENL+L + VK+ADFGL+ + + G+ + APE
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 3e-15
Identities = 39/133 (29%), Positives = 62/133 (46%), Gaps = 23/133 (17%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-------IVTELL---LGGTLRKYLLNMRPRCLDIHV 50
+M V H+N++ + + +V EL+ L ++ L +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERM 166
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
+ + ++ LHS GIIHRDLKP N+++ +D +K+ DFGLAR + MMT
Sbjct: 167 SY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYV 224
Query: 111 GT--YRWMAPENM 121
T YR APE +
Sbjct: 225 VTRYYR--APEVI 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-15
Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 21/132 (15%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-------IVTELL---LGGTLRKYLLNMRPRCLDIHV 50
+M V H+N++ + + IV EL+ L ++ L +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-------HERM 129
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
+ + ++ LHS GIIHRDLKP N+++ +D +K+ DFGLAR + MMT
Sbjct: 130 SY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYV 187
Query: 111 GTYRWM-APENM 121
T R+ APE +
Sbjct: 188 VT-RYYRAPEVI 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 5e-15
Identities = 37/119 (31%), Positives = 57/119 (47%), Gaps = 4/119 (3%)
Query: 2 MSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ RH +++K P + +V E + GG L Y+ LD + I
Sbjct: 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILS 127
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
++ H H ++HRDLKPEN++L A K+ADFGL+ S E + G+ + APE
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRTSCGSPNYAAPE 185
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 6e-15
Identities = 32/89 (35%), Positives = 43/89 (48%), Gaps = 7/89 (7%)
Query: 34 LRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLAD 93
L+K L L+ A F L + + H ++HRDLKP+NL L +K+AD
Sbjct: 86 LKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL-LINREGELKIAD 143
Query: 94 FGLAREESL-TEMMTAETGT--YRWMAPE 119
FGLAR + T E T YR AP+
Sbjct: 144 FGLARAFGIPVRKYTHEIVTLWYR--APD 170
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-15
Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 19/136 (13%)
Query: 1 MMSRVRHRNLVKFI--------GACKEPVMVIVTELLLGGTLRKYLLNMRPRCL---DIH 49
++ + H N+V+ ++ + +V E + TL + N R + I
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 50 VAIGFALDIARAMECLH--SHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMT 107
+ + F + R++ CLH S + HRD+KP N+++ T+KL DFG A++ S +E
Sbjct: 131 IKV-FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189
Query: 108 AETGT--YRWMAPENM 121
A + YR APE +
Sbjct: 190 AYICSRYYR--APELI 203
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-15
Identities = 28/125 (22%), Positives = 51/125 (40%), Gaps = 9/125 (7%)
Query: 1 MMSRVR----HRNLVKFIGACKEPVM-VIVTELLL-GGTLRKYLLNMRPRCLDIHVAIGF 54
++ +V H +++ + + ++V E L L Y+ L + F
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGPLGEGPSRCF 144
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYR 114
+ A++ HS G++HRD+K EN+++ KL DFG + GT
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRV 203
Query: 115 WMAPE 119
+ PE
Sbjct: 204 YSPPE 208
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 9e-15
Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 25 VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPENLILT 83
V E GG L +L R R A + +I A++ LHS +++RDLK ENL+L
Sbjct: 226 VMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD 283
Query: 84 AD-HKTVKLADFGLAREESLTEMMTAET--GTYRWMAPE 119
D H +K+ DFGL +E + + T +T GT ++APE
Sbjct: 284 KDGH--IKITDFGLCKEG-IKDGATMKTFCGTPEYLAPE 319
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-15
Identities = 33/129 (25%), Positives = 59/129 (45%), Gaps = 17/129 (13%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-------IVTELLLGGTLRKYLLNMRPRCLDIHVAIG 53
++ ++H N++ + + +V + L+K M + + +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKI---MGLKFSEEKIQY- 130
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY 113
+ + ++ +HS G++HRDLKP NL + D + +K+ DFGLAR MT T
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHAD--AEMTGYVVT- 186
Query: 114 RW-MAPENM 121
RW APE +
Sbjct: 187 RWYRAPEVI 195
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 1e-14
Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 34 LRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLAD 93
L+KY + LD + F + + + HS ++HRDLKP+NL L + +KLA+
Sbjct: 87 LKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL-LINRNGELKLAN 144
Query: 94 FGLAREESL-TEMMTAETGT--YRWMAPE 119
FGLAR + +AE T YR P+
Sbjct: 145 FGLARAFGIPVRCYSAEVVTLWYR--PPD 171
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-14
Identities = 32/89 (35%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 34 LRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLAD 93
L+K L + L + + R + H H I+HRDLKP+NL++ +KLAD
Sbjct: 105 LKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN-SDGALKLAD 162
Query: 94 FGLAREESL-TEMMTAETGT--YRWMAPE 119
FGLAR + T E T YR AP+
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYR--APD 189
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-14
Identities = 41/132 (31%), Positives = 61/132 (46%), Gaps = 22/132 (16%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-------IVTELL---LGGTLRKYLLNMRPRCLDIHV 50
++ ++H N++ + + +VT L+ L ++ L D HV
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT------DDHV 134
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
I R ++ +HS IIHRDLKP NL + D + +K+ DFGLAR + MT
Sbjct: 135 QF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR--HTADEMTGYV 190
Query: 111 GTYRW-MAPENM 121
T RW APE M
Sbjct: 191 AT-RWYRAPEIM 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-14
Identities = 30/93 (32%), Positives = 44/93 (47%), Gaps = 11/93 (11%)
Query: 34 LRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKT----V 89
L+KY+ + + V F + + HS +HRDLKP+NL+L+ + +
Sbjct: 119 LKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176
Query: 90 KLADFGLAREESL-TEMMTAETGT--YRWMAPE 119
K+ DFGLAR + T E T YR PE
Sbjct: 177 KIGDFGLARAFGIPIRQFTHEIITLWYR--PPE 207
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-14
Identities = 23/70 (32%), Positives = 37/70 (52%), Gaps = 8/70 (11%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR----EESLTEMMTAETGT- 112
+ R ++ +HS ++HRDLKP NL + + +K+ DFGLAR S ++ T
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 113 -YRWMAPENM 121
YR +P +
Sbjct: 189 WYR--SPRLL 196
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-14
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 10/93 (10%)
Query: 34 LRKYL----LNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTV 89
L+KY+ + PR L++++ F + + + H + I+HRDLKP+NL++ +
Sbjct: 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN-KRGQL 147
Query: 90 KLADFGLAREESL-TEMMTAETGT--YRWMAPE 119
KL DFGLAR + ++E T YR AP+
Sbjct: 148 KLGDFGLARAFGIPVNTFSSEVVTLWYR--APD 178
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-14
Identities = 42/136 (30%), Positives = 64/136 (47%), Gaps = 25/136 (18%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV------IVTELL---LGGTLRKYLLNMRPRCLDIHVA 51
++ R RH N++ + P + IV +L+ L L+ L+ + H+
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS------NDHIC 131
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR----EESLTEMMT 107
F I R ++ +HS ++HRDLKP NL+L +K+ DFGLAR + T +T
Sbjct: 132 Y-FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLT 189
Query: 108 AETGT--YRWMAPENM 121
T YR APE M
Sbjct: 190 EYVATRWYR--APEIM 203
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-14
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 7/89 (7%)
Query: 34 LRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLAD 93
L++YL + +++H F + R + H ++HRDLKP+NL++ +KLAD
Sbjct: 86 LKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLAD 143
Query: 94 FGLAREESL-TEMMTAETGT--YRWMAPE 119
FGLAR +S+ T+ E T YR P+
Sbjct: 144 FGLARAKSIPTKTYDNEVVTLWYR--PPD 170
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 7e-14
Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 22/132 (16%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-------IVTELL---LGGTLRKYLLNMRPRCLDIHV 50
++ +RH N++ + + +V + LG ++ L + +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG------EDRI 130
Query: 51 AIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAET 110
+ + + +H+ GIIHRDLKP NL + D + +K+ DFGLAR+ MT
Sbjct: 131 QF-LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQAD--SEMTGYV 186
Query: 111 GTYRWM-APENM 121
T RW APE +
Sbjct: 187 VT-RWYRAPEVI 197
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-13
Identities = 33/142 (23%), Positives = 61/142 (42%), Gaps = 14/142 (9%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV------IVTELLLGGT-LRKYLLNMRPRCL-DIHVAI 52
+++R+ H ++VK + + +V E+ + +K P L ++H+
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLF--RTPVYLTELHIKT 160
Query: 53 GFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT 112
++ ++ +HS GI+HRDLKP N ++ D +VK+ DFGLAR E ++
Sbjct: 161 -LLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 113 YRWMAPENMRPSAENLPEDLAL 134
N+ L
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQL 240
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-13
Identities = 32/89 (35%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 34 LRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLAD 93
L + + H+ + L + +E LH H I+HRDLKP NL+L + +KLAD
Sbjct: 98 LEVIIKDNSLVLTPSHIKA-YMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLAD 155
Query: 94 FGLAREESL-TEMMTAETGT--YRWMAPE 119
FGLA+ T + T YR APE
Sbjct: 156 FGLAKSFGSPNRAYTHQVVTRWYR--APE 182
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-13
Identities = 38/143 (26%), Positives = 59/143 (41%), Gaps = 32/143 (22%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV------IVTELL---LGGTLRKYLLNMRPRCLDIHVA 51
++ +H N++ + I+ EL+ L + +L+ D H+
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLS------DDHIQ 115
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR-----------EE 100
F RA++ LH +IHRDLKP NL++ ++ +K+ DFGLAR
Sbjct: 116 Y-FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEPT 173
Query: 101 SLTEMMTAETGT--YRWMAPENM 121
M T YR APE M
Sbjct: 174 GQQSGMVEFVATRWYR--APEVM 194
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-12
Identities = 32/138 (23%), Positives = 50/138 (36%), Gaps = 33/138 (23%)
Query: 4 RVRHRNLVKFIGACKEPVMVIVTELLLGGT---------------LRKYLLNMRPRCLDI 48
++H N+V I + T+ L L N+ +
Sbjct: 72 LLKHENVVNLIE-------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 49 HVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-----ESLT 103
+ + + +H + I+HRD+K N+++T +KLADFGLAR S
Sbjct: 125 EIKR-VMQMLLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQP 182
Query: 104 EMMTAETGT--YRWMAPE 119
T T YR PE
Sbjct: 183 NRYTNRVVTLWYR--PPE 198
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-12
Identities = 24/73 (32%), Positives = 38/73 (52%), Gaps = 1/73 (1%)
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ + ++ LHS G++HRD+KP N++L A+ VK+ADFGL+R +T
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 118 PENMRPSAENLPE 130
EN L +
Sbjct: 177 TENFDDDQPILTD 189
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-12
Identities = 16/42 (38%), Positives = 26/42 (61%), Gaps = 3/42 (7%)
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHK---TVKLADFGLAR 98
+ LH++ ++HRDLKP N+++ + VK+AD G AR
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-11
Identities = 25/83 (30%), Positives = 44/83 (53%), Gaps = 8/83 (9%)
Query: 21 VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80
MV+ LLG +L + L ++ R + + A+ + ME +HS +I+RD+KPEN
Sbjct: 81 AMVLE---LLGPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENF 136
Query: 81 IL----TADHKTVKLADFGLARE 99
++ + + + DF LA+E
Sbjct: 137 LIGRPGNKTQQVIHIIDFALAKE 159
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-11
Identities = 23/105 (21%), Positives = 38/105 (36%), Gaps = 13/105 (12%)
Query: 21 VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80
M++ G L+K + + + +L I +E +H H +H D+K NL
Sbjct: 128 FMIM---DRFGSDLQK-IYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNL 183
Query: 81 IL-TADHKTVKLADFGLARE----ESLTEMMTAE----TGTYRWM 116
+L + V L D+GLA GT +
Sbjct: 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 1e-11
Identities = 20/80 (25%), Positives = 34/80 (42%), Gaps = 4/80 (5%)
Query: 21 VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80
+V+ LG +L+ L L + A + A+E LH + +H ++ EN+
Sbjct: 134 FLVLP---SLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190
Query: 81 IL-TADHKTVKLADFGLARE 99
+ D V LA +G A
Sbjct: 191 FVDPEDQSQVTLAGYGFAFR 210
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-11
Identities = 20/83 (24%), Positives = 43/83 (51%), Gaps = 8/83 (9%)
Query: 21 VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80
V+VI LLG +L + LL++ R + A + ++ +H +++RD+KP+N
Sbjct: 82 VLVID---LLGPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 137
Query: 81 IL----TADHKTVKLADFGLARE 99
++ + + + + DFG+ +
Sbjct: 138 LIGRPNSKNANMIYVVDFGMVKF 160
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-11
Identities = 30/134 (22%), Positives = 54/134 (40%), Gaps = 12/134 (8%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV------IVTELLLGGT-LRKYLLNMRPRCLDIHVAIG 53
+++R++ +++ ++ IV E+ + L+K L + H+
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKK-LFKTPIFLTEEHIKT- 133
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY 113
++ +H GIIHRDLKP N +L D VK+ DFGLAR + +
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLE 192
Query: 114 RWMAPENMRPSAEN 127
P + +
Sbjct: 193 ENEEPGPHNKNLKK 206
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-11
Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 14/106 (13%)
Query: 21 VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80
VMV+ LLG +L + L N R + + A + +E +HS IHRD+KP+N
Sbjct: 81 VMVME---LLGPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF 136
Query: 81 IL--TADHKTVKLADFGLARE--ESLTEMMTAE------TGTYRWM 116
++ V + DFGLA++ ++ T TGT R+
Sbjct: 137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-11
Identities = 23/77 (29%), Positives = 39/77 (50%), Gaps = 2/77 (2%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN-L 80
+ + ELL L + + + + + + FA I + ++ LH + IIH DLKPEN L
Sbjct: 174 ICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENIL 232
Query: 81 ILTADHKTVKLADFGLA 97
+ +K+ DFG +
Sbjct: 233 LKQQGRSGIKVIDFGSS 249
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-10
Identities = 20/80 (25%), Positives = 35/80 (43%), Gaps = 6/80 (7%)
Query: 21 VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80
MV+ LG L+K + + + + +E +H + +H D+K NL
Sbjct: 128 FMVME---RLGIDLQK-ISGQNGT-FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182
Query: 81 IL-TADHKTVKLADFGLARE 99
+L + V LAD+GL+
Sbjct: 183 LLGYKNPDQVYLADYGLSYR 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 1e-09
Identities = 26/79 (32%), Positives = 43/79 (54%), Gaps = 4/79 (5%)
Query: 23 VIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL 82
V+V +LL G +L + L N R L + + A + +E +HS +HRD+KP+N ++
Sbjct: 79 VLVMDLL-GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136
Query: 83 --TADHKTVKLADFGLARE 99
V + DFGLA++
Sbjct: 137 GLGRRANQVYIIDFGLAKK 155
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-09
Identities = 27/104 (25%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKPENL 80
+V+V E+L G L + R + + + + ++ +H GIIH D+KPEN+
Sbjct: 105 VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 163
Query: 81 ILT-----ADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
++ + +K+AD G A + +T YR +PE
Sbjct: 164 LMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR--SPE 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-08
Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 6/101 (5%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH--GIIHRDLKPEN 79
+ +V E+L L L N R + +++ FA + A+ L + IIH DLKPEN
Sbjct: 131 LCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPEN 189
Query: 80 -LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
L+ +K+ DFG + + ++ YR +PE
Sbjct: 190 ILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPE 228
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 6e-08
Identities = 28/164 (17%), Positives = 63/164 (38%), Gaps = 20/164 (12%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKPENL 80
+ +V E+L G L K+++ + L + + + ++ LH+ IIH D+KPEN+
Sbjct: 120 ICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI 178
Query: 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIV---- 136
+L+ + + ++ + + + A P++ +
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 137 ---TSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFS 177
+CW F++ IQ Y + E V++ ++
Sbjct: 239 DLGNACWVHKH-----FTEDIQ-TRQY----RSLE-VLIGSGYN 271
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-07
Identities = 28/116 (24%), Positives = 42/116 (36%), Gaps = 21/116 (18%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
M I ELL G ++L + + A + A+ LH + + H DLKPEN++
Sbjct: 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL 155
Query: 82 LTADHKT------------------VKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+++ADFG A + T YR PE
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR--PPE 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 30/116 (25%), Positives = 45/116 (38%), Gaps = 21/116 (18%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
+ IV ELL G + ++ + A I +++ LHS+ + H DLKPEN++
Sbjct: 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENIL 150
Query: 82 LTADHKT------------------VKLADFGLAREESLTEMMTAETGTYRWMAPE 119
T +K+ DFG A + T YR APE
Sbjct: 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--APE 204
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-06
Identities = 22/98 (22%), Positives = 36/98 (36%), Gaps = 25/98 (25%)
Query: 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81
M ++ E L G +L + + I + ++I +A+ L + H DLKPEN++
Sbjct: 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENIL 169
Query: 82 L------------------------TADHKTVKLADFG 95
L +KL DFG
Sbjct: 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 9e-06
Identities = 18/77 (23%), Positives = 25/77 (32%), Gaps = 5/77 (6%)
Query: 24 IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLH-SHGIIHRDLKPENLIL 82
IV E GG L MR + + A + ++ S HRDL N +L
Sbjct: 139 IVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN-VL 194
Query: 83 TADHKTVKLADFGLARE 99
KL +
Sbjct: 195 LKKTSLKKLHYTLNGKS 211
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 6e-04
Identities = 19/75 (25%), Positives = 28/75 (37%), Gaps = 12/75 (16%)
Query: 30 LGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTV 89
+ G L K ++ I + LH + +IH DL N I D
Sbjct: 421 INGKLAKDVIEDNLDIAY---------KIGEIVGKLHKNDVIHNDLTTSNFIF--DKDLY 469
Query: 90 KLADFGLAREESLTE 104
+ DFGL + +L E
Sbjct: 470 -IIDFGLGKISNLDE 483
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 223 | |||
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.98 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.98 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.98 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.98 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.98 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.98 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.98 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.98 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.98 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.98 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.98 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.98 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.98 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.96 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.96 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.95 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.95 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.95 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.95 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.95 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.95 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.95 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.95 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.95 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.95 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.95 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.94 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.94 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.94 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.93 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.93 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.32 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.96 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.78 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.69 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.28 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.22 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.11 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.98 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.66 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.56 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.13 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.91 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.1 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.01 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 92.91 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.8 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.51 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 91.33 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 91.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 90.91 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 89.65 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.47 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.89 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 88.67 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 87.84 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.31 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 83.76 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 83.6 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 83.58 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 81.9 |
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=280.22 Aligned_cols=163 Identities=24% Similarity=0.306 Sum_probs=138.3
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++|+|||||+++++|.+ +.+|+|||||+||+|.+++.+.+. +++..++.++.||+.||+|||++||+||||||+|
T Consensus 103 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 180 (336)
T 4g3f_A 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILHGDVKADN 180 (336)
T ss_dssp TTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHH
Confidence 5889999999999999975 578999999999999999987654 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc------ccccCCCccccccCCCCCCC-----------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE------MMTAETGTYRWMAPENMRPS----------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~----------------------------- 124 (223)
||++.++.++||+|||+|+...... .....+||+.|||||++...
T Consensus 181 ILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 260 (336)
T 4g3f_A 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260 (336)
T ss_dssp EEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred EEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 9999887569999999998643321 12335799999999965422
Q ss_pred ------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCC
Q 027476 125 ------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165 (223)
Q Consensus 125 ------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~ 165 (223)
+..++.++.+++.+||+.+|.+||++.|++++|...+....
T Consensus 261 ~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 261 RGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 34566677789999999999999999999999988876543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=274.26 Aligned_cols=159 Identities=34% Similarity=0.537 Sum_probs=134.7
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++|||||+++|++.++.+++|||||+||+|.+++.... ..+++..++.|+.|++.||+|||+++|+||||||+||
T Consensus 85 il~~l~HpNIV~l~g~~~~~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NI 163 (307)
T 3omv_A 85 VLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNI 163 (307)
T ss_dssp HHTTCCCTTBCCEEEEECSSSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSE
T ss_pred HHHhCCCCCEeeEEEEEECCeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHE
Confidence 478999999999999998888999999999999999997643 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc---ccccccCCCccccccCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESL---TEMMTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
|++.++ .+||+|||+|+.... .......+||+.|||||++.
T Consensus 164 Ll~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 164 FLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp EEETTE-EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EECCCC-cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 999887 899999999985432 22234568999999999542
Q ss_pred ------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 123 ------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 123 ------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
..+.+++.++.+++.+||+.+|.+||++.+++++|+.+.
T Consensus 243 ~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 243 RDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp HHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 113457788999999999999999999999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=281.92 Aligned_cols=155 Identities=28% Similarity=0.481 Sum_probs=135.0
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++|+|||||+++++|++ +.+|+|||||+||+|.+++...+...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 76 il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 155 (350)
T 4b9d_A 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQN 155 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGG
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHH
Confidence 4678999999999999975 578999999999999999987666678999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
||++.++ .+||+|||+|+...... .....+||+.|||||++.+.
T Consensus 156 ILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 234 (350)
T 4b9d_A 156 IFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234 (350)
T ss_dssp EEECTTC-CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEECCCC-CEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 9999888 89999999998765432 33456899999999965522
Q ss_pred -----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++.+|+.+||+.||.+||++++++++
T Consensus 235 ~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 235 LKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 34566777889999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=273.71 Aligned_cols=161 Identities=25% Similarity=0.525 Sum_probs=132.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR-------------PRCLDIHVAIGFALDIARAMECLH 66 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~~l~~lH 66 (223)
+|++|+|||||+++|+|.+ +.+++|||||+||+|.+++.... ...+++.+++.|+.|++.||.|||
T Consensus 96 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 4789999999999999976 57899999999999999997643 235999999999999999999999
Q ss_pred hCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC---------------------
Q 027476 67 SHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR--------------------- 122 (223)
Q Consensus 67 ~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~--------------------- 122 (223)
+++|+||||||+|||++.++ .+||+|||+++...... ......||+.|||||++.
T Consensus 176 ~~~iiHRDLKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ell 254 (329)
T 4aoj_A 176 GLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254 (329)
T ss_dssp HTTCCCSCCCGGGEEEETTT-EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred cCCeecccccHhhEEECCCC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHH
Confidence 99999999999999999887 89999999998543322 223457999999999443
Q ss_pred -------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 -------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 -------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
+.+..++.++++|+.+||+.+|.+||++++++++|+.+..
T Consensus 255 t~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 255 TYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp TTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 2355688889999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=270.17 Aligned_cols=162 Identities=28% Similarity=0.538 Sum_probs=139.5
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR-----------PRCLDIHVAIGFALDIARAMECLHSH 68 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~~l~~lH~~ 68 (223)
+|++|+|||||+++|+|.+ +.+++|||||+||+|.+++...+ ...+++.+++.++.|++.||.|||++
T Consensus 68 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T 4asz_A 68 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ 147 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4789999999999999975 57899999999999999997632 34699999999999999999999999
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCC-----------------------
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMR----------------------- 122 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~----------------------- 122 (223)
+|+||||||+|||++.++ .+||+|||+++....... .....||+.|||||++.
T Consensus 148 ~iiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~ 226 (299)
T 4asz_A 148 HFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 226 (299)
T ss_dssp TCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CcccCccCHhhEEECCCC-cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcC
Confidence 999999999999999887 899999999985433322 22346899999999332
Q ss_pred -----------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 -----------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 -----------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++++|+..||+.+|.+||+++++.+.|+++...
T Consensus 227 G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 227 GKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp TCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 33567888999999999999999999999999999987654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=276.19 Aligned_cols=158 Identities=26% Similarity=0.459 Sum_probs=132.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||++++|||||+++++|.+ +.+|+|||||+||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 124 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 200 (346)
T 4fih_A 124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 200 (346)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHH
Confidence 4678999999999999975 6799999999999999999763 39999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCCCCC-------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPSAEN------------------------------- 127 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~------------------------------- 127 (223)
||++.++ .+||+|||+|+..... ....+.+||+.|||||++....++
T Consensus 201 ILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 279 (346)
T 4fih_A 201 ILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 279 (346)
T ss_dssp EEECTTC-CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EEECCCC-CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 9999888 8999999999865433 334567899999999966543333
Q ss_pred ----------------ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 128 ----------------LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 128 ----------------~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
++.++.+|+.+||+.||.+||+++|++++ .++...
T Consensus 280 ~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H--p~~~~~ 330 (346)
T 4fih_A 280 KMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAKA 330 (346)
T ss_dssp HHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGGC
T ss_pred HHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhcCC
Confidence 45566668888999999999998888776 555443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=269.94 Aligned_cols=159 Identities=28% Similarity=0.529 Sum_probs=137.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--------------PRCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~l 65 (223)
+|++|+|||||+++|+|.+ +.+++|||||++|+|.+++.... ...+++..++.++.||+.||+||
T Consensus 82 il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 161 (308)
T 4gt4_A 82 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 161 (308)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 3678999999999999975 57899999999999999997532 13589999999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC--------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR-------------------- 122 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-------------------- 122 (223)
|+++|+||||||+||||+.++ .+||+|||+++...... ......||+.|||||++.
T Consensus 162 H~~~iiHRDLK~~NILl~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El 240 (308)
T 4gt4_A 162 SSHHVVHKDLATRNVLVYDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240 (308)
T ss_dssp HHTTCCCSCCSGGGEEECGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HhCCCCCCCccccceEECCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHH
Confidence 999999999999999999887 89999999998653322 234457999999999332
Q ss_pred --------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 123 --------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 123 --------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
+.+.+++.++++++..||+.+|.+||++.+|+++|+++
T Consensus 241 ~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 241 FSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 34667889999999999999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=265.93 Aligned_cols=129 Identities=33% Similarity=0.552 Sum_probs=107.0
Q ss_pred CCCCCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Q 027476 1 MMSRVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG--IIHR 73 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~ 73 (223)
+|++|+|||||+++++|++ +.+++|||||+||+|.+++.+... +++..+..++.||+.||+|||++| |+||
T Consensus 78 il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH~~~~~IiHR 155 (290)
T 3fpq_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHR 155 (290)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCC
T ss_pred HHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCEEec
Confidence 4678999999999999853 347899999999999999987654 999999999999999999999998 9999
Q ss_pred CCCCCCEEEeC-CCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHH
Q 027476 74 DLKPENLILTA-DHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLAL 134 (223)
Q Consensus 74 dlkp~Nill~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~ 134 (223)
||||+|||++. ++ .+||+|||+|+.... ....+.+||+.|||||++.. .++...|+|+
T Consensus 156 DlKp~NILl~~~~g-~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwS 214 (290)
T 3fpq_A 156 DLKCDNIFITGPTG-SVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYA 214 (290)
T ss_dssp CCCGGGEEESSTTS-CEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHH
T ss_pred ccChhheeEECCCC-CEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC-CCCcHHHHHH
Confidence 99999999985 45 899999999985433 33456789999999997653 2333344333
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=277.79 Aligned_cols=157 Identities=26% Similarity=0.470 Sum_probs=132.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||++++|||||+++++|.+ +.+|+|||||+||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 201 il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~N 277 (423)
T 4fie_A 201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 277 (423)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTT
T ss_pred HHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHH
Confidence 4678999999999999975 6799999999999999999753 39999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPSA--------------------------------- 125 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--------------------------------- 125 (223)
||++.++ .+||+|||+|+..... ....+.+||+.|||||++....
T Consensus 278 ILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 356 (423)
T 4fie_A 278 ILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 356 (423)
T ss_dssp EEECTTC-CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EEEcCCC-CEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 9999888 8999999999865433 3345678999999999665332
Q ss_pred --------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 126 --------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 126 --------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..++.++.+|+.+||+.||.+||+++|++++ .++..
T Consensus 357 ~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H--p~~~~ 406 (423)
T 4fie_A 357 KMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAK 406 (423)
T ss_dssp HHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGG
T ss_pred HHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HHhcC
Confidence 3455666778888999999999999888776 55544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=263.55 Aligned_cols=156 Identities=28% Similarity=0.450 Sum_probs=124.1
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|||||++++++++ +.+|+||||+ +|+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~N 142 (275)
T 3hyh_A 66 YLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPEN 142 (275)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTT
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHH
Confidence 3678999999999999975 5789999999 7899999987654 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
||++.++ .+||+|||+|+.........+.+||+.|+|||++.+.
T Consensus 143 ILl~~~~-~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~ 221 (275)
T 3hyh_A 143 LLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF 221 (275)
T ss_dssp EEECTTC-CEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eEECCCC-CEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999887 8999999999876655555667899999999966532
Q ss_pred ----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 125 ----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 125 ----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
+..++.++.+++.+||+.+|.+|||++|++++ .++.
T Consensus 222 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--pw~k 267 (275)
T 3hyh_A 222 KNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD--DWFK 267 (275)
T ss_dssp HHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC--HHHH
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC--cccc
Confidence 33456667778999999999999999999886 5554
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=262.03 Aligned_cols=155 Identities=30% Similarity=0.480 Sum_probs=122.4
Q ss_pred CCCCCCCCCccceEEEeecC-------------ceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH
Q 027476 1 MMSRVRHRNLVKFIGACKEP-------------VMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIARAMECLH 66 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~-------------~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH 66 (223)
+|++|+|||||+++++|.+. .+|+|||||.||+|.+++..... ...++..++.++.||+.||+|||
T Consensus 56 il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH 135 (299)
T 4g31_A 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH 135 (299)
T ss_dssp HHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH
Confidence 47899999999999998532 26899999999999999986543 23566778999999999999999
Q ss_pred hCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc-------------ccccCCCccccccCCCCCCCCCCChHHHH
Q 027476 67 SHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE-------------MMTAETGTYRWMAPENMRPSAENLPEDLA 133 (223)
Q Consensus 67 ~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~l~ 133 (223)
++||+||||||+|||++.++ .+||+|||+|+...... .....+||+.|||||++.+..++...|+|
T Consensus 136 ~~~IiHRDlKp~NILl~~~~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Diw 214 (299)
T 4g31_A 136 SKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIF 214 (299)
T ss_dssp HTTCCCCCCCGGGEEECTTC-CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHH
T ss_pred HCcCccccCcHHHeEECCCC-cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHH
Confidence 99999999999999999888 89999999998543321 12335799999999988877777666665
Q ss_pred H-------------------------------------------HHHHhcccCCCCCCCHHHHHHH
Q 027476 134 L-------------------------------------------IVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 134 ~-------------------------------------------l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+ ++.+||+.+|.+||++.+++++
T Consensus 215 SlGvilyell~Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 215 SLGLILFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 5 5677888888888888888764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=263.53 Aligned_cols=147 Identities=28% Similarity=0.399 Sum_probs=131.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
||++|+|||||+++++|++ +.+|+|||||+||+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|
T Consensus 85 il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeN 162 (311)
T 4aw0_A 85 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162 (311)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHH
Confidence 4789999999999999976 578999999999999999987655 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc---ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCH
Q 027476 80 LILTADHKTVKLADFGLAREESL---TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
||++.++ .+||+|||+|+.... .....+.+||+.|||||++....++...|+|+++..++++-.++.|+.
T Consensus 163 ILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 235 (311)
T 4aw0_A 163 ILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 235 (311)
T ss_dssp EEECTTS-CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eEEcCCC-CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999888 899999999986532 223456789999999999999999999999999999998888887754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=260.77 Aligned_cols=147 Identities=28% Similarity=0.355 Sum_probs=131.1
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|||||++++++++ +.+|+|||||+||+|.+++.+.+. +++.++..++.||+.||+|||++||+||||||+|
T Consensus 79 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 156 (304)
T 3ubd_A 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN 156 (304)
T ss_dssp CCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence 5889999999999999975 678999999999999999987655 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCCH
Q 027476 80 LILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
||++.++ .+||+|||+|+.... .....+.+||+.|||||++....++...|+|+++..++++-.++.|..
T Consensus 157 ILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~ 227 (304)
T 3ubd_A 157 ILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227 (304)
T ss_dssp EEECTTS-CEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eEEcCCC-CEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCC
Confidence 9999888 899999999986433 233456789999999999999999999999999999998888888854
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=267.06 Aligned_cols=162 Identities=30% Similarity=0.587 Sum_probs=136.2
Q ss_pred CCCCC-CCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHH
Q 027476 2 MSRVR-HRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMR--------------PRCLDIHVAIGFALDIARAMEC 64 (223)
Q Consensus 2 l~~l~-Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~ 64 (223)
|++++ |||||+++|+|.+ +.+++|||||++|+|.+++.... ...+++..++.++.||+.||+|
T Consensus 121 l~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~y 200 (353)
T 4ase_A 121 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200 (353)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence 45675 5999999999854 46899999999999999997532 2348999999999999999999
Q ss_pred HHhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC-------------------
Q 027476 65 LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR------------------- 122 (223)
Q Consensus 65 lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~------------------- 122 (223)
||+++|+||||||+|||++.++ .+||+|||+|+...... ......||+.|||||++.
T Consensus 201 LH~~~iiHRDLK~~NILl~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~E 279 (353)
T 4ase_A 201 LASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 279 (353)
T ss_dssp HHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HhhCCeecCccCccceeeCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHH
Confidence 9999999999999999999888 89999999998643322 223457899999999332
Q ss_pred ----------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 ----------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 ----------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
+.+..++.++++++..||+.+|.+||++.+++++|++++...
T Consensus 280 l~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 280 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp HTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 234567888999999999999999999999999999987543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=256.09 Aligned_cols=158 Identities=29% Similarity=0.432 Sum_probs=128.9
Q ss_pred CCCCCCCCccceEEEeecC-----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------
Q 027476 2 MSRVRHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH-------- 68 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-------- 68 (223)
+++++|||||+++++|.++ .+++||||++||+|.+++... .++++.+++++.|++.||+|||++
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~ 127 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence 5688999999999999642 479999999999999999763 389999999999999999999987
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCcccccccccc-----ccccCCCccccccCCCCCCC-------------------
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLAREESLTE-----MMTAETGTYRWMAPENMRPS------------------- 124 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------------------- 124 (223)
+|+||||||+|||++.++ .+||+|||+++...... .....+||+.|||||++...
T Consensus 128 ~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gv 206 (303)
T 3hmm_A 128 AIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206 (303)
T ss_dssp CEECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred CEeeccCCcccEEECCCC-CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHH
Confidence 899999999999999888 89999999998543322 12235799999999954210
Q ss_pred --------------------C------------------------CC---------ChHHHHHHHHHhcccCCCCCCCHH
Q 027476 125 --------------------A------------------------EN---------LPEDLALIVTSCWKEDPNERPNFS 151 (223)
Q Consensus 125 --------------------~------------------------~~---------~~~~l~~l~~~~l~~~p~~Rp~~~ 151 (223)
+ .. .+..+.+|+.+||+.+|.+|||+.
T Consensus 207 vl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 286 (303)
T 3hmm_A 207 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286 (303)
T ss_dssp HHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred HHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHH
Confidence 0 00 123578899999999999999999
Q ss_pred HHHHHHHHHhhc
Q 027476 152 QIIQMLLHYIST 163 (223)
Q Consensus 152 ~~~~~L~~~~~~ 163 (223)
++++.|+++...
T Consensus 287 ei~~~L~~l~~~ 298 (303)
T 3hmm_A 287 RIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHHHHC
T ss_pred HHHHHHHHHHHH
Confidence 999999987654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=261.07 Aligned_cols=129 Identities=26% Similarity=0.312 Sum_probs=109.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++|||||+++++|++ +.+|+||||+.||+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+||
T Consensus 246 l~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNI 323 (689)
T 3v5w_A 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323 (689)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred HhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHe
Confidence 567899999999999976 578999999999999999987655 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCC-CCCCCChHHHHH
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR-PSAENLPEDLAL 134 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~l~~ 134 (223)
|++.++ ++||+|||+|+...... ..+.+||+.|||||++. +..++.+.|+|+
T Consensus 324 Lld~~G-~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWS 376 (689)
T 3v5w_A 324 LLDEHG-HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFS 376 (689)
T ss_dssp EECTTS-CEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHH
T ss_pred EEeCCC-CEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHH
Confidence 999888 89999999998654433 34578999999999774 233444444433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=248.84 Aligned_cols=118 Identities=28% Similarity=0.494 Sum_probs=100.5
Q ss_pred CCCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 1 MMSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
+|++|+|||||++++++.. +.+|+|||||. |+|.+++.+.+. +++..+..++.||+.||+|||++||+||
T Consensus 106 il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~--l~~~~~~~~~~qil~al~ylH~~~iiHR 182 (398)
T 4b99_A 106 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQP--LTLEHVRYFLYQLLRGLKYMHSAQVIHR 182 (398)
T ss_dssp HHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred HHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCcCcCC
Confidence 4678999999999998742 46899999995 789999976544 9999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCcccccccc-----ccccccCCCccccccCCCCC
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESL-----TEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~ 122 (223)
||||+|||++.++ .+||+|||+|+.... .....+.+||+.|+|||++.
T Consensus 183 DlKP~NIl~~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~ 235 (398)
T 4b99_A 183 DLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 235 (398)
T ss_dssp CCCGGGEEECTTC-CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHT
T ss_pred CcCccccccCCCC-CEEEeecceeeecccCccccccccccceeChHhcCHHHhc
Confidence 9999999999888 899999999985432 22334568999999999654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=260.19 Aligned_cols=160 Identities=26% Similarity=0.438 Sum_probs=135.1
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++|+|||||+++++|++ +.+++|||||.||+|.+++.+.. +.+++.++..++.||+.||+|||++||+||||||+|
T Consensus 207 il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~N 285 (573)
T 3uto_A 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285 (573)
T ss_dssp HHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence 4678999999999999976 57899999999999999986533 349999999999999999999999999999999999
Q ss_pred EEEeCC-CCceEEccCccccccccccccccCCCccccccCCCCCCCC---------------------------------
Q 027476 80 LILTAD-HKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA--------------------------------- 125 (223)
Q Consensus 80 ill~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------------------- 125 (223)
||++.+ .+.+||+|||+++...........+||+.|||||++....
T Consensus 286 ill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~ 365 (573)
T 3uto_A 286 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 365 (573)
T ss_dssp EEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred ccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 999854 2389999999999776655556778999999999655332
Q ss_pred ---------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 126 ---------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 126 ---------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..++.++.+|+.+||+.||.+||++.+++++ .++..
T Consensus 366 ~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H--pw~~~ 416 (573)
T 3uto_A 366 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH--PWLTP 416 (573)
T ss_dssp HHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS--TTTSC
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC--cCcCC
Confidence 2356677778999999999999999999876 45443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=243.34 Aligned_cols=132 Identities=23% Similarity=0.352 Sum_probs=103.6
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|+++ +||||++++++|++ +.+++||||++||+|.+++.. +++.++..++.||+.||+|||++||+||||||+|
T Consensus 73 l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeN 147 (361)
T 4f9c_A 73 LTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSN 147 (361)
T ss_dssp HHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHH
Confidence 3455 79999999999975 678999999999999999842 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-----------------------------cccccCCCccccccCCCCCCCC-CCCh
Q 027476 80 LILTADHKTVKLADFGLAREESLT-----------------------------EMMTAETGTYRWMAPENMRPSA-ENLP 129 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~ 129 (223)
||++.+.+.+||+|||+|+..... ......+||+.|+|||++.+.. ++.+
T Consensus 148 iLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~ 227 (361)
T 4f9c_A 148 FLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTA 227 (361)
T ss_dssp EEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTH
T ss_pred eEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCc
Confidence 999987458999999999743211 1123457999999999765432 3444
Q ss_pred HHHHHHHHH
Q 027476 130 EDLALIVTS 138 (223)
Q Consensus 130 ~~l~~l~~~ 138 (223)
.|+|++++.
T Consensus 228 ~DiWSlG~i 236 (361)
T 4f9c_A 228 IDMWSAGVI 236 (361)
T ss_dssp HHHHHHHHH
T ss_pred cchhhhHHH
Confidence 444444333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=227.41 Aligned_cols=162 Identities=34% Similarity=0.507 Sum_probs=134.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|
T Consensus 60 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~N 138 (310)
T 3s95_A 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN 138 (310)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTS
T ss_pred HHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCe
Confidence 3678999999999999965 57899999999999999998743 349999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccccc---------------ccCCCccccccCCCCCCC--------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMM---------------TAETGTYRWMAPENMRPS-------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~---------------~~~~gt~~y~aPE~~~~~-------------------- 124 (223)
|+++.++ .+||+|||+++........ ....||+.|+|||.+...
T Consensus 139 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 217 (310)
T 3s95_A 139 CLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217 (310)
T ss_dssp EEECTTS-CEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred EEECCCC-CEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhc
Confidence 9999887 7999999999754322111 145799999999965432
Q ss_pred ---------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 125 ---------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 125 ---------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
+..++.++.+++..||+.+|.+||++.++++.|+++....
T Consensus 218 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 218 RVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp TCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 2344556777899999999999999999999998876553
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=230.67 Aligned_cols=152 Identities=28% Similarity=0.404 Sum_probs=133.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||++|++|.+++...+. +++..++.++.|++.||+|||++||+||||||+||
T Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NI 145 (328)
T 3fe3_A 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145 (328)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHE
Confidence 567899999999999975 578999999999999999987654 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------- 123 (223)
+++.++ .+||+|||+++...........+||+.|+|||.+..
T Consensus 146 ll~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 224 (328)
T 3fe3_A 146 LLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE 224 (328)
T ss_dssp EECTTS-CEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEcCCC-CEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999888 899999999986655555567789999999995432
Q ss_pred --------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 --------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 --------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+++.+||+.+|.+||++++++++
T Consensus 225 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 225 RVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 233466778889999999999999999999876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-33 Score=228.67 Aligned_cols=154 Identities=26% Similarity=0.383 Sum_probs=131.3
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +.+++||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 68 il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~N 145 (361)
T 2yab_A 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145 (361)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 3678999999999999976 57899999999999999997644 49999999999999999999999999999999999
Q ss_pred EEEeCCCC---ceEEccCccccccccccccccCCCccccccCCCCCCCC-------------------------------
Q 027476 80 LILTADHK---TVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA------------------------------- 125 (223)
Q Consensus 80 ill~~~~~---~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------------------- 125 (223)
|+++.++. .+||+|||+++............||+.|+|||++....
T Consensus 146 Ill~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~ 225 (361)
T 2yab_A 146 IMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225 (361)
T ss_dssp EEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred EEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99986653 69999999998765554455678999999999654222
Q ss_pred -----------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 -----------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 -----------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++..||..+|.+||++.+++++
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 226 TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2345567789999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=224.19 Aligned_cols=152 Identities=28% Similarity=0.408 Sum_probs=130.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +.+++||||+.||+|.+++..... +++..++.++.||+.||+|||++||+||||||+||
T Consensus 59 l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 136 (337)
T 1o6l_A 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 136 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHE
Confidence 567899999999999975 578999999999999999987654 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccc-cccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREES-LTEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .+||+|||+++... ........+||+.|+|||++...
T Consensus 137 ll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 215 (337)
T 1o6l_A 137 MLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215 (337)
T ss_dssp EECTTS-CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EECCCC-CEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH
Confidence 999888 89999999998532 22334556799999999966422
Q ss_pred ---------CCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 125 ---------AENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 125 ---------~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
+..++.++.+++..||+.+|.+|| ++++++++
T Consensus 216 ~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 216 LILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 334567778899999999999998 88888765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=226.23 Aligned_cols=164 Identities=38% Similarity=0.664 Sum_probs=127.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIARAMECLHSHG--IIHRDLKP 77 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp 77 (223)
|++++||||+++++++.+ +..++||||+.+++|.+++..... ..+++..++.++.|++.||+|||++| |+||||||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp 167 (309)
T 3p86_A 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKS 167 (309)
T ss_dssp HHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCG
T ss_pred HHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCCh
Confidence 567899999999999975 578999999999999999976432 23899999999999999999999999 99999999
Q ss_pred CCEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCC---------------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRP--------------------------------- 123 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--------------------------------- 123 (223)
+||+++.++ .+||+|||+++...... ......||+.|+|||.+..
T Consensus 168 ~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~ 246 (309)
T 3p86_A 168 PNLLVDKKY-TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246 (309)
T ss_dssp GGEEECTTC-CEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred hhEEEeCCC-cEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999887 89999999997543322 2334579999999995432
Q ss_pred -------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCC
Q 027476 124 -------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSA 166 (223)
Q Consensus 124 -------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~ 166 (223)
.+..++.++.+++..||+.+|.+||+++++++.|+.++....+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 247 VVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 2345667788899999999999999999999999999875433
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=225.74 Aligned_cols=168 Identities=20% Similarity=0.330 Sum_probs=138.8
Q ss_pred CCCCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLK 76 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 76 (223)
+++++||||+++++++.+ ...++||||+ |++|.+++... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlk 179 (364)
T 3op5_A 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIK 179 (364)
T ss_dssp HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCC
Confidence 467899999999999854 2478999999 99999999774 3459999999999999999999999999999999
Q ss_pred CCCEEEe--CCCCceEEccCccccccccccc--------cccCCCccccccCCCCCCC----------------------
Q 027476 77 PENLILT--ADHKTVKLADFGLAREESLTEM--------MTAETGTYRWMAPENMRPS---------------------- 124 (223)
Q Consensus 77 p~Nill~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~---------------------- 124 (223)
|+||+++ .++ .+||+|||+++....... .....||+.|+|||.+...
T Consensus 180 p~Nill~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 180 ASNLLLNYKNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp GGGEEEESSCTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred HHHEEEecCCCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999998 666 899999999975433221 1234599999999954421
Q ss_pred ---------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCCCCC
Q 027476 125 ---------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVI 171 (223)
Q Consensus 125 ---------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~~~~ 171 (223)
...++.++.+++..||+.+|.+||++.++++.|++++..........
T Consensus 259 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~ 338 (364)
T 3op5_A 259 LPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGK 338 (364)
T ss_dssp CTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCC
T ss_pred CCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCc
Confidence 13457788899999999999999999999999999998876665443
Q ss_pred C
Q 027476 172 L 172 (223)
Q Consensus 172 ~ 172 (223)
+
T Consensus 339 ~ 339 (364)
T 3op5_A 339 L 339 (364)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-33 Score=225.56 Aligned_cols=160 Identities=25% Similarity=0.516 Sum_probs=132.5
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++++.++..++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil 147 (325)
T 3kex_A 69 IGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVL 147 (325)
T ss_dssp HHTCCCTTBCCEEEEECBSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEE
T ss_pred HhcCCCCCcCeEEEEEcCCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEE
Confidence 46789999999999999888999999999999999997642 34899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCC-----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRP----------------------------------- 123 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~----------------------------------- 123 (223)
++.++ .+||+|||+++...... ......++..|+|||.+..
T Consensus 148 ~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 226 (325)
T 3kex_A 148 LKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226 (325)
T ss_dssp ESSSS-CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH
T ss_pred ECCCC-eEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH
Confidence 99877 79999999998653322 2234467889999994431
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
.+..++.++.+++..||+.+|.+||++.+++++|+.+...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 227 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1233455677789999999999999999999999988643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=226.31 Aligned_cols=161 Identities=32% Similarity=0.633 Sum_probs=135.7
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--------------RCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~l 65 (223)
|+++ +||||++++++|.+ +.+++||||+.+|+|.+++..... ..+++..++.++.||+.||+||
T Consensus 140 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 219 (370)
T 2psq_A 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219 (370)
T ss_dssp HHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4567 89999999999965 578999999999999999986542 3489999999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC--------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR-------------------- 122 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-------------------- 122 (223)
|++||+||||||+||+++.++ .+||+|||+++...... ......+++.|+|||++.
T Consensus 220 H~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~el 298 (370)
T 2psq_A 220 ASQKCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298 (370)
T ss_dssp HHTTEECSCCCGGGEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred HhCCeeccccchhhEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999887 89999999998543322 123345788999999332
Q ss_pred --------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 --------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 --------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++..||+.+|.+||++.++++.|++++..
T Consensus 299 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 299 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 12345677899999999999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=221.48 Aligned_cols=162 Identities=29% Similarity=0.548 Sum_probs=134.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+.|++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 103 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 181 (325)
T 3kul_A 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARN 181 (325)
T ss_dssp HHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcce
Confidence 3678999999999999975 57899999999999999997543 349999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR--------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~--------------------------------- 122 (223)
|+++.++ .+||+|||+++...... ......+|+.|+|||.+.
T Consensus 182 Ill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 182 VLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp EEECTTC-CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred EEECCCC-CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999887 89999999998543321 122234677899999321
Q ss_pred -------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 -------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 -------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
+.+..++.++.+++..||+.+|.+||++.++++.|+.++...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 261 RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 224467888999999999999999999999999999988653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=223.53 Aligned_cols=156 Identities=28% Similarity=0.455 Sum_probs=135.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+ +|+|.+++...+. +++..++.++.|++.||.|||++||+||||||+||
T Consensus 63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 139 (336)
T 3h4j_B 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENL 139 (336)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTE
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhE
Confidence 678999999999999975 5789999999 7899999877654 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------- 123 (223)
+++.++ .+||+|||++............+||+.|+|||.+..
T Consensus 140 ll~~~~-~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~ 218 (336)
T 3h4j_B 140 LLDDNL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK 218 (336)
T ss_dssp EECTTC-CEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC
T ss_pred EEcCCC-CEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 999887 899999999987665555566789999999996541
Q ss_pred --------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 124 --------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 124 --------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
.+..++.++.+++.+||+.+|.+||++++++++ .++..
T Consensus 219 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h--p~~~~ 264 (336)
T 3h4j_B 219 KVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD--PWFNV 264 (336)
T ss_dssp CCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC--HHHHT
T ss_pred HHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC--hhhcc
Confidence 133467888999999999999999999999886 55543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=221.49 Aligned_cols=151 Identities=28% Similarity=0.496 Sum_probs=128.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.|++|.+++.+. .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 71 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Ni 147 (297)
T 3fxz_A 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147 (297)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHE
Confidence 567899999999999864 6789999999999999999764 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .+||+|||++....... ......||+.|+|||.+...
T Consensus 148 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 226 (297)
T 3fxz_A 148 LLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (297)
T ss_dssp EECTTC-CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EECCCC-CEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999888 89999999987544322 23456799999999954322
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++..+.+++..||+.+|.+||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 227 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 23455667888999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=217.75 Aligned_cols=160 Identities=32% Similarity=0.579 Sum_probs=127.4
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++++.++..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 148 (281)
T 1mp8_A 70 MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 148 (281)
T ss_dssp HHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HHhCCCCccceEEEEEccCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEE
Confidence 56789999999999998888999999999999999997643 34999999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC-------------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
++.++ .+||+|||+++....... .....+++.|+|||.+.
T Consensus 149 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~ 227 (281)
T 1mp8_A 149 VSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 227 (281)
T ss_dssp EEETT-EEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred ECCCC-CEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH
Confidence 99887 899999999986543222 22335678899999321
Q ss_pred ---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ---------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ---------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++.+++..||+.+|.+||++.++++.|+++...
T Consensus 228 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 228 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 12345678899999999999999999999999999988754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=232.85 Aligned_cols=162 Identities=33% Similarity=0.571 Sum_probs=138.4
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++||||+++++++.++..++||||+.+|+|.+++.......+++..++.++.|++.||.|||++||+||||||+||
T Consensus 236 ~l~~l~h~~iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 315 (454)
T 1qcf_A 236 VMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315 (454)
T ss_dssp HHTTCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred HHhhCCCCCEeeEEEEEeCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 46889999999999999888899999999999999999865434589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+++.++ .+||+|||+++....... .....++..|+|||.+.
T Consensus 316 ll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~ 394 (454)
T 1qcf_A 316 LVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 394 (454)
T ss_dssp EECTTC-CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EECCCC-cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999887 899999999986543221 22335678899999331
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++.+++.+||+.+|.+||+++++++.|+++...
T Consensus 395 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 395 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 23456788999999999999999999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.6e-32 Score=219.69 Aligned_cols=164 Identities=23% Similarity=0.328 Sum_probs=136.4
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++ +||||+++++++.+ +..++||||+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|
T Consensus 58 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N 135 (330)
T 2izr_A 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPEN 135 (330)
T ss_dssp HHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 4567 89999999999975 5679999999 99999999864 3459999999999999999999999999999999999
Q ss_pred EEEeCCCCc-----eEEccCccccccccccc--------cccCCCccccccCCCCCCCC---------------------
Q 027476 80 LILTADHKT-----VKLADFGLAREESLTEM--------MTAETGTYRWMAPENMRPSA--------------------- 125 (223)
Q Consensus 80 ill~~~~~~-----~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~--------------------- 125 (223)
|+++.++ . +||+|||+++....... .....||+.|+|||.+....
T Consensus 136 ill~~~~-~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~ 214 (330)
T 2izr_A 136 FLIGRPG-NKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214 (330)
T ss_dssp EEECCGG-GTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred eeeccCC-CCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCC
Confidence 9998766 5 99999999985433221 23567999999999554221
Q ss_pred -------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCCC
Q 027476 126 -------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEP 169 (223)
Q Consensus 126 -------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~~ 169 (223)
..++ ++.+++..||+.+|.+||+++++.+.|+++....+....
T Consensus 215 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 288 (330)
T 2izr_A 215 LPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFD 288 (330)
T ss_dssp CTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred CCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence 1133 788899999999999999999999999999887765544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=218.47 Aligned_cols=161 Identities=27% Similarity=0.495 Sum_probs=130.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||++|++|.+++..... +++..++.++.|++.||.|||++|++||||||+||
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Ni 142 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 578899999999999975 578999999999999999987654 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
+++.++ .+||+|||+++...... ......||+.|+|||.+...
T Consensus 143 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~ 221 (294)
T 4eqm_A 143 LIDSNK-TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA 221 (294)
T ss_dssp EECTTS-CEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred EECCCC-CEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999887 89999999998654322 22345699999999944321
Q ss_pred ---------------CCCChHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHhhcCC
Q 027476 125 ---------------AENLPEDLALIVTSCWKEDPNERP-NFSQIIQMLLHYISTNS 165 (223)
Q Consensus 125 ---------------~~~~~~~l~~l~~~~l~~~p~~Rp-~~~~~~~~L~~~~~~~~ 165 (223)
...++..+.+++.+|++.+|.+|| +++++.+.|..+.....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 222 IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred HHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 234567788899999999999998 88888888887765443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-31 Score=222.67 Aligned_cols=166 Identities=31% Similarity=0.539 Sum_probs=130.9
Q ss_pred CCCCCCCCCccceEEEee--cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACK--EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+|++++||||+++++++. ++..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+
T Consensus 143 il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 221 (373)
T 3c1x_A 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR 221 (373)
T ss_dssp TSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred HHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchh
Confidence 578899999999999874 357889999999999999997643 34899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc-----ccccCCCccccccCCCCC-------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE-----MMTAETGTYRWMAPENMR------------------------------- 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~------------------------------- 122 (223)
||+++.++ .+||+|||+++...... ......+++.|+|||.+.
T Consensus 222 NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 222 NCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp GEEECTTC-CEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred eEEECCCC-CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 99999887 89999999997543221 112345778999999331
Q ss_pred ---------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCC
Q 027476 123 ---------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168 (223)
Q Consensus 123 ---------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~ 168 (223)
..+..++.++.+++..||+.+|.+||++.++++.|+++........
T Consensus 301 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 301 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp CSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 1234577889999999999999999999999999999987655443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=222.93 Aligned_cols=153 Identities=26% Similarity=0.392 Sum_probs=129.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 68 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NI 145 (326)
T 2y0a_A 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145 (326)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHE
Confidence 567899999999999976 57899999999999999997644 499999999999999999999999999999999999
Q ss_pred EEeCCCC---ceEEccCccccccccccccccCCCccccccCCCCCCCCC-------------------------------
Q 027476 81 ILTADHK---TVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAE------------------------------- 126 (223)
Q Consensus 81 ll~~~~~---~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------------------------------- 126 (223)
+++.++. .+||+|||+++............||+.|+|||++.....
T Consensus 146 ll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 225 (326)
T 2y0a_A 146 MLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225 (326)
T ss_dssp EESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred EEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 9986552 699999999987654444456689999999996543222
Q ss_pred -----------------CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 127 -----------------NLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 127 -----------------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.++.++.+++..||+.+|.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 226 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 345566778899999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=218.03 Aligned_cols=161 Identities=27% Similarity=0.489 Sum_probs=136.0
Q ss_pred CCCCCCCCccceEEEeec-----------------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 027476 2 MSRVRHRNLVKFIGACKE-----------------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMEC 64 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~ 64 (223)
+++++||||+++++++.+ +.+++||||+.+++|.+++.......+++..++.++.|++.||.|
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 137 (284)
T 2a19_B 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDY 137 (284)
T ss_dssp HHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 567899999999998743 247899999999999999987655569999999999999999999
Q ss_pred HHhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC--------------------
Q 027476 65 LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS-------------------- 124 (223)
Q Consensus 65 lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------- 124 (223)
||++|++|+||||+||+++.++ .+||+|||++.............|++.|+|||.+...
T Consensus 138 lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 216 (284)
T 2a19_B 138 IHSKKLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216 (284)
T ss_dssp HHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHS
T ss_pred HHhCCeeeccCCHHHEEEcCCC-CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHh
Confidence 9999999999999999999887 8999999999866544444556799999999955432
Q ss_pred --------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 125 --------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 125 --------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+..++.++.+++..||+.+|.+||++.+++++|..+...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 217 VCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp CCSSHHHHHHHHHHHHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred cCCcchhHHHHHHHhhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 234556677789999999999999999999999887543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=221.69 Aligned_cols=163 Identities=23% Similarity=0.441 Sum_probs=133.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
+|++++||||+++++++.+ +..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||++|++||||||
T Consensus 88 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp 167 (321)
T 2qkw_B 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKS 167 (321)
T ss_dssp GGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCS
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCH
Confidence 4678999999999999965 578999999999999999865432 3489999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCCCCC-----------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMRPSA----------------------------- 125 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----------------------------- 125 (223)
+||+++.++ .+||+|||+++..... .......||+.|+|||.+....
T Consensus 168 ~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 168 INILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp TTEEECTTC-CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred HHEEECCCC-CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 999999887 8999999999753321 1223345899999999432110
Q ss_pred --------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 126 --------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 126 --------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
...+.++.+++..||+.+|.+||++.+++++|+......
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 112356778889999999999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=229.25 Aligned_cols=153 Identities=25% Similarity=0.384 Sum_probs=129.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.||+|.+.+..... +++..+..++.||+.||.|||++||+||||||+||
T Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NI 141 (444)
T 3soa_A 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENL 141 (444)
T ss_dssp HHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTE
T ss_pred HHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 567899999999999975 578999999999999999987654 99999999999999999999999999999999999
Q ss_pred EEeCC--CCceEEccCcccccccccc-ccccCCCccccccCCCCCCCC--------------------------------
Q 027476 81 ILTAD--HKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPSA-------------------------------- 125 (223)
Q Consensus 81 ll~~~--~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-------------------------------- 125 (223)
+++.+ +..+||+|||++....... ......||+.|+|||++....
T Consensus 142 ll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~ 221 (444)
T 3soa_A 142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221 (444)
T ss_dssp EESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 99842 2379999999997654332 234568999999999554211
Q ss_pred ----------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ----------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ----------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++..||+.+|.+||++.+++++
T Consensus 222 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 222 YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2467788889999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=225.98 Aligned_cols=153 Identities=28% Similarity=0.455 Sum_probs=130.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.|++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NI 159 (362)
T 2bdw_A 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 159 (362)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHE
Confidence 567899999999999976 57899999999999999997654 399999999999999999999999999999999999
Q ss_pred EEeCCC--CceEEccCccccccccccccccCCCccccccCCCCCCCC---------------------------------
Q 027476 81 ILTADH--KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA--------------------------------- 125 (223)
Q Consensus 81 ll~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------------------- 125 (223)
+++.++ ..+||+|||++.............||+.|+|||++....
T Consensus 160 ll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~ 239 (362)
T 2bdw_A 160 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 239 (362)
T ss_dssp EESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 998653 259999999998765544445678999999999554221
Q ss_pred ---------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ---------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ---------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++..||+.+|.+||++.+++++
T Consensus 240 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 240 AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1346678889999999999999999998765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-32 Score=219.96 Aligned_cols=160 Identities=25% Similarity=0.514 Sum_probs=134.9
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
|++++||||++++++|.++..++|+||+.+|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl 149 (327)
T 3poz_A 71 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149 (327)
T ss_dssp HHHCCBTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEE
Confidence 56789999999999999888999999999999999998743 34999999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccc---cccCCCccccccCCCCC------------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
++.++ .+||+|||+++....... .....+|+.|+|||.+.
T Consensus 150 l~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 228 (327)
T 3poz_A 150 VKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp EEETT-EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred ECCCC-CEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH
Confidence 99888 899999999975432221 22345688999999332
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++..||+.+|.+||++.+++++|+.+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 22345677899999999999999999999999999987653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=226.02 Aligned_cols=152 Identities=26% Similarity=0.442 Sum_probs=129.6
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||++++++|.+ +..++||||+.||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|
T Consensus 68 il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 145 (384)
T 4fr4_A 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145 (384)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHH
Confidence 3578899999999999975 578999999999999999986544 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC------------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------ 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------ 123 (223)
|+++.++ .+||+|||+++...........+||+.|+|||++..
T Consensus 146 Ill~~~g-~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~ 224 (384)
T 4fr4_A 146 ILLDEHG-HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224 (384)
T ss_dssp EEECTTS-CEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC
T ss_pred eEECCCC-CEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc
Confidence 9999888 899999999987655555567789999999997641
Q ss_pred --------------CCCCChHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 027476 124 --------------SAENLPEDLALIVTSCWKEDPNERPN-FSQIIQ 155 (223)
Q Consensus 124 --------------~~~~~~~~l~~l~~~~l~~~p~~Rp~-~~~~~~ 155 (223)
.+..++.++.+++..||+.+|.+||+ ++++.+
T Consensus 225 ~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 225 SKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 12334566777888999999999997 666654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-32 Score=216.93 Aligned_cols=160 Identities=28% Similarity=0.586 Sum_probs=132.0
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++||||+++++++.+ ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~ 143 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 143 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHh
Confidence 578899999999999843 46899999999999999997643 34899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC--------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR-------------------------------- 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-------------------------------- 122 (223)
||+++.++ .+||+|||+++...... ......++..|+|||.+.
T Consensus 144 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 222 (295)
T 3ugc_A 144 NILVENEN-RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 222 (295)
T ss_dssp GEEEEETT-EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH
T ss_pred hEEEcCCC-eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH
Confidence 99999887 89999999998643322 122345777899999332
Q ss_pred -----------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 -----------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 -----------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++.+++..||+.+|.+||++.++++.|+++...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 223 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 12345778899999999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-32 Score=224.48 Aligned_cols=161 Identities=32% Similarity=0.576 Sum_probs=134.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+++|+|.+++...+ ..+++..++.++.|++.||+|||++|++||||||+|
T Consensus 165 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 243 (377)
T 3cbl_A 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN 243 (377)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHH
Confidence 3678999999999999975 57899999999999999997643 248999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccccc---ccCCCccccccCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMM---TAETGTYRWMAPENMR---------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~---------------------------------- 122 (223)
|+++.++ .+||+|||+++........ ....+++.|+|||.+.
T Consensus 244 il~~~~~-~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~ 322 (377)
T 3cbl_A 244 CLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322 (377)
T ss_dssp EEECTTC-CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH
T ss_pred EEEcCCC-cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999887 8999999999854332211 1123567899999321
Q ss_pred ------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++.+++..||+.+|.+||+++++++.|+++...
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 323 QTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 22455788999999999999999999999999999987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=228.20 Aligned_cols=160 Identities=33% Similarity=0.604 Sum_probs=135.4
Q ss_pred CCCCCCCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+|++++||||+++++++.+ +..++||||+.+|+|.+++.......+++..++.++.|++.||+|||++|++||||||+
T Consensus 239 ~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~ 318 (450)
T 1k9a_A 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318 (450)
T ss_dssp HHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred HHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence 3678999999999999854 36899999999999999998876666899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC------------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
||+++.++ .+||+|||+++...... ....++..|+|||.+.
T Consensus 319 Nill~~~~-~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~ 395 (450)
T 1k9a_A 319 NVLVSEDN-VAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 395 (450)
T ss_dssp GEEECTTS-CEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH
T ss_pred hEEECCCC-CEEEeeCCCcccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999887 89999999998543222 2336788999999331
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++..||+.+|.+||++.++++.|+++...
T Consensus 396 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 396 VPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 22456788999999999999999999999999999987653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=220.18 Aligned_cols=134 Identities=31% Similarity=0.505 Sum_probs=108.2
Q ss_pred eEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccccc
Q 027476 22 MVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREE 100 (223)
Q Consensus 22 ~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~ 100 (223)
.++||||+.|++|.+++..... ...++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus 136 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~ 214 (332)
T 3qd2_B 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAM 214 (332)
T ss_dssp EEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCccccc
Confidence 7899999999999999986543 2356778899999999999999999999999999999999887 8999999999865
Q ss_pred cccc-------------ccccCCCccccccCCCCCCCCCCChHHH-----------------------------------
Q 027476 101 SLTE-------------MMTAETGTYRWMAPENMRPSAENLPEDL----------------------------------- 132 (223)
Q Consensus 101 ~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~l----------------------------------- 132 (223)
.... ......||+.|+|||.+.....+...|+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (332)
T 3qd2_B 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLL 294 (332)
T ss_dssp SCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHH
T ss_pred ccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcc
Confidence 4321 2234579999999997765555544444
Q ss_pred --------HHHHHHhcccCCCCCCCHHHHHHH
Q 027476 133 --------ALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 133 --------~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+++..||+.+|.+||++++++++
T Consensus 295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 446788999999999998888764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=223.02 Aligned_cols=166 Identities=34% Similarity=0.633 Sum_probs=138.9
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--------------RCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~l 65 (223)
++++ +||||+++++++.+ +..++||||+.+|+|.+++..... ..+++..++.++.|++.||.||
T Consensus 128 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 207 (382)
T 3tt0_A 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207 (382)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 4456 89999999999975 578999999999999999987542 3599999999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC--------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR-------------------- 122 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-------------------- 122 (223)
|++||+||||||+||+++.++ .+||+|||+++...... ......+|+.|+|||.+.
T Consensus 208 H~~~ivH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el 286 (382)
T 3tt0_A 208 ASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286 (382)
T ss_dssp HHTTCCCSCCCGGGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred HhCCEecCCCCcceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHH
Confidence 999999999999999999887 89999999998544322 223345788999999432
Q ss_pred --------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCC
Q 027476 123 --------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168 (223)
Q Consensus 123 --------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~ 168 (223)
..+..++.++.+++..||+.+|.+||++.+++++|+++........
T Consensus 287 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 287 FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 1234567889999999999999999999999999999987654444
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=224.21 Aligned_cols=162 Identities=28% Similarity=0.555 Sum_probs=127.6
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 99 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 177 (373)
T 2qol_A 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 177 (373)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcce
Confidence 3678999999999999975 57899999999999999997643 349999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccc----cccCCCccccccCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMR--------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~--------------------------------- 122 (223)
|+++.++ .+||+|||+++....... .....+++.|+|||.+.
T Consensus 178 Ill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~ 256 (373)
T 2qol_A 178 ILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256 (373)
T ss_dssp EEECTTC-CEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred EEEcCCC-CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999887 899999999985433211 11223567899999332
Q ss_pred -------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 -------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 -------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
+.+..++.++.+++..||+.+|.+||++.++++.|++++...
T Consensus 257 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 257 QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 123456788999999999999999999999999999988653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=218.62 Aligned_cols=159 Identities=26% Similarity=0.414 Sum_probs=132.3
Q ss_pred CCCCCCCCCccceEEEeecC-----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-------
Q 027476 1 MMSRVRHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH------- 68 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~------- 68 (223)
+|++++||||+++++++.++ .+++||||+++|+|.+++... .+++..++.++.|++.||.|||+.
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~ 147 (322)
T 3soc_A 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDG 147 (322)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTE
T ss_pred HHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccc
Confidence 47889999999999998642 369999999999999999763 299999999999999999999999
Q ss_pred ---CcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCCCC-----------------
Q 027476 69 ---GIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRPSA----------------- 125 (223)
Q Consensus 69 ---~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----------------- 125 (223)
||+||||||+||+++.++ .+||+|||+++...... ......||+.|+|||.+....
T Consensus 148 ~~~~ivH~Dlkp~Nill~~~~-~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 226 (322)
T 3soc_A 148 HKPAISHRDIKSKNVLLKNNL-TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226 (322)
T ss_dssp EECEEECSCCSGGGEEECTTC-CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred cCCCEEeCCCChHhEEECCCC-eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHH
Confidence 999999999999999887 89999999997543322 123357999999999654210
Q ss_pred -------------------------------------------------------CCChHHHHHHHHHhcccCCCCCCCH
Q 027476 126 -------------------------------------------------------ENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 126 -------------------------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
...+.++.+++.+||+.+|.+||++
T Consensus 227 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (322)
T 3soc_A 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306 (322)
T ss_dssp HHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH
Confidence 0012348889999999999999999
Q ss_pred HHHHHHHHHHhhc
Q 027476 151 SQIIQMLLHYIST 163 (223)
Q Consensus 151 ~~~~~~L~~~~~~ 163 (223)
.++++.|+++...
T Consensus 307 ~ell~~L~~l~~~ 319 (322)
T 3soc_A 307 GCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999988654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=220.69 Aligned_cols=161 Identities=30% Similarity=0.540 Sum_probs=134.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHH
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP----------------------RCLDIHVAIGFALDI 58 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~----------------------~~l~~~~~~~i~~qi 58 (223)
|++++||||+++++++.+ +..++||||+.+++|.+++..... ..+++..++.++.|+
T Consensus 104 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 567899999999999975 578999999999999999986431 459999999999999
Q ss_pred HHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC-------------
Q 027476 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR------------- 122 (223)
Q Consensus 59 ~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~------------- 122 (223)
+.||.|||++||+||||||+||+++.++ .+||+|||+++...... ......+++.|+|||.+.
T Consensus 184 ~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 262 (343)
T 1luf_A 184 AAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 262 (343)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHhCCeecCCCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHH
Confidence 9999999999999999999999999887 89999999997543222 223456788999999321
Q ss_pred ---------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ---------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ---------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++..||+.+|.+||++.++++.|+++...
T Consensus 263 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 263 GVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 12346778899999999999999999999999999997654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=216.05 Aligned_cols=161 Identities=29% Similarity=0.581 Sum_probs=136.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHH
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP----------------------RCLDIHVAIGFALDI 58 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~----------------------~~l~~~~~~~i~~qi 58 (223)
|++++||||+++++++.+ +..++||||+.+++|.+++..... ..+++..++.++.|+
T Consensus 80 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 159 (314)
T 2ivs_A 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159 (314)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred HhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence 678899999999999965 578999999999999999986432 238999999999999
Q ss_pred HHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC-------------
Q 027476 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR------------- 122 (223)
Q Consensus 59 ~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~------------- 122 (223)
+.||.|||++|++||||||+||+++.++ .+||+|||+++...... ......+++.|+|||.+.
T Consensus 160 ~~~l~~lH~~~ivH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 238 (314)
T 2ivs_A 160 SQGMQYLAEMKLVHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238 (314)
T ss_dssp HHHHHHHHHTTEECCCCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHHHHCCCcccccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHH
Confidence 9999999999999999999999999877 89999999997543322 123345788999999321
Q ss_pred ---------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ---------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ---------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++..||+.+|.+||++.+++++|++++..
T Consensus 239 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 239 GVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 12346788999999999999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=223.52 Aligned_cols=157 Identities=21% Similarity=0.335 Sum_probs=132.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||++|++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 55 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NI 133 (321)
T 1tki_A 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHE
Confidence 567899999999999975 57899999999999999996533 3499999999999999999999999999999999999
Q ss_pred EEeC--CCCceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------------
Q 027476 81 ILTA--DHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 81 ll~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
+++. ++ .+||+|||+++............||+.|+|||++...
T Consensus 134 l~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 212 (321)
T 1tki_A 134 IYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212 (321)
T ss_dssp EESSSSCC-CEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred EEccCCCC-CEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence 9986 44 8999999999876554444556799999999954311
Q ss_pred --------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 125 --------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 125 --------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
...++.++.+++..||+.+|.+||++.+++++ .++.
T Consensus 213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h--p~~~ 262 (321)
T 1tki_A 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH--PWLK 262 (321)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS--HHHH
T ss_pred HHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--hhhc
Confidence 12466788899999999999999999999886 4444
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=211.37 Aligned_cols=160 Identities=28% Similarity=0.544 Sum_probs=135.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Ni 137 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 137 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheE
Confidence 568899999999999975 57899999999999999997643 4589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+++.++ .+||+|||+++...... ......+++.|+|||.+.
T Consensus 138 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~ 216 (269)
T 4hcu_A 138 LVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 216 (269)
T ss_dssp EECGGG-CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEcCCC-CEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 999877 79999999998543322 223345678899999432
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+...+.++.+++..||+.+|.+||++.+++++|+++...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 217 VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11334677889999999999999999999999999998653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=231.19 Aligned_cols=163 Identities=30% Similarity=0.560 Sum_probs=134.1
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++||||+++++++.++..++||||+.+|+|.+++.......+++..++.++.|++.||+|||++|++||||||+||
T Consensus 232 ~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 311 (452)
T 1fmk_A 232 VMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311 (452)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHHhCCCCCEeeEEEEEcCCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 35788999999999999888899999999999999999764444599999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+++.++ .+||+|||+++....... .....++..|+|||.+.
T Consensus 312 ll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~ 390 (452)
T 1fmk_A 312 LVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 390 (452)
T ss_dssp EECGGG-CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred EECCCC-CEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999877 899999999986433221 22335678899999321
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
+.+..++.++.+++..||+.+|.+||+++++++.|++++...
T Consensus 391 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 391 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 224567888999999999999999999999999999887543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=230.84 Aligned_cols=153 Identities=27% Similarity=0.432 Sum_probs=133.6
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+.|++|.+++.+.+. +++..++.++.||+.||+|||++||+||||||+|
T Consensus 69 ~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~N 146 (476)
T 2y94_A 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPEN 146 (476)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSS--CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHH
Confidence 3678999999999999975 578999999999999999976443 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC------------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------ 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------ 123 (223)
|+++.++ .+||+|||+++...........+||+.|+|||.+..
T Consensus 147 Ill~~~~-~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 225 (476)
T 2y94_A 147 VLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF 225 (476)
T ss_dssp EEECTTC-CEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH
T ss_pred EEEecCC-CeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH
Confidence 9999887 799999999987655555566789999999995432
Q ss_pred ---------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 ---------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 ---------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+++..||+.+|.+||++++++++
T Consensus 226 ~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 226 KKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 133466788899999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=227.43 Aligned_cols=153 Identities=29% Similarity=0.400 Sum_probs=129.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~ 78 (223)
+|++++||||++++++|.+ +.+++||||+.|++|.+++..... +++..+..++.|++.||+|||+ +||+||||||+
T Consensus 201 ~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~ 278 (446)
T 4ejn_A 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 278 (446)
T ss_dssp CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGG
T ss_pred HHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHH
Confidence 5788999999999999965 578999999999999999987654 9999999999999999999998 99999999999
Q ss_pred CEEEeCCCCceEEccCccccccc-cccccccCCCccccccCCCCCC----------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREES-LTEMMTAETGTYRWMAPENMRP---------------------------------- 123 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~---------------------------------- 123 (223)
||+++.++ .+||+|||+++... ........+||+.|+|||++..
T Consensus 279 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 357 (446)
T 4ejn_A 279 NLMLDKDG-HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357 (446)
T ss_dssp GEEECSSS-CEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HEEECCCC-CEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH
Confidence 99999888 89999999998532 2333456789999999995432
Q ss_pred ----------CCCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 124 ----------SAENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 124 ----------~~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
.+..++.++.+++..||+.+|.+|| ++++++++
T Consensus 358 ~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 358 FELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 2345667788899999999999999 88888765
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=220.18 Aligned_cols=153 Identities=26% Similarity=0.386 Sum_probs=131.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGG-TLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+|++++||||+++++++.+ +..++||||+.+| +|.+++..... +++..++.++.|++.||.|||++||+||||||+
T Consensus 82 ~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 159 (335)
T 3dls_A 82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDE 159 (335)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHH
Confidence 3678899999999999975 5788999999766 99999986544 999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
||+++.++ .+||+|||+++............||+.|+|||.+...
T Consensus 160 NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 238 (335)
T 3dls_A 160 NIVIAEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE 238 (335)
T ss_dssp GEEECTTS-CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT
T ss_pred HEEEcCCC-cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh
Confidence 99999887 8999999999866555444556799999999955422
Q ss_pred -----CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -----AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -----~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++.+++..||+.+|.+||++++++++
T Consensus 239 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33456778889999999999999999999876
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=225.51 Aligned_cols=152 Identities=27% Similarity=0.470 Sum_probs=121.7
Q ss_pred CCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 4 RVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
..+||||++++++|.. +.+++||||+.||+|.+++.......+++..++.++.||+.||.|||++||+||||||+
T Consensus 111 ~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 190 (400)
T 1nxk_A 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190 (400)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcc
Confidence 4589999999998853 45889999999999999998765556999999999999999999999999999999999
Q ss_pred CEEEeC---CCCceEEccCccccccccccccccCCCccccccCCCCCCCC------------------------------
Q 027476 79 NLILTA---DHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA------------------------------ 125 (223)
Q Consensus 79 Nill~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------------------ 125 (223)
||+++. ++ .+||+|||+++...........+||+.|+|||++....
T Consensus 191 Nill~~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 269 (400)
T 1nxk_A 191 NLLYTSKRPNA-ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_dssp GEEESSSSTTC-CEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred eEEEecCCCCc-cEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccc
Confidence 999987 44 79999999998665444455678999999999664211
Q ss_pred ----------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ----------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ----------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+|+..||+.+|.+||++.+++++
T Consensus 270 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 270 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp SSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2466788889999999999999999999886
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=216.63 Aligned_cols=116 Identities=36% Similarity=0.534 Sum_probs=101.2
Q ss_pred CCCCCccceEEEeecC------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 5 VRHRNLVKFIGACKEP------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 5 l~Hpniv~l~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
++||||+++++++.+. ..++||||+. ++|.+++.......+++..++.++.|++.||+|||++||+||||||+
T Consensus 71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~ 149 (308)
T 3g33_A 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 149 (308)
T ss_dssp HCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred cCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 4599999999998542 3789999995 69999998876666999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
||+++.++ .+||+|||+++............||+.|+|||.+.
T Consensus 150 Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 192 (308)
T 3g33_A 150 NILVTSGG-TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL 192 (308)
T ss_dssp TEEECTTS-CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHH
T ss_pred HEEEcCCC-CEEEeeCccccccCCCcccCCccccccccCchHHc
Confidence 99999887 89999999998665555555668999999999553
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=218.60 Aligned_cols=158 Identities=26% Similarity=0.476 Sum_probs=131.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.|++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 144 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNI 144 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceE
Confidence 568899999999999975 57899999999999999997643 3489999999999999999999999999999999999
Q ss_pred EEeCCCCc--------eEEccCccccccccccccccCCCccccccCCCCCC-----------------------------
Q 027476 81 ILTADHKT--------VKLADFGLAREESLTEMMTAETGTYRWMAPENMRP----------------------------- 123 (223)
Q Consensus 81 ll~~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------------- 123 (223)
+++.++ . +||+|||++...... ....|++.|+|||.+..
T Consensus 145 ll~~~~-~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 145 LLIREE-DRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp EEEECC-BGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEecCC-cccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 998776 4 999999998754332 22357888999995432
Q ss_pred ----------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 124 ----------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 124 ----------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
.+...+.++.+++..||+.+|.+||++.+++++|++++...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 221 ALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp TSCHHHHHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ccchHHHHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 12334556778999999999999999999999999987643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=212.67 Aligned_cols=159 Identities=27% Similarity=0.508 Sum_probs=135.5
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++++.++..++||||+.+++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+
T Consensus 72 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil 149 (291)
T 1xbb_A 72 MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL 149 (291)
T ss_dssp HHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HHhCCCCCEEEEEEEECCCCcEEEEEeCCCCCHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEE
Confidence 567899999999999988889999999999999999987544 999999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccc----cccCCCccccccCCCCC-----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
++.++ .+||+|||++........ .....+++.|+|||.+.
T Consensus 150 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 228 (291)
T 1xbb_A 150 LVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228 (291)
T ss_dssp EEETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred EeCCC-cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99887 899999999975433221 12234678899999321
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++..||+.+|.+||++.++++.|++++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 229 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 12345788999999999999999999999999999998765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=230.76 Aligned_cols=160 Identities=32% Similarity=0.592 Sum_probs=136.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||++++++|.+ +.+++||||+.+|+|.+++.......+++..++.++.|++.||+|||++||+||||||+||
T Consensus 270 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 349 (495)
T 1opk_A 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNC 349 (495)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 567899999999999975 5789999999999999999876666699999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+++.++ .+||+|||+++....... .....++..|+|||.+.
T Consensus 350 ll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~ 428 (495)
T 1opk_A 350 LVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 428 (495)
T ss_dssp EECGGG-CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EECCCC-cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999877 899999999986543221 22335678899999321
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
..+..++.++.+++..||+.+|.+||++.++++.|+.++.
T Consensus 429 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 429 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 2245678899999999999999999999999999988753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=214.94 Aligned_cols=159 Identities=35% Similarity=0.609 Sum_probs=127.0
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++||||+++++++.++..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 73 ~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Ni 151 (289)
T 3og7_A 73 VLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNI 151 (289)
T ss_dssp HHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHHhCCCCcEEEEEeeccCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 367899999999999888888999999999999999996533 4499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc---ccccccCCCccccccCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESL---TEMMTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
+++.++ .+||+|||++..... ........||+.|+|||.+.
T Consensus 152 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 152 FLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp EEETTT-EEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred EECCCC-CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence 999887 899999999975432 22223457899999999542
Q ss_pred ------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 123 ------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 123 ------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
.....++.++.+++..||+.+|.+||++.++++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 231 RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 011256788999999999999999999999999998864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=236.18 Aligned_cols=159 Identities=27% Similarity=0.511 Sum_probs=134.1
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
|++++||||+++++++.++..++||||+.+|+|.+++..... +++..++.++.||+.||+|||++||+||||||+||+
T Consensus 424 l~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NIL 501 (635)
T 4fl3_A 424 MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL 501 (635)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEEEccCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEE
Confidence 567899999999999988889999999999999999976544 999999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC-----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
++.++ .+||+|||+++...... ......+++.|+|||++.
T Consensus 502 l~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~ 580 (635)
T 4fl3_A 502 LVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 580 (635)
T ss_dssp EEETT-EEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred EeCCC-CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99887 89999999998543322 122335678899999332
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++..||+.+|.+||+++++++.|++++..
T Consensus 581 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 581 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 23456788999999999999999999999999999988754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=215.48 Aligned_cols=163 Identities=30% Similarity=0.572 Sum_probs=136.4
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--------------PRCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~l 65 (223)
|+++ +||||+++++++.+ +..++||||+++++|.+++.... ...+++..++.++.|++.||.||
T Consensus 79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 5678 89999999999975 57899999999999999997643 23599999999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC-----------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR----------------------- 122 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----------------------- 122 (223)
|++|++||||||+||+++.++ .+||+|||+++............+++.|+|||.+.
T Consensus 159 H~~~ivH~dlkp~NIl~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 237 (327)
T 1fvr_A 159 SQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 237 (327)
T ss_dssp HHTTEECSCCSGGGEEECGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred HhCCccCCCCccceEEEcCCC-eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcC
Confidence 999999999999999999877 89999999997544333334446788999999321
Q ss_pred -----------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCC
Q 027476 123 -----------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165 (223)
Q Consensus 123 -----------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~ 165 (223)
..+..++.++.+++.+||+.+|.+||++++++++|.++.....
T Consensus 238 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 238 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp SCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1234567889999999999999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=232.42 Aligned_cols=164 Identities=23% Similarity=0.502 Sum_probs=136.2
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++||||+++++++.++..++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 389 il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI 467 (613)
T 2ozo_A 389 IMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNV 467 (613)
T ss_dssp HHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHE
Confidence 46789999999999999888899999999999999999753 34599999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc----cccCCCccccccCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMR---------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~---------------------------------- 122 (223)
+++.++ .+||+|||+++....... .....+++.|+|||++.
T Consensus 468 Ll~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 546 (613)
T 2ozo_A 468 LLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546 (613)
T ss_dssp EEEETT-EEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH
T ss_pred EEcCCC-cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 999887 899999999986532221 12234568899999331
Q ss_pred ------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCC
Q 027476 123 ------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSA 166 (223)
Q Consensus 123 ------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~ 166 (223)
..+..++.++.+++..||+.+|.+||++.++++.|+++......
T Consensus 547 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 547 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 22456788999999999999999999999999999998766433
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=212.58 Aligned_cols=161 Identities=32% Similarity=0.559 Sum_probs=134.7
Q ss_pred CCCCCCCCccceEEEee--cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACK--EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++||||+++++++. ++..++||||+.+++|.+++... ...+++..++.++.|++.||.|||++|++||||||+|
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~N 158 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARN 158 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence 57889999999999864 35788999999999999999763 3458999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccc-----cccCCCccccccCCCCC--------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEM-----MTAETGTYRWMAPENMR-------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~-------------------------------- 122 (223)
|+++.++ .+||+|||+++....... .....+|+.|+|||.+.
T Consensus 159 il~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 159 CMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp EEECTTC-CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred EEECCCC-CEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 9999877 899999999975433221 23345778999999332
Q ss_pred --------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 --------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 --------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+..++.++.+++..||+.+|.+||++.++++.|++++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 238 TFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp TTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 113456788999999999999999999999999999988754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-32 Score=223.22 Aligned_cols=151 Identities=30% Similarity=0.376 Sum_probs=123.8
Q ss_pred CCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 3 SRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 3 ~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++ +||||+++++++.+ +.+++||||+.||+|.+++..... +++..++.++.||+.||+|||++||+||||||+||
T Consensus 78 ~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 155 (353)
T 3txo_A 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155 (353)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHE
Confidence 344 79999999999975 578999999999999999987654 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccc-cccccccCCCccccccCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREES-LTEMMTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
+++.++ .+||+|||+++... ........+||+.|+|||++.
T Consensus 156 Ll~~~g-~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~ 234 (353)
T 3txo_A 156 LLDHEG-HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234 (353)
T ss_dssp EECTTS-CEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EECCCC-CEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999888 89999999998533 223344568999999999442
Q ss_pred -------CCCCCChHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 027476 123 -------PSAENLPEDLALIVTSCWKEDPNERPNF------SQIIQM 156 (223)
Q Consensus 123 -------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~------~~~~~~ 156 (223)
..+..++.++.+++..||+.+|.+||++ ++++++
T Consensus 235 ~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 235 AILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1234567788889999999999999988 667654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=213.12 Aligned_cols=158 Identities=27% Similarity=0.621 Sum_probs=134.4
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++||||+++++++.+ +.+++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+
T Consensus 77 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~ 155 (302)
T 4e5w_A 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR 155 (302)
T ss_dssp HHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchh
Confidence 567899999999999864 45889999999999999996543 34999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC--------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR-------------------------------- 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-------------------------------- 122 (223)
||+++.++ .+||+|||++....... ......||..|+|||.+.
T Consensus 156 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 234 (302)
T 4e5w_A 156 NVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA 234 (302)
T ss_dssp GEEEEETT-EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred eEEEcCCC-CEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh
Confidence 99999887 89999999997544322 223456888899999321
Q ss_pred ----------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 123 ----------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 123 ----------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
+.+..++.++.+++..||+.+|.+||++.++++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 235 LFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 123467788999999999999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=218.17 Aligned_cols=150 Identities=27% Similarity=0.419 Sum_probs=127.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.||+|.+++..... +++..++.++.|++.||.|||++||+||||||+||
T Consensus 60 l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 137 (318)
T 1fot_A 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 137 (318)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred HhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheE
Confidence 567899999999999976 578999999999999999987544 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS------------------------------------ 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------------------------ 124 (223)
+++.++ .+||+|||+++.... .....+||+.|+|||++...
T Consensus 138 ll~~~g-~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 214 (318)
T 1fot_A 138 LLDKNG-HIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 214 (318)
T ss_dssp EECTTS-CEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred EEcCCC-CEEEeecCcceecCC--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999888 899999999986433 23456899999999965432
Q ss_pred --------CCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 125 --------AENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 125 --------~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
+..++.++.+++..||+.+|.+|| ++++++++
T Consensus 215 i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 215 ILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 234556777788888999999998 77777654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=215.96 Aligned_cols=159 Identities=29% Similarity=0.439 Sum_probs=122.7
Q ss_pred CCCCCCCCCccceEEEeecC-----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 1 MMSRVRHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
++++++||||+++++++... ..++||||++|++|.+++..... +++..++.++.|++.||.|||++|++||||
T Consensus 65 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 142 (311)
T 3ork_A 65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDV 142 (311)
T ss_dssp TCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 47889999999999998542 24899999999999999987654 999999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCCCC---------------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMRPS--------------------------- 124 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~--------------------------- 124 (223)
||+||+++.++ .+||+|||+++...... ......||+.|+|||.+...
T Consensus 143 kp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 143 KPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp CGGGEEEETTS-CEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CHHHEEEcCCC-CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999887 79999999997543221 12334689999999954311
Q ss_pred ---------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHH-HHHHHHhh
Q 027476 125 ---------------------AENLPEDLALIVTSCWKEDPNERPNFSQII-QMLLHYIS 162 (223)
Q Consensus 125 ---------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~-~~L~~~~~ 162 (223)
...++.++.+++.+||+.+|.+||+..+++ ..+.+...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 222 DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp SSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred CChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 123667788899999999999999666554 44554433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=223.03 Aligned_cols=120 Identities=15% Similarity=0.280 Sum_probs=102.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.+++|.+++.......+++..++.++.||+.||.|||++||+||||||+||
T Consensus 80 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NI 159 (389)
T 3gni_B 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 159 (389)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 567899999999999965 6789999999999999999876556699999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc--------cccccCCCccccccCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLT--------EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~ 122 (223)
+++.++ .+||+|||.+...... .......||+.|+|||++.
T Consensus 160 ll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 208 (389)
T 3gni_B 160 LISVDG-KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208 (389)
T ss_dssp EECTTC-CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHS
T ss_pred EEcCCC-CEEEcccccceeeccccccccccccccccccccccccCHHHHh
Confidence 999887 8999999988643211 1112347899999999654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=211.92 Aligned_cols=160 Identities=31% Similarity=0.545 Sum_probs=135.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 73 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni 151 (283)
T 3gen_A 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 151 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred HhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceE
Confidence 567899999999999975 57899999999999999997632 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+++.++ .+||+|||+++....... .....+++.|+|||.+.
T Consensus 152 li~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~ 230 (283)
T 3gen_A 152 LVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 230 (283)
T ss_dssp EECTTS-CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EEcCCC-CEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH
Confidence 999877 899999999975443222 22345678899999332
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+...+.++.+++..||+.+|.+||++.+++++|.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 231 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 12344678899999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=220.44 Aligned_cols=152 Identities=27% Similarity=0.400 Sum_probs=128.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.|++|.+++..... +++..++.++.|++.||+|||++||+||||||+||
T Consensus 59 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 136 (323)
T 3tki_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136 (323)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHE
Confidence 567899999999999976 568999999999999999875443 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCCCC---------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
+++.++ .+||+|||+++..... .......||+.|+|||.+...
T Consensus 137 ll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 215 (323)
T 3tki_A 137 LLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (323)
T ss_dssp EECTTC-CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS
T ss_pred EEeCCC-CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 999887 8999999999754322 223456799999999944211
Q ss_pred ---------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ---------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ---------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++.+||+.+|.+||++++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 216 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 12356778889999999999999999999876
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=221.27 Aligned_cols=158 Identities=25% Similarity=0.384 Sum_probs=123.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.||+|.+++...+. +++..++.++.|++.||.|||++||+||||||+||
T Consensus 70 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Ni 147 (361)
T 3uc3_A 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENT 147 (361)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 567899999999999975 578999999999999999977554 99999999999999999999999999999999999
Q ss_pred EEeCCCC-ceEEccCccccccccccccccCCCccccccCCCCC-------------------------------------
Q 027476 81 ILTADHK-TVKLADFGLAREESLTEMMTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 81 ll~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
+++.++. .+||+|||+++............||+.|+|||++.
T Consensus 148 ll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 227 (361)
T 3uc3_A 148 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY 227 (361)
T ss_dssp EECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH
T ss_pred EEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH
Confidence 9986551 49999999998544444445567999999999432
Q ss_pred --------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 --------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 --------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+....++.++.+++.+||+.+|.+||++.+++++ .++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h--p~f~~ 280 (361)
T 3uc3_A 228 RKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH--SWFLK 280 (361)
T ss_dssp HHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS--HHHHT
T ss_pred HHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC--cchhc
Confidence 1112467889999999999999999999999887 45443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=211.89 Aligned_cols=160 Identities=31% Similarity=0.564 Sum_probs=133.6
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++++.++..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 67 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil 145 (281)
T 3cc6_A 67 MKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 145 (281)
T ss_dssp HHHHCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred HHhCCCCCcceEEEEEcCCCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEE
Confidence 56789999999999998888899999999999999997643 34899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC-------------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
++.++ .+||+|||++........ .....+++.|+|||.+.
T Consensus 146 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~ 224 (281)
T 3cc6_A 146 VASPE-CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224 (281)
T ss_dssp EEETT-EEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH
T ss_pred ECCCC-cEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH
Confidence 99887 899999999986543221 23345788999999321
Q ss_pred ---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ---------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ---------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++.+++..||+.+|.+||++.+++++|+++...
T Consensus 225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 225 GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 12334678899999999999999999999999999987643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=220.03 Aligned_cols=155 Identities=24% Similarity=0.369 Sum_probs=128.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++||||+++++++.+ +..++||||+.|++|.+.+... ....+++..++.++.||+.||.|||++||+||||||+
T Consensus 80 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~ 159 (351)
T 3c0i_A 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPH 159 (351)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChH
Confidence 567899999999999975 5789999999999999887643 2335899999999999999999999999999999999
Q ss_pred CEEEeCCC--CceEEccCcccccccccc-ccccCCCccccccCCCCCCCC------------------------------
Q 027476 79 NLILTADH--KTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPSA------------------------------ 125 (223)
Q Consensus 79 Nill~~~~--~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------------------------------ 125 (223)
||+++.++ ..+||+|||++....... ......||+.|+|||++....
T Consensus 160 NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 239 (351)
T 3c0i_A 160 CVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER 239 (351)
T ss_dssp GEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH
T ss_pred HeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH
Confidence 99998654 249999999998654332 234567999999999654221
Q ss_pred -----------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 -----------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 -----------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++.+||+.+|.+||++.+++++
T Consensus 240 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 240 LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2356677889999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=221.75 Aligned_cols=162 Identities=31% Similarity=0.558 Sum_probs=134.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP-----RCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
|++++||||+++++++.+ +..++||||+.||+|.+++..... ..+++..++.++.|++.||.|||++||+||||
T Consensus 128 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 207 (367)
T 3l9p_A 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDI 207 (367)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 567899999999999975 578999999999999999986542 35999999999999999999999999999999
Q ss_pred CCCCEEEeCCC--CceEEccCccccccccc---cccccCCCccccccCCCCC----------------------------
Q 027476 76 KPENLILTADH--KTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMR---------------------------- 122 (223)
Q Consensus 76 kp~Nill~~~~--~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~---------------------------- 122 (223)
||+||+++.++ ..+||+|||+++..... .......||+.|+|||.+.
T Consensus 208 kp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf 287 (367)
T 3l9p_A 208 AARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287 (367)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999998544 25999999999743221 1223346789999999331
Q ss_pred ------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++..||+.+|.+||++.+++++|+.+...
T Consensus 288 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 288 PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 12345778899999999999999999999999999887654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=210.44 Aligned_cols=154 Identities=34% Similarity=0.633 Sum_probs=131.1
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG--IIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~N 79 (223)
+++++||||+++++++.+.. ++||||+.+++|.+.+.... ..+++..++.++.|++.||.|||++| ++||||||+|
T Consensus 77 l~~l~h~~i~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~N 154 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPP-RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPN 154 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTT-EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGG
T ss_pred HHhCCCCCchhhheeecCCC-eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcce
Confidence 57889999999999997655 69999999999999887643 45999999999999999999999999 9999999999
Q ss_pred EEEeCCCC----ceEEccCccccccccccccccCCCccccccCCCCC---------------------------------
Q 027476 80 LILTADHK----TVKLADFGLAREESLTEMMTAETGTYRWMAPENMR--------------------------------- 122 (223)
Q Consensus 80 ill~~~~~----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--------------------------------- 122 (223)
|+++.++. .+||+|||+++.... ......||+.|+|||.+.
T Consensus 155 il~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 155 IFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp EEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred EEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 99987652 299999999975433 234567999999999762
Q ss_pred -----------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 123 -----------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 123 -----------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
..+..++.++.+++..||+.+|.+||+++++++.|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 233 YGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1134567789999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=212.55 Aligned_cols=165 Identities=29% Similarity=0.507 Sum_probs=137.8
Q ss_pred CCCCCCCCccceEEEeec-C-ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-P-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~-~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++||||+++++++.+ + ..++||||+.+++|.+++... ...+++..++.++.|++.||.|||++|++||||||+|
T Consensus 76 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~N 154 (298)
T 3pls_A 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARN 154 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence 567899999999999964 3 358999999999999999763 3458999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-----ccccCCCccccccCCCCC--------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-----MMTAETGTYRWMAPENMR-------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-------------------------------- 122 (223)
|+++.++ .+||+|||+++...... ......+++.|+|||.+.
T Consensus 155 ili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 155 CMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp EEECTTC-CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred EEEcCCC-cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 9999887 89999999997543322 223346788999999443
Q ss_pred --------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCC
Q 027476 123 --------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168 (223)
Q Consensus 123 --------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~ 168 (223)
..+..++.++.+++..||+.+|.+||++.++++.|++++.......
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 234 PFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred HHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 1234467788999999999999999999999999999988765444
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=215.88 Aligned_cols=160 Identities=25% Similarity=0.513 Sum_probs=131.3
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
|++++||||+++++++.++..++|+||+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 71 l~~l~hp~iv~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 149 (327)
T 3lzb_A 71 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149 (327)
T ss_dssp HTTCCBTTBCCCCEEEESSSEEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhCCCCCeeEEEEEEecCCceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEE
Confidence 67899999999999999888999999999999999998643 34999999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccc---cccCCCccccccCCCCC------------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
++.++ .+||+|||+++....... .....+++.|+|||.+.
T Consensus 150 ~~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 228 (327)
T 3lzb_A 150 VKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp EEETT-EEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred EcCCC-CEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 99887 899999999985433221 22335678899999331
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++.+++..||+.+|.+||++.++++.|+++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 229 SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 22345778899999999999999999999999999998743
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=219.34 Aligned_cols=151 Identities=26% Similarity=0.342 Sum_probs=129.6
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+.||+|.+++.+.+. +++..++.++.||+.||.|||++||+||||||+|
T Consensus 94 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 171 (350)
T 1rdq_E 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCccce
Confidence 3678899999999999975 578999999999999999987654 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
|+++.++ .+||+|||+++..... ....+||+.|+|||++...
T Consensus 172 Ill~~~g-~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 248 (350)
T 1rdq_E 172 LLIDQQG-YIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248 (350)
T ss_dssp EEECTTS-CEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEECCCC-CEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH
Confidence 9999888 8999999999865432 2355799999999955422
Q ss_pred ---------CCCChHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 027476 125 ---------AENLPEDLALIVTSCWKEDPNERPN-----FSQIIQM 156 (223)
Q Consensus 125 ---------~~~~~~~l~~l~~~~l~~~p~~Rp~-----~~~~~~~ 156 (223)
+..++.++.+++..||+.+|.+||+ ++++.++
T Consensus 249 ~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 249 KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 3456677888999999999999998 7777665
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=212.34 Aligned_cols=162 Identities=30% Similarity=0.556 Sum_probs=137.4
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
|++++||||+++++++.++..++||||+.+++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 141 (279)
T 1qpc_A 62 MKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (279)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HHhCCCcCcceEEEEEcCCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEE
Confidence 56789999999999998888999999999999999997543334999999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC-------------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
++.++ .+||+|||++........ .....++..|+|||.+.
T Consensus 142 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 220 (279)
T 1qpc_A 142 VSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220 (279)
T ss_dssp ECTTS-CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred EcCCC-CEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH
Confidence 99877 799999999986543221 22345678899999321
Q ss_pred ---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 ---------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 ---------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+..++.++.+++..||+.+|.+||+++++++.|++++...
T Consensus 221 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 123456788999999999999999999999999999988654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=216.15 Aligned_cols=161 Identities=29% Similarity=0.529 Sum_probs=133.2
Q ss_pred CCCCCCCCccceEEEee---cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACK---EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++||||+++++++. ++..++||||+.+++|.+++..... .+++..++.++.|++.||.|||++|++||||||+
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~ 156 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR 156 (327)
T ss_dssp HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChh
Confidence 56889999999999884 2468899999999999999976432 3999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC--------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR-------------------------------- 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-------------------------------- 122 (223)
||+++.++ .+||+|||++....... ......+++.|+|||.+.
T Consensus 157 NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 157 NILVESEA-HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp GEEEEETT-EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred hEEECCCC-CEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 99999887 89999999998543222 223346788899999331
Q ss_pred ----------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 ----------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 ----------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+..++.++.+++..||+.+|.+||++.+++++|+.+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 236 EFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 123467788999999999999999999999999999986654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=227.22 Aligned_cols=153 Identities=27% Similarity=0.404 Sum_probs=123.8
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
|++++||||+++++++.++..++||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 194 l~~l~hpniv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl 271 (419)
T 3i6u_A 194 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 271 (419)
T ss_dssp HHHCCCTTBCCCCEEEESSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhCCCCCEeeEEEEEecCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEE
Confidence 56789999999999998888999999999999999887654 3999999999999999999999999999999999999
Q ss_pred EeCCC--CceEEccCccccccccccccccCCCccccccCCCCCC---C--------------------------------
Q 027476 82 LTADH--KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP---S-------------------------------- 124 (223)
Q Consensus 82 l~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~-------------------------------- 124 (223)
++.++ ..+||+|||+++............||+.|+|||++.. .
T Consensus 272 l~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 351 (419)
T 3i6u_A 272 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351 (419)
T ss_dssp ESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred EecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence 97543 2599999999987665555566789999999997631 0
Q ss_pred -----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++.+||+.+|.+||++++++++
T Consensus 352 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 352 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 02356778899999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-31 Score=212.46 Aligned_cols=160 Identities=37% Similarity=0.686 Sum_probs=128.5
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIARAMECLHS---HGIIHRDLKP 77 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp 77 (223)
|++++||||+++++++.+ ..++||||++|++|.+++..... ..+++..++.++.|++.||.|||+ +|++||||||
T Consensus 55 l~~l~hp~iv~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp 133 (307)
T 2eva_A 55 LSRVNHPNIVKLYGACLN-PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133 (307)
T ss_dssp HHHCCCTTBCCEEEBCTT-TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSG
T ss_pred HhcCCCCCcCeEEEEEcC-CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCCh
Confidence 567899999999999875 47899999999999999986443 247899999999999999999999 8999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC---------------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
+||+++.++..+||+|||++...... .....||+.|+|||.+...
T Consensus 134 ~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 211 (307)
T 2eva_A 134 PNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211 (307)
T ss_dssp GGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH
T ss_pred hHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH
Confidence 99999987745899999999754322 2344689999999954321
Q ss_pred --------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 125 --------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 125 --------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
...++.++.+++.+||+.+|.+||+++++++.|+.+....
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 212 RIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 2345677888999999999999999999999999987654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=233.46 Aligned_cols=162 Identities=30% Similarity=0.563 Sum_probs=137.8
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++||||+++++++.++..++||||+.+|+|.+++.......+++..++.++.||+.||.|||++||+||||||+||
T Consensus 315 ~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 394 (535)
T 2h8h_A 315 VMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394 (535)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHHhCCCCCEeeEEEEEeeccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 36788999999999999888899999999999999999764444599999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
|++.++ .+||+|||+++....... .....++..|+|||.+.
T Consensus 395 ll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~ 473 (535)
T 2h8h_A 395 LVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 473 (535)
T ss_dssp EECGGG-CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH
T ss_pred EEcCCC-cEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999877 899999999986543221 22345678899999321
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++.+++..||+.+|.+||+++++++.|++++..
T Consensus 474 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 474 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 12446778899999999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=222.33 Aligned_cols=155 Identities=23% Similarity=0.423 Sum_probs=131.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+.|++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|
T Consensus 101 il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~N 179 (387)
T 1kob_A 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179 (387)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHH
Confidence 3678999999999999975 57899999999999999987543 349999999999999999999999999999999999
Q ss_pred EEEeCC-CCceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------------
Q 027476 80 LILTAD-HKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 80 ill~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
|+++.+ ...+||+|||+++............||+.|+|||++...
T Consensus 180 Ill~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~ 259 (387)
T 1kob_A 180 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259 (387)
T ss_dssp EEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred eEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 999753 237999999999876544444556899999999954311
Q ss_pred --------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 --------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 --------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++..||+.+|.+||++.+++++
T Consensus 260 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 260 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 13467788899999999999999999999876
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=217.21 Aligned_cols=152 Identities=30% Similarity=0.402 Sum_probs=124.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.|++|.+++..... +++..++.++.|++.||.|||++||+||||||+||
T Consensus 75 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Ni 152 (327)
T 3a62_A 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENI 152 (327)
T ss_dssp HHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTE
T ss_pred HHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHe
Confidence 567899999999999975 678999999999999999987654 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .+||+|||+++.... ........||+.|+|||.+...
T Consensus 153 ll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 231 (327)
T 3a62_A 153 MLNHQG-HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231 (327)
T ss_dssp EECTTS-CEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EECCCC-cEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999887 899999999875332 2233456799999999955422
Q ss_pred ---------CCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 125 ---------AENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 125 ---------~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
+..++.++.+++.+||+.+|.+|| ++++++++
T Consensus 232 ~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 232 KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 334566777888999999999998 66777664
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=216.06 Aligned_cols=159 Identities=26% Similarity=0.398 Sum_probs=133.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.|||++||+||||||+||
T Consensus 95 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 172 (335)
T 2owb_A 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172 (335)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhE
Confidence 567899999999999976 568999999999999999887554 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRP------------------------------------ 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~------------------------------------ 123 (223)
+++.++ .+||+|||++...... .......|++.|+|||.+..
T Consensus 173 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 251 (335)
T 2owb_A 173 FLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 251 (335)
T ss_dssp EECTTC-CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred EEcCCC-CEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence 999887 7999999999864322 22344579999999994431
Q ss_pred --------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCC
Q 027476 124 --------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165 (223)
Q Consensus 124 --------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~ 165 (223)
.+..++.++.+++.+||+.+|.+||++++++++ .++....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~--~~~~~~~ 299 (335)
T 2owb_A 252 RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLND--EFFTSGY 299 (335)
T ss_dssp HHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS--HHHHTSC
T ss_pred HHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC--ccccCCC
Confidence 233456778889999999999999999999876 5555443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=220.41 Aligned_cols=161 Identities=29% Similarity=0.585 Sum_probs=132.7
Q ss_pred CCCC-CCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcCC-----------------------------------
Q 027476 2 MSRV-RHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRP----------------------------------- 43 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~----------------------------------- 43 (223)
|+++ +||||+++++++.+ ...++||||+.+|+|.+++.....
T Consensus 79 l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (359)
T 3vhe_A 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITS 158 (359)
T ss_dssp HHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------
T ss_pred HHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCc
Confidence 3456 79999999999865 348999999999999999976432
Q ss_pred -----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccC
Q 027476 44 -----------------------------RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADF 94 (223)
Q Consensus 44 -----------------------------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Df 94 (223)
..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Df 237 (359)
T 3vhe_A 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDF 237 (359)
T ss_dssp -------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCC
T ss_pred cccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEec
Confidence 1289999999999999999999999999999999999999877 8999999
Q ss_pred cccccccccc---ccccCCCccccccCCCCC-----------------------------------------------CC
Q 027476 95 GLAREESLTE---MMTAETGTYRWMAPENMR-----------------------------------------------PS 124 (223)
Q Consensus 95 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~-----------------------------------------------~~ 124 (223)
|+++...... ......||+.|+|||.+. ..
T Consensus 238 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (359)
T 3vhe_A 238 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 317 (359)
T ss_dssp GGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC
T ss_pred cceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC
Confidence 9997543221 223456788999999331 12
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 125 AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 125 ~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+..++.++.+++..||+.+|.+||++.+++++|++++..
T Consensus 318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 334667899999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=215.31 Aligned_cols=151 Identities=28% Similarity=0.442 Sum_probs=128.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.|++|.+++... .+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 172 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSI 172 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 678999999999999864 6789999999999999998642 399999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPSA---------------------------------- 125 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~---------------------------------- 125 (223)
+++.++ .+||+|||++...... .......||+.|+|||.+....
T Consensus 173 ll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~ 251 (321)
T 2c30_A 173 LLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251 (321)
T ss_dssp EECTTC-CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EECCCC-cEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999887 8999999998754432 2234567999999999553221
Q ss_pred -------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 -------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 -------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++..||+.+|.+||++++++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1345677889999999999999999999876
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=212.93 Aligned_cols=149 Identities=28% Similarity=0.411 Sum_probs=123.5
Q ss_pred CCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEe
Q 027476 5 VRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83 (223)
Q Consensus 5 l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 83 (223)
.+||||++++++|.+ +..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence 389999999999975 5789999999 789999987654 3499999999999999999999999999999999999999
Q ss_pred CCCCceEEccCccccccccccccccCCCccccccCCCCCCC---------------------------------------
Q 027476 84 ADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS--------------------------------------- 124 (223)
Q Consensus 84 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------------------------------------- 124 (223)
.++ .+||+|||++.............||+.|+|||++.+.
T Consensus 192 ~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~ 270 (311)
T 3p1a_A 192 PRG-RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP 270 (311)
T ss_dssp GGG-CEEECCCTTCEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCC
T ss_pred CCC-CEEEccceeeeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCC
Confidence 887 8999999999866555445556799999999966521
Q ss_pred ---CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ---AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ---~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++..||+.+|.+||++++++++
T Consensus 271 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 12345667778889999999999999998865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=213.34 Aligned_cols=162 Identities=35% Similarity=0.608 Sum_probs=135.9
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPR----------------CLDIHVAIGFALDIARAME 63 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~----------------~l~~~~~~~i~~qi~~~l~ 63 (223)
|+++ +||||+++++++.+ +..++||||+++++|.+++...... .+++..++.++.|++.||.
T Consensus 80 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 4566 89999999999965 5789999999999999999865422 4899999999999999999
Q ss_pred HHHhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCC------------------
Q 027476 64 CLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMR------------------ 122 (223)
Q Consensus 64 ~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~------------------ 122 (223)
|||++|++||||||+||+++.++ .+||+|||++........ .....+++.|+|||.+.
T Consensus 160 ~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 238 (313)
T 1t46_A 160 FLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238 (313)
T ss_dssp HHHHTTCCCSCCSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHHHCCeecCCCccceEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHH
Confidence 99999999999999999999877 899999999976543321 22345678899999321
Q ss_pred -----------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 -----------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 -----------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+..++.++.+++..||+.+|.+||++.+++++|++.+...
T Consensus 239 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 113456788999999999999999999999999999988654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=215.12 Aligned_cols=161 Identities=28% Similarity=0.580 Sum_probs=135.5
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++||||+++++++.+ ..+++||||+++++|.+++.... +++..++.++.|++.||.|||++|++||||||+
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~ 163 (318)
T 3lxp_A 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAAR 163 (318)
T ss_dssp HHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchh
Confidence 567899999999999965 35789999999999999997643 899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC--------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR-------------------------------- 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-------------------------------- 122 (223)
||+++.++ .+||+|||++....... ......++..|+|||.+.
T Consensus 164 Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 242 (318)
T 3lxp_A 164 NVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242 (318)
T ss_dssp GEEECTTC-CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred eEEEcCCC-CEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch
Confidence 99999887 89999999998654322 223446788899999332
Q ss_pred ----------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCC
Q 027476 123 ----------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSA 166 (223)
Q Consensus 123 ----------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~ 166 (223)
..+..++.++.+++..||+.+|.+||+++++++.|+.+......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 243 KFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred hhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 22446778899999999999999999999999999998765443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=211.20 Aligned_cols=152 Identities=26% Similarity=0.418 Sum_probs=130.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.|||++|++||||||+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Ni 137 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENF 137 (277)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHE
Confidence 567899999999999976 568999999999999999987654 99999999999999999999999999999999999
Q ss_pred EE---eCCCCceEEccCccccccccccccccCCCccccccCCCCCCC---------------------------------
Q 027476 81 IL---TADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 81 ll---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
++ +.++ .+||+|||++.............||+.|+|||.+...
T Consensus 138 l~~~~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 216 (277)
T 3f3z_A 138 LFLTDSPDS-PLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM 216 (277)
T ss_dssp EESSSSTTC-CEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEecCCCCC-cEEEEecccceeccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99 5555 7999999999866555555566899999999954311
Q ss_pred ----------C----CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------A----ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------~----~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+ ..++.++.+++..||+.+|.+||++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 217 LKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 1466788999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=211.58 Aligned_cols=161 Identities=32% Similarity=0.592 Sum_probs=137.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.|++|.+++.......+++..++.++.|++.||.|||++|++||||||+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Ni 142 (288)
T 3kfa_A 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 142 (288)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceE
Confidence 567899999999999975 5789999999999999999886666799999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+++.++ .+||+|||++....... ......+++.|+|||.+.
T Consensus 143 l~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~ 221 (288)
T 3kfa_A 143 LVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 221 (288)
T ss_dssp EECGGG-CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EEcCCC-CEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999877 79999999998654322 222335678899999321
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++..||+.+|.+||+++++++.|++++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 222 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 22345778899999999999999999999999999988764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=219.98 Aligned_cols=152 Identities=31% Similarity=0.442 Sum_probs=117.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.|||++||+||||||+||
T Consensus 102 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 179 (349)
T 2w4o_A 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENGIVHRDLKPENL 179 (349)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccE
Confidence 567899999999999976 578999999999999999976543 99999999999999999999999999999999999
Q ss_pred EEeC---CCCceEEccCccccccccccccccCCCccccccCCCCCCCC--------------------------------
Q 027476 81 ILTA---DHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA-------------------------------- 125 (223)
Q Consensus 81 ll~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------------------------- 125 (223)
+++. ++ .+||+|||+++............||+.|+|||.+....
T Consensus 180 ll~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 258 (349)
T 2w4o_A 180 LYATPAPDA-PLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF 258 (349)
T ss_dssp EESSSSTTC-CEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH
T ss_pred EEecCCCCC-CEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH
Confidence 9975 45 79999999998655444445567999999999554221
Q ss_pred -----------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 -----------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 -----------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++.+||+.+|.+||++.+++++
T Consensus 259 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 259 MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2456677788888888888888888888765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=214.90 Aligned_cols=151 Identities=28% Similarity=0.467 Sum_probs=126.6
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++||||+++++++.+ +..++||||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 567899999999999964 468999999999999886532 34999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCC---------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
||+++.++ .+||+|||+++..... .......||+.|+|||.+...
T Consensus 167 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999887 8999999999865432 223456799999999965321
Q ss_pred ----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++.+||+.+|.+||++.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 12466788889999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=209.15 Aligned_cols=159 Identities=31% Similarity=0.526 Sum_probs=133.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni 135 (268)
T 3sxs_A 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNC 135 (268)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGE
T ss_pred HHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceE
Confidence 567899999999999975 57899999999999999997643 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+++.++ .+||+|||++........ .....+++.|+|||.+.
T Consensus 136 l~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 214 (268)
T 3sxs_A 136 LVDRDL-CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV 214 (268)
T ss_dssp EECTTC-CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCC-CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH
Confidence 999887 899999999975433322 22345677899999331
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
..+...+.++.+++..||+.+|.+||++.+++++|+.+..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 215 VLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1233467889999999999999999999999999988753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=211.31 Aligned_cols=158 Identities=26% Similarity=0.402 Sum_probs=132.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.|||++|++||||||+||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Ni 146 (294)
T 2rku_A 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146 (294)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence 567899999999999976 568899999999999999877554 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRP------------------------------------ 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~------------------------------------ 123 (223)
+++.++ .+||+|||++..... ........|++.|+|||.+..
T Consensus 147 l~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 225 (294)
T 2rku_A 147 FLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL 225 (294)
T ss_dssp EECTTC-CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred EEcCCC-CEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999887 799999999976432 222344578999999995432
Q ss_pred --------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 124 --------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 124 --------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
.+..++..+.+++.+||+.+|.+||++++++++ .++...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~--~~~~~~ 272 (294)
T 2rku_A 226 RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLND--EFFTSG 272 (294)
T ss_dssp HHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS--HHHHTS
T ss_pred HHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC--hheecC
Confidence 234456778889999999999999999999876 455443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=211.02 Aligned_cols=163 Identities=24% Similarity=0.505 Sum_probs=138.3
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++++.++..++||||+.+++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 64 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 142 (287)
T 1u59_A 64 MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 142 (287)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HHhCCCCCEeEEEEEecCCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEE
Confidence 5678999999999999888899999999999999998653 345999999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccc----cccCCCccccccCCCCC-----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
++.++ .+||+|||++........ .....+++.|+|||.+.
T Consensus 143 i~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 221 (287)
T 1u59_A 143 LVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221 (287)
T ss_dssp EEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred EcCCC-CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99887 899999999985432221 12335688999999321
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCC
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSA 166 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~ 166 (223)
..+..++.++.+++..||+.+|.+||++.+++++|.+++.....
T Consensus 222 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 222 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 12356788999999999999999999999999999999876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-31 Score=214.09 Aligned_cols=159 Identities=24% Similarity=0.337 Sum_probs=131.3
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
|++++||||+++++++.+ ...++||||+.+++|.+++..... ..+++..++.++.|++.||.|||++||+||||||
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 140 (319)
T 4euu_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP 140 (319)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence 567899999999999864 267999999999999999986433 3399999999999999999999999999999999
Q ss_pred CCEEE----eCCCCceEEccCccccccccccccccCCCccccccCCCCC--------CCCC-------------------
Q 027476 78 ENLIL----TADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR--------PSAE------------------- 126 (223)
Q Consensus 78 ~Nill----~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~------------------- 126 (223)
+||++ +.++ .+||+|||+++............||+.|+|||.+. ....
T Consensus 141 ~NIll~~~~~~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g 219 (319)
T 4euu_A 141 GNIMRVIGEDGQS-VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (319)
T ss_dssp GGEEEEECTTSCE-EEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS
T ss_pred HHEEEeccCCCCc-eEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC
Confidence 99998 5544 79999999998765555555667999999999542 0100
Q ss_pred ------------------------------------------------------CChHHHHHHHHHhcccCCCCCCCHHH
Q 027476 127 ------------------------------------------------------NLPEDLALIVTSCWKEDPNERPNFSQ 152 (223)
Q Consensus 127 ------------------------------------------------------~~~~~l~~l~~~~l~~~p~~Rp~~~~ 152 (223)
.++..+.+++..||+.+|.+||++++
T Consensus 220 ~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (319)
T 4euu_A 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (319)
T ss_dssp SCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred CCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence 12346777889999999999999999
Q ss_pred HHHHHHHHh
Q 027476 153 IIQMLLHYI 161 (223)
Q Consensus 153 ~~~~L~~~~ 161 (223)
++++..+..
T Consensus 300 ll~h~~d~~ 308 (319)
T 4euu_A 300 FFAETSDIL 308 (319)
T ss_dssp HHHHHHHHT
T ss_pred hhhccHHHh
Confidence 999987753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=222.03 Aligned_cols=155 Identities=27% Similarity=0.414 Sum_probs=130.3
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 139 ~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 217 (373)
T 2x4f_A 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPEN 217 (373)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHH
Confidence 3678999999999999975 57899999999999999887533 348999999999999999999999999999999999
Q ss_pred EEEeC-CCCceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------------
Q 027476 80 LILTA-DHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 80 ill~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
|+++. +...+||+|||+++............||+.|+|||.+...
T Consensus 218 Ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 297 (373)
T 2x4f_A 218 ILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL 297 (373)
T ss_dssp EEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred EEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99942 2238999999999876555445556799999999944311
Q ss_pred --------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 --------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 --------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++..||+.+|.+||++++++++
T Consensus 298 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 298 NNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 13467788899999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=209.52 Aligned_cols=164 Identities=16% Similarity=0.252 Sum_probs=135.9
Q ss_pred CCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 3 SRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 3 ~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++ +|+||+++++++.+ ...++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 60 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NI 137 (298)
T 1csn_A 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 137 (298)
T ss_dssp HHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred HHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 455 79999999999975 5789999999 999999998643 3499999999999999999999999999999999999
Q ss_pred EEeCCCC----ceEEccCcccccccccc--------ccccCCCccccccCCCCCCC------------------------
Q 027476 81 ILTADHK----TVKLADFGLAREESLTE--------MMTAETGTYRWMAPENMRPS------------------------ 124 (223)
Q Consensus 81 ll~~~~~----~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~------------------------ 124 (223)
+++.++. .+||+|||+++...... ......||+.|+|||.+...
T Consensus 138 l~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 217 (298)
T 1csn_A 138 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217 (298)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred EeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCC
Confidence 9986651 39999999998543321 12345799999999955311
Q ss_pred ----------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCC
Q 027476 125 ----------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168 (223)
Q Consensus 125 ----------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~ 168 (223)
...++.++.+++..||+.+|.+||+++++++.|+++........
T Consensus 218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 218 WQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp TSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred cchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 12467788999999999999999999999999999988765443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=213.27 Aligned_cols=157 Identities=27% Similarity=0.453 Sum_probs=129.9
Q ss_pred CCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------Cc
Q 027476 4 RVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH--------GI 70 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~--------~i 70 (223)
.++||||+++++++.+ ...++||||+++++|.+++... .+++..++.++.|++.||.|||++ ||
T Consensus 87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 163 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163 (337)
T ss_dssp TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCE
T ss_pred hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCE
Confidence 4599999999999854 4689999999999999999764 399999999999999999999999 99
Q ss_pred ccCCCCCCCEEEeCCCCceEEccCccccccccccc-----cccCCCccccccCCCCCCCC--------------------
Q 027476 71 IHRDLKPENLILTADHKTVKLADFGLAREESLTEM-----MTAETGTYRWMAPENMRPSA-------------------- 125 (223)
Q Consensus 71 vH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-------------------- 125 (223)
+||||||+||+++.++ .+||+|||+++....... .....||+.|+|||.+....
T Consensus 164 vH~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 242 (337)
T 3mdy_A 164 AHRDLKSKNILVKKNG-TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242 (337)
T ss_dssp ECSCCCGGGEEECTTS-CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHH
T ss_pred EecccchHHEEECCCC-CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHH
Confidence 9999999999999887 899999999975433221 12457999999999543111
Q ss_pred ----------------------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHH
Q 027476 126 ----------------------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQI 153 (223)
Q Consensus 126 ----------------------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~ 153 (223)
..++.++.+++..||+.+|.+||++.++
T Consensus 243 ~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 0233457889999999999999999999
Q ss_pred HHHHHHHhhcC
Q 027476 154 IQMLLHYISTN 164 (223)
Q Consensus 154 ~~~L~~~~~~~ 164 (223)
+++|+++....
T Consensus 323 l~~L~~l~~~~ 333 (337)
T 3mdy_A 323 KKTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHhhc
Confidence 99999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=214.72 Aligned_cols=164 Identities=31% Similarity=0.625 Sum_probs=136.2
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--------------RCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~l 65 (223)
|+++ +||||+++++++.+ +..++||||+.+++|.+++..... ..+++..++.++.|++.||.||
T Consensus 94 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 173 (334)
T 2pvf_A 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173 (334)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 3456 89999999999965 578999999999999999986542 2489999999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC--------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR-------------------- 122 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-------------------- 122 (223)
|++|++||||||+||+++.++ .+||+|||+++...... ......+++.|+|||.+.
T Consensus 174 H~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 252 (334)
T 2pvf_A 174 ASQKCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252 (334)
T ss_dssp HHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred HhCCeeCCCCccceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHH
Confidence 999999999999999999887 89999999997544322 123345778999999321
Q ss_pred --------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCC
Q 027476 123 --------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSA 166 (223)
Q Consensus 123 --------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~ 166 (223)
..+..++.++.+++..||+.+|.+||++.++++.|++++.....
T Consensus 253 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 253 FTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 12345778899999999999999999999999999999876443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=216.68 Aligned_cols=162 Identities=30% Similarity=0.543 Sum_probs=132.9
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP---------------------RCLDIHVAIGFALDI 58 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---------------------~~l~~~~~~~i~~qi 58 (223)
|+++ +||||+++++++.+ +..++||||+++|+|.+++..... ..+++..++.++.|+
T Consensus 102 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 4567 89999999999975 578999999999999999986542 237999999999999
Q ss_pred HHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC-------------
Q 027476 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR------------- 122 (223)
Q Consensus 59 ~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~------------- 122 (223)
+.||.|||++||+||||||+||+++.++ .+||+|||++....... ......+|+.|+|||.+.
T Consensus 182 ~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 260 (344)
T 1rjb_A 182 AKGMEFLEFKSCVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260 (344)
T ss_dssp HHHHHHHHHTTEEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHhCCcccCCCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHH
Confidence 9999999999999999999999999887 89999999997543322 122345678999999321
Q ss_pred ----------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 ----------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 ----------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+..++.++.+++..||+.+|.+||++.+++++|+.+....
T Consensus 261 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 261 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred HHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 113446788999999999999999999999999999986543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=210.77 Aligned_cols=157 Identities=26% Similarity=0.477 Sum_probs=130.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.|||++|++||||||+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Ni 140 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENL 140 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGE
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhE
Confidence 578899999999999976 568999999999999999987654 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------- 123 (223)
+++.++ .+||+|||++....... .....|++.|+|||.+..
T Consensus 141 li~~~~-~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 218 (279)
T 3fdn_A 141 LLGSAG-ELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 218 (279)
T ss_dssp EECTTS-CEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred EEcCCC-CEEEEeccccccCCccc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence 999887 89999999986543322 244578999999995432
Q ss_pred -------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 124 -------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 124 -------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
.+..++.++.+++..||+.+|.+||++.+++++ .++...
T Consensus 219 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h--~~~~~~ 264 (279)
T 3fdn_A 219 ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH--PWITAN 264 (279)
T ss_dssp HHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC--HHHHHH
T ss_pred HHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC--ccccCC
Confidence 233466778889999999999999999999987 555543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=215.51 Aligned_cols=153 Identities=26% Similarity=0.383 Sum_probs=129.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.+++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NI 146 (321)
T 2a2a_A 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146 (321)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHE
Confidence 567899999999999975 57899999999999999997644 399999999999999999999999999999999999
Q ss_pred EEeCCCC---ceEEccCccccccccccccccCCCccccccCCCCCCCC--------------------------------
Q 027476 81 ILTADHK---TVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA-------------------------------- 125 (223)
Q Consensus 81 ll~~~~~---~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------------------------- 125 (223)
+++.++. .+||+|||++.............||+.|+|||.+....
T Consensus 147 l~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 226 (321)
T 2a2a_A 147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226 (321)
T ss_dssp EESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred EEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9987653 69999999998665544445667999999999554221
Q ss_pred ----------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ----------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ----------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...+.++.+++..||+.+|.+||++++++++
T Consensus 227 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 227 LANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 2345667788999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=218.60 Aligned_cols=155 Identities=22% Similarity=0.391 Sum_probs=128.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|+.++||||++++++|.+ +.+++||||+.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+||
T Consensus 123 l~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NI 199 (410)
T 3v8s_A 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 199 (410)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence 567899999999999976 5789999999999999999763 389999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
+++.++ .+||+|||+++...... .....+||+.|+|||++...
T Consensus 200 Ll~~~g-~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 200 LLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp EECTTS-CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eECCCC-CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 999888 89999999997654332 23456899999999954311
Q ss_pred ------------------CCCChHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHHhh
Q 027476 125 ------------------AENLPEDLALIVTSCWKEDPNE--RPNFSQIIQMLLHYIS 162 (223)
Q Consensus 125 ------------------~~~~~~~l~~l~~~~l~~~p~~--Rp~~~~~~~~L~~~~~ 162 (223)
...++.++.+|+..||..+|.+ ||++++++++ .++.
T Consensus 279 ~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H--p~f~ 334 (410)
T 3v8s_A 279 VGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH--LFFK 334 (410)
T ss_dssp HHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS--GGGC
T ss_pred hhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC--cccc
Confidence 1246677788888888877777 8888888776 4443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=206.20 Aligned_cols=156 Identities=24% Similarity=0.431 Sum_probs=133.9
Q ss_pred CCCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG--IIHRDL 75 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~dl 75 (223)
++++++||||+++++++.+ +..++||||+++++|.+++.......+++..++.++.|++.||.|||++| ++||||
T Consensus 60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~di 139 (271)
T 3kmu_A 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHAL 139 (271)
T ss_dssp GGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCC
T ss_pred HHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCC
Confidence 4678999999999999965 46799999999999999998766556999999999999999999999999 999999
Q ss_pred CCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC---------------------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR--------------------------------- 122 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--------------------------------- 122 (223)
||+||+++.++ .++|.|||++.... .....||+.|+|||.+.
T Consensus 140 kp~Nil~~~~~-~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 140 NSRSVMIDEDM-TARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp SGGGEEECTTS-CEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ccceEEEcCCc-ceeEEeccceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99999999877 79999888765422 23457899999999432
Q ss_pred ----------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 123 ----------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 123 ----------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
..+..++.++.+++..||+.+|.+||+++++++.|+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 215 SNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 123457788999999999999999999999999998864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=217.34 Aligned_cols=145 Identities=28% Similarity=0.325 Sum_probs=127.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++||||+++++++.+ +.+|+||||+.||+|.+++.+... +++..++.++.||+.||+|||++||+||||||+||
T Consensus 93 l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 170 (373)
T 2r5t_A 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI 170 (373)
T ss_dssp BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 577899999999999975 578999999999999999987654 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccc-cccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREES-LTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+++.++ .+||+|||+++... ........+||+.|+|||++.....+...|+|+++..++++-.+..|.
T Consensus 171 ll~~~g-~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf 239 (373)
T 2r5t_A 171 LLDSQG-HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239 (373)
T ss_dssp EECTTS-CEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred EECCCC-CEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 999888 89999999998532 223345568999999999999999999999999998888776665553
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=230.94 Aligned_cols=154 Identities=26% Similarity=0.413 Sum_probs=132.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +.+++||||+.||+|.+++.......+++..++.++.||+.||+|||++||+||||||+||
T Consensus 238 L~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNI 317 (576)
T 2acx_A 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317 (576)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheE
Confidence 567899999999999975 5789999999999999999876655699999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------- 123 (223)
+++.++ .+||+|||+++...........+||+.|+|||++..
T Consensus 318 Lld~~g-~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~ 396 (576)
T 2acx_A 318 LLDDHG-HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396 (576)
T ss_dssp EECTTS-CEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH
T ss_pred EEeCCC-CeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH
Confidence 999888 899999999987654444456689999999995431
Q ss_pred -----------CCCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 124 -----------SAENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 124 -----------~~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
.+..++.++.+++..||+.+|.+|| ++++++++
T Consensus 397 i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 397 VERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1234667888899999999999999 67888765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=210.72 Aligned_cols=158 Identities=28% Similarity=0.442 Sum_probs=133.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+.+..... +++..++.++.|++.||.|||++|++||||||+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Ni 136 (284)
T 3kk8_A 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 136 (284)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHE
Confidence 567899999999999975 568899999999999999887654 99999999999999999999999999999999999
Q ss_pred EEeCCC--CceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------------
Q 027476 81 ILTADH--KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 81 ll~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
+++.++ ..+||+|||++.............||+.|+|||.+...
T Consensus 137 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 216 (284)
T 3kk8_A 137 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 216 (284)
T ss_dssp EESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH
Confidence 997654 24999999999866555555566899999999954321
Q ss_pred --------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 125 --------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 125 --------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
...++.++.+++..||+.+|.+||++++++++ .++..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h--~~~~~ 267 (284)
T 3kk8_A 217 AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV--PWICN 267 (284)
T ss_dssp HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS--HHHHS
T ss_pred HHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC--ccccC
Confidence 13567788889999999999999999999876 45443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-31 Score=226.37 Aligned_cols=154 Identities=26% Similarity=0.392 Sum_probs=132.1
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||++++++|.+ +.+++||||+.||+|.+.+..... +++..++.++.||+.||.|||++||+||||||+|
T Consensus 89 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N 166 (494)
T 3lij_A 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPEN 166 (494)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhh
Confidence 3678999999999999976 578999999999999999877654 9999999999999999999999999999999999
Q ss_pred EEEeCCC--CceEEccCccccccccccccccCCCccccccCCCCCCC---------------------------------
Q 027476 80 LILTADH--KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 80 ill~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
|+++..+ ..+||+|||++.............||+.|+|||++...
T Consensus 167 il~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 246 (494)
T 3lij_A 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL 246 (494)
T ss_dssp EEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9997543 25999999999876655555667899999999954311
Q ss_pred --------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 --------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 --------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++..||+.+|.+||++.+++++
T Consensus 247 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 247 RKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 12466788899999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=211.35 Aligned_cols=119 Identities=28% Similarity=0.509 Sum_probs=99.3
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+.+ +|.+.+.... +.+++..++.++.|++.||+|||++||+||||||+|
T Consensus 54 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~N 131 (292)
T 3o0g_A 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN 131 (292)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 3678999999999999965 578999999965 6666665432 349999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 122 (223)
|+++.++ .+||+|||+++..... .......||+.|+|||.+.
T Consensus 132 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 174 (292)
T 3o0g_A 132 LLINRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174 (292)
T ss_dssp EEECTTS-CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHT
T ss_pred EEEcCCC-CEEEeecccceecCCccccccCCccccCCcChHHHc
Confidence 9999887 8999999999865432 2334557899999999654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=212.68 Aligned_cols=162 Identities=30% Similarity=0.515 Sum_probs=128.1
Q ss_pred CCCCCCCCccceEEEeecC-c------eEEEEEcCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027476 2 MSRVRHRNLVKFIGACKEP-V------MVIVTELLLGGTLRKYLLNMR----PRCLDIHVAIGFALDIARAMECLHSHGI 70 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~-~------~~lv~e~~~~~sL~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~i 70 (223)
+++++||||+++++++.+. . .++||||+.+++|.+++.... ...+++..++.++.|++.||.|||++|+
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i 158 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF 158 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCc
Confidence 6788999999999998653 2 389999999999999996533 1249999999999999999999999999
Q ss_pred ccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCC-------------------------
Q 027476 71 IHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMR------------------------- 122 (223)
Q Consensus 71 vH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~------------------------- 122 (223)
+||||||+||+++.++ .+||+|||+++....... .....+++.|+|||.+.
T Consensus 159 vH~Dikp~NIli~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~ 237 (323)
T 3qup_A 159 IHRDLAARNCMLAEDM-TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237 (323)
T ss_dssp CCSCCSGGGEEECTTS-CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCCCCcceEEEcCCC-CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCC
Confidence 9999999999999887 899999999975433222 22335678899999321
Q ss_pred ---------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 ---------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 ---------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+..++.++.+++..||+.+|.+||++.++++.|++++...
T Consensus 238 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 238 TPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp CTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 224456788999999999999999999999999999998753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-31 Score=212.67 Aligned_cols=161 Identities=29% Similarity=0.549 Sum_probs=134.6
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--------PRCLDIHVAIGFALDIARAMECLHSHGII 71 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~l~~lH~~~iv 71 (223)
+|++++||||+++++++.+ +..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+
T Consensus 81 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 160 (322)
T 1p4o_A 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 160 (322)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 3678899999999999975 57899999999999999987532 13479999999999999999999999999
Q ss_pred cCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC--------------------------
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR-------------------------- 122 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-------------------------- 122 (223)
||||||+||+++.++ .+||+|||+++...... ......+++.|+|||.+.
T Consensus 161 H~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 239 (322)
T 1p4o_A 161 HRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239 (322)
T ss_dssp CSCCSGGGEEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred cCCCccceEEEcCCC-eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 999999999999887 89999999997543322 122345688999999332
Q ss_pred --------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 --------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 --------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
..+..++.++.+++..||+.+|.+||++.+++++|++...
T Consensus 240 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 240 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 2234677889999999999999999999999999988654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-31 Score=212.62 Aligned_cols=118 Identities=31% Similarity=0.488 Sum_probs=99.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+. ++|.+.+.... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 73 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NI 150 (311)
T 3niz_A 73 LKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150 (311)
T ss_dssp HHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhE
Confidence 567899999999999975 57899999996 58888887643 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 122 (223)
+++.++ .+||+|||+++..... .......||+.|+|||.+.
T Consensus 151 l~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~ 192 (311)
T 3niz_A 151 LINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM 192 (311)
T ss_dssp EECTTC-CEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHT
T ss_pred EECCCC-CEEEccCcCceecCCCcccccCCcccCCcCCHHHhc
Confidence 999887 8999999999865422 2234457899999999654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=212.12 Aligned_cols=160 Identities=27% Similarity=0.550 Sum_probs=130.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 100 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 178 (333)
T 1mqb_A 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 178 (333)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheE
Confidence 567899999999999975 57899999999999999997643 4599999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR---------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~---------------------------------- 122 (223)
+++.++ .+||+|||+++...... ......+++.|+|||.+.
T Consensus 179 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 257 (333)
T 1mqb_A 179 LVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 257 (333)
T ss_dssp EECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred EECCCC-cEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH
Confidence 999877 89999999997543321 112234678899999332
Q ss_pred ------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++.+++..||+.+|.+||++.++++.|++++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 258 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 12345678899999999999999999999999999998764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-31 Score=224.34 Aligned_cols=158 Identities=26% Similarity=0.447 Sum_probs=131.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +.+++||||+.|++|.+.+..... +++..++.++.|++.||.|||++||+||||||+||
T Consensus 75 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 152 (486)
T 3mwu_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152 (486)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHE
Confidence 567899999999999976 578999999999999999877654 99999999999999999999999999999999999
Q ss_pred EEeCCC--CceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------------
Q 027476 81 ILTADH--KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 81 ll~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
+++..+ ..+||+|||+++............||+.|+|||++.+.
T Consensus 153 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 232 (486)
T 3mwu_A 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232 (486)
T ss_dssp EESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 996432 27999999999866555555566899999999965421
Q ss_pred -------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 125 -------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 125 -------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
...++.++.+++..||+.+|.+||++.+++++ .++..
T Consensus 233 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h--p~~~~ 282 (486)
T 3mwu_A 233 RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH--PWIQK 282 (486)
T ss_dssp HHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC--HHHHH
T ss_pred HHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC--Hhhcc
Confidence 12356778899999999999999999999886 44443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=212.67 Aligned_cols=159 Identities=31% Similarity=0.485 Sum_probs=132.3
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP--RCLDIHVAIGFALDIARAMECLHSH---GIIHRD 74 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 74 (223)
++++++||||+++++++.+ +..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||++ |++|||
T Consensus 80 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~D 159 (326)
T 3uim_A 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRD 159 (326)
T ss_dssp GGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCC
T ss_pred HHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Confidence 4678899999999999965 578999999999999999986532 3499999999999999999999999 999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccc--cccccCCCccccccCCCCCCC----------------------------
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLT--EMMTAETGTYRWMAPENMRPS---------------------------- 124 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~---------------------------- 124 (223)
|||+||+++.++ .+||+|||+++..... .......||+.|+|||.+...
T Consensus 160 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (326)
T 3uim_A 160 VKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238 (326)
T ss_dssp CSGGGEEECTTC-CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHH
T ss_pred CchhhEEECCCC-CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccc
Confidence 999999999887 8999999999854322 223345699999999943200
Q ss_pred -----------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 125 -----------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 125 -----------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
....+.++.+++..||+.+|.+||++.+++++|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 239 RLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 011236788999999999999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=207.75 Aligned_cols=156 Identities=28% Similarity=0.438 Sum_probs=124.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.|||++|++|+||||+||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 142 (276)
T 2h6d_A 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENV 142 (276)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGE
T ss_pred HhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhE
Confidence 567899999999999975 578999999999999999987654 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------- 123 (223)
+++.++ .+||+|||++.............|++.|+|||.+..
T Consensus 143 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 221 (276)
T 2h6d_A 143 LLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK 221 (276)
T ss_dssp EECTTS-CEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EECCCC-CEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 999887 799999999986655444455678999999996542
Q ss_pred --------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 124 --------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 124 --------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
.+..++.++.+++..||+.+|.+||++++++++ .++.
T Consensus 222 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h--~~~~ 266 (276)
T 2h6d_A 222 KIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH--EWFK 266 (276)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS--HHHH
T ss_pred HhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC--hhhc
Confidence 123456778889999999999999999999886 4444
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=208.96 Aligned_cols=155 Identities=28% Similarity=0.477 Sum_probs=123.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++||||+++++++.+ +..++||||+.+++|.+.+... ....+++..++.++.|++.||+|||++|++||||||+
T Consensus 74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~ 153 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPE 153 (285)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHH
Confidence 578899999999999975 5789999999999999998643 2345999999999999999999999999999999999
Q ss_pred CEEEeCC--CCceEEccCccccccccccccccCCCccccccCCCCCC---------------------------------
Q 027476 79 NLILTAD--HKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP--------------------------------- 123 (223)
Q Consensus 79 Nill~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------------------------------- 123 (223)
||+++.+ ...+||+|||++.............||+.|+|||.+..
T Consensus 154 NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~ 233 (285)
T 3is5_A 154 NILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233 (285)
T ss_dssp GEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999532 23799999999986555444556679999999995431
Q ss_pred -------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 -------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 -------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.....+.++.+++..||+.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 234 QQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112356788899999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=208.06 Aligned_cols=154 Identities=37% Similarity=0.747 Sum_probs=122.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG---IIHRDLKP 77 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp 77 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++.. +.+++..++.++.|++.||.|||++| ++||||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp 136 (271)
T 3dtc_A 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS 136 (271)
T ss_dssp HHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSG
T ss_pred HHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCch
Confidence 457899999999999965 578999999999999999854 34999999999999999999999999 89999999
Q ss_pred CCEEEeCC-------CCceEEccCccccccccccccccCCCccccccCCCCC----------------------------
Q 027476 78 ENLILTAD-------HKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR---------------------------- 122 (223)
Q Consensus 78 ~Nill~~~-------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------------------------- 122 (223)
+||+++.+ ...+||+|||++........ ....|++.|+|||.+.
T Consensus 137 ~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 215 (271)
T 3dtc_A 137 SNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215 (271)
T ss_dssp GGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred HHEEEecccccccccCcceEEccCCcccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999862 23799999999975443322 3457899999999332
Q ss_pred ------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 123 ------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 123 ------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
..+..++.++.+++..||+.+|.+||++.+++++|++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 216 GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 2235677889999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=210.37 Aligned_cols=159 Identities=30% Similarity=0.482 Sum_probs=131.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR-PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++||||+++++++.+ +..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+|
T Consensus 84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~N 163 (307)
T 2nru_A 84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSAN 163 (307)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHH
Confidence 567899999999999965 57899999999999999997432 3459999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCCCC--------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMRPS-------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~-------------------------------- 124 (223)
|+++.++ .+||+|||+++..... .......|++.|+|||.+.+.
T Consensus 164 ili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 164 ILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EEECTTC-CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEEcCCC-cEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 9999877 8999999998754322 122345789999999943310
Q ss_pred --------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 125 --------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 125 --------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
....+..+.+++..||+.+|.+||++.+++++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 0112356788999999999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=219.26 Aligned_cols=141 Identities=26% Similarity=0.372 Sum_probs=125.9
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
+||||++++++|.+ +.+++||||+.||+|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~ 188 (396)
T 4dc2_A 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 188 (396)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECC
Confidence 89999999999975 578999999999999999987654 999999999999999999999999999999999999998
Q ss_pred CCCceEEccCcccccc-ccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 85 DHKTVKLADFGLAREE-SLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 85 ~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
++ .+||+|||+++.. .........+||+.|+|||++....++...|+|+++..++++-.++.|.
T Consensus 189 ~g-~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf 253 (396)
T 4dc2_A 189 EG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253 (396)
T ss_dssp TS-CEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CC-CEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 88 8999999999853 2333445678999999999999999999999999999988877666665
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=213.19 Aligned_cols=160 Identities=23% Similarity=0.244 Sum_probs=128.6
Q ss_pred CCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 4 RVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM---RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
...|+||+++++++.+ +..++||||+.||+|.+++... ....+++..++.++.|++.||+|||++||+||||||+|
T Consensus 123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~N 202 (365)
T 3e7e_A 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDN 202 (365)
T ss_dssp GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGG
T ss_pred hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHH
Confidence 3459999999999864 6889999999999999999742 23459999999999999999999999999999999999
Q ss_pred EEEeC-----------CCCceEEccCccccccc---cccccccCCCccccccCCCCCCCCCCChHHHHH-----------
Q 027476 80 LILTA-----------DHKTVKLADFGLAREES---LTEMMTAETGTYRWMAPENMRPSAENLPEDLAL----------- 134 (223)
Q Consensus 80 ill~~-----------~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~----------- 134 (223)
|+++. ++ .+||+|||+++... .........||+.|+|||++.....+...|+|+
T Consensus 203 Ill~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 203 FILGNGFLEQDDEDDLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp EEECGGGTCC------CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred EEecccccCccccccccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 99987 55 89999999996432 233345568999999999887666666666665
Q ss_pred -----------------------------HHHHhcccCCCCC-CCHHHHHHHHHHHhhcC
Q 027476 135 -----------------------------IVTSCWKEDPNER-PNFSQIIQMLLHYISTN 164 (223)
Q Consensus 135 -----------------------------l~~~~l~~~p~~R-p~~~~~~~~L~~~~~~~ 164 (223)
++..|+..+|.+| |+++++.+.|++++...
T Consensus 282 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 282 TYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp SCCCEEEETTEEEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCccccCCCCceeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 4555677777777 46777777777776553
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=214.65 Aligned_cols=132 Identities=28% Similarity=0.423 Sum_probs=90.4
Q ss_pred CCCCC-CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVR-HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~-Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|+++. ||||+++++++.+ +..++||||+.|++|.+++..... +++..++.++.|++.||.|||++||+||||||+|
T Consensus 59 l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 136 (325)
T 3kn6_A 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPEN 136 (325)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHH
Confidence 34565 9999999999976 578999999999999999987544 9999999999999999999999999999999999
Q ss_pred EEEeCCCC--ceEEccCccccccccc-cccccCCCccccccCCCCCCCCCCChHHHHHH
Q 027476 80 LILTADHK--TVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPSAENLPEDLALI 135 (223)
Q Consensus 80 ill~~~~~--~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l 135 (223)
|+++.++. .+||+|||+++..... .......||+.|+|||.+.....+...|+|++
T Consensus 137 Ill~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 195 (325)
T 3kn6_A 137 LLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSL 195 (325)
T ss_dssp EEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHH
T ss_pred EEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHH
Confidence 99976542 6999999999754332 22345578999999997764433333343333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=211.39 Aligned_cols=153 Identities=29% Similarity=0.468 Sum_probs=126.3
Q ss_pred CCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCc
Q 027476 4 RVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLH--------SHGI 70 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH--------~~~i 70 (223)
+++||||+++++++.+ ...++||||+.+|+|.+++.. ..+++..++.++.|++.||.||| +.+|
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 134 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI 134 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEE
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCe
Confidence 4799999999998632 357899999999999999954 34999999999999999999999 9999
Q ss_pred ccCCCCCCCEEEeCCCCceEEccCccccccccccc-----cccCCCccccccCCCCCCC---------------------
Q 027476 71 IHRDLKPENLILTADHKTVKLADFGLAREESLTEM-----MTAETGTYRWMAPENMRPS--------------------- 124 (223)
Q Consensus 71 vH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~--------------------- 124 (223)
+||||||+||+++.++ .+||+|||+++....... .....||+.|+|||.+...
T Consensus 135 vH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il 213 (301)
T 3q4u_A 135 AHRDLKSKNILVKKNG-QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213 (301)
T ss_dssp ECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHH
T ss_pred ecCCCChHhEEEcCCC-CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHH
Confidence 9999999999999887 899999999975332221 2234799999999954321
Q ss_pred ------------------C---------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHH
Q 027476 125 ------------------A---------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQI 153 (223)
Q Consensus 125 ------------------~---------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~ 153 (223)
+ ...+.++.+++..||+.+|.+||++.++
T Consensus 214 ~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 293 (301)
T 3q4u_A 214 WEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293 (301)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence 0 0123568889999999999999999999
Q ss_pred HHHHHHH
Q 027476 154 IQMLLHY 160 (223)
Q Consensus 154 ~~~L~~~ 160 (223)
++.|+++
T Consensus 294 ~~~L~~i 300 (301)
T 3q4u_A 294 KKTLTKI 300 (301)
T ss_dssp HHHHHHH
T ss_pred HHHHhcc
Confidence 9999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=205.19 Aligned_cols=160 Identities=28% Similarity=0.553 Sum_probs=134.6
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 135 (267)
T 3t9t_A 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 135 (267)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred HHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheE
Confidence 567899999999999965 57899999999999999997643 3589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+++.++ .+||+|||++....... ......++..|+|||.+.
T Consensus 136 li~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 214 (267)
T 3t9t_A 136 LVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 214 (267)
T ss_dssp EECGGG-CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EECCCC-CEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH
Confidence 999877 79999999997543322 123345778899999332
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+...+.++.+++..||+.+|.+||++.+++++|+++...
T Consensus 215 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 215 VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11334577899999999999999999999999999998653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=210.13 Aligned_cols=160 Identities=24% Similarity=0.385 Sum_probs=128.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.|||++|++||||||+||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NI 165 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHE
Confidence 578899999999999965 678999999999999999987654 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
+++.++ .+||+|||++....... ......|++.|+|||.+...
T Consensus 166 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (309)
T 2h34_A 166 LVSADD-FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG 244 (309)
T ss_dssp EECTTS-CEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH
T ss_pred EEcCCC-CEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH
Confidence 999887 89999999987544322 22345789999999965311
Q ss_pred -------------CCCChHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHhhcC
Q 027476 125 -------------AENLPEDLALIVTSCWKEDPNERP-NFSQIIQMLLHYISTN 164 (223)
Q Consensus 125 -------------~~~~~~~l~~l~~~~l~~~p~~Rp-~~~~~~~~L~~~~~~~ 164 (223)
...++.++.+++.+||+.+|.+|| +++++++.|++.+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 245 AHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 234667788999999999999999 9999999999876544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=215.07 Aligned_cols=161 Identities=30% Similarity=0.556 Sum_probs=133.0
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR------------PRCLDIHVAIGFALDIARAMECLHS 67 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~------------~~~l~~~~~~~i~~qi~~~l~~lH~ 67 (223)
|+++ +||||+++++++.+ +..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+
T Consensus 103 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 4566 89999999999975 57899999999999999997532 2358999999999999999999999
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC----------------------
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR---------------------- 122 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~---------------------- 122 (223)
+|++||||||+||+++.++ .+||+|||+++...... ......+++.|+|||.+.
T Consensus 183 ~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 261 (333)
T 2i1m_A 183 KNCIHRDVAARNVLLTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261 (333)
T ss_dssp TTEECSCCSGGGCEEEGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred CCcccCCcccceEEECCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHc
Confidence 9999999999999999877 89999999997543222 122345678999999321
Q ss_pred -------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 -------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 -------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++..||+.+|.+||++.++++.|++....
T Consensus 262 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 262 LGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp TSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 11334677899999999999999999999999999987653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=210.82 Aligned_cols=159 Identities=23% Similarity=0.368 Sum_probs=132.0
Q ss_pred CCCCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+++++||||+++++++.+ ...++||||+.+++|.+++... ....+++..++.++.|++.||.|||++|++|||
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~d 159 (317)
T 2buj_A 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRD 159 (317)
T ss_dssp HHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 567899999999999852 3688999999999999998753 234599999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCcccccccccc----------ccccCCCccccccCCCCCC---------------------
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTE----------MMTAETGTYRWMAPENMRP--------------------- 123 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~--------------------- 123 (223)
|||+||+++.++ .+||+|||++....... ......||+.|+|||.+..
T Consensus 160 lkp~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e 238 (317)
T 2buj_A 160 LKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238 (317)
T ss_dssp CCGGGEEECTTS-CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCC-CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHH
Confidence 999999999887 79999999887543211 1123357999999996531
Q ss_pred -----------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 124 -----------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 124 -----------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
....++.++.+++..||+.+|.+||++.+++++|+.+.
T Consensus 239 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 239 MMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred HHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 12346778999999999999999999999999998864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=209.64 Aligned_cols=162 Identities=30% Similarity=0.551 Sum_probs=129.4
Q ss_pred CCCCCCCCccceEEEeecC------ceEEEEEcCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 027476 2 MSRVRHRNLVKFIGACKEP------VMVIVTELLLGGTLRKYLLNM----RPRCLDIHVAIGFALDIARAMECLHSHGII 71 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~------~~~lv~e~~~~~sL~~~l~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~iv 71 (223)
+++++||||+++++++.+. ..++||||+.+++|.+++... ....+++..++.++.|++.||.|||++|++
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 169 (313)
T 3brb_A 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFL 169 (313)
T ss_dssp HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 5678999999999998642 358999999999999998532 234599999999999999999999999999
Q ss_pred cCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC--------------------------
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR-------------------------- 122 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-------------------------- 122 (223)
||||||+||+++.++ .+||+|||+++...... ......+++.|+|||.+.
T Consensus 170 H~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 248 (313)
T 3brb_A 170 HRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT 248 (313)
T ss_dssp CCCCSGGGEEECTTS-CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCcceEEEcCCC-cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCC
Confidence 999999999999887 89999999997543322 122345788999999332
Q ss_pred --------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 --------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 --------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+..++.++.+++..||+.+|.+||++.+++++|+++....
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 249 PYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 123456788999999999999999999999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=226.10 Aligned_cols=158 Identities=26% Similarity=0.440 Sum_probs=134.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +.+++||||+.||+|.+.+..... +++..++.++.||+.||.|||++||+||||||+||
T Consensus 100 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni 177 (504)
T 3q5i_A 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177 (504)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHE
Confidence 568899999999999976 578999999999999999987654 99999999999999999999999999999999999
Q ss_pred EEeCCCC--ceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------------
Q 027476 81 ILTADHK--TVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 81 ll~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
+++.++. .+||+|||++.............||+.|+|||++...
T Consensus 178 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 257 (504)
T 3q5i_A 178 LLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257 (504)
T ss_dssp EESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9987652 5999999999876555555667899999999955411
Q ss_pred -------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 125 -------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 125 -------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
...++.++.+++..||+.+|.+||++++++++ .++..
T Consensus 258 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h--~~~~~ 307 (504)
T 3q5i_A 258 KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS--RWIKK 307 (504)
T ss_dssp HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS--HHHHH
T ss_pred HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC--Hhhhh
Confidence 02456778889999999999999999999876 44443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=221.58 Aligned_cols=164 Identities=21% Similarity=0.321 Sum_probs=130.6
Q ss_pred CCCCCCC-CccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHR-NLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hp-niv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++.|+|. +|..+..++.+ +..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 56 l~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~N 133 (483)
T 3sv0_A 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133 (483)
T ss_dssp HHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcce
Confidence 4566664 44455555544 5678999999 999999997533 349999999999999999999999999999999999
Q ss_pred EEE---eCCCCceEEccCccccccccccc--------cccCCCccccccCCCCCCC------------------------
Q 027476 80 LIL---TADHKTVKLADFGLAREESLTEM--------MTAETGTYRWMAPENMRPS------------------------ 124 (223)
Q Consensus 80 ill---~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~------------------------ 124 (223)
||+ +.++ .+||+|||+++....... .....||+.|+|||.+...
T Consensus 134 ILl~~~~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~P 212 (483)
T 3sv0_A 134 FLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (483)
T ss_dssp EEECCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred EEEecCCCCC-eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 999 4555 899999999986443221 1255799999999954321
Q ss_pred ----------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCC
Q 027476 125 ----------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168 (223)
Q Consensus 125 ----------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~ 168 (223)
...++.++.+++..||+.+|.+||++.++++.|++++.....+.
T Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~ 284 (483)
T 3sv0_A 213 WQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQF 284 (483)
T ss_dssp TSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred CccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCc
Confidence 13456778899999999999999999999999999987665443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=222.62 Aligned_cols=117 Identities=28% Similarity=0.453 Sum_probs=96.1
Q ss_pred CCCCCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 1 MMSRVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+|++++||||+++++++.. ..+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+|||
T Consensus 105 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrD 181 (458)
T 3rp9_A 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRD 181 (458)
T ss_dssp HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred HHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCC
Confidence 3567899999999999832 3589999998 689999997654 499999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccc----------------------------cccccCCCccccccCCCC
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLT----------------------------EMMTAETGTYRWMAPENM 121 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~----------------------------~~~~~~~gt~~y~aPE~~ 121 (223)
|||+|||++.++ .+||+|||+++..... ......+||+.|+|||++
T Consensus 182 lKp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~ 255 (458)
T 3rp9_A 182 LKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI 255 (458)
T ss_dssp CCGGGEEECTTC-CEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHH
T ss_pred CChhhEEECCCC-CEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHh
Confidence 999999999888 8999999999854321 122345789999999954
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=208.02 Aligned_cols=159 Identities=33% Similarity=0.601 Sum_probs=132.5
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+++++||||+++++++.++..++|+||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+
T Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil 153 (291)
T 1u46_A 75 MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 153 (291)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HHhCCCCCcccEEEEEccCCceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEE
Confidence 46789999999999998888999999999999999997643 34899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC-----------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
++.++ .+||+|||++....... ......++..|+|||.+.
T Consensus 154 i~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 232 (291)
T 1u46_A 154 LATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232 (291)
T ss_dssp EEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EcCCC-CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH
Confidence 99887 89999999987543322 122345778899999321
Q ss_pred ------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 ------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 ------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
+.+..++.++.+++..||+.+|.+||++.++++.|++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 233 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1234677899999999999999999999999999988754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=208.09 Aligned_cols=119 Identities=31% Similarity=0.484 Sum_probs=97.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+. ++|.+++.... +.+++..++.++.|++.||.|||++||+||||||+|
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 130 (288)
T 1ob3_A 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQN 130 (288)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHhcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 4678999999999999975 57899999996 59999887643 349999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 122 (223)
|+++.++ .+||+|||+++..... .......||+.|+|||.+.
T Consensus 131 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 173 (288)
T 1ob3_A 131 LLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173 (288)
T ss_dssp EEECTTS-CEEECCTTHHHHHCC---------CCCTTCCHHHHT
T ss_pred EEEcCCC-CEEEeECccccccCccccccccccccccccCchhee
Confidence 9999887 8999999999754322 2233457899999999653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=228.82 Aligned_cols=160 Identities=32% Similarity=0.576 Sum_probs=134.2
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
|++++||||+++++++.++..++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 445 l~~l~HpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NIL 523 (656)
T 2j0j_A 445 MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 523 (656)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HHhCCCCCCCeEEEEEecCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEE
Confidence 56789999999999998888999999999999999997643 34899999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC-------------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
++.++ .+||+|||+++....... .....+++.|+|||.+.
T Consensus 524 l~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~ 602 (656)
T 2j0j_A 524 VSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602 (656)
T ss_dssp EEETT-EEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred EeCCC-CEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99887 899999999986543322 12345678999999321
Q ss_pred ---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ---------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ---------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++.+++..||+.+|.+||++.++++.|++++..
T Consensus 603 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 603 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 22456778899999999999999999999999999988653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=209.00 Aligned_cols=166 Identities=27% Similarity=0.480 Sum_probs=128.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++... ....+++..++.++.|++.||.|||++|++||||||+
T Consensus 86 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~ 165 (310)
T 2wqm_A 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPA 165 (310)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred HHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHH
Confidence 567899999999999864 6789999999999999998642 3345999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC---------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
||+++.++ .+||+|||++....... ......|++.|+|||.+...
T Consensus 166 NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 244 (310)
T 2wqm_A 166 NVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 244 (310)
T ss_dssp GEEECTTS-CEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH
T ss_pred HEEEcCCC-CEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH
Confidence 99999887 89999999987543322 22345689999999943210
Q ss_pred ---------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCC
Q 027476 125 ---------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168 (223)
Q Consensus 125 ---------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~ 168 (223)
...++.++.+++..||+.+|.+||++.++++.|+++......++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 245 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp HHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 13467889999999999999999999999999999887654443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=213.80 Aligned_cols=145 Identities=23% Similarity=0.288 Sum_probs=126.5
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|+.+ +||||+++++++.+ +..++||||+.||+|.+++...+. +++..++.++.||+.||+|||++||+||||||+|
T Consensus 74 l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 151 (353)
T 2i0e_A 74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 151 (353)
T ss_dssp HTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred HHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHH
Confidence 4455 89999999999976 578999999999999999987654 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccc-cccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREES-LTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
|+++.++ .+||+|||+++... ........+||+.|+|||++.....+...|+|+++..++++-.++.|.
T Consensus 152 Ill~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf 221 (353)
T 2i0e_A 152 VMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221 (353)
T ss_dssp EEECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEcCCC-cEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCC
Confidence 9999888 89999999998532 223345568999999999999999999999999999888776666663
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=207.82 Aligned_cols=153 Identities=28% Similarity=0.420 Sum_probs=125.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.|||++|++||||||+||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 139 (283)
T 3bhy_A 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 139 (283)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHE
Confidence 567899999999999975 578999999999999999987554 99999999999999999999999999999999999
Q ss_pred EEeCCCC---ceEEccCccccccccccccccCCCccccccCCCCCCCC--------------------------------
Q 027476 81 ILTADHK---TVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA-------------------------------- 125 (223)
Q Consensus 81 ll~~~~~---~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------------------------- 125 (223)
+++.++. .+||+|||++.............|++.|+|||.+....
T Consensus 140 l~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 219 (283)
T 3bhy_A 140 MLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET 219 (283)
T ss_dssp EESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH
Confidence 9986542 69999999998655444445567999999999554221
Q ss_pred ----------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ----------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ----------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...+.++.+++.+||+.+|.+||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 220 LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 2345567788999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=206.92 Aligned_cols=153 Identities=27% Similarity=0.445 Sum_probs=115.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 143 (278)
T 3cok_A 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNL 143 (278)
T ss_dssp HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGE
T ss_pred HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 578899999999999976 56889999999999999997642 4589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRP------------------------------------ 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~------------------------------------ 123 (223)
+++.++ .+||+|||++...... .......|++.|+|||.+..
T Consensus 144 li~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 222 (278)
T 3cok_A 144 LLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN 222 (278)
T ss_dssp EECTTC-CEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----
T ss_pred EEcCCC-CEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH
Confidence 999887 8999999999764422 22234578999999995431
Q ss_pred --------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 --------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 --------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+++.+||+.+|.+||++++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 223 KVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 123467788999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-31 Score=212.01 Aligned_cols=156 Identities=26% Similarity=0.414 Sum_probs=124.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.|||++|++||||||+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Ni 133 (311)
T 4agu_A 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI 133 (311)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhE
Confidence 567899999999999975 578999999999999998876544 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCC-CC---------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRP-SA--------------------------------- 125 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~--------------------------------- 125 (223)
+++.++ .+||+|||++...... .......||+.|+|||.+.. ..
T Consensus 134 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 212 (311)
T 4agu_A 134 LITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212 (311)
T ss_dssp EECTTS-CEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCC-CEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999887 8999999999765432 22345578999999995431 11
Q ss_pred ------------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 126 ------------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 126 ------------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
.+++.++.+++..||+.+|.+||++++++++ .++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~ 289 (311)
T 4agu_A 213 YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH--PYFE 289 (311)
T ss_dssp HHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS--GGGT
T ss_pred HHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC--hHHH
Confidence 2345567789999999999999999999876 4443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-31 Score=215.69 Aligned_cols=157 Identities=18% Similarity=0.259 Sum_probs=130.6
Q ss_pred CCCCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLK 76 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 76 (223)
+++++||||+++++++.+ +..++||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+|||||
T Consensus 102 ~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 178 (345)
T 2v62_A 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIK 178 (345)
T ss_dssp HHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred hccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcC
Confidence 456799999999999854 4689999999 999999997655 49999999999999999999999999999999
Q ss_pred CCCEEEeCCC-CceEEccCcccccccccc--------ccccCCCccccccCCCCCCC-----------------------
Q 027476 77 PENLILTADH-KTVKLADFGLAREESLTE--------MMTAETGTYRWMAPENMRPS----------------------- 124 (223)
Q Consensus 77 p~Nill~~~~-~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~----------------------- 124 (223)
|+||+++.++ ..+||+|||+++...... ......||+.|+|||.+...
T Consensus 179 p~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~ 258 (345)
T 2v62_A 179 AANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKL 258 (345)
T ss_dssp GGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999998654 279999999997543221 11345799999999944211
Q ss_pred --------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 125 --------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 125 --------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
...++.++.+++..||+.+|.+||+++++++.|++..
T Consensus 259 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 259 PWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred CccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1156678999999999999999999999999987753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=207.84 Aligned_cols=159 Identities=33% Similarity=0.605 Sum_probs=128.4
Q ss_pred CCCCCCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++.......+++..++.++.|++.||.|||++|++||||||+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 147 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 147 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcce
Confidence 678999999999998743 468999999999999999986544448999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC-------------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
|+++.++ .+||+|||++....... ....+++.|+|||.+.
T Consensus 148 il~~~~~-~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 224 (278)
T 1byg_A 148 VLVSEDN-VAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224 (278)
T ss_dssp EEECTTS-CEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred EEEeCCC-cEEEeeccccccccccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999877 89999999987543322 2346788999999321
Q ss_pred ---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ---------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ---------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++..||+.+|.+||++.++++.|+++...
T Consensus 225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 225 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 12345678899999999999999999999999999987643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=204.95 Aligned_cols=159 Identities=25% Similarity=0.434 Sum_probs=130.7
Q ss_pred CCCCCCCCccceEEEee--c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACK--E-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~--~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++||||+++++++. + +..++||||+.++ |.+++.......+++..++.++.|++.||.|||++|++||||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 138 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPG 138 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcc
Confidence 67889999999999983 2 4789999999765 888887765667999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccc---ccccccCCCccccccCCCCCC--------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESL---TEMMTAETGTYRWMAPENMRP-------------------------------- 123 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-------------------------------- 123 (223)
||+++.++ .+||+|||++..... ........|++.|+|||.+..
T Consensus 139 NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 139 NLLLTTGG-TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp GEEECTTC-CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cEEEcCCC-cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 99999887 899999999975432 222334578999999995431
Q ss_pred --------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 124 --------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 124 --------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
.+..++.++.+++.+||+.+|.+||++++++++ .++...
T Consensus 218 ~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--~~~~~~ 270 (305)
T 2wtk_C 218 IYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH--SWFRKK 270 (305)
T ss_dssp HHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS--HHHHSC
T ss_pred HHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC--cccccC
Confidence 133567788999999999999999999999876 555443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=211.22 Aligned_cols=158 Identities=26% Similarity=0.427 Sum_probs=129.0
Q ss_pred CCCCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-------
Q 027476 2 MSRVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH------- 68 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~------- 68 (223)
++.++||||+++++.+.. ..+++||||+++|+|.+++.... .++..++.++.|++.||.|||+.
T Consensus 61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~ 137 (336)
T 3g2f_A 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHY 137 (336)
T ss_dssp STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGC
T ss_pred HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhcccccc
Confidence 456899999999986521 25789999999999999997643 68999999999999999999999
Q ss_pred --CcccCCCCCCCEEEeCCCCceEEccCccccccccc---------cccccCCCccccccCCCCCCC-------------
Q 027476 69 --GIIHRDLKPENLILTADHKTVKLADFGLAREESLT---------EMMTAETGTYRWMAPENMRPS------------- 124 (223)
Q Consensus 69 --~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~------------- 124 (223)
||+||||||+||+++.++ .+||+|||+++..... .......||+.|+|||.+...
T Consensus 138 ~~~ivH~Dikp~Nill~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 216 (336)
T 3g2f_A 138 KPAISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQV 216 (336)
T ss_dssp BCCEECSSCSGGGEEECTTS-CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHH
T ss_pred ccceeecccccceEEEcCCC-cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccccc
Confidence 999999999999999887 8999999999754321 112244699999999955320
Q ss_pred ----------------------------------------------------------C------CCChHHHHHHHHHhc
Q 027476 125 ----------------------------------------------------------A------ENLPEDLALIVTSCW 140 (223)
Q Consensus 125 ----------------------------------------------------------~------~~~~~~l~~l~~~~l 140 (223)
+ ...+.++.+++..||
T Consensus 217 DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (336)
T 3g2f_A 217 DMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296 (336)
T ss_dssp HHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHS
T ss_pred chHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHh
Confidence 0 002336899999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHhhc
Q 027476 141 KEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 141 ~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+|.+||++.++++.|++++..
T Consensus 297 ~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 297 DQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCChhhCcchHHHHHHHHHHHHH
Confidence 99999999999999999998864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=210.90 Aligned_cols=152 Identities=27% Similarity=0.418 Sum_probs=128.5
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
|++++||||+++++++.++..++||||+.+++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl 146 (322)
T 2ycf_A 69 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 146 (322)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HHhCCCCCCceEeeEEcCCceEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 56789999999999998878999999999999999987644 4999999999999999999999999999999999999
Q ss_pred EeCCCC--ceEEccCccccccccccccccCCCccccccCCCCC---CC--------------------------------
Q 027476 82 LTADHK--TVKLADFGLAREESLTEMMTAETGTYRWMAPENMR---PS-------------------------------- 124 (223)
Q Consensus 82 l~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~-------------------------------- 124 (223)
++.++. .+||+|||+++............||+.|+|||.+. ..
T Consensus 147 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (322)
T 2ycf_A 147 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226 (322)
T ss_dssp ESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS
T ss_pred EecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH
Confidence 986552 49999999998655444344557899999999641 00
Q ss_pred -----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 125 -----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 125 -----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
...++.++.+++..||+.+|.+||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 227 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0234667889999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=213.91 Aligned_cols=142 Identities=27% Similarity=0.366 Sum_probs=124.5
Q ss_pred CCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEe
Q 027476 5 VRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83 (223)
Q Consensus 5 l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 83 (223)
++||||+++++++.+ +.+++||||+.||+|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 152 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 152 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC
Confidence 389999999999976 578999999999999999987554 99999999999999999999999999999999999999
Q ss_pred CCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 84 ADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 84 ~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
.++ .+||+|||+++.... .......+||+.|+|||++.....+...|+|+++..+++.-.+..|.
T Consensus 153 ~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 218 (345)
T 1xjd_A 153 KDG-HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218 (345)
T ss_dssp TTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCC-CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCC
Confidence 888 899999999985432 22345568999999999999999999999999998888776666553
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=207.19 Aligned_cols=152 Identities=30% Similarity=0.550 Sum_probs=126.3
Q ss_pred CCCCCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Q 027476 1 MMSRVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG--IIHR 73 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~ 73 (223)
+|++++||||+++++++.+ ..+++||||+.+++|.+++..... +++..++.++.|++.||.|||++| ++||
T Consensus 78 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~ 155 (290)
T 1t4h_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHR 155 (290)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCS
T ss_pred HHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcCCCCEEEC
Confidence 3678999999999998853 347899999999999999987554 999999999999999999999999 9999
Q ss_pred CCCCCCEEEe-CCCCceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------
Q 027476 74 DLKPENLILT-ADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------- 124 (223)
Q Consensus 74 dlkp~Nill~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------- 124 (223)
||||+||+++ .++ .+||+|||++...... ......|++.|+|||.+...
T Consensus 156 dikp~Nil~~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 156 DLKCDNIFITGPTG-SVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp CCCGGGEEESSTTS-CEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CCCHHHEEEECCCC-CEEEeeCCCccccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999999998 455 8999999999754332 23445799999999965421
Q ss_pred ------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....+.++.+++..||+.+|.+||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 234 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp SHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11234678889999999999999999999865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-31 Score=223.40 Aligned_cols=116 Identities=34% Similarity=0.471 Sum_probs=92.7
Q ss_pred CCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
|++++||||+++++++.. ...++||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+|||
T Consensus 115 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrD 189 (464)
T 3ttj_A 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 189 (464)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 567899999999999853 246999999965 57666643 289999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP 123 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 123 (223)
|||+||+++.++ .+||+|||+++............||+.|+|||++..
T Consensus 190 lkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 237 (464)
T 3ttj_A 190 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 237 (464)
T ss_dssp CCGGGEEECTTS-CEEECCCCCC-----CCCC----CCCTTCCHHHHTT
T ss_pred CChHhEEEeCCC-CEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC
Confidence 999999999888 899999999987655545566789999999996653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=225.97 Aligned_cols=157 Identities=23% Similarity=0.412 Sum_probs=132.5
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+.|++|.+.+..... +++..++.++.|++.||.|||++||+||||||+|
T Consensus 79 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N 156 (484)
T 3nyv_A 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPEN 156 (484)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHH
Confidence 3678999999999999976 578999999999999999976544 9999999999999999999999999999999999
Q ss_pred EEEe---CCCCceEEccCccccccccccccccCCCccccccCCCCCCC--------------------------------
Q 027476 80 LILT---ADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS-------------------------------- 124 (223)
Q Consensus 80 ill~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------------------- 124 (223)
|+++ .++ .+||+|||+++............||+.|+|||++.+.
T Consensus 157 il~~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 235 (484)
T 3nyv_A 157 LLLESKSKDA-NIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDI 235 (484)
T ss_dssp EEESSSSTTC-CEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEecCCCCC-cEEEEeeeeeEEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9994 344 7999999999865544444556899999999954310
Q ss_pred ---------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 125 ---------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 125 ---------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
...++.++.+++..||+.+|.+||++.+++++ .++.
T Consensus 236 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h--~~~~ 286 (484)
T 3nyv_A 236 LKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH--EWIQ 286 (484)
T ss_dssp HHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS--HHHH
T ss_pred HHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC--hhhc
Confidence 12456788899999999999999999999876 4443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=214.35 Aligned_cols=153 Identities=20% Similarity=0.331 Sum_probs=124.2
Q ss_pred CCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 3 SRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 3 ~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++ +||||+++++++.+ +..++||||+.+++|.+++.......+++..++.++.|++.||+|||++||+||||||+||
T Consensus 83 ~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NI 162 (327)
T 3lm5_A 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNI 162 (327)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHE
Confidence 345 57999999999975 5789999999999999998765556699999999999999999999999999999999999
Q ss_pred EEeC---CCCceEEccCccccccccccccccCCCccccccCCCCCCC---------------------------------
Q 027476 81 ILTA---DHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 81 ll~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
+++. ++ .+||+|||+++............||+.|+|||.+...
T Consensus 163 l~~~~~~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 241 (327)
T 3lm5_A 163 LLSSIYPLG-DIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET 241 (327)
T ss_dssp EESCBTTBC-CEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEecCCCCC-cEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 9986 45 7999999999876555444556899999999955422
Q ss_pred ---------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ---------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ---------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++..+.+++..||+.+|.+||++++++++
T Consensus 242 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 242 YLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 12456677888999999999999999999865
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=212.81 Aligned_cols=127 Identities=26% Similarity=0.364 Sum_probs=105.7
Q ss_pred CCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q 027476 4 RVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL 82 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill 82 (223)
.++||||+++++++.+ +..++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 170 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEE
Confidence 3469999999999965 6789999999 9999999988766669999999999999999999999999999999999999
Q ss_pred eC-------------------------CCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHH
Q 027476 83 TA-------------------------DHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLAL 134 (223)
Q Consensus 83 ~~-------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~ 134 (223)
+. ++ .+||+|||+++.... ......||+.|+|||++.....+...|+|+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 171 DDPYFEKSLITVRRVTDGKKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp SCTTCCEEEEEEECTTTCCEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred ccccccccccchhcccccccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHH
Confidence 74 44 799999999975432 234567999999999776554444444443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=206.44 Aligned_cols=151 Identities=23% Similarity=0.382 Sum_probs=129.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+++++|.+++..... +++..++.++.|++.||.|||++|++||||||+||
T Consensus 68 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 145 (284)
T 2vgo_A 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERKVIHRDIKPENL 145 (284)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred HhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 567899999999999975 578999999999999999987654 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------- 123 (223)
+++.++ .+||+|||++...... ......|++.|+|||.+..
T Consensus 146 l~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 223 (284)
T 2vgo_A 146 LMGYKG-ELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR 223 (284)
T ss_dssp EECTTC-CEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred EEcCCC-CEEEecccccccCccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH
Confidence 999887 8999999998754332 2244578999999995432
Q ss_pred -------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 -------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 -------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+++..||+.+|.+||++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 224 IVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 134466788889999999999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=211.16 Aligned_cols=168 Identities=25% Similarity=0.365 Sum_probs=120.8
Q ss_pred CCCC-CCCCccceEEEee--------c-CceEEEEEcCCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 027476 2 MSRV-RHRNLVKFIGACK--------E-PVMVIVTELLLGGTLRKYLLN-MRPRCLDIHVAIGFALDIARAMECLHSHG- 69 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~--------~-~~~~lv~e~~~~~sL~~~l~~-~~~~~l~~~~~~~i~~qi~~~l~~lH~~~- 69 (223)
++++ +||||+++++++. + ..+++||||+ +|+|.+++.. .....+++..++.++.|++.||.|||++|
T Consensus 79 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ 157 (337)
T 3ll6_A 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP 157 (337)
T ss_dssp HHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS
T ss_pred HHHhccCCChhhccccccccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3456 4999999999983 1 2478999999 5799998865 23345999999999999999999999999
Q ss_pred -cccCCCCCCCEEEeCCCCceEEccCccccccccccc-------------cccCCCccccccCCCC---CCCC-------
Q 027476 70 -IIHRDLKPENLILTADHKTVKLADFGLAREESLTEM-------------MTAETGTYRWMAPENM---RPSA------- 125 (223)
Q Consensus 70 -ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~---~~~~------- 125 (223)
++||||||+||+++.++ .+||+|||+++....... .....||+.|+|||.+ ....
T Consensus 158 ~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv 236 (337)
T 3ll6_A 158 PIIHRDLKVENLLLSNQG-TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236 (337)
T ss_dssp CCBCCCCCGGGCEECTTS-CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHH
T ss_pred CEEEccCCcccEEECCCC-CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhH
Confidence 99999999999999887 899999999975433211 1134589999999976 2211
Q ss_pred -----------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCCCC
Q 027476 126 -----------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPV 170 (223)
Q Consensus 126 -----------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~~~ 170 (223)
...+..+.+++..||+.+|.+||++.+++++|..+.......+..
T Consensus 237 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 237 WALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp HHHHHHHHHHHHSSCCC------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred HHHHHHHHHHHhCCCCCcchhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 223345677899999999999999999999999998766555443
Q ss_pred C
Q 027476 171 I 171 (223)
Q Consensus 171 ~ 171 (223)
.
T Consensus 317 ~ 317 (337)
T 3ll6_A 317 P 317 (337)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=213.78 Aligned_cols=166 Identities=17% Similarity=0.230 Sum_probs=134.9
Q ss_pred CCCCCCCCccc---------------eEEEee--cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 027476 2 MSRVRHRNLVK---------------FIGACK--EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMEC 64 (223)
Q Consensus 2 l~~l~Hpniv~---------------l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~ 64 (223)
+++++||||++ +++++. ++..++||||+ +++|.+++.......+++..++.++.|++.||.|
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~ 174 (352)
T 2jii_A 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEF 174 (352)
T ss_dssp HHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHH
Confidence 45667888776 666664 45789999999 9999999987634559999999999999999999
Q ss_pred HHhCCcccCCCCCCCEEEeCCC-CceEEccCccccccccccc--------cccCCCccccccCCCCCCCC----------
Q 027476 65 LHSHGIIHRDLKPENLILTADH-KTVKLADFGLAREESLTEM--------MTAETGTYRWMAPENMRPSA---------- 125 (223)
Q Consensus 65 lH~~~ivH~dlkp~Nill~~~~-~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---------- 125 (223)
||++||+||||||+||+++.++ ..+||+|||+++....... .....||+.|+|||.+....
T Consensus 175 LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 254 (352)
T 2jii_A 175 LHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSL 254 (352)
T ss_dssp HHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred HHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHH
Confidence 9999999999999999999764 2699999999975433221 13347899999999543110
Q ss_pred ---------------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 126 ---------------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 126 ---------------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
..++.++.+++..||+.+|.+||+++++++.|+++
T Consensus 255 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 255 GYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp HHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 13578899999999999999999999999999999
Q ss_pred hhcCCCCC
Q 027476 161 ISTNSAPE 168 (223)
Q Consensus 161 ~~~~~~~~ 168 (223)
........
T Consensus 335 ~~~~~~~~ 342 (352)
T 2jii_A 335 LQDLRVSP 342 (352)
T ss_dssp HHHTTCCT
T ss_pred HHhcCCCc
Confidence 88765443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=212.22 Aligned_cols=144 Identities=26% Similarity=0.364 Sum_probs=126.0
Q ss_pred CCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 3 SRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 3 ~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++ +||||+++++++.+ +..++||||+.||+|.+++..... +++..++.++.||+.||+|||++||+||||||+||
T Consensus 64 ~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 141 (345)
T 3a8x_A 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 141 (345)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 345 89999999999975 578999999999999999987654 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccc-cccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREES-LTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+++.++ .+||+|||+++... ........+||+.|+|||.+.....+...|+|+++..+++.-.++.|.
T Consensus 142 ll~~~g-~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 210 (345)
T 3a8x_A 142 LLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210 (345)
T ss_dssp EECTTS-CEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred EECCCC-CEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCc
Confidence 999888 89999999998532 223345568999999999999999999999999999888776666664
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-30 Score=204.42 Aligned_cols=164 Identities=23% Similarity=0.353 Sum_probs=133.7
Q ss_pred CCCCCCCCccceEEEe-e-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGAC-K-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~-~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++|++++..++.+ . ++..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 135 (296)
T 4hgt_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 135 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 4567788888777766 3 35678999999 999999997533 349999999999999999999999999999999999
Q ss_pred EEE---eCCCCceEEccCccccccccccc--------cccCCCccccccCCCCCCC------------------------
Q 027476 80 LIL---TADHKTVKLADFGLAREESLTEM--------MTAETGTYRWMAPENMRPS------------------------ 124 (223)
Q Consensus 80 ill---~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~------------------------ 124 (223)
|++ +.++ .+||+|||+++....... .....||+.|+|||.+...
T Consensus 136 Il~~~~~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 214 (296)
T 4hgt_A 136 FLMGLGKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214 (296)
T ss_dssp EEECCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eeeeccCCCC-eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCC
Confidence 999 6666 799999999985433221 2345789999999954311
Q ss_pred ----------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCC
Q 027476 125 ----------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168 (223)
Q Consensus 125 ----------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~ 168 (223)
...++.++.+++..||+.+|.+||+++++++.|++++.......
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 215 WQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp TSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred CcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 13457788999999999999999999999999999998766544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=205.72 Aligned_cols=150 Identities=22% Similarity=0.402 Sum_probs=124.5
Q ss_pred CC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 4 RV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 4 ~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++ +||||+++++++.+ +..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|
T Consensus 66 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~N 145 (289)
T 1x8b_A 66 VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSN 145 (289)
T ss_dssp HSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHH
Confidence 45 89999999999965 67899999999999999997642 2459999999999999999999999999999999999
Q ss_pred EEEeCCC------------------CceEEccCccccccccccccccCCCccccccCCCCC-------------------
Q 027476 80 LILTADH------------------KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR------------------- 122 (223)
Q Consensus 80 ill~~~~------------------~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------------------- 122 (223)
|+++.++ ..+||+|||.+...... ....||+.|+|||.+.
T Consensus 146 Il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ 222 (289)
T 1x8b_A 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVV 222 (289)
T ss_dssp EEEC--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHH
T ss_pred EEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHH
Confidence 9998432 26999999998765432 2346899999999543
Q ss_pred ------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 ------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 ------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..+..++.++.+++..||+.+|.+||++.+++++
T Consensus 223 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 223 CAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHTTCCCCCSSSHHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHhcCCCCCcchhHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1234567888999999999999999999999765
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=211.36 Aligned_cols=149 Identities=23% Similarity=0.468 Sum_probs=125.8
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
+||||+++++++.+ +..++||||+.||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+||++..
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~ 151 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVD 151 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESS
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEec
Confidence 79999999999976 578999999999999999986544 999999999999999999999999999999999999854
Q ss_pred CC---CceEEccCccccccccc-cccccCCCccccccCCCCC--------------------------------------
Q 027476 85 DH---KTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR-------------------------------------- 122 (223)
Q Consensus 85 ~~---~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-------------------------------------- 122 (223)
+. ..+||+|||+++..... ......+||+.|+|||++.
T Consensus 152 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~ 231 (342)
T 2qr7_A 152 ESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231 (342)
T ss_dssp SSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH
T ss_pred CCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH
Confidence 32 25999999999854332 2334567899999999332
Q ss_pred -------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 -------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 -------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.....++.++.+++..||+.+|.+||++.+++++
T Consensus 232 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 232 LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0113578889999999999999999999999876
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=213.31 Aligned_cols=118 Identities=25% Similarity=0.449 Sum_probs=100.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~ 78 (223)
+|++++||||+++++++.+ +..++||||++|++|.+++..... +++..+..++.|++.||.|||+. ||+||||||+
T Consensus 84 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~ 161 (360)
T 3eqc_A 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 161 (360)
T ss_dssp GGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGG
T ss_pred HHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHH
Confidence 4678999999999999865 578999999999999999987654 99999999999999999999996 9999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
||+++.++ .+||+|||++...... ......||+.|+|||.+.
T Consensus 162 Nil~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~ 203 (360)
T 3eqc_A 162 NILVNSRG-EIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQ 203 (360)
T ss_dssp GEEECTTC-CEEECCCCCCHHHHHH-C----CCCCTTCCHHHHT
T ss_pred HEEECCCC-CEEEEECCCCcccccc-cccCCCCCCCeECHHHHc
Confidence 99999887 7999999998754322 234457999999999543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=210.05 Aligned_cols=162 Identities=30% Similarity=0.590 Sum_probs=133.6
Q ss_pred CCCC-CCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRP--------------RCLDIHVAIGFALDIARAMEC 64 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~l~~ 64 (223)
|+++ +||||+++++++.+ +.+++||||+.+++|.+++..... ..+++..++.++.|++.||.|
T Consensus 84 l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 163 (316)
T 2xir_A 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163 (316)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHH
Confidence 3455 79999999999864 358999999999999999986543 228999999999999999999
Q ss_pred HHhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC-------------------
Q 027476 65 LHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR------------------- 122 (223)
Q Consensus 65 lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~------------------- 122 (223)
||++|++||||||+||+++.++ .+||+|||+++...... ......+|+.|+|||.+.
T Consensus 164 lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~ 242 (316)
T 2xir_A 164 LASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242 (316)
T ss_dssp HHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHhCCcccccCccceEEECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHH
Confidence 9999999999999999999877 79999999997543221 122345788999999321
Q ss_pred ----------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 ----------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 ----------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+..++.++.+++..||+.+|.+||++.+++++|++++...
T Consensus 243 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 243 IFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 123446778999999999999999999999999999987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=203.42 Aligned_cols=165 Identities=22% Similarity=0.347 Sum_probs=134.2
Q ss_pred CCCCCCCCccceEEEe-e-cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGAC-K-EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~-~-~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++|++++..++.+ . ++..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 135 (296)
T 3uzp_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 135 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred HHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 4567888877777665 3 35679999999 999999997533 349999999999999999999999999999999999
Q ss_pred EEEe---CCCCceEEccCccccccccccc--------cccCCCccccccCCCCCCC------------------------
Q 027476 80 LILT---ADHKTVKLADFGLAREESLTEM--------MTAETGTYRWMAPENMRPS------------------------ 124 (223)
Q Consensus 80 ill~---~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~------------------------ 124 (223)
|+++ .++ .+||+|||++........ .....||+.|+|||.+...
T Consensus 136 Il~~~~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 214 (296)
T 3uzp_A 136 FLMGLGKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214 (296)
T ss_dssp EEECCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eEEecCCCCC-eEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 9994 555 899999999985443221 2345799999999954311
Q ss_pred ----------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCCC
Q 027476 125 ----------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEP 169 (223)
Q Consensus 125 ----------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~~ 169 (223)
...++.++.+++..||+.+|.+||+++++++.|+++......+..
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 215 WQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp TSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred CCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 134677899999999999999999999999999999887765443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=207.06 Aligned_cols=160 Identities=28% Similarity=0.578 Sum_probs=133.9
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++||||+++++++.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+
T Consensus 96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~ 174 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 174 (326)
T ss_dssp HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcc
Confidence 567899999999999853 36899999999999999998753 34899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccc----cccCCCccccccCCCCC--------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMR-------------------------------- 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~-------------------------------- 122 (223)
||+++.++ .+||+|||++........ .....++..|+|||.+.
T Consensus 175 NIli~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 253 (326)
T 2w1i_A 175 NILVENEN-RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253 (326)
T ss_dssp GEEEEETT-EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH
T ss_pred eEEEcCCC-cEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH
Confidence 99999887 899999999986543221 22345777899999321
Q ss_pred -----------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 -----------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 -----------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++.+++..||+.+|.+||++.++++.|+++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 254 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 12345778999999999999999999999999999987653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=218.62 Aligned_cols=116 Identities=28% Similarity=0.426 Sum_probs=96.7
Q ss_pred CCCCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
|++++||||+++++++.. +..++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||
T Consensus 79 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDl 155 (432)
T 3n9x_A 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDL 155 (432)
T ss_dssp HHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHcCCCCcceEEEEEecCCCCcCCeEEEEEecC-CcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 567899999999999853 3589999998 569999997654 3999999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCcccccccccc-----------------------ccccCCCccccccCCCC
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTE-----------------------MMTAETGTYRWMAPENM 121 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~ 121 (223)
||+||+++.++ .+||+|||+++...... .....+||+.|+|||++
T Consensus 156 kp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 223 (432)
T 3n9x_A 156 KPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223 (432)
T ss_dssp CGGGEEECTTC-CEEECCCTTCEEC-------------------------------CCCCCTTCCHHHH
T ss_pred CHHHeEECCCC-CEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHH
Confidence 99999999888 89999999998543221 12456799999999953
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=213.22 Aligned_cols=152 Identities=26% Similarity=0.453 Sum_probs=127.6
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++ +||||+++++++.. +..++||||+.|++|.+++..... +++..++.++.|++.||.|||+.|++|+||||+|
T Consensus 153 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~N 230 (365)
T 2y7j_A 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230 (365)
T ss_dssp HHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 3455 79999999999975 578999999999999999987544 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC------CC----------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------SA---------------------------- 125 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~---------------------------- 125 (223)
|+++.++ .+||+|||++.............||+.|+|||.+.. ..
T Consensus 231 Il~~~~~-~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 231 ILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp EEECTTC-CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCC-CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999887 899999999986655444556789999999995420 00
Q ss_pred --------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 --------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 --------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...+.++.+++..||+.+|.+||++++++++
T Consensus 310 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 310 QILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1344557788888999999999999888764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=210.02 Aligned_cols=119 Identities=27% Similarity=0.480 Sum_probs=94.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+. ++|.+++..... +++..++.++.|++.||.|||++||+||||||+|
T Consensus 86 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~N 162 (329)
T 3gbz_A 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQN 162 (329)
T ss_dssp HGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHH
Confidence 3678999999999999975 57899999996 599999987654 9999999999999999999999999999999999
Q ss_pred EEEeCCC----CceEEccCccccccccc-cccccCCCccccccCCCCC
Q 027476 80 LILTADH----KTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 80 ill~~~~----~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 122 (223)
|+++.++ ..+||+|||+++..... .......||+.|+|||.+.
T Consensus 163 Ill~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~ 210 (329)
T 3gbz_A 163 LLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL 210 (329)
T ss_dssp EEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHT
T ss_pred EEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhc
Confidence 9995332 26999999999754322 2234457899999999654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-31 Score=228.62 Aligned_cols=117 Identities=18% Similarity=0.228 Sum_probs=98.4
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|+++ +|+||+++++++++ +..||||||++|++|.+++.+.+. +++. +|+.||+.||+|+|++||+||||||+|
T Consensus 295 l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeN 369 (569)
T 4azs_A 295 LTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQGFWHDDVRPWN 369 (569)
T ss_dssp HHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGG
T ss_pred HHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHCCceeccCchHh
Confidence 5677 79999999999986 579999999999999999987554 7765 478999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPS 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 124 (223)
||++.++ .+||+|||+|+..... ....+.+||+.|+|||++.+.
T Consensus 370 ILL~~dg-~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~ 414 (569)
T 4azs_A 370 VMVDARQ-HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN 414 (569)
T ss_dssp EEECTTS-CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC---
T ss_pred EEECCCC-CEEEeecccCeeCCCCCccccCceechhhccHHHhCCC
Confidence 9999888 8999999999865432 233456799999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-30 Score=208.26 Aligned_cols=120 Identities=29% Similarity=0.554 Sum_probs=101.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR----PRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
+|++++||||+++++++.+ +..++||||+. ++|.+++.... ...+++..+..++.|++.||.|||++||+||||
T Consensus 56 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dl 134 (317)
T 2pmi_A 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL 134 (317)
T ss_dssp HHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 3678999999999999975 57899999996 69999987532 235899999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~ 122 (223)
||+||+++.++ .+||+|||+++..... .......||+.|+|||.+.
T Consensus 135 kp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 181 (317)
T 2pmi_A 135 KPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181 (317)
T ss_dssp CGGGEEECTTC-CEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHT
T ss_pred ChHHeEEcCCC-CEEECcCccceecCCCcccCCCCcccccccCchHhh
Confidence 99999999887 8999999999865422 2234557899999999553
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-30 Score=207.69 Aligned_cols=162 Identities=31% Similarity=0.559 Sum_probs=133.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP-----RCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
+++++||||+++++++.+ +..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||||
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dl 166 (327)
T 2yfx_A 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDI 166 (327)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcC
Confidence 567899999999999975 578999999999999999987542 34899999999999999999999999999999
Q ss_pred CCCCEEEeCCC--CceEEccCcccccccccc---ccccCCCccccccCCCCC----------------------------
Q 027476 76 KPENLILTADH--KTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR---------------------------- 122 (223)
Q Consensus 76 kp~Nill~~~~--~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~---------------------------- 122 (223)
||+||+++.++ ..+||+|||++....... ......+++.|+|||.+.
T Consensus 167 kp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 246 (327)
T 2yfx_A 167 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246 (327)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99999998433 269999999987432221 122346788999999331
Q ss_pred ------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++..+.+++..||+.+|.+||++.+++++|..+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 247 PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 12345678899999999999999999999999999887653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=206.38 Aligned_cols=158 Identities=25% Similarity=0.414 Sum_probs=124.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~N 130 (324)
T 3mtl_A 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQN 130 (324)
T ss_dssp HHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGG
T ss_pred HHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHH
Confidence 3678999999999999975 57899999996 69999887643 459999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCC-CCC-------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRP-SAE------------------------------- 126 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~------------------------------- 126 (223)
|+++.++ .+||+|||+++..... .......||+.|+|||.+.. ...
T Consensus 131 Il~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 209 (324)
T 3mtl_A 131 LLINERG-ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ 209 (324)
T ss_dssp EEECTTC-CEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEECCCC-CEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999887 8999999999754422 22344578999999995532 111
Q ss_pred -------------------------------------------CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 127 -------------------------------------------NLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 127 -------------------------------------------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
.++.++.+++.+||+.+|.+||++++++++ .++..
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~ 287 (324)
T 3mtl_A 210 LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH--PFFLS 287 (324)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGGG
T ss_pred HHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC--hhhhh
Confidence 245667789999999999999999999876 55544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=212.44 Aligned_cols=152 Identities=26% Similarity=0.366 Sum_probs=126.1
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|+++ +||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.|||++||+||||||+|
T Consensus 112 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~N 189 (355)
T 1vzo_A 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN 189 (355)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 3455 69999999999865 578999999999999999987654 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMRP---------------------------------- 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~---------------------------------- 123 (223)
|+++.++ .+||+|||+++...... ......||+.|+|||.+..
T Consensus 190 Ill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 268 (355)
T 1vzo_A 190 ILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268 (355)
T ss_dssp EEECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred EEECCCC-cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc
Confidence 9999887 89999999997543222 2234579999999995541
Q ss_pred ----------------CCCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 124 ----------------SAENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 124 ----------------~~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
.+..++..+.+++.+||+.+|.+|| ++++++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 269 NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred chHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1234556677888999999999998 88888765
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=204.61 Aligned_cols=151 Identities=28% Similarity=0.447 Sum_probs=127.0
Q ss_pred CCCCCCccceEEEee-----c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 4 RVRHRNLVKFIGACK-----E-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~-----~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
+++||||+++++++. + ...++||||+. ++|.+++.......+++..++.++.|++.||.|||++|++||||||
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp 148 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 148 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCH
Confidence 358999999999985 2 46889999996 6999999876656699999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCC--------------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA-------------------------------- 125 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------------------------- 125 (223)
+||+++.++ .+||+|||+++............|++.|+|||.+....
T Consensus 149 ~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (326)
T 1blx_A 149 QNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227 (326)
T ss_dssp GGEEECTTC-CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred HHeEEcCCC-CEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 999999887 89999999998665444445668999999999543221
Q ss_pred ---------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ---------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ---------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++.+||+.+|.+||++.+++++
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2345667788889999999999999999865
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=205.26 Aligned_cols=156 Identities=27% Similarity=0.464 Sum_probs=130.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++...+. +++..++.++.|++.||.|||++|++||||||+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NI 137 (304)
T 2jam_A 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENL 137 (304)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGC
T ss_pred HHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 567899999999999975 578999999999999999977654 99999999999999999999999999999999999
Q ss_pred EE---eCCCCceEEccCccccccccccccccCCCccccccCCCCCCC---------------------------------
Q 027476 81 IL---TADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 81 ll---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
++ +.++ .+||+|||++...... ......|++.|+|||.+...
T Consensus 138 l~~~~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 215 (304)
T 2jam_A 138 LYLTPEENS-KIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL 215 (304)
T ss_dssp EESSSSTTC-CEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred EEecCCCCC-CEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 99 5555 7999999998754332 22334689999999965421
Q ss_pred ---------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 125 ---------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 125 ---------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
...++.++.+++..||+.+|.+||++++++++ .++..
T Consensus 216 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h--~~~~~ 267 (304)
T 2jam_A 216 FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH--PWIDG 267 (304)
T ss_dssp HHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS--HHHHS
T ss_pred HHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--ccccC
Confidence 13456788899999999999999999999876 44443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=202.95 Aligned_cols=155 Identities=27% Similarity=0.501 Sum_probs=125.6
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM------RPRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~------~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
++++++||||+++++++.+ +..++||||+.+++|.+++... ....+++..++.++.|++.||.|||++|++||
T Consensus 66 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 145 (303)
T 2vwi_A 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR 145 (303)
T ss_dssp CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 4678899999999999965 6789999999999999998741 23459999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccccccc------cccccCCCccccccCCCCCC------------------------
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLT------EMMTAETGTYRWMAPENMRP------------------------ 123 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~------------------------ 123 (223)
||||+||+++.++ .+||+|||++...... .......||+.|+|||.+..
T Consensus 146 dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 224 (303)
T 2vwi_A 146 DVKAGNILLGEDG-SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224 (303)
T ss_dssp CCSGGGEEECTTC-CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCChhhEEEcCCC-CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999887 8999999998754321 11234468999999994310
Q ss_pred -------------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 -------------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 -------------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....++.++.+++..||+.+|.+||++.+++++
T Consensus 225 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 225 APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 012456788999999999999999999999865
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=207.55 Aligned_cols=160 Identities=31% Similarity=0.568 Sum_probs=128.7
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++++++||||+++++++.+ +..++||||+.|++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|
T Consensus 82 ~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~N 160 (319)
T 2y4i_B 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKN 160 (319)
T ss_dssp GGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTT
T ss_pred HHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhh
Confidence 4678899999999999975 57899999999999999997643 358999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc------ccccccCCCccccccCCCCCC------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESL------TEMMTAETGTYRWMAPENMRP------------------------------ 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~------------------------------ 123 (223)
|+++ ++ .+||+|||+++.... ........|++.|+|||.+..
T Consensus 161 Il~~-~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~ 238 (319)
T 2y4i_B 161 VFYD-NG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238 (319)
T ss_dssp EEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEe-CC-CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 9998 55 799999999864321 112233468999999996531
Q ss_pred -------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 124 -------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 124 -------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
....++.++.+++..||..+|.+||++.++++.|+++...
T Consensus 239 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 239 REWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp SSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 0123556788899999999999999999999999887654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=211.03 Aligned_cols=159 Identities=27% Similarity=0.417 Sum_probs=124.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------------------------------------
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR-------------------------------------- 42 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-------------------------------------- 42 (223)
|++++||||+++++++.+ +..++||||++||+|.+++....
T Consensus 82 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (345)
T 3hko_A 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL 161 (345)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEEC
T ss_pred HHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 567899999999999975 56899999999999999985210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCC-ceEEccCcccccccccc-----ccccCCCccccc
Q 027476 43 PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHK-TVKLADFGLAREESLTE-----MMTAETGTYRWM 116 (223)
Q Consensus 43 ~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~-~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~ 116 (223)
...+++..++.++.|++.||.|||++||+||||||+||+++.++. .+||+|||+++...... ......||+.|+
T Consensus 162 ~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 241 (345)
T 3hko_A 162 DFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV 241 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGC
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcccc
Confidence 112467888999999999999999999999999999999986542 69999999997543211 123457999999
Q ss_pred cCCCCCC--CC------------------------------------------------CCChHHHHHHHHHhcccCCCC
Q 027476 117 APENMRP--SA------------------------------------------------ENLPEDLALIVTSCWKEDPNE 146 (223)
Q Consensus 117 aPE~~~~--~~------------------------------------------------~~~~~~l~~l~~~~l~~~p~~ 146 (223)
|||.+.. .. ..++.++.+++..||+.+|.+
T Consensus 242 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp CHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred CchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 9996531 11 125677888999999999999
Q ss_pred CCCHHHHHHHHHHHhh
Q 027476 147 RPNFSQIIQMLLHYIS 162 (223)
Q Consensus 147 Rp~~~~~~~~L~~~~~ 162 (223)
||++.+++++ .++.
T Consensus 322 Rps~~~~l~h--p~~~ 335 (345)
T 3hko_A 322 RFDAMRALQH--PWIS 335 (345)
T ss_dssp SCCHHHHHHS--HHHH
T ss_pred CCCHHHHhcC--hhhc
Confidence 9999999876 4444
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-31 Score=219.03 Aligned_cols=150 Identities=16% Similarity=0.287 Sum_probs=121.6
Q ss_pred CCCCCCCCccceE-------EEeecC------------------ceEEEEEcCCCCCHHHHHHhcCC-----CCCCHHHH
Q 027476 2 MSRVRHRNLVKFI-------GACKEP------------------VMVIVTELLLGGTLRKYLLNMRP-----RCLDIHVA 51 (223)
Q Consensus 2 l~~l~Hpniv~l~-------~~~~~~------------------~~~lv~e~~~~~sL~~~l~~~~~-----~~l~~~~~ 51 (223)
|++++||||++++ ++++++ ..++||||+ +|+|.+++..... ..+++..+
T Consensus 130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~ 208 (377)
T 3byv_A 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHAR 208 (377)
T ss_dssp STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHH
T ss_pred ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHH
Confidence 6778999999998 555433 278999999 7899999986432 11335888
Q ss_pred HHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-------
Q 027476 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS------- 124 (223)
Q Consensus 52 ~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------- 124 (223)
+.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++.... ......| +.|+|||.+...
T Consensus 209 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~ 284 (377)
T 3byv_A 209 LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHR 284 (377)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHH
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccc
Confidence 89999999999999999999999999999999887 899999999986433 2345567 999999964321
Q ss_pred --------------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 --------------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 --------------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++..||+.+|.+||++.+++++
T Consensus 285 ~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp CCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred cccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 23566778889999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=213.40 Aligned_cols=161 Identities=24% Similarity=0.339 Sum_probs=134.1
Q ss_pred CCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
|++++||||+++++++.+ ...++||||+.+++|.+++..... ..+++..++.++.|++.||+|||++||+||||||
T Consensus 61 l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 140 (396)
T 4eut_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP 140 (396)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCH
Confidence 567899999999999864 267999999999999999976432 3399999999999999999999999999999999
Q ss_pred CCEEE----eCCCCceEEccCccccccccccccccCCCccccccCCCCCC------------------------------
Q 027476 78 ENLIL----TADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------ 123 (223)
Q Consensus 78 ~Nill----~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------ 123 (223)
+||++ +.++ .+||+|||+++............||+.|+|||.+..
T Consensus 141 ~NIll~~~~~~~~-~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg 219 (396)
T 4eut_A 141 GNIMRVIGEDGQS-VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (396)
T ss_dssp GGEEEEECTTSCE-EEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHEEEeecCCCce-eEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC
Confidence 99998 5444 799999999987655555556789999999995310
Q ss_pred -----------------------CC----------------------------CCChHHHHHHHHHhcccCCCCCCCHHH
Q 027476 124 -----------------------SA----------------------------ENLPEDLALIVTSCWKEDPNERPNFSQ 152 (223)
Q Consensus 124 -----------------------~~----------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~ 152 (223)
.+ ...+..+.+++..||+.+|.+||++++
T Consensus 220 ~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (396)
T 4eut_A 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (396)
T ss_dssp SCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred CCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence 00 113456788999999999999999999
Q ss_pred HHHHHHHHhhc
Q 027476 153 IIQMLLHYIST 163 (223)
Q Consensus 153 ~~~~L~~~~~~ 163 (223)
+++.+.+++..
T Consensus 300 ~l~~l~~il~~ 310 (396)
T 4eut_A 300 FFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHHTC
T ss_pred HHHHHHHHhhc
Confidence 99999888764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=203.59 Aligned_cols=152 Identities=27% Similarity=0.399 Sum_probs=127.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 136 (276)
T 2yex_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136 (276)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHE
Confidence 567899999999999975 57889999999999999886543 399999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCCCC---------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
+++.++ .+||+|||++...... .......|++.|+|||.+...
T Consensus 137 l~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 215 (276)
T 2yex_A 137 LLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (276)
T ss_dssp EECTTC-CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS
T ss_pred EEccCC-CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 999877 7999999999754322 223455789999999965311
Q ss_pred ---------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ---------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ---------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++..||+.+|.+||++++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 216 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 12356778889999999999999999988764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=208.34 Aligned_cols=159 Identities=23% Similarity=0.327 Sum_probs=126.9
Q ss_pred CCCCCCCCccceEEEeec---------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 2 MSRVRHRNLVKFIGACKE---------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~---------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
|++++||||+++++++.+ +..++||||+. ++|.+.+.... ..+++..++.++.|++.||.|||++||+|
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 147 (351)
T 3mi9_A 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILH 147 (351)
T ss_dssp HHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence 567899999999999854 35789999996 58888776543 34999999999999999999999999999
Q ss_pred CCCCCCCEEEeCCCCceEEccCcccccccc-----ccccccCCCccccccCCCCCCC-CCCC------------------
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESL-----TEMMTAETGTYRWMAPENMRPS-AENL------------------ 128 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~-~~~~------------------ 128 (223)
|||||+||+++.++ .+||+|||+++.... ........||+.|+|||.+... ..+.
T Consensus 148 ~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 226 (351)
T 3mi9_A 148 RDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226 (351)
T ss_dssp CCCSGGGEEECTTS-CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCCHHHEEEcCCC-CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCC
Confidence 99999999999888 899999999975432 1223445789999999965421 1122
Q ss_pred ----------------------------------------------------------hHHHHHHHHHhcccCCCCCCCH
Q 027476 129 ----------------------------------------------------------PEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 129 ----------------------------------------------------------~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
+.++.+++.+||+.+|.+||++
T Consensus 227 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 306 (351)
T 3mi9_A 227 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306 (351)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH
Confidence 3446678889999999999999
Q ss_pred HHHHHHHHHHhhcCC
Q 027476 151 SQIIQMLLHYISTNS 165 (223)
Q Consensus 151 ~~~~~~L~~~~~~~~ 165 (223)
++++++ .++....
T Consensus 307 ~e~l~h--p~f~~~~ 319 (351)
T 3mi9_A 307 DDALNH--DFFWSDP 319 (351)
T ss_dssp HHHHTS--GGGGSSS
T ss_pred HHHhCC--CCcCCCC
Confidence 999887 6665433
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=203.89 Aligned_cols=153 Identities=27% Similarity=0.421 Sum_probs=120.5
Q ss_pred CCCCCCCCccceEEEeec--------------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 027476 2 MSRVRHRNLVKFIGACKE--------------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS 67 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~--------------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~ 67 (223)
+++++||||+++++++.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~ 134 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS 134 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHh
Confidence 678999999999998743 35789999999999999998643 348899999999999999999999
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccccccc---------------cccccCCCccccccCCCCCCC--------
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLAREESLT---------------EMMTAETGTYRWMAPENMRPS-------- 124 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-------- 124 (223)
+|++||||||+||+++.++ .+||+|||++...... .......|++.|+|||.+...
T Consensus 135 ~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 213 (303)
T 1zy4_A 135 QGIIHRDLKPMNIFIDESR-NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKID 213 (303)
T ss_dssp TTCCCSCCCGGGEEECTTS-CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHH
T ss_pred CCeecccCCHHhEEEcCCC-CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhh
Confidence 9999999999999999887 7999999998754321 122345689999999965421
Q ss_pred ---------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ---------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ---------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....+..+.+++..||+.+|.+||++++++++
T Consensus 214 i~slG~il~~l~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 214 MYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHHHHSCCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHHHHhccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 12234457788999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-30 Score=217.46 Aligned_cols=146 Identities=19% Similarity=0.292 Sum_probs=125.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||++++++|.+ +.+++||||+.||+|.+++.+.. +.+++..++.++.|++.||.|||++||+||||||+||
T Consensus 128 l~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NI 206 (437)
T 4aw2_A 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 206 (437)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHe
Confidence 456899999999999976 57899999999999999997632 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCC-----CCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMR-----PSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-----~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+++.++ .+||+|||+++...... .....+||+.|+|||++. ...++...|+|+++..++++-.++.|.
T Consensus 207 Ll~~~g-~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf 281 (437)
T 4aw2_A 207 LMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281 (437)
T ss_dssp EECTTS-CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eEcCCC-CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCC
Confidence 999888 89999999997543322 223468999999999986 456788999999999988877676664
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=208.17 Aligned_cols=159 Identities=26% Similarity=0.396 Sum_probs=130.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 143 (346)
T 1ua2_A 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 143 (346)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHE
Confidence 567899999999999965 578999999965 8988887643 4589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCC-C---------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPS-A--------------------------------- 125 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~--------------------------------- 125 (223)
+++.++ .+||+|||+++..... .......||+.|+|||.+... .
T Consensus 144 l~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~ 222 (346)
T 1ua2_A 144 LLDENG-VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 222 (346)
T ss_dssp EECTTC-CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEcCCC-CEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 999887 8999999999865332 233456789999999954210 0
Q ss_pred ---------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCC
Q 027476 126 ---------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165 (223)
Q Consensus 126 ---------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~ 165 (223)
...+.++.+++..||+.+|.+||++++++++ .++....
T Consensus 223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--~~f~~~~ 299 (346)
T 1ua2_A 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNRP 299 (346)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSSS
T ss_pred HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC--hhhhcCC
Confidence 2335778889999999999999999999887 5655443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-30 Score=213.01 Aligned_cols=116 Identities=27% Similarity=0.443 Sum_probs=95.6
Q ss_pred CCCCC-CCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 2 MSRVR-HRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 2 l~~l~-Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
|+++. ||||+++++++.. ..+++||||+. ++|.+++... .+++..+..++.|++.||+|||+.||+||||||
T Consensus 62 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 137 (388)
T 3oz6_A 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKP 137 (388)
T ss_dssp HHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCH
Confidence 45565 9999999999953 26899999996 6999998763 489999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCcccccccc----------------------ccccccCCCccccccCCCCC
Q 027476 78 ENLILTADHKTVKLADFGLAREESL----------------------TEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~----------------------~~~~~~~~gt~~y~aPE~~~ 122 (223)
+||+++.++ .+||+|||+++.... .......+||+.|+|||++.
T Consensus 138 ~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 203 (388)
T 3oz6_A 138 SNILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL 203 (388)
T ss_dssp GGEEECTTC-CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT
T ss_pred HHeEEcCCC-CEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhc
Confidence 999999888 899999999975321 11223457999999999654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=207.16 Aligned_cols=149 Identities=28% Similarity=0.448 Sum_probs=125.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++++++.+ +..++||||+. |+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 108 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 185 (348)
T 1u5q_A 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 185 (348)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 567899999999999965 57899999996 68888876533 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCC---C----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR---P---------------------------------- 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~---------------------------------- 123 (223)
+++.++ .+||+|||+++..... ....||+.|+|||.+. .
T Consensus 186 ll~~~~-~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 261 (348)
T 1u5q_A 186 LLSEPG-LVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261 (348)
T ss_dssp EEETTT-EEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred EECCCC-CEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999887 8999999999764432 3457999999999641 0
Q ss_pred ------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 ------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 ------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....++.++.+++..||+.+|.+||++++++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 262 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 123456778889999999999999999999876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=206.62 Aligned_cols=153 Identities=29% Similarity=0.454 Sum_probs=114.2
Q ss_pred CCCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 3 SRVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
+.++||||+++++++.. ...++||||+.||+|.+++.......+++..++.++.|++.||.|||++|++||||||
T Consensus 77 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp 156 (336)
T 3fhr_A 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKP 156 (336)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 45689999999999853 2478999999999999999877666799999999999999999999999999999999
Q ss_pred CCEEEeCCC--CceEEccCccccccccccccccCCCccccccCCCCCC--------------------------------
Q 027476 78 ENLILTADH--KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP-------------------------------- 123 (223)
Q Consensus 78 ~Nill~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------------------------------- 123 (223)
+||+++.++ ..+||+|||+++..... ......||+.|+|||.+..
T Consensus 157 ~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 157 ENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred HHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 999997533 25999999999765432 2344578999999995531
Q ss_pred --------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 --------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 --------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....++.++.+++..||+.+|.+||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 013567889999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=205.47 Aligned_cols=157 Identities=29% Similarity=0.434 Sum_probs=130.8
Q ss_pred CCCCCCccceEEEeecC-----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCc
Q 027476 4 RVRHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLH--------SHGI 70 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH--------~~~i 70 (223)
+++||||+++++++.+. ..++||||+.+|+|.+++.+. .+++..++.++.|++.||.||| +.|+
T Consensus 92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 168 (342)
T 1b6c_B 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168 (342)
T ss_dssp CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE
T ss_pred hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCe
Confidence 37999999999998653 689999999999999999763 3899999999999999999999 8999
Q ss_pred ccCCCCCCCEEEeCCCCceEEccCcccccccccc-----ccccCCCccccccCCCCCCC---------------------
Q 027476 71 IHRDLKPENLILTADHKTVKLADFGLAREESLTE-----MMTAETGTYRWMAPENMRPS--------------------- 124 (223)
Q Consensus 71 vH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--------------------- 124 (223)
+||||||+||+++.++ .+||+|||++....... ......||+.|+|||.+...
T Consensus 169 vH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 247 (342)
T 1b6c_B 169 AHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247 (342)
T ss_dssp ECSCCSGGGEEECTTS-CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHH
T ss_pred eeCCCCHHHEEECCCC-CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHH
Confidence 9999999999999887 89999999997543322 22445799999999954211
Q ss_pred ------------------C------------------------C---------CChHHHHHHHHHhcccCCCCCCCHHHH
Q 027476 125 ------------------A------------------------E---------NLPEDLALIVTSCWKEDPNERPNFSQI 153 (223)
Q Consensus 125 ------------------~------------------------~---------~~~~~l~~l~~~~l~~~p~~Rp~~~~~ 153 (223)
+ . ..+..+.+++..||+.+|.+||++.++
T Consensus 248 ~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 248 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 0 0 112467889999999999999999999
Q ss_pred HHHHHHHhhcC
Q 027476 154 IQMLLHYISTN 164 (223)
Q Consensus 154 ~~~L~~~~~~~ 164 (223)
+++|+++....
T Consensus 328 ~~~L~~i~~~~ 338 (342)
T 1b6c_B 328 KKTLSQLSQQE 338 (342)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHHh
Confidence 99999987654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=210.77 Aligned_cols=155 Identities=26% Similarity=0.378 Sum_probs=126.4
Q ss_pred CCCCCCCCCccceEEEeec---------------------------------------CceEEEEEcCCCCCHHHHHHh-
Q 027476 1 MMSRVRHRNLVKFIGACKE---------------------------------------PVMVIVTELLLGGTLRKYLLN- 40 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---------------------------------------~~~~lv~e~~~~~sL~~~l~~- 40 (223)
+|++++||||++++++|.. ...++||||+. ++|.+.+..
T Consensus 53 il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~ 131 (383)
T 3eb0_A 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF 131 (383)
T ss_dssp HHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHH
T ss_pred HHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH
Confidence 3678999999999998832 13789999996 688877764
Q ss_pred -cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCC
Q 027476 41 -MRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119 (223)
Q Consensus 41 -~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE 119 (223)
.....+++..++.++.||+.||.|||++||+||||||+||+++.++..+||+|||+++............||+.|+|||
T Consensus 132 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE 211 (383)
T 3eb0_A 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPE 211 (383)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHH
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHH
Confidence 2344599999999999999999999999999999999999998544489999999998665555555667899999999
Q ss_pred CCCCC--------------------------------------------------------------------------C
Q 027476 120 NMRPS--------------------------------------------------------------------------A 125 (223)
Q Consensus 120 ~~~~~--------------------------------------------------------------------------~ 125 (223)
.+... +
T Consensus 212 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (383)
T 3eb0_A 212 LMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291 (383)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSC
T ss_pred HhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCC
Confidence 54311 1
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...+.++.+++.+||+.+|.+||++.+++++
T Consensus 292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2255668889999999999999999999865
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=204.11 Aligned_cols=153 Identities=27% Similarity=0.399 Sum_probs=128.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Ni 156 (314)
T 3com_A 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI 156 (314)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHE
Confidence 567899999999999864 67899999999999999987432 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .+||+|||++....... ......|++.|+|||.+...
T Consensus 157 l~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 235 (314)
T 3com_A 157 LLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF 235 (314)
T ss_dssp EECTTC-CEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EECCCC-CEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 999887 89999999997544322 23345789999999954321
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++.+++..||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 236 MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 12346778889999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=202.62 Aligned_cols=153 Identities=28% Similarity=0.460 Sum_probs=119.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLN--MRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKP 77 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp 77 (223)
++.++||||+++++++.+ +..++||||+. ++|.+++.. .....+++..++.++.|++.||.|||++ |++||||||
T Consensus 60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp 138 (290)
T 3fme_A 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138 (290)
T ss_dssp HTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSG
T ss_pred HHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCH
Confidence 467899999999999975 57899999996 588887754 2334599999999999999999999998 999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC----C------------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR----P------------------------------ 123 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~------------------------------ 123 (223)
+||+++.++ .+||+|||+++............||+.|+|||.+. .
T Consensus 139 ~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (290)
T 3fme_A 139 SNVLINALG-QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217 (290)
T ss_dssp GGCEECTTC-CEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS
T ss_pred HHEEECCCC-CEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC
Confidence 999999877 89999999998655544445557999999999741 0
Q ss_pred -----------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 -----------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 -----------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....++.++.+++..||+.+|.+||++++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 218 TPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp CHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred chHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 013467788999999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=204.67 Aligned_cols=151 Identities=30% Similarity=0.473 Sum_probs=128.2
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++.. +.+++..++.++.|++.||.|||++|++|+||||+||
T Consensus 74 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 150 (303)
T 3a7i_A 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 150 (303)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheE
Confidence 567899999999999865 678999999999999999864 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS----------------------------------- 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------------------- 124 (223)
+++.++ .+||+|||++....... ......|++.|+|||.+...
T Consensus 151 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 229 (303)
T 3a7i_A 151 LLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF 229 (303)
T ss_dssp EECTTS-CEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred EECCCC-CEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH
Confidence 999887 89999999997644322 23445789999999955321
Q ss_pred ----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++..||+.+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 230 LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 23456778889999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=206.28 Aligned_cols=116 Identities=22% Similarity=0.387 Sum_probs=100.8
Q ss_pred CCCCC-CCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 2 MSRVR-HRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 2 l~~l~-Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
|++++ ||||+++++++.+ ...++||||+.+++|.+++.. +++..++.++.|++.||+|||++||+||||||
T Consensus 84 l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 158 (330)
T 3nsz_A 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKP 158 (330)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 45565 9999999999975 468999999999999998854 89999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
+||+++.++..+||+|||+++............|+..|+|||.+.
T Consensus 159 ~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~ 203 (330)
T 3nsz_A 159 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 203 (330)
T ss_dssp GGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHT
T ss_pred HHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhc
Confidence 999999776689999999998655544455668999999999543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=203.64 Aligned_cols=152 Identities=24% Similarity=0.414 Sum_probs=128.9
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|+++ +||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.|||++|++|+||||+|
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 154 (298)
T 1phk_A 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 154 (298)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcce
Confidence 3456 49999999999975 568999999999999999987544 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC------C------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR------P------------------------------ 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------~------------------------------ 123 (223)
|+++.++ .+||+|||++.............|++.|+|||.+. .
T Consensus 155 il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 155 ILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp EEECTTC-CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCC-cEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 9999887 79999999998655444445567999999999541 0
Q ss_pred ------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 ------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 ------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....++.++.+++..||+.+|.+||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 234 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 002356778899999999999999999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=210.77 Aligned_cols=115 Identities=35% Similarity=0.480 Sum_probs=88.3
Q ss_pred CCCCCCCCccceEEEeecC-------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKEP-------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+++++||||+++++++... ..++||||+. ++|.+.+.. .+++..+..++.|++.||.|||++||+|||
T Consensus 78 l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~D 152 (371)
T 2xrw_A 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 152 (371)
T ss_dssp HHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 5678999999999998542 5799999996 578888853 289999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
|||+||+++.++ .+||+|||+++............||+.|+|||.+.
T Consensus 153 lkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 199 (371)
T 2xrw_A 153 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199 (371)
T ss_dssp CCGGGEEECTTS-CEEECCCCC----------------CTTCCHHHHT
T ss_pred CCHHHEEEcCCC-CEEEEEeecccccccccccCCceecCCccCHHHhc
Confidence 999999999887 89999999998655444445568999999999554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=200.46 Aligned_cols=155 Identities=24% Similarity=0.456 Sum_probs=128.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR-PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++||||+++++++.+ +..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 73 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 152 (295)
T 2clq_A 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDN 152 (295)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhh
Confidence 567899999999999965 57889999999999999998653 2347899999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCC------------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
|+++...+.+||+|||++....... ......|++.|+|||.+.
T Consensus 153 il~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 232 (295)
T 2clq_A 153 VLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ 232 (295)
T ss_dssp EEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH
T ss_pred EEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh
Confidence 9999733389999999997644322 233457899999999431
Q ss_pred -------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 -------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 -------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..+..++.++.+++..||+.+|.+||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 233 AAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1234567889999999999999999999999765
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=209.39 Aligned_cols=152 Identities=32% Similarity=0.520 Sum_probs=122.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++..... +++..++.++.|++.||.|||++|++||||||+||
T Consensus 78 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni 155 (331)
T 4aaa_A 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENI 155 (331)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheE
Confidence 567899999999999975 578999999999999888765443 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCC-C---------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPS-A--------------------------------- 125 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~--------------------------------- 125 (223)
+++.++ .+||+|||+++..... .......|++.|+|||.+... .
T Consensus 156 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 234 (331)
T 4aaa_A 156 LVSQSG-VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234 (331)
T ss_dssp EECTTS-CEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCC-cEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999887 8999999999754332 233455789999999955321 1
Q ss_pred ------------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ------------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ------------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++..||+.+|.+||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 235 YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1345677888899999999999999988765
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=211.49 Aligned_cols=158 Identities=22% Similarity=0.295 Sum_probs=125.2
Q ss_pred CCCCCCCCCccceEEEeec-C------ceEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 027476 1 MMSRVRHRNLVKFIGACKE-P------VMVIVTELLLGGTLRKYLLN--MRPRCLDIHVAIGFALDIARAMECLHSHGII 71 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~------~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iv 71 (223)
+|++++||||++++++|.. + .+++||||+.++ +.+.+.. .....+++..++.++.|++.||.|||++||+
T Consensus 85 il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 163 (394)
T 4e7w_A 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGIC 163 (394)
T ss_dssp HHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 3678899999999999842 1 278999999764 4443331 2234599999999999999999999999999
Q ss_pred cCCCCCCCEEEe-CCCCceEEccCccccccccccccccCCCccccccCCCCCCC--------------------------
Q 027476 72 HRDLKPENLILT-ADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS-------------------------- 124 (223)
Q Consensus 72 H~dlkp~Nill~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------------- 124 (223)
||||||+||+++ .++ .+||+|||+++............||+.|+|||.+...
T Consensus 164 HrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 242 (394)
T 4e7w_A 164 HRDIKPQNLLLDPPSG-VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242 (394)
T ss_dssp CSCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCCCHHHEEEcCCCC-cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999 455 8999999999876555545566889999999954311
Q ss_pred ------------------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ------------------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ------------------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....+.++.+++.+||+.+|.+||++.+++++
T Consensus 243 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 243 PGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 01255678889999999999999999999876
Q ss_pred HHHHhh
Q 027476 157 LLHYIS 162 (223)
Q Consensus 157 L~~~~~ 162 (223)
.++.
T Consensus 323 --p~f~ 326 (394)
T 4e7w_A 323 --PFFD 326 (394)
T ss_dssp --GGGS
T ss_pred --hhhh
Confidence 4444
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-29 Score=201.78 Aligned_cols=150 Identities=27% Similarity=0.430 Sum_probs=121.5
Q ss_pred CCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEe
Q 027476 5 VRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83 (223)
Q Consensus 5 l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 83 (223)
++||||+++++++.+ +.+++||||+.|++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 145 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCE 145 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEc
Confidence 479999999999965 678999999999999999987654 99999999999999999999999999999999999998
Q ss_pred CCCC--ceEEccCccccccccc--------cccccCCCccccccCCCCCC----------------------------CC
Q 027476 84 ADHK--TVKLADFGLAREESLT--------EMMTAETGTYRWMAPENMRP----------------------------SA 125 (223)
Q Consensus 84 ~~~~--~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~----------------------------~~ 125 (223)
.++. .+||+|||++...... .......||+.|+|||.+.. .+
T Consensus 146 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 225 (316)
T 2ac3_A 146 HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225 (316)
T ss_dssp CSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCC
Confidence 7652 3999999998754321 11223469999999995420 00
Q ss_pred ----------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ----------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ----------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++.+||+.+|.+||++++++++
T Consensus 226 f~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 226 FVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1356678999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=207.93 Aligned_cols=153 Identities=20% Similarity=0.347 Sum_probs=130.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKY------LLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHR 73 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~------l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~ 73 (223)
+++++||||+++++++.+ +..++||||+++++|.++ +.......+++..++.++.|++.||.|||+ +|++||
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~ 176 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence 678999999999999975 578999999999999998 655435669999999999999999999999 999999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-----------------------------
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS----------------------------- 124 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------------- 124 (223)
||||+||+++.++ .+||+|||++...... ......|++.|+|||.+...
T Consensus 177 dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 177 DVKPSNILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp CCCGGGEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCChHhEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999887 8999999999865433 33456799999999954311
Q ss_pred ------------------C-------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ------------------A-------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ------------------~-------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+ ..++.++.+++..||+.+|.+||++++++++
T Consensus 255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 3467889999999999999999999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=222.44 Aligned_cols=145 Identities=23% Similarity=0.288 Sum_probs=127.0
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|+.+ +||||+++++++++ +.+|+||||+.||+|.+++...+. +++..++.++.||+.||+|||++||+||||||+|
T Consensus 395 l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~N 472 (674)
T 3pfq_A 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 472 (674)
T ss_dssp HTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTT
T ss_pred HHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhh
Confidence 3444 79999999999976 578999999999999999987654 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccc-cccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREES-LTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
||++.++ .+||+|||+++... ........+||+.|+|||++....++...|+|+++..++++-.++.|.
T Consensus 473 ILl~~~g-~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf 542 (674)
T 3pfq_A 473 VMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542 (674)
T ss_dssp EEECSSS-CEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEcCCC-cEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCC
Confidence 9999888 89999999998532 233345678999999999999999999999999999888877666664
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=202.93 Aligned_cols=153 Identities=26% Similarity=0.446 Sum_probs=128.7
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++|+||+.+++|.+.+..... +++..++.++.|++.||.|||++|++|+||||+||
T Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NI 152 (287)
T 2wei_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152 (287)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhE
Confidence 567899999999999975 578999999999999999876554 99999999999999999999999999999999999
Q ss_pred EEeCCC--CceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------------
Q 027476 81 ILTADH--KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 81 ll~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
+++.++ ..+||+|||++.............|++.|+|||.+.+.
T Consensus 153 lv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 232 (287)
T 2wei_A 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232 (287)
T ss_dssp EESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 997543 26999999999865443333444688999999944310
Q ss_pred -------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++..||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 233 RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 13467789999999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=206.24 Aligned_cols=154 Identities=27% Similarity=0.477 Sum_probs=123.6
Q ss_pred CCCC-CCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 2 MSRV-RHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
++++ +||||+++++++.. +..++||||+.+++|.+++.......+++..++.++.|++.||.|||++|++|+
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 153 (326)
T 2x7f_A 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR 153 (326)
T ss_dssp HHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 3455 79999999999853 468999999999999999987654569999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC-----C------------------------
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR-----P------------------------ 123 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~------------------------ 123 (223)
||||+||+++.++ .+||+|||++...... .......|++.|+|||.+. .
T Consensus 154 dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 232 (326)
T 2x7f_A 154 DIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232 (326)
T ss_dssp CCSGGGEEECTTC-CEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCcHHHEEEcCCC-CEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCC
Confidence 9999999999877 7999999998754322 1223457899999999653 0
Q ss_pred ----------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 ----------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 ----------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....++.++.+++..||..+|.+||++++++++
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 233 PLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp TTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 013456788899999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=203.97 Aligned_cols=153 Identities=27% Similarity=0.458 Sum_probs=122.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 70 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 148 (302)
T 2j7t_A 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNV 148 (302)
T ss_dssp HHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred HhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence 567899999999999865 57899999999999999987633 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC-----CC------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR-----PS------------------------------ 124 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~------------------------------ 124 (223)
+++.++ .+||+|||++...... .......|++.|+|||.+. ..
T Consensus 149 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 227 (302)
T 2j7t_A 149 LMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227 (302)
T ss_dssp EECTTS-CEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EECCCC-CEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 999887 7999999987643221 1223457899999999651 11
Q ss_pred -----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+..++.++.+++..||+.+|.+||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 228 MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 12345677888899999999999999888764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=211.85 Aligned_cols=120 Identities=23% Similarity=0.353 Sum_probs=91.6
Q ss_pred CCCCCCCCCccceEEEee---cCceEEEEEcCCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 027476 1 MMSRVRHRNLVKFIGACK---EPVMVIVTELLLGGTLRKYLLNMR-------PRCLDIHVAIGFALDIARAMECLHSHGI 70 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~-------~~~l~~~~~~~i~~qi~~~l~~lH~~~i 70 (223)
+|++++||||+++++++. +...++||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i 149 (405)
T 3rgf_A 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWV 149 (405)
T ss_dssp HHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 356789999999999984 346899999995 68888876321 2249999999999999999999999999
Q ss_pred ccCCCCCCCEEE----eCCCCceEEccCccccccccc----cccccCCCccccccCCCCC
Q 027476 71 IHRDLKPENLIL----TADHKTVKLADFGLAREESLT----EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 71 vH~dlkp~Nill----~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~ 122 (223)
+||||||+||++ +.++ .+||+|||+++..... .......||+.|+|||++.
T Consensus 150 vH~Dlkp~NIll~~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 208 (405)
T 3rgf_A 150 LHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 208 (405)
T ss_dssp CCCCCCGGGEEECCSSTTTT-CEEECCTTCCC----------------CCCTTCCHHHHT
T ss_pred eCCCcCHHHeEEecCCCCCC-cEEEEECCCceecCCCCcccccCCCceecCcccCchhhc
Confidence 999999999999 4445 8999999999864432 2234457899999999654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=213.12 Aligned_cols=146 Identities=21% Similarity=0.317 Sum_probs=124.5
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||++++++|.+ +.+++||||+.||+|.+++.+.+ ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 115 l~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NI 193 (412)
T 2vd5_A 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNI 193 (412)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHe
Confidence 456799999999999976 57899999999999999998643 2499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC-------CCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR-------PSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
+++.++ ++||+|||+++....... ....+||+.|+|||++. ...++...|+|+++..+++.-.++.|.
T Consensus 194 Lld~~g-~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 194 LLDRCG-HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp EECTTS-CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eecCCC-CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 999888 899999999986543222 23458999999999987 356788999999999888776666553
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=217.35 Aligned_cols=147 Identities=27% Similarity=0.393 Sum_probs=127.8
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++||||+++++++.+ +.+++||||+.||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 239 L~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~ 318 (543)
T 3c4z_A 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPE 318 (543)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChH
Confidence 567899999999999975 57899999999999999997643 345999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccc-cccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
||+++.++ .+||+|||+++....... ....+||+.|+|||++....++...|+|+++..++++-.++.|.
T Consensus 319 NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF 389 (543)
T 3c4z_A 319 NVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389 (543)
T ss_dssp GEEECTTS-CEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred HEEEeCCC-CEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCC
Confidence 99999888 899999999986543332 23458999999999999999999999999999888776666554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=208.62 Aligned_cols=157 Identities=21% Similarity=0.331 Sum_probs=118.5
Q ss_pred CCCCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
|++++||||+++++++.. ...++||||+. ++|.+.+... ...+++..++.++.|++.||.|||++||+||||
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 160 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDL 160 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCC
Confidence 567899999999998832 25799999996 6888888753 345999999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-CCC----------------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP-SAE---------------------------- 126 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~---------------------------- 126 (223)
||+||+++.++ .+||+|||+++............||+.|+|||.+.. ...
T Consensus 161 kp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 161 HPGNILLADNN-DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp CGGGEEECTTC-CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ChHHEEEcCCC-CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999877 799999999986554444455678999999996542 111
Q ss_pred ------------------------------------------------CChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 127 ------------------------------------------------NLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 127 ------------------------------------------------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
..+.++.+++..||+.+|.+||++.+++++
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h-- 317 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH-- 317 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS--
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC--
Confidence 224556778899999999999999999876
Q ss_pred HHhhc
Q 027476 159 HYIST 163 (223)
Q Consensus 159 ~~~~~ 163 (223)
.++..
T Consensus 318 p~f~~ 322 (362)
T 3pg1_A 318 PYFES 322 (362)
T ss_dssp GGGTT
T ss_pred chhhh
Confidence 45443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-30 Score=203.48 Aligned_cols=154 Identities=27% Similarity=0.446 Sum_probs=126.4
Q ss_pred CCCCCCCCccceEEEee---cCceEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cc
Q 027476 2 MSRVRHRNLVKFIGACK---EPVMVIVTELLLGGTLRKYLLNMR--PRCLDIHVAIGFALDIARAMECLHSHG-----II 71 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~---~~~~~lv~e~~~~~sL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~-----iv 71 (223)
+++++||||+++++++. ++..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.| ++
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iv 138 (279)
T 2w5a_A 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 138 (279)
T ss_dssp HHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------C
T ss_pred HHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeE
Confidence 56789999999999873 357899999999999999997532 345999999999999999999999999 99
Q ss_pred cCCCCCCCEEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCC----------------------------
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMR---------------------------- 122 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~---------------------------- 122 (223)
||||||+||+++.++ .+||+|||++....... ......|++.|+|||.+.
T Consensus 139 H~dl~p~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 217 (279)
T 2w5a_A 139 HRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217 (279)
T ss_dssp CCCCSGGGEEECSSS-CEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EeccchhhEEEcCCC-CEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 999999999999887 89999999987543322 123346899999999432
Q ss_pred -----------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 -----------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 -----------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..+..++.++.+++..||+.+|.+||++++++++
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 218 AFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp CSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 2234567889999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-29 Score=209.89 Aligned_cols=115 Identities=24% Similarity=0.366 Sum_probs=98.7
Q ss_pred CCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q 027476 4 RVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL 82 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill 82 (223)
..+|+||+++++.+.. +..++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl 233 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL 233 (429)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE
T ss_pred ccCCcCEEEEEeecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 3478999999999974 6789999999 5799999988766669999999999999999999999999999999999999
Q ss_pred eCCCC-ceEEccCccccccccccccccCCCccccccCCCC
Q 027476 83 TADHK-TVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121 (223)
Q Consensus 83 ~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 121 (223)
+.++. .+||+|||++..... ......||+.|+|||++
T Consensus 234 ~~~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~ 271 (429)
T 3kvw_A 234 KQQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVI 271 (429)
T ss_dssp SSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHH
T ss_pred ccCCCcceEEeecccceecCC--cccccCCCCCccChHHH
Confidence 98762 299999999975432 23456799999999954
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-29 Score=206.24 Aligned_cols=153 Identities=25% Similarity=0.371 Sum_probs=127.3
Q ss_pred CCCCCCCCccceEEEeecC-------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKEP-------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
|++++||||+++++++..+ .+++||||+ +++|.+++... .+++..+..++.|++.||+|||++||+|||
T Consensus 78 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~D 153 (367)
T 1cm8_A 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRD 153 (367)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 5678999999999998542 369999999 89999998762 399999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-C-----------------------------
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP-S----------------------------- 124 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~----------------------------- 124 (223)
|||+||+++.++ .+||+|||+++.... ......+|+.|+|||.+.. .
T Consensus 154 lkp~NIll~~~~-~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 154 LKPGNLAVNEDC-ELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp CCGGGEEECTTC-CEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCHHHEEEcCCC-CEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999888 899999999986443 2345678999999994421 0
Q ss_pred ----------------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 125 ----------------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 125 ----------------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
....+.++.+++.+||+.+|.+||++++++++
T Consensus 231 ~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h-- 308 (367)
T 1cm8_A 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH-- 308 (367)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC--
Confidence 02345677889999999999999999999876
Q ss_pred HHhhc
Q 027476 159 HYIST 163 (223)
Q Consensus 159 ~~~~~ 163 (223)
.++..
T Consensus 309 p~f~~ 313 (367)
T 1cm8_A 309 PYFES 313 (367)
T ss_dssp GGGTT
T ss_pred hHHHh
Confidence 44443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=204.92 Aligned_cols=150 Identities=23% Similarity=0.469 Sum_probs=121.4
Q ss_pred CCCCCC--CCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVRH--RNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~H--pniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++| |||+++++++.+ +..++|||+ .+++|.+++..... +++..++.++.|++.||.|||++||+||||||+
T Consensus 61 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~ 137 (343)
T 3dbq_A 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 137 (343)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred HHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 455665 999999999975 578899995 58999999987554 999999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCC--------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRP-------------------------------- 123 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-------------------------------- 123 (223)
||+++ ++ .+||+|||+++...... ......||+.|+|||.+..
T Consensus 138 NIll~-~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 215 (343)
T 3dbq_A 138 NFLIV-DG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215 (343)
T ss_dssp GEEEE-TT-EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH
T ss_pred eEEEE-CC-cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 99998 45 79999999998653322 2234579999999996521
Q ss_pred --------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 --------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 --------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+...+.++.+++..||+.+|.+||++.+++++
T Consensus 216 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 216 GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 122344678899999999999999999999886
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-29 Score=208.77 Aligned_cols=155 Identities=22% Similarity=0.306 Sum_probs=125.4
Q ss_pred CCCCCCCCCccceEEEeec-----C--ceEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 027476 1 MMSRVRHRNLVKFIGACKE-----P--VMVIVTELLLGGTLRKYLLN--MRPRCLDIHVAIGFALDIARAMECLHSHGII 71 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-----~--~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iv 71 (223)
+|++++||||++++++|.. + .+++||||+. ++|.+.+.. .....+++..++.++.||+.||.|||++||+
T Consensus 100 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 178 (420)
T 1j1b_A 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 178 (420)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 3678999999999998832 1 3679999996 477766643 2334599999999999999999999999999
Q ss_pred cCCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC---------------------------
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS--------------------------- 124 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------------------------- 124 (223)
||||||+||+++.++..+||+|||+++............||+.|+|||++...
T Consensus 179 HrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 179 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp CSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999976657899999999865544444556889999999954210
Q ss_pred -----------------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 -----------------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 -----------------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....+.++.+|+.+||+.+|.+||++.+++++
T Consensus 259 ~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 259 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 01345778899999999999999999999876
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=208.68 Aligned_cols=150 Identities=23% Similarity=0.461 Sum_probs=121.9
Q ss_pred CCCCC--CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVR--HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~--Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
|++++ ||||+++++++.+ +.+++||| +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 108 l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~ 184 (390)
T 2zmd_A 108 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 184 (390)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGG
T ss_pred HHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence 34554 6999999999865 57899999 55899999998755 4899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCC--------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRP-------------------------------- 123 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-------------------------------- 123 (223)
||+++ ++ .+||+|||+++...... ......||+.|+|||++..
T Consensus 185 NIll~-~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~ 262 (390)
T 2zmd_A 185 NFLIV-DG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262 (390)
T ss_dssp GEEES-SS-CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH
T ss_pred HEEEE-CC-eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH
Confidence 99996 45 79999999998654322 2245579999999996521
Q ss_pred --------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 --------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 --------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+...+.++.+++..||+.+|.+||++.+++++
T Consensus 263 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 263 GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp SSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 122335678889999999999999999999876
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-29 Score=205.03 Aligned_cols=155 Identities=28% Similarity=0.399 Sum_probs=127.0
Q ss_pred CCCCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
|++++||||+++++++.. ...++||||+. ++|.+++... .+++..++.++.|++.||.|||++||+||||
T Consensus 79 l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 154 (364)
T 3qyz_A 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDL 154 (364)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 567899999999999853 25899999995 6999998763 3999999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCccccccccccc----cccCCCccccccCCCCCCC---------------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTEM----MTAETGTYRWMAPENMRPS--------------------------- 124 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~--------------------------- 124 (223)
||+||+++.++ .+||+|||+++....... .....||+.|+|||++...
T Consensus 155 kp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 233 (364)
T 3qyz_A 155 KPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233 (364)
T ss_dssp CGGGEEECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ChHhEEECCCC-CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCC
Confidence 99999999887 799999999985543221 2345799999999953210
Q ss_pred -------------------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 125 -------------------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 125 -------------------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
...++.++.+++.+||+.+|.+||+++++++
T Consensus 234 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 234 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0234667888999999999999999999987
Q ss_pred HHHHHhhc
Q 027476 156 MLLHYIST 163 (223)
Q Consensus 156 ~L~~~~~~ 163 (223)
+ .++..
T Consensus 314 h--p~~~~ 319 (364)
T 3qyz_A 314 H--PYLEQ 319 (364)
T ss_dssp S--GGGTT
T ss_pred C--cchhh
Confidence 6 45443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=201.12 Aligned_cols=153 Identities=24% Similarity=0.422 Sum_probs=112.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLN---MRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLK 76 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~---~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlk 76 (223)
++.++||||+++++++.+ +..++||||+. ++|.+++.. .....+++..++.++.|++.||.|||+. |++|||||
T Consensus 75 ~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlk 153 (327)
T 3aln_A 75 MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153 (327)
T ss_dssp HSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCC
T ss_pred HHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCC
Confidence 467899999999999865 57889999996 588887763 2234599999999999999999999999 99999999
Q ss_pred CCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC----CC----------------------------
Q 027476 77 PENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR----PS---------------------------- 124 (223)
Q Consensus 77 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----~~---------------------------- 124 (223)
|+||+++.++ .+||+|||+++............||+.|+|||.+. ..
T Consensus 154 p~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 154 PSNILLDRSG-NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp GGGEEEETTT-EEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred HHHEEEcCCC-CEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999887 89999999998655444444457999999999761 00
Q ss_pred ----------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++..||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 233 NSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred chHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 12367889999999999999999999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=202.15 Aligned_cols=157 Identities=25% Similarity=0.322 Sum_probs=124.1
Q ss_pred CCCCCCCccceEEEeec-C-------ceEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCc
Q 027476 3 SRVRHRNLVKFIGACKE-P-------VMVIVTELLLGGTLRKYLLN--MRPRCLDIHVAIGFALDIARAMECLH--SHGI 70 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~-~-------~~~lv~e~~~~~sL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~lH--~~~i 70 (223)
++++||||+++++++.+ + ..++||||+.+ +|.+.+.. .....+++..++.++.|++.||.||| ++||
T Consensus 74 ~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~i 152 (360)
T 3e3p_A 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNV 152 (360)
T ss_dssp HHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCC
T ss_pred HhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCe
Confidence 45789999999999843 2 27899999965 55554442 23345899999999999999999999 9999
Q ss_pred ccCCCCCCCEEEeC-CCCceEEccCccccccccccccccCCCccccccCCCCCCCC-CC---------------------
Q 027476 71 IHRDLKPENLILTA-DHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA-EN--------------------- 127 (223)
Q Consensus 71 vH~dlkp~Nill~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~--------------------- 127 (223)
+||||||+||+++. ++ .+||+|||+++............||+.|+|||.+.... .+
T Consensus 153 vH~Dlkp~NIll~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~p 231 (360)
T 3e3p_A 153 CHRDIKPHNVLVNEADG-TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPI 231 (360)
T ss_dssp BCSCCCGGGEEEETTTT-EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecCcCCHHHEEEeCCCC-cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999997 55 89999999998765555555667899999999553110 11
Q ss_pred -------------------------------------------------------ChHHHHHHHHHhcccCCCCCCCHHH
Q 027476 128 -------------------------------------------------------LPEDLALIVTSCWKEDPNERPNFSQ 152 (223)
Q Consensus 128 -------------------------------------------------------~~~~l~~l~~~~l~~~p~~Rp~~~~ 152 (223)
.+.++.+++..||+.+|.+||++.+
T Consensus 232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 311 (360)
T 3e3p_A 232 FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311 (360)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence 3567788999999999999999999
Q ss_pred HHHHHHHHhhc
Q 027476 153 IIQMLLHYIST 163 (223)
Q Consensus 153 ~~~~L~~~~~~ 163 (223)
++++ .++..
T Consensus 312 ~l~h--p~f~~ 320 (360)
T 3e3p_A 312 ALCH--PYFDE 320 (360)
T ss_dssp HTTS--GGGGG
T ss_pred HhcC--ccccc
Confidence 9876 55544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9e-29 Score=209.26 Aligned_cols=152 Identities=23% Similarity=0.396 Sum_probs=116.1
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|+++ +||||+++++++.+ +..++||||+. |+|.+++..... ...+..++.++.||+.||.|||++||+||||||+|
T Consensus 71 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~N 148 (432)
T 3p23_A 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHN 148 (432)
T ss_dssp HHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTS
T ss_pred HHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHH
Confidence 4556 79999999999976 56899999995 699999986543 35555678899999999999999999999999999
Q ss_pred EEEeCCC----CceEEccCccccccccc----cccccCCCccccccCCCCCC---CCCCC--------------------
Q 027476 80 LILTADH----KTVKLADFGLAREESLT----EMMTAETGTYRWMAPENMRP---SAENL-------------------- 128 (223)
Q Consensus 80 ill~~~~----~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~---~~~~~-------------------- 128 (223)
|+++.++ ..+||+|||+++..... .......||+.|+|||++.. ...+.
T Consensus 149 Ill~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~ 228 (432)
T 3p23_A 149 ILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228 (432)
T ss_dssp EEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCB
T ss_pred EEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 9995322 25889999999865432 22344579999999997752 11111
Q ss_pred ----------------------------hHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 129 ----------------------------PEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 129 ----------------------------~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
+..+.+++..||+.+|.+||+++++++
T Consensus 229 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 229 PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 233567888999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=196.62 Aligned_cols=147 Identities=24% Similarity=0.385 Sum_probs=124.1
Q ss_pred CCCCccceEEEeec-CceEEEEEc-CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEe
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTEL-LLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~-~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 83 (223)
+||||+++++++.+ +..++|+|| +.+++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID 173 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe
Confidence 89999999999864 578899999 789999999987654 99999999999999999999999999999999999999
Q ss_pred -CCCCceEEccCccccccccccccccCCCccccccCCCCC---------------------------------------C
Q 027476 84 -ADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR---------------------------------------P 123 (223)
Q Consensus 84 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------------------------------------~ 123 (223)
.++ .+||+|||++....... .....|+..|+|||.+. .
T Consensus 174 ~~~~-~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 251 (312)
T 2iwi_A 174 LRRG-CAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELH 251 (312)
T ss_dssp TTTT-EEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCC
T ss_pred CCCC-eEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccC
Confidence 555 89999999998654332 34557899999999432 1
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 ~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+++.+||+.+|.+||++++++++
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 234577889999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=202.30 Aligned_cols=154 Identities=25% Similarity=0.376 Sum_probs=124.4
Q ss_pred CCCCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 2 MSRVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
|++++||||+++++++.. ...++||||+. ++|.+++... .+++..++.++.|++.||.|||++|++||||
T Consensus 63 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dl 138 (353)
T 2b9h_A 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDL 138 (353)
T ss_dssp HHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 567899999999998753 46899999995 6999998763 3999999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCcccccccccc-----------ccccCCCccccccCCCCCC-CC------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTE-----------MMTAETGTYRWMAPENMRP-SA------------------ 125 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~~gt~~y~aPE~~~~-~~------------------ 125 (223)
||+||+++.++ .+||+|||+++...... ......||+.|+|||++.. ..
T Consensus 139 kp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 217 (353)
T 2b9h_A 139 KPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217 (353)
T ss_dssp CGGGEEECTTC-CEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHH
T ss_pred CHHHeEEcCCC-cEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHH
Confidence 99999999887 79999999997543211 1123468999999994321 00
Q ss_pred ----------------------------------------------------------CCChHHHHHHHHHhcccCCCCC
Q 027476 126 ----------------------------------------------------------ENLPEDLALIVTSCWKEDPNER 147 (223)
Q Consensus 126 ----------------------------------------------------------~~~~~~l~~l~~~~l~~~p~~R 147 (223)
..++.++.+++.+||+.+|.+|
T Consensus 218 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (353)
T 2b9h_A 218 LRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297 (353)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGS
T ss_pred hCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccC
Confidence 1456677889999999999999
Q ss_pred CCHHHHHHHHHHHhh
Q 027476 148 PNFSQIIQMLLHYIS 162 (223)
Q Consensus 148 p~~~~~~~~L~~~~~ 162 (223)
|++++++++ .++.
T Consensus 298 pt~~ell~h--p~~~ 310 (353)
T 2b9h_A 298 ITAKEALEH--PYLQ 310 (353)
T ss_dssp CCHHHHHTS--GGGT
T ss_pred CCHHHHhcC--cccc
Confidence 999999875 4443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-28 Score=196.38 Aligned_cols=116 Identities=24% Similarity=0.335 Sum_probs=97.8
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeC
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTA 84 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 84 (223)
.|++|+++++++.+ +..++||||+ +++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 153 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ 153 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEec
Confidence 45569999999965 6789999999 899999998876556999999999999999999999999999999999999986
Q ss_pred C------------------CCceEEccCccccccccccccccCCCccccccCCCCCCC
Q 027476 85 D------------------HKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS 124 (223)
Q Consensus 85 ~------------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 124 (223)
+ ...+||+|||+++.... ......||+.|+|||.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 209 (339)
T 1z57_A 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL 209 (339)
T ss_dssp CCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS
T ss_pred cccccccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC
Confidence 2 22699999999975432 23456799999999966533
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=198.50 Aligned_cols=148 Identities=22% Similarity=0.375 Sum_probs=125.2
Q ss_pred CCCCccceEEEeec-CceEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEe
Q 027476 6 RHRNLVKFIGACKE-PVMVIVTELLLG-GTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83 (223)
Q Consensus 6 ~Hpniv~l~~~~~~-~~~~lv~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 83 (223)
.||||+++++++.+ +..++|+|++.+ ++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 183 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe
Confidence 36999999999975 578899999976 899999987554 99999999999999999999999999999999999999
Q ss_pred CCCCceEEccCccccccccccccccCCCccccccCCCCC---------------------------------------CC
Q 027476 84 ADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR---------------------------------------PS 124 (223)
Q Consensus 84 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------------------------------------~~ 124 (223)
.+.+.+||+|||+++..... ......||+.|+|||.+. ..
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 262 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 262 (320)
T ss_dssp TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCC
T ss_pred CCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccc
Confidence 44338999999999865433 234457999999999442 12
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++.+||+.+|.+||++++++++
T Consensus 263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 34567889999999999999999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=218.53 Aligned_cols=152 Identities=27% Similarity=0.385 Sum_probs=121.3
Q ss_pred CCCCCCCCCccceEEEeec-Cc-----eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PV-----MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~-----~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+|++++||||+++++++.+ +. .|+||||+.|++|.+++.. .+++..++.++.||+.||.|||++||+|||
T Consensus 132 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrD 207 (681)
T 2pzi_A 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYND 207 (681)
T ss_dssp GGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Confidence 4678999999999999964 33 6999999999999987754 499999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC------------------------------
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS------------------------------ 124 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~------------------------------ 124 (223)
|||+||+++.+ .+||+|||+++..... ....||+.|+|||++...
T Consensus 208 lkp~NIll~~~--~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~ 282 (681)
T 2pzi_A 208 LKPENIMLTEE--QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD 282 (681)
T ss_dssp CSGGGEEECSS--CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS
T ss_pred cChHHeEEeCC--cEEEEecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc
Confidence 99999999864 6999999999865432 455799999999954311
Q ss_pred --CCC-----ChHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHHh
Q 027476 125 --AEN-----LPEDLALIVTSCWKEDPNERPN-FSQIIQMLLHYI 161 (223)
Q Consensus 125 --~~~-----~~~~l~~l~~~~l~~~p~~Rp~-~~~~~~~L~~~~ 161 (223)
+.. .+.++.+++.+||+.+|.+||+ .+++...|...+
T Consensus 283 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 283 GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 111 1256778999999999999994 566666666554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-29 Score=205.77 Aligned_cols=153 Identities=27% Similarity=0.370 Sum_probs=112.5
Q ss_pred CCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
|++++||||+++++++.. ...++|+|++ +++|.+++.. +.+++..++.++.||+.||.|||++||+|||
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~D 157 (367)
T 2fst_X 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRD 157 (367)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence 567899999999999853 3578999999 8999998865 3499999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-CC----------------------------
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP-SA---------------------------- 125 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~---------------------------- 125 (223)
|||+||+++.++ .+||+|||+++..... .....||+.|+|||.+.. ..
T Consensus 158 lkp~NIll~~~~-~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 158 LKPSNLAVNEDC-ELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp CCGGGEEECTTC-CEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCHhhEEECCCC-CEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999887 8999999999764322 344578999999995432 11
Q ss_pred -----------------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 126 -----------------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 126 -----------------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
...+.++.+|+.+||+.+|.+||++++++++
T Consensus 235 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h-- 312 (367)
T 2fst_X 235 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH-- 312 (367)
T ss_dssp HHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--
T ss_pred HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC--
Confidence 1234567788999999999999999999876
Q ss_pred HHhhc
Q 027476 159 HYIST 163 (223)
Q Consensus 159 ~~~~~ 163 (223)
.++..
T Consensus 313 p~~~~ 317 (367)
T 2fst_X 313 AYFAQ 317 (367)
T ss_dssp GGGTT
T ss_pred hhhhh
Confidence 44443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=199.04 Aligned_cols=152 Identities=24% Similarity=0.451 Sum_probs=118.1
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~N 79 (223)
++.++||||+++++++.+ +..++||||+ ++.+..+.... ...+++..++.++.|++.||.|||++ |++|+||||+|
T Consensus 78 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~N 155 (318)
T 2dyl_A 78 LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 155 (318)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGG
T ss_pred HHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHH
Confidence 456799999999999965 5789999999 66776666542 34599999999999999999999995 99999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC------------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------ 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------ 123 (223)
|+++.++ .+||+|||++.............|++.|+|||.+..
T Consensus 156 il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (318)
T 2dyl_A 156 ILLDERG-QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234 (318)
T ss_dssp EEECTTS-CEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred EEECCCC-CEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc
Confidence 9999887 899999999976544444445679999999996520
Q ss_pred -----------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 -----------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 -----------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....++.++.+++..||+.+|.+||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 235 DFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 012367889999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=199.18 Aligned_cols=113 Identities=25% Similarity=0.309 Sum_probs=94.4
Q ss_pred CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---
Q 027476 7 HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLIL--- 82 (223)
Q Consensus 7 Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill--- 82 (223)
|.+++.+++++.. +..++||||+ +++|.+.+.......+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS 159 (355)
T ss_dssp CSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCC
T ss_pred ceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecc
Confidence 3348999998864 6789999999 7788888877665569999999999999999999999999999999999999
Q ss_pred ----------------eCCCCceEEccCccccccccccccccCCCccccccCCCCCC
Q 027476 83 ----------------TADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP 123 (223)
Q Consensus 83 ----------------~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 123 (223)
+.++ .+||+|||+++.... ......||+.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~ 213 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE 213 (355)
T ss_dssp CEEEEECCC-CCCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT
T ss_pred cccccccccccccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeec
Confidence 4455 799999999975432 2345679999999996653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-28 Score=194.43 Aligned_cols=157 Identities=24% Similarity=0.332 Sum_probs=125.1
Q ss_pred CCCCCCCCccceEEEee---------------cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRVRHRNLVKFIGACK---------------EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLH 66 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~---------------~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH 66 (223)
+++++||||+++++++. .+..++||||+. ++|.+++.. +.+++..++.++.|++.||+|||
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH 137 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH 137 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH
Confidence 56889999999999873 246789999996 699999864 34899999999999999999999
Q ss_pred hCCcccCCCCCCCEEEeCCCCceEEccCccccccccc----cccccCCCccccccCCCCCC-C-----------------
Q 027476 67 SHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT----EMMTAETGTYRWMAPENMRP-S----------------- 124 (223)
Q Consensus 67 ~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~----------------- 124 (223)
++|++||||||+||+++.++..+||+|||+++..... .......++..|+|||.+.. .
T Consensus 138 ~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~e 217 (320)
T 2i6l_A 138 SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217 (320)
T ss_dssp HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHH
T ss_pred hCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHH
Confidence 9999999999999999855558999999999854321 11233457889999994321 0
Q ss_pred ---------------------------------------------------------CCCChHHHHHHHHHhcccCCCCC
Q 027476 125 ---------------------------------------------------------AENLPEDLALIVTSCWKEDPNER 147 (223)
Q Consensus 125 ---------------------------------------------------------~~~~~~~l~~l~~~~l~~~p~~R 147 (223)
...++.++.+++.+||+.+|.+|
T Consensus 218 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 218 MLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297 (320)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGS
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcccc
Confidence 02357788999999999999999
Q ss_pred CCHHHHHHHHHHHhhcC
Q 027476 148 PNFSQIIQMLLHYISTN 164 (223)
Q Consensus 148 p~~~~~~~~L~~~~~~~ 164 (223)
|++++++++ .++...
T Consensus 298 pt~~ell~h--p~~~~~ 312 (320)
T 2i6l_A 298 LTAEEALSH--PYMSIY 312 (320)
T ss_dssp CCHHHHHTS--HHHHTT
T ss_pred CCHHHHhCC--cccccc
Confidence 999999876 555443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=201.49 Aligned_cols=151 Identities=23% Similarity=0.362 Sum_probs=121.0
Q ss_pred CCCCCCCCccceEEEeecC-c------eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKEP-V------MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~-~------~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+++++||||+++++++.+. . +++||||+. ++|.+.+.. .+++..++.++.|++.||.|||++||+|||
T Consensus 95 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 169 (371)
T 4exu_A 95 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRD 169 (371)
T ss_dssp HHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 5678999999999999643 2 389999995 788887732 399999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-CC----------------------------
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP-SA---------------------------- 125 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~---------------------------- 125 (223)
|||+||+++.++ .+||+|||+++..... .....||+.|+|||.+.. ..
T Consensus 170 ikp~NIll~~~~-~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 170 LKPGNLAVNEDC-ELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp CCGGGEEECTTC-CEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCHHHeEECCCC-CEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999887 7999999999754322 345578999999995532 10
Q ss_pred -----------------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 126 -----------------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 126 -----------------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
..++.++.+|+..||+.+|.+||++++++++
T Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h-- 324 (371)
T 4exu_A 247 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH-- 324 (371)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS--
T ss_pred hHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC--
Confidence 1346778889999999999999999999876
Q ss_pred HHhh
Q 027476 159 HYIS 162 (223)
Q Consensus 159 ~~~~ 162 (223)
.++.
T Consensus 325 p~f~ 328 (371)
T 4exu_A 325 PFFE 328 (371)
T ss_dssp GGGT
T ss_pred cccc
Confidence 4544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-29 Score=205.10 Aligned_cols=130 Identities=15% Similarity=0.179 Sum_probs=106.0
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCc
Q 027476 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVA------IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFG 95 (223)
Q Consensus 22 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~------~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg 95 (223)
+++||||+. ++|.+++..... .+++..+ +.++.||+.||+|||++||+||||||+||+++.++ .+||+|||
T Consensus 163 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG 239 (371)
T 3q60_A 163 YLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGDVS 239 (371)
T ss_dssp EEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTS-CEEECCGG
T ss_pred EEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCC-CEEEEecc
Confidence 799999997 899999986432 2455555 67779999999999999999999999999999887 89999999
Q ss_pred cccccccccccccCCCccccccCCCCCC----------------------------------------------------
Q 027476 96 LAREESLTEMMTAETGTYRWMAPENMRP---------------------------------------------------- 123 (223)
Q Consensus 96 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------------------------------------------------- 123 (223)
+++...... ....+|+.|+|||.+..
T Consensus 240 ~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 317 (371)
T 3q60_A 240 ALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL 317 (371)
T ss_dssp GEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSC
T ss_pred eeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhcccccc
Confidence 998654322 23456799999994431
Q ss_pred ---CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 ---SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 ---~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....++.++.+++.+||+.+|.+||++.+++++
T Consensus 318 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 318 AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 012567889999999999999999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=197.81 Aligned_cols=114 Identities=24% Similarity=0.373 Sum_probs=96.3
Q ss_pred CCCCccceEEEeecC-----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCC
Q 027476 6 RHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKPEN 79 (223)
Q Consensus 6 ~Hpniv~l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~N 79 (223)
.||||+++++++.+. ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~N 162 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 162 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHH
Confidence 489999999998542 578999999 99999999876666699999999999999999999998 99999999999
Q ss_pred EEEeCCC-----CceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 80 LILTADH-----KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 80 ill~~~~-----~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
|+++.++ ..+||+|||+++..... .....||+.|+|||++.
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~ 208 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLL 208 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHH
T ss_pred eEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHh
Confidence 9995322 26999999999765432 34457899999999554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-28 Score=200.35 Aligned_cols=123 Identities=27% Similarity=0.416 Sum_probs=98.8
Q ss_pred CCCCccceEEEee----c-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCC
Q 027476 6 RHRNLVKFIGACK----E-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH-GIIHRDLKPEN 79 (223)
Q Consensus 6 ~Hpniv~l~~~~~----~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~N 79 (223)
+|+||+++++++. + ...++||||+ +++|.+.+.......+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 4899999999885 2 3689999999 77777777765555699999999999999999999998 99999999999
Q ss_pred EEEeCCC------------------------------------------------CceEEccCccccccccccccccCCC
Q 027476 80 LILTADH------------------------------------------------KTVKLADFGLAREESLTEMMTAETG 111 (223)
Q Consensus 80 ill~~~~------------------------------------------------~~~kl~Dfg~a~~~~~~~~~~~~~g 111 (223)
|+++.++ ..+||+|||+++..... .....|
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~g 255 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQ 255 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCS
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCC
Confidence 9998654 26999999999765432 345579
Q ss_pred ccccccCCCCCCCCCCChHH
Q 027476 112 TYRWMAPENMRPSAENLPED 131 (223)
Q Consensus 112 t~~y~aPE~~~~~~~~~~~~ 131 (223)
|+.|+|||++.....+...|
T Consensus 256 t~~y~aPE~~~~~~~~~~~D 275 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPAD 275 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHH
T ss_pred CCcccCChhhcCCCCCcHHH
Confidence 99999999665433333333
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=206.20 Aligned_cols=150 Identities=24% Similarity=0.392 Sum_probs=111.6
Q ss_pred CCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 5 VRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRC-----LDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 5 l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~-----l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
.+||||+++++++.+ +..++||||+ +|+|.+++....... .++..++.++.||+.||+|||++||+||||||+
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~ 144 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChH
Confidence 389999999999975 5689999999 569999997644311 133356789999999999999999999999999
Q ss_pred CEEEeCCC------------CceEEccCcccccccccc-----ccccCCCccccccCCCCCC-------CCC--------
Q 027476 79 NLILTADH------------KTVKLADFGLAREESLTE-----MMTAETGTYRWMAPENMRP-------SAE-------- 126 (223)
Q Consensus 79 Nill~~~~------------~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~-------- 126 (223)
||+++.++ ..+||+|||+++...... ......||+.|+|||++.. ...
T Consensus 145 NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwS 224 (434)
T 2rio_A 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224 (434)
T ss_dssp GEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHH
T ss_pred hEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHh
Confidence 99997532 379999999998654322 1234579999999996532 000
Q ss_pred ------------------------------------------CChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 127 ------------------------------------------NLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 127 ------------------------------------------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
.++.++.+++.+||+.+|.+||++.++++
T Consensus 225 lG~il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 225 MGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 12356788999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=192.25 Aligned_cols=150 Identities=23% Similarity=0.455 Sum_probs=118.8
Q ss_pred CCCCC--CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 2 MSRVR--HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 2 l~~l~--Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+++++ ||||+++++++.+ +..++||| +.+++|.+++..... +++..++.++.|++.||.|||++|++||||||+
T Consensus 80 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~ 156 (313)
T 3cek_A 80 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 156 (313)
T ss_dssp HHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred HHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcc
Confidence 34555 6999999999965 56889999 558999999987544 899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCCC--------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMRP-------------------------------- 123 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-------------------------------- 123 (223)
||+++. + .+||+|||+++...... ......|++.|+|||.+..
T Consensus 157 NIl~~~-~-~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~ 234 (313)
T 3cek_A 157 NFLIVD-G-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234 (313)
T ss_dssp GEEEET-T-EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH
T ss_pred cEEEEC-C-eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh
Confidence 999974 5 89999999997543322 1234568999999996532
Q ss_pred --------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 --------------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 --------------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+...+.++.+++..||+.+|.+||++.+++++
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 235 GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 122345678889999999999999999999876
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=193.64 Aligned_cols=113 Identities=25% Similarity=0.308 Sum_probs=94.8
Q ss_pred CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCCEEEe
Q 027476 7 HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLH--SHGIIHRDLKPENLILT 83 (223)
Q Consensus 7 Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nill~ 83 (223)
|++|+++++++.. +..++||||+. ++|.+++.......+++..++.++.|++.||.||| +.||+||||||+||+++
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~ 193 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLC 193 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEES
T ss_pred ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEe
Confidence 4469999999864 67899999995 69999998766566999999999999999999999 57999999999999995
Q ss_pred C--CCCceEEccCccccccccccccccCCCccccccCCCCCC
Q 027476 84 A--DHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP 123 (223)
Q Consensus 84 ~--~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 123 (223)
. ++ .+||+|||+++.... ......||+.|+|||++..
T Consensus 194 ~~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~ 232 (382)
T 2vx3_A 194 NPKRS-AIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLG 232 (382)
T ss_dssp STTSC-CEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTT
T ss_pred cCCCC-cEEEEeccCceeccc--ccccccCCccccChHHHcC
Confidence 4 44 799999999986543 2345679999999996553
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=195.14 Aligned_cols=147 Identities=23% Similarity=0.351 Sum_probs=118.9
Q ss_pred CCCCCCCCccceEEEeecC-------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 2 MSRVRHRNLVKFIGACKEP-------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
|++++||||+++++++.+. .+++||||+. ++|.+++.. .+++..++.++.|++.||.|||++|++|||
T Consensus 77 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~d 151 (353)
T 3coi_A 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRD 151 (353)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSS
T ss_pred HHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 5678999999999999653 2589999996 688877632 399999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-C-----------------------------
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP-S----------------------------- 124 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~----------------------------- 124 (223)
|||+||+++.++ .+||+|||+++..... .....||+.|+|||.+.. .
T Consensus 152 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 152 LKPGNLAVNEDC-ELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp CCGGGEEECTTC-CEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CCHHHEeECCCC-cEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999887 8999999999764322 234578999999995431 0
Q ss_pred ----------------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....+.++.+++.+||+.+|.+||++++++++
T Consensus 229 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01346778899999999999999999999876
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.3e-26 Score=183.21 Aligned_cols=153 Identities=24% Similarity=0.424 Sum_probs=119.4
Q ss_pred CCCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 3 SRVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
+.++||||+++++++.+ +..++||||+.|++|.+++.......+++..++.++.|++.||.|||++|++||||||
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp 145 (299)
T 3m2w_A 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 145 (299)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 44689999999998853 4688999999999999999887666799999999999999999999999999999999
Q ss_pred CCEEEeC---CCCceEEccCcccccccccccccc-------------CCCccccccCC----------CCCCC----C--
Q 027476 78 ENLILTA---DHKTVKLADFGLAREESLTEMMTA-------------ETGTYRWMAPE----------NMRPS----A-- 125 (223)
Q Consensus 78 ~Nill~~---~~~~~kl~Dfg~a~~~~~~~~~~~-------------~~gt~~y~aPE----------~~~~~----~-- 125 (223)
+||+++. ++ .+||+|||++........... ..|...|.... .+... +
T Consensus 146 ~Nil~~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 146 ENLLYTSKRPNA-ILKLTDFGFAKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp GGEEESSSSTTC-CEEECCCTTCEECTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred HHEEEecCCCCC-cEEEeccccccccccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence 9999997 44 799999999975432211100 01222221110 00000 1
Q ss_pred --CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 --ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 --~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++..||+.+|.+||++++++++
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 4578899999999999999999999999886
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-26 Score=186.24 Aligned_cols=124 Identities=17% Similarity=0.147 Sum_probs=101.8
Q ss_pred cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCEEEeCCC-----------
Q 027476 19 EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLH-SHGIIHRDLKPENLILTADH----------- 86 (223)
Q Consensus 19 ~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~----------- 86 (223)
++..++||||+.+|++.+.+.+ +.+++..++.++.||+.||.||| ++||+||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~ 210 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTE
T ss_pred cCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCc
Confidence 4679999999999976666643 34899999999999999999999 99999999999999999764
Q ss_pred --------CceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHH-hcccCCCCCCCH
Q 027476 87 --------KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTS-CWKEDPNERPNF 150 (223)
Q Consensus 87 --------~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~-~l~~~p~~Rp~~ 150 (223)
..+||+|||+++..... ...||+.|+|||++.+.. +...|+|+++.. ....-+...|..
T Consensus 211 ~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 211 SSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp EEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 17999999999865432 347999999999999777 889999998766 444444555543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-26 Score=199.61 Aligned_cols=148 Identities=30% Similarity=0.398 Sum_probs=128.6
Q ss_pred CCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 2 MSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRP-RCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
|++++||||+++++++.+ +..++||||+.|++|.+++..... ..+++..++.++.|++.||.|||+.||+||
T Consensus 66 L~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHr 145 (676)
T 3qa8_A 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHR 145 (676)
T ss_dssp HHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCC
T ss_pred HHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence 567899999999998743 457899999999999999986432 358999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCC--ceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 74 DLKPENLILTADHK--TVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 74 dlkp~Nill~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
||||+||+++.++. .+||+|||++.............||+.|+|||.+.....+...|+|+++..+++.-.+..|.
T Consensus 146 DLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 146 DLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp CCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 99999999996652 48999999998765555555668999999999999999999999999999999888777775
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=180.28 Aligned_cols=156 Identities=14% Similarity=0.178 Sum_probs=119.0
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||+++++++.+ +..|+||||+.|++|.+++... ....++.+++.|++.||+|||++||+||||||+||
T Consensus 85 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NI 160 (286)
T 3uqc_A 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRV 160 (286)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred HhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccE
Confidence 467899999999999975 5789999999999999998542 45667899999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc-c-------ccCCCccccccCC----------CCC-------CCCCCChHHHHHH
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM-M-------TAETGTYRWMAPE----------NMR-------PSAENLPEDLALI 135 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~-~-------~~~~gt~~y~aPE----------~~~-------~~~~~~~~~l~~l 135 (223)
+++.++ .+||+++|.......... + ....|...|.... .+. ....+++.++.++
T Consensus 161 ll~~~g-~~kl~~~~~~~~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (286)
T 3uqc_A 161 RVSIDG-DVVLAYPATMPDANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239 (286)
T ss_dssp EEETTS-CEEECSCCCCTTCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHH
T ss_pred EEcCCC-CEEEEeccccCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHH
Confidence 999887 899998876543211100 0 0001222221111 111 1124688899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 136 VTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 136 ~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+||+.+|.+| ++.++++.|++....
T Consensus 240 i~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 240 AARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred HHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 999999999999 999999999997643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=187.62 Aligned_cols=130 Identities=18% Similarity=0.333 Sum_probs=106.4
Q ss_pred ceEEEEEcCCCCCHHHHHH-----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCc
Q 027476 21 VMVIVTELLLGGTLRKYLL-----NMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFG 95 (223)
Q Consensus 21 ~~~lv~e~~~~~sL~~~l~-----~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg 95 (223)
.++++|+++ +++|.+++. ......+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~-~~kL~DFG 256 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFE 256 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGG
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCC-eEEEEecc
Confidence 356777766 789999985 22234478889999999999999999999999999999999999888 79999999
Q ss_pred cccccccccccccCCCccccccCCCC----------CC----------------------------------------CC
Q 027476 96 LAREESLTEMMTAETGTYRWMAPENM----------RP----------------------------------------SA 125 (223)
Q Consensus 96 ~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~----------------------------------------~~ 125 (223)
+++..... .....| +.|+|||.+ .. ..
T Consensus 257 ~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~ 333 (413)
T 3dzo_A 257 HLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC 333 (413)
T ss_dssp GCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSC
T ss_pred ceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhc
Confidence 98865433 345577 999999977 31 12
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 126 ENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 126 ~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
..++.++.+++..||+.+|.+||++.++++
T Consensus 334 ~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 334 KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 457788999999999999999999877743
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-24 Score=188.84 Aligned_cols=109 Identities=20% Similarity=0.213 Sum_probs=90.6
Q ss_pred CCCCCCCCccceEEEe-ecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||+++..++ .++..++||||++|++|.+++.. +..++.|++.||+|||++||+||||||+||
T Consensus 393 l~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NI 462 (540)
T 3en9_A 393 LALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNF 462 (540)
T ss_dssp HHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSE
T ss_pred HHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHE
Confidence 5678999999544433 34567999999999999999865 467999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--------cccCCCccccccCCCCCC
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--------MTAETGTYRWMAPENMRP 123 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 123 (223)
+++. .+||+|||+++....... .....||+.|+|||.+..
T Consensus 463 Ll~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 463 IFDK---DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp EESS---SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred EECC---eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 9996 699999999986544321 235579999999998865
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=7e-19 Score=140.66 Aligned_cols=84 Identities=15% Similarity=0.191 Sum_probs=69.1
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
|++++ | +++.+++..+..++||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+||+
T Consensus 158 l~~l~--~-~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NIL 225 (282)
T 1zar_A 158 LQKLQ--G-LAVPKVYAWEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVL 225 (282)
T ss_dssp HHHTT--T-SSSCCEEEEETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred HHhcc--C-CCcCeEEeccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEE
Confidence 34455 4 66666666677899999999999988 421 224569999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccc
Q 027476 82 LTADHKTVKLADFGLARE 99 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~ 99 (223)
++ ++ .+||+|||+++.
T Consensus 226 l~-~~-~vkl~DFG~a~~ 241 (282)
T 1zar_A 226 VS-EE-GIWIIDFPQSVE 241 (282)
T ss_dssp EE-TT-EEEECCCTTCEE
T ss_pred EE-CC-cEEEEECCCCeE
Confidence 99 76 899999999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-16 Score=125.21 Aligned_cols=87 Identities=20% Similarity=0.183 Sum_probs=66.7
Q ss_pred CCCCCCCc--cceEEEeecCceEEEEEcCCC-C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCC
Q 027476 3 SRVRHRNL--VKFIGACKEPVMVIVTELLLG-G----TLRKYLLNMRPRCLDIHVAIGFALDIARAMECLH-SHGIIHRD 74 (223)
Q Consensus 3 ~~l~Hpni--v~l~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH-~~~ivH~d 74 (223)
++++|++| ..+++. +..++||||+.+ | +|.+.... .++..+..++.|++.||.||| +.||+|||
T Consensus 125 ~~l~~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrD 196 (258)
T 1zth_A 125 ERAKEAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHAD 196 (258)
T ss_dssp HHHHHTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred HHHHhCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 44556653 334432 356899999932 3 78876543 234567889999999999999 99999999
Q ss_pred CCCCCEEEeCCCCceEEccCcccccc
Q 027476 75 LKPENLILTADHKTVKLADFGLAREE 100 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~ 100 (223)
|||+|||++. .++|+|||++...
T Consensus 197 lkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS---SEEECCCTTCEET
T ss_pred CCHHHEEEcC---cEEEEECcccccC
Confidence 9999999986 6999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.32 E-value=3.9e-13 Score=111.21 Aligned_cols=70 Identities=20% Similarity=0.270 Sum_probs=57.0
Q ss_pred eEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEeCCCC---------ceEEc
Q 027476 22 MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHK---------TVKLA 92 (223)
Q Consensus 22 ~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~---------~~kl~ 92 (223)
.++||||+.|++|.++.. ......++.|++.+|.+||+.|||||||||.|||++.++. .+.|+
T Consensus 186 ~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iI 257 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIII 257 (397)
T ss_dssp TEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEEC
T ss_pred ceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEE
Confidence 479999999988865431 1234568899999999999999999999999999987652 38999
Q ss_pred cCccccc
Q 027476 93 DFGLARE 99 (223)
Q Consensus 93 Dfg~a~~ 99 (223)
||+-+..
T Consensus 258 D~~Q~V~ 264 (397)
T 4gyi_A 258 XFPQMVS 264 (397)
T ss_dssp CCTTCEE
T ss_pred EeCCccc
Confidence 9997753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=1.1e-09 Score=85.79 Aligned_cols=84 Identities=14% Similarity=0.070 Sum_probs=66.7
Q ss_pred CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q 027476 7 HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS------------------ 67 (223)
Q Consensus 7 Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~------------------ 67 (223)
+..+.++++++.+ +..|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~ 141 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE 141 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHH
Confidence 5678889988865 57899999999999987632 112234678899999999998
Q ss_pred -----------------------------------------CCcccCCCCCCCEEEeCCCCceEEccCcccc
Q 027476 68 -----------------------------------------HGIIHRDLKPENLILTADHKTVKLADFGLAR 98 (223)
Q Consensus 68 -----------------------------------------~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~ 98 (223)
..++|+|+++.||+++.++ .+.|+||+.+.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~ 212 (263)
T 3tm0_A 142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred HHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence 3489999999999998543 56799999775
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.78 E-value=1.9e-08 Score=82.49 Aligned_cols=89 Identities=16% Similarity=0.303 Sum_probs=71.1
Q ss_pred CCCccceEEEeecC----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------
Q 027476 7 HRNLVKFIGACKEP----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS--------------- 67 (223)
Q Consensus 7 Hpniv~l~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~--------------- 67 (223)
+..+.+++.++.+. ..|+||||++|.++.+.. ...++......++.+++..|..||+
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~ 172 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPG 172 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCS
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCC
Confidence 45678899888653 478999999998875421 1237888889999999999999997
Q ss_pred -------------------------------------------CCcccCCCCCCCEEEeCCCC-ceEEccCccccc
Q 027476 68 -------------------------------------------HGIIHRDLKPENLILTADHK-TVKLADFGLARE 99 (223)
Q Consensus 68 -------------------------------------------~~ivH~dlkp~Nill~~~~~-~~kl~Dfg~a~~ 99 (223)
..++|+|+++.||+++.++. .+.|+||+.+..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 173 NYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987652 469999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.69 E-value=2e-08 Score=78.20 Aligned_cols=79 Identities=18% Similarity=0.115 Sum_probs=58.7
Q ss_pred ccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------
Q 027476 10 LVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG------------------- 69 (223)
Q Consensus 10 iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~------------------- 69 (223)
+.+++++..+ +..++||||++|.+|. ... .+. ..++.+++..|..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~ 146 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERART 146 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHH
Confidence 5668887764 5689999999998884 211 222 246677777777777643
Q ss_pred ---------------------------------------cccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 70 ---------------------------------------IIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 70 ---------------------------------------ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
++|+|++|.||+++.++ .++|+|||.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~ 214 (264)
T 1nd4_A 147 RMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLGV 214 (264)
T ss_dssp HHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred HHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence 99999999999998554 567999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.22 E-value=1.6e-06 Score=69.41 Aligned_cols=86 Identities=23% Similarity=0.286 Sum_probs=64.8
Q ss_pred ccceEEEeecC----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q 027476 10 LVKFIGACKEP----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS------------------ 67 (223)
Q Consensus 10 iv~l~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~------------------ 67 (223)
+.+++....++ ..|+||++++|.+|.+.... .++..+...++.+++..|..||+
T Consensus 75 vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~ 150 (304)
T 3sg8_A 75 IPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKI 150 (304)
T ss_dssp CCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHH
T ss_pred CCceEeecCCCCCCCcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHH
Confidence 44555554332 24789999999998764332 27788888888899988888886
Q ss_pred ----------------------------------------CCcccCCCCCCCEEEeCC-CCceEEccCccccc
Q 027476 68 ----------------------------------------HGIIHRDLKPENLILTAD-HKTVKLADFGLARE 99 (223)
Q Consensus 68 ----------------------------------------~~ivH~dlkp~Nill~~~-~~~~kl~Dfg~a~~ 99 (223)
..++|+|+++.||+++.+ +..+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 151 NEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 136999999999999974 43689999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=1.5e-05 Score=63.89 Aligned_cols=86 Identities=21% Similarity=0.257 Sum_probs=58.7
Q ss_pred ccceEEEee--cCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------
Q 027476 10 LVKFIGACK--EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH------------------- 68 (223)
Q Consensus 10 iv~l~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~------------------- 68 (223)
|.+++.++. ++..++|||+++|.++.+.... .++......++.+++..|..||+.
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~ 149 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKI 149 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHH
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHH
Confidence 556666664 3567899999999988764221 144555555555555555555532
Q ss_pred -----------------------------------------CcccCCCCCCCEEEeC---CCCceEEccCccccc
Q 027476 69 -----------------------------------------GIIHRDLKPENLILTA---DHKTVKLADFGLARE 99 (223)
Q Consensus 69 -----------------------------------------~ivH~dlkp~Nill~~---~~~~~kl~Dfg~a~~ 99 (223)
.++|+|+++.||+++. ++..+.|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 150 LLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999986 343568999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=2.2e-05 Score=61.33 Aligned_cols=83 Identities=19% Similarity=0.161 Sum_probs=58.7
Q ss_pred ccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------
Q 027476 10 LVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSH-------------------- 68 (223)
Q Consensus 10 iv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~-------------------- 68 (223)
|.++++++.+ +..++|||+++|.++.+...... .....+..+++..|.-||..
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~ 155 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQS 155 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHH
Confidence 5678888865 57899999999999887654311 11233455555555555531
Q ss_pred --------------------------------------CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 69 --------------------------------------GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 69 --------------------------------------~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.++|+|+.+.||+++.++ .+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~ 223 (272)
T 4gkh_A 156 RMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred HHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence 168999999999998654 677999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0001 Score=60.04 Aligned_cols=31 Identities=13% Similarity=0.249 Sum_probs=25.8
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
..++|+|+.+.||+++. +..+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~-~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRD-FQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEET-TEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeC-CcEEEEEccccccc
Confidence 46899999999999994 43579999998864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.002 Score=51.65 Aligned_cols=31 Identities=16% Similarity=0.263 Sum_probs=26.8
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.+++|+|+++.||+++.++ .+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGG-CEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCC-cEEEEehhhccc
Confidence 5799999999999997666 799999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0043 Score=49.83 Aligned_cols=32 Identities=28% Similarity=0.427 Sum_probs=26.4
Q ss_pred CCcccCCCCCCCEEEeCC---CCceEEccCccccc
Q 027476 68 HGIIHRDLKPENLILTAD---HKTVKLADFGLARE 99 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~---~~~~kl~Dfg~a~~ 99 (223)
..++|||+.+.||+++.+ ...+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 468999999999999864 13799999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0066 Score=48.04 Aligned_cols=29 Identities=17% Similarity=0.178 Sum_probs=23.8
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.++|+|+.+.||+. .++ .+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil~-~~~-~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLD-TGE-RMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEE-CSS-CEEECCCTTCEE
T ss_pred eeeccCCCcCCEEE-CCC-CEEEEecccccC
Confidence 37999999999994 455 689999988763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.0061 Score=50.71 Aligned_cols=32 Identities=22% Similarity=0.391 Sum_probs=27.1
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
+...++|+|+++.||+++.++ ++++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS--TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC--EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC--CEEEeCccccc
Confidence 346799999999999998654 99999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.10 E-value=0.3 Score=36.88 Aligned_cols=126 Identities=11% Similarity=0.080 Sum_probs=73.3
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEeCCCCceEEccCccccc----ccccccc
Q 027476 32 GTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPENLILTADHKTVKLADFGLARE----ESLTEMM 106 (223)
Q Consensus 32 ~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~----~~~~~~~ 106 (223)
-||.+++...+ ++++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+| .|.+.+ +.+.. .......
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~~~~~~~~~pe~~ 109 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADDAGEPPPVAGKLG 109 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C------------CCS
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-ccccccccCCCChhhc
Confidence 48999987643 569999999999999999887622 2212333456889999888 677664 21110 0000000
Q ss_pred ------c---cCCCccccccCCCCC--CCCCCChHHHHHHHHHhccc-------------------------CCCCCCCH
Q 027476 107 ------T---AETGTYRWMAPENMR--PSAENLPEDLALIVTSCWKE-------------------------DPNERPNF 150 (223)
Q Consensus 107 ------~---~~~gt~~y~aPE~~~--~~~~~~~~~l~~l~~~~l~~-------------------------~p~~Rp~~ 150 (223)
. ...|..-|.|-+.-. .....++.++.+|+..|... .+..|.++
T Consensus 110 ~~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl 189 (229)
T 2yle_A 110 YSQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSY 189 (229)
T ss_dssp SSSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSH
T ss_pred cccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCH
Confidence 0 001222222222211 22346888999999988755 24577888
Q ss_pred HHHHHHHHHH
Q 027476 151 SQIIQMLLHY 160 (223)
Q Consensus 151 ~~~~~~L~~~ 160 (223)
++|++.-..-
T Consensus 190 ~~Vi~~C~~h 199 (229)
T 2yle_A 190 RDVMKLCAAH 199 (229)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHHhh
Confidence 8887654443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.01 E-value=0.011 Score=46.94 Aligned_cols=30 Identities=37% Similarity=0.562 Sum_probs=25.2
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
+++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 188 ~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~ 217 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDE-LSGLIDFYFACN 217 (322)
T ss_dssp EEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred ccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence 689999999999998654 458999998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.35 E-value=0.037 Score=44.08 Aligned_cols=29 Identities=24% Similarity=0.279 Sum_probs=24.7
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D--GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence 3589999999999998 4 699999988763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=92.91 E-value=0.089 Score=43.15 Aligned_cols=31 Identities=23% Similarity=0.312 Sum_probs=25.7
Q ss_pred hCCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 67 SHGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 67 ~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
...++|||+.+.||+++.+ .++++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~--~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH--ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS--CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC--CeEEEeCccccc
Confidence 3578999999999999854 489999987753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.80 E-value=0.067 Score=43.09 Aligned_cols=31 Identities=13% Similarity=0.296 Sum_probs=26.4
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
..++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence 3589999999999998665 699999987764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.51 E-value=0.11 Score=42.18 Aligned_cols=29 Identities=31% Similarity=0.440 Sum_probs=24.1
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.++|+|+.+.||+++. + .+.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~-~-~~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTN-K-CLRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC---CEEECCCTTCEE
T ss_pred EEEeCCCCcccEEecC-C-cEEEEEecCCCC
Confidence 5899999999999974 3 489999988763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=91.33 E-value=0.092 Score=41.77 Aligned_cols=33 Identities=15% Similarity=0.246 Sum_probs=27.4
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 027476 124 SAENLPEDLALIVTSCWKEDPNERPNF-----SQIIQM 156 (223)
Q Consensus 124 ~~~~~~~~l~~l~~~~l~~~p~~Rp~~-----~~~~~~ 156 (223)
.+..++.++.+|+.+||+.+|.+||++ ++++++
T Consensus 245 ~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 245 MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 355688999999999999999999984 566554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=91.04 E-value=0.09 Score=43.89 Aligned_cols=31 Identities=29% Similarity=0.432 Sum_probs=24.7
Q ss_pred CcccCCCCCCCEEEeCC---------------------------CCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTAD---------------------------HKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~---------------------------~~~~kl~Dfg~a~~ 99 (223)
.++|+|+.+.||+++.+ .+.+.|+||..+..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 48999999999999875 13689999988763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=90.91 E-value=0.18 Score=42.49 Aligned_cols=15 Identities=40% Similarity=0.434 Sum_probs=14.0
Q ss_pred CcccCCCCCCCEEEe
Q 027476 69 GIIHRDLKPENLILT 83 (223)
Q Consensus 69 ~ivH~dlkp~Nill~ 83 (223)
.++|+|+.+.||+++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 489999999999998
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=89.65 E-value=0.18 Score=41.44 Aligned_cols=31 Identities=23% Similarity=0.445 Sum_probs=25.9
Q ss_pred CcccCCCCCCCEEEeCC---CCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTAD---HKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~---~~~~kl~Dfg~a~~ 99 (223)
.++|+|+.+.||+++.+ .+.+.++||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 48999999999999876 23799999998863
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.47 E-value=1.2 Score=33.53 Aligned_cols=82 Identities=12% Similarity=0.020 Sum_probs=55.4
Q ss_pred CCCCccceEEEeecCceEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHHhCCcccCCCCCCCEEEe
Q 027476 6 RHRNLVKFIGACKEPVMVIVTELLLGG-TLRKYLLNMRPRCLDIHVAIGFALDIARAME-CLHSHGIIHRDLKPENLILT 83 (223)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~-~lH~~~ivH~dlkp~Nill~ 83 (223)
.||++ ..-=.-.++.+.+.++.-+++ ++. .+.. ++..+.++++.+|+.... ++ ..-+|--|.|+|++++
T Consensus 48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~-~i~~-----~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFA-AIRK-----TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS-EEEEEECSSEEEEEEECCTTCEEHH-HHHT-----SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC-CeEEEEeCCEEEEEEEcCcccCcHH-HHHh-----cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 56776 222122345666667665343 444 3433 888999999888877544 33 4567888999999999
Q ss_pred CCCCceEEccCccc
Q 027476 84 ADHKTVKLADFGLA 97 (223)
Q Consensus 84 ~~~~~~kl~Dfg~a 97 (223)
.++ .+++.-.|+-
T Consensus 119 ~~~-~p~i~hRGi~ 131 (219)
T 4ano_A 119 RAL-EPFFLHVGVK 131 (219)
T ss_dssp TTC-CEEESCCEET
T ss_pred CCC-cEEEEEcCCc
Confidence 887 8999988764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=88.67 E-value=0.099 Score=41.73 Aligned_cols=31 Identities=13% Similarity=0.067 Sum_probs=27.3
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 125 AENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 125 ~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
+..++.++.+|+.+||+.||.+||+++|+..
T Consensus 254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 254 PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 4568899999999999999999999988643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.31 E-value=0.35 Score=39.84 Aligned_cols=30 Identities=23% Similarity=0.438 Sum_probs=24.2
Q ss_pred cccCCCCCCCEEEeC-----CCCceEEccCccccc
Q 027476 70 IIHRDLKPENLILTA-----DHKTVKLADFGLARE 99 (223)
Q Consensus 70 ivH~dlkp~Nill~~-----~~~~~kl~Dfg~a~~ 99 (223)
++|+|+.+.||++.. +.+.++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 579999999999942 234799999998863
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.78 E-value=0.98 Score=33.87 Aligned_cols=82 Identities=13% Similarity=0.118 Sum_probs=56.1
Q ss_pred CCCCccceEEEee-cCceEEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEe
Q 027476 6 RHRNLVKFIGACK-EPVMVIVTELLL-GGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILT 83 (223)
Q Consensus 6 ~Hpniv~l~~~~~-~~~~~lv~e~~~-~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 83 (223)
.||+.+.. .+-+ ++.+.+.++.-. +.++.. +.. ++....++++.+|+....++ ..-+|--|.|+|++++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~-----~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS-----FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG-----SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh-----cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEc
Confidence 57877766 3333 345555555443 223333 332 88899999999998876443 3456778999999999
Q ss_pred CCCCceEEccCccc
Q 027476 84 ADHKTVKLADFGLA 97 (223)
Q Consensus 84 ~~~~~~kl~Dfg~a 97 (223)
.++ .+++.-.|+.
T Consensus 114 ~~~-~p~i~~RGik 126 (215)
T 4ann_A 114 RDG-LPIAKTRGLQ 126 (215)
T ss_dssp TTS-CEEESCCEET
T ss_pred CCC-CEEEEEccCc
Confidence 888 7999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=83.76 E-value=0.51 Score=39.32 Aligned_cols=29 Identities=21% Similarity=0.486 Sum_probs=24.6
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.++|+|+.+.||+ +.++ .+.++||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~-~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQN-NIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSS-CEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCC-cEEEEecccCCc
Confidence 4799999999999 5555 799999998864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=83.60 E-value=0.55 Score=37.66 Aligned_cols=32 Identities=25% Similarity=0.334 Sum_probs=26.7
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 027476 125 AENLPEDLALIVTSCWKEDPNERPNF------SQIIQM 156 (223)
Q Consensus 125 ~~~~~~~l~~l~~~~l~~~p~~Rp~~------~~~~~~ 156 (223)
+..++.++.+++..||+.+|.+||+. ++++++
T Consensus 239 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 239 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 45678899999999999999999985 566554
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=83.58 E-value=0.93 Score=37.25 Aligned_cols=27 Identities=26% Similarity=0.351 Sum_probs=23.9
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCH
Q 027476 124 SAENLPEDLALIVTSCWKEDPNERPNF 150 (223)
Q Consensus 124 ~~~~~~~~l~~l~~~~l~~~p~~Rp~~ 150 (223)
.+..++.++.+++..||+.+|.+||+.
T Consensus 281 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 345688999999999999999999985
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=81.90 E-value=0.54 Score=36.54 Aligned_cols=25 Identities=28% Similarity=0.296 Sum_probs=20.5
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFG 95 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg 95 (223)
.++|+|+.+.||+++.++ ..+.|-.
T Consensus 189 ~LvHGDlw~gNvl~~~~g--~~~iDp~ 213 (288)
T 3f7w_A 189 ARIHGDLWNGNVLWQDDG--AVVIDPA 213 (288)
T ss_dssp EEECSCCSGGGEEEETTE--EEECSCC
T ss_pred eeeecCCCCCcEEEcCCC--eEEEecc
Confidence 489999999999999776 5677743
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 223 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-35 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-35 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-33 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-33 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-33 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-32 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-30 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-30 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-30 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-30 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-29 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-29 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-28 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-28 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-28 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-27 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-26 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-25 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-25 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-05 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-24 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-23 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-22 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-21 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-21 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-21 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-21 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-20 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-20 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-17 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-17 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-17 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-16 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-15 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-14 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-14 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 6e-40
Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 58/213 (27%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
++ + RH N++ F+G P + IVT+ G +L +L + + ++ I A A+
Sbjct: 57 VLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQ 115
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR---EESLTEMMTAETGTYRWMA 117
M+ LH+ IIHRDLK N+ L D TVK+ DFGLA S + +G+ WMA
Sbjct: 116 GMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 118 PENMRPSAEN-------------------------------------------------- 127
PE +R +N
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 128 ---LPEDLALIVTSCWKEDPNERPNFSQIIQML 157
P+ + ++ C K+ +ERP F QI+ +
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-38
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 49/210 (23%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M +++H+ LV+ + + I+TE + G+L +L L I+ + A IA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR--EESLTEMMTAETGTYRWMAP 118
M + IHRDL+ N IL +D + K+ADFGLAR E++ +W AP
Sbjct: 121 GMAFIEERNYIHRDLRAAN-ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 119 ENMR----------------------------------------------PSAENLPEDL 132
E + +N PE+L
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 133 ALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162
++ CWKE P +RP F + +L + +
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-36
Identities = 45/220 (20%), Positives = 83/220 (37%), Gaps = 53/220 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M ++ + +V+ IG C+ +++V E+ GG L K+L+ R + + ++
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSM 120
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR----EESLTEMMTAETGTYRWM 116
M+ L +HRDL N++L H K++DFGL++ ++S +A +W
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 117 APENMR----------------------------------------------PSAENLPE 130
APE + P
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 239
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLH-YISTNSAPEP 169
+L +++ CW +RP+F + Q + Y S S E
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-35
Identities = 44/212 (20%), Positives = 85/212 (40%), Gaps = 53/212 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ S +RH N+++ G + V ++ E GT+ + L + D + ++A
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELA 116
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
A+ HS +IHRD+KPENL+L + +K+ADFG + + T GT ++ PE
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTT-LCGTLDYLPPE 174
Query: 120 NMR--------------------------------------------PSAENLPEDLALI 135
+ + + E +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234
Query: 136 VTSCWKEDPNERPNFSQIIQMLLH-YISTNSA 166
++ K +P++RP ++++ H +I+ NS+
Sbjct: 235 ISRLLKHNPSQRPMLREVLE---HPWITANSS 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-35
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 51/207 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEP--VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M+++RH NLV+ +G E + IVTE + G+L YL + L + F+LD+
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAP 118
AME L + +HRDL N++++ D+ K++DFGL +E + +W AP
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE--ASSTQDTGKLPVKWTAP 169
Query: 119 ENMR----------------------------------------------PSAENLPEDL 132
E +R + + P +
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 229
Query: 133 ALIVTSCWKEDPNERPNFSQIIQMLLH 159
++ +CW D RP+F Q+ + L H
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 5e-35
Identities = 43/210 (20%), Positives = 77/210 (36%), Gaps = 53/210 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M ++ + +V+ IG C+ ++V E+ G L KYL + R + I ++
Sbjct: 61 VMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSM 118
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR----EESLTEMMTAETGTYRWM 116
M+ L +HRDL N++L H K++DFGL++ +E+ + T +W
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 117 APENMR----------------------------------------------PSAENLPE 130
APE + P
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 237
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLHY 160
++ ++ CW D RP F+ + L +Y
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 4e-34
Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 56/208 (26%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-----MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
M+ ++H N+V+F + + V +V+VTEL+ GTL+ YL + + I V +
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWC 118
Query: 56 LDIARAMECLHSHG--IIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY 113
I + ++ LH+ IIHRDLK +N+ +T +VK+ D GLA + A GT
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTP 177
Query: 114 RWMAPENMR----------------------------------------------PSAEN 127
+MAPE +
Sbjct: 178 EFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQ 155
++ I+ C +++ +ER + ++
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-33
Identities = 51/229 (22%), Positives = 76/229 (33%), Gaps = 73/229 (31%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPR--------------- 44
M H N+V +GAC + ++ E G L YL + R +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 45 ------CLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR 98
L + FA +A+ ME L +HRDL N +L K VK+ DFGLAR
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN-VLVTHGKVVKICDFGLAR 212
Query: 99 ---EESLTEMMTAETGTYRWMAPENMR--------------------------------- 122
+S + +WMAPE++
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 123 --------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
E++ +I+ SCW D +RP+F + L
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (299), Expect = 3e-33
Identities = 48/232 (20%), Positives = 81/232 (34%), Gaps = 59/232 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ ++RH N +++ G +V E LG ++ +P L
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGAL 125
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+ + LHSH +IHRD+K N++L+ VKL DFG A + + GT WMAPE
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSAS---IMAPANSFVGTPYWMAPE 181
Query: 120 NMR-------------------------------------------------PSAENLPE 130
+ + + E
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAV 182
V SC ++ P +RP +++ H P VI+ + +++AV
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLK---HRFVLRERPPTVIMDLIQRTKDAV 290
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 6e-33
Identities = 52/209 (24%), Positives = 76/209 (36%), Gaps = 53/209 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M + HRNL++ G P M +VTEL G+L L + + +A+ +A
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAE 122
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR----EESLTEMMTAETGTYRWM 116
M L S IHRDL NL+L VK+ DFGL R + M + W
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 117 APENMR-----------------------------------------------PSAENLP 129
APE+++ P E+ P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLL 158
+D+ ++ CW P +RP F + LL
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 7e-33
Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 50/205 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M + H ++VK IG E + I+ EL G LR +L + LD+ I +A ++
Sbjct: 61 TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 119
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR--EESLTEMMTAETGTYRWMAP 118
A+ L S +HRD+ N +L + + VKL DFGL+R E+S + +WMAP
Sbjct: 120 ALAYLESKRFVHRDIAARN-VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 119 ENMR----------------------------------------------PSAENLPEDL 132
E++ P N P L
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238
Query: 133 ALIVTSCWKEDPNERPNFSQIIQML 157
++T CW DP+ RP F+++ L
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 7e-33
Identities = 49/215 (22%), Positives = 79/215 (36%), Gaps = 49/215 (22%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M ++RH LV+ E + IVTE + G+L +L + L + + A IA
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR--EESLTEMMTAETGTYRWMAP 118
M + +HRDL+ N+++ + K+ADFGLAR E++ +W AP
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 119 ENMR----------------------------------------------PSAENLPEDL 132
E P PE L
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 243
Query: 133 ALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAP 167
++ CW+++P ERP F + L Y ++
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 8e-33
Identities = 43/209 (20%), Positives = 72/209 (34%), Gaps = 56/209 (26%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+++ H N+VK + A + I+ E GG + +L + R L
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTL 120
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWMAP 118
A+ LH + IIHRDLK N++ T D +KLADFG++ + + + GT WMAP
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 179
Query: 119 ENMR----------------------------------------------------PSAE 126
E +
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 239
Query: 127 NLPEDLALIVTSCWKEDPNERPNFSQIIQ 155
+ + C +++ + R SQ++Q
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-32
Identities = 49/207 (23%), Positives = 72/207 (34%), Gaps = 51/207 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M + H LV+ G C + + I+TE + G L YL MR R + D+
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVC 110
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE--ESLTEMMTAETGTYRWMA 117
AME L S +HRDL N ++ VK++DFGL+R + RW
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 169
Query: 118 PENMR----------------------------------------------PSAENLPED 131
PE + E
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 229
Query: 132 LALIVTSCWKEDPNERPNFSQIIQMLL 158
+ I+ SCW E +ERP F ++ +L
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (292), Expect = 3e-32
Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 50/219 (22%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++H NLV+ +G C +EP I+TE + G L YL + + V + A I+
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 125
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR--EESLTEMMTAETGTYRWMA 117
AME L IHRDL N ++ +H VK+ADFGL+R +W A
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 118 PENMR----------------------------------------------PSAENLPED 131
PE++ E PE
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244
Query: 132 LALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPV 170
+ ++ +CW+ +P++RP+F++I Q +S + V
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 115 bits (289), Expect = 2e-31
Identities = 43/256 (16%), Positives = 91/256 (35%), Gaps = 57/256 (22%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M+++ H L+ A ++ MV++ E L GG L + + + I +
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQAC 137
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHK-TVKLADFGLAREESLTEMMTAETGTYRWMAP 118
++ +H H I+H D+KPEN++ +VK+ DFGLA + + E++ T T + AP
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 197
Query: 119 ENMR------------------------------------------------PSAENLPE 130
E + + ++
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLH-YISTNSAPEPVILPRMFSSENAVLPPESPG 189
+ + + +++P +R ++ H ++ + + +P S N +
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALE---HPWLKGDHSNLTSRIPS--SRYNKIRQKIKEK 312
Query: 190 TSSLMPPRDDSERNPN 205
+ P+ R N
Sbjct: 313 YADWPAPQPAIGRIAN 328
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 7e-31
Identities = 46/250 (18%), Positives = 88/250 (35%), Gaps = 54/250 (21%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+M+ V + ++ + +G C + ++T+L+ G L Y+ + + + + IA+
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAK 122
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR---EESLTEMMTAETGTYRWMA 117
M L ++HRDL N+++ VK+ DFGLA+ E +WMA
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 118 PENMR----------------------------------------------PSAENLPED 131
E++ P D
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 241
Query: 132 LALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENAVLPPESPGTS 191
+ +I+ CW D + RP F ++I P+ ++ + + P +S
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIEFSKMARD---PQRYLVIQGDERMHLPSPTDSNFYR 298
Query: 192 SLMPPRDDSE 201
+LM D +
Sbjct: 299 ALMDEEDMDD 308
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-30
Identities = 56/232 (24%), Positives = 86/232 (37%), Gaps = 68/232 (29%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRC-------------- 45
+ H N+V +GAC +++TE G L +L R
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 46 --LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR---EE 100
LD+ + F+ +A+ M L S IHRDL N IL + K+ DFGLAR +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN-ILLTHGRITKICDFGLARDIKND 198
Query: 101 SLTEMMTAETGTYRWMAPENMR-------------------------------------- 122
S + +WMAPE++
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 123 ---------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165
S E+ P ++ I+ +CW DP +RP F QI+Q++ IS ++
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-30
Identities = 41/207 (19%), Positives = 70/207 (33%), Gaps = 55/207 (26%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ + H N+VKF G +E + + E GG L + + A F +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLM 113
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR---EESLTEMMTAETGTYRWM 116
+ LH GI HRD+KPENL+L +K++DFGLA + ++ GT ++
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 117 APENMR------------------------------------------------PSAENL 128
APE ++ + +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 129 PEDLALIVTSCWKEDPNERPNFSQIIQ 155
++ E+P+ R I +
Sbjct: 233 DSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 112 bits (282), Expect = 2e-30
Identities = 45/220 (20%), Positives = 78/220 (35%), Gaps = 55/220 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
MS +RH LV A ++ MV++ E + GG L + + + + A+ + +
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVC 134
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHK-TVKLADFGLAREESLTEMMTAETGTYRWMAP 118
+ + +H + +H DLKPEN++ T +KL DFGL + + TGT + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194
Query: 119 ENMR------------------------------------------------PSAENLPE 130
E + + E
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQMLLH-YISTNSAPEP 169
D + DPN R Q ++ H +++ +AP
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALE---HPWLTPGNAPGR 291
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 6e-30
Identities = 46/206 (22%), Positives = 73/206 (35%), Gaps = 51/206 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++ H LV+ G C E + +V E + G L YL R +G LD+
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVC 111
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR--EESLTEMMTAETGTYRWMA 117
M L +IHRDL N L +++ +K++DFG+ R + T +W +
Sbjct: 112 EGMAYLEEACVIHRDLAARN-CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170
Query: 118 PENMR----------------------------------------------PSAENLPED 131
PE
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230
Query: 132 LALIVTSCWKEDPNERPNFSQIIQML 157
+ I+ CWKE P +RP FS++++ L
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 6e-30
Identities = 45/211 (21%), Positives = 71/211 (33%), Gaps = 57/211 (27%)
Query: 1 MMSRVRHRNLVKFIGACKEP---VMVIVTELLLGGTLRKYLLNMRPR--CLDIHVAIGFA 55
++ ++H N+V++ + + IV E GG L + LD +
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 56 LDIARAMECLH-----SHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAE 109
+ A++ H H ++HRDLKP N+ L VKL DFGLAR T A
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKAF 174
Query: 110 TGTYRWMAPE---------------------------------------------NMRPS 124
GT +M+PE R
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 234
Query: 125 AENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155
++L I+T RP+ +I++
Sbjct: 235 PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 8e-30
Identities = 30/124 (24%), Positives = 60/124 (48%), Gaps = 6/124 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ +V F GA + I E + GG+L + L + + + ++ +
Sbjct: 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVI 114
Query: 60 RAMECLHS-HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAP 118
+ + L H I+HRD+KP N+++ + +KL DFG++ + M + GT +M+P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI-DSMANSFVGTRSYMSP 172
Query: 119 ENMR 122
E ++
Sbjct: 173 ERLQ 176
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 8e-30
Identities = 47/230 (20%), Positives = 87/230 (37%), Gaps = 56/230 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M ++ N+V ++ + + +V E L GG+L + C+D +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECL 126
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAP 118
+A+E LHS+ +IHRD+K +N++L D +VKL DFG + + + + GT WMAP
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 119 ENMR-----------------------------------------------PSAENLPED 131
E + + E L
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 132 LALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSENA 181
+ C D +R + +++Q H + P + P + +++ A
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQ---HQFLKIAKPLSSLTPLIAAAKEA 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-29
Identities = 51/223 (22%), Positives = 79/223 (35%), Gaps = 55/223 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEP--VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+M H N++ +G C ++V + G LR ++ + IGF L +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQV 139
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR-----EESLTEMMTAETGTY 113
A+ M+ L S +HRDL N +L TVK+ADFGLAR E T
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 114 RWMAPENMR----------------------------------------------PSAEN 127
+WMA E+++ E
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPV 170
P+ L ++ CW RP+FS+++ + ST V
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 301
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (272), Expect = 2e-29
Identities = 45/210 (21%), Positives = 76/210 (36%), Gaps = 55/210 (26%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M + H N++ G + V I+TE + G+L +L + + +G IA
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLRGIA 138
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR------EESLTEMMTAETGTY 113
M+ L +HRDL N+++ ++ K++DFGL+R +
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 114 RWMAPENMR----------------------------------------------PSAEN 127
RW APE ++ P +
Sbjct: 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD 257
Query: 128 LPEDLALIVTSCWKEDPNERPNFSQIIQML 157
P L ++ CW++D N RP F QI+ L
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-29
Identities = 51/241 (21%), Positives = 84/241 (34%), Gaps = 62/241 (25%)
Query: 1 MMSRVRHRNLVKFIGACK-EPVMVIVTELLLGGTLRKYLLNMRPRC-------------- 45
+ H N++ +GAC+ + + E G L +L R
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 46 LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM 105
L + FA D+AR M+ L IHRDL N+++ ++ K+ADFGL+R + +
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVK 182
Query: 106 MTAETGTYRWMAPENMR------------------------------------------- 122
T RWMA E++
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242
Query: 123 ---PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSSE 179
N +++ ++ CW+E P ERP+F+QI+ L + L F+
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302
Query: 180 N 180
Sbjct: 303 G 303
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-28
Identities = 44/190 (23%), Positives = 74/190 (38%), Gaps = 11/190 (5%)
Query: 1 MMSRVRHRNLVKFIGACK-----EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
+ ++V+ + + ++IV E L GG L + + + A
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 56 LDIARAMECLHSHGIIHRDLKPENLILTA--DHKTVKLADFGLAREESLTEMMTAETGTY 113
I A++ LHS I HRD+KPENL+ T+ + +KL DFG A+E + +T T
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177
Query: 114 RWMAPENMRPSAENLPEDL----ALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEP 169
++APE + P + D+ ++ P + I + I P
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 170 VILPRMFSSE 179
S E
Sbjct: 238 NPEWSEVSEE 247
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 4e-28
Identities = 34/205 (16%), Positives = 72/205 (35%), Gaps = 51/205 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+++ RHRN++ + + +V++ E + G + + + N L+ + + +
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVC 112
Query: 60 RAMECLHSHGIIHRDLKPENLILTAD-HKTVKLADFGLAREESLTEMMTAETGTYRWMAP 118
A++ LHSH I H D++PEN+I T+K+ +FG AR+ + + AP
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
Query: 119 ENMR------------------------------------------------PSAENLPE 130
E + + + +
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 131 DLALIVTSCWKEDPNERPNFSQIIQ 155
+ V ++ R S+ +Q
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (263), Expect = 5e-28
Identities = 49/229 (21%), Positives = 79/229 (34%), Gaps = 73/229 (31%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRC-------------- 45
+M+ + N+VK +G C M ++ E + G L ++L +M P
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 46 --------LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLA 97
L + A +A M L +HRDL N ++ + VK+ADFGL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLS 187
Query: 98 R---EESLTEMMTAETGTYRWMAPE----------------------------------- 119
R + + RWM PE
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 120 -----------NMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
N+ EN P +L ++ CW + P +RP+F I ++L
Sbjct: 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 6e-28
Identities = 43/208 (20%), Positives = 81/208 (38%), Gaps = 53/208 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+M + H N+++ G + M+I+TE + G L K+L + + +G IA
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIA 120
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR----EESLTEMMTAETGTYRW 115
M+ L + +HRDL N+++ ++ K++DFGL+R + T + RW
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 116 MAPENMR----------------------------------------------PSAENLP 129
APE + P+ + P
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQML 157
+ ++ CW+++ RP F+ I+ +L
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-27
Identities = 47/215 (21%), Positives = 83/215 (38%), Gaps = 59/215 (27%)
Query: 1 MMSRVRHRNLVKFIGAC-KEPVMVIVTELLLGGTLRKYLLNMRPRC--------LDIHVA 51
+M ++V+ +G + +++ EL+ G L+ YL ++RP +
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR---EESLTEMMTA 108
I A +IA M L+++ +HRDL N ++ D TVK+ DFG+ R E
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGK 194
Query: 109 ETGTYRWMAPENMR---------------------------------------------- 122
RWM+PE+++
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254
Query: 123 PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
+N P+ L ++ CW+ +P RP+F +II +
Sbjct: 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 7e-27
Identities = 43/203 (21%), Positives = 70/203 (34%), Gaps = 51/203 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+MSR+ H VK ++ + G L KY+ + D + +I
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIV 118
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR---EESLTEMMTAETGTYRWM 116
A+E LH GIIHRDLKPEN++L D +++ DFG A+ ES + GT +++
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 117 APENMRPSA--------------------------------------------ENLPEDL 132
+PE + + E
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237
Query: 133 ALIVTSCWKEDPNERPNFSQIIQ 155
+V D +R ++
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEG 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 2e-26
Identities = 34/197 (17%), Positives = 68/197 (34%), Gaps = 44/197 (22%)
Query: 1 MMSRVR--HRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
++ +V +++ + + P V++ E + R L +A F
Sbjct: 60 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQ 118
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
+ A+ H+ G++HRD+K EN+++ + +KL DFG + T GT +
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSP 177
Query: 118 PENMRPSA---------------------------------------ENLPEDLALIVTS 138
PE +R + + + ++
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 237
Query: 139 CWKEDPNERPNFSQIIQ 155
C P++RP F +I
Sbjct: 238 CLALRPSDRPTFEEIQN 254
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (253), Expect = 2e-26
Identities = 42/225 (18%), Positives = 88/225 (39%), Gaps = 57/225 (25%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ +++H N+V + + ++ +L+ GG L + + A +
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVL 117
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHK--TVKLADFGLAREESLTEMMTAETGTYRWMA 117
A++ LH GI+HRDLKPENL+ + + + ++DFGL++ E +++ GT ++A
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177
Query: 118 PENMR------------------------------------------------PSAENLP 129
PE + P +++
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 130 EDLALIVTSCWKEDPNERPNFSQIIQMLLH-YISTNSAPEPVILP 173
+ + ++DP +R Q +Q H +I+ ++A + I
Sbjct: 238 DSAKDFIRHLMEKDPEKRFTCEQALQ---HPWIAGDTALDKNIHQ 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 1e-25
Identities = 49/231 (21%), Positives = 88/231 (38%), Gaps = 67/231 (29%)
Query: 1 MMSRVRHRNLVKFIGACKEP--VMVIVTELLLGGTLRKYLLNMR--------------PR 44
++ H N+V +GAC +P ++++ E G L YL + R
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 45 CLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE 104
L + I ++ +A+ ME L S IHRDL N++L+ + VK+ DFGLAR+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP 188
Query: 105 MMTAET---GTYRWMAPENMR--------------------------------------- 122
+ +WMAPE +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 123 --------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNS 165
+ + ++ + CW +P++RP FS++++ L + + N+
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 2e-25
Identities = 38/142 (26%), Positives = 61/142 (42%), Gaps = 22/142 (15%)
Query: 1 MMSRVRHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
+RH N++ FI A + + +V++ G+L YL + + I A
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLA 106
Query: 56 LDIARAMECLHSH--------GIIHRDLKPENLILTADHKTVKLADFGLAR-----EESL 102
L A + LH I HRDLK +N+++ + T +AD GLA +++
Sbjct: 107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTI 165
Query: 103 TEMMTAETGTYRWMAPENMRPS 124
GT R+MAPE + S
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDS 187
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 4e-05
Identities = 8/36 (22%), Positives = 14/36 (38%)
Query: 122 RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
R + +A I+ CW + R +I + L
Sbjct: 257 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 97.4 bits (242), Expect = 4e-25
Identities = 35/126 (27%), Positives = 57/126 (45%), Gaps = 5/126 (3%)
Query: 1 MMSRVR-HRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
++ +V H N+++ + +V +L+ G L YL L +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRAL 119
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAP 118
+ LH I+HRDLKPEN++L D +KL DFG + + E + GT ++AP
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 119 ENMRPS 124
E + S
Sbjct: 179 EIIECS 184
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 2e-24
Identities = 54/221 (24%), Positives = 84/221 (38%), Gaps = 65/221 (29%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-IVTELLLGGTLRKYLLNMRPRC-------------- 45
M +H+N++ +GAC + + ++ E G LR+YL RP
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 46 LDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR---EESL 102
L + A +AR ME L S IHRDL N+++T D+ +K+ADFGLAR
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDY 190
Query: 103 TEMMTAETGTYRWMAPENMR---------------------------------------- 122
+ T +WMAPE +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 123 ------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157
N +L +++ CW P++RP F Q+++ L
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 6e-24
Identities = 40/205 (19%), Positives = 70/205 (34%), Gaps = 51/205 (24%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
+ H L + + V E L GG L ++ + D+ A +A +I
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEII 113
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAP 118
++ LHS GI++RDLK +N IL +K+ADFG+ +E L + GT ++AP
Sbjct: 114 LGLQFLHSKGIVYRDLKLDN-ILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172
Query: 119 ENMR--------------------------------------------PSAENLPEDLAL 134
E + L ++
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232
Query: 135 IVTSCWKEDPNERPNFSQIIQMLLH 159
++ + +P +R + H
Sbjct: 233 LLVKLFVREPEKRLGVRG--DIRQH 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.5 bits (234), Expect = 6e-24
Identities = 35/228 (15%), Positives = 67/228 (29%), Gaps = 66/228 (28%)
Query: 1 MMSRVRHRNLVKFIGAC--KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
+ ++ + I C + V+V ELL + R + + A +
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQM 112
Query: 59 ARAMECLHSHGIIHRDLKPENLILTAD--HKTVKLADFGLAR--------EESLTEMMTA 108
+E +HS IHRD+KP+N ++ V + DFGLA+ +
Sbjct: 113 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 109 ETGTYRWMAPENM----------------------------------------------- 121
TGT R+ +
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232
Query: 122 -----RPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164
+ P + A + C +++P++S + Q+ +
Sbjct: 233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.3 bits (231), Expect = 2e-23
Identities = 39/207 (18%), Positives = 66/207 (31%), Gaps = 54/207 (26%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++H N++ + ++++ EL+ GG L + L A F I
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQIL 123
Query: 60 RAMECLHSHGIIHRDLKPENLILTADH---KTVKLADFGLAREESLTEMMTAETGTYRWM 116
+ LHS I H DLKPEN++L + +K+ DFGLA + GT ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 117 APENMR------------------------------------------------PSAENL 128
APE + N
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 129 PEDLALIVTSCWKEDPNERPNFSQIIQ 155
+ +DP +R +Q
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 4e-22
Identities = 32/130 (24%), Positives = 58/130 (44%), Gaps = 8/130 (6%)
Query: 1 MMSRVRHRNLVKFIGACKEP-------VMVIVTELLLGGTLRKYLLNMRPR-CLDIHVAI 52
+M ++ H N+V+ + +V + + R R + L +
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 53 GFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGT 112
+ + R++ +HS GI HRD+KP+NL+L D +KL DFG A++ E + +
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 113 YRWMAPENMR 122
+ APE +
Sbjct: 186 RYYRAPELIF 195
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 88.6 bits (219), Expect = 7e-22
Identities = 41/217 (18%), Positives = 71/217 (32%), Gaps = 59/217 (27%)
Query: 1 MMSRVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
+ + H +V + P+ IV E + G TLR + P + AI
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVI 117
Query: 56 LDIARAMECLHSHGIIHRDLKPENLILTADHK---TVKLADFGLAREESLTEMMTAETGT 112
D +A+ H +GIIHRD+KP N++++A + +A + A GT
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 113 YRWMAPENMR------------------------------------------------PS 124
++++PE R
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 125 AENLPEDLALIVTSCWKEDPNERP-NFSQIIQMLLHY 160
E L DL +V ++P R +++ L+
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 1e-21
Identities = 40/130 (30%), Positives = 60/130 (46%), Gaps = 13/130 (10%)
Query: 1 MMSRVRHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
++ R RH N++ + P V + L+G L K L + + L F
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFL 115
Query: 56 LDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAR----EESLTEMMTAETG 111
I R ++ +HS ++HRDLKP NL+L +K+ DFGLAR + T +T
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 112 TYRWMAPENM 121
T + APE M
Sbjct: 175 TRWYRAPEIM 184
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 88.6 bits (219), Expect = 1e-21
Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 16/183 (8%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
M+S V H +++ G ++ + + + G LL R + +A ++
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCL 115
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEN 120
A+E LHS II+RDLKPEN++L + +K+ DFG A+ + ++ GT ++APE
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKY--VPDVTYTLCGTPDYIAPEV 172
Query: 121 MRPSAENLPEDL----ALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMF 176
+ N D LI P N + + +L+ + P F
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------AELRFPPFF 224
Query: 177 SSE 179
+ +
Sbjct: 225 NED 227
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 88.4 bits (218), Expect = 2e-21
Identities = 27/125 (21%), Positives = 57/125 (45%), Gaps = 8/125 (6%)
Query: 1 MMSRVRHRNLVKFIGACKEPV---MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALD 57
+ + N++ K+PV +V E + ++ + L + + +
Sbjct: 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE 137
Query: 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 117
I +A++ HS GI+HRD+KP N+++ +H+ ++L D+GLA + + +
Sbjct: 138 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 197
Query: 118 PENMR 122
PE +
Sbjct: 198 PELLV 202
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.3 bits (218), Expect = 2e-21
Identities = 34/123 (27%), Positives = 62/123 (50%), Gaps = 5/123 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++S +V A P + + +L+ GG L +L +A +I
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA--DMRFYAAEII 117
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+E +H+ +++RDLKP N++L +H V+++D GLA + S + A GT+ +MAPE
Sbjct: 118 LGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPE 175
Query: 120 NMR 122
++
Sbjct: 176 VLQ 178
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 86.4 bits (213), Expect = 5e-21
Identities = 23/232 (9%), Positives = 61/232 (26%), Gaps = 64/232 (27%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ + + + + V + L G + LL++ R + A +
Sbjct: 53 TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 112
Query: 61 AMECLHSHGIIHRDLKPENLILTADHK----TVKLADFGLAR--------EESLTEMMTA 108
++ +H +++RD+KP+N ++ + + + DFG+ + +
Sbjct: 113 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172
Query: 109 ETGTYRWMAPE------------------------------------------------N 120
+GT R+M+
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232
Query: 121 MRPSAENLPED----LALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168
L + + P++ + + + + E
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 1e-20
Identities = 47/181 (25%), Positives = 75/181 (41%), Gaps = 9/181 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ RH L A + + V E GG L +L R R A + +I
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIV 115
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWMAP 118
A+E LHS +++RD+K EN ++ +K+ DFGL +E S M GT ++AP
Sbjct: 116 SALEYLHSRDVVYRDIKLEN-LMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 119 ENMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMFSS 178
E + + D + ++ P ++Q + L I E + PR S
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPRTLSP 230
Query: 179 E 179
E
Sbjct: 231 E 231
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 1e-20
Identities = 52/228 (22%), Positives = 82/228 (35%), Gaps = 25/228 (10%)
Query: 1 MMSRVRHRNLVKFIGAC------KEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGF 54
+ H N+V+ C +E + +V E + YL + +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDM 121
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYR 114
+ R ++ LHSH ++HRDLKP+N IL +KLADFGLAR S +T+ T
Sbjct: 122 MFQLLRGLDFLHSHRVVHRDLKPQN-ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 180
Query: 115 WMAPENMRPSAENLPEDL----ALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPV 170
+ APE + S+ P DL + ++ + + +L I P
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL---PGEE 237
Query: 171 ILPRMFSSENAVLPPESPGTSSLMPPRDDSE----------RNPNTRM 208
PR + +S D NP R+
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 78.4 bits (192), Expect = 4e-18
Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 17/223 (7%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
++ ++H N+VK +++ L L+K L L+ A F L +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLN 111
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRW-MAPE 119
+ H ++HRDLKP+NL++ + +K+ADFGLAR + W AP+
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
Query: 120 NMRPSAENLPEDLALIVTSCWKEDPNERPNF-----SQIIQMLLHYISTNSAPEPVILPR 174
+ S + V + E N P F + + + + T ++ +
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230
Query: 175 MFSSENAVLPPESPGTSSLMPPRDDS---------ERNPNTRM 208
+ + E S + D+S + +PN R+
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.6 bits (190), Expect = 1e-17
Identities = 30/138 (21%), Positives = 53/138 (38%), Gaps = 17/138 (12%)
Query: 1 MMSRVRHRNLVKFIGACKEPV---------MVIVTELLLGGTLRKYLLNMRPRCLDIHVA 51
++ ++H N+V I C+ + +V + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEI 119
Query: 52 IGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE-----MM 106
+ + +H + I+HRD+K N+++T D +KLADFGLAR SL +
Sbjct: 120 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRY 178
Query: 107 TAETGTYRWMAPENMRPS 124
T T + PE +
Sbjct: 179 TNRVVTLWYRPPELLLGE 196
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (187), Expect = 3e-17
Identities = 33/120 (27%), Positives = 59/120 (49%), Gaps = 2/120 (1%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
++ + H N+VK + + + L L+K++ + + + + + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPE 119
+ HSH ++HRDLKP+NL++ + +KLADFGLAR + T E T + APE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.3 bits (184), Expect = 7e-17
Identities = 34/121 (28%), Positives = 54/121 (44%), Gaps = 5/121 (4%)
Query: 1 MMSRVRHRNLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ + H N++ + A + +V + + N + L
Sbjct: 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS--HIKAYMLMTL 110
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWMAP 118
+ +E LH H I+HRDLKP NL+L + +KLADFGLA+ S T + T + AP
Sbjct: 111 QGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 169
Query: 119 E 119
E
Sbjct: 170 E 170
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 7e-17
Identities = 46/187 (24%), Positives = 73/187 (39%), Gaps = 16/187 (8%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMV-------IVTELLLGGTLRKYLLNMRPRCLDIHVAIG 53
+M V H+N++ + + +V EL+ + LD
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSY 123
Query: 54 FALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTY 113
+ ++ LHS GIIHRDLKP N+++ +D T+K+ DFGLAR + MMT T
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTR 182
Query: 114 RWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPNF--SQIIQMLLHYISTNSAPEPVI 171
+ APE + D+ V E + F I I P P
Sbjct: 183 YYRAPEVILGMGYKENVDI-WSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 172 LPRMFSS 178
+ ++ +
Sbjct: 242 MKKLQPT 248
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 75.2 bits (184), Expect = 1e-16
Identities = 42/177 (23%), Positives = 67/177 (37%), Gaps = 6/177 (3%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVI-VTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ V LVK + K+ + V E + GG + +L R A +A I
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIV 151
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
E LHS +I+RDLKPENL++ +++ DFG A+ GT +APE
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRV--KGRTWTLCGTPEALAPE 208
Query: 120 NMRPSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPEPVILPRMF 176
+ N D + ++ P F+ + I + P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (170), Expect = 5e-15
Identities = 46/225 (20%), Positives = 85/225 (37%), Gaps = 20/225 (8%)
Query: 1 MMSRVRHRNLVKFIGACKEPV-MVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIA 59
++ ++H+N+V+ + +V E + + + LD + F +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF--DSCNGDLDPEIVKSFLFQLL 111
Query: 60 RAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPE 119
+ + HS ++HRDLKP+N +L + +KLA+FGLAR + + W P
Sbjct: 112 KGLGFCHSRNVLHRDLKPQN-LLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 120 NMRPSAENLPE--DLALIVTSCWKEDPNERPNF--SQIIQMLLHYISTNSAPEPVILPRM 175
++ A+ D+ + RP F + + L P P M
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 176 FSSENAVLPPESPGTSSL--MPPRDDSE----------RNPNTRM 208
+ P P T+SL + P+ ++ NP R+
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (165), Expect = 4e-14
Identities = 33/127 (25%), Positives = 52/127 (40%), Gaps = 10/127 (7%)
Query: 1 MMSRVRHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFA 55
++ +RH N++ + + GT L+ L
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLV 127
Query: 56 LDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRW 115
+ + + +H+ GIIHRDLKP NL + D + K+ DFGLAR+ MT T +
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLARQ--ADSEMTGYVVTRWY 184
Query: 116 MAPENMR 122
APE +
Sbjct: 185 RAPEVIL 191
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.2 bits (163), Expect = 6e-14
Identities = 38/126 (30%), Positives = 62/126 (49%), Gaps = 7/126 (5%)
Query: 1 MMSRVRHR-NLVKFIGACKEP-VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDI 58
++ +R LV A + + ++ + + GG L +L H + +I
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEI 138
Query: 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE--ESLTEMMTAETGTYRWM 116
A+E LH GII+RD+K EN++L ++ V L DFGL++E TE GT +M
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 117 APENMR 122
AP+ +R
Sbjct: 198 APDIVR 203
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.4 bits (153), Expect = 2e-12
Identities = 35/128 (27%), Positives = 56/128 (43%), Gaps = 12/128 (9%)
Query: 1 MMSRVRHRNLVKFIGACK------EPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGF 54
++ ++H N++ + E V + L+G L ++ + L
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFL 126
Query: 55 ALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYR 114
I R ++ +HS IIHRDLKP N + + +K+ DFGLAR + MT T
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSN-LAVNEDCELKILDFGLARHTD--DEMTGYVATRW 183
Query: 115 WMAPENMR 122
+ APE M
Sbjct: 184 YRAPEIML 191
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.3 bits (148), Expect = 2e-12
Identities = 12/99 (12%), Positives = 33/99 (33%), Gaps = 14/99 (14%)
Query: 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIAR 60
+ +++ + K ++ E + + + I
Sbjct: 67 ALQKLQGLAVPKVYAWEG---NAVLME---------LIDAKELYRVRVENPDEVLDMILE 114
Query: 61 AMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLARE 99
+ + GI+H DL N++++ + + + DF + E
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG--IWIIDFPQSVE 151
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 49.3 bits (116), Expect = 1e-07
Identities = 26/151 (17%), Positives = 52/151 (34%), Gaps = 19/151 (12%)
Query: 1 MMSRVRHRNLVKFIGACKEPVM---------------VIVTELLLGGTLRKYLLNMRPRC 45
++ RV + K ++ V++ +LG L + R
Sbjct: 62 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121
Query: 46 LDIHVAIGFALDIARAMECLH-SHGIIHRDLKPENLILTADHKTVKLADFGLAR---EES 101
+ + + + ++ +H GIIH D+KPEN+++ L +A
Sbjct: 122 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181
Query: 102 LTEMMTAETGTYRWMAPENMRPSAENLPEDL 132
E T T + +PE + + D+
Sbjct: 182 YDEHYTNSIQTREYRSPEVLLGAPWGCGADI 212
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 223 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.71 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.74 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.97 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.36 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.7 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.86 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 87.77 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 87.67 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 86.57 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 81.0 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=262.35 Aligned_cols=161 Identities=34% Similarity=0.558 Sum_probs=135.8
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++|||||++++++.++.+++||||++||+|.+++...+ ..+++..++.++.|++.||+|||+++|+||||||+||
T Consensus 57 ~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~Ni 135 (276)
T d1uwha_ 57 VLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNI 135 (276)
T ss_dssp HHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHHhCCCCCEeeeeEEEeccEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHE
Confidence 468899999999999998888999999999999999997643 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
|++.++ .+||+|||+++..... .......||+.|+|||++.
T Consensus 136 Ll~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 136 FLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp EEETTS-SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EEcCCC-CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 999887 8999999999754322 2234567999999999552
Q ss_pred ------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
....+++.++.+++.+||+.+|.+|||+++++++|+.+...
T Consensus 215 ~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 215 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 11345677899999999999999999999999999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=257.24 Aligned_cols=152 Identities=26% Similarity=0.471 Sum_probs=128.6
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||++||+|.+++..... +++..++.++.||+.||+|||++||+||||||+|
T Consensus 59 il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~N 136 (263)
T d2j4za1 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136 (263)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccc
Confidence 3678999999999999976 578999999999999999987655 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAE--------------------------------- 126 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------------------- 126 (223)
|+++.++ .+||+|||+++...... .....||+.|+|||++....+
T Consensus 137 ill~~~~-~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~ 214 (263)
T d2j4za1 137 LLLGSAG-ELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214 (263)
T ss_dssp EEECTTS-CEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred ceecCCC-CEeecccceeeecCCCc-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999887 89999999998654432 345689999999997664433
Q ss_pred -----------CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 127 -----------NLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 127 -----------~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.++.++.+++.+||+.+|.+|||+++++++
T Consensus 215 ~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 215 RISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 345556667788888888888888888765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-40 Score=258.90 Aligned_cols=162 Identities=30% Similarity=0.559 Sum_probs=140.5
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++|||||+++|++.++..++||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 61 ~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NI 140 (272)
T d1qpca_ 61 LMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANI 140 (272)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHHhCCCCCEeEEEeeeccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhe
Confidence 36788999999999999888899999999999999988655444599999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+|+.++ .+||+|||+++...... ......||+.|+|||++.
T Consensus 141 ll~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~ 219 (272)
T d1qpca_ 141 LVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219 (272)
T ss_dssp EECTTS-CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred eeeccc-ceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999887 89999999998654332 233457899999999332
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+++.+||+.+|.+|||++++++.|++++..
T Consensus 220 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 220 IQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 23456888999999999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-39 Score=254.10 Aligned_cols=159 Identities=27% Similarity=0.514 Sum_probs=136.7
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++|||||+++|+|.++..++||||+++|+|.+++.+... +++..++.++.||+.||+|||+++|+||||||+||
T Consensus 61 il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Ni 138 (277)
T d1xbba_ 61 VMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV 138 (277)
T ss_dssp HHHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHHhCCCCCCceEEEEeccCCEEEEEEcCCCCcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhh
Confidence 3678999999999999988889999999999999999987554 99999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR---------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~---------------------------------- 122 (223)
+++.++ .+||+|||+++...... ......||+.|+|||.+.
T Consensus 139 ll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~ 217 (277)
T d1xbba_ 139 LLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217 (277)
T ss_dssp EEEETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred cccccC-cccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence 999888 89999999998543221 223346899999999321
Q ss_pred ------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 ------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 ------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
+.+..++.++++|+.+||+.+|.+||+++++.+.|++.+.
T Consensus 218 ~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 218 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 2356688999999999999999999999999999888754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-39 Score=256.97 Aligned_cols=161 Identities=32% Similarity=0.596 Sum_probs=139.0
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|||||+++++|.+ +.+++||||+++|+|.+++.......+++..++.++.|++.||+|||++||+||||||+|
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~N 145 (287)
T d1opja_ 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 145 (287)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCe
Confidence 3678999999999999975 678999999999999999987766779999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
||++.++ .+||+|||+++...... ......|++.|+|||++.
T Consensus 146 ILl~~~~-~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~ 224 (287)
T d1opja_ 146 CLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224 (287)
T ss_dssp EEECGGG-CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEECCCC-cEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH
Confidence 9999888 89999999998654322 223345788999999432
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
+.+..++.++.+|+..||+.+|.+||+++++++.|+.+..
T Consensus 225 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2345688899999999999999999999999999887654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-38 Score=255.16 Aligned_cols=161 Identities=28% Similarity=0.539 Sum_probs=128.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|||||+++|+|.+ +..++||||++||+|.+++.... +.+++.+++.++.||+.||.|||+++|+||||||+|
T Consensus 80 ~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~N 158 (299)
T d1jpaa_ 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARN 158 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccce
Confidence 4788999999999999965 67899999999999999887643 349999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccc------cccCCCccccccCCCCC-------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEM------MTAETGTYRWMAPENMR------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~------------------------------- 122 (223)
||++.++ .+||+|||+++....... .....||+.|+|||.+.
T Consensus 159 ILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 159 ILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp EEECTTC-CEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEECCCC-cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 9999888 899999999985433221 11235789999999332
Q ss_pred ---------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ---------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ---------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++++++.+||+.+|.+||+++++++.|++++..
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 238 TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 23456788899999999999999999999999999988753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=251.82 Aligned_cols=159 Identities=28% Similarity=0.547 Sum_probs=127.9
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
|++++||||++++|+|.+ +..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+||
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Ni 132 (263)
T d1sm2a_ 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 132 (263)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGE
T ss_pred HHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhhe
Confidence 578899999999999964 67899999999999999987643 4589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+++.++ .+||+|||+++....... .....||+.|+|||.+.
T Consensus 133 ll~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~ 211 (263)
T d1sm2a_ 133 LVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211 (263)
T ss_dssp EECGGG-CEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH
T ss_pred eecCCC-CeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH
Confidence 999888 899999999986543322 23356899999999543
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
..+..++.++++++..||+.+|.+||++++++++|+++..
T Consensus 212 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 212 VEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 2245567788899999999999999999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=252.82 Aligned_cols=161 Identities=25% Similarity=0.531 Sum_probs=138.4
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++|||||+++|++.++.+++||||++||+|.+++...+ ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 62 il~~l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Ni 140 (285)
T d1u59a_ 62 IMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 140 (285)
T ss_dssp HHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHHhCCCCCEeeEeeeeccCeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhe
Confidence 367899999999999998888999999999999999886533 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR---------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~---------------------------------- 122 (223)
+++.++ .+||+|||+++...... ......||+.|+|||.+.
T Consensus 141 ll~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 141 LLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp EEEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred eeccCC-ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 999888 89999999998643322 123446899999999321
Q ss_pred ------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++++|+..||+.+|.+||++.++.+.|++....
T Consensus 220 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 23567889999999999999999999999999999887654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=255.02 Aligned_cols=152 Identities=29% Similarity=0.496 Sum_probs=128.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|||||+++++|.+ +.+|+||||++||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 70 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~N 146 (293)
T d1yhwa1 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146 (293)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHH
Confidence 3678999999999999965 6789999999999999988653 39999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPSA--------------------------------- 125 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--------------------------------- 125 (223)
||++.++ .+||+|||+++..... ......+||+.|+|||++....
T Consensus 147 ILl~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 225 (293)
T d1yhwa1 147 ILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (293)
T ss_dssp EEECTTC-CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred eEECCCC-cEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH
Confidence 9999887 8999999999865432 2345567999999999665332
Q ss_pred --------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 --------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 --------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+++.+||+.+|.+||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2345667778889999999999999998765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-39 Score=254.21 Aligned_cols=153 Identities=27% Similarity=0.402 Sum_probs=129.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 56 ~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~N 133 (271)
T d1nvra_ 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 133 (271)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred HHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHH
Confidence 3678999999999999975 57889999999999999987544 49999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCCCC--------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMRPS-------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~-------------------------------- 124 (223)
||++.++ .+||+|||+|+..... ......+||+.|+|||++...
T Consensus 134 ILl~~~~-~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 134 LLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp EEECTTC-CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred EEECCCC-CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 9999887 7999999999864322 223456899999999954311
Q ss_pred ----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+|+.+||+.+|.+||++++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 213 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp SHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12456777889999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=249.16 Aligned_cols=119 Identities=35% Similarity=0.607 Sum_probs=102.4
Q ss_pred CCCCCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccC
Q 027476 1 MMSRVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHG--IIHR 73 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~ 73 (223)
+|++++|||||+++++|.+ +.+++||||++||+|.+++.+... +++..++.++.||+.||+|||+++ |+||
T Consensus 61 il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH~~~~~IiHr 138 (270)
T d1t4ha_ 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHR 138 (270)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCS
T ss_pred HHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHHHCCCCEEeC
Confidence 4789999999999999853 247899999999999999987654 999999999999999999999998 9999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
||||+|||++.+.+.+||+|||+++..... .....+||+.|+|||++.
T Consensus 139 DiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~ 186 (270)
T d1t4ha_ 139 DLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE 186 (270)
T ss_dssp CCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG
T ss_pred CcChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhC
Confidence 999999999753338999999999754332 334568999999999765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-38 Score=254.93 Aligned_cols=153 Identities=25% Similarity=0.458 Sum_probs=118.6
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +.+|+||||++||+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|
T Consensus 60 il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~N 137 (307)
T d1a06a_ 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPEN 137 (307)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccC--CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccc
Confidence 3678999999999999975 578999999999999999976544 9999999999999999999999999999999999
Q ss_pred EEEeC---CCCceEEccCccccccccccccccCCCccccccCCCCCCC--------------------------------
Q 027476 80 LILTA---DHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS-------------------------------- 124 (223)
Q Consensus 80 ill~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------------------- 124 (223)
|++.. ++ .+||+|||+++...........+||+.|+|||++...
T Consensus 138 il~~~~~~~~-~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 216 (307)
T d1a06a_ 138 LLYYSLDEDS-KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 216 (307)
T ss_dssp EEESSSSTTC-CEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred eeecccCCCc-eEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 99953 44 7999999999876655555667899999999955422
Q ss_pred ----------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+++.+||+.+|.+||+++|++++
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 217 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 23566778889999999999999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-38 Score=250.62 Aligned_cols=162 Identities=30% Similarity=0.559 Sum_probs=135.6
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
|++++|||||+++|++.++..++||||+++|+|..++.....+.+++.+++.++.||+.||+|||++||+||||||+||+
T Consensus 66 l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIl 145 (285)
T d1fmka3 66 MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 145 (285)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HHhcccCCEeEEEEEEecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEE
Confidence 67899999999999998888999999999999999987655556999999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCC-------------------------------------
Q 027476 82 LTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
++.++ .+||+|||+++...... ......||+.|+|||.+.
T Consensus 146 l~~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~ 224 (285)
T d1fmka3 146 VGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224 (285)
T ss_dssp ECGGG-CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred ECCCC-cEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99887 89999999998543222 223456899999999332
Q ss_pred ---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 ---------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 ---------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
+.+..++.++.+++.+||+.+|.+||++++|+++|++++...
T Consensus 225 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 225 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 345677888999999999999999999999999999877543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-38 Score=255.54 Aligned_cols=118 Identities=25% Similarity=0.464 Sum_probs=102.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~ 78 (223)
+|++++|||||+++++|.+ +.+++||||++||+|.+++.+.+. +++..++.++.|++.||.|||+ +||+||||||+
T Consensus 57 il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~ 134 (322)
T d1s9ja_ 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134 (322)
T ss_dssp GGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHH
Confidence 5789999999999999975 578999999999999999987654 9999999999999999999997 49999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
|||++.++ .+||+|||+|+..... ...+.+||+.|+|||++.
T Consensus 135 NILl~~~~-~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~ 176 (322)
T d1s9ja_ 135 NILVNSRG-EIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQ 176 (322)
T ss_dssp GEEECTTC-CEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHH
T ss_pred HeeECCCC-CEEEeeCCCccccCCC-ccccccCCccccCchHHc
Confidence 99999888 8999999999864432 234568999999999543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-38 Score=255.38 Aligned_cols=157 Identities=31% Similarity=0.556 Sum_probs=132.3
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRP---------------------RCLDIHVAIGFALDI 58 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~---------------------~~l~~~~~~~i~~qi 58 (223)
|+++ +|||||++++++.+ +..++||||++||+|.+++..... ..+++..++.++.|+
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 173 (325)
T d1rjba_ 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173 (325)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence 4456 89999999999975 678999999999999999976432 348999999999999
Q ss_pred HHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC-------------
Q 027476 59 ARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR------------- 122 (223)
Q Consensus 59 ~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~------------- 122 (223)
+.||+|||+++|+||||||+||+++.++ .+||+|||+|+...... ......||+.|+|||.+.
T Consensus 174 ~~gl~yLH~~~IiHRDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~ 252 (325)
T d1rjba_ 174 AKGMEFLEFKSCVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252 (325)
T ss_dssp HHHHHHHHHTTEEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHhCCeeeccCchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccch
Confidence 9999999999999999999999999887 89999999998544332 223456799999999332
Q ss_pred ----------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 123 ----------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 123 ----------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
+.+..++.++.+|+..||+.+|.+|||+++++++|..
T Consensus 253 Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 2345678889999999999999999999999999853
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-38 Score=252.15 Aligned_cols=154 Identities=29% Similarity=0.446 Sum_probs=130.5
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|||||++++++.+ +..++||||++||+|.+++.+.. +.+++..+..++.||+.||.|||++||+||||||+|
T Consensus 62 il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~N 140 (288)
T d2jfla1 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGN 140 (288)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhh
Confidence 3678999999999999965 67899999999999999976543 349999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCC-----C------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMR-----P------------------------------ 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~------------------------------ 123 (223)
||++.++ .+||+|||+++..... .......||+.|+|||++. .
T Consensus 141 Ill~~~~-~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 141 ILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp EEECTTS-CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred eeECCCC-CEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence 9999888 7999999999754432 2334568999999999652 0
Q ss_pred -----------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 -----------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 -----------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+|+.+||+.+|.+||++++++++
T Consensus 220 ~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 220 PMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp GGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122456778889999999999999999999765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-37 Score=250.44 Aligned_cols=150 Identities=28% Similarity=0.458 Sum_probs=129.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|||||++++++.+ +..++|||||.+|+|..++..... +++..++.++.||+.||.|||++||+||||||+|
T Consensus 68 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~N 145 (309)
T d1u5ra_ 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145 (309)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred HHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcce
Confidence 4789999999999999965 578999999999999877765444 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC------------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP------------------------------------ 123 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------------------ 123 (223)
||++.++ .+||+|||+++.... .....||+.|+|||++..
T Consensus 146 ILl~~~~-~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~ 221 (309)
T d1u5ra_ 146 ILLSEPG-LVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (309)
T ss_dssp EEEETTT-EEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred EEECCCC-CEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH
Confidence 9999887 899999999986443 244689999999996531
Q ss_pred -------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 -------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 -------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....++.++.+|+.+||+.+|.+|||+++++++
T Consensus 222 ~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 123456778889999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-37 Score=249.45 Aligned_cols=153 Identities=28% Similarity=0.409 Sum_probs=131.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||++++++|++ +.+|+||||++||+|.+++.+.+. +++..++.++.||+.||+|||++||+||||||+|
T Consensus 58 il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~N 135 (337)
T d1o6la_ 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135 (337)
T ss_dssp HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred HHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHH
Confidence 4678999999999999976 578999999999999999987665 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
||++.++ .+||+|||+|+.... .......+||+.|+|||++...
T Consensus 136 ILl~~~g-~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 214 (337)
T d1o6la_ 136 LMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214 (337)
T ss_dssp EEECTTS-CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eEecCCC-CEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH
Confidence 9999888 899999999986543 3334556899999999977633
Q ss_pred ----------CCCChHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 027476 125 ----------AENLPEDLALIVTSCWKEDPNERPN-----FSQIIQM 156 (223)
Q Consensus 125 ----------~~~~~~~l~~l~~~~l~~~p~~Rp~-----~~~~~~~ 156 (223)
+..++.++.+|+.+||+.+|.+|++ +++++++
T Consensus 215 ~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 215 ELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 3456666777899999999999995 6777664
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-37 Score=243.83 Aligned_cols=161 Identities=27% Similarity=0.552 Sum_probs=131.9
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|||||+++|++.+ +..++||||+.++++.+++.... ..+++..++.++.|++.||+|||+++|+||||||+|
T Consensus 62 il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~N 140 (283)
T d1mqba_ 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN 140 (283)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccce
Confidence 3678999999999999965 67899999999999999887643 459999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC---------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR--------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~--------------------------------- 122 (223)
|||+.++ .+||+|||+++...... ......||+.|+|||++.
T Consensus 141 ILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~ 219 (283)
T d1mqba_ 141 ILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 219 (283)
T ss_dssp EEECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EEECCCC-eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH
Confidence 9999888 89999999998643321 122346899999999432
Q ss_pred -------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 -------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 -------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+..++.++++++.+||+.+|.+||++.++++.|++++..
T Consensus 220 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 33456778899999999999999999999999999988753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-37 Score=243.87 Aligned_cols=161 Identities=32% Similarity=0.572 Sum_probs=129.3
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++||||++++|++.++..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+++++||||||+||
T Consensus 61 ~l~~l~HpnIv~l~~~~~~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NI 139 (273)
T d1mp8a_ 61 TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 139 (273)
T ss_dssp HHHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHHhCCCCCEeeEEEEEecCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhhe
Confidence 367899999999999998888999999999999999876543 4589999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc--ccccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE--MMTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+++.++ .+||+|||+++...... ......||+.|+|||++.
T Consensus 140 ll~~~~-~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~ 218 (273)
T d1mp8a_ 140 LVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218 (273)
T ss_dssp EEEETT-EEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred eecCCC-cEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH
Confidence 999888 89999999998654322 223456899999999332
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
+.+.+++.++.+|+.+||+.+|.+||++.+++++|++++..
T Consensus 219 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 219 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 33556888999999999999999999999999999887643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-38 Score=251.75 Aligned_cols=152 Identities=28% Similarity=0.408 Sum_probs=125.5
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +.+|+||||++||+|.+++...+. +++..++.++.|++.||+|||++||+||||||+|
T Consensus 61 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~N 138 (288)
T d1uu3a_ 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 138 (288)
T ss_dssp HHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccc
Confidence 3678999999999999975 578999999999999999887655 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCCCC--------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMRPS-------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~-------------------------------- 124 (223)
|+++.++ .+||+|||+|+..... ......+||+.|+|||++...
T Consensus 139 Ill~~~~-~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 217 (288)
T d1uu3a_ 139 ILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217 (288)
T ss_dssp EEECTTS-CEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cccCCCc-eEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH
Confidence 9999888 7999999999865432 223456799999999965432
Q ss_pred ------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 125 ------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 125 ------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
+..++.++.+|+.+||+.+|.+|||++|+.+
T Consensus 218 ~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 218 IFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 3445666777888888888888888887654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-37 Score=247.26 Aligned_cols=154 Identities=26% Similarity=0.402 Sum_probs=132.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|||||+++++|.+ +.+++|||||+||+|.+++...+. +++..++.++.|++.||+|||++||+||||||+|
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~N 143 (293)
T d1jksa_ 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 143 (293)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhhhcceeecccccce
Confidence 3678899999999999976 578999999999999999987654 9999999999999999999999999999999999
Q ss_pred EEEeCCCC---ceEEccCccccccccccccccCCCccccccCCCCCCCC-------------------------------
Q 027476 80 LILTADHK---TVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA------------------------------- 125 (223)
Q Consensus 80 ill~~~~~---~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------------------- 125 (223)
|+++.++. .+|++|||+++............||+.|+|||++....
T Consensus 144 ill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 223 (293)
T d1jksa_ 144 IMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223 (293)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH
Confidence 99987652 59999999998766555556678999999999665322
Q ss_pred -----------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 -----------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 -----------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+|+.+||+.+|.+||++++++++
T Consensus 224 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 224 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2355667778999999999999999998765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=246.31 Aligned_cols=155 Identities=28% Similarity=0.459 Sum_probs=120.2
Q ss_pred CCCCCCCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----c
Q 027476 1 MMSRVRHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNM--RPRCLDIHVAIGFALDIARAMECLHSHG-----I 70 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~-----i 70 (223)
+|++++||||+++++++.+ +.+|+||||++||+|.+++.+. ....+++..++.++.|++.||+|||++| |
T Consensus 56 il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~I 135 (269)
T d2java1 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 135 (269)
T ss_dssp HTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-----
T ss_pred HHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCE
Confidence 4789999999999998853 4689999999999999998642 2345999999999999999999999976 9
Q ss_pred ccCCCCCCCEEEeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCC--------------------------
Q 027476 71 IHRDLKPENLILTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRP-------------------------- 123 (223)
Q Consensus 71 vH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-------------------------- 123 (223)
+||||||+|||++.++ .+||+|||+++..... .......||+.|+|||++..
T Consensus 136 iHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 136 LHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp ----CCGGGEEECTTS-CEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EeCcCchhhcCcCCCC-cEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCC
Confidence 9999999999999887 8999999999865433 23345689999999995542
Q ss_pred -------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 124 -------------------SAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 124 -------------------~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
.+..++.++.+++.+||+.+|.+||++++++++
T Consensus 215 ~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 215 TAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 234567778889999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-37 Score=253.15 Aligned_cols=154 Identities=23% Similarity=0.425 Sum_probs=132.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++|+|||||+++++|.+ +.+|+|||||+||+|.+.+.... ..+++.+++.++.||+.||+|||++||+||||||+|
T Consensus 79 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~N 157 (352)
T d1koba_ 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 157 (352)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccc
Confidence 4788999999999999975 57899999999999999876533 349999999999999999999999999999999999
Q ss_pred EEEeC--CCCceEEccCccccccccccccccCCCccccccCCCCCCC---------------------------------
Q 027476 80 LILTA--DHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS--------------------------------- 124 (223)
Q Consensus 80 ill~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------------------------------- 124 (223)
||++. ++ .+||+|||+|+............||+.|+|||++.+.
T Consensus 158 ILl~~~~~~-~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 236 (352)
T d1koba_ 158 IMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236 (352)
T ss_dssp EEESSTTCC-CEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred ccccccCCC-eEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99973 44 8999999999877665555667899999999955411
Q ss_pred ---------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ---------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ---------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+|+.+||+.+|.+||++++++++
T Consensus 237 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 23567788889999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-37 Score=253.99 Aligned_cols=155 Identities=27% Similarity=0.436 Sum_probs=132.0
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|||||++++++.+ +.+++||||++||+|.+++.+.. +.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 76 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~N 154 (350)
T d1koaa2 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 154 (350)
T ss_dssp HHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhH
Confidence 3678999999999999965 68999999999999999986533 349999999999999999999999999999999999
Q ss_pred EEEeCC-CCceEEccCccccccccccccccCCCccccccCCCCCCCC---------------------------------
Q 027476 80 LILTAD-HKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSA--------------------------------- 125 (223)
Q Consensus 80 ill~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------------------- 125 (223)
|+++.+ .+.+||+|||+++............||+.|+|||++....
T Consensus 155 Ill~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 234 (350)
T d1koaa2 155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234 (350)
T ss_dssp EEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred eeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 999643 2379999999998766555556678999999999554221
Q ss_pred ---------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 126 ---------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 126 ---------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..++.++.+|+.+||+.+|.+|||+++++++
T Consensus 235 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 235 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2356778889999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=245.55 Aligned_cols=160 Identities=25% Similarity=0.510 Sum_probs=135.5
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++|||||+++|+|.++..++++||+.+++|.+.+... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 64 ~l~~l~HpnIv~l~g~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NI 142 (317)
T d1xkka_ 64 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 142 (317)
T ss_dssp HHHHCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHHhCCCCCEeeEEEEEecCCeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcc
Confidence 36788999999999999988899999999999999988764 34599999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC-----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
+++.++ .+||+|||+++...... ......||+.|+|||.+.
T Consensus 143 ll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~ 221 (317)
T d1xkka_ 143 LVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221 (317)
T ss_dssp EEEETT-EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred eeCCCC-CeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 999888 89999999998643322 123346899999999332
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 -----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 -----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
+.+..++.++++++.+||+.+|.+||++.+++++|..+..
T Consensus 222 ~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 222 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 2345678889999999999999999999999999888754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-37 Score=248.16 Aligned_cols=153 Identities=27% Similarity=0.467 Sum_probs=131.0
Q ss_pred CCCCCCccceEEEeec-----CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 4 RVRHRNLVKFIGACKE-----PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
.++|||||+++++|++ ..+|+|||||+||+|.+++.+.+...+++.+++.++.||+.||+|||++||+||||||+
T Consensus 61 ~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~ 140 (335)
T d2ozaa1 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 140 (335)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred hcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence 3589999999999853 45899999999999999998766567999999999999999999999999999999999
Q ss_pred CEEEeCCC--CceEEccCccccccccccccccCCCccccccCCCCCCC--------------------------------
Q 027476 79 NLILTADH--KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS-------------------------------- 124 (223)
Q Consensus 79 Nill~~~~--~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------------------- 124 (223)
||+++.++ ..+||+|||+++............||+.|+|||++.+.
T Consensus 141 NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~ 220 (335)
T d2ozaa1 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220 (335)
T ss_dssp GEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred ccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence 99998532 37999999999876655555677899999999965411
Q ss_pred ----------------C----CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------A----ENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------~----~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+ ..++.++.+|+.+||+.+|.+||++++++++
T Consensus 221 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 221 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 1256778899999999999999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-36 Score=237.10 Aligned_cols=156 Identities=31% Similarity=0.555 Sum_probs=133.4
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+++++||||++++|+|.+ +.+++||||+.+|+|.+++.... ..+++..+++++.|++.||+|||++||+||||||+||
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Ni 131 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 131 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGE
T ss_pred HHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeE
Confidence 578999999999999975 68999999999999999976543 3489999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccc--cccCCCccccccCCCCC------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEM--MTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
+++.++ .+||+|||+++....... .....||+.|+|||.+.
T Consensus 132 ll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~ 210 (258)
T d1k2pa_ 132 LVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 210 (258)
T ss_dssp EECTTC-CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred EEcCCC-cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH
Confidence 999877 899999999975443322 22356899999999332
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLH 159 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~ 159 (223)
..+..++.++++++.+||+.+|.+||++++++++|.+
T Consensus 211 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 211 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 3355677889999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-36 Score=240.92 Aligned_cols=162 Identities=30% Similarity=0.565 Sum_probs=138.0
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNM--------------RPRCLDIHVAIGFALDIARAMECL 65 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~~l~~l 65 (223)
|+++ +|||||+++|+|.+ +.+++||||++||+|.+++... ....+++..++.++.||+.||.|+
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 6677 79999999999965 5789999999999999999753 234699999999999999999999
Q ss_pred HhCCcccCCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC-----------------------
Q 027476 66 HSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR----------------------- 122 (223)
Q Consensus 66 H~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----------------------- 122 (223)
|+++|+||||||+|||++.++ .+||+|||+++............||..|+|||.+.
T Consensus 144 H~~~iiHrDlkp~NIL~~~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~ 222 (309)
T d1fvra_ 144 SQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222 (309)
T ss_dssp HHTTEECSCCSGGGEEECGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred hcCCccccccccceEEEcCCC-ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhc
Confidence 999999999999999999887 89999999998655544444557899999999322
Q ss_pred -----------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 -----------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 -----------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+.+++.++.+|+.+||+.+|.+||++++++++|++++...
T Consensus 223 ~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 223 GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp SCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 234568889999999999999999999999999999987654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-36 Score=242.00 Aligned_cols=159 Identities=30% Similarity=0.585 Sum_probs=128.1
Q ss_pred CCCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027476 5 VRHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMR--------------PRCLDIHVAIGFALDIARAMECLHSH 68 (223)
Q Consensus 5 l~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~~ 68 (223)
.+|+||+.+++++.+ +.+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 379999999998854 46899999999999999997532 23489999999999999999999999
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC-----------------------
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR----------------------- 122 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~----------------------- 122 (223)
||+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||.+.
T Consensus 154 ~ivHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~ 232 (299)
T d1ywna1 154 KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 232 (299)
T ss_dssp TCCCSCCCGGGEEECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCcCCcCCccceeECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhC
Confidence 999999999999999887 89999999998543222 233457999999999332
Q ss_pred ------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 ------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 ------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+..++.++.+++.+||+.+|.+||++++++++|++++..+
T Consensus 233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 233 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 224567788999999999999999999999999999987543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.3e-36 Score=245.71 Aligned_cols=151 Identities=24% Similarity=0.323 Sum_probs=130.3
Q ss_pred CCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 2 MSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
++.++|||||+++++|.+ +.+|+||||++||+|.+++.+... +++..++.++.||+.||.|||++||+||||||+||
T Consensus 61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NI 138 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 138 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHCCccceeecccee
Confidence 567899999999999975 578999999999999999987654 89999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCccccccccccccccCCCccccccCCCCC--------------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR-------------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-------------------------------------- 122 (223)
|++.++ .+||+|||+|+...... .....||+.|+|||++.
T Consensus 139 Ll~~~g-~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 216 (364)
T d1omwa3 139 LLDEHG-HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 216 (364)
T ss_dssp EECSSS-CEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH
T ss_pred EEcCCC-cEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999888 89999999998654432 34568999999999553
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPN-----FSQIIQM 156 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~-----~~~~~~~ 156 (223)
..+..++.++.+|+.+||+.+|.+||+ +++++++
T Consensus 217 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 217 IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 113456777888999999999999998 5788765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-36 Score=236.61 Aligned_cols=158 Identities=33% Similarity=0.607 Sum_probs=133.2
Q ss_pred CCCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 027476 1 MMSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENL 80 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 80 (223)
+|++++||||++++|+|.++..++||||+++|++.+.+.... ..+++..++.++.|++.||.|||++||+||||||+||
T Consensus 64 ~l~~l~H~nIv~~~g~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NI 142 (273)
T d1u46a_ 64 AMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 142 (273)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HHHhCCCCCEEEEEEEEeecchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHh
Confidence 367899999999999998888899999999999999887643 3499999999999999999999999999999999999
Q ss_pred EEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCC----------------------------------
Q 027476 81 ILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMR---------------------------------- 122 (223)
Q Consensus 81 ll~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~---------------------------------- 122 (223)
+++.++ .+||+|||+++...... ......|+..|+|||.+.
T Consensus 143 ll~~~~-~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 143 LLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp EEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred cccccc-ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence 999887 89999999998643322 223346788999999321
Q ss_pred -------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 027476 123 -------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHY 160 (223)
Q Consensus 123 -------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~ 160 (223)
+.+..++.++.+++.+||+.+|.+||+++++.+.|.+.
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 222 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 23456889999999999999999999999999988764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-36 Score=238.53 Aligned_cols=152 Identities=25% Similarity=0.434 Sum_probs=132.2
Q ss_pred CCCCC-CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVR-HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~-Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|++++ ||||+++++++.+ +..|+||||++||+|.+++..++. +++..++.++.||+.||+|||++||+||||||+|
T Consensus 63 l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~N 140 (277)
T d1phka_ 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 140 (277)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccccccce
Confidence 45665 9999999999976 578999999999999999987655 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC-------------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR------------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------------------------------------- 122 (223)
|+++.++ .+||+|||+++............||+.|+|||.+.
T Consensus 141 ill~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 141 ILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp EEECTTC-CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCC-CeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 9999887 89999999998765554556678999999999432
Q ss_pred -----------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 -----------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 -----------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
+...++++++.+++.+||+.+|.+||++++++++
T Consensus 220 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 220 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1122577889999999999999999999998765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-35 Score=234.83 Aligned_cols=162 Identities=31% Similarity=0.549 Sum_probs=137.1
Q ss_pred CCCCCCCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+|++++||||++++|++.+ +..++||||+++|+|.+++... ...+++..++.++.|++.||.|+|+.+|+||||||+
T Consensus 81 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~ 159 (311)
T d1r0pa_ 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR 159 (311)
T ss_dssp HHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred HHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHH
Confidence 3678999999999999753 4689999999999999988754 345889999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCcccccccccc-----ccccCCCccccccCCCCC-------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTE-----MMTAETGTYRWMAPENMR------------------------------- 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~------------------------------- 122 (223)
|||++.++ .+||+|||+++...... ......||+.|+|||.+.
T Consensus 160 NILl~~~~-~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 160 NCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp GEEECTTC-CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred hEeECCCC-CEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 99999877 89999999998643322 122346899999999322
Q ss_pred ---------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 123 ---------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 123 ---------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
..+..++.++++++.+||+.+|.+||++.+++++|+++....
T Consensus 239 ~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 239 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp ----CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 234567789999999999999999999999999999987653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=234.06 Aligned_cols=159 Identities=33% Similarity=0.603 Sum_probs=130.1
Q ss_pred CCCCCCCCCccceEEEeec--CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE--PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPE 78 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 78 (223)
+|++++||||++++|+|.+ +.+++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+|+||||||+
T Consensus 53 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~ 132 (262)
T d1byga_ 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 132 (262)
T ss_dssp HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred HHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchH
Confidence 3688999999999999843 46899999999999999997655445899999999999999999999999999999999
Q ss_pred CEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC------------------------------------
Q 027476 79 NLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR------------------------------------ 122 (223)
Q Consensus 79 Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------------------------------------ 122 (223)
||+++.++ .+||+|||+++..... .....+++.|+|||.+.
T Consensus 133 Nil~~~~~-~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~ 209 (262)
T d1byga_ 133 NVLVSEDN-VAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209 (262)
T ss_dssp GEEECTTS-CEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred hheecCCC-CEeecccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 99999888 7999999999864432 23457889999999332
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 027476 123 ----------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIS 162 (223)
Q Consensus 123 ----------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~ 162 (223)
+.+..++..+.+++.+||+.+|.+||++.+++++|+++..
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 210 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 2345677889999999999999999999999999988743
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-35 Score=235.10 Aligned_cols=160 Identities=30% Similarity=0.546 Sum_probs=134.5
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHH
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR----------------------PRCLDIHVAIGFALD 57 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~----------------------~~~l~~~~~~~i~~q 57 (223)
+|++++||||++++++|.+ +..++||||+.+|+|.+++.... ...+++..++.++.|
T Consensus 69 il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 148 (301)
T d1lufa_ 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 148 (301)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred HHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHH
Confidence 3678999999999999965 57899999999999999996432 124899999999999
Q ss_pred HHHHHHHHHhCCcccCCCCCCCEEEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCC------------
Q 027476 58 IARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMR------------ 122 (223)
Q Consensus 58 i~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~------------ 122 (223)
++.||+|||+++++||||||+||+++.++ .+||+|||+++..... .......|++.|+|||.+.
T Consensus 149 i~~gl~ylH~~~ivHrDlKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS 227 (301)
T d1lufa_ 149 VAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 227 (301)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHhhhcccCCeEeeEEcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhcc
Confidence 99999999999999999999999999887 7999999999754322 2223457889999999322
Q ss_pred ----------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 123 ----------------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 123 ----------------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
+.+..++.++++|+..||+.+|.+||++.+|+++|+++.
T Consensus 228 ~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 228 YGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 335678889999999999999999999999999998863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-35 Score=232.79 Aligned_cols=159 Identities=33% Similarity=0.625 Sum_probs=136.0
Q ss_pred CC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 027476 4 RV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--------------PRCLDIHVAIGFALDIARAMECLHS 67 (223)
Q Consensus 4 ~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~l~~lH~ 67 (223)
++ +|||||+++++|.+ +..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+
T Consensus 74 ~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~ 153 (299)
T d1fgka_ 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 153 (299)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh
Confidence 44 79999999999975 57899999999999999997543 2358999999999999999999999
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccccccccc---cccCCCccccccCCCCC----------------------
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLAREESLTEM---MTAETGTYRWMAPENMR---------------------- 122 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~---------------------- 122 (223)
++|+||||||+|||++.++ .+||+|||+++....... .....|++.|+|||.+.
T Consensus 154 ~~ivHrDiKp~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 154 KKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp TTCCCSCCSGGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCEEeeeecccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhcc
Confidence 9999999999999999888 899999999986543322 23457899999999332
Q ss_pred ------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 ------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 ------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+|+.+||+.+|.+|||+.++++.|+++++.
T Consensus 233 ~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 233 LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 23456778899999999999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-35 Score=237.28 Aligned_cols=144 Identities=28% Similarity=0.390 Sum_probs=128.7
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +.+|+||||+.||+|.+++..... +++..+..++.||+.||+|||++||+||||||+|
T Consensus 57 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~N 134 (316)
T d1fota_ 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPEN 134 (316)
T ss_dssp HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred HHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccCcEEccccCchh
Confidence 3678999999999999975 578999999999999999987655 8999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
||++.++ .+||+|||+|+..... ....+||+.|+|||++....++...|+|+++..++++-.+++|.
T Consensus 135 ILl~~~g-~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf 201 (316)
T d1fota_ 135 ILLDKNG-HIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 201 (316)
T ss_dssp EEECTTS-CEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred eeEcCCC-CEEEecCccceEeccc--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCC
Confidence 9999888 8999999999865432 34568999999999999999999999999999988877777764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-35 Score=239.76 Aligned_cols=155 Identities=21% Similarity=0.332 Sum_probs=132.1
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||++++++|++ +.+|+|||||.||+|.+++...+ ..+++.+++.++.||+.||+|||++||+||||||+|
T Consensus 54 il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~N 132 (321)
T d1tkia_ 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132 (321)
T ss_dssp HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccc
Confidence 3678999999999999975 68999999999999999997643 349999999999999999999999999999999999
Q ss_pred EEEeCCC-CceEEccCccccccccccccccCCCccccccCCCCCCC----------------------------------
Q 027476 80 LILTADH-KTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 80 ill~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
|+++.++ ..+||+|||+++............+|+.|+|||.+...
T Consensus 133 Ill~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~ 212 (321)
T d1tkia_ 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212 (321)
T ss_dssp EEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred eeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9997543 37999999999876555555566899999999944311
Q ss_pred --------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 --------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 --------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
...++.++.+|+.+||+.+|.+||++++++++
T Consensus 213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12467788899999999999999999999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-35 Score=236.51 Aligned_cols=159 Identities=26% Similarity=0.371 Sum_probs=129.2
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++|||||++++++.+ +.+++||||+.++++..+.... ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~N 130 (299)
T d1ua2a_ 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNN 130 (299)
T ss_dssp HHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcce
Confidence 3678899999999999975 5789999999888777665433 349999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCCCCC-C--------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENMRPS-A-------------------------------- 125 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~-------------------------------- 125 (223)
|+++.++ .+||+|||+++...... .....+||+.|+|||++... .
T Consensus 131 Ili~~~~-~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 209 (299)
T d1ua2a_ 131 LLLDENG-VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209 (299)
T ss_dssp EEECTTC-CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEecCCC-ccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH
Confidence 9999887 89999999998654332 33456799999999954311 1
Q ss_pred ----------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 126 ----------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 126 ----------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
...+.++.+|+.+||+.||.+|||++|++++ .++...
T Consensus 210 l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H--p~f~~~ 286 (299)
T d1ua2a_ 210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSNR 286 (299)
T ss_dssp HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTSS
T ss_pred HHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC--HhhCCC
Confidence 1345677888999999999999999999876 555443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.6e-35 Score=232.93 Aligned_cols=158 Identities=29% Similarity=0.447 Sum_probs=125.2
Q ss_pred CCCCCCCCCccceEEEeec-C----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-P----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
+|++++||||+++++++.+ + .+|+||||++|++|.+++...+. +++.+++.++.||+.||+|||++||+||||
T Consensus 60 ~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~~iiHrDi 137 (277)
T d1o6ya_ 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDV 137 (277)
T ss_dssp HHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhCCccCccc
Confidence 3678999999999999853 2 37899999999999999887655 999999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCccccccccc----cccccCCCccccccCCCCCCC---------------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLT----EMMTAETGTYRWMAPENMRPS--------------------------- 124 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~--------------------------- 124 (223)
||+||+++.++ .++++|||.+...... ......+||+.|+|||++...
T Consensus 138 KP~NIll~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 138 KPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp SGGGEEEETTS-CEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCcccccCccc-cceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence 99999999888 7999999988743222 223455799999999965422
Q ss_pred ---------------------CCCChHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHh
Q 027476 125 ---------------------AENLPEDLALIVTSCWKEDPNERP-NFSQIIQMLLHYI 161 (223)
Q Consensus 125 ---------------------~~~~~~~l~~l~~~~l~~~p~~Rp-~~~~~~~~L~~~~ 161 (223)
..+++.++.+++.+||+.+|.+|| +++++.+.|.++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 217 DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp SSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 234667788899999999999998 7888888887653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=233.22 Aligned_cols=161 Identities=35% Similarity=0.610 Sum_probs=135.9
Q ss_pred CCCC-CCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHH
Q 027476 2 MSRV-RHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR----------------PRCLDIHVAIGFALDIARAME 63 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~----------------~~~l~~~~~~~i~~qi~~~l~ 63 (223)
++++ +|||||+++++|.+ +..++||||+++|+|.+++.... ...+++..+..++.||+.||+
T Consensus 80 ~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 159 (311)
T d1t46a_ 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (311)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 3455 79999999999975 57899999999999999997543 225899999999999999999
Q ss_pred HHHhCCcccCCCCCCCEEEeCCCCceEEccCccccccccc---cccccCCCccccccCCCCC------------------
Q 027476 64 CLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLT---EMMTAETGTYRWMAPENMR------------------ 122 (223)
Q Consensus 64 ~lH~~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~------------------ 122 (223)
|||+++++||||||+||+++.++ .+|++|||+++..... .......||+.|+|||.+.
T Consensus 160 ~LH~~~ivHrDLKp~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ 238 (311)
T d1t46a_ 160 FLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238 (311)
T ss_dssp HHHHTTCCCSCCSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHHhCCeeecccccccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHH
Confidence 99999999999999999999887 8999999999854432 2223457899999999332
Q ss_pred -----------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhc
Q 027476 123 -----------------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYIST 163 (223)
Q Consensus 123 -----------------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~ 163 (223)
..+..++.++.+|+.+||+.+|.+||++++++++|++.+..
T Consensus 239 ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 22345778899999999999999999999999999988765
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-35 Score=232.28 Aligned_cols=152 Identities=22% Similarity=0.387 Sum_probs=128.8
Q ss_pred CCCCC--CCCccceEEEeec-CceEEEEEcCCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 2 MSRVR--HRNLVKFIGACKE-PVMVIVTELLLG-GTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 2 l~~l~--Hpniv~l~~~~~~-~~~~lv~e~~~~-~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
|++++ ||||+++++++.+ +..++||||+.+ +++.+++..... +++..++.++.|++.||+|||++||+||||||
T Consensus 61 l~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp 138 (273)
T d1xwsa_ 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 138 (273)
T ss_dssp HHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCccccCcc
Confidence 34454 9999999999976 578999999976 688888877554 99999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC-----------------------------------
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
+||+++.++..+||+|||+++..... ......||+.|+|||++.
T Consensus 139 ~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~ 217 (273)
T d1xwsa_ 139 ENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 217 (273)
T ss_dssp GGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH
T ss_pred cceEEecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh
Confidence 99999976558999999999864433 335668999999999543
Q ss_pred ----CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 123 ----PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 123 ----~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
..+..++.++.+++.+||+.+|.+|||+++++++
T Consensus 218 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 218 RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 2245677888999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-35 Score=234.19 Aligned_cols=159 Identities=28% Similarity=0.418 Sum_probs=130.0
Q ss_pred CCCCCCCCccceEEEeec-C----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------C
Q 027476 2 MSRVRHRNLVKFIGACKE-P----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS--------H 68 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~-~----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~--------~ 68 (223)
+++++||||+++++++.+ + .+++||||+++|+|.+++.+. .+++..++.++.|++.||.|+|+ +
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~ 127 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCC
Confidence 567899999999999953 2 478999999999999999864 38999999999999999999996 5
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCcccccccccc-----ccccCCCccccccCCCCCCC-------------------
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLAREESLTE-----MMTAETGTYRWMAPENMRPS------------------- 124 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------------------- 124 (223)
||+||||||+||+|+.++ .+||+|||+++...... ......||+.|+|||.+...
T Consensus 128 ~IvHrDlKp~NILl~~~~-~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gv 206 (303)
T d1vjya_ 128 AIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206 (303)
T ss_dssp EEECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred CeeccccCccceEEcCCC-CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHH
Confidence 999999999999999888 89999999998543221 22345799999999943210
Q ss_pred -----------------------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHH
Q 027476 125 -----------------------------------------------------AENLPEDLALIVTSCWKEDPNERPNFS 151 (223)
Q Consensus 125 -----------------------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~ 151 (223)
......++.+++.+||+.+|.+||++.
T Consensus 207 vl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 286 (303)
T d1vjya_ 207 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286 (303)
T ss_dssp HHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred HHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHH
Confidence 001123588999999999999999999
Q ss_pred HHHHHHHHHhhcC
Q 027476 152 QIIQMLLHYISTN 164 (223)
Q Consensus 152 ~~~~~L~~~~~~~ 164 (223)
++++.|+++....
T Consensus 287 ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 287 RIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhc
Confidence 9999999887654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-34 Score=236.18 Aligned_cols=144 Identities=26% Similarity=0.308 Sum_probs=129.4
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +..++||||+.||+|.+++.+.+. +++..++.++.||+.||.|||++||+||||||+|
T Consensus 94 il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~N 171 (350)
T d1rdqe_ 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHH
Confidence 4788999999999999976 568899999999999999987655 9999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
||++.++ .+||+|||+++..... .....||+.|+|||++....++...|+|+++..++++-.+++|.
T Consensus 172 ILl~~~g-~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf 238 (350)
T d1rdqe_ 172 LLIDQQG-YIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238 (350)
T ss_dssp EEECTTS-CEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccCCCC-CEEeeeceeeeecccc--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCC
Confidence 9999888 8999999999865432 24567999999999999999999999999999988887777774
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-34 Score=230.71 Aligned_cols=160 Identities=29% Similarity=0.552 Sum_probs=135.5
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMR--------PRCLDIHVAIGFALDIARAMECLHSHGII 71 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~--------~~~l~~~~~~~i~~qi~~~l~~lH~~~iv 71 (223)
++++++||||++++++|.+ +..++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+++|+
T Consensus 76 il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~iv 155 (308)
T d1p4oa_ 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155 (308)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 4788999999999999964 67899999999999999986422 13479999999999999999999999999
Q ss_pred cCCCCCCCEEEeCCCCceEEccCcccccccccc---ccccCCCccccccCCCCC--------------------------
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLTE---MMTAETGTYRWMAPENMR-------------------------- 122 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-------------------------- 122 (223)
||||||+|||++.++ .+||+|||+++...... ......||+.|+|||.+.
T Consensus 156 HrDlk~~NiLld~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~ 234 (308)
T d1p4oa_ 156 HRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234 (308)
T ss_dssp CSCCSGGGEEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCC
T ss_pred eceEcCCceeecCCc-eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCC
Confidence 999999999999887 89999999998543322 223346899999999322
Q ss_pred --------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 027476 123 --------------------PSAENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYI 161 (223)
Q Consensus 123 --------------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~ 161 (223)
+.+..++..+.+++.+||+.+|.+||++++++++|++.+
T Consensus 235 p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 235 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 335677889999999999999999999999999987764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-34 Score=229.80 Aligned_cols=163 Identities=26% Similarity=0.451 Sum_probs=131.8
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||+++++++.+ +.+++||||+. +++.+++.......+++..++.++.|++.||+|||++||+||||||+|
T Consensus 54 il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeN 132 (298)
T d1gz8a_ 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132 (298)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHhCCCCcEEEeccccccccceeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchh
Confidence 4789999999999999976 57899999995 555566655455569999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccc-ccccccCCCccccccCCCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESL-TEMMTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
|+++.++ .+||+|||+++.... ........||+.|+|||.+...
T Consensus 133 Il~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~ 211 (298)
T d1gz8a_ 133 LLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211 (298)
T ss_dssp EEECTTS-CEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eeecccC-cceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH
Confidence 9999887 899999999985433 2333455799999999943211
Q ss_pred ----------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcC
Q 027476 125 ----------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTN 164 (223)
Q Consensus 125 ----------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~ 164 (223)
...++.++.+|+.+||+.+|.+|||++|++++ .++...
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H--~ff~~~ 289 (298)
T d1gz8a_ 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDV 289 (298)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGTTC
T ss_pred HHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC--HhhccC
Confidence 01345678889999999999999999999886 555544
Q ss_pred CCC
Q 027476 165 SAP 167 (223)
Q Consensus 165 ~~~ 167 (223)
..|
T Consensus 290 ~~p 292 (298)
T d1gz8a_ 290 TKP 292 (298)
T ss_dssp CCC
T ss_pred CCC
Confidence 333
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-34 Score=230.41 Aligned_cols=144 Identities=27% Similarity=0.352 Sum_probs=128.1
Q ss_pred CCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 3 SRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 3 ~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
+.++||||+++++++.+ +..|+||||++||+|.+++..... +++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 58 ~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL 135 (320)
T d1xjda_ 58 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 135 (320)
T ss_dssp HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred HhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCccccee
Confidence 35899999999999976 578999999999999999987655 999999999999999999999999999999999999
Q ss_pred EeCCCCceEEccCccccccccc-cccccCCCccccccCCCCCCCCCCChHHHHHHHHHhcccCCCCCCC
Q 027476 82 LTADHKTVKLADFGLAREESLT-EMMTAETGTYRWMAPENMRPSAENLPEDLALIVTSCWKEDPNERPN 149 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~l~~~~l~~~p~~Rp~ 149 (223)
++.++ .+||+|||+++..... .......||+.|+|||++....++...|+|+++..++++-.++.|.
T Consensus 136 ~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF 203 (320)
T d1xjda_ 136 LDKDG-HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 203 (320)
T ss_dssp ECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ecCCC-ceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCC
Confidence 99887 8999999999854432 3334568999999999999999999999999999988887777774
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-33 Score=225.44 Aligned_cols=129 Identities=29% Similarity=0.427 Sum_probs=105.4
Q ss_pred CCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 4 RVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 4 ~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
.++||||++++++|.. ...+++|||+.++++..... .....+++..++.++.|++.||+|||++||+||||||
T Consensus 66 ~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp 144 (305)
T d1blxa_ 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 144 (305)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred hcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCc
Confidence 4589999999999842 35789999998776654443 3445699999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCCCCCChHHHHH
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPSAENLPEDLAL 134 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~l~~ 134 (223)
+|||++.++ .+||+|||+++............||+.|+|||++....++...|+|+
T Consensus 145 ~NILi~~~~-~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwS 200 (305)
T d1blxa_ 145 QNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWS 200 (305)
T ss_dssp GGEEECTTC-CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHH
T ss_pred cEEEEcCCC-CeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhc
Confidence 999999887 89999999998766666667788999999999766554444444443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-32 Score=225.46 Aligned_cols=156 Identities=22% Similarity=0.291 Sum_probs=125.6
Q ss_pred CCCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 027476 1 MMSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLL-NMRPRCLDIHVAIGFALDIARAMECLHSHGIIH 72 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~-~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 72 (223)
+|++++||||++++++|.. ..+++||||+.++.+..+.. ......+++..++.++.||+.||+|||++||+|
T Consensus 66 il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiH 145 (350)
T d1q5ka_ 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 145 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 3678999999999998832 13689999997654443332 123445999999999999999999999999999
Q ss_pred CCCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCC-C---------------------------
Q 027476 73 RDLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRP-S--------------------------- 124 (223)
Q Consensus 73 ~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~--------------------------- 124 (223)
|||||+|||++.++..+||+|||+++............||+.|+|||.+.. .
T Consensus 146 rDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 999999999998766899999999987665555566789999999994321 0
Q ss_pred ----------------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....+.++.+|+.+||+.||.+|||+.|++++
T Consensus 226 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12345677888999999999999999999876
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=2.3e-32 Score=217.52 Aligned_cols=153 Identities=28% Similarity=0.396 Sum_probs=123.0
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||++++++|.+ +..++++||+.++.+..+.... +.+++..++.++.||+.||+|||+.||+||||||+|
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~N 130 (286)
T d1ob3a_ 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQN 130 (286)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCce
Confidence 5789999999999999975 6789999999777666665544 349999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccccc-cccCCCccccccCCCCCCC----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLTEM-MTAETGTYRWMAPENMRPS---------------------------------- 124 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~---------------------------------- 124 (223)
|+++.++ .+|++|||.+........ .....+++.|+|||.+...
T Consensus 131 Ill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~ 209 (286)
T d1ob3a_ 131 LLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209 (286)
T ss_dssp EEECTTS-CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eeEcCCC-CEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH
Confidence 9999888 899999999976443222 2344689999999944211
Q ss_pred ----------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 027476 125 ----------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQM 156 (223)
Q Consensus 125 ----------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~ 156 (223)
....+.++.+++.+||+.||.+|||++|++++
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12345677889999999999999999999765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=1e-32 Score=223.65 Aligned_cols=115 Identities=22% Similarity=0.386 Sum_probs=99.4
Q ss_pred CCCC-CCCCccceEEEeec---CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 027476 2 MSRV-RHRNLVKFIGACKE---PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKP 77 (223)
Q Consensus 2 l~~l-~Hpniv~l~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 77 (223)
|+++ +||||++++++|.. ...++||||+.+++|.++. +.+++..+..++.||+.||+|||++||+||||||
T Consensus 83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp 157 (328)
T d3bqca1 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKP 157 (328)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccc
Confidence 5567 49999999999863 4689999999999997754 2399999999999999999999999999999999
Q ss_pred CCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCC
Q 027476 78 ENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121 (223)
Q Consensus 78 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 121 (223)
+|||++.++..+||+|||+++............+|+.|+|||.+
T Consensus 158 ~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~ 201 (328)
T d3bqca1 158 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201 (328)
T ss_dssp GGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHH
T ss_pred cceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccc
Confidence 99999977657999999999876655555667899999999943
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.5e-32 Score=220.79 Aligned_cols=152 Identities=29% Similarity=0.421 Sum_probs=124.2
Q ss_pred CCCCCCCCCccceEEEeecC-----ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 027476 1 MMSRVRHRNLVKFIGACKEP-----VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDL 75 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 75 (223)
+|++++||||+++++++... ..+++++|+.||+|.+++... .+++..++.++.|++.||+|||++||+||||
T Consensus 59 il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDI 135 (345)
T d1pmea_ 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDL 135 (345)
T ss_dssp HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 46789999999999998542 245566677799999999763 3999999999999999999999999999999
Q ss_pred CCCCEEEeCCCCceEEccCcccccccccc----ccccCCCccccccCCCCCCC---------------------------
Q 027476 76 KPENLILTADHKTVKLADFGLAREESLTE----MMTAETGTYRWMAPENMRPS--------------------------- 124 (223)
Q Consensus 76 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~--------------------------- 124 (223)
||+|||++.++ .+||+|||+++...... .....+||+.|+|||.+...
T Consensus 136 Kp~NILl~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~ 214 (345)
T d1pmea_ 136 KPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214 (345)
T ss_dssp CGGGEEECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcceEEECCCC-CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence 99999999887 89999999997543322 23445799999999965311
Q ss_pred -------------------------------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 027476 125 -------------------------------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQ 155 (223)
Q Consensus 125 -------------------------------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~ 155 (223)
..+.+.++.+|+.+||+.||.+||+++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 215 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1133456778999999999999999999987
Q ss_pred H
Q 027476 156 M 156 (223)
Q Consensus 156 ~ 156 (223)
+
T Consensus 295 h 295 (345)
T d1pmea_ 295 H 295 (345)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=3.3e-31 Score=212.10 Aligned_cols=164 Identities=23% Similarity=0.357 Sum_probs=127.4
Q ss_pred CCCCCCCCccceEEEe-ec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRHRNLVKFIGAC-KE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~-~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+++++|+|++..++.+ .+ +..++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus 56 ~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~N 133 (299)
T d1ckia_ 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 133 (299)
T ss_dssp HHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred HHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhh
Confidence 5678777766655544 44 5688999999 677777665433 449999999999999999999999999999999999
Q ss_pred EEEeCC--CCceEEccCcccccccccc--------ccccCCCccccccCCCCCCC-------------------------
Q 027476 80 LILTAD--HKTVKLADFGLAREESLTE--------MMTAETGTYRWMAPENMRPS------------------------- 124 (223)
Q Consensus 80 ill~~~--~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~------------------------- 124 (223)
|+++.. +..+||+|||+|+...... ......||+.|+|||.+...
T Consensus 134 Il~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~ 213 (299)
T d1ckia_ 134 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 213 (299)
T ss_dssp EEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcc
Confidence 998642 2369999999998543221 22345799999999954311
Q ss_pred ---------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCC
Q 027476 125 ---------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAP 167 (223)
Q Consensus 125 ---------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~ 167 (223)
..+++.++.+++..||+.+|.+||+++++.+.|++.+......
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 214 QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp CCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred cccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 2356778889999999999999999999999998887654433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=218.75 Aligned_cols=153 Identities=25% Similarity=0.375 Sum_probs=127.1
Q ss_pred CCCCCCCCCccceEEEeecC-------ceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 1 MMSRVRHRNLVKFIGACKEP-------VMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~~-------~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
+|++++|||||+++++|... .+++||||+ +.+|..++... .+++..++.++.||+.||+|||++||+||
T Consensus 70 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHr 145 (346)
T d1cm8a_ 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHR 145 (346)
T ss_dssp HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCccc
Confidence 36789999999999999542 479999999 78888877652 39999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-C---------------------------
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS-A--------------------------- 125 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~--------------------------- 125 (223)
||||+|||++.++ .+|++|||+++..... .+...||+.|+|||++... .
T Consensus 146 DiKp~NIL~~~~~-~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 146 DLKPGNLAVNEDC-ELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp CCCGGGEEECTTC-CEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCcchhhccccc-ccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 9999999999888 8999999999865432 3456899999999954311 1
Q ss_pred ------------------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 027476 126 ------------------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQML 157 (223)
Q Consensus 126 ------------------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L 157 (223)
...+.++.+|+.+||+.+|.+|||+++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H- 301 (346)
T d1cm8a_ 223 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH- 301 (346)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS-
T ss_pred ChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC-
Confidence 2345667778899999999999999999886
Q ss_pred HHHhh
Q 027476 158 LHYIS 162 (223)
Q Consensus 158 ~~~~~ 162 (223)
.++.
T Consensus 302 -p~f~ 305 (346)
T d1cm8a_ 302 -PYFE 305 (346)
T ss_dssp -GGGT
T ss_pred -hhhC
Confidence 4444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-31 Score=215.62 Aligned_cols=119 Identities=25% Similarity=0.360 Sum_probs=96.5
Q ss_pred CCCCCCCCCccceEEEeec---------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 027476 1 MMSRVRHRNLVKFIGACKE---------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGII 71 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~---------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iv 71 (223)
+|++++||||+++++++.. +..++||||+.++.+...... ...+++..++.++.|++.||.|||++||+
T Consensus 62 il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~iv 139 (318)
T d3blha1 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKIL 139 (318)
T ss_dssp HHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEE
Confidence 3678999999999998733 357899999977766554433 33499999999999999999999999999
Q ss_pred cCCCCCCCEEEeCCCCceEEccCccccccccc-----cccccCCCccccccCCCCC
Q 027476 72 HRDLKPENLILTADHKTVKLADFGLAREESLT-----EMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 72 H~dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~ 122 (223)
||||||+||+++.++ .+||+|||+++..... ......+||+.|+|||++.
T Consensus 140 HrDlKp~NILl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~ 194 (318)
T d3blha1 140 HRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194 (318)
T ss_dssp CCCCCGGGEEECTTS-CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHT
T ss_pred ecCcCchheeecCCC-cEEeeecceeeecccccccccccccceecCHHHhhHHHHc
Confidence 999999999999888 8999999999754321 1223457999999999654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=2.1e-30 Score=206.93 Aligned_cols=165 Identities=16% Similarity=0.253 Sum_probs=132.5
Q ss_pred CCCCC-CCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVR-HRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~-Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
++.|+ |+||+.+++++.+ ...++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus 54 ~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~N 131 (293)
T d1csna_ 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDN 131 (293)
T ss_dssp HHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred HHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccc
Confidence 34565 5899999999865 5788999999 899999887643 459999999999999999999999999999999999
Q ss_pred EEEeCC----CCceEEccCccccccccc--------cccccCCCccccccCCCCCCC-----------------------
Q 027476 80 LILTAD----HKTVKLADFGLAREESLT--------EMMTAETGTYRWMAPENMRPS----------------------- 124 (223)
Q Consensus 80 ill~~~----~~~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~----------------------- 124 (223)
|+++.+ ...+||+|||+++..... .......||+.|+|||.+...
T Consensus 132 ili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~ 211 (293)
T d1csna_ 132 FLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 211 (293)
T ss_dssp EEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCC
Confidence 999742 237999999999854321 122345799999999955422
Q ss_pred -----------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhcCCCCC
Q 027476 125 -----------------------------AENLPEDLALIVTSCWKEDPNERPNFSQIIQMLLHYISTNSAPE 168 (223)
Q Consensus 125 -----------------------------~~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~~~~~~~~~~~ 168 (223)
..+++.++.+++..|+..+|.+||+++.+.+.|++++.......
T Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~ 284 (293)
T d1csna_ 212 PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284 (293)
T ss_dssp TTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred cCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCC
Confidence 13466778888999999999999999999999988877655443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-30 Score=207.03 Aligned_cols=118 Identities=25% Similarity=0.449 Sum_probs=100.3
Q ss_pred CCCCCCCCCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 1 MMSRVRHRNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
+|++++||||++++++|.+ ...++|+|++.+++|..++...+ .+++..++.++.|++.||+|||++||+||||||+|
T Consensus 54 il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~N 131 (292)
T d1unla_ 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN 131 (292)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHhcCcCCEEeeccccccccceeEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcc
Confidence 4688999999999999976 56889999999999988876544 48999999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCcccccccccc-ccccCCCccccccCCCC
Q 027476 80 LILTADHKTVKLADFGLAREESLTE-MMTAETGTYRWMAPENM 121 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~ 121 (223)
|+++.++ .+||+|||.++...... ......+++.|+|||.+
T Consensus 132 Ili~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~ 173 (292)
T d1unla_ 132 LLINRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173 (292)
T ss_dssp EEECTTC-CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHH
T ss_pred cccccCC-ceeeeecchhhcccCCCccceeeccccchhhhhHh
Confidence 9999877 89999999998654433 22344577888999844
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-31 Score=216.93 Aligned_cols=116 Identities=33% Similarity=0.472 Sum_probs=87.8
Q ss_pred CCCCCCCCCccceEEEeec-------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 027476 1 MMSRVRHRNLVKFIGACKE-------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHR 73 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~-------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~ 73 (223)
+|++++||||++++++|.. ..+|+||||+.++.+ +.+. ..+++..++.++.||+.||.|||++||+||
T Consensus 69 il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHr 143 (355)
T d2b1pa1 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHR 143 (355)
T ss_dssp HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccc
Confidence 3678899999999999842 468999999966544 4442 238999999999999999999999999999
Q ss_pred CCCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCC
Q 027476 74 DLKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMR 122 (223)
Q Consensus 74 dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 122 (223)
||||+||+++.++ .+|++|||+++............+|+.|+|||++.
T Consensus 144 DlKP~Nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~ 191 (355)
T d2b1pa1 144 DLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191 (355)
T ss_dssp CCCGGGEEECTTC-CEEECCCCC---------------CCTTCCHHHHT
T ss_pred cCCcccccccccc-ceeeechhhhhccccccccccccccccccChhhhc
Confidence 9999999999888 79999999998766666556678999999999654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.9e-31 Score=214.01 Aligned_cols=155 Identities=26% Similarity=0.335 Sum_probs=123.4
Q ss_pred CCCCCCCCCccceEEEeec------CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 027476 1 MMSRVRHRNLVKFIGACKE------PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRD 74 (223)
Q Consensus 1 il~~l~Hpniv~l~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~d 74 (223)
+|++++||||+++++++.. ...+++++|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+|||
T Consensus 70 il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrD 146 (348)
T d2gfsa1 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRD 146 (348)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccc
Confidence 4678999999999999842 345677888889999999854 2499999999999999999999999999999
Q ss_pred CCCCCEEEeCCCCceEEccCccccccccccccccCCCccccccCCCCCCC-C----------------------------
Q 027476 75 LKPENLILTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPENMRPS-A---------------------------- 125 (223)
Q Consensus 75 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~---------------------------- 125 (223)
|||+||+++.++ .+|++|||++..... ......|++.|+|||.+... .
T Consensus 147 iKp~NILi~~~~-~~kl~dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 147 LKPSNLAVNEDC-ELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp CCGGGEEECTTC-CEEECCC----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCccccccccc-cccccccchhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 999999999888 899999999975433 23456789999999943311 0
Q ss_pred -----------------------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 027476 126 -----------------------------------------------ENLPEDLALIVTSCWKEDPNERPNFSQIIQMLL 158 (223)
Q Consensus 126 -----------------------------------------------~~~~~~l~~l~~~~l~~~p~~Rp~~~~~~~~L~ 158 (223)
.+.+.++.+|+.+||+.||.+|||++|++++
T Consensus 224 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H-- 301 (348)
T d2gfsa1 224 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH-- 301 (348)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--
T ss_pred HHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC--
Confidence 1345667788999999999999999999876
Q ss_pred HHhhc
Q 027476 159 HYIST 163 (223)
Q Consensus 159 ~~~~~ 163 (223)
.++..
T Consensus 302 p~f~~ 306 (348)
T d2gfsa1 302 AYFAQ 306 (348)
T ss_dssp GGGTT
T ss_pred HhhCC
Confidence 55544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.9e-31 Score=211.32 Aligned_cols=152 Identities=28% Similarity=0.392 Sum_probs=127.6
Q ss_pred CCCCCC-CCccceEEEeec-CceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 027476 2 MSRVRH-RNLVKFIGACKE-PVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPEN 79 (223)
Q Consensus 2 l~~l~H-pniv~l~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 79 (223)
|++++| |||+++++++++ ..+++||||+.||+|.+++..... +++..++.++.||+.||+|+|++||+||||||+|
T Consensus 82 l~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~N 159 (322)
T d1vzoa_ 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN 159 (322)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccc
Confidence 567766 899999999975 578999999999999999987665 8899999999999999999999999999999999
Q ss_pred EEEeCCCCceEEccCccccccccc--cccccCCCccccccCCCCC-----------------------------------
Q 027476 80 LILTADHKTVKLADFGLAREESLT--EMMTAETGTYRWMAPENMR----------------------------------- 122 (223)
Q Consensus 80 ill~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~----------------------------------- 122 (223)
|+++.++ .+||+|||+++..... .......|++.|++||.+.
T Consensus 160 ill~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 160 ILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp EEECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred eeecCCC-CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999887 8999999999864332 2234457999999999543
Q ss_pred ---------------CCCCCChHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 027476 123 ---------------PSAENLPEDLALIVTSCWKEDPNERPN-----FSQIIQM 156 (223)
Q Consensus 123 ---------------~~~~~~~~~l~~l~~~~l~~~p~~Rp~-----~~~~~~~ 156 (223)
+.+..++.++.+++.+||+.+|.+||+ ++|++++
T Consensus 239 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 239 NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 123457778888999999999999995 6777654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.91 E-value=9.8e-25 Score=178.32 Aligned_cols=115 Identities=21% Similarity=0.325 Sum_probs=88.9
Q ss_pred CCCCCccceEEEeec---CceEEEEEcCCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCC
Q 027476 5 VRHRNLVKFIGACKE---PVMVIVTELLLGG-TLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHS-HGIIHRDLKPEN 79 (223)
Q Consensus 5 l~Hpniv~l~~~~~~---~~~~lv~e~~~~~-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~N 79 (223)
+.|+||+++++++.. ...+++++++..+ .............+++..+..++.|++.||+|||+ .||+||||||+|
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence 358999999998853 3455666665444 44444444455669999999999999999999998 899999999999
Q ss_pred EEEeCCCC-----ceEEccCccccccccccccccCCCccccccCCCC
Q 027476 80 LILTADHK-----TVKLADFGLAREESLTEMMTAETGTYRWMAPENM 121 (223)
Q Consensus 80 ill~~~~~-----~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 121 (223)
||++.++. .+|++|||.+..... .....+||+.|+|||++
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~ 201 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVL 201 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHH
T ss_pred eeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhc
Confidence 99986542 499999999875443 23456899999999943
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.71 E-value=3.2e-18 Score=127.33 Aligned_cols=85 Identities=16% Similarity=0.216 Sum_probs=69.1
Q ss_pred CCCCCCCCccceEEEeecCceEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 027476 2 MSRVRHRNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPRCLDIHVAIGFALDIARAMECLHSHGIIHRDLKPENLI 81 (223)
Q Consensus 2 l~~l~Hpniv~l~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 81 (223)
|.++.|.+++..+++.. .+++|||+.+..+.+ ++...+..++.|++.+|.|||++||+||||||+||+
T Consensus 68 l~~l~~~~v~~~~~~~~---~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NIL 135 (191)
T d1zara2 68 LQKLQGLAVPKVYAWEG---NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVL 135 (191)
T ss_dssp HHHTTTSSSCCEEEEET---TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred HHHccCCCcceEEEecC---CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhhee
Confidence 34678889888876542 379999998765533 445556789999999999999999999999999999
Q ss_pred EeCCCCceEEccCcccccc
Q 027476 82 LTADHKTVKLADFGLAREE 100 (223)
Q Consensus 82 l~~~~~~~kl~Dfg~a~~~ 100 (223)
++.+ .++|+|||.|...
T Consensus 136 v~~~--~~~liDFG~a~~~ 152 (191)
T d1zara2 136 VSEE--GIWIIDFPQSVEV 152 (191)
T ss_dssp EETT--EEEECCCTTCEET
T ss_pred eeCC--CEEEEECCCcccC
Confidence 9954 5899999998654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.74 E-value=3.5e-05 Score=58.03 Aligned_cols=29 Identities=21% Similarity=0.368 Sum_probs=24.4
Q ss_pred cccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 70 IIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 70 ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 185 l~HgD~~~~Nil~~~~~-~~~lIDwe~a~~ 213 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGK-VSGFIDLGRSGR 213 (263)
T ss_dssp EECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred EEEeeccCcceeecCCc-eEEEeechhccc
Confidence 78999999999998654 567999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.97 E-value=0.00056 Score=50.79 Aligned_cols=29 Identities=17% Similarity=0.205 Sum_probs=24.6
Q ss_pred cccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 70 IIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 70 ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~~-~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGR-FSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCCc-eEEEEEchhccc
Confidence 79999999999998654 578999997753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.36 E-value=0.0023 Score=50.92 Aligned_cols=29 Identities=24% Similarity=0.316 Sum_probs=24.9
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.++|||+.+.|||++.+ .++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~--~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH--ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS--CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC--ceEEechhhccc
Confidence 58999999999999865 489999988753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.70 E-value=0.0016 Score=50.00 Aligned_cols=31 Identities=35% Similarity=0.535 Sum_probs=26.6
Q ss_pred CCcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 68 HGIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 68 ~~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
.|++|+|+.+.||+++.+. ..-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred cccccCCcchhhhhccccc-ceeEeccccccc
Confidence 3799999999999999765 668999998863
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.86 E-value=0.072 Score=40.68 Aligned_cols=28 Identities=25% Similarity=0.309 Sum_probs=23.3
Q ss_pred CcccCCCCCCCEEEeCCCCceEEccCccccc
Q 027476 69 GIIHRDLKPENLILTADHKTVKLADFGLARE 99 (223)
Q Consensus 69 ~ivH~dlkp~Nill~~~~~~~kl~Dfg~a~~ 99 (223)
+++|+|+.+.||+++ ++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~-~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWR-DG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEES-SS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEe-CC--ceEEechhccc
Confidence 689999999999997 33 45899998863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=87.77 E-value=0.15 Score=39.32 Aligned_cols=33 Identities=15% Similarity=0.175 Sum_probs=28.4
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 124 SAENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 124 ~~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
.+..++.++.+++..||+.+|.+|+ ++++++++
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 3567889999999999999999994 88888764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.67 E-value=0.034 Score=42.57 Aligned_cols=31 Identities=16% Similarity=0.267 Sum_probs=26.9
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 027476 125 AENLPEDLALIVTSCWKEDPNERPNFS-QIIQ 155 (223)
Q Consensus 125 ~~~~~~~l~~l~~~~l~~~p~~Rp~~~-~~~~ 155 (223)
+..++.++.+|+.+||+.+|.+||++. ++++
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 456789999999999999999999985 6754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=86.57 E-value=0.2 Score=37.98 Aligned_cols=33 Identities=12% Similarity=0.112 Sum_probs=28.5
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 027476 124 SAENLPEDLALIVTSCWKEDPNERP-----NFSQIIQM 156 (223)
Q Consensus 124 ~~~~~~~~l~~l~~~~l~~~p~~Rp-----~~~~~~~~ 156 (223)
.+..++.++.+++.+||+.+|.+|+ ++++++++
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 3456889999999999999999996 88888765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=81.00 E-value=0.29 Score=38.18 Aligned_cols=30 Identities=30% Similarity=0.459 Sum_probs=22.5
Q ss_pred cccCCCCCCCEEEeC---------------------------CCCceEEccCccccc
Q 027476 70 IIHRDLKPENLILTA---------------------------DHKTVKLADFGLARE 99 (223)
Q Consensus 70 ivH~dlkp~Nill~~---------------------------~~~~~kl~Dfg~a~~ 99 (223)
+.|+|+.+.||++.. +++.++++||..|..
T Consensus 220 ~CHnDL~~~NiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~lID~EYa~~ 276 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 276 (395)
T ss_dssp EECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEecCCCcccEeeccccccccccccccccccccccccccccCCCCcEEEEeecccCC
Confidence 579999999999853 123688999987753
|